false2021FY000031206900003120692021-01-012021-12-310000312069dei:BusinessContactMember2021-01-012021-12-310000312069bcs:AmericanDepositorySharesMember2021-01-012021-12-310000312069bcs:A4338FixedToFloatingRateSeniorNotesMember2021-01-012021-12-310000312069bcs:FloatingRateSeniorNotesDue2024Member2021-01-012021-12-310000312069bcs:A4972FixedToFloatingRateSeniorNotesDue2029Member2021-01-012021-12-310000312069bcs:A4610FixedToFloatingRateSeniorNotesDue2023Member2021-01-012021-12-310000312069bcs:SubordinatedFloatingRateNotesDue2023BCS23CMember2021-01-012021-12-310000312069bcs:FourPointThreeSevenFivePercentSubordinatedNotesMember2021-01-012021-12-310000312069bcs:A365FixedRateSeniorNotesDue2025Member2021-01-012021-12-310000312069bcs:A525FixedRateSeniorNotesDue2045Member2021-01-012021-12-310000312069bcs:A4375FixedRateSeniorNotesDue2026Member2021-01-012021-12-310000312069bcs:FivePointTwoZeroPercentSubordinatedNotesMember2021-01-012021-12-310000312069bcs:SubordinatedFloatingRateNotesDue2023Member2021-01-012021-12-310000312069bcs:A3684FixedRateSeniorNotesDue2023Member2021-01-012021-12-310000312069bcs:A4337FixedRateSeniorNotesDue2028Member2021-01-012021-12-310000312069bcs:A4950FixedRateSeniorNotesDue2047Member2021-01-012021-12-310000312069bcs:FourPointThreeEightSixPercentSubordinatedNotesMember2021-01-012021-12-310000312069bcs:A3250FixedRateSeniorNotesDue2033Member2021-01-012021-12-310000312069bcs:A3932FixedToFloatingRateSeniorNotesDue2025Member2021-01-012021-12-310000312069bcs:A5088CallableTierTwoNotesMember2021-01-012021-12-310000312069bcs:A2852FixedToFloatingRateSeniorNotesDue2026Member2021-01-012021-12-310000312069bcs:A2645FixedRateResettingSeniorCallableNotesDue2031Member2021-01-012021-12-310000312069bcs:A3564ResettingSubordinatedCallableNotesMember2021-01-012021-12-310000312069bcs:A1007FixedRateResettingSeniorCallableNotesDue2024Member2021-01-012021-12-310000312069bcs:A2667FixedRateResettingSeniorCallableNotesDue2032Member2021-01-012021-12-310000312069bcs:A3811FixedRateResettingSubordinatedCallableNotesUSD1000mMember2021-01-012021-12-310000312069bcs:A2279FixedRateResettingSeniorCallableNotesDue2027Member2021-01-012021-12-310000312069bcs:A2894FixedRateResettingSeniorCallableNotesDue2032Member2021-01-012021-12-310000312069bcs:A3330FixedRateResettingSeniorCallableNotesDue2042Member2021-01-012021-12-3100003120692021-12-31xbrli:shares0000312069ifrs-full:CreditRiskMemberbcs:CashAndBankBalancesAtCentralBanksMember2021-12-31iso4217:GBP0000312069ifrs-full:TradeReceivablesMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:MortgagesMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CreditRiskMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:TradedLoansMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:ReverseRepurchaseAgreementsMemberbcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMemberbcs:OtherFinancialAssetsMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberbcs:OnBalanceSheetAssetsMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CreditRiskMemberifrs-full:OtherAssetsMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CreditRiskMemberifrs-full:ItemsOfContingentLiabilitiesMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CreditRiskMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CreditRiskMemberifrs-full:LoansToGovernmentMember2021-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CreditRiskMemberifrs-full:LoansToGovernmentMember2020-12-310000312069ifrs-full:CreditRiskMemberbcs:CashAndBankBalancesAtCentralBanksMember2020-12-310000312069ifrs-full:TradeReceivablesMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:MortgagesMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CreditRiskMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:TradedLoansMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:ReverseRepurchaseAgreementsMemberbcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMemberbcs:OtherFinancialAssetsMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:CreditRiskMemberifrs-full:OtherAssetsMember2020-12-310000312069bcs:OnBalanceSheetAssetsMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CreditRiskMemberifrs-full:ItemsOfContingentLiabilitiesMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CreditRiskMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069bcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-31xbrli:pure0000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsSubjectToImpairmentMember2021-01-012021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GovernmentMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:BarclaysGroupWholesaleMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:OtherAssetsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:OtherAssetsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupRetailMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:UnallocatedAmountsMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:AccumulatedImpairmentMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069bcs:LoansAndAdvancesAtAmortisedCostIncludingOffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:UnallocatedAmountsMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupRetailMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:BarclaysGroupWholesaleMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:BarclaysGroupWholesaleMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsSubjectToImpairmentMember2020-01-012020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-3100003120692020-12-3100003120692020-01-012020-12-310000312069bcs:BarclaysGroupWholesaleMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:OtherAssetsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:OtherAssetsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CurrentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:NotLaterThanOneMonthMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:GreaterThanOneMonthPastDueMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMember2021-01-012021-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageTwoToStageOneMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:TransfersToStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageThreeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:DebtSecuritiesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:BarclaysAssetFinanceMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:MortgagesMember2021-01-012021-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMember2021-01-012021-12-310000312069ifrs-full:LoansAndReceivablesCategoryMember2021-01-012021-12-310000312069ifrs-full:FinancialGuaranteeContractsMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:MortgagesMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:MortgagesMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMember2020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMember2021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageTwoToStageOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageThreeMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2019-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2019-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMember2019-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMember2020-01-012020-12-310000312069bcs:TransfersFromStageOneToStageTwoMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageTwoToStageOneMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageTwoToStageOneMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageTwoToStageOneMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:TransfersToStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageThreeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:TransfersFromStageThreeMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BarclaysPartnerFinanceMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-01-012020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2019-01-012019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:OtherFinancialAssetsSubjectToImpairmentMember2019-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:OtherAssetsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:OtherAssetsMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:MortgagesMember2020-01-012020-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMember2020-01-012020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMember2020-01-012020-12-310000312069ifrs-full:FinancialGuaranteeContractsMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:MortgagesMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMember2019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:AccumulatedImpairmentMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMemberifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMember2020-01-012020-12-310000312069ifrs-full:MortgagesMember2021-12-310000312069ifrs-full:MortgagesMember2020-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:CorporateLoansMember2021-12-310000312069ifrs-full:CorporateLoansMember2020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069ifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberifrs-full:MortgagesMember2021-12-310000312069ifrs-full:MortgagesMemberbcs:OtherAdjustmentsMember2021-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:OtherAdjustmentsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:CorporateLoansMemberbcs:EconomicUncertaintyAdjustmentsMember2021-12-310000312069ifrs-full:CorporateLoansMemberbcs:OtherAdjustmentsMember2021-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:OtherAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberifrs-full:MortgagesMember2020-12-310000312069ifrs-full:MortgagesMemberbcs:OtherAdjustmentsMember2020-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:OtherAdjustmentsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:CorporateLoansMemberbcs:EconomicUncertaintyAdjustmentsMember2020-12-310000312069ifrs-full:CorporateLoansMemberbcs:OtherAdjustmentsMember2020-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069bcs:OtherAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069ifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069ifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069ifrs-full:ExpectedCreditLossesIndividuallyAssessedMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069ifrs-full:ExpectedCreditLossesIndividuallyAssessedMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberbcs:ExpectedCreditLossesFromNonModelledExposuresMember2021-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberbcs:ExpectedCreditLossesFromNonModelledExposuresMember2020-12-310000312069bcs:OtherAdjustmentsMemberifrs-full:LoansToGovernmentMember2021-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberifrs-full:LoansToGovernmentMember2021-12-310000312069bcs:OtherAdjustmentsMemberifrs-full:LoansToGovernmentMember2020-12-310000312069bcs:EconomicUncertaintyAdjustmentsMemberifrs-full:LoansToGovernmentMember2020-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMember2021-01-012021-12-31bcs:method0000312069bcs:Covid19RelatedUncertaintyAdjustmentsMember2021-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMember2020-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMemberifrs-full:MajorCustomersMember2021-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMemberifrs-full:MajorCustomersMember2020-12-310000312069bcs:ModelUncertaintyRiskMemberbcs:Covid19RelatedUncertaintyAdjustmentsMember2021-12-310000312069bcs:ModelUncertaintyRiskMemberbcs:Covid19RelatedUncertaintyAdjustmentsMember2020-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMemberifrs-full:MajorCustomersMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMemberifrs-full:MajorCustomersMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:GuaranteesMember2021-01-012021-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMembercountry:USbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:Covid19RelatedUncertaintyAdjustmentsMembercountry:USbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:CorporateLoansMemberbcs:Covid19RelatedUncertaintyAdjustmentsMember2021-12-310000312069ifrs-full:CorporateLoansMemberbcs:Covid19RelatedUncertaintyAdjustmentsMember2020-12-310000312069country:GBbcs:Covid19RelatedUncertaintyAdjustmentsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069country:GBbcs:Covid19RelatedUncertaintyAdjustmentsMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:ModelUncertaintyRiskMemberbcs:Covid19RelatedUncertaintyAdjustmentsMember2021-01-012021-12-310000312069ifrs-full:CreditRiskMember2021-01-012021-12-31bcs:economic_scenario0000312069bcs:DownsideScenarioMemberifrs-full:CreditRiskMember2021-01-012021-12-310000312069bcs:UpsideScenarioMemberifrs-full:CreditRiskMember2021-01-012021-12-31bcs:economicVariable0000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMember2021-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:US2021-01-012021-12-310000312069bcs:LaterThanSixMonthsAndNotLaterThanNineMonthsMembercountry:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMember2021-12-310000312069bcs:LaterThanSixMonthsAndNotLaterThanNineMonthsMemberbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2021-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMemberbcs:BaselineMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BaselineMemberbcs:BankRateMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMemberbcs:BankRateMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMemberbcs:BankRateMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069ifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:US2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:US2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:US2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069ifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2021-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMemberbcs:BaselineMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:BaselineMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BaselineMemberbcs:BankRateMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMemberbcs:BankRateMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMemberbcs:BankRateMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069ifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:US2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:US2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:US2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069ifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069ifrs-full:NotLaterThanOneYearMemberbcs:BaselineMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:BaselineMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BaselineMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BaselineMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:BaselineMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMemberbcs:BankRateMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:US2021-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2021-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMemberbcs:BankRateMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMember2020-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:US2020-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2020-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:BankRateMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:US2021-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2021-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideOneMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:BankRateMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMember2020-12-310000312069bcs:DownsideOneMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:US2020-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2020-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideOneMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:BankRateMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:US2021-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2021-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:UpsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:NotLaterThanOneYearMemberbcs:BankRateMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:US2020-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:US2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:US2020-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:UpsideTwoMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:FederalFundsRateMember2020-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMemberbcs:UpsideOneMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:UpsideOneMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:UpsideOneMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMember2021-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BankRateMemberbcs:UpsideOneMember2021-12-310000312069country:GBbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMember2021-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMemberbcs:UpsideOneMember2021-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMemberbcs:UpsideOneMember2021-12-310000312069country:GBbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMember2021-12-310000312069ifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMember2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:UpsideOneMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:UpsideOneMember2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMember2021-12-310000312069ifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2021-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2021-12-310000312069country:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:FederalFundsRateMember2021-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMemberbcs:UpsideOneMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:UpsideOneMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:UpsideOneMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMember2020-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBifrs-full:NotLaterThanOneYearMemberbcs:BankRateMemberbcs:UpsideOneMember2020-12-310000312069country:GBbcs:BankRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:UpsideOneMember2020-12-310000312069country:GBifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:BankRateMemberbcs:UpsideOneMember2020-12-310000312069country:GBifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:BankRateMemberbcs:UpsideOneMember2020-12-310000312069country:GBbcs:BankRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMember2020-12-310000312069ifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMember2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:UpsideOneMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:UpsideOneMember2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMembercountry:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMember2020-12-310000312069ifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069ifrs-full:NotLaterThanOneYearMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2020-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2020-12-310000312069country:USifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberbcs:UpsideOneMemberbcs:FederalFundsRateMember2020-12-310000312069bcs:UpsideTwoMember2021-12-310000312069bcs:UpsideOneMember2021-12-310000312069bcs:BaselineMember2021-12-310000312069bcs:DownsideOneMember2021-12-310000312069bcs:DownsideTwoMember2021-12-310000312069bcs:UpsideTwoMember2020-12-310000312069bcs:UpsideOneMember2020-12-310000312069bcs:BaselineMember2020-12-310000312069bcs:DownsideOneMember2020-12-310000312069bcs:DownsideTwoMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:UpsideOneMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:BankRateMemberbcs:UpsideOneMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberbcs:SpecificBasesMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideTwoMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:SpecificBasesMember2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:UpsideOneMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:USbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069country:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideTwoMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2021-12-310000312069country:USbcs:UpsideOneMemberbcs:FederalFundsRateMemberbcs:SpecificBasesMember2021-12-310000312069bcs:BaselineMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideOneMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2021-12-310000312069bcs:DownsideTwoMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:UpsideOneMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:BankRateMemberbcs:UpsideOneMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberbcs:SpecificBasesMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:BaselineMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideTwoMembercountry:USbcs:GrossDomesticProductEconomicVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:SpecificBasesMember2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:UpsideOneMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMembercountry:USbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMembercountry:USbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069country:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:BaselineMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideTwoMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2020-12-310000312069country:USbcs:UpsideOneMemberbcs:FederalFundsRateMemberbcs:SpecificBasesMember2020-12-310000312069bcs:BaselineMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideOneMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2020-12-310000312069bcs:DownsideTwoMembercountry:USbcs:FederalFundsRateMemberbcs:SpecificBasesMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:FiveYearAveragesMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMemberbcs:UpsideOneMember2021-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberbcs:FiveYearAveragesMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:FiveYearAveragesMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberbcs:FiveYearAveragesMember2021-12-310000312069country:GBbcs:BankRateMemberbcs:FiveYearAveragesMemberbcs:UpsideOneMember2021-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberbcs:FiveYearAveragesMember2021-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberbcs:FiveYearAveragesMember2021-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberbcs:FiveYearAveragesMember2021-12-310000312069bcs:UpsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:BaselineMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideOneMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:DownsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2021-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:US2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMember2021-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberbcs:FiveYearAveragesMembercountry:US2021-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:US2021-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:US2021-12-310000312069bcs:UpsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:BaselineMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideOneMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:DownsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069bcs:UpsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2021-12-310000312069bcs:BaselineMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideOneMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:DownsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2021-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:FiveYearAveragesMemberbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:FiveYearAveragesMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMemberbcs:UpsideOneMember2020-12-310000312069country:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberbcs:FiveYearAveragesMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:FiveYearAveragesMemberbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:FiveYearAveragesMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMembercountry:GBbcs:BankRateMemberbcs:FiveYearAveragesMember2020-12-310000312069country:GBbcs:BankRateMemberbcs:FiveYearAveragesMemberbcs:UpsideOneMember2020-12-310000312069country:GBbcs:BaselineMemberbcs:BankRateMemberbcs:FiveYearAveragesMember2020-12-310000312069bcs:DownsideOneMembercountry:GBbcs:BankRateMemberbcs:FiveYearAveragesMember2020-12-310000312069country:GBbcs:DownsideTwoMemberbcs:BankRateMemberbcs:FiveYearAveragesMember2020-12-310000312069bcs:UpsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMemberbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:BaselineMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideOneMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:DownsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:GrossDomesticProductEconomicVariableMember2020-12-310000312069bcs:UpsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:US2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMember2020-12-310000312069bcs:UnemploymentEconomicCoreVariableMemberbcs:BaselineMemberbcs:FiveYearAveragesMembercountry:US2020-12-310000312069bcs:DownsideOneMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:US2020-12-310000312069bcs:DownsideTwoMemberbcs:UnemploymentEconomicCoreVariableMemberbcs:FiveYearAveragesMembercountry:US2020-12-310000312069bcs:UpsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMemberbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:BaselineMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideOneMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:DownsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:HousePriceIndexEconomicCoreVariableMember2020-12-310000312069bcs:UpsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:FiveYearAveragesMembercountry:USbcs:UpsideOneMemberbcs:FederalFundsRateMember2020-12-310000312069bcs:BaselineMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideOneMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069bcs:DownsideTwoMemberbcs:FiveYearAveragesMembercountry:USbcs:FederalFundsRateMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMember2021-12-310000312069ifrs-full:GrossCarryingAmountMembercountry:GBbcs:DownsideTwoMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideTwoMembercountry:USifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideTwoMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:ExpectedCreditLossesIndividuallyAssessedMemberifrs-full:AccumulatedImpairmentMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesFromManagementAdjustmentsMember2021-12-310000312069bcs:ECLFromPostModelAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:ECLFromNonModelledAndOtherManagementAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BaselineMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:BaselineMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:BaselineMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMember2021-12-310000312069country:GBbcs:DownsideTwoMemberifrs-full:MortgagesMemberbcs:HousePriceIndexEconomicCoreVariableMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BaselineMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-01-012021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BaselineMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:AccumulatedImpairmentMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:BaselineMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-01-012020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:BaselineMember2021-01-012021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:AccumulatedImpairmentMemberbcs:BaselineMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:CorporateLoansMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:MortgagesMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:CorporateLoansMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CreditRiskMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:UpsideTwoMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberbcs:UpsideOneMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:BaselineMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:DownsideOneMemberifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:DownsideTwoMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:ExpectedCreditLossesIndividuallyAssessedMemberifrs-full:AccumulatedImpairmentMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:ExpectedCreditLossesCollectivelyAssessedMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesFromNonModelledAndOtherManagementAdjustmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMember2020-12-31iso4217:USD0000312069bcs:ECLFromNonModelledAndOtherManagementAdjustmentsMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069ifrs-full:CountryOfDomicileMemberifrs-full:CreditRiskMember2021-12-310000312069srt:AmericasMemberifrs-full:CreditRiskMember2021-12-310000312069srt:EuropeMemberifrs-full:CreditRiskMember2021-12-310000312069srt:AsiaMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:AfricaAndMiddleEastMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CountryOfDomicileMemberifrs-full:CreditRiskMember2020-12-310000312069srt:AmericasMemberifrs-full:CreditRiskMember2020-12-310000312069srt:EuropeMemberifrs-full:CreditRiskMember2020-12-310000312069srt:AsiaMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:AfricaAndMiddleEastMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:BanksMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OtherFinancialInstitutionsMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CreditRiskMemberbcs:ManufacturingMember2021-12-310000312069bcs:ConstructionAndPropertyMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CreditRiskMemberbcs:GovernmentAndCentralBankMember2021-12-310000312069bcs:EnergyAndWaterMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CreditRiskMemberbcs:WholesaleAndRetailDistributionAndLeisureMember2021-12-310000312069bcs:BusinessAndOtherServicesMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:CreditRiskMemberifrs-full:MortgagesMember2021-12-310000312069bcs:CardsUnsecuredLoansAndOtherPersonalLendingMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:OtherFinancialAssetsMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:BanksMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OtherFinancialInstitutionsMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:CreditRiskMemberbcs:ManufacturingMember2020-12-310000312069bcs:ConstructionAndPropertyMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:CreditRiskMemberbcs:GovernmentAndCentralBankMember2020-12-310000312069bcs:EnergyAndWaterMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:CreditRiskMemberbcs:WholesaleAndRetailDistributionAndLeisureMember2020-12-310000312069bcs:BusinessAndOtherServicesMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:CreditRiskMemberifrs-full:MortgagesMember2020-12-310000312069bcs:CardsUnsecuredLoansAndOtherPersonalLendingMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:OtherFinancialAssetsMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069ifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:CorporateLoansMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:CorporateLoansMemberbcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:CorporateLoansMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:DebtSecuritiesMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:DebtSecuritiesMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberbcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberbcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberbcs:ReverseRepurchaseAgreementsMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ReverseRepurchaseAgreementsMemberbcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:ReverseRepurchaseAgreementsMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ReverseRepurchaseAgreementsMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberbcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberbcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:MortgagesMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069ifrs-full:InternalCreditGradesMemberbcs:CreditCardsUnsecuredAndOtherRetailLendingMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:CorporateLoansMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:CorporateLoansMemberbcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:CorporateLoansMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:DebtSecuritiesMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberbcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberbcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:TradedLoansMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberbcs:ReverseRepurchaseAgreementsMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ReverseRepurchaseAgreementsMemberbcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:ReverseRepurchaseAgreementsMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ReverseRepurchaseAgreementsMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointSixtyPercentMemberbcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultPointSixtyToElevenPointThreeFivePercentMemberbcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2020-12-310000312069bcs:OtherFinancialAssetsMemberifrs-full:InternalCreditGradesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:LoansAndReceivablesCategoryMemberifrs-full:LoanCommitmentsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberbcs:HigherRiskBMinusAndBelowMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMember2021-12-310000312069ifrs-full:ContingentLiabilitiesMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:ContingentLiabilitiesMemberbcs:HigherRiskBMinusAndBelowMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberbcs:ProbabilityOfDefaultOneHundredPercentMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:ContingentLiabilitiesMemberbcs:ExpectedCreditLossesMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMember2020-12-310000312069ifrs-full:ContingentLiabilitiesMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069bcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069bcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultZeroToPointZeroFivePercentMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityofdefaultpointzerofivetopointonefivepercentmemberMemberbcs:StrongIncludingInvestmentGradeMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointonefivetopointthreepercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:StrongIncludingInvestmentGradeMemberbcs:ProbabilityofdefaultpointthreetopointsixpercentmemberMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069bcs:ProbabilityofdefaultpointsixtytotwopointonefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069bcs:ProbabilityofdefaulttwopointonefivetotenpercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069bcs:ProbabilityofdefaulttentoelevenpointthreefivepercentmemberMemberifrs-full:LoanCommitmentsMemberbcs:SatisfactoryBbPlusToBMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultElevenPointThreeFiveToOneHundredPercentMemberbcs:HigherRiskBMinusAndBelowMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberbcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:ProbabilityOfDefaultOneHundredPercentMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:TwelvemonthExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsNotCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberifrs-full:LifetimeExpectedCreditLossesMemberifrs-full:FinancialInstrumentsCreditimpairedMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AccumulatedImpairmentMemberbcs:ExpectedCreditLossesMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:DerivativesMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:DerivativesMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069ifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069ifrs-full:DerivativesMemberifrs-full:CommodityPriceRiskMember2021-12-310000312069ifrs-full:DerivativesMemberifrs-full:CommodityPriceRiskMember2020-12-310000312069ifrs-full:DerivativesMember2021-12-310000312069ifrs-full:DerivativesMember2020-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:CreditRiskMember2021-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:CreditRiskMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:WeightedAverageMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:TopOfRangeMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:BottomOfRangeMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:WeightedAverageMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:TopOfRangeMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:BottomOfRangeMember2020-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:EquityPriceRiskMember2021-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:EquityPriceRiskMember2021-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:EquityPriceRiskMember2020-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:EquityPriceRiskMember2020-12-310000312069ifrs-full:WeightedAverageMemberbcs:BasisRiskMember2021-12-310000312069bcs:BasisRiskMemberifrs-full:TopOfRangeMember2021-12-310000312069ifrs-full:BottomOfRangeMemberbcs:BasisRiskMember2021-12-310000312069ifrs-full:WeightedAverageMemberbcs:BasisRiskMember2020-12-310000312069bcs:BasisRiskMemberifrs-full:TopOfRangeMember2020-12-310000312069ifrs-full:BottomOfRangeMemberbcs:BasisRiskMember2020-12-310000312069ifrs-full:WeightedAverageMemberbcs:SpreadRiskMember2021-12-310000312069bcs:SpreadRiskMemberifrs-full:TopOfRangeMember2021-12-310000312069bcs:SpreadRiskMemberifrs-full:BottomOfRangeMember2021-12-310000312069ifrs-full:WeightedAverageMemberbcs:SpreadRiskMember2020-12-310000312069bcs:SpreadRiskMemberifrs-full:TopOfRangeMember2020-12-310000312069bcs:SpreadRiskMemberifrs-full:BottomOfRangeMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:WeightedAverageMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:TopOfRangeMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:BottomOfRangeMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:WeightedAverageMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:TopOfRangeMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:BottomOfRangeMember2020-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:CommodityPriceRiskMember2021-12-310000312069ifrs-full:CommodityPriceRiskMemberifrs-full:TopOfRangeMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:CommodityPriceRiskMember2021-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:CommodityPriceRiskMember2020-12-310000312069ifrs-full:CommodityPriceRiskMemberifrs-full:TopOfRangeMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:CommodityPriceRiskMember2020-12-310000312069ifrs-full:WeightedAverageMemberbcs:InflationRiskMember2021-12-310000312069ifrs-full:TopOfRangeMemberbcs:InflationRiskMember2021-12-310000312069ifrs-full:BottomOfRangeMemberbcs:InflationRiskMember2021-12-310000312069ifrs-full:WeightedAverageMemberbcs:InflationRiskMember2020-12-310000312069ifrs-full:TopOfRangeMemberbcs:InflationRiskMember2020-12-310000312069ifrs-full:BottomOfRangeMemberbcs:InflationRiskMember2020-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:RiskDiversificationEffectMember2021-12-310000312069ifrs-full:WeightedAverageMemberifrs-full:RiskDiversificationEffectMember2020-12-310000312069ifrs-full:WeightedAverageMember2021-12-310000312069ifrs-full:TopOfRangeMember2021-12-310000312069ifrs-full:BottomOfRangeMember2021-12-310000312069ifrs-full:WeightedAverageMember2020-12-310000312069ifrs-full:TopOfRangeMember2020-12-310000312069ifrs-full:BottomOfRangeMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2020-12-310000312069ifrs-full:UnallocatedAmountsMember2021-12-310000312069ifrs-full:OnDemandMember2021-12-310000312069ifrs-full:NotLaterThanThreeMonthsMember2021-12-310000312069ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2021-12-310000312069bcs:LaterThanSixMonthsAndNotLaterThanNineMonthsMember2021-12-310000312069bcs:LaterThanNineMonthsAndNotLaterThanOneYearMember2021-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember2021-12-310000312069ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember2021-12-310000312069ifrs-full:LaterThanTenYearsMember2021-12-310000312069ifrs-full:OnDemandMember2020-12-310000312069ifrs-full:NotLaterThanThreeMonthsMember2020-12-310000312069ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2020-12-310000312069bcs:LaterThanSixMonthsAndNotLaterThanNineMonthsMember2020-12-310000312069bcs:LaterThanNineMonthsAndNotLaterThanOneYearMember2020-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember2020-12-310000312069ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember2020-12-310000312069ifrs-full:LaterThanTenYearsMember2020-12-310000312069ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2021-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember2021-12-310000312069ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2020-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember2020-12-310000312069ifrs-full:OnDemandMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:NotLaterThanThreeMonthsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069bcs:LaterThanSixMonthsAndNotLaterThanNineMonthsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069bcs:LaterThanNineMonthsAndNotLaterThanOneYearMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:LaterThanTenYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069bcs:OffBalanceSheetCommitmentsReceivedMember2021-12-310000312069ifrs-full:OnDemandMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069ifrs-full:NotLaterThanThreeMonthsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069bcs:LaterThanSixMonthsAndNotLaterThanNineMonthsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069bcs:LaterThanNineMonthsAndNotLaterThanOneYearMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069ifrs-full:LaterThanTenYearsMemberbcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069bcs:OffBalanceSheetCommitmentsReceivedMember2020-12-310000312069bcs:FullyLoadedCommonEquityTierOneCapitalMember2021-12-310000312069bcs:FullyLoadedCommonEquityTierOneCapitalMember2020-12-310000312069bcs:TransitionalAtOneCapitalMember2021-12-310000312069bcs:TransitionalAtOneCapitalMember2020-12-310000312069bcs:PraTransitionalTierOneCapitalMember2021-12-310000312069bcs:PraTransitionalTierOneCapitalMember2020-12-310000312069bcs:TierTwoCapitalInstrumentsMember2021-12-310000312069bcs:TierTwoCapitalInstrumentsMember2020-12-310000312069currency:USD2021-12-310000312069currency:EUR2021-12-310000312069currency:JPY2021-12-310000312069bcs:OtherCurrenciesMember2021-12-310000312069ifrs-full:CurrencyRiskMember2021-12-310000312069currency:USD2020-12-310000312069currency:EUR2020-12-310000312069currency:JPY2020-12-310000312069bcs:OtherCurrenciesMember2020-12-310000312069ifrs-full:CurrencyRiskMember2020-12-310000312069ifrs-full:CurrencyRiskMember2021-01-012021-12-310000312069currency:EUR2021-01-012021-12-310000312069bcs:OtherCurrenciesMember2021-01-012021-12-310000312069currency:USD2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:BarclaysUkMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:BarclaysInternationalMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:UnallocatedAmountsMember2021-01-012021-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:InterestRateRiskMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:BarclaysUkMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:BarclaysInternationalMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:UnallocatedAmountsMember2020-01-012020-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:InterestRateRiskMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMembersrt:ProFormaMemberbcs:BarclaysInternationalMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMembersrt:ProFormaMember2021-01-012021-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMembercurrency:GBP2021-01-012021-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMembercurrency:GBP2020-01-012020-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMembercurrency:USD2021-01-012021-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMembercurrency:USD2020-01-012020-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMembercurrency:EUR2021-01-012021-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMembercurrency:EUR2020-01-012020-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:OtherCurrencyMember2021-01-012021-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:OtherCurrencyMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMembersrt:ProFormaMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:TaxExpenseIncomeMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:TaxExpenseIncomeMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:RetainedEarningsMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:RetainedEarningsMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:RetainedEarningsMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:RetainedEarningsMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:ReserveOfCashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:ReserveOfCashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:TaxExpenseIncomeMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberbcs:TaxExpenseIncomeMember2020-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:InterestRateRiskMember2021-12-310000312069bcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:InterestRateRiskMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:EquityAttributableToOwnersOfParentMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMemberifrs-full:EquityAttributableToOwnersOfParentMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:TwentyFiveBasisPointsSensitivityAnalysisMembersrt:ProFormaMember2020-12-3100003120692019-01-012019-12-31iso4217:GBPxbrli:shares0000312069bcs:IssuedCapitalAndSharePremiumMember2020-12-310000312069ifrs-full:OtherEquityInterestMember2020-12-310000312069ifrs-full:OtherReservesMember2020-12-310000312069ifrs-full:RetainedEarningsMember2020-12-310000312069ifrs-full:EquityAttributableToOwnersOfParentMember2020-12-310000312069ifrs-full:NoncontrollingInterestsMember2020-12-310000312069ifrs-full:OtherEquityInterestMember2021-01-012021-12-310000312069ifrs-full:RetainedEarningsMember2021-01-012021-12-310000312069ifrs-full:EquityAttributableToOwnersOfParentMember2021-01-012021-12-310000312069ifrs-full:NoncontrollingInterestsMember2021-01-012021-12-310000312069ifrs-full:OtherReservesMember2021-01-012021-12-310000312069bcs:IssuedCapitalAndSharePremiumMember2021-01-012021-12-310000312069bcs:IssuedCapitalAndSharePremiumMember2021-12-310000312069ifrs-full:OtherEquityInterestMember2021-12-310000312069ifrs-full:OtherReservesMember2021-12-310000312069ifrs-full:RetainedEarningsMember2021-12-310000312069ifrs-full:EquityAttributableToOwnersOfParentMember2021-12-310000312069ifrs-full:NoncontrollingInterestsMember2021-12-310000312069bcs:IssuedCapitalAndSharePremiumMember2019-12-310000312069ifrs-full:OtherEquityInterestMember2019-12-310000312069ifrs-full:OtherReservesMember2019-12-310000312069ifrs-full:RetainedEarningsMember2019-12-310000312069ifrs-full:EquityAttributableToOwnersOfParentMember2019-12-310000312069ifrs-full:NoncontrollingInterestsMember2019-12-3100003120692019-12-310000312069ifrs-full:OtherEquityInterestMember2020-01-012020-12-310000312069ifrs-full:RetainedEarningsMember2020-01-012020-12-310000312069ifrs-full:EquityAttributableToOwnersOfParentMember2020-01-012020-12-310000312069ifrs-full:NoncontrollingInterestsMember2020-01-012020-12-310000312069ifrs-full:OtherReservesMember2020-01-012020-12-310000312069bcs:IssuedCapitalAndSharePremiumMember2020-01-012020-12-310000312069bcs:IssuedCapitalAndSharePremiumMember2018-12-310000312069ifrs-full:OtherEquityInterestMember2018-12-310000312069ifrs-full:OtherReservesMember2018-12-310000312069ifrs-full:RetainedEarningsMember2018-12-310000312069ifrs-full:EquityAttributableToOwnersOfParentMember2018-12-310000312069ifrs-full:NoncontrollingInterestsMember2018-12-3100003120692018-12-310000312069ifrs-full:OtherEquityInterestMember2019-01-012019-12-310000312069ifrs-full:OtherReservesMember2019-01-012019-12-310000312069ifrs-full:RetainedEarningsMember2019-01-012019-12-310000312069ifrs-full:EquityAttributableToOwnersOfParentMember2019-01-012019-12-310000312069ifrs-full:NoncontrollingInterestsMember2019-01-012019-12-310000312069bcs:IssuedCapitalAndSharePremiumMember2019-01-012019-12-310000312069srt:ParentCompanyMember2021-01-012021-12-310000312069srt:ParentCompanyMember2020-01-012020-12-310000312069srt:ParentCompanyMember2019-01-012019-12-310000312069srt:ParentCompanyMember2021-12-31bcs:Employees0000312069srt:ParentCompanyMember2020-12-310000312069srt:ParentCompanyMemberbcs:IssuedCapitalAndSharePremiumMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:OtherEquityInterestMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:OtherReservesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:RetainedEarningsMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:OtherEquityInterestMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:RetainedEarningsMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:IssuedCapitalAndSharePremiumMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:OtherReservesMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:IssuedCapitalAndSharePremiumMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:OtherEquityInterestMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:OtherReservesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:RetainedEarningsMember2021-12-310000312069srt:ParentCompanyMemberbcs:IssuedCapitalAndSharePremiumMember2019-12-310000312069srt:ParentCompanyMemberifrs-full:OtherEquityInterestMember2019-12-310000312069srt:ParentCompanyMemberifrs-full:OtherReservesMember2019-12-310000312069srt:ParentCompanyMemberifrs-full:RetainedEarningsMember2019-12-310000312069srt:ParentCompanyMember2019-12-310000312069srt:ParentCompanyMemberifrs-full:OtherEquityInterestMember2020-01-012020-12-310000312069srt:ParentCompanyMemberifrs-full:RetainedEarningsMember2020-01-012020-12-310000312069srt:ParentCompanyMemberbcs:IssuedCapitalAndSharePremiumMember2020-01-012020-12-310000312069srt:ParentCompanyMemberbcs:IssuedCapitalAndSharePremiumMember2018-12-310000312069srt:ParentCompanyMemberifrs-full:OtherEquityInterestMember2018-12-310000312069srt:ParentCompanyMemberifrs-full:OtherReservesMember2018-12-310000312069srt:ParentCompanyMemberifrs-full:RetainedEarningsMember2018-12-310000312069srt:ParentCompanyMember2018-12-310000312069srt:ParentCompanyMemberifrs-full:OtherEquityInterestMember2019-01-012019-12-310000312069srt:ParentCompanyMemberifrs-full:RetainedEarningsMember2019-01-012019-12-310000312069srt:ParentCompanyMemberbcs:IssuedCapitalAndSharePremiumMember2019-01-012019-12-310000312069srt:ParentCompanyMemberifrs-full:FinancialEffectOfChangesInAccountingPolicyMember2020-01-012020-12-310000312069srt:ParentCompanyMemberifrs-full:FinancialEffectOfChangesInAccountingPolicyMember2019-01-012019-12-31bcs:Segments0000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2021-01-012021-12-310000312069ifrs-full:UnallocatedAmountsMember2021-01-012021-12-310000312069bcs:BarclaysUkMember2021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2020-01-012020-12-310000312069ifrs-full:UnallocatedAmountsMember2020-01-012020-12-310000312069ifrs-full:UnallocatedAmountsMember2020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysPartnerFinanceMember2020-04-010000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysPartnerFinanceMember2020-04-012020-04-010000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2019-01-012019-12-310000312069ifrs-full:UnallocatedAmountsMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2019-12-310000312069ifrs-full:UnallocatedAmountsMember2019-12-310000312069ifrs-full:CountryOfDomicileMember2021-01-012021-12-310000312069ifrs-full:CountryOfDomicileMember2020-01-012020-12-310000312069ifrs-full:CountryOfDomicileMember2019-01-012019-12-310000312069srt:EuropeMember2021-01-012021-12-310000312069srt:EuropeMember2020-01-012020-12-310000312069srt:EuropeMember2019-01-012019-12-310000312069srt:AmericasMember2021-01-012021-12-310000312069srt:AmericasMember2020-01-012020-12-310000312069srt:AmericasMember2019-01-012019-12-310000312069bcs:AfricaAndMiddleEastMember2021-01-012021-12-310000312069bcs:AfricaAndMiddleEastMember2020-01-012020-12-310000312069bcs:AfricaAndMiddleEastMember2019-01-012019-12-310000312069srt:AsiaMember2021-01-012021-12-310000312069srt:AsiaMember2020-01-012020-12-310000312069srt:AsiaMember2019-01-012019-12-310000312069country:US2021-01-012021-12-310000312069country:US2020-01-012020-12-310000312069country:US2019-01-012019-12-310000312069ifrs-full:FinancialGuaranteeContractsMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:TransactionalBankingServicesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:TransactionalBankingServicesMember2021-01-012021-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:TransactionalBankingServicesMember2021-01-012021-12-310000312069bcs:TransactionalBankingServicesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:ManagementAndAdvisorySevicesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:ManagementAndAdvisorySevicesMemberbcs:BarclaysInternationalMember2021-01-012021-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:ManagementAndAdvisorySevicesMember2021-01-012021-12-310000312069bcs:ManagementAndAdvisorySevicesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BrokerageCommissionsAndClientExecutionFeesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BrokerageCommissionsAndClientExecutionFeesMemberbcs:BarclaysInternationalMember2021-01-012021-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:BrokerageCommissionsAndClientExecutionFeesMember2021-01-012021-12-310000312069bcs:BrokerageCommissionsAndClientExecutionFeesMember2021-01-012021-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2021-01-012021-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2021-01-012021-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:UnallocatedAmountsMember2021-01-012021-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:OtherFeesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:OtherFeesMemberbcs:BarclaysInternationalMember2021-01-012021-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:OtherFeesMember2021-01-012021-12-310000312069bcs:OtherFeesMember2021-01-012021-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:TransactionalBankingServicesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:TransactionalBankingServicesMember2020-01-012020-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:TransactionalBankingServicesMember2020-01-012020-12-310000312069bcs:TransactionalBankingServicesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:ManagementAndAdvisorySevicesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:ManagementAndAdvisorySevicesMemberbcs:BarclaysInternationalMember2020-01-012020-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:ManagementAndAdvisorySevicesMember2020-01-012020-12-310000312069bcs:ManagementAndAdvisorySevicesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BrokerageCommissionsAndClientExecutionFeesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BrokerageCommissionsAndClientExecutionFeesMemberbcs:BarclaysInternationalMember2020-01-012020-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:BrokerageCommissionsAndClientExecutionFeesMember2020-01-012020-12-310000312069bcs:BrokerageCommissionsAndClientExecutionFeesMember2020-01-012020-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2020-01-012020-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2020-01-012020-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:UnallocatedAmountsMember2020-01-012020-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:OtherFeesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:OtherFeesMemberbcs:BarclaysInternationalMember2020-01-012020-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:OtherFeesMember2020-01-012020-12-310000312069bcs:OtherFeesMember2020-01-012020-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:TransactionalBankingServicesMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMemberbcs:TransactionalBankingServicesMember2019-01-012019-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:TransactionalBankingServicesMember2019-01-012019-12-310000312069bcs:TransactionalBankingServicesMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:ManagementAndAdvisorySevicesMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:ManagementAndAdvisorySevicesMemberbcs:BarclaysInternationalMember2019-01-012019-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:ManagementAndAdvisorySevicesMember2019-01-012019-12-310000312069bcs:ManagementAndAdvisorySevicesMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:BrokerageCommissionsAndClientExecutionFeesMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BrokerageCommissionsAndClientExecutionFeesMemberbcs:BarclaysInternationalMember2019-01-012019-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:BrokerageCommissionsAndClientExecutionFeesMember2019-01-012019-12-310000312069bcs:BrokerageCommissionsAndClientExecutionFeesMember2019-01-012019-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMember2019-01-012019-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:OperatingSegmentsMemberbcs:BarclaysInternationalMember2019-01-012019-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMemberifrs-full:UnallocatedAmountsMember2019-01-012019-12-310000312069bcs:UnderwritingSyndicationAndCommitmentFeesMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:BarclaysUkMemberbcs:OtherFeesMember2019-01-012019-12-310000312069ifrs-full:OperatingSegmentsMemberbcs:OtherFeesMemberbcs:BarclaysInternationalMember2019-01-012019-12-310000312069ifrs-full:UnallocatedAmountsMemberbcs:OtherFeesMember2019-01-012019-12-310000312069bcs:OtherFeesMember2019-01-012019-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2019-01-012019-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2019-01-012019-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember2019-01-012019-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:FixedRateResettingPerpetualSubordinatedContingentConvertibleSecuritiesMember2021-01-012021-12-310000312069ifrs-full:DebtSecuritiesMember2020-01-012020-12-310000312069bcs:WholesalePortfoliosMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMemberbcs:WholesalePortfoliosMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMembersrt:MinimumMemberbcs:RetailPortfoliosMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMembersrt:MaximumMemberbcs:RetailPortfoliosMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMemberbcs:RetailPortfoliosMember2021-01-012021-12-310000312069bcs:RetailPortfoliosMember2021-01-012021-12-310000312069bcs:RetailPortfoliosMember2020-01-012020-12-310000312069bcs:RetailPortfoliosMember2019-01-012019-12-310000312069bcs:WholesalePortfoliosMember2020-01-012020-12-310000312069bcs:WholesalePortfoliosMember2019-01-012019-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostMemberifrs-full:LoansAndReceivablesCategoryMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostMemberifrs-full:LoansAndReceivablesCategoryMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostMemberifrs-full:LoansAndReceivablesCategoryMember2019-01-012019-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2021-01-012021-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2020-01-012020-12-310000312069bcs:OffBalanceSheetLoanCommitmentsAndFinancialGuaranteeContractsMember2019-01-012019-12-310000312069ifrs-full:LoansAndReceivablesCategoryMember2019-01-012019-12-310000312069ifrs-full:TradeReceivablesMember2021-01-012021-12-310000312069ifrs-full:TradeReceivablesMember2020-01-012020-12-310000312069ifrs-full:TradeReceivablesMember2019-01-012019-12-310000312069ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-01-012019-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostMemberbcs:OtherFinancialAssetsMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostMemberbcs:OtherFinancialAssetsMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostMemberbcs:OtherFinancialAssetsMember2019-01-012019-12-310000312069bcs:ThirdPartiesMemberifrs-full:FinancialGuaranteeContractsMember2021-01-012021-12-310000312069bcs:ThirdPartiesMemberifrs-full:FinancialGuaranteeContractsMember2020-01-012020-12-310000312069ifrs-full:WeightedAverageMember2021-01-012021-12-310000312069ifrs-full:WeightedAverageMember2020-01-012020-12-310000312069ifrs-full:WeightedAverageMember2019-01-012019-12-310000312069country:GBsrt:ProFormaMemberifrs-full:ChangesInTaxRatesOrTaxLawsEnactedOrAnnouncedMember2020-01-012020-12-310000312069country:GB2021-01-012021-12-310000312069country:GB2020-01-012020-12-310000312069bcs:IntermediateHoldingCompanyMember2021-12-310000312069bcs:IntermediateHoldingCompanyMember2020-12-310000312069bcs:UnitedStatesBranchTaxGroupMemberMember2021-12-310000312069bcs:UnitedStatesBranchTaxGroupMemberMember2020-12-310000312069bcs:OtherSubsidiariesMember2021-12-310000312069bcs:OtherSubsidiariesMember2020-12-310000312069bcs:IntermediateHoldingCompanyMemberifrs-full:UnusedTaxLossesMember2021-12-310000312069bcs:IntermediateHoldingCompanyMemberifrs-full:UnusedTaxLossesMember2020-12-310000312069bcs:BarclaysBankPlcMember2021-12-310000312069bcs:BarclaysBankPlcMember2020-12-310000312069bcs:IntermediateHoldingCompanyMemberbcs:LossInCurrentOrPriorYearMember2021-12-310000312069bcs:IntermediateHoldingCompanyMemberbcs:LossInCurrentOrPriorYearMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:UnusedTaxLossesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:UnusedTaxLossesMember2020-12-310000312069bcs:OtherSubsidiariesMemberifrs-full:UnusedTaxLossesMember2021-12-310000312069bcs:OtherSubsidiariesMemberifrs-full:UnusedTaxLossesMember2020-12-310000312069bcs:OtherSubsidiariesMemberbcs:LossInCurrentOrPriorYearMember2021-12-310000312069bcs:OtherSubsidiariesMemberbcs:LossInCurrentOrPriorYearMember2020-12-310000312069bcs:FixedAssetTimingDifferencesMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310000312069ifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:PresentValueOfDefinedBenefitObligationMember2020-12-310000312069ifrs-full:AllowanceForCreditLossesMember2020-12-310000312069ifrs-full:MiscellaneousOtherProvisionsMember2020-12-310000312069bcs:SharebasedCompensationAndDeferredCompensationMember2020-12-310000312069ifrs-full:OtherTemporaryDifferencesMember2020-12-310000312069ifrs-full:UnusedTaxLossesMember2020-12-310000312069bcs:FixedAssetTimingDifferencesMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-01-012021-12-310000312069ifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:PresentValueOfDefinedBenefitObligationMember2021-01-012021-12-310000312069ifrs-full:AllowanceForCreditLossesMember2021-01-012021-12-310000312069ifrs-full:MiscellaneousOtherProvisionsMember2021-01-012021-12-310000312069bcs:SharebasedCompensationAndDeferredCompensationMember2021-01-012021-12-310000312069ifrs-full:OtherTemporaryDifferencesMember2021-01-012021-12-310000312069ifrs-full:UnusedTaxLossesMember2021-01-012021-12-310000312069bcs:FixedAssetTimingDifferencesMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-12-310000312069ifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:PresentValueOfDefinedBenefitObligationMember2021-12-310000312069ifrs-full:AllowanceForCreditLossesMember2021-12-310000312069ifrs-full:MiscellaneousOtherProvisionsMember2021-12-310000312069bcs:SharebasedCompensationAndDeferredCompensationMember2021-12-310000312069ifrs-full:OtherTemporaryDifferencesMember2021-12-310000312069ifrs-full:UnusedTaxLossesMember2021-12-310000312069bcs:FixedAssetTimingDifferencesMember2019-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310000312069ifrs-full:CashFlowHedgesMember2019-12-310000312069ifrs-full:PresentValueOfDefinedBenefitObligationMember2019-12-310000312069ifrs-full:AllowanceForCreditLossesMember2019-12-310000312069ifrs-full:MiscellaneousOtherProvisionsMember2019-12-310000312069bcs:SharebasedCompensationAndDeferredCompensationMember2019-12-310000312069ifrs-full:OtherTemporaryDifferencesMember2019-12-310000312069ifrs-full:UnusedTaxLossesMember2019-12-310000312069bcs:FixedAssetTimingDifferencesMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-01-012020-12-310000312069ifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:PresentValueOfDefinedBenefitObligationMember2020-01-012020-12-310000312069ifrs-full:AllowanceForCreditLossesMember2020-01-012020-12-310000312069ifrs-full:MiscellaneousOtherProvisionsMember2020-01-012020-12-310000312069bcs:SharebasedCompensationAndDeferredCompensationMember2020-01-012020-12-310000312069ifrs-full:OtherTemporaryDifferencesMember2020-01-012020-12-310000312069ifrs-full:UnusedTaxLossesMember2020-01-012020-12-310000312069ifrs-full:LaterThanOneYearMember2021-12-310000312069ifrs-full:LaterThanOneYearMember2020-12-310000312069ifrs-full:TemporaryDifferenceMember2021-12-310000312069ifrs-full:TemporaryDifferenceMember2020-12-310000312069bcs:CapitalLossMember2021-12-310000312069bcs:CapitalLossMember2020-12-310000312069bcs:WithinFiveYearsMember2021-12-310000312069bcs:WithinFiveYearsMember2020-12-310000312069bcs:WithinSixToTenYearsMember2021-12-310000312069bcs:WithinSixToTenYearsMember2020-12-310000312069bcs:WithinElevenToTwentyYearsMember2021-12-310000312069bcs:WithinElevenToTwentyYearsMember2020-12-310000312069bcs:IndefinitelyMember2021-12-310000312069bcs:IndefinitelyMember2020-12-310000312069bcs:EmployeeShareSchemesAndScripDividendProgrammeMember2021-01-012021-12-310000312069bcs:EmployeeShareSchemesAndScripDividendProgrammeMember2020-01-012020-12-310000312069ifrs-full:BottomOfRangeMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMember2021-01-012021-12-310000312069bcs:AntidilutiveMember2021-01-012021-12-310000312069bcs:AntidilutiveMember2020-01-012020-12-310000312069ifrs-full:WeightedAverageMemberbcs:EmployeeShareSchemesAndScripDividendProgrammeMember2021-01-012021-12-310000312069ifrs-full:WeightedAverageMemberbcs:EmployeeShareSchemesAndScripDividendProgrammeMember2020-01-012020-12-310000312069ifrs-full:OrdinarySharesMember2021-01-012021-12-310000312069ifrs-full:OrdinarySharesMember2021-12-310000312069ifrs-full:OrdinarySharesMember2021-07-012021-12-310000312069ifrs-full:PotentialOrdinaryShareTransactionsMembersrt:ScenarioForecastMember2021-01-012021-12-3100003120692021-04-012021-06-3000003120692020-04-012020-06-30bcs:shareBuyback0000312069ifrs-full:OrdinarySharesMember2021-01-012021-06-300000312069ifrs-full:OrdinarySharesMember2020-01-012020-06-300000312069ifrs-full:OrdinarySharesMember2020-07-012020-12-310000312069ifrs-full:DebtSecuritiesMember2021-12-310000312069ifrs-full:DebtSecuritiesMember2020-12-310000312069ifrs-full:TradingEquitySecuritiesMember2021-12-310000312069ifrs-full:TradingEquitySecuritiesMember2020-12-310000312069bcs:TradedLoansMember2021-12-310000312069bcs:TradedLoansMember2020-12-310000312069bcs:CommoditiesMember2021-12-310000312069bcs:CommoditiesMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2020-12-310000312069ifrs-full:DerivativesMemberifrs-full:CreditRiskMember2021-01-012021-12-310000312069ifrs-full:DerivativesMemberifrs-full:CreditRiskMember2020-01-012020-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:DerivativesMemberbcs:CentralCounterpartyClearingHouseCCPMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberifrs-full:CreditRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberifrs-full:CreditRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:CommodityPriceRiskMemberifrs-full:DerivativesMember2021-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:CommodityPriceRiskMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:CommodityPriceRiskMemberifrs-full:DerivativesMember2020-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:CommodityPriceRiskMemberifrs-full:AtFairValueMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:DerivativesMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:DerivativesMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:CommodityPriceRiskMemberifrs-full:AtFairValueMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:HeldForTradingMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:HeldForTradingMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:DerivativesMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForTradingMemberifrs-full:AtFairValueMember2020-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMember2021-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:DerivativesMember2020-12-310000312069bcs:HeldForTradingMemberbcs:ExchangeTradedDerivativesMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:DerivativesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:DerivativesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:AtFairValueMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:DerivativesMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:HeldForRiskManagementMemberifrs-full:AtFairValueMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:DerivativesMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:HeldForRiskManagementMemberifrs-full:AtFairValueMember2020-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:GBP2021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:USD2021-12-310000312069currency:SGDbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:InterbankOfferedRateReformMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:DebtSecuritiesMemberifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:DebtSecuritiesMemberifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:HedgedAssetsMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:HedgedAssetsMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069bcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069bcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069bcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2021-12-310000312069bcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMemberifrs-full:DebtSecuritiesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMemberifrs-full:DebtSecuritiesMember2021-01-012021-12-310000312069ifrs-full:FairValueHedgesMemberbcs:HedgedLiabilitiesMember2021-12-310000312069ifrs-full:FairValueHedgesMemberbcs:HedgedLiabilitiesMember2021-01-012021-12-310000312069ifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:DebtSecuritiesMemberifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:HedgedAssetsMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberbcs:HedgedAssetsMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069bcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2020-12-310000312069bcs:HedgedAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069bcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2020-12-310000312069bcs:HedgedAssetsMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMemberifrs-full:DebtSecuritiesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMemberifrs-full:DebtSecuritiesMember2020-01-012020-12-310000312069ifrs-full:FairValueHedgesMemberbcs:HedgedLiabilitiesMember2020-12-310000312069ifrs-full:FairValueHedgesMemberbcs:HedgedLiabilitiesMember2020-01-012020-12-310000312069ifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-01-012021-12-310000312069ifrs-full:OtherPriceRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:LoanCommitmentsMemberifrs-full:FairValueHedgesMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2020-01-012020-12-310000312069ifrs-full:OtherPriceRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:DerivativesMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:LoanCommitmentsMemberifrs-full:FairValueHedgesMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FixedInterestRateMemberifrs-full:CurrentMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FixedInterestRateMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FixedInterestRateMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FixedInterestRateMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FixedInterestRateMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:LaterThanFourYearsAndNotLaterThanSixYearsMemberifrs-full:FixedInterestRateMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:LaterThanSixYearsMemberifrs-full:FixedInterestRateMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberifrs-full:OtherPriceRiskMemberifrs-full:CurrentMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberifrs-full:OtherPriceRiskMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberifrs-full:OtherPriceRiskMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrs-full:FairValueHedgesMember2021-12-310000312069bcs:LaterThanFourYearsAndNotLaterThanSixYearsMemberifrs-full:FixedInterestRateMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069bcs:LaterThanSixYearsMemberifrs-full:FixedInterestRateMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FixedInterestRateMemberifrs-full:FairValueHedgesMember2021-12-31bcs:Hedges0000312069ifrs-full:InterestRateRiskMemberifrs-full:FixedInterestRateMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:FixedInterestRateMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberifrs-full:OtherPriceRiskMemberifrs-full:FairValueHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:USD2021-01-012021-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:USD2021-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:EUR2021-01-012021-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:EUR2021-12-310000312069bcs:OtherCurrenciesMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2021-01-012021-12-310000312069bcs:OtherCurrenciesMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2021-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2021-01-012021-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LoansAndReceivablesCategoryMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:OtherPriceRiskMemberifrs-full:DebtSecuritiesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:USD2020-01-012020-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:USD2020-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:EUR2020-01-012020-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMembercurrency:EUR2020-12-310000312069bcs:OtherCurrenciesMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2020-01-012020-12-310000312069bcs:OtherCurrenciesMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2020-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2020-01-012020-12-310000312069ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:CashFlowHedgesMember2021-01-012021-12-310000312069ifrs-full:OtherPriceRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:DerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:OtherPriceRiskMemberifrs-full:CashFlowHedgesMember2020-01-012020-12-310000312069ifrs-full:OtherPriceRiskMemberbcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:DerivativesMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:LoanCommitmentsMemberifrs-full:CashFlowHedgesMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:CashFlowHedgesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:DerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:HedgesOfNetInvestmentInForeignOperationsMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterestIncomeMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterestIncomeMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterestIncomeMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterestIncomeMember2020-01-012020-12-310000312069bcs:OtherIncomeMember2021-01-012021-12-310000312069bcs:OtherIncomeMember2020-01-012020-12-310000312069ifrs-full:DebtSecuritiesMember2021-12-310000312069ifrs-full:DebtSecuritiesMember2020-12-310000312069ifrs-full:EquityInvestmentsMember2021-12-310000312069ifrs-full:EquityInvestmentsMember2020-12-310000312069bcs:ContractualCarryingAmountDueOnMaturityMember2021-12-310000312069bcs:ContractualCarryingAmountDueOnMaturityMember2020-12-310000312069ifrs-full:AtFairValueMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:AtFairValueMember2021-12-310000312069ifrs-full:AtFairValueMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:AtFairValueMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:AtFairValueMember2020-12-310000312069ifrs-full:AtFairValueMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:ReverseRepurchaseAndRepurchaseAgreementsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:ReverseRepurchaseAndRepurchaseAgreementsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:NonassetbackedLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:AssetbackedFinancingsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:CorporateLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:NonassetbackedLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:AssetbackedFinancingsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:EquityCashProductsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:NonassetbackedLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:EquityCashProductsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:NonassetbackedLoansMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:AssetbackedFinancingsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:AssetbackedFinancingsMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialAssetsAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberbcs:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2019-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level3OfFairValueHierarchyMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryTradingIncomeMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:NetAssetsLiabilitiesAtFairValueThroughProfitOrLossCategoryOtherIncomeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2021-01-012021-12-310000312069ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember2020-01-012020-12-310000312069ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:InterestRateRiskMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:CorrelationModelMemberifrs-full:BottomOfRangeMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:CorrelationModelMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:CorrelationModelMemberifrs-full:BottomOfRangeMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:CorrelationModelMemberifrs-full:CurrentEstimateOfFutureCashOutflowsToBePaidToFulfilObligationMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:InterestRateMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:InterestRateMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:InterestRateMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:InterestRateMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ProbabilityOfDefaultForeignExchangeMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ProbabilityOfDefaultForeignExchangeMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ProbabilityOfDefaultForeignExchangeMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:ProbabilityOfDefaultForeignExchangeMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:ProbabilityOfDefaultMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:ProbabilityOfDefaultMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:ProbabilityOfDefaultMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:ProbabilityOfDefaultMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RevenueMultipleMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RevenueMultipleMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:RevenueMultipleMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:RevenueMultipleMeasurementInputMemberifrs-full:OptionPricingModelMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:BottomOfRangeMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:OptionPricingModelMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:AssetbackedFinancingsMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:AssetbackedFinancingsMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:AssetbackedFinancingsMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:AssetbackedFinancingsMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:BottomOfRangeMemberbcs:MultiPeriodExcessEBITDAMethodMemberbcs:EBITDAMultipleMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:PrivateEquityInvestmentsMemberbcs:MultiPeriodExcessEBITDAMethodMemberbcs:EBITDAMultipleMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:BottomOfRangeMemberbcs:MultiPeriodExcessEBITDAMethodMemberbcs:EBITDAMultipleMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:PrivateEquityInvestmentsMemberbcs:MultiPeriodExcessEBITDAMethodMemberbcs:EBITDAMultipleMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:MultiperiodExcessEarningsMethodMemberbcs:PrivateEquityInvestmentsMemberifrs-full:BottomOfRangeMemberbcs:EarningsMultipleMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:MultiperiodExcessEarningsMethodMemberbcs:PrivateEquityInvestmentsMemberifrs-full:TopOfRangeMemberbcs:EarningsMultipleMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:MultiperiodExcessEarningsMethodMemberbcs:PrivateEquityInvestmentsMemberifrs-full:BottomOfRangeMemberbcs:EarningsMultipleMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:MultiperiodExcessEarningsMethodMemberbcs:PrivateEquityInvestmentsMemberifrs-full:TopOfRangeMemberbcs:EarningsMultipleMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberbcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberbcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberbcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberbcs:PrivateEquityInvestmentsMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:MarketComparablePricesMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:MarketComparablePricesMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:AdjustmentToMidmarketConsensusPriceMeasurementInputMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:DiscountRateMeasurementInputMemberbcs:CommercialMortgageBackedSecurityMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:TopOfRangeMemberbcs:CommercialMortgageBackedSecurityMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberifrs-full:DiscountRateMeasurementInputMemberbcs:CommercialMortgageBackedSecurityMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DiscountedCashFlowMemberifrs-full:DiscountRateMeasurementInputMemberifrs-full:TopOfRangeMemberbcs:CommercialMortgageBackedSecurityMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberbcs:EquityCashProductsMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberifrs-full:BottomOfRangeMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:DiscountedCashFlowMemberbcs:EquityCashProductsMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:BottomOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:CreditSpreadMeasurementInputMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:BottomOfRangeMemberbcs:EducationSocialHousingAndLocalAuthorityPorfolioMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:LoanSpreadMeasurementInputMemberbcs:EducationSocialHousingAndLocalAuthorityPorfolioMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:LoanSpreadMeasurementInputMemberifrs-full:BottomOfRangeMemberbcs:EducationSocialHousingAndLocalAuthorityPorfolioMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:LoanSpreadMeasurementInputMemberbcs:EducationSocialHousingAndLocalAuthorityPorfolioMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:EducationSocialHousingAndLocalAuthorityPorfolioMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:LoanSpreadMeasurementInputMemberbcs:EducationSocialHousingAndLocalAuthorityPorfolioMembersrt:MaximumMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:InterestRateRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:CurrencyRiskMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:CreditRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:EquityPriceRiskMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:CorporateLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberbcs:NonassetbackedLoansMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:EquityCashProductsMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberbcs:EquityCashProductsMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberbcs:EquityCashProductsMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberbcs:PrivateEquityInvestmentsMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:OtherFinancialAssetsAndLiabilitiesGroupOneMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:RecurringFairValueMeasurementMemberifrs-full:BottomOfRangeMemberifrs-full:DerivativesMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:ExitPriceAdjustmentsDerivedFromMarketBidofferSpreadsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:ExitPriceAdjustmentsDerivedFromMarketBidofferSpreadsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:UncollateralisedDerivativeFundingMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:UncollateralisedDerivativeFundingMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:DerivativeCreditValuationAdjustmentsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:DerivativeCreditValuationAdjustmentsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:DerivativeDebitValuationAdjustmentsMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:DerivativeDebitValuationAdjustmentsMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:ExitPriceAdjustmentsDerivedFromMarketBidofferSpreadsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:UncollateralisedDerivativeFundingMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:DerivativeCreditValuationAdjustmentsMember2021-01-012021-12-310000312069bcs:DerivativeCreditValuationAdjustmentsMember2021-12-310000312069bcs:DerivativeDebitValuationAdjustmentsMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:FinancialInstrumentsAtFairValueCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:FinancialInstrumentsAtFairValueCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:FinancialInstrumentsAtAmortisedCostCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069bcs:FinancialInstrumentsAtAmortisedCostCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069bcs:FinancialInstrumentsAtFairValueCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:FinancialInstrumentsAtFairValueCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:FinancialInstrumentsAtAmortisedCostCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2021-01-012021-12-310000312069bcs:FinancialInstrumentsAtAmortisedCostCategoryMemberifrs-full:Level3OfFairValueHierarchyMember2020-01-012020-12-310000312069bcs:BrokeredCertificatesOfDepositMember2021-12-310000312069bcs:BrokeredCertificatesOfDepositMember2020-12-310000312069ifrs-full:GrossCarryingAmountMember2021-12-310000312069ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember2021-12-310000312069ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember2021-12-310000312069ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMemberifrs-full:Level3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:GrossCarryingAmountMember2020-12-310000312069ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember2020-12-310000312069ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember2020-12-310000312069ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMemberifrs-full:Level3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DerivativesMember2021-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMember2021-12-310000312069bcs:FinancialAssetsSubjectToOffsettingMember2021-12-310000312069ifrs-full:DerivativesMember2021-12-310000312069bcs:RepurchaseAgreementsAndOtherSimilarSecuredBorrowingMember2021-12-310000312069bcs:FinancialLiabilitiesSubjectToOffsettingMember2021-12-310000312069ifrs-full:DerivativesMember2020-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMember2020-12-310000312069bcs:FinancialAssetsSubjectToOffsettingMember2020-12-310000312069ifrs-full:DerivativesMember2020-12-310000312069bcs:RepurchaseAgreementsAndOtherSimilarSecuredBorrowingMember2020-12-310000312069bcs:FinancialLiabilitiesSubjectToOffsettingMember2020-12-310000312069ifrs-full:DerivativesMemberbcs:CashCollateralNettedMember2021-12-310000312069ifrs-full:DerivativesMemberbcs:CashCollateralNettedMember2020-12-310000312069bcs:CashCollateralNettedMemberifrs-full:DerivativesMember2021-12-310000312069bcs:CashCollateralNettedMemberifrs-full:DerivativesMember2020-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2021-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember2020-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:ReverseRepurchaseAgreementsAndOtherSimilarSecuredLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:RepurchaseAgreementsAndOtherSimilarSecuredBorrowingMemberifrs-full:FinancialLiabilitiesAtFairValueMember2021-12-310000312069bcs:RepurchaseAgreementsAndOtherSimilarSecuredBorrowingMemberifrs-full:FinancialLiabilitiesAtFairValueMember2020-12-310000312069bcs:RepurchaseAgreementsAndOtherSimilarSecuredBorrowingMemberifrs-full:FinancialLiabilitiesAtAmortisedCostMember2021-12-310000312069bcs:RepurchaseAgreementsAndOtherSimilarSecuredBorrowingMemberifrs-full:FinancialLiabilitiesAtAmortisedCostMember2020-12-310000312069bcs:BanksMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069bcs:BanksMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069ifrs-full:MarketsOfCustomersMemberifrs-full:LoansAndReceivablesCategoryMember2021-12-310000312069ifrs-full:MarketsOfCustomersMemberifrs-full:LoansAndReceivablesCategoryMember2020-12-310000312069ifrs-full:DebtSecuritiesMember2021-12-310000312069ifrs-full:DebtSecuritiesMember2020-12-310000312069bcs:BanksMemberbcs:DepositsAtAmortisedCostMember2021-12-310000312069bcs:BanksMemberbcs:DepositsAtAmortisedCostMember2020-12-310000312069ifrs-full:MarketsOfCustomersMemberbcs:DepositsAtAmortisedCostMember2021-12-310000312069ifrs-full:MarketsOfCustomersMemberbcs:DepositsAtAmortisedCostMember2020-12-310000312069bcs:DepositsAtAmortisedCostMember2021-12-310000312069bcs:DepositsAtAmortisedCostMember2020-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:BuildingsMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:BuildingsMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:LeaseholdImprovementsMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:LeaseholdImprovementsMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:CommunicationAndNetworkEquipmentMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:CommunicationAndNetworkEquipmentMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:ComputerEquipmentMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMemberifrs-full:ComputerEquipmentMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMemberifrs-full:FixturesAndFittingsMember2021-01-012021-12-310000312069ifrs-full:FixturesAndFittingsMemberifrs-full:TopOfRangeMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InvestmentPropertyMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CommunicationAndNetworkEquipmentMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InvestmentPropertyMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CommunicationAndNetworkEquipmentMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InvestmentPropertyMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CommunicationAndNetworkEquipmentMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:LandAndBuildingsMember2020-12-310000312069ifrs-full:CommunicationAndNetworkEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:LandAndBuildingsMember2021-01-012021-12-310000312069ifrs-full:CommunicationAndNetworkEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:LandAndBuildingsMember2021-12-310000312069ifrs-full:CommunicationAndNetworkEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:InvestmentPropertyMember2021-12-310000312069ifrs-full:LandAndBuildingsMember2021-12-310000312069ifrs-full:CommunicationAndNetworkEquipmentMember2021-12-310000312069ifrs-full:RightofuseAssetsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InvestmentPropertyMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CommunicationAndNetworkEquipmentMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2019-12-310000312069ifrs-full:GrossCarryingAmountMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InvestmentPropertyMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CommunicationAndNetworkEquipmentMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMember2020-01-012020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:LandAndBuildingsMember2019-12-310000312069ifrs-full:CommunicationAndNetworkEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:LandAndBuildingsMember2020-01-012020-12-310000312069ifrs-full:CommunicationAndNetworkEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:InvestmentPropertyMember2020-12-310000312069ifrs-full:LandAndBuildingsMember2020-12-310000312069ifrs-full:CommunicationAndNetworkEquipmentMember2020-12-310000312069ifrs-full:RightofuseAssetsMember2020-12-310000312069ifrs-full:InvestmentPropertyMember2021-01-012021-12-310000312069ifrs-full:InvestmentPropertyMember2020-01-012020-12-310000312069ifrs-full:NotLaterThanOneYearMember2021-12-310000312069ifrs-full:NotLaterThanOneYearMember2020-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2021-12-310000312069ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2020-12-310000312069ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2021-12-310000312069ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2020-12-310000312069ifrs-full:LaterThanFiveYearsMember2021-12-310000312069ifrs-full:LaterThanFiveYearsMember2020-12-31bcs:leases0000312069ifrs-full:InternallyGeneratedMemberifrs-full:BottomOfRangeMemberifrs-full:ComputerSoftwareMember2021-01-012021-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:TopOfRangeMemberifrs-full:ComputerSoftwareMember2021-01-012021-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:BottomOfRangeMemberifrs-full:ComputerSoftwareMember2021-01-012021-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:TopOfRangeMemberifrs-full:ComputerSoftwareMember2021-01-012021-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:BottomOfRangeMember2021-01-012021-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:TopOfRangeMember2021-01-012021-12-310000312069ifrs-full:BottomOfRangeMemberbcs:LicencesAndOtherMember2021-01-012021-12-310000312069ifrs-full:TopOfRangeMemberbcs:LicencesAndOtherMember2021-01-012021-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:BottomOfRangeMemberbcs:CoreBankingPlatformsMember2021-01-012021-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:TopOfRangeMemberbcs:CoreBankingPlatformsMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:GoodwillMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:LicencesAndOtherMember2020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:GoodwillMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:LicencesAndOtherMember2021-01-012021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:GoodwillMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:LicencesAndOtherMember2021-12-310000312069ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069bcs:LicencesAndOtherMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310000312069ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069bcs:LicencesAndOtherMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-01-012021-12-310000312069ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069bcs:LicencesAndOtherMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310000312069ifrs-full:GoodwillMember2021-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMember2021-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMember2021-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMember2021-12-310000312069bcs:LicencesAndOtherMember2021-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:GoodwillMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:LicencesAndOtherMember2019-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:GoodwillMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2020-01-012020-12-310000312069ifrs-full:GrossCarryingAmountMemberbcs:LicencesAndOtherMember2020-01-012020-12-310000312069ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069bcs:LicencesAndOtherMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310000312069ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069bcs:LicencesAndOtherMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-01-012020-12-310000312069ifrs-full:GoodwillMember2020-12-310000312069ifrs-full:InternallyGeneratedMemberifrs-full:ComputerSoftwareMember2020-12-310000312069ifrs-full:NotInternallyGeneratedMemberifrs-full:ComputerSoftwareMember2020-12-310000312069ifrs-full:CustomerrelatedIntangibleAssetsMember2020-12-310000312069bcs:LicencesAndOtherMember2020-12-310000312069bcs:BarclaysUkMemberbcs:PersonalBankingUnitedKingdomMember2021-12-310000312069bcs:BarclaysUkMemberbcs:PersonalBankingUnitedKingdomMember2020-12-310000312069bcs:BarclaysUkMemberbcs:WoolwichMember2021-12-310000312069bcs:BarclaysUkMemberbcs:WoolwichMember2020-12-310000312069bcs:BarclaysUkMemberbcs:OtherBarclaysUnitedKingdomMember2021-12-310000312069bcs:BarclaysUkMemberbcs:OtherBarclaysUnitedKingdomMember2020-12-310000312069bcs:CardsAndPaymentsMember2021-12-310000312069bcs:CardsAndPaymentsMember2020-12-310000312069bcs:PersonalBankingUnitedKingdomMember2021-12-310000312069bcs:PersonalBankingUnitedKingdomMember2020-12-310000312069bcs:OtherBarclaysUnitedKingdomMember2021-12-310000312069bcs:OtherBarclaysUnitedKingdomMember2020-12-310000312069ifrs-full:IndividualAssetsOrCashgeneratingUnitsMember2021-12-310000312069ifrs-full:IndividualAssetsOrCashgeneratingUnitsMember2020-12-310000312069bcs:PersonalBankingUnitedKingdomMemberifrs-full:DiscountRateMeasurementInputMember2021-12-310000312069bcs:PersonalBankingUnitedKingdomMemberbcs:GrowthRateMeasurementInputMember2021-12-310000312069bcs:PersonalBankingUnitedKingdomMemberifrs-full:CapitalisationRateMeasurementInputMember2021-12-310000312069bcs:PersonalBankingUnitedKingdomMemberifrs-full:FinancialForecastOfCashFlowsForCashgeneratingUnitMeasurementInputMember2021-12-310000312069ifrs-full:DiscountRateMeasurementInputMemberbcs:CardsAndPaymentsMember2021-12-310000312069bcs:GrowthRateMeasurementInputMemberbcs:CardsAndPaymentsMember2021-12-310000312069ifrs-full:CapitalisationRateMeasurementInputMemberbcs:CardsAndPaymentsMember2021-12-310000312069bcs:CardsAndPaymentsMemberifrs-full:FinancialForecastOfCashFlowsForCashgeneratingUnitMeasurementInputMember2021-12-310000312069bcs:PersonalBankingUKAndCardAndPaymentsMember2021-12-310000312069ifrs-full:OnerousContractsProvisionMember2020-12-310000312069ifrs-full:RestructuringProvisionMember2020-12-310000312069bcs:UndrawnContractuallyCommittedFacilitiesAndGuaranteesMember2020-12-310000312069bcs:CustomerRedressMember2020-12-310000312069ifrs-full:LegalProceedingsProvisionMember2020-12-310000312069ifrs-full:OnerousContractsProvisionMember2021-01-012021-12-310000312069ifrs-full:RestructuringProvisionMember2021-01-012021-12-310000312069bcs:UndrawnContractuallyCommittedFacilitiesAndGuaranteesMember2021-01-012021-12-310000312069bcs:CustomerRedressMember2021-01-012021-12-310000312069ifrs-full:LegalProceedingsProvisionMember2021-01-012021-12-310000312069ifrs-full:OnerousContractsProvisionMember2021-12-310000312069ifrs-full:RestructuringProvisionMember2021-12-310000312069bcs:UndrawnContractuallyCommittedFacilitiesAndGuaranteesMember2021-12-310000312069bcs:CustomerRedressMember2021-12-310000312069ifrs-full:LegalProceedingsProvisionMember2021-12-310000312069ifrs-full:FinancialGuaranteeContractsMemberbcs:GuaranteesAndLettersOfCreditPledgedAsCollateralSecurityMember2021-12-310000312069ifrs-full:FinancialGuaranteeContractsMemberbcs:GuaranteesAndLettersOfCreditPledgedAsCollateralSecurityMember2020-12-310000312069bcs:PerformanceGuaranteesAcceptancesAndEndorsementsMemberifrs-full:FinancialGuaranteeContractsMember2021-12-310000312069bcs:PerformanceGuaranteesAcceptancesAndEndorsementsMemberifrs-full:FinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:FinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:FinancialGuaranteeContractsMember2020-12-310000312069ifrs-full:AtFairValueMemberifrs-full:FinancialGuaranteeContractsMember2021-12-310000312069ifrs-full:AtFairValueMemberifrs-full:FinancialGuaranteeContractsMember2020-12-310000312069bcs:DocumentaryCreditsAndOtherShortTermTradeRelatedTransactionsMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:DocumentaryCreditsAndOtherShortTermTradeRelatedTransactionsMemberifrs-full:LoanCommitmentsMember2020-12-310000312069bcs:StandbyFacilitiesCreditLinesAndOtherCommitmentsMemberifrs-full:LoanCommitmentsMember2021-12-310000312069bcs:StandbyFacilitiesCreditLinesAndOtherCommitmentsMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:AtFairValueMemberifrs-full:LoanCommitmentsMember2021-12-310000312069ifrs-full:AtFairValueMemberifrs-full:LoanCommitmentsMember2020-12-310000312069ifrs-full:ProvisionForCreditCommitmentsMember2021-12-310000312069ifrs-full:ProvisionForCreditCommitmentsMember2020-12-310000312069bcs:FcaProceedingsAndOtherInvestigationsMemberbcs:BarclaysBankPlcMember2008-01-012008-12-31bcs:agreement0000312069bcs:FcaProceedingsAndOtherInvestigationsMemberbcs:BarclaysBankPlcMember2013-01-012013-12-310000312069bcs:LawsuitsWithSpecifiedDamagesSoughtMemberbcs:UsdLiborCasesInMdlCourtMemberbcs:BarclaysBankPlcMember2012-01-012012-12-31bcs:lawsuits0000312069bcs:UsdLiborCasesInMdlCourtMember2021-01-012021-12-31bcs:settlement0000312069bcs:UsdLiborCasesInMdlCourtMemberbcs:ExchangeBasedClassClaimsMemberbcs:BarclaysBankPlcMember2021-01-012021-05-310000312069bcs:UsdLiborCasesInMdlCourtMemberbcs:DebtSecuritiesClassClaimsMemberbcs:BarclaysBankPlcMember2021-01-012021-05-310000312069bcs:UsdLiborCasesInMdlCourtMemberbcs:ExchangeBasedClassClaimsMemberbcs:BarclaysBankPlcMember2021-06-012021-06-300000312069bcs:SterlingLIBORCaseInSDNYMember2016-01-012016-12-310000312069bcs:ForeignExchangeInvestigationsMemberbcs:BarclaysBankPlcMember2015-01-012015-12-310000312069bcs:ForeignExchangeInvestigationsMemberbcs:FineSettlementMember2019-05-012019-05-31iso4217:EUR0000312069bcs:ForeignExchangeInvestigationsMemberbcs:FineSettlementMember2019-06-012019-06-300000312069bcs:ForeignExchangeInvestigationsMemberbcs:SecuritiesAndExchangeCommissionMember2019-06-012019-06-30iso4217:CHF0000312069bcs:ForeignExchangeInvestigationsMemberbcs:FineSettlementMember2021-12-012021-12-310000312069bcs:SecuritiesAndExchangeCommissionMemberbcs:BarclaysBankPlcMemberbcs:ConsolidatedFxActionMemberbcs:BarclaysCapitalIncMember2018-01-012018-12-310000312069bcs:NonUSForexCivilActionsMember2021-01-012021-12-310000312069bcs:MetalsRelatedCivilActionsMember2021-01-012021-12-310000312069bcs:OriginatedAndSoldToThirdPartiesByAcquiredSubsidiaryMemberbcs:UsResidentialAndCommercialMortgageRelatedActivityAndLitigationMemberbcs:RmbsRepurchaseRequestsMember2007-01-012007-07-010000312069bcs:OriginatedAndSoldToThirdPartiesByAcquiredSubsidiaryMemberbcs:BarclaysBankPlcMemberbcs:UsResidentialAndCommercialMortgageRelatedActivityAndLitigationMemberbcs:RmbsRepurchaseRequestsMember2021-12-310000312069bcs:OriginatedAndSoldToThirdPartiesByAcquiredSubsidiaryMemberbcs:UsResidentialAndCommercialMortgageRelatedActivityAndLitigationMemberbcs:RmbsRepurchaseRequestsMember2021-01-012021-12-310000312069bcs:LegacyRMBSPurchasesMemberbcs:UsResidentialAndCommercialMortgageRelatedActivityAndLitigationMember2020-12-012020-12-31bcs:defendant0000312069stpr:NMbcs:LegacyRMBSPurchasesMemberbcs:UsResidentialAndCommercialMortgageRelatedActivityAndLitigationMember2020-12-012020-12-31bcs:pensionFund0000312069bcs:LegacyRMBSPurchasesMemberbcs:UsResidentialAndCommercialMortgageRelatedActivityAndLitigationMember2020-12-310000312069bcs:SupranationalSovereignAndAgencyBondsCivilActionsMember2021-01-012021-12-310000312069bcs:CivilActionsInRespectOfVRDOPrivatePlaintiffsMember2021-01-012021-12-310000312069bcs:CivilActionsInRespectOfVRDOSNDYMember2021-01-012021-12-310000312069bcs:GovernmentAndAgencySecuritiesCivilActionsAndRelatedMattersMemberbcs:BarclaysCapitalIncMember2020-12-012020-12-310000312069bcs:GovernmentAndAgencySecuritiesCivilActionsAndRelatedMattersMemberbcs:BarclaysBankPlcMember2018-01-012018-12-310000312069bcs:BdcFinanceLlcMemberbcs:BarclaysBankPlcMember2008-01-012008-12-310000312069bcs:BdcFinanceLlcMemberbcs:BarclaysBankPlcMember2021-04-012021-04-300000312069bcs:CivilActionsInRespectOfTheUSAntiTerrorismActEDNYMember2021-01-012021-12-31bcs:plaintiff0000312069bcs:CivilActionsInRespectOfTheUSAntiTerrorismActSDNYMember2021-01-012021-12-310000312069bcs:DerivativeTransactionsCivilActionMember2021-01-012021-12-310000312069bcs:CFSRemediationOfASLLoansMember2020-08-310000312069bcs:HmRevenueCustomsHmrcAssessmentsConcerningUkValueAddedTaxMember2018-01-012018-12-310000312069bcs:BarclaysUkMemberbcs:HmRevenueCustomsHmrcAssessmentsConcerningUkValueAddedTaxMember2018-01-012018-12-310000312069bcs:BarclaysBankPlcMemberbcs:HmRevenueCustomsHmrcAssessmentsConcerningUkValueAddedTaxMember2018-01-012018-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:A1125FixedRateResettingSubordinatedCallableNotesEUR1000mMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:A1125FixedRateResettingSubordinatedCallableNotesEUR1000mMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:A3811FixedRateResettingSubordinatedCallableNotesUSD1000mMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:A3811FixedRateResettingSubordinatedCallableNotesUSD1000mMember2021-12-310000312069bcs:OtherSubsidiariesMemberbcs:UndatedNotesUnitedStatesDollarOriginalCurrencyDenominatedMemberifrs-full:FloatingInterestRateMember2021-01-012021-12-310000312069bcs:OtherSubsidiariesMemberifrs-full:FloatingInterestRateMemberbcs:SouthAfricanRandNotesMember2021-01-012021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:TenPercentSubordinatedNotesMemberbcs:BarclaysBankPlcMember2021-01-012021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:TenPercentSubordinatedNotesMemberbcs:BarclaysBankPlcMember2021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:SixPercentSubordinatedNotesTwoMember2021-01-012021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:SixPercentSubordinatedNotesTwoMember2021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:TenPointOneSevenNinePercentSubordinatedNotesMember2021-01-012021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:TenPointOneSevenNinePercentSubordinatedNotesMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:NinePointFivePercentSubordinatedBondsExWoolwichPlcMember2021-01-012021-12-310000312069bcs:BarclaysBankPlcMemberbcs:NinePointFivePercentSubordinatedBondsExWoolwichPlcMember2021-12-310000312069bcs:SubordinatedNotesSixMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMember2021-01-012021-12-310000312069bcs:JuniorUndatedFloatingRateNotesGBP67mMemberbcs:OtherSubsidiariesMemberifrs-full:FloatingInterestRateMember2020-12-012020-12-310000312069bcs:SixPercentCallablePerpetualCoreTierOneNotesMemberbcs:BarclaysBankPlcMember2021-12-310000312069bcs:SixPercentCallablePerpetualCoreTierOneNotesMemberbcs:BarclaysBankPlcMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:SixPointEightSixPercentCallablePerpetualCoreTierOneNotesUsdOriginalCurrencyMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:SixPointEightSixPercentCallablePerpetualCoreTierOneNotesUsdOriginalCurrencyMember2020-12-310000312069bcs:FivePointThreeThreeZeroFourPercentStepUpCallablePerpetualReserveCapitalInstrumentsMemberbcs:BarclaysBankPlcMember2021-12-310000312069bcs:FivePointThreeThreeZeroFourPercentStepUpCallablePerpetualReserveCapitalInstrumentsMemberbcs:BarclaysBankPlcMember2020-12-310000312069bcs:JuniorUndatedNotesUsdOriginalCurrencyMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMember2021-12-310000312069bcs:JuniorUndatedNotesUsdOriginalCurrencyMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMember2020-12-310000312069bcs:JuniorUndatedFloatingRateNotesGBP67mMemberbcs:OtherSubsidiariesMemberifrs-full:FloatingInterestRateMember2021-12-310000312069bcs:JuniorUndatedFloatingRateNotesGBP67mMemberbcs:OtherSubsidiariesMemberifrs-full:FloatingInterestRateMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:TwoPercentSubordinatedNotesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:TwoPercentSubordinatedNotesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FourPointThreeSevenFivePercentSubordinatedNotesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FourPointThreeSevenFivePercentSubordinatedNotesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:ThreePointSevenFivePercentResettingSubordinatedCallableNotesUnitedStatesDollarDenominatedDueTwentyThirtyMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:ThreePointSevenFivePercentResettingSubordinatedCallableNotesUnitedStatesDollarDenominatedDueTwentyThirtyMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:ThreePointSevenFivePercentResettingSubordinatedCallableNoteDueTwentyThirtyMember2021-12-31iso4217:SGD0000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:ThreePointSevenFivePercentResettingSubordinatedCallableNoteDueTwentyThirtyMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FivePointTwoZeroPercentSubordinatedNotesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FivePointTwoZeroPercentSubordinatedNotesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:A1125FixedRateResettingSubordinatedCallableNotesEUR1000mMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FourPointThreeEightSixPercentSubordinatedNotesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FourPointThreeEightSixPercentSubordinatedNotesMember2020-12-310000312069srt:ParentCompanyMemberbcs:A5088CallableTierTwoNotesMemberbcs:FixedOrFloatingInterestRateMember2021-12-310000312069srt:ParentCompanyMemberbcs:A5088CallableTierTwoNotesMemberbcs:FixedOrFloatingInterestRateMember2020-12-310000312069srt:ParentCompanyMemberbcs:A3564ResettingSubordinatedCallableNotesMemberifrs-full:FixedInterestRateMember2021-12-310000312069srt:ParentCompanyMemberbcs:A3564ResettingSubordinatedCallableNotesMemberifrs-full:FixedInterestRateMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:A3811FixedRateResettingSubordinatedCallableNotesUSD1000mMember2020-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:SixPercentSubordinatedNotesTwoMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:NinePointFivePercentSubordinatedBondsExWoolwichPlcMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:SubordinatedNotesThreeMemberifrs-full:FloatingInterestRateMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:SubordinatedNotesThreeMemberifrs-full:FloatingInterestRateMember2021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:TenPercentSubordinatedNotesMemberbcs:BarclaysBankPlcMember2020-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:TenPointOneSevenNinePercentSubordinatedNotesMember2020-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:SubordinatedNotesFourMember2021-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:SubordinatedNotesFourMember2020-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:SixPointSixTwoFivePercentSubordinatedNotesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:SixPointSixTwoFivePercentSubordinatedNotesMember2020-12-310000312069bcs:SevenPointSixTwoFivePercentContingentCapitalNotesMemberbcs:BarclaysBankPlcMember2021-12-310000312069bcs:SevenPointSixTwoFivePercentContingentCapitalNotesMemberbcs:BarclaysBankPlcMember2020-12-310000312069bcs:SubordinatedFloatingRateNotesDue2023BCS23CMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMember2021-12-310000312069bcs:SubordinatedFloatingRateNotesDue2023BCS23CMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMember2020-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:FivePointSevenFivePercentSubordinatedNotesMember2021-12-310000312069ifrs-full:FixedInterestRateMemberbcs:BarclaysBankPlcMemberbcs:FivePointSevenFivePercentSubordinatedNotesMember2020-12-310000312069bcs:FivePointFourPercentReverseDualCurrencySubordinatedLoanMemberbcs:BarclaysBankPlcMember2021-12-31iso4217:JPY0000312069bcs:FivePointFourPercentReverseDualCurrencySubordinatedLoanMemberbcs:BarclaysBankPlcMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:SixPointThreeThreePercentSubordinatedNotesMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:SixPointThreeThreePercentSubordinatedNotesMember2020-12-310000312069bcs:SubordinatedNotesSixMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMember2021-12-310000312069bcs:SubordinatedNotesSixMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMember2020-12-310000312069bcs:SevenPointSixTwoFivePercentContingentCapitalNotesMemberbcs:BarclaysBankPlcMember2021-01-012021-12-310000312069bcs:SevenPointSixTwoFivePercentContingentCapitalNotesMemberbcs:BarclaysBankPlcMembersrt:MinimumMember2021-12-310000312069ifrs-full:OrdinarySharesMember2020-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2020-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:SharePremiumMember2020-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2021-01-012021-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:SharePremiumMember2021-01-012021-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2021-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:SharePremiumMember2021-12-310000312069ifrs-full:OrdinarySharesMember2019-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2019-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:SharePremiumMember2019-12-310000312069ifrs-full:OrdinarySharesMember2020-01-012020-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2020-01-012020-12-310000312069ifrs-full:OrdinarySharesMemberifrs-full:SharePremiumMember2020-01-012020-12-310000312069ifrs-full:OrdinarySharesMember2021-05-050000312069bcs:AdditionalTierOneSecuritiesMemberbcs:FixedRateResettingPerpetualSubordinatedContingentConvertibleSecuritiesMember2021-01-012021-12-31bcs:dummy0000312069bcs:AdditionalTierOneSecuritiesMemberbcs:FixedRateResettingPerpetualSubordinatedContingentConvertibleSecuritiesMember2020-01-012020-12-31bcs:Redemptions0000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SevenPointEightSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesOneMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SevenPointEightSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesOneMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SevenPointEightSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesTwoMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SevenPointEightSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesTwoMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:SevenPointTwoFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberbcs:AdditionalTierOneSecuritiesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:SevenPointTwoFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberbcs:AdditionalTierOneSecuritiesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SevenPointSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SevenPointSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FivePointEightSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberbcs:AdditionalTierOneSecuritiesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:FivePointEightSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberbcs:AdditionalTierOneSecuritiesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:EightPercentPerpetualSubordinatedContingentConvertibleSecuritiesUSDMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:EightPercentPerpetualSubordinatedContingentConvertibleSecuritiesUSDMember2020-12-310000312069srt:ParentCompanyMemberbcs:SevenPointOneTwoFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMember2021-12-310000312069srt:ParentCompanyMemberbcs:SevenPointOneTwoFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SixPointThreeSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:SixPointThreeSevenFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:SixPointOneTwoFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberbcs:AdditionalTierOneSecuritiesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:SixPointOneTwoFivePercentPerpetualSubordinatedContingentConvertibleSecuritiesMemberbcs:AdditionalTierOneSecuritiesMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:A4375PerpetualSubordinatedContingentConvertibleSecuritiesUSD1500mMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMemberbcs:A4375PerpetualSubordinatedContingentConvertibleSecuritiesUSD1500mMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:AdditionalTierOneSecuritiesMember2020-12-310000312069ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310000312069ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310000312069ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember2021-12-310000312069ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember2020-12-310000312069ifrs-full:ReserveOfCashFlowHedgesMember2021-12-310000312069ifrs-full:ReserveOfCashFlowHedgesMember2020-12-310000312069ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember2021-12-310000312069ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember2020-12-310000312069bcs:OtherReservesAndTreasurySharesMember2021-12-310000312069bcs:OtherReservesAndTreasurySharesMember2020-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMember2021-01-012021-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMember2020-01-012020-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMember2021-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMember2021-01-012021-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMember2020-01-012020-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMember2020-12-310000312069bcs:OtherNoncontrollingInterestMember2021-01-012021-12-310000312069bcs:OtherNoncontrollingInterestMember2020-01-012020-12-310000312069bcs:OtherNoncontrollingInterestMember2021-12-310000312069bcs:OtherNoncontrollingInterestMember2020-12-310000312069ifrs-full:NoncontrollingInterestsMemberbcs:UpperTierTwoInstrumentsMember2021-12-310000312069ifrs-full:NoncontrollingInterestsMemberbcs:UpperTierTwoInstrumentsMember2020-12-310000312069ifrs-full:NoncontrollingInterestsMemberbcs:UpperTierTwoInstrumentsMember2021-01-012021-12-310000312069ifrs-full:NoncontrollingInterestsMemberbcs:UpperTierTwoInstrumentsMember2020-01-012020-12-310000312069bcs:NinePointTwoFivePercentPerpetualSubordinatedBondsExWoolwichPlcMemberbcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:BarclaysBankPlcMember2021-01-012021-12-310000312069bcs:BarclaysBankPlcMemberbcs:NinePercentPermanentInterestBearingCapitalBondsMemberbcs:UpperTierTwoInstrumentsMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:SixPointOneTwoFivePercentUndatedSubordinatedNotesMemberbcs:UpperTierTwoInstrumentsMember2021-12-310000312069bcs:SixDecimalTwoHundredSeventyEightNonCumulativeCallablePreferenceSharesMemberbcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMember2021-12-310000312069bcs:SixDecimalTwoHundredSeventyEightNonCumulativeCallablePreferenceSharesMemberbcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMember2020-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMemberbcs:FourDecimalSeventyFivePercentNonCumulatieCallablePrefrenceSharesMember2021-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:PreferenceSharesMemberbcs:FourDecimalSeventyFivePercentNonCumulatieCallablePrefrenceSharesMember2020-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:UpperTierTwoInstrumentsMemberbcs:UndatedFloatingRatePrimaryCapitalNotesSeriesOneMember2021-12-310000312069bcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:UpperTierTwoInstrumentsMemberbcs:UndatedFloatingRatePrimaryCapitalNotesSeriesOneMember2020-12-310000312069bcs:UndatedFloatingRatePrimaryCapitalNotesSeriesTwoMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:UpperTierTwoInstrumentsMember2021-12-310000312069bcs:UndatedFloatingRatePrimaryCapitalNotesSeriesTwoMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:UpperTierTwoInstrumentsMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMemberbcs:FivePointZeroThreePercentReverseDualCurrencyUndatedSubordinatedLoanJpyOriginalCurrencyMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMemberbcs:FivePointZeroThreePercentReverseDualCurrencyUndatedSubordinatedLoanJpyOriginalCurrencyMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMemberbcs:FivePercentReverseDualCurrencyUndatedSubordinatedLoanJpyOriginalCurrencyMember2021-12-310000312069bcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMemberbcs:FivePercentReverseDualCurrencyUndatedSubordinatedLoanJpyOriginalCurrencyMember2020-12-310000312069bcs:UndatedPrimaryCapitalNotesSeriesThreeMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:UpperTierTwoInstrumentsMember2021-12-310000312069bcs:UndatedPrimaryCapitalNotesSeriesThreeMemberbcs:BarclaysBankPlcMemberifrs-full:FloatingInterestRateMemberbcs:UpperTierTwoInstrumentsMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:NinePercentPermanentInterestBearingCapitalBondsMemberbcs:UpperTierTwoInstrumentsMember2020-12-310000312069bcs:BarclaysBankPlcMemberbcs:SixPointOneTwoFivePercentUndatedSubordinatedNotesMemberbcs:UpperTierTwoInstrumentsMember2020-12-310000312069bcs:NinePointTwoFivePercentPerpetualSubordinatedBondsExWoolwichPlcMemberbcs:BarclaysBankPlcMemberbcs:UpperTierTwoInstrumentsMember2020-12-310000312069bcs:DefinedContributionPlansMember2021-01-012021-12-310000312069bcs:DefinedContributionPlansMember2020-01-012020-12-310000312069bcs:DefinedContributionPlansMember2019-01-012019-12-310000312069ifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069ifrs-full:PensionDefinedBenefitPlansMember2019-01-012019-12-310000312069ifrs-full:InternallyGeneratedMember2021-01-012021-12-310000312069ifrs-full:InternallyGeneratedMember2020-01-012020-12-310000312069ifrs-full:InternallyGeneratedMember2019-01-012019-12-310000312069bcs:DeferredShareValuePlanShareValuePlanMember2021-01-012021-12-310000312069bcs:DeferredShareValuePlanShareValuePlanMember2020-01-012020-12-310000312069bcs:DeferredShareValuePlanShareValuePlanMember2019-01-012019-12-310000312069bcs:OtherSchemesMember2021-01-012021-12-310000312069bcs:OtherSchemesMember2020-01-012020-12-310000312069bcs:OtherSchemesMember2019-01-012019-12-310000312069bcs:DeferredShareValuePlanShareValuePlanMember2021-12-310000312069bcs:DeferredShareValuePlanShareValuePlanMember2020-12-310000312069bcs:OtherSchemesMemberifrs-full:BottomOfRangeMember2021-12-310000312069bcs:OtherSchemesMemberifrs-full:TopOfRangeMember2021-12-310000312069bcs:OtherSchemesMemberifrs-full:BottomOfRangeMember2021-01-012021-12-310000312069bcs:OtherSchemesMemberifrs-full:TopOfRangeMember2021-01-012021-12-310000312069bcs:OtherSchemesMember2021-12-310000312069bcs:OtherSchemesMemberifrs-full:BottomOfRangeMember2020-12-310000312069bcs:OtherSchemesMemberifrs-full:TopOfRangeMember2020-12-310000312069bcs:OtherSchemesMemberifrs-full:BottomOfRangeMember2020-01-012020-12-310000312069bcs:OtherSchemesMemberifrs-full:TopOfRangeMember2020-01-012020-12-310000312069bcs:OtherSchemesMember2020-12-310000312069ifrs-full:BottomOfRangeMemberbcs:SharesaveMember2021-01-012021-12-310000312069bcs:SharesaveMemberifrs-full:TopOfRangeMember2021-01-012021-12-310000312069bcs:DeferredShareValuePlanShareValuePlanMember2019-12-310000312069bcs:OtherSchemesMember2019-12-310000312069bcs:SharesaveMember2020-12-310000312069bcs:SharesaveMember2019-12-310000312069bcs:SharesaveMember2021-01-012021-12-310000312069bcs:SharesaveMember2020-01-012020-12-310000312069bcs:SharesaveMember2021-12-310000312069bcs:EmployeeBenefitAndOtherTrustsMember2021-12-310000312069bcs:EmployeeBenefitAndOtherTrustsMember2020-12-310000312069bcs:EmployeeBenefitAndOtherTrustsMember2021-01-012021-12-310000312069bcs:EmployeeBenefitAndOtherTrustsMember2020-01-012020-12-310000312069ifrs-full:AtCostMemberifrs-full:ForwardContractMemberbcs:CertainShareBasedPaymentSchemesMemberifrs-full:RetainedEarningsMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069srt:DirectorMember2021-12-31bcs:director0000312069bcs:IndependentDirectorMember2021-12-310000312069bcs:MemberNominatedDirectorMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2019-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:PlanAssetsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:PlanAssetsMember2019-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2019-12-310000312069ifrs-full:PlanAssetsMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:PlanAssetsMember2020-01-012020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069ifrs-full:PlanAssetsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:ForeignCountriesMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:ForeignCountriesMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:PostemploymentMedicalDefinedBenefitPlansMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberbcs:OtherPensionSchemesMember2021-12-310000312069ifrs-full:PostemploymentMedicalDefinedBenefitPlansMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberbcs:OtherPensionSchemesMember2020-12-310000312069bcs:DeficitContributionsValuationRecoveryPlanTwentyNineteenMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:NotLaterThanTenYearsMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberbcs:LaterThanElevenYearsAndNotLaterThanTwentyYearsMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069bcs:LaterThanTwentyYearsAndNotLaterThanThirtyYearsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:ActuarialAssumptionOfKeyFinancialAssumptionsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:ActuarialAssumptionOfKeyFinancialAssumptionsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForMalesAtSixtyYearsAgeMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForMalesAtSixtyYearsAgeMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForMalesAtSixtyYearsAgeMemberifrs-full:PensionDefinedBenefitPlansMember2019-01-012019-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForFemalesAtSixtyYearsAgeMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForFemalesAtSixtyYearsAgeMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForFemalesAtSixtyYearsAgeMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2019-01-012019-12-310000312069bcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForMalesAtSixtyYearsAgeForFuturePensionersAtFourtyYearsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069bcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForMalesAtSixtyYearsAgeForFuturePensionersAtFourtyYearsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069bcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForMalesAtSixtyYearsAgeForFuturePensionersAtFourtyYearsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2019-01-012019-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForFemalesAtSixtyYearsAgeForFuturePensionersAtFourtyYearsMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForFemalesAtSixtyYearsAgeForFuturePensionersAtFourtyYearsMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfLifeExpectancyAfterRetirementForFemalesAtSixtyYearsAgeForFuturePensionersAtFourtyYearsMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2019-01-012019-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:SwapContractMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfChangeInDiscountRateByFiftyBasisPointsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfChangeInDiscountRateByFiftyBasisPointsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfChangeInDiscountRateByTwentyFiveBasisPointsMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberbcs:ActuarialAssumptionOfChangeInDiscountRateByTwentyFiveBasisPointsMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfChangeInExpectedInflationRateByFiftyBasisPointsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfChangeInExpectedInflationRateByFiftyBasisPointsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069bcs:ActuarialAssumptionOfChangeInExpectedInflationRateByTwentyFiveBasisPointsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069bcs:ActuarialAssumptionOfChangeInExpectedInflationRateByTwentyFiveBasisPointsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfChangeInLifeExpectancyAfterRetirementMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:ActuarialAssumptionOfChangeInLifeExpectancyAfterRetirementMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069ifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberbcs:PrivateEquityInvestmentsMember2021-12-310000312069ifrs-full:PlanAssetsMemberbcs:PrivateEquityInvestmentsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:PlanAssetsMemberbcs:PrivateEquityInvestmentsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:PrivateEquityInvestmentsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:PrivateEquityInvestmentsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:PrivateEquityInvestmentsMember2021-12-310000312069ifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069ifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:PlanAssetsMember2021-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069bcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069bcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069bcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069ifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:PlanAssetsMember2021-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:InvestmentFundsMember2021-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMemberifrs-full:InvestmentFundsMember2021-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:InvestmentFundsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:InvestmentFundsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMemberifrs-full:InvestmentFundsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:InvestmentFundsMember2020-12-310000312069bcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069bcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069bcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2021-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2021-12-310000312069ifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069ifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:EquityInvestmentsMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberbcs:PrivateEquityInvestmentsMember2020-12-310000312069ifrs-full:PlanAssetsMemberbcs:PrivateEquityInvestmentsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:PlanAssetsMemberbcs:PrivateEquityInvestmentsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:PrivateEquityInvestmentsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:PrivateEquityInvestmentsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberbcs:PrivateEquityInvestmentsMember2020-12-310000312069ifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069ifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberbcs:BondsFixedGovernmentMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:PlanAssetsMember2020-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069bcs:BondsIndexLinkedGovernmentMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069bcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069bcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069bcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:BondsCorporateAndOtherMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:InvestmentPropertyMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069ifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:NetworkInfrastructureMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:PlanAssetsMember2020-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069bcs:CashAndCashEquivalentsMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:InvestmentFundsMember2020-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMemberifrs-full:InvestmentFundsMember2020-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:InvestmentFundsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:InvestmentFundsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMemberifrs-full:InvestmentFundsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:InvestmentFundsMember2019-12-310000312069bcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069bcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069bcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:OtherNonquotedAssetsHeldMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310000312069ifrs-full:PlanAssetsMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMemberifrs-full:PensionDefinedBenefitPlansMemberifrs-full:Level2And3OfFairValueHierarchyMember2020-12-310000312069srt:ParentCompanyMemberifrs-full:PlanAssetsMember2021-12-310000312069srt:ParentCompanyMemberifrs-full:PlanAssetsMember2020-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PlanAssetsMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:DeficitContributionsValuationRecoveryPlanCurrentYearMemberifrs-full:PensionDefinedBenefitPlansMember2021-09-300000312069bcs:DeficitContributionsValuationRecoveryPlanTwentyNineteenMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-09-300000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2020-10-012021-09-300000312069bcs:DeficitContributionsValuationRecoveryPlanTwentyNineteenMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:CurrentMemberifrs-full:PensionDefinedBenefitPlansMember2020-06-122020-06-120000312069bcs:DeficitContributionsValuationRecoveryPlanTwentyNineteenMembersrt:ScenarioForecastMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069bcs:DeficitContributionsValuationRecoveryPlanTwentyNineteenMembersrt:ScenarioForecastMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069bcs:DeficitContributionsValuationRecoveryPlanTwentyNineteenMembersrt:ScenarioForecastMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:LaterThanThreeYearsMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310000312069bcs:TheSeniorNotesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CountryOfDomicileMember2021-12-310000312069bcs:TheSeniorNotesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CountryOfDomicileMember2021-01-012021-12-31bcs:tranche0000312069bcs:TheSeniorNotesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CountryOfDomicileMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2021-01-012021-12-310000312069bcs:TheSeniorNotesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrs-full:CountryOfDomicileMember2021-01-012021-12-310000312069bcs:TheSeniorNotesMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CountryOfDomicileMember2021-01-012021-12-310000312069bcs:TheSeniorNotesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CountryOfDomicileMemberbcs:HeronIssuerLimitedMember2021-12-310000312069bcs:TheSeniorNotesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberifrs-full:CountryOfDomicileMemberbcs:HeronIssuerNumber2LimitedMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:BottomOfRangeMemberbcs:BarclaysBankPlcMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberbcs:BarclaysBankPlcMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310000312069ifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMemberifrs-full:PensionDefinedBenefitPlansMember2019-01-012019-12-310000312069bcs:Section75ContributionPlanMember2021-01-012021-12-310000312069bcs:Section75ContributionPlanMember2020-01-012020-12-310000312069bcs:Section75ContributionPlanMember2019-01-012019-12-310000312069bcs:DefinedContributionPlansMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMember2021-01-012021-12-310000312069bcs:DefinedContributionPlansMemberifrs-full:DefinedBenefitPlansOtherThanMultiemployerPlansStatePlansAndPlansThatShareRisksBetweenEntitiesUnderCommonControlMemberifrs-full:CountryOfDomicileMember2020-01-012020-12-310000312069bcs:DefinedContributionPlansMemberifrs-full:CountryOfDomicileMemberbcs:BarclaysPensionSavingsPlanMember2021-01-012021-12-310000312069bcs:DefinedContributionPlansMemberifrs-full:CountryOfDomicileMemberbcs:BarclaysPensionSavingsPlanMember2020-01-012020-12-310000312069bcs:BarclaysBankPlcMember2021-01-012021-12-310000312069bcs:BarclaysBankUkPlcMember2021-01-012021-12-310000312069bcs:BarclaysBankIrelandPlcMember2021-01-012021-12-310000312069bcs:BarclaysServicesLimitedMember2021-01-012021-12-310000312069bcs:BarclaysCapitalIncMember2021-01-012021-12-310000312069bcs:BarclaysCapitalSecuritiesLimitedMember2021-01-012021-12-310000312069bcs:BarclaysSecuritiesJapanLimitedMember2021-01-012021-12-310000312069bcs:BarclaysUsLlcMember2021-01-012021-12-310000312069bcs:BarclaysBankDelawareMember2021-01-012021-12-310000312069ifrs-full:UnconsolidatedStructuredEntitiesMember2021-01-012021-12-310000312069ifrs-full:SubsidiariesMember2021-12-310000312069ifrs-full:SubsidiariesMember2020-12-310000312069bcs:CommercialPaperAndMediumTermNoteConduitMemberbcs:ContractualBackstopLiquidityFacilitiesMember2021-12-310000312069bcs:CommercialPaperAndMediumTermNoteConduitMemberbcs:ContractualBackstopLiquidityFacilitiesMember2020-12-310000312069bcs:EmployeeBenefitAndOtherTrustsMember2021-12-310000312069bcs:EmployeeBenefitAndOtherTrustsMember2020-12-310000312069ifrs-full:AssetbackedFinancingsMember2021-12-310000312069bcs:ShortTermTradedInterestsMember2021-12-310000312069bcs:TradedDerivativesMember2021-12-310000312069bcs:OtherInterestsMember2021-12-310000312069ifrs-full:UnconsolidatedStructuredEntitiesMember2021-12-310000312069ifrs-full:AssetbackedFinancingsMember2020-12-310000312069bcs:ShortTermTradedInterestsMember2020-12-310000312069bcs:TradedDerivativesMember2020-12-310000312069bcs:OtherInterestsMember2020-12-310000312069ifrs-full:UnconsolidatedStructuredEntitiesMember2020-12-31bcs:entity0000312069ifrs-full:SecuritisationVehiclesMember2020-12-310000312069ifrs-full:DebtSecuritiesMemberifrs-full:NotLaterThanThreeMonthsMemberifrs-full:SecuritisationVehiclesMember2021-01-012021-12-310000312069ifrs-full:DerivativesMemberifrs-full:UnconsolidatedStructuredEntitiesMember2021-12-310000312069ifrs-full:DerivativesMemberifrs-full:UnconsolidatedStructuredEntitiesMember2020-12-310000312069ifrs-full:SecuritisationVehiclesMember2021-12-310000312069ifrs-full:SecuritiesLendingMember2021-12-310000312069bcs:OtherInvestmentProgramsMember2021-12-310000312069srt:ConsolidationEliminationsMemberbcs:OtherInterestsMember2021-12-310000312069ifrs-full:SecuritisationVehiclesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:SecuritiesLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:OtherInvestmentProgramsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069bcs:OtherInterestsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069srt:ConsolidationEliminationsMemberbcs:OtherInterestsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310000312069ifrs-full:SecuritiesLendingMember2020-12-310000312069bcs:OtherInvestmentProgramsMember2020-12-310000312069srt:ConsolidationEliminationsMemberbcs:OtherInterestsMember2020-12-310000312069ifrs-full:SecuritisationVehiclesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:SecuritiesLendingMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:OtherInvestmentProgramsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069bcs:OtherInterestsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069srt:ConsolidationEliminationsMemberbcs:OtherInterestsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310000312069ifrs-full:SecuritiesLendingMemberifrs-full:DebtSecuritiesMember2021-01-012021-12-310000312069ifrs-full:SecuritiesLendingMemberifrs-full:DebtSecuritiesMember2020-01-012020-12-310000312069bcs:BusinessGrowthFundMember2021-12-310000312069bcs:BusinessGrowthFundMember2020-12-310000312069bcs:BusinessGrowthFundMember2021-01-012021-12-310000312069bcs:BusinessGrowthFundMember2020-01-012020-12-310000312069ifrs-full:AssociatesMember2021-01-012021-12-310000312069ifrs-full:AssociatesMember2020-01-012020-12-310000312069ifrs-full:JointVenturesMember2021-01-012021-12-310000312069ifrs-full:JointVenturesMember2020-01-012020-12-310000312069ifrs-full:JointVenturesMemberifrs-full:AssociatesMember2021-01-012021-12-310000312069ifrs-full:JointVenturesMemberifrs-full:AssociatesMember2020-01-012020-12-310000312069ifrs-full:JointVenturesMemberifrs-full:AssociatesMember2021-12-310000312069ifrs-full:JointVenturesMemberifrs-full:AssociatesMember2020-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2021-12-310000312069bcs:CreditCardsUnsecuredAndOtherRetailLendingMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2020-12-310000312069ifrs-full:AssetbackedFinancingsMember2021-12-310000312069ifrs-full:AssetbackedFinancingsMember2021-01-012021-12-310000312069bcs:ResidentialMortgageBackedSecuritiesMember2021-12-310000312069bcs:ResidentialMortgageBackedSecuritiesMember2021-01-012021-12-310000312069bcs:CommercialMortgageBackedSecurityMember2021-12-310000312069bcs:CommercialMortgageBackedSecurityMember2021-01-012021-12-310000312069ifrs-full:AssetbackedFinancingsMember2020-12-310000312069ifrs-full:AssetbackedFinancingsMember2020-01-012020-12-310000312069bcs:ResidentialMortgageBackedSecuritiesMember2020-12-310000312069bcs:ResidentialMortgageBackedSecuritiesMember2020-01-012020-12-310000312069bcs:CommercialMortgageBackedSecurityMember2020-12-310000312069bcs:CommercialMortgageBackedSecurityMember2020-01-012020-12-310000312069ifrs-full:TradeReceivablesMember2021-12-310000312069ifrs-full:TradeReceivablesMember2020-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember2021-12-310000312069ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember2020-12-310000312069ifrs-full:DerivativesMember2021-12-310000312069bcs:ReverseRepurchaseAndRepurchaseAgreementsMember2021-12-310000312069ifrs-full:SecuritiesLendingMember2021-12-310000312069bcs:OtherFinancialAssetsMember2021-12-310000312069ifrs-full:DerivativesMember2020-12-310000312069bcs:ReverseRepurchaseAndRepurchaseAgreementsMember2020-12-310000312069ifrs-full:SecuritiesLendingMember2020-12-310000312069bcs:OtherFinancialAssetsMember2020-12-310000312069bcs:OtherFinancialAssetsMemberifrs-full:SecuritisationVehiclesMember2021-12-310000312069bcs:OtherFinancialAssetsMemberifrs-full:SecuritisationVehiclesMember2020-12-310000312069bcs:AssetBackedFundingProgrammesMember2021-12-310000312069bcs:AssetBackedFundingProgrammesMember2020-12-310000312069ifrs-full:AssociatesMember2021-01-012021-12-310000312069ifrs-full:JointVenturesWhereEntityIsVenturerMember2021-01-012021-12-310000312069bcs:PensionFundsUnitTrustsAndInvestmentFundsMember2021-01-012021-12-310000312069ifrs-full:AssociatesMember2021-12-310000312069ifrs-full:JointVenturesWhereEntityIsVenturerMember2021-12-310000312069bcs:PensionFundsUnitTrustsAndInvestmentFundsMember2021-12-310000312069ifrs-full:AssociatesMember2020-01-012020-12-310000312069ifrs-full:JointVenturesWhereEntityIsVenturerMember2020-01-012020-12-310000312069bcs:PensionFundsUnitTrustsAndInvestmentFundsMember2020-01-012020-12-310000312069ifrs-full:AssociatesMember2020-12-310000312069ifrs-full:JointVenturesWhereEntityIsVenturerMember2020-12-310000312069bcs:PensionFundsUnitTrustsAndInvestmentFundsMember2020-12-310000312069ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2020-12-310000312069ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2019-12-310000312069ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2021-01-012021-12-310000312069ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2020-01-012020-12-310000312069ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2021-12-310000312069bcs:DirectorsMemberbcs:DeferredShareValuePlanShareValuePlanMember2021-01-012021-12-310000312069bcs:DirectorsMemberbcs:DeferredShareValuePlanShareValuePlanMember2020-01-012020-12-310000312069bcs:DirectorsMember2021-01-012021-12-310000312069bcs:DirectorsMember2020-01-012020-12-310000312069ifrs-full:OrdinarySharesMemberbcs:DirectorsAndOfficersMember2021-12-310000312069ifrs-full:OrdinarySharesMemberbcs:DirectorsAndOfficersMember2020-12-310000312069ifrs-full:OrdinarySharesMemberbcs:SharesaveMemberbcs:DirectorsAndOfficersMember2021-12-310000312069ifrs-full:OrdinarySharesMemberbcs:SharesaveMemberbcs:DirectorsAndOfficersMember2020-12-310000312069ifrs-full:OrdinarySharesMemberbcs:SharesaveMemberbcs:DirectorsAndOfficersMember2021-01-012021-12-310000312069bcs:DirectorsMemberbcs:DefinedContributionPlansMember2021-12-310000312069bcs:DirectorsMemberbcs:DefinedContributionPlansMember2020-12-310000312069ifrs-full:SubsidiariesMember2021-01-012021-12-310000312069ifrs-full:SubsidiariesMember2020-01-012020-12-310000312069ifrs-full:SubsidiariesMember2019-01-012019-12-310000312069bcs:OtherAuditRelatedFeesMember2021-01-012021-12-310000312069bcs:OtherAuditRelatedFeesMember2020-01-012020-12-310000312069bcs:OtherAuditRelatedFeesMember2019-01-012019-12-310000312069bcs:OtherAuditorServicesMember2021-01-012021-12-310000312069bcs:OtherAuditorServicesMember2020-01-012020-12-310000312069bcs:OtherAuditorServicesMember2019-01-012019-12-310000312069bcs:AuditFeeRelatingToPreviousYearMember2021-01-012021-12-310000312069bcs:AuditFeeRelatingToPreviousYearMember2020-01-012020-12-310000312069bcs:KlynveldPeatMarwickGoerdelerMember2021-01-012021-12-310000312069bcs:KlynveldPeatMarwickGoerdelerMember2020-01-012020-12-310000312069bcs:KlynveldPeatMarwickGoerdelerMember2019-01-012019-12-310000312069bcs:OtherAuditRelatedFeesMemberbcs:KlynveldPeatMarwickGoerdelerMember2021-01-012021-12-310000312069bcs:OtherAuditRelatedFeesMemberbcs:KlynveldPeatMarwickGoerdelerMember2020-01-012020-12-310000312069bcs:OtherAuditRelatedFeesMemberbcs:KlynveldPeatMarwickGoerdelerMember2019-01-012019-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHF2021-12-310000312069bcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMembercurrency:GBP2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMembercurrency:USD2021-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHFifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:GBP2020-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:USD2020-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHF2020-12-310000312069bcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMembercurrency:GBP2020-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMembercurrency:USD2020-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2020-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHFifrs-full:OtherEquityInterestMember2020-12-310000312069bcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2020-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:USD2021-01-012021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:GBP2021-01-012021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:GBP2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:USD2021-12-310000312069ifrs-full:InterestRateRiskMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMembercurrency:GBP2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMembercurrency:USD2021-12-310000312069bcs:ClearedByCentralCounterpartyMembercurrency:EURbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMembercurrency:JPYbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMembercurrency:CHF2021-12-310000312069bcs:OtherCurrenciesMemberbcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMembercurrency:GBP2021-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMembercurrency:USD2021-12-310000312069currency:EURbcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069currency:JPYbcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMembercurrency:CHF2021-12-310000312069bcs:OtherCurrenciesMemberbcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:GBP2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:USD2021-12-310000312069ifrs-full:CurrencyRiskMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMembercurrency:GBP2021-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMembercurrency:USD2021-12-310000312069currency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2021-12-310000312069currency:EURbcs:InterbankOfferedRateReformMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:GBP2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:USD2020-12-310000312069ifrs-full:InterestRateRiskMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMembercurrency:GBP2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMembercurrency:USD2020-12-310000312069bcs:ClearedByCentralCounterpartyMembercurrency:EURbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMembercurrency:JPYbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMembercurrency:CHF2020-12-310000312069bcs:OtherCurrenciesMemberbcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:ClearedByCentralCounterpartyMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMembercurrency:GBP2020-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMembercurrency:USD2020-12-310000312069currency:EURbcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069currency:JPYbcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMembercurrency:CHF2020-12-310000312069bcs:OtherCurrenciesMemberbcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:ExchangeTradedDerivativesMemberbcs:InterbankOfferedRateReformMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:GBP2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:USD2020-12-310000312069ifrs-full:CurrencyRiskMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMembercurrency:GBP2020-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMembercurrency:USD2020-12-310000312069currency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:OtherCurrenciesMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberifrs-full:EquityPriceRiskMember2020-12-310000312069currency:EURbcs:InterbankOfferedRateReformMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:CurrencySwapContractMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:CurrencySwapContractMember2020-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:ProvisionForCreditCommitmentsMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:ProvisionForCreditCommitmentsMember2020-12-310000312069bcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMembercurrency:GBP2021-12-310000312069bcs:WithAppropriateFallbackClauseMembercurrency:JPYbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMembercurrency:CHF2021-12-310000312069bcs:WithAppropriateFallbackClauseMembercurrency:EURbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:WithoutAppropriateFallbackClauseMembercurrency:GBP2021-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHFbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069currency:EURbcs:InterbankOfferedRateReformMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069bcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMembercurrency:GBP2021-12-310000312069bcs:WithAppropriateFallbackClauseMembercurrency:JPYbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMembercurrency:CHFifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:WithAppropriateFallbackClauseMembercurrency:EURbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMemberbcs:WithoutAppropriateFallbackClauseMembercurrency:GBP2021-12-310000312069currency:JPYbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069bcs:InterbankOfferedRateReformMembercurrency:CHFifrs-full:OtherEquityInterestMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069currency:EURbcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberifrs-full:OtherEquityInterestMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:GBP2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberbcs:EuroOvernightIndexAverageEoniaMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:WithAppropriateFallbackClauseMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:WithAppropriateFallbackClauseMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMembercurrency:GBP2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:EuroOvernightIndexAverageEoniaMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:InterestRateRiskMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:InterestRateRiskMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:InterestRateRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMembercurrency:GBP2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberbcs:EuroOvernightIndexAverageEoniaMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:WithAppropriateFallbackClauseMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:WithAppropriateFallbackClauseMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMembercurrency:GBP2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:EuroOvernightIndexAverageEoniaMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:CurrencyRiskMembercurrency:JPYbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMembercurrency:CHFbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:CurrencyRiskMembercurrency:EURbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069ifrs-full:CurrencyRiskMemberbcs:InterbankOfferedRateReformMemberbcs:OverTheCounterDerivativesMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069bcs:WithAppropriateFallbackClauseMemberbcs:InterbankOfferedRateReformMemberbcs:EuroOvernightIndexAverageEoniaMember2021-12-310000312069bcs:InterbankOfferedRateReformMemberbcs:EuroOvernightIndexAverageEoniaMemberbcs:WithoutAppropriateFallbackClauseMember2021-12-310000312069srt:ParentCompanyMemberbcs:BarclaysBankPlcMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:BarclaysExecutionServicesLimitedMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:BarclaysUkMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMember2020-01-012020-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMember2019-01-012019-12-310000312069srt:ParentCompanyMemberifrs-full:SubsidiariesMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:SubsidiariesMember2020-01-012020-12-310000312069srt:ParentCompanyMemberbcs:BarclaysBankPlcMember2021-12-310000312069srt:ParentCompanyMemberbcs:BarclaysBankPlcMember2020-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMemberbcs:BarclaysBankPlcMember2021-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMemberbcs:BarclaysBankPlcMember2020-12-310000312069srt:ParentCompanyMemberbcs:BarclaysUkMember2021-12-310000312069srt:ParentCompanyMemberbcs:BarclaysUkMember2020-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMemberbcs:BarclaysUkMember2021-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMemberbcs:BarclaysUkMember2020-12-310000312069srt:ParentCompanyMemberbcs:BarclaysUkMember2020-01-012020-12-310000312069srt:ParentCompanyMemberbcs:AdditionalTierOneSecuritiesMemberbcs:BarclaysUkMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:SubordinatedNotesMemberifrs-full:SubsidiariesMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:SubordinatedNotesMemberbcs:BarclaysUkMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberbcs:SeniorNotessMemberifrs-full:OnDemandMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:FixedAndFloatingRateMemberbcs:SeniorNotessMemberifrs-full:OnDemandMember2021-01-012021-12-310000312069srt:ParentCompanyMemberbcs:ZeroCouponMemberifrs-full:OnDemandMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberifrs-full:OnDemandMember2021-01-012021-12-310000312069srt:ParentCompanyMemberifrs-full:FixedInterestRateMemberifrs-full:SubsidiariesMemberifrs-full:OnDemandMember2021-01-012021-12-31


















SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 20-F
(Mark One)
¨REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
þANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended 31 December 2021
OR
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________to _______________
¨SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report _______________
Commission file numberBarclays PLC1-09246

BARCLAYS PLC
(Exact Name of Registrant as Specified in its Charter)

England
(Jurisdiction of Incorporation or Organization)

1 CHURCHILL PLACE, LONDON E14 5HP, England
(Address of Principal Executive Offices)

GARTH WRIGHT, +44 (0)20 7116 3170, GARTH.WRIGHT@BARCLAYS.COM
1 CHURCHILL PLACE, LONDON E14 5HP, England
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport



















Title of each classTrading symbol(s)Name of each exchange on which registered
25p ordinary shares*Not applicable*New York Stock Exchange*
American Depositary Shares, each representing four 25p ordinary sharesBCSNew York Stock Exchange
4.338% Fixed-to-Floating Rate Senior Notes due 2024BCS24ANew York Stock Exchange
Floating Rate Senior Notes due 2024BCS24BNew York Stock Exchange
4.972% Fixed-to-Floating Rate Senior Notes due 2029BCS29New York Stock Exchange
4.610% Fixed-to-Floating Rate Senior Notes due 2023BCS23BNew York Stock Exchange
Floating Rate Senior Notes due 2023BCS23CNew York Stock Exchange
4.375% Fixed Rate Subordinated Notes due 2024BCS24New York Stock Exchange
3.65% Fixed Rate Senior Notes due 2025BCS25New York Stock Exchange
5.25% Fixed Rate Senior Notes due 2045BCS45New York Stock Exchange
4.375% Fixed Rate Senior Notes due 2026BCS26New York Stock Exchange
5.20% Fixed Rate Subordinated Notes due 2026BCS26ANew York Stock Exchange
Floating Rate Senior Notes due 2023BCS23New York Stock Exchange
3.684% Fixed Rate Senior Notes due 2023BCS23ANew York Stock Exchange
4.337% Fixed Rate Senior Notes due 2028BCS28New York Stock Exchange
4.950% Fixed Rate Senior Notes due 2047BCS47New York Stock Exchange
4.836% Fixed Rate Subordinated Callable Notes due 2028BCS28ANew York Stock Exchange
3.250% Fixed Rate Senior Notes due 2033BCS33New York Stock Exchange
3.932% Fixed-to-Floating Rate Senior Notes due 2025BCS25ANew York Stock Exchange
5.088% Fixed-to-Floating Rate Subordinated Notes due 2030BCS30New York Stock Exchange
2.852% Fixed-to-Floating Rate Senior Notes due 2026BCS26BNew York Stock Exchange
2.645% Fixed Rate Resetting Senior Callable Notes due 2031BCS31New York Stock Exchange
3.564% Fixed Rate Resetting Subordinated Callable Notes due 2035BCS35New York Stock Exchange
1.007% Fixed Rate Resetting Senior Callable Notes due 2024BCS24CNew York Stock Exchange
2.667% Fixed Rate Resetting Senior Callable Notes due 2032BCS32New York Stock Exchange
3.811% Fixed Rate Resetting Subordinated Callable Notes due 2042BCS42New York Stock Exchange
2.279% Fixed Rate Resetting Senior Callable Notes due 2027BCS27New York Stock Exchange
2.894% Fixed Rate Resetting Senior Callable Notes due 2032BCS32ANew York Stock Exchange
3.330% Fixed Rate Resetting Senior Callable Notes due 2042BCS42ANew York Stock Exchange
* Not for trading, but in connection with the registration of American Depository Shares, pursuant to the requirements to the Securities and Exchange Commission.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport



















Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.
25p ordinary shares16,752,457,128 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes þ No ¨

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934.
Yes ¨ No þ

Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and submit such files).
Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large Accelerated FilerþAccelerated Filer¨Non-Accelerated Filer¨Emerging growth company¨

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ¨

The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. þ

*Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
U.S. GAAP ¨
International Financial Reporting Standards as issued by the International Accounting Standards Board þ
Other ¨
*If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:
Item 17 ¨
Item 18 ¨

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No þ

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
Yes ¨ No ¨
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport



















SEC Form 20-F Cross reference information
Form 20-F item numberPage and caption references
in this document*
1Identity of Directors, Senior Management and AdvisersNot applicable
2Offer Statistics and Expected TimetableNot applicable
3Key Information
A. [Reserved]
B. Capitalization and indebtednessNot applicable
C. Reason for the offer and use of proceedNot applicable
D. Risk factors102-113
4Information on the Company
A. History and development of the companyi (Notes), 11 – 14, 193 – 211, 274 – 278 (Note 26), 303 – 307 (Note 41), 312, 317
B. Business overviewii (Market and other data), 104 – 105, 187 – 192, 228 – 229 (Note 2)
C. Organizational structure
293 – 296 (Notes 34 and 35), 329 - 332
D. Property, plants and equipment
264 - 267 (Notes 20 and 21)
4AUnresolved staff commentsNot applicable
5Operating and Financial Review and Prospects
A. Operating result31 – 33, 100 – 121, 109, 179 – 180, 184 – 185, 187 – 192, 244 – 251 (Note 14)
B. Liquidity and capital resource108, 119, 163 – 172, 174 – 175, 182 – 183, 220, 223, 244 – 251 (Note 14), 279 – 283 (Notes 27 and 28), 293 – 294 (Note 34), 298 – 299 (Note 37), 333 – 345

C. Research and development, patents and licenses, etc50
D. Trend information
102 – 113, 161 – 183, 197 - 199
E. Critical Accounting EstimatesNot applicable
F. [Reserved]
G. [Reserved]
6Directors, Senior Management and Employees
A. Directors and senior management
3 – 6, 47 – 59, 321 - 322
B. Compensation
56 – 77, 78 – 83, 286 - 292 (Notes 32 and 33), 301 - 303 (Note 39), 324 - 325
C. Board practice
4 – 9, 22 – 30, 39 – 46, 56 – 77, 98 – 100, 100 - 101
D. Employee
92 – 94, 200, 202, 206, 228 - 229 (Note 2)
E. Share ownership
89, 286 - 287 (Note 32), 301 - 303 (Note 39), 324 - 325
7Major Shareholders and Related Party Transactions
A. Major shareholder
52, 320
B. Related party transaction
301 - 303 (Note 39), 345
C. Interest of experts and counselNot applicable
8Financial Information
A. Consolidated statements and other financial information
212 – 309, 314
B. Significant changeNot applicable
9The Offer and Listing
A. Offer and listing detail
314, 319
B. Plan of distributionNot applicable
C. Market
314, 319
D. Selling shareholderNot applicable
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport



















E. DilutionNot applicable
F. Expenses of the issueNot applicable
10Additional Information
A. Share capitalNot applicable
B. Memorandum and Articles of Association47 – 59, 312 - 314
C. Material contract
62 – 66, 89
D. Exchange control317
E. Taxation315 - 317
F. Dividends and paying agentNot applicable
G. Statement by expertNot applicable
H. Documents on display317
I. Subsidiary information293 - 294 (Note 34), 329 - 332
11Quantitative and Qualitative Disclosure about Market Risk98 – 192, 244 - 262 (Notes 14-17)
12Description of Securities Other than Equity Securities
A. Debt SecuritiesNot applicable
B. Warrants and RightsNot applicable
C. Other SecuritiesNot applicable
D. American Depository Shares318
13Defaults, Dividend Averages and DelinquenciesNot applicable
14Material Modifications to the Rights of Security Holders and Use of ProceedsNot applicable
15Controls and Procedures
A. Disclosure controls and procedures321
B. Management's annual report on internal control over financial reporting45
C. Attestation report of the registered public accounting firm213 - 214
D. Changes in internal control over financial reporting46
16AAudit Committee Financial Expert22 - 30
16BCode of Ethics319
16CPrincipal Accountant Fees and Services303 (Note 40)
16DExemptions from Listing Standards for Audit CommitteesNot applicable
16EPurchases of Equity Securities by the Issuer and Affiliated Purchasers322
16FChange in Registrant's Certifying AccountantNot applicable
16GCorporate Governance39 – 46, 319
16HMine Safety DisclosureNot applicable
16IDisclosure Regarding Foreign Jurisdictions that Prevent InspectionsNot applicable
17Financial StatementsNot applicable (See item 8)
18Financial StatementsNot applicable (See item 8)
19ExhibitsExhibit Index

* Captions have been included only in respect of pages with multiple sections on the same page in order to identify the relevant caption on that page covered by the corresponding Form 20-F item number.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport



















2021 Annual Report on Form 20-F
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport



















Notes
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the year ended 31 December 2021 to the corresponding twelve months of 2020 and balance sheet analysis as at 31 December 2021 with comparatives relating to 31 December 2020. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary that can be accessed at home.barclays/investor-relations/reports-and-events/latest-financial-results.

The information in this document, which was approved by the Board of Directors on 22 February 2022, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2021, which contain an unmodified audit report under Section 495 of the Companies Act 2006 (which does not make any statements under Section 498 of the Companies Act 2006), will be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

Non-IFRS performance measures
Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 207 to 211 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

Key non-IFRS measures included in this document, and the most directly comparable IFRS measures, are:

– Average allocated equity represents the average shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is average equity. A reconciliation is provided on page 209;

– Average allocated tangible equity is calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. Period end allocated tangible equity is calculated as 13.5% (2020: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group’s tangible shareholders’ equity and the amounts allocated to businesses. The comparable IFRS measure is average equity. A reconciliation is provided on page 209;

– Average tangible shareholders’ equity is calculated as the average of the previous month’s period end tangible equity and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period. The comparable IFRS measure is average equity. A reconciliation is provided on page 209;

– Return on average allocated equity represents the return on shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is return on equity. A reconciliation is provided on page 211;

– Return on average allocated tangible equity is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The comparable IFRS measure is return on equity. A reconciliation is provided on page 208;

– Return on average tangible shareholders’ equity excluding structural cost actions and the re-measurement of UK DTAs is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent excluding structural cost actions and the re-measurement of UK DTAs, as a proportion of average allocated tangible equity. The comparable IFRS measure is return on equity. A reconciliation is provided on page 210;

– Return on average tangible shareholders’ equity excluding structural cost actions and community aid package is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent excluding structural cost actions and community aid package, as a proportion of average allocated tangible equity. The comparable IFRS measure is return on equity. A reconciliation is provided on page 210;

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport



















– Return on average tangible shareholders’ equity is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The comparable IFRS measure is return on equity. A reconciliation is provided on page 209; and

– Tangible net asset value per share is calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. A reconciliation is provided on page 210.

Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, income growth, assets, impairment charges, provisions, business strategy, capital, leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings, any commitments and targets (including, without limitation, environmental, social and governance (ESG) commitments and targets), estimates of capital expenditures, plans and objectives for future operations, projected employee numbers, IFRS impacts and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. The forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, the development of standards and interpretations under IFRS, including evolving practices with regard to the interpretation and application of accounting and regulatory standards, emerging and developing ESG reporting standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of conduct provisions, the policies and actions of governmental and regulatory authorities, the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, environmental, social and geopolitical risks, and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; the effects of any volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of any entity within the Group or any securities issued by such entities; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (“EU”), the effects of the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or operations; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a result, the Group’s actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance measures or ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements.

Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Market and other data
This document contains information, including statistical data, about certain Barclays markets and its competitive position. Except as otherwise indicated, this information is taken or derived from Datastream and other external sources. Barclays cannot guarantee the accuracy of information taken from external sources, or that, in respect of internal estimates, a third party using different methods would obtain the same estimates as Barclays.

Uses of Internet addresses
This document contains inactive textual addresses to internet websites operated by us and third parties. Reference to such websites is made for information purposes only, and information found at such websites is not incorporated by reference into this document.

References to Strategic Report, Pillar 3 Report and TCFD Report
This document contains references throughout to the Barclays PLC Strategic Report, Pillar 3 Report and TCFD Report. References to the aforementioned reports are made for information purposes only, and information found in said reports is not incorporated by reference into this document.








Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport

Contents
What's inside this report
Governance
Governance contents
2
Directors’ report
3
Remuneration report
54
Our people and culture
92
Risk review
Risk review contents
98
Risk management
100
Material existing and emerging risks
102
Climate change risk management
114
Principal risk management
116
Risk performance
122
Supervision and regulation
187
Financial review
Financial review contents
193
Key performance indicators
194
Consolidated summary income statement
196
Income statement commentary
197
Consolidated summary balance sheet
198
Balance sheet commentary
199
Analysis of results by business
200
Non-IFRS performance measures
207
Financial statements
Financial statements contents
212
Consolidated financial statements
215
Notes to the financial statements
224
Shareholder information
Key dates, Annual General Meeting, dividends, and other useful information
310
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
1


Our Governance
Welcome to our 2021 Governance report. In this report you can see the composition of our Board and our Executive Committee, and find out how our governance framework operates, along with information about the Board's key areas of focus in 2021.
Aim of our governance
The primary aim of our governance is that it:
seeks to ensure that our decision-making is aligned to our Purpose, Values and Mindset
creates long-term sustainable value for our shareholders, having regard to the interests of all our stakeholders
is effective in providing constructive challenge, advice and support to management
provides checks and balances and drives informed, collaborative and accountable decision-making.

Compliance with the Code and Regulations
Our Governance report reflects the requirements of the 2018 UK Corporate Governance Code (the Code) and the Companies (Miscellaneous Reporting) Regulations 2018 (the Regulations).

To view our specific compliance as against the Code, please see pages 39 to 46.

Certain additional information, signposted throughout this report, is available at home.barclays/corporategovernance
Directors’ report
Our Board of Directors
3
Group Executive Committee
7
Our Governance Framework
8
Key Board Activities in 2021
11
Board Nominations Committee report
15
Board Audit Committee report
22
Board Risk Committee report
31
How we comply
39
Other statutory information
47
Remuneration report54
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
2


Directors’ report: Our Board of Directors

Informed by our Purpose, responsible for setting our strategic direction
Nigel Higgins
Group Chairman
C.S. Venkatakrishnan
Group Chief Executive

Brian Gilvary
Senior Independent
Director
Mike Ashley
Independent
Non-Executive
Director
Robert Berry
Independent
Non-Executive
Director

Tim Breedon CBE
Independent
Non-Executive
Director
Mohamed A. El-Erian
Independent
Non-Executive
Director
Dawn Fitzpatrick
Independent
Non-Executive
Director

Mary Francis CBE
Independent
Non-Executive
Director
Crawford Gillies
Independent Non-Executive
Director
Tushar Morzaria
Group Finance
Director

Diane Schueneman
Independent
Non-Executive
Director
Julia Wilson
Independent
Non-Executive
Director
Stephen Shapiro
Group General
Counsel and Group
Company Secretary

bcs-20211231_g1.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
3


Nigel Higgins
Group Chairman
Appointed:
March 2019 (Board), May 2019 (Chairman)
Skills, experience and contribution:
Seasoned business leader with extensive experience in, and understanding of, banking and the financial services industry
Strong track record in leading and chairing organisations
Significant experience in providing strategic advice to major international organisations and governments
Keenly focused on culture and corporate governance
Nigel spent 36 years at Rothschild & Co. where he was most recently Deputy Chairman. Prior to that he was Chairman of the Group Executive Committee and Managing Partner of Rothschild & Co.
Key current appointments:
Chairman, Sadler’s Wells; Non- Executive Director, Tetra Laval Group
C.S. Venkatakrishnan
Group Chief Executive
Appointed:
November 2021
Skills, experience and contribution:
Highly regarded leader with significant banking and financial services experience
Extensive experience in risk management
Deep understanding of the business and the markets within which the Group operates
Prior to his appointment as Group Chief Executive, Venkat served as Head of Global Markets and Co-President of Barclays Bank PLC from October 2020 and Group Chief Risk Officer from 2016 to 2020. Venkat is the executive sponsor for Embrace, the global multi-cultural network at Barclays. Prior to joining Barclays in 2016, Venkat worked at JPMorgan Chase from 1994, holding senior roles in Asset Management where he was Chief Investment Officer in Global Fixed Income, as well as in Investment Banking, and in Risk.
Key current appointments:
Board Member, Institute of International Finance; Advisory member to the Board, Massachusetts Institute of Technology Golub Centre for Finance and Policy
Brian Gilvary
Senior Independent Director (SID)
Appointed:
February 2020 (Board), January 2021 (SID)
Skills, experience and contribution:
Extensive senior level experience of management, finance and strategy
Deep experience of US and UK shareholder engagement
Significant experience with, and understanding of, the challenges and opportunities inherent in advancing a sustainable energy future
Brian spent much of his career with bp p.l.c. in senior leadership roles, where he was most recently Chief Financial Officer. His other senior-level experience includes serving on the boards of various commercial and charitable organisations. Brian was Chair of the FTSE 100 Group of Finance Directors, a member of the UK Treasury Financial Management Review Board and has served on various HRH Prince of Wales' Business in the Community Leadership Teams.
Key current appointments:
Executive Chairman, INEOS Energy, an INEOS group company
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
4


Mike Ashley
Independent Non-Executive Director
Appointed:
September 2013
Skills, experience and contribution:
Specialised knowledge of accounting and audit related matters
Extensive experience of auditing large international financial institutions
Deep financial services and regulatory knowledge and experience
Mike previously worked at KPMG for over 20 years. Mike's former roles include acting as the lead engagement partner on the audits of large financial services groups including HSBC, Standard Chartered and the Bank of England, as Head of Quality and Risk Management for KPMG Europe LLP and as KPMG UK's Ethics Partner.
Key current appointments:
Member, Cabinet Office Board; Member, UK Endorsement Board; Member, ICAEW Ethics Standards Committee; Treasurer, The Scout Association
Robert Berry
Independent Non-Executive Director
Appointed:
February 2022
Skills, experience and contribution:
Proven track record of management of risk exposure for a global financial institution and building a modern group-wide risk management organisation
Strong record of integrating risk management with strategy
Significant experience in finance, model development and trading
Robert was appointed to the Board on 8 February 2022 and, with effect from 1 March 2022, will take over the role of Chair of the Board Risk Committee (subject to regulatory approval) and become a member of the Board Audit Committee. Robert had a 28-year career at Goldman Sachs, where, most recently, he was the Co-Deputy Chief Risk Officer until 2018.
Key current appointments:
Board President, Alina Lodge
Tim Breedon CBE
Independent Non-Executive Director
Appointed:
November 2012
Skills, experience and contribution:
Significant experience in strategic planning
Extensive financial services experience
Detailed knowledge of risk management and UK and EU regulation
Tim is a member of the Board and is also Chair of Barclays Bank Ireland PLC (also referred to as Barclays Europe). He had a distinguished career with Legal & General, where, among other roles, he was the Group Chief Executive Officer until June 2012. Tim also served as Chair of the Association of British Insurers. Tim will retire as a member and Chair of the Board Risk Committee and a member of the Board Nominations Committee with effect from 28 February 2022.
Key current appointments:
Chairman, Apax Global Alpha Limited; Non-Executive Director, Quilter PLC
Mohamed A. El-Erian
Independent Non-Executive Director
Appointed:
January 2020
Skills, experience and contribution:
Highly respected economist and investor
Extensive experience in the asset management industry and multilateral institutions
Deep knowledge and understanding of international economics and financial services sector
Mohamed is Chief Economic Advisor at Allianz SE, the corporate parent of PIMCO (Pacific Investment Management Company LLC) where he formerly served as Chief Executive and Co-Chief Investment Officer. Mohamed is a regular columnist for Bloomberg Opinion and a contributing editor at the Financial Times. He spent 15 years at the IMF where he served as Deputy Director before moving to the private sector and financial services. He currently serves as President of Queens' College, Cambridge University.
Key current appointments:
Lead Independent Director, Under Armour Inc.; Chief Economic Adviser, Allianz SE; Chairman, Gramercy Funds Management; Senior Advisor, Investcorp Bank BSC
Dawn Fitzpatrick
Independent Non-Executive Director
Appointed:
September 2019
Skills, experience and contribution:
Extensive management experience of international financial institutions
Strong financial and strategic leadership experience
Detailed knowledge of the markets in which the Group operates
Dawn holds the role of Chief Executive Officer and Chief Investment Officer at Soros Fund Management LLC. Her previous experience includes 25 years with UBS, most recently as Head of Investments for UBS Asset Management.
Key current appointments:
Chief Executive Officer and Chief Investment Officer, Soros Fund Management LLC; Member, The New York Federal Reserve’s Investor Advisory Committee on Financial Markets; Member, Advisory Board and Investment Committee of the Open Society Foundations’ Economic Justice Programme;
Advisory Council Member, The Bretton Woods Committee
Mary Francis CBE
Independent Non-Executive Director
Appointed:
October 2016
Skills, experience and contribution:
Extensive board-level experience across a range of industries
Strong focus on reputation management and promoting board governance values
Detailed understanding of the interaction between public and private sectors
Mary's previous appointments include Non-Executive Directorships at the Bank of England, Alliance & Leicester, Aviva, Centrica and Swiss Re Group. In her executive career, Mary held senior positions with both HM Treasury and the Prime Minister's Office and served as Director General of the Association of British Insurers.
Key current appointments:
Senior Independent Director, PensionBee Group PLC; Member, UK Takeover Appeal Board
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
5


Crawford Gillies
Independent Non-Executive
Director
Appointed:
May 2014
Skills, experience and contribution:
Extensive business transformation and management experience in international and cross-sector organisations
Deep understanding and experience of stakeholder engagement
Strong leadership qualities and expert at strategic decision-making
Crawford is a member of the Board having previously held the roles of Senior Independent Director and Chair of the Board Remuneration Committee. He is Chair of Barclays Bank UK PLC. Crawford has held a number of roles during his 30-year career including Managing Partner Europe of Bain & Company, Chair of Scottish Enterprise and the Confederation of British Industry London (CBI) and Non-Executive Director roles at both Standard Life and SSE.
Key current appointments:
Chairman, Edrington Group
Tushar Morzaria
Group Finance
Director
Appointed:
October 2013*
Skills, experience and contribution:
Extensive knowledge of strategic financial management, investment banking and operational and regulatory relations
Deep understanding of equity and debt capital management
Significant financial leadership experience of international financial institutions
Tushar is a chartered accountant and Group Finance Director with responsibility for Finance, Tax, Treasury, Investor Relations and Strategy. Immediately prior to joining Barclays, Tushar was Chief Financial Officer of the Corporate and Investment Bank at JPMorgan Chase and before that, held various roles at SG Warburg, Credit Suisse and JPMorgan Chase.
Key current appointments:
Non-Executive Director bp p.l.c.; Member, 100 Group Main Committee; Chair, Sterling Risk Free Reference Rates Working Group
*On 22 February 2022, Tushar notified the Board of his intention to retire from the Board and as Group Finance Director, and the Board has agreed that this will take effect on 22 April 2022.
Diane Schueneman
Independent Non-Executive Director
Appointed:
June 2015
Skills, experience and contribution:
Significant experience of managing global, cross-discipline business operations and client services in the financial services industry
Strong transformational programme experience
Extensive technology and information security expertise
Diane is Chair of Barclays Execution Services Limited and a member of the Board of Barclays US LLC. Diane was previously Global Chief Infrastructure Officer of Merrill Lynch, where she was responsible for all technology and operations across retail, corporates and banking.
Key current appointments:
None
Julia Wilson
Independent Non-Executive Director
Appointed:
April 2021
Skills, experience and contribution:
Significant board and executive-level strategic and financial leadership experience
Extensive accounting, audit and financial services expertise
Strong UK regulatory experience
Julia is a chartered accountant and is the Group Finance Director of 3i Group plc, having served on its board since 2008. Prior to joining 3i she was Group Director of Corporate Finance at Cable & Wireless where she also held a number of finance related roles. Julia was appointed as a Non-Executive Director at Legal & General Group PLC in 2011. She chaired L&G’s Audit Committee between 2013 and 2016 and was Senior Independent Director from 2016 until she stepped down from L&G in March 2021.
Key current appointments:
Group Finance Director, Director, 3i Group plc;
Chair, The 100 Group of FTSE 100 Finance Director

Stephen Shapiro
Group General Counsel
and Group Company Secretary
Appointed:
November 2017
Relevant skills and experience
Stephen is an experienced lawyer and company secretary with a deep understanding of legal, corporate governance and regulatory matters. Holding the combined role of Group General Counsel and Group Company Secretary, he oversees Barclays’ global Legal and Corporate Secretariat functions. Stephen is also a member of the Group Executive Committee (ExCo).
Career
Stephen previously served as the Group Company Secretary and Deputy General Counsel of SABMiller plc. Prior to this, he practised law as a partner in a law firm in South Africa, and subsequently in corporate law and M&A at Hogan Lovells in the UK. He was appointed as Group Company Secretary of Barclays in November 2017 and was subsequently appointed Group General Counsel in August 2020, in addition to his role as Company Secretary. Stephen is an active industry contributor and serves as a member of the GC100 Executive Committee, the association of General Counsel and Company Secretaries working in FTSE 100 companies, having previously served as Vice-Chair until January 2022. Stephen also previously served as Chairman of the ICC UK’s Committee on Anti-Corruption.


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
6


Directors’ report: Our Group Executive Committee
Barclays has a deep bench of senior leadership talent, with a balance of skills and experience to deliver our strategic ambitions.
Continuity in Barclays’ strategy and leadership within ExCo
C.S. Venkatakrishnan (known as Venkat) was appointed as the Group Chief Executive on 1 November 2021, as detailed in the report of the Board Nominations Committee on pages 15 to 21. Shortly after his appointment, Venkat announced a series of changes to the roles of the existing members of the ExCo, with effect from 9 November 2021. These changes will ensure that, as our most senior management committee for the Group, ExCo is well-placed to support Venkat in his new role. ExCo will continue to have the right balance of skills and experience that we need in order to deliver for our stakeholders, and to not only maintain, but accelerate the Group's performance. The changes detailed below remain subject to regulatory approval where necessary.
Changes to ExCo in 2021
On Venkat's appointment as Group Chief Executive, Paul Compton became the sole President of Barclays Bank PLC (BBPLC) and the Global Head of the
Corporate and Investment Bank. Paul joined Barclays in 2016, initially as the Chief Operating Officer, and was most recently a Co-President of BBPLC (alongside Venkat), and the Global Head of Banking. Paul has been the driving force behind our success with the Power of One Barclays initiative – bringing the whole organisation more closely together to deliver the best of Barclays to our clients.
Stephen Dainton stepped down from ExCo to take on the role of Co-Head of Global Markets alongside Adeel Khan, reporting into Paul Compton. We are grateful to Stephen for his continued contribution as he takes on his new role.
Ashok Vaswani, previously Chief Executive Officer, Consumer Banking and Payments, stepped down from ExCo in order to take on a new role as the Chief Digital Strategy Officer. We firmly believe that digital will be one of the defining opportunities for financial services
in the coming years and Ashok has a huge depth of digital expertise, to help us capitalise on these opportunities. We are incredibly grateful for his continued contribution in his new role, which will help Venkat and ExCo to continue to explore, and take advantage of digital opportunities to reshape the Group.
Alistair Currie became Global Head of Consumer Banking and Payments, taking over from Ashok. Alistair defined and delivered a very successful strategy in his previous role as Head of the Corporate Bank, and created a fantastic platform for the business’s future growth. His deep experience of digital transformation, in particular, is a major asset in his new role as Global Head of Consumer Banking and Payments.

C.S. Venkatakrishnan
Group Chief Executive
Tushar Morzaria
Group Finance Director
Mark Ashton Rigby
Group Chief Operating Officer and Chief Executive, BX

Paul Compton
Global Head of the Corporate and Investment Bank and President of BBPLC
Alistair Currie
Global Head of Consumer Banking and Payments
Matt Hammerstein
Chief Executive Officer, Barclays UK

Laura Padovani
Group Chief Compliance Officer
Tristram Roberts
Group Human Resources Director
Taalib Shah
Group Chief Risk Officer

Stephen Shapiro
Group General Counsel and Group Company Secretary
Sasha Wiggins
Group Head of Public Policy & Corporate Responsibility


bcs-20211231_g2.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
7


Directors’ report: Our Governance Framework
Governance is how the Board makes decisions and provides oversight.
A Group-wide governance framework to facilitate the effective management of the Group across its diverse businesses
Board Governance
At Barclays we think of governance as how the Board makes decisions and provides oversight in order to promote Barclays’ success for the long-term benefit of our shareholders having regard to the interests of our other priority stakeholder groups – our clients, customers, colleagues and the society in which we operate.
The Barclays PLC (BPLC) Board sets the purpose and strategic direction and risk appetite of the Group and is the ultimate decision-making body for matters of Group-wide strategic, financial, regulatory or reputational significance. A bespoke corporate governance framework sets out those matters reserved solely to the decision-making power of the Board.
The Matters Reserved to the Board specifies those decisions to be taken by the Board, including but not limited to material decisions relating to strategy, risk appetite, medium term plans, capital and liquidity plans, risk management and controls frameworks, approval of financial statements, approval of large transactions, approval of share allotments and dividends. The Board has delegated the responsibility for making and implementing operational decisions and running the Group’s business on a day-to-day basis to the Group Chief Executive and his senior management team.
Individual roles on the Board and their responsibilities are set out in our Charter of Expectations. This includes role profiles and the behaviours and competencies required for each role on the Board, namely the Chair, Non-Executive Directors, Executive Directors and Committee Chairs. In accordance with the Charter of Expectations, Non-Executive Directors are responsible for providing effective oversight and scrutiny, strategic guidance and constructive challenge whilst holding the Executive Directors to account against their agreed performance objectives.
The membership of the BPLC and BBPLC Boards was partially consolidated and streamlined in 2019, leading to significantly improved coordination and efficiency and reducing complexity and unnecessary duplication.
The Board is supported in its work by its Committees, each of which has its own Committee terms of reference, which clearly set out its remit and decision-making powers. The principal Committees of the Board and their core responsibilities are set out in the 'Board Governance Framework' on page 9. This structure enables the Board to spend a significant proportion of its time focusing on the strategic direction of the Group.
The Chairs of each of the Board Committees provide a report on the work of the Committee at every Board meeting. In line with best practice, the Board Committees are comprised only of Non-Executive Directors. You can find out more about the Committees, their membership and their work during 2021 on pages 15 to 38 and 90 to 91.
We believe that an effective Board is one which delivers value for our four priority stakeholder groups – our customers and clients, colleagues, society and investors. We assess the effectiveness of our Board, its Committees and Board members annually. You can read about the 2021 effectiveness review, and progress against the 2020 review and recommendations carried forward, in the report of the Board Nominations Committee on pages 15 to 21.
Changes to our Board during 2021
In 2021, the Board welcomed the addition of two new Directors:
Venkat, who was appointed as the Group Chief Executive and Executive Director on 1 November 2021
Julia Wilson, who was appointed as a Non-Executive Director on 1 April 2021.
Brian Gilvary succeeded Crawford Gillies in the role of SID with effect from 1 January 2021.
Jes Staley stepped down as Group Chief Executive and Director of BPLC and BBPLC on 31 October 2021 and, as reported in our 2020 Annual Report, Sir Ian Cheshire stepped down from the Board on 5 May 2021.
You can read more about changes to Board composition during 2021, and succession planning for the Board, Board Committees and ExCo, including succession planning for the role of Group Chief Executive which led to Venkat's appointment as Jes Staley's successor and consideration of Non-Executive Director independence, in the report of the Board Nominations Committee on pages 15 to 21.
More recently, Robert Berry joined the Board as a Non-Executive Director with effect from 8 February 2022.
On 22 February 2022, Tushar Morzaria notified the Board of his intention to retire from the Board and as Group Finance Director, and the Board has agreed that this will take effect on 22 April 2022, with Anna Cross succeeding him as a member of the Board and as Group Finance Director on 23 April 2022.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
8

Directors’ report continued
Our Board Governance Framework
Board of Barclays PLC
Responsible for the overall leadership of the Group (with direct oversight of matters relating to reputation, environment and culture)
Nominations
Committee

Reviews the composition of the Board
Recommends the appointment of new Directors
Considers succession plans for Board, Board Committee and ExCo positions
Oversees the annual Board, Board Committee and Director effectiveness review
For more information see page 15
Audit
Committee

Assesses the integrity of the Group’s financial statements
Evaluates the effectiveness of the Group’s internal controls
Scrutinises the activities and performance of internal and external auditors
Reviews and monitors the Group’s whistleblowing policies
For more information see page 22
Risk
Committee

Monitors and recommends the Group’s financial, operational and legal risk appetite
Monitors the Group’s financial, operational, conduct and legal risk profile
Considers and reports on key financial and non-financial risk issues
Oversees conduct and compliance and the leadership of the Risk and Compliance functions
For more information see page 31
Remuneration
Committee

Sets overarching principles and parameters of remuneration across the Group
Considers and approves remuneration for the Chair, Executive Directors, other senior executives and certain Group employees
Oversees remuneration issues
For more information see page 90


Group-wide Governance
BPLC, a premium listed company on the London Stock Exchange, is the parent company for the Group. The Group has a number of key operating entities, BBPLC, Barclays Bank UK PLC (BBUKPLC), Barclays Bank Ireland PLC (known as Barclays Europe), Barclays US LLC and Barclays Bank Delaware, each of which has its own board (comprising Executive and Non-Executive Directors) and board committees. Barclays Execution Services (known as BX) is our Group-wide service company and supports these main operating companies by providing technology, operations and functional services to businesses across the Group.
We have designed a Group-wide governance framework in order to facilitate the effective management of the Group across its diverse businesses by our Group Chief Executive and his ExCo, while preserving the constructive challenge, support and oversight of the Group’s major subsidiary boards in the UK, Ireland and the US, consistent with their respective legal and regulatory responsibilities and in compliance with UK ring-fencing requirements.
The Group’s corporate governance manual clearly sets out guidelines as to how the Barclays Group entities and their respective Boards and Board Committees should interact, while also providing guidance and clarity for management and Directors as to how these relationships and processes should work in practice. It is a dynamic document that continues to evolve with the changing nature of the Group.
How the Board discharged its responsibilities in 2021
Please refer to the high-level flow diagram on page 10 for details of the framework within which the Board discharges its responsibilities. You can read about the key activities of the Board during 2021 on pages 11 to 14.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
9

Directors’ report continued
bcs-20211231_g3.jpg
bcs-20211231_g4.jpg
Notes
a    The percentages are subject to rounding and therefore may not equal 100% when rounded.
Including ad hoc meetings.
b     Please refer to the report of the Board Nominations Committee on page 15 to 21 in relation to the tenure and continued independence of Tim Breedon, who has served on the Board for more than nine years.
c    Individual Directors may fall into one or more categories.
d    In relation to board experience based on the location of the headquarters/registered office of a company.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
10

Directors’ report continued
Key Board Activities in 2021
The continuation and evolution of the COVID-19 pandemic formed the defining backdrop to the year and consequently its impact on the Group constituted one of the Board’s areas of focus for 2021. This theme ran through a wide range of areas, from the associated economic uncertainties to our future ways of working.
Against this backdrop, the Board retained its focus on our strategy, including in the context of our refreshed Purpose and newly launched Barclays Mindset. In November, the Board appointed Venkat to take on the role of Group Chief Executive. Venkat is now driving forwards the implementation of the clear strategy that the Board has established.
Beyond its consideration of the COVID-19 pandemic and its impacts, the Board spent time discussing a broad range of financial and non-financial areas over the course of the year including a variety of ESG, and Diversity and Inclusion matters, as well as the Group’s return to distributions. Alongside overarching strategy considerations, significant attention was given to consideration in detail of our climate strategy.
You can read more about some key areas of focus for the Board in 2021 in this section.
Embedding our Purpose and Mindset and continuing to build a supportive and inclusive culture
The Board recognises that business success cannot be separated from the culture of the Group and strongly believes that the Group should have a common Purpose and a single Mindset.
Following the work completed in 2020 on reinvigorating our Purpose, the Board oversaw the launch of the Group-wide Mindset – Empower, Challenge and Drive – in February 2021. Our Mindset defines the way in which we want to get things done at Barclays.
The Board reviewed the implementation and embedment of the Mindset, challenging management to ensure the global nature of the Group’s footprint was taken into account. The Board discussed how the success of the Mindset would be tracked and measured, including the launch of a new recognition platform which enables the recognition of colleagues displaying the Barclays’ Mindset (as well as our shared Values). The Board also reviewed the newly created Mindset Dashboard which highlights early insights and areas of focus, as well as management actions that are being taken to embed and enact the Mindset going forward.
Mindset is a core part of the Group’s culture and a core focus for the Board. The Board receives feedback on our culture through a number of channels including:
receiving reports on the outcome of colleague survey results (including measurement of progress against the Mindset), and colleague views on areas such as wellbeing and ways of working
direct engagement with colleagues locally to hear their views through channels such as town hall meetings, listening sessions on our flagship talent programmes and office visits. In 2021, this included an inaugural Global Inclusion Summit for over 600 senior leaders including our Group Chief Executive.
At the end of 2021, the Board reviewed the multiple workforce engagement mechanisms employed which enable management and the Board to listen to colleagues, monitor organisational culture and take colleague feedback into account in our key decision-making processes. It also discussed the key insights that management had gained from those mechanisms and the actions that had been, and are planned to be, taken to address colleague feedback.
Our people and culture section on pages 92 to 97 includes more information on workforce matters, including the Barclays Mindset.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
11

Directors’ report continued
Continuing our support through the COVID-19 pandemic
During 2021, the Board continued to monitor Barclays’ response to the impact of the COVID-19 pandemic on the Group’s activities across the globe, making decisions to support each of the following key stakeholder groups:
.
Customers and clients
The Board discussed the difficulties that many of our customers and clients were experiencing such as making repayments on their mortgages and experiencing challenges with cash flow to ensure the adequacy of the support that Barclays was providing to its customers and clients. This support included repayment holidays, as well as the UK Government support schemes for businesses, such as the Bounce Back Loan Scheme (BBLS).
.
Colleagues
The Board was keenly aware of the impact of the COVID-19 pandemic for our colleagues, closely overseeing the support provided to them, whilst also having regard to colleagues' health and wellbeing. The Board considered in particular the situation in India where it was clear that the impact of the COVID-19 pandemic differed from city to city, in order to ensure that there was an increased focus on colleague engagement and support during this difficult time.

One of the Board’s key focus areas in 2021 was the consideration of our strategy regarding the return to office of our colleagues and how Barclays would move to a future way of working.
The Board was keen to ensure a balanced and flexible approach, which met both the needs of the business whilst also preserving the benefits of flexible working. It reviewed the plans for a phased return to office developed by the ExCo with the wellbeing, and health and safety of colleagues a key consideration. As a result, and as detailed in Our people and culture section on page 92, the opportunity to work in a hybrid pattern has been extended to many colleagues (spending part of their time working from a Barclays site and part of their time working from home).
.
Society
During the year, the Board discussed the extension of Barclays’ 100x100 Programme to support communities impacted by COVID-19. This forms part of Barclays’ £100m COVID-19 Community Aid Package and has been delivering vital relief to vulnerable communities throughout the COVID-19 pandemic. In 2021, this included support in the form of donations to organisations providing emergency relief in India.

.
Investors
In 2021, Barclays held its first 'hybrid' Annual General Meeting (AGM); a combined physical and electronic meeting. The Board shared the frustration and disappointment of our shareholders that, like the 2020 AGM, the 2021 AGM was impacted by the COVID-19 pandemic preventing shareholders from attending in person. Recognising the value of the AGM as a means of engaging with our shareholders, the Board decided to hold a hybrid AGM in order to maximise engagement whilst respecting the Government restrictions and guidance in place at the time. The hybrid nature of the meeting meant that shareholders were able to attend remotely by means of electronic facilities and to vote and to raise questions (either via the electronic platform or by telephone) in real time. For information about our 2021 AGM and our forthcoming 2022 AGM, please see the How we comply section on pages 39 to 46.

Given Barclays’ financial position, the Board also considered it appropriate to approve the payment of a dividend and a share buyback programme at both the FY 2020 Results and the HY 2021 Results. For more details of this return to distributions, please see below.

For details of shareholder and investor (retail and institutional) engagement throughout the year, please refer to the How we comply section on pages 39 to 46.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
12

Directors’ report continued
Strategy
The Board considered strategy matters at each of its Board meetings throughout 2021 continuing to deepen its understanding of the Group’s business and the risks and opportunities Barclays and the wider banking industry faces with a prioritised series of ‘deep dive’ sessions. This enabled the Board to spend a good proportion of its time considering longer-term and strategic issues.
Deep dive topics were informed by discussions with our shareholders and other stakeholders, as well as formal and informal Board discussions. Deep dive topics discussed by the Board covered a broad range of topics, including Payments, Investments and Advice, Transaction Banking, US Consumer Bank, Risk areas including Cyber, Ransomware and Cloud, as well as Conduct risk. In addition, the Board received updates from individual business areas and from key Group functions including Legal, Compliance, Public Policy and Corporate Responsibility, Risk and HR.
Key decisions:
Endorsement of strategy
Approval of the Group’s Medium Term Plan (MTP)

Succession
The Board approved Venkat's appointment as the new Group Chief Executive with effect from 1 November 2021. Succession planning for the Board, the Board Committees and ExCo is a key focus for the Board and the Nominations Committee. You can read more about Venkat's appointment and the succession planning for the role of Group Chief Executive which led to Venkat’s appointment as Jes Staley’s successor, and details of the work the Board Nominations Committee has undertaken with respect to succession planning for the Board, Board Committees and ExCo, in the report of the Board Nominations Committee on pages 15 to 21.
Key decisions:
Appointment of Venkat as Group Chief Executive
Delivering on Diversity and Inclusion
The Board, together with management, remains focused on building a supportive and inclusive culture and driving measurable progress. One specific area of focus during 2021 was the Group’s Race at Work ambitions and progress made against its Race at Work Action Plan. The Board reviewed and discussed the progress that had been made against these ambitions and oversaw the publication of our inaugural Diversity and Inclusion Report, as well as the appointment of the Group Chief Diversity officer and a new Global Head of Race at Work.
The Board discussed management’s review of Barclays’ workforce policies and practices which are designed to support Barclays’ efforts to attract, develop and retain diverse talent, and embed an inclusive culture. The Board agreed with management that the workforce policies and practices remain consistent with Barclays’ Values and support Barclays’ long-term sustainable success.
In addition, the Board scrutinised the existing Board Diversity Policy which includes a gender diversity target (33% female) and adopted an updated Policy on 9 February 2021. The updated Policy includes a new ethnic diversity target aligned with the Parker Review (at least one Board member to be a Person of Colour). The Board reconfirmed its commitment to these targets on 9 February 2022. Further detail can be found in the report of our Board Nominations Committee on page 18.
The Board reviewed Barclays’ response to the diversity consultation papers jointly issued by Barclays' regulators, the Prudential Regulation Authority (the PRA), the Financial Conduct Authority (the FCA) and the Bank of England (the BoE), and discussed the practical challenges to the implementation of the proposals.
Key decisions:
Adoption of an updated Board Diversity Policy
Sustainability and ESG (including Climate)
Barclays' climate ambition, set by the Board, is to be a net zero bank by 2050 and Barclays is committed to Paris alignment across all of its financing activities. Within this context, the Board is focused on the delivery of this ambition. Towards the end of 2021, our Group Chief Executive addressed more than 1,500 clients, investors and corporates at Barclays' Investment Bank's flagship ESG conference 'Making the transition' to discuss Barclays' role in the transition.
During 2021, the Board:
monitored and provided oversight of Barclays' climate strategy and policies and discussed in detail its progress and evolution
considered the proposed scope of the 'Say on Climate' vote that was announced at the 2021 AGM and which will be put to shareholders at the 2022 AGM. Further details of the 'Say on Climate' vote will be set out in the 2022 Notice of AGM
reinforced its strategic climate leadership ambition including Barclays' status as a founding member of the Net Zero Banking Alliance together with other banks across multiple countries
reviewed the potential financial, operational, commercial and legal implications of Barclays’ climate strategy
considered climate-related data and reporting, and discussed how progress could be monitored
agreed that the ESG report should form part of the Annual Report
reviewed and approved the updated ERMF which included Climate risk as a Principal Risk with effect from 1 January 2022.
The Board also recognises that the Group has a core social duty to execute its business well, efficiently, responsibly, and to a high quality. The Board accordingly received a deep dive presentation on social impact (the S Strategy), considering how the S Strategy linked to Barclays’ Values and in particular considered the approach we take for our communities.
In 2021, a new Group Head of Sustainability was appointed to assist the Group Head of Public Policy and Corporate Responsibility in taking forward the Group’s ESG agenda.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
13

Directors’ report continued
The Board received regular updates on Public Policy and Corporate Responsibility matters (together with Group Reputation Risk Reports) from the Group Head of Public Policy and Corporate Responsibility (PPCR). These updates covered matters such as key government and regulatory policy, regulatory engagement and ESG matters including climate and modern slavery. Four climate-specific updates were provided to the Board by the Group Head of PPCR and the Group Head of Sustainability, covering areas such as progress on our climate strategy, policy updates, industry trends, stakeholder engagement and target-setting.
In line with our commitment to offer shareholders a 'Say on Climate', we will be publishing an update on our climate strategy, targets and methodology in advance of the 2022 AGM.
Key decisions:
Approval of the Group’s ESG report for 2020
Approval of the Group’s 2020 Modern Slavery Statement
Approval in principle of Barclays' approach to 'Say on Climate'
Approval in principle of Barclays’ climate strategy
Approval of the Group’s Taskforce on Climate-related Financial Disclosures Report for 2020
Approval of the Group's Enterprise Risk Management Framework (ERMF) including Climate risk as a Principal Risk within the ERMF
Return to Distributions for 2021
In response to the impact of the COVID-19 pandemic, the PRA made a public statement in 2020 and wrote to the CEOs of a number of banks, including Barclays, requesting that dividend payments and buybacks be suspended temporarily. 2021 saw the PRA permit the resumption of capital distributions by UK financial institutions provided that boards operate within the PRA’s framework.
The Board considered the Group’s capital distributions strategy, having regard to the appropriate balance of dividends and share buybacks and considering other uses of excess capital as well as the longer-term approach to distributions.
Having undertaken this assessment, and noting the strength of our business, the Board decided for the FY 2020 Results to approve the payment of a dividend of 1p per share, coupled with a share buyback programme of up to £700m. Given Barclays’ strong capital position and strong business performance at the HY 2021 Results, the Board approved a half year dividend for the period ended 30 June 2021 of 2p per share and a share buyback of up to £500m.
Following the withdrawal of the SCRIP dividend programme, the Board also approved the introduction of a dividend reinvestment plan (DRIP) for those shareholders who wish to elect to use their dividend payments to purchase additional ordinary shares, rather than receive a cash payment.
Key decisions:
Approval of a full year dividend for the year ended 31 December 2020 of 1p per share and approval of a share buyback of up to £700m
Approval of a half year dividend for the period ended 30 June 2021 of 2p per share and approval of a share buyback of up to £500m
Approval of the introduction of a DRIP

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
14


Directors’ report: Board Nominations Committee report
Balancing skills, experience and diversity to support the continued delivery of the Group’s strategy.
Robust succession planning for the Board, Committees and ExCo
Having the right balance of skills, experience and diversity of background and opinion on the Board is key to supporting the continued delivery of the Group’s strategy, and to providing, informed and constructive challenge to management whilst acting fairly and in the interests of all stakeholders. The Committee plays a vital role in ensuring we are able to achieve this, with its focus on effective Board, Board Committee and ExCo composition and robust succession planning for these and other critical senior management roles.
As reflected in the Committee’s allocation of time, succession planning was an area of significant focus during the year, notably in the context of the Board’s appointment of Venkat as our new Group Chief Executive. The Committee and the Board were pleased to have identified strong internal successors for the roles of Group Chief Executive, and Group Finance Director, following ongoing review of the succession planning for these roles during 2020 and 2021. At the time of his appointment, Venkat held the role of Head of Markets and Global Co-Head of the CIB, and had been identified by the Committee and the Board as the ‘Ready Now’ successor for the role of Group Chief Executive. The Board is confident that Venkat will be a great leader of Barclays.
The Chairman (with the support of the Committee) has overseen a significant refresh of the Board since his appointment, with the appointment of five new independent Non-Executive Directors, Dawn Fitzpatrick, Mohamed El-Erian, Brian Gilvary, Julia Wilson and Robert Berry since 2019, as well as reviewing succession planning for key Board roles including the role of Board Risk Committee Chair as outlined further below. These Board appointments have brought new and diverse perspectives to the Board, enhancing its effectiveness and also providing valuable input and support to the work of its Committees.
bcs-20211231_g5.jpg

bcs-20211231_g6.jpg


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
15

Directors’ report: Board Nominations Committee report continued
During the course of 2021, the Committee considered and assessed the skills and experience required for the Board looking ahead over the next four years, taking account of the anticipated needs of the Board, its Committees and the business, as well as the ordinary course retirements of a number of long-serving Directors. The Committee agreed a series of priorities which will be considered and refreshed as it reviews potential additions to the Board and manages a robust and orderly succession plan. As ever, diversity remains a priority in all our searches.
As important as the 'who' is the 'how': a key part of the Board's effectiveness is how it operates in practice.
In 2021, we continued to strive for simplicity and clear focus in the Board’s agendas, papers and presentations, building on the progress made in previous years. The Board continued to operate on the basis of a partial consolidation and streamlining of the BPLC and BBPLC Boards which was implemented in 2019, whereby the membership of the BBPLC Board became a subset of the BPLC Board, with all members of the BPLC Board, except the SID, the Chair of BBUKPLC and one other Non-Executive Director, also serving on the Board of BBPLC. In addition, having the Chairs of some of the Group’s main subsidiaries as members of the BPLC Board, has continued to support significantly improved coordination and efficiency, whilst enabling appropriate focus on the matters relevant to each entity.
This year’s Board Effectiveness Review specifically reviewed the effectiveness of the Board and Board Committee structure during the year, and the results of the review confirmed that our Board governance structure continues to deliver its intended benefits whilst respecting the spirit of the ring-fencing legislation in relation to decision-making affecting BBUKPLC.
Committee membership
The Committee is composed solely of Non-Executive Directors and is chaired by our Chairman. Details on Committee membership and meeting attendance are set out on page 15.
Principal activities
The Committee’s allocation of time during 2021 is set out on page 15 and the Committee’s principal activities during 2021 are set out on this page.
In discharging its responsibilities, the Committee takes into account feedback from key stakeholders and from Board discussions more widely.
Committee responsibilities
1    Ensuring the right individuals are appointed – in line with suitability criteria – who can discharge the duties and responsibilities of Directors.
2     Planning for effective ExCo, Board and Committee composition, through focusing on appointment and succession based on merit and skill, through a diversity lens.
3     Leading candidate search and identification.
4     Regularly reviewing succession planning and recommendations for key executive and non-executive roles.
5     Monitoring time commitments for incoming and existing Directors to ensure sufficient time for effective discharge of duties.
6     Monitoring compliance against corporate governance guidelines and the Diversity Policy, including yearly review and any recommendations for enhancements.
7     Ensuring compliance by the Board with legal and regulatory requirements.
8     Agreeing the approach to individual Director, Board and Committee effectiveness reviews and implementing any required actions.
9     Considering and authorising, subject to ratification by the Board, conflicts of interest.

Approval of the appointment of Venkat as Group Chief Executive.
1||2||3||4
Candidate evaluation for both executive and non-executive current and future roles including review of core skills and (for internal candidates) scrutiny of internal feedback.1||2||3||4
Review of the balance of skills and diversity on the Board, and leading the search and recruitment process (including conflict analysis) for potential candidates. The Committee utilised external search consultants Spencer Stuart and Egon Zehnder to facilitate the targeted external mapping and search processes based on agreed and reviewed criteria.
1||2||3||4|6|9
Review of Directors’ tenure and effectiveness, and identifying candidates for re-election at the AGM.
I1|2|4|5|6|7|8
Approval of changes in Board Committee composition during the year, including the appointment of Dawn Fitzpatrick as a member of the Board Remuneration Committee.
1|2I|3|4|5
Review and approval of the extension of Tim Breedon’s tenure as a Non-Executive Director – refer to page 19 for further information.1||2||4||6||7
Review of ExCo composition and succession planning for strengths and diversity of the development of ExCo members and key successors.
1|3||4||6
Review of recommendations and suggested improvements arising from the 2020 Board effectiveness review.
1||2||7||8
Oversight of the externally facilitated 2021 Board Effectiveness Review undertaken by Christopher Saul Associates (CSA).
8
Consideration of Director training and development, including the Board briefing session.
7||8
Review and approval of size, composition and succession planning for the Board and the Board Committees, including updates on succession planning for the Group’s main subsidiary company Boards.
1||2||4|5
Review and update of the Board Diversity Policy in February 2021, including re-affirming the existing gender diversity target (33% female) and adopting a new ethnic diversity target aligned with the Parker Review on the ethnic diversity of UK Boards (at least one Board member to be a Person of Colour) – refer to page 18 for further information.
2||6

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
16

Directors’ report: Board Nominations Committee report continued
Changes to the Board in 2021:
Group Chief Executive
With effect from 1 November 2021, Venkat took over as Group Chief Executive, and became an Executive Director of BPLC and BBPLC.
Venkat brings significant skills and experience to the Board, as set out in his biography on page 4. He has over 26 years of experience in financial services, and since joining Barclays in March 2016 has held the roles of Group Chief Risk Officer (from 2016 to 2020) and Global Head of Markets & Co-President of BBPLC (from October 2020 until his appointment as Group Chief Executive).
As part of the Board’s oversight over long-term succession planning, the Committee reviewed succession planning for the role of Group Chief Executive in September 2020. This review included discussion regarding potential internal and external candidates, including an external market mapping review, which was refreshed again over the summer of 2021. Reflecting on the market mapping exercise, the Committee noted the likely challenges around the recruitment of an external candidate with the requisite skill set and experience, and also discussed development for Venkat as part of the approach to 'ready' key successors.
Venkat’s appointment to the role of Global Head of Markets & Co-President of BBPLC in October 2020, which followed the Committee’s discussions in 2020, was designed to build on and develop his commercial experience and to provide a potential internal candidate for Group Chief Executive succession. With regard to the latter, the Board put in place development for Venkat for the role of Group Chief Executive, and had been working to this for the 12-month period leading up to Venkat’s appointment. This included Venkat attending regular meetings with the Chairman, the Chair of the Board Risk Committee, and through external mentoring.
In considering Venkat’s appointment, the Committee – and the Board – took into account feedback on his development, and from ongoing discussions with Board members over the previous year which demonstrated broad support for Venkat as a possible internal successor as Group Chief Executive. The Committee and the Board also had regard to Venkat’s significant strength as an enterprise leader as part of the Group ExCo, his expanded leadership and commercial experience through his appointment to the Global Head of Markets role, including leading Front Office personnel and engaging directly with clients and key stakeholders of the CIB, as well as his background in Risk.
The Committee and the Board also took into account the broader contributions Venkat had made to Group-wide areas such as Barclays’ ESG agenda (through the development of Green Finance initiatives and the development of the BlueTrack™ methodology), and to Barclays’ diversity agenda. The Committee and the Board had regard to the stability that his appointment as an internal candidate would bring to the Group’s key stakeholder groups, in particular shareholders, colleagues, and customers/clients.
Jes Staley stepped down as Group Chief Executive and as a Director of BPLC and BBPLC with effect from 31 October 2021.
Changes to the Board in 2021:
Non-Executive Directors
We welcomed a new Non-Executive Director in 2021, Julia Wilson, who was appointed as a Non-Executive Director and as a member of the Board Audit Committee with effect from 1 April 2021. Julia’s appointment reflects our commitment to strengthening our Board through the addition of highly respected individuals with strong financial services expertise. She brings significant corporate finance, tax and accounting experience to the Board and to the Board Audit Committee, and the details of her skills and experience are set out in her biography on page 6.
The Board was also pleased to announce that Robert Berry (latterly Co-Deputy Chief Risk Officer of Goldman Sachs prior to his retirement in 2018) joined the Board as a Non-Executive Director on 8 February 2022, and will become Chair of the Board Risk Committee (subject to regulatory approval) and a member of the Board Audit Committee with effect from 1 March 2022.
As foreshadowed in our 2020 Annual Report, Sir Ian Cheshire stepped down from the Board at the conclusion of the 2021 AGM on 5 May 2021. We are grateful to Sir Ian for his contribution to Barclays, in particular as Chair of BBUKPLC until 31 December 2020 and the important role he played in establishing the Board of our ring-fenced bank.
In light of Crawford Gillies’ appointment as Chair of the BBUKPLC Board on 1 January 2021, Brian Gilvary succeeded Crawford in the roles of SID (with effect from 1 January 2021) and Board Remuneration Committee Chair (with effect from 1 March 2021). As at the date of succeeding Crawford as Board Remuneration Committee Chair, Brian had served as a member of the Board Remuneration Committee for a period of 12 months as recommended by the Code.
In light of the time commitment associated with his appointment as Chair of Barclays Bank Ireland PLC in April 2021, during the year Tim Breedon stepped down as a member of the Board Remuneration and Audit Committees. Tim will also retire as a member and Chair of the Board Risk Committee, and as a member of this Committee, with effect from 28 February 2022. Tim has served as Chair of the Board Risk Committee since 2014 (and as a member since 2012). The Board is grateful to Tim for his valuable contribution to each of these Committees and the Board is pleased that he will remain part of the Group as Chair of Barclays Bank Ireland PLC and through his ongoing membership of the Board as a Non-Executive Director.
In addition, Dawn Fitzpatrick was appointed as a member of the Board Remuneration Committee with effect from 1 July 2021.
Board size
The appointment of Julia Wilson, effective 1 April 2021, temporarily increased the size of the Board from 12 to 13 before it reduced to 12 following the resignation of Sir Ian Cheshire on 5 May 2021. The size of the Board returned to 13, following the departure of Jes Staley on 31 October 2021, Venkat’s appointment on 1 November 2021 and Robert Berry’s appointment on 8 February 2022.
The Committee is confident that the size of the Board remains effective taking into account the need to be small enough to operate in an efficient and collaborative manner and the need to be large enough to have an appropriate mix of skills and diversity and to support succession planning and the additional roles and responsibilities of some of our Directors on Board Committees, and on the Boards of BBPLC, BBUKPLC, Barclays US LLC, BX and Barclays Bank Ireland PLC.
Non-Executive Director recruitment
In addition to discussions at formal meetings, the Board and the Committee have discussed succession in detail at regular points in 2021, as detailed on page 19. This included consideration of longer-term succession planning (looking ahead to the skills that may be required on the Board in the future) and medium-term succession planning to ensure the orderly refreshing of the Board and its Committees.
As a result of our long-term and medium-term succession planning in 2021, as noted on page 19, we have reviewed our search criteria to complement the current range of skills on the Board with additional Non-Executive Directors. The Committee approved a series of skills-based priorities for potential candidates which is now underpinning our searches going into 2022, with the aim of finding candidates with sufficient board experience and the relevant skills to make a meaningful contribution to Board deliberations, and enhance the Board’s ability to provide informed and constructive challenge to management in the development of the Group’s strategy, and therefore its effectiveness. As noted above, these priorities are reflective of the skills and experience anticipated to be required for the Board over the next four years, taking account of the needs of the Board, its Committees and the business, as well as ordinary course retirements of a number of long-serving Directors.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
17

Directors’ report: Board Nominations Committee report continued
Our priorities include identifying potential candidates with technology experience, continuing our previous search as detailed in our 2020 Annual Report, as well as for a finance professional with recent and relevant financial experience.
The search for potential candidates with technology experience has remained challenging. Going into 2022, the Committee has discussed broadening the search base, including in regard to the particular nature of the technology experience that might be desirable.
Independent external search firms Spencer Stuart and Egon Zehnder have supported our search for potential Board candidates during the year. Capturing the clear benefits of diversity of background and opinion is at the forefront of that search. Spencer Stuart and Egon Zehnder do not have any connection to Barclays or any of the Directors other than to assist with searches for executive and non-executive talent.
The Committee has set rigorous criteria for the roles it is seeking to fill based on the strategic priorities identified in 2021, both in terms of experience and personal qualities. The Committee continues to review the search remit and give further consideration to the desired skills and experience, in order to ensure due consideration is given to strong potential candidates that would further enhance the effectiveness of the Board. Open advertising for Board positions was not used this year.
The Committee reviewed the Non-Executive Director selection and appointment process in 2021, which was refreshed in 2019, and concluded that no material changes were required to the current process. It was agreed that, where possible, all Board members should have the opportunity to meet potential candidates, and also that searches for potential candidates should be coordinated across the Group’s significant subsidiaries where appropriate.
As referenced above, Robert Berry joined the Board as a Non-Executive Director on 8 February 2022, and will become Chair of the Board Risk Committee (subject to regulatory approval) and a member of the Board Audit Committee with effect from 1 March 2022.
Robert will bring to the Board robust risk management expertise and a proven track record of risk management for a global financial institution, as he takes on the important role of Chair of the Board Risk Committee. He will also bring an international perspective having worked and lived in the United States for much of his life. The Committee and the Board are confident that he will be a positive addition to the balance, skills and experience of the Board and the Board Risk and Audit Committees.
Diversity
Both the Committee and the Board recognise and embrace the benefits of diversity – of gender, ethnicity, cognitive and personal strengths and social backgrounds – at Board, ExCo and senior management level, and consider this an essential element of maintaining a competitive advantage and effective governance, as well as mitigating the risk of ‘group think’.
Further to the Committee’s recommendation, the Board adopted a revised version of the Board Diversity Policy on 9 February 2021, re-affirming the existing gender diversity target (33% female) and adopting a new ethnic diversity target aligned with the Parker Review on the ethnic diversity of UK Boards (at least one Board member to be a Person of Colour). The Board Diversity Policy confirms that the Committee will consider candidates on merit against objective criteria with due regard to the benefits of diversity when identifying suitable candidates for appointment to the Board. The Board reconfirmed its commitment to these targets on 9 February 2022. You can read more about the Board’s consideration of diversity and inclusion related matters on page 13.
Following changes in Board composition in 2020, the Board’s gender diversity was 25% female as at 31 December 2020. With the appointment of Julia Wilson to the Board, and Sir Ian Cheshire stepping down, as at 31 December 2021 Board gender diversity was 33% female, in line with both the Board Diversity Policy and the Hampton Alexander Review target.
Ensuring diversity at Board Committee level remains a priority for the Board and the Committee. As at 31 December 2021, the gender diversity of each of the Board Committees was as follows: Board Audit Committee - 67% female; Board Remuneration Committee - 67% female; Board Risk Committee - 33% female; and Board Nominations Committee - 17% female.
Whilst the appointment of Robert Berry as a Non-Executive Director (effective 8 February 2022) took us to 31% (as at the date of this report), just below the Board’s gender diversity target of 33% female, the Committee remains committed to continuing to bring the very best, diverse talent we can attract to the Board.
Group-wide, Barclays remains committed to improving the diversity of its leaders and has set a number of targets focused on creating more gender diversity in its wider workforce, including its ambition to achieve 28% female Managing Directors and Directors by the end of 2021. You can read more about gender diversity at Barclays, including data on the percentage of females at Managing Director and Director level, on Group ExCo and within ExCo direct reports and in Barclays’ wider workforce in Our people and culture section on pages 92 to 97.
As at 31 December 2021, 25% of the Board was from an ethnically diverse background, meeting the recommendations contained within the Parker Review Committee Report into the Ethnic Diversity of UK Boards and the ethnic diversity target in the Board Diversity Policy.
The Parker Review and Board Diversity Policy ethnicity targets continue to be met following the appointment of Robert Berry on 8 February 2022 (and as at the date of this report), although the percentage of Directors from an ethnically diverse background has reduced from 25% to 23%.
Alongside the Board, the Committee continues to champion the Group’s Race at Work Action Plan, designed to increase the number of under-represented minority employees in our wider workforce; providing more Black and ethnically diverse colleagues with access to career and development opportunities; creating a culture of allyship; and being transparent and measuring our outcomes. Venkat, our Group Chief Executive, has made a significant contribution to Barclays’ diversity agenda, and is the executive sponsor for Embrace, the global multicultural network at Barclays. As described on page 13, the Board received regular updates during the year on the Group’s Race at Work ambitions and progress against its Race at Work Action Plan.
You can find more information on diversity and inclusion, including Barclays’ Race at Work Action Plan and targets to increase the number of under-represented minority employees in the UK and US within our wider workforce by the end of 2025, in Our people and culture section on pages 92 to 97. You can also read more in our Diversity and Inclusion Report, which will be made available on our website.
Non-Executive Director Independence
The Committee reviewed the independence of the Non-Executive Directors and, in the cases of Mike Ashley, Crawford Gillies and Diane Schueneman, all of whom have served on the Board for more than six years, and Tim Breedon who has served on the Board for more than nine years, their independence was subjected to a more rigorous review. The Committee remains satisfied that the lengths of their tenure have no impact on their respective levels of independence or the effectiveness of their contributions. The Committee and the Board consider all of the Non-Executive Directors to be independent.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
18

Directors’ report: Board Nominations Committee report continued
For details of the Committee’s review of the independence of Tim Breedon in the context of the extension of his tenure beyond a nine-year term, please refer to the Succession section below.
Succession
Robust succession planning for both the Board and the ExCo, taking into account current and anticipated future business needs and ensuring a good balance of skills, experience and effectiveness while recognising the benefits of diversity, is a key role of the Committee. In addition to formal meetings, as noted in further detail above, the Committee has discussed succession at regular points throughout 2021, including with the Board.
Effective succession planning should take into account contingency planning (for any unforeseen departures or unexpected absences), medium-term planning (orderly refreshing of the Board, Committees and the ExCo) and long-term planning (looking ahead to the skills that may be required on the Board and the ExCo in the future).
The succession planning for the role of Group Chief Executive is described in further detail on page 17 above.
On 1 November 2021, Tim Breedon had served on the Board for nine years. The Board considers that Tim's breadth of financial services sector experience and deep knowledge of risk and regulatory issues continues to bring significant value to Board discussions, and that his continued tenure as a Non-Executive Director will support a smooth transition of the role of Board Risk Committee Chair in March 2022 (as described on pages 17 to 18).
The Board also considers it advantageous to Group-wide decision-making and appropriate in the near term for the Chairs of the Group's significant subsidiaries to sit on the BPLC Board, considering that it brings important insight to Board discussions, and connectivity with our significant subsidiaries. Accordingly, given Tim's role as Chair of Barclays Bank Ireland PLC, the Group's principal European subsidiary, the Board believes it is appropriate for Tim to continue as an independent Non-Executive Director on the Board. This is consistent with the approach in respect of Crawford Gillies (who is also the Chair of BBUKPLC) and Diane Schueneman (who is also the Chair of BX).
Tim remains strongly independent and continues to provide effective challenge, advice and support to management on business performance and decision-making. Having undertaken a rigorous review of Tim's performance as a Non-Executive Director and taking into account other relevant factors that might be considered likely to impair, or could appear to impair, independence including as set out in Provision 10 of the Code, the Board considers Tim to be independent.
Tim stepped down as a member of the Audit and Remuneration Committees on 31 October 2021 as noted above.
Following Venkat’s appointment as Group Chief Executive, a number of changes were made to the roles of the existing members of our ExCo with effect from 9 November 2021, to ensure that it continues to have the right balance of skills and experience that we need to deliver for our stakeholders and continue to accelerate our performance. The Committee reviews and discusses all ExCo changes prior to announcement, taking into account executive succession plans, and considers all the changes to ExCo composition during the year. You can read more about the changes made to the roles of the existing members of the ExCo on page 7.
Director training and development
In accordance with its Terms of Reference available at home.barclays/who-we-are/our-governance/board-committees, the Committee supports the Chairman in developing and monitoring effective induction, training and development for the Board.
Opportunities for in-person Director training remained limited in 2021 due to the impact of the COVID-19 pandemic and social distancing guidance. However, Directors continued to deepen their understanding of the business through Board deep dives, briefings for Board members on key risk topics, and Group function reviews, as described in more detail on page 13. Deep dive topics covered in 2021 covered many areas of the business including Payments, Investments and Advice, Transaction Banking, US Consumer Bank, and Risk areas including Cyber, Ransomware and Cloud, as well as Conduct risk.
In addition, the Board received updates from selected individual business areas and from key Group functions including Legal, Compliance, Risk and HR. The Board also continued to receive regular updates on Public Policy and Corporate Responsibility matters, as described on page 14, on Reputation Risk matters (for which the Board has direct oversight), as well as a broad range of topics including Barclays’ government, industry and regulatory advocacy in addition to ESG matters including climate change. Board members were also invited to attend an Operational Resilience ‘teach-in’ session at the Board Risk Committee’s October 2021 meeting, which focused on the Group’s approach to resilience and evolving regulatory expectations in this area.
The Board also received an annual briefing on regulatory responsibilities, including the Senior Managers Regime and on Barclays’ conduct and financial crime policies and standards.
Following his appointment as Group Chief Executive and Executive Director of BPLC and BBPLC, Venkat received a tailored Executive Director induction to the Board which included sessions covering Board governance key matters such as Directors’ duties, Senior Managers Regime and Conduct rules, indemnity and insurance cover for Directors, conflicts of interest, disclosure requirements pursuant to the Market Abuse Regime and the Disclosure Guidance and Transparency Rules (DTRs), the Group Securities Dealing Code, US Corporate Compliance and the Code. Venkat has also had regular one-to-one meetings with the Chairman throughout his induction period, which also included attending one-to-one meetings with each of the Non-Executive Directors, and the Chairs of the Group’s main subsidiary Boards (including the Chair of Barclays US LLC).
A comprehensive Non-Executive Director induction was completed for Julia Wilson, with sessions covering Board engagement and introductions, strategy, culture, finance, specific business areas, risk, sustainability and ESG, compliance, internal audit, governance matters and additional meetings with the business. A Non-Executive Director induction is currently in progress for Robert Berry, following his appointment to the Board on 8 February 2022.
Brian Gilvary received a briefing on his responsibilities as the Board Remuneration Committee Chair from the Group Reward and Performance director, and a briefing from Crawford Gillies (as outgoing Board Remuneration Committee Chair) by way of a formal handover meeting in accordance with the requirements of the Senior Managers Regime. He also received a briefing on his responsibilities under the Code as SID.
In addition, Dawn Fitzpatrick received an induction in relation to her appointment as a new member of the Board Remuneration Committee. The induction covered Barclays’ remuneration philosophy and Fair Pay Agenda, governance, the regulatory environment, the Directors’ Remuneration Policy, Barclays’ incentive pools, risk adjustments and wider context relating to Fair Pay, Pay Gaps and Wider Workforce issues.
Board members who joined the boards of the Group’s main subsidiary companies during 2021, including Crawford Gillies as Chair of BBUKPLC and Tim Breedon as Chair of Barclays Bank Ireland PLC, have also received comprehensive inductions in respect of these businesses which has further broadened their knowledge and understanding of the Group and brought helpful insight to the Board.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
19

Directors’ report: Board Nominations Committee report continued
In 2022, we plan to reprise the bi-annual briefing sessions delivered to the Board prior to the onset of the COVID-19 pandemic. These sessions were intended to deepen and broaden the Board's understanding of some of the more complex and technical areas of the business, typically covering three or four topics per session. Subject to any changes in social distancing guidance, it is anticipated that these sessions will be conducted in person in the US and the UK, with Non-Executive Directors from our significant subsidiaries in attendance, and would be combined with a site visit which would also provide the Board with an opportunity for direct workforce engagement.
Review of Board, Committee and individual Director effectiveness
Progress against 2020 Board Effectiveness Review, including recommendations carried forward
As reported in our last Annual Report, we carried forward certain recommendations which had been partially addressed in light of disruption due to the demands of the COVID-19 pandemic. These included the following recommendations:
schedule fewer deep dives and allocate more time to each of them in 2021, to allow for increased discussion and debate, and facilitate deeper discussion of complex issues without significantly increasing demands on the Board’s time
increase input to the Board from outside Barclays on a wider range of issues
consider providing Board members with more opportunities to visit parts of the business in person (once COVID-19 pandemic-related restrictions are lifted), to gain a broader understanding of the business and to help facilitate direct workforce engagement
add greater technology expertise to the Board, through greater external input or by looking to expand or adjust Board membership.
Whilst we made good progress against some of these recommendations, the ongoing restrictions arising from the COVID-19 pandemic, particularly the continued lack of opportunity for in-person engagement and informal interaction, made matters such as scheduling business site visits to facilitate greater business and colleague engagement challenging.
While good efforts have been made to provide opportunities for online engagement and our Chairman was able to travel to the US when the opportunity allowed, we hope that we will be able to enable more of these things in the year ahead.
As noted in further detail above, we are continuing to search for a suitable candidate with technology expertise, who also can contribute to the overall effectiveness and diversity of the Board.
The Board deep dives schedule provided the basis for a dynamic programme of strategic business reviews during 2021, and was updated throughout the year to take account of feedback from Board members and the Group’s strategic priorities, as well as key developments. During the course of the year, the Chairman continued to invest a significant amount of time with management developing the key questions for the Board’s consideration in the deep dive papers, and re-instituted an annual corporate strategy discussion which provides an important framework against which to set the deep dives, consolidates areas of strategic follow up, and which also provides opportunity for a more wide-ranging discussion regarding the challenges and opportunities for the business. Going into 2022, and with the Board now having considered the main business areas and strategic issues through the deep dives schedule, the Board has determined that it is now appropriate to revert to a more typical agenda cadence and approach to the consideration of strategy. Feedback from our 2021 Board Effectiveness Review also highlighted that there was merit in now refreshing these sessions.
2021 Board, Board Committee and Individual Director Effectiveness Reviews: Process
The 2021 evaluation of the performance of the BPLC Board, Board Committees and individual Directors was externally facilitated, as required by the Code.
Further to a selection process facilitated by the Committee to identify a suitable external facilitator, which involved consideration of a number of potential facilitators, CSA, an independent, external corporate governance advisory firm was chosen to facilitate the 2021 review.
CSA was chosen on the basis that it offered not only the relevant skills but also some prior knowledge of the Group in the context of past advisory roles of CSA and its Managing Director (as disclosed below), and thus the ability to provide more insightful feedback. CSA has no connection to the Group or any individual Director, save as disclosed below.
In 2017 to 2018 and February 2020, CSA was engaged by Barclays in an advisory capacity (alongside external legal counsel, Slaughter and May) in relation to certain legal and regulatory matters. From July 2019 to June 2021, CSA’s Managing Director, Christopher Saul, provided mentoring support to a current member of the ExCo. Whilst acting in his capacity as a partner at Slaughter and May (from which he retired in April 2016), Christopher Saul gave legal advice to Barclays in relation to certain corporate law related matters. CSA and Christopher Saul have no current advisory or mentoring engagements relating to Barclays, its Board or ExCo.
The Committee considered CSA’s independence prior to the firm’s appointment and was confident that, notwithstanding that CSA and Christopher Saul had previously advised Barclays as outlined above, CSA would not be constrained in its ability to express an independent view as the external facilitator of the 2021 Board, Board Committee and individual Director effectiveness evaluation.
The Boards of each of BBPLC, BBUKPLC and Barclays Bank Ireland PLC also elected to appoint CSA to undertake an independent, external evaluation of their effectiveness, and CSA’s review of the effectiveness of BBPLC’s Board, Board Committees and individual Directors was conducted in parallel with the BPLC review given the partially consolidated structure of the BPLC and BBPLC Boards.
As part of the BPLC and BBPLC review, CSA conducted a structured one-on-one interview process with each member of the Board, all members of ExCo, certain members of the BBPLC ExCo, and the lead audit engagement partner of the Group’s auditor, KPMG, to obtain feedback on the effectiveness of the Board, the Board Committees and individual directors throughout 2021. CSA also observed certain meetings of the Board and the Board Committees during September, October, November and December 2021. CSA issued its final reports on the findings of the effectiveness review to the Boards of BPLC and BBPLC in December 2021.
CSA’s feedback provides an important input into the further development of the performance and effectiveness of the Board, in particular in identifying areas in which the Board could be more effective.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
20

Directors’ report: Board Nominations Committee report continued
Feedback from the review indicated that the Board is operating effectively and that the Board is collegiate, positive, professional and supportive, yet challenging, and benefits from a strong mix of skills and experience with contributions by all Directors during meetings despite restrictions on physical attendance as a result of the continuing COVID-19 pandemic. Meetings were considered to be well and inclusively chaired, including in hybrid format.
It was noted that the Board takes timely and well-informed decisions, and has a good understanding of the Group’s business. Constructive challenge of management by Non-Executive Directors was observed, noting significant positive development in the Board’s relationship with management which was observed as being constructive and respectful.
The size of the Board was considered to be effective, with a variety of skills and backgrounds. This enabled meaningful and stimulating diversity of thought and contribution, whilst acknowledging the potential benefits of appointing an additional Non-Executive Director with an understanding of digitally-led consumer-facing businesses. This would be given further consideration in the context of the current search for an additional Non-Executive Director with technology expertise. The Chairman’s inclusive and thoughtful style, and progress made in refreshing the Board, were recognised.
Board succession planning was observed as being very much front of mind for the Non-Executive Directors, and the transition following Venkat’s appointment as Group Chief Executive was seen to be progressing well.
Feedback from the review confirms that concurrent meetings of the BPLC and BBPLC Boards remain effective and work well in practice, with Board Committees operating effectively and being duly integrated into overall Board processes. In addition, the roles of Crawford Gillies, Diane Schueneman and Tim Breedon as the Chairs of BBUKPLC, BX and Barclays Bank Ireland PLC were felt to facilitate the sharing of additional perspectives relating to these significant subsidiaries.
2021 Board Effectiveness Review: Recommendations
The Committee has reviewed the Board Effectiveness Review report recommendations from CSA and will be giving further consideration to the implementation of the following matters during 2022:
whilst feedback indicated that Board deep dive sessions were generally appreciated by members, consideration should be given to how the approach to these sessions might be refreshed
since it had been necessary for the Board to devote a significant part of its agenda to immediate challenges and business strategy over the last two years through the COVID-19 pandemic, consideration should be given to how future Board agendas might be moved more towards important aspects of corporate strategy, including enhanced focus on capital allocation and issues presented by the external environment over the next three to five years
further consideration should be given to increasing input to the Board from thought leaders, customers and others to provide relevant outside perspectives
the process of making Board papers shorter and more focused should be continued.
The Board has already taken action to address some of these recommendations, including – as outlined above – reverting to a more typical agenda cadence and approach to the consideration of strategy. The other items will be subject to further consideration and discussion through the course of this year.
Review of Nominations Committee effectiveness
The 2021 Committee effectiveness review was externally facilitated, as required by the Code. The Board appointed CSA to facilitate the review. As part of its review, CSA conducted one-on-one interviews with each member of the Committee, the Group Human Resources Director and Group Company Secretary, and observed the December 2021 Committee meeting. The review is an important part of the way Barclays monitors and improves Committee performance and effectiveness, enabling the Board to build on areas of strength, and highlighting areas for further development.
Feedback from the review indicated that the Committee is operating effectively, with a good level of debate and clear decision-making. The Committee is considered well chaired, with a good level of engagement by other Committee members and constructive challenge of management observed. Succession planning for the Board and ExCo was recognised as having been at the core of the Committee’s role during the year, noting that the Committee also considered matters relating to Board succession for its key subsidiaries such as BBUKPLC and Barclays Bank Ireland PLC.
The review recommended that there may be benefit in a further reflection upon Committee membership and the desired composition and scope of activities of the Committee, given that other Non-Executive Directors attended a number of Committee meetings in 2021 in light of there having been some important matters to be considered regarding succession planning and the desire to hear from all Non-Executive Directors on these matters. While routine matters were covered in line with the Committee’s terms of reference, it was noted that the Committee may benefit from a more formalised meeting schedule and training sessions for members, as suggested in previous evaluations. It was acknowledged, however, that a more formalised meeting schedule might not always be possible in the context of the nature of the Committee’s roles and responsibilities and that opportunities for in-person training had remained limited in 2021 as a result of the ongoing COVID-19 pandemic. Further consideration will be given to these points during the year.
Review of the effectiveness of the other Committees
In addition to facilitating the review of this Committee’s effectiveness, CSA facilitated the effectiveness reviews of the Board Audit, Remuneration and Risk Committees, which were also conducted by way of one-on-one interviews with Committee members and relevant senior management, in the same manner as the review of the Board Nominations Committee. As part of its reviews, CSA also observed meetings of the Board Audit, Remuneration and Risk Committees. You can read about those reviews in the individual Committee reports elsewhere in this Governance report.
Following consideration of the findings of the 2021 Board and Board Committee effectiveness reviews facilitated by CSA, the Committee remains satisfied that the Board and each of the Board Committees are operating effectively.
Individual Director effectiveness
All Directors in office at the end of 2021 were subject to an individual effectiveness review as part of the external review facilitated by the Group Chairman with input and feedback from CSA. CSA considered each Director’s individual contribution to the Board as well as any feedback received as part of the broader Board and Committee effectiveness review.
Based on the feedback obtained through the individual effectiveness reviews facilitated by CSA, the Board supported the view of the Nominations Committee that each Director to be proposed for election or re-election at the 2022 AGM continues to be effective and contributes to Barclays’ long-term sustainable success.
In accordance with the Code, all of the current Directors of the Company who will be continuing in office, and Anna Cross in her capacity as a Director from 23 April 2022, intend to submit themselves for election or re-election at the 2022 AGM to be held on 4 May 2022 and will be unanimously recommended by the Board for election or re-election as appropriate.
Group Finance Director succession
Tushar Morzaria has informed the Board of his intention to retire as Group Finance Director and from the Board and the Committee recommended to the Board the appointment of a strong internal candidate, Anna Cross, as his successor. Anna was identified over a year ago as the Board's preferred successor, following a review of potential internal and external candidates.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
21


Directors’ report: Board Audit Committee report
Overseeing the integrity of our financial disclosures and the effectiveness of the internal control environment.
Keenly focused on the Group's internal control environment
Dear Fellow Shareholders
As the COVID-19 pandemic extended into 2021, the Committee continued to pay close attention to the reporting of the Group's financial performance as well as monitoring closely the impact on the internal control environment.
Although the macroeconomic environment remains challenging, more positive developments signal an improved growth and unemployment outlook in many economies. The path to recovery, however, is still uncertain as the impact of the withdrawal of the various government and central bank support measures as well as new inflationary pressures is not yet fully reflected in the macroeconomic consensus. As in 2020, the COVID-19 pandemic has increased the level of judgement that management has been required to exercise over the course of 2021 and to date. The Committee has considered in detail how management has applied COVID-19 specific adjustments to its expected credit losses (ECL) charge to ensure the full potential impacts of credit stress are provided for. These adjustments address the temporary nature of government support, the uncertain timing of an economic stress and reflect where economic consensus used in the ECL calculation may not yet have captured the range of economic uncertainty, particularly in the UK.
The Committee continued to oversee the ongoing evolution and enhancement of the internal control environment, noting that most of the Group's operations have now achieved a Satisfactory rating. The Committee also closely monitored the control issues, including in respect of a number of ongoing remediation programmes (particularly in the trading areas) and responses to regulatory findings in both the UK and US. Given the ongoing impact of the COVID-19 pandemic throughout 2021, the Committee has considered at length the impact of this both on our colleagues working arrangements and on our operational environment. It has overseen management's development and roll out of new 'hybrid' working arrangements for the Group with a focus on the control environment elements.
As part of its determination of whether any control issues required specific disclosure in this Annual Report, the Committee continued to apply similar concepts to those used for assessing internal financial controls for the purposes of the US Sarbanes-Oxley Act (SOx). The Committee reached the conclusion that there are no control issues that are considered to be a material weakness and which merit specific disclosure.
As in previous years, I held frequent meetings with the Chair of the BBUKPLC Board Audit Committee and I also had discussions with the Chairs of the Board Audit Committees of Barclays US LLC and Barclays Bank Ireland PLC during 2021. I have also recently attended a meeting of the Barclays Bank Ireland PLC Board Audit Committee, and I will be attending meetings of the BBUKPLC Board Audit Committee and the Barclays US LLC Board Audit Committee later in 2022. I also continued to meet frequently with members of senior management, including in particular the Group Finance Director and Group Chief Internal Auditor.
Barclays Internal Audit (BIA) is a key component in supporting the Committee’s work. I am pleased with the way that the function has performed throughout the year, with respect to scoping, performing and reporting the outcomes of its work both to management and the Committee. I held regular meetings with the Group Chief Internal Auditor and members of her senior management team to ensure that I was aware of current work programmes and any emerging issues. I also agreed the Group Chief Internal Auditor’s objectives and the outcomes of her performance assessment and remuneration. I was delighted to have the opportunity to meet some of the BIA team in person whilst in New York towards the end of 2021.
I have continued my regular engagement with the Group’s regulators, both in the UK and US. This has encompassed not only my work as the Chair of the Committee, but also my role as the Group’s Whistleblowing Champion. In that respect, I oversaw the production of the third and final annual report which we had agreed to submit to the FCA and PRA in the UK and to the New York Department of Financial Services regarding our whistleblowing programme.
Barclays' climate strategy has been a key area of focus for the Group during 2021. The impact of climate change on the Group’s financial statements continues to be limited at this time, but this is an area that the Committee will continue to monitor.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
22

Directors’ report: Board Audit Committee report continued
Committee effectiveness
The 2021 Committee effectiveness review was externally facilitated, as required by the Code. The review is an important part of the way Barclays monitors and improves Committee performance and effectiveness, maximising strengths and highlighting areas for further development.
The Board appointed CSA to facilitate the review. As part of the review, CSA conducted one-on-one interviews with each member of the Committee, the Group Finance Director, Group Chief Operating Officer, Group Chief Compliance Officer, Group Chief Risk Officer and Group Chief Internal Auditor. CSA also observed the September and October 2021 Committee meetings.
Feedback from the review confirms that the Committee is operating effectively, with constructive engagement with management observed in meetings and appropriate challenge. The appointment of Julia Wilson as an additional member of the Committee in April 2021 was noted as a very positive addition to the balance of skills and experience of the Committee, particularly in light of her significant corporate finance, tax and accounting expertise.
The review also confirms that concurrent meetings of the BPLC and the BBPLC Board Audit Committees continue to be effective, with reporting of Committee proceedings at Board meetings pitched at an appropriate level of detail. A good level of interaction with the BBUKPLC Board Audit Committee was also reported.
It was noted that the Board’s strategic priorities for Non-Executive Director recruitment included those with recent and relevant financial experience, which would be of benefit to the Committee.
The review recommended that consideration be given to how the Committee’s future agendas might be shaped more towards ‘bigger picture’ issues, whilst acknowledging the Committee’s broad remit, the complexity of Barclays and the expectations of the Group’s regulators. A continued focus on the split of work between the Board and the Committee, and potential overlap between the work of the Committee and the subsidiary Board Audit Committees, was considered to be beneficial.
Changes to Committee composition
As noted above, Julia Wilson joined the Committee at the time of her appointment as a Director of BPLC in April 2021. The Committee has benefited from her expertise and her previous audit committee experience at Legal & General Group PLC. On 31 October 2021, Tim Breedon stepped down from the Committee. I would like to extend both my personal thanks and the Committee’s gratitude to Tim for his valuable insights and contribution to the work of the Committee during his tenure. I also look forward to welcoming Robert Berry as a new member of the Committee on 1 March 2022, further to his recent appointment to the Board.
Looking ahead
In 2022 it is anticipated that the Committee’s main focus in respect of financial reporting will continue to be on the ECL charge. I noted last year the intention of management to simplify the models used for ECL forecasting which should make them more readily responsive to major changes in the economic environment as well as providing greater flexibility to run different scenarios to support sensitivity analysis. This development is underway, but given the ongoing disruption caused by the COVID-19 pandemic is inevitably taking longer than might have been hoped. Nonetheless the first new models are projected to be deployed during 2022 and the Committee will be monitoring this closely. Also in 2022, the Committee will increase its review of the Group’s regulatory reporting processes which is an area of increasing regulatory focus both in the UK and US, not just for Barclays but for the industry as a whole. To support this, the Committee will continue to receive regular reports from the Regulatory Management Oversight Committee on the more significant and judgemental interpretations applied in the Group’s regulatory reporting.
With respect to internal audit, the Committee has recently commissioned Ernst and Young to perform the independent External Quality Assessment (EQA) review of BIA which is required every five years.
As regards internal controls, the Committee will look to assure itself that management continues to make progress on the various remediation programmes and is also positioned to meet the various commitments given to regulators on issues they have raised. It is also likely that there will be continuing developments in relation to new ways of working, the control implications of which the Committee will wish to be assured about.




Mike Ashley
Chair, Board Audit Committee
22 February 2022
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
23

Directors’ report: Board Audit Committee report continued
Committee composition and meetings
The Committee is composed solely of independent Non-Executive Directors. Membership of the Committee is designed to provide the breadth of financial expertise and commercial acumen that the Committee needs to fulfil its responsibilities. Its members as a whole have recent and relevant experience of the banking and financial services sector, in addition to general management and commercial experience; and are financially literate. Mike Ashley, the Committee Chair, who is the designated financial expert on the Committee for the purposes of SOx, is a former audit partner who, during his executive career, acted as lead engagement partner on the audits of a number of large financial services groups. Having joined the Committee in April 2021, Julia Wilson has brought to the Committee significant financial, tax and accounting experience, coupled with strong financial services expertise. You can find more details of the experience of the current Committee members in their biographies on pages 3 to 6.
During 2021, the Committee met 11 times including one ad hoc meeting (2020: 10 times) and the chart opposite shows how the Committee allocated its time. Attendance by members at Committee meetings is also shown opposite. Committee meetings were attended by representatives from management, including the Group Chief Executive, Group Finance Director, Group Chief Internal Auditor, Group Chief Controls Officer, Group Chief Risk Officer, Group Chief Operating Officer, Group General Counsel and Group Chief Compliance Officer, as well as representatives from the businesses and other functions, and from BBPLC senior management reflecting the partially consolidated operation of the BPLC and BBPLC Committee meetings.
The lead audit engagement partner of KPMG, Michelle Hinchliffe, also attended Committee meetings. The Committee held a number of separate private sessions with each of the Group Chief Internal Auditor and the lead audit engagement partner during 2021, which were not attended by management.
Michelle Hinchliffe is standing down as lead audit engagement partner following the conclusion of the audit. The Committee has approved the appointment of Stuart Crisp of KPMG as the new lead engagement partner. The Committee would like to take this opportunity to express its thanks to Michelle for her work on behalf of shareholders and her contribution to the Committee’s deliberations during her tenure as lead audit engagement partner.
Role of the Committee
The role of the Committee is to review and monitor, among other things:
the integrity of the Group’s financial statements and related announcements
the effectiveness of the Group’s internal controls
the independence and effectiveness of the internal and external audit processes
the Group’s relationship with the external auditor
the effectiveness of the Group’s whistleblowing procedures.
The Committee’s terms of reference are available at home.barclays/who-we-are/our-governance/board-committees

bcs-20211231_g7.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
24

Directors’ report: Board Audit Committee report continued
Primary activities
The Committee has diligently discharged its responsibilities in 2021, reviewing the effectiveness of internal control environment, and internal and external audit processes, as well as the integrity of financial statements and related announcements having regard to the current macroeconomic environment.
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Fair, balanced and understandable reporting
(including Country- by-Country Reporting and Modern Slavery Statement)
In light of the Board’s obligation under the Code, the Committee assesses external reporting to ensure it is fair, balanced and understandable.In addition to this Annual Report and associated year-end reports, the Committee also reviewed the Group’s quarterly reports and the presentations to analysts. The Committee informed these reviews by:
In light of the ongoing effects of the COVID-19 pandemic during 2021, the Committee continued to closely scrutinise the Group's disclosures regarding the impact of the COVID-19 pandemic, both in relation to the impact on the financial statements and the actions taken and support provided by the Group to ensure they met the required standard. With regard to the Group's financial disclosures, the Committee paid particular attention to the ECL judgements and related IFRS 9 disclosures, having regard to guidance issued by regulators as part of their response to the COVID-19 pandemic.
Having evaluated all of the available information, the assurances by management and underlying processes used to prepare the published financial information, the Committee concluded and advised the Board that the 2021 Annual Report and financial statements are fair, balanced and understandable.
consideration of reports of the Disclosure Committee which included views on content, accuracy and tone
direct questioning of management, including the Group Chief Executive and Group Finance Director, on the transparency and accuracy of disclosures
consideration of management’s response to letters issued by the Financial Reporting Council (FRC) and other industry reporting guidance
evaluation of the output of the Group’s internal control assessments and SOx s404 internal control process
consideration of the results of management’s processes relating to financial reporting matters and evidencing the representations provided to the external auditors.
Distributions and return of capital to shareholdersThe Committee assesses the distributable reserves position.In 2021, the PRA permitted the resumption of capital distributions by UK financial institutions provided that boards operate within the PRA’s framework. The Committee considered management’s proposals for distributions (dividends and share buy-backs) for the full year ended 31 December 2020 and for the 2021 half-year ended 30 June 2021.Having regard to the distributable reserves available to the Company, the Committee reviewed and reported to the Board on proposals for (1) a dividend for the financial year ended 31 December 2020 of 1p per share along with a share buyback of up to £700m; and (2) a dividend for the half year ended 30 June 2021 of 2p per share, along with a share buy-back of up to £500m.
Going concern and long-term viability
Barclays is required to assess whether it is appropriate to prepare the financial statements on a going concern basis. In accordance with the Code, Barclays must provide a statement of its viability.The Committee considered both the going concern assumption and the form and content of the Viability Statement taking into account:
The Committee recommended to the Board that the financial statements should be prepared on a going concern basis and that there were no material uncertainties that would impact the going concern statement which required disclosure. The Committee noted that forecast capital ratios remained above minimum mandatory requirements.
The Committee agreed that the appropriate timeframe for the Viability Statement continued to be three years in line with the MTP and recommended the Viability Statement to the Board for approval.
the MTP and Working Capital Report
the forecast capital, liquidity and funding profiles
the results of stress tests based on internal and regulatory assumptions
current risk and strategy disclosures.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
25

Directors’ report: Board Audit Committee report continued
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Impairment of Financial Instruments
(refer to Note 7 to the financial statements)
ECLs are modelled using a range of forecast economic scenarios. They use forward-looking models which require judgements to be made over modelling assumptions, including:
As part of its monitoring, the Committee considered a number of reports from management on:
Having considered and scrutinised the reports, the Committee agreed with management’s conclusion that the impairment provision (including specifically the £653m for credit impairment releases) was appropriate.
The Committee reviewed closely the refreshed macroeconomic scenarios and the judgement exercised by management in determining post-model adjustments, in particular at the end of the year, the emerging risks associated with the Omicron variant of COVID-19 and the related ongoing economic uncertainty.
The Committee discussed with management the modelled ECL outputs and reviewed the plans to redevelop and enhance the ECL model control environment.
the economic impact of the ongoing COVID-19 pandemic
the impact of the ongoing uncertain macroeconomic environment, the effectiveness of government support measures and the impact of the tapering and, ultimately, cessation of such measures
model changes and model validation
refresh of the macroeconomic variables and associated weighting
adjustments made to the modelled output to reflect updated data and known model deficiencies, including in relation to the impact of government support
comparisons between actual experience and forecast losses.
the determination of macroeconomic scenarios to be used
the methodology for weighting of scenarios
the criteria used to determine significant deterioration in credit quality
the application of management adjustments to the ECL modelled output.
Impairments of Goodwill and Intangibles
(refer to Note 22 to the financial statements)
The carrying value of goodwill and intangible assets is assessed on the basis of discounted forecast future earnings. Given the significant component of earnings attributable to net interest income, such forecasts are particularly sensitive to the level of long-term interest rates and assumed levels of future lending. The period over which intangible assets are amortised appropriately reflects the useful economic life.
The Committee considered the allocation of goodwill and intangibles to the cash-generating units, ensuring consistency with the treatment adopted in prior years.
The Committee discussed with management its amortisation policy with respect to intangible assets, particularly in light of the Group's strategy to further digitise and migrate applications to cloud-based technology.
Finally, the Committee considered the sensitivity analyses prepared by management, which indicated what changes to assumptions would trigger any need for impairments.
The Committee was satisfied that the forecasts supported the recoverability of the goodwill and intangibles and no impairment was required.
The Committee carefully reviewed the disclosures made to ensure that the key sensitivities and the potential impacts were appropriately highlighted, noting that the headroom on most businesses had increased compared to the previous year and, in particular, that given the improvement in macroeconomic outlook and forecast performance of the businesses in BBUKPLC, the impairment taken on the investment in BBUKPLC was reversed.
Conduct provisions
(refer to Note 24 to the financial statements)
Barclays makes certain assumptions and estimates, analysis of which underpins provisions made for the costs of customer redress.With a view to evaluating the adequacy of the provisions, the Committee analysed the judgements and estimates made with regards to Barclays' provisioning for legacy conduct issues.
The Committee agreed with management that the overall level of provision in relation to the various conduct matters was adequate and appropriate at £310m as at the end of 2021.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
26

Directors’ report: Board Audit Committee report continued
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Legal, competition and regulatory provisions
(refer to Notes 24 and 26 to the financial statements)
Barclays is engaged in various legal, competition and regulatory matters which may give rise to provisioning based on the facts.
The level of provisioning is subject to management judgement on the basis of legal advice and is, therefore, an area of focus for the Committee.
The Committee evaluated advice on the status of current legal, competition and regulatory matters. It considered management’s judgements on the level of provision to be taken and accompanying disclosures.The Committee discussed provisions and utilisation and, having reviewed the information available to determine what was both probable and could be reliably estimated, the Committee agreed that the level of provision at the year end was appropriate. The Committee reviewed the disclosures made in respect of legal, competition and regulatory matters and concluded that they provided the appropriate information for investors.
Valuations
(refer to Notes 13 to 17 to the financial statements)
Barclays exercises judgement in the valuation and disclosure of financial instruments, derivative assets and certain portfolios, particularly where quoted market prices are not available.The Committee:
The Committee noted that there were no new significant valuation judgements at the end of the year.
The Committee was satisfied with the accounting treatment in respect of the various matters.
evaluated reports outlining the Group's material valuation judgements
considered valuations in the light of benchmark reform, in particular the transition from interbank offered rates
monitored the valuation methods applied and revisions to certain valuation approaches including for derivatives under Credit Support Annexes
considered the Valuation Committee's report on the main assumptions underlying the valuation of the Group's main pension scheme as advised by the actuary.
Tax
(refer to Note 9 to the financial statements)
Barclays is subject to taxation in a number of jurisdictions globally and makes judgements with regard to provisioning for tax at risk and to the recognition and measurement of deferred tax assets.
The Committee is responsible for considering the Group's tax strategy and overseeing compliance with the Group's Tax Principles. To support this, the Committee received reports from the Tax Management Oversight Committee and, in particular, considered the substantial amount of tax and fiscal policy change that was underway both in the UK and elsewhere.
The Committee reviewed the appropriateness of provisions made for uncertain tax positions, including VAT.
The Committee also reviewed the estimates and assumptions used in assessing the recoverability of deferred tax assets which were supported by the MTP and consistent with those made in relation to the recoverability of goodwill and intangibles.
The Committee was satisfied that specific strategies were in line with the Group's Tax Principles and on behalf of the Board approved the UK Tax Strategy statement published as part of the Country-by-Country Report.
The Committee noted that the uncertain tax positions covered a diverse range of issues and, as a consequence, agreed with management's view that there was not a significant risk of a material adjustment during the next year.
The Committee was also satisfied that deferred tax assets recognition was appropriate.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
27

Directors’ report: Board Audit Committee report continued
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Internal controls and business control environment
(read more about Barclays' internal control and risk management processes on pages 45 to 46)
The effectiveness of the overall control environment, including the status of any significant control issues and the progress of specific remediation plans.
The Committee:
evaluated and tracked the status of the more significant control issues through regular reports from the Chief Controls Officer, including updates on the progress of remediation programmes, ongoing COVID-19 related issues and return to office planning
discussed reports relating to individual Group entities, businesses and functions on the control aspects of key matters such as the COVID-19 related environment including Government loan schemes and return to office planning
received an update on operational resilience, which included a review of the operational resilience planning framework
received an annual update on data protection
received independent evaluations from BIA and external auditors
monitored Client Assets Sourcebook (CASS) updates and compliance with CASS.
Throughout 2021, the Committee has:
scrutinised the pathway to 'Return to Satisfactory' in respect of internal controls (operated by the various functions and businesses) that were not already rated 'Satisfactory'
reviewed the 2020 Risk and Control Self Assessment (RCSA) results and monitored the 2021 RCSA plan.
Raising concernsThe adequacy of the Group’s arrangements to allow employees to raise concerns in confidence and anonymously without fear of retaliation, and the outcomes of any substantiated cases.The Committee has received reports from management and monitored whistleblowing metrics and retaliation reports including consideration as to potential whistleblowing trends which might emerge.The Committee received detailed semi-annual reports on whistleblowing from management, with a thematic review having been completed in connection with the Group's response to the COVID-19 pandemic.
Internal auditThe performance of BIA and delivery of the internal audit plan, including scope of work performed, the level of resources, and the methodology and coverage of the internal audit plan.
The Committee has during the year:
scrutinised and agreed internal audit plans, methodology and deliverables for 2021
reviewed BIA's audit reports in relation to specific audits, key areas of focus and themes
tracked the levels of adverse audits and issues raised by BIA and monitored related remediation plans
received regular updates on resourcing, a deep dive into the audit team and the move to hybrid working
discussed BIA's assessment of the management control approach and control environment in the Group companies and functions
noted the appointment of the Chief Internal Auditor for BBPLC
continued to monitor BIA's implementation of its three-year internal audit plan ending December 2022.
The Committee reviewed BIA's Audit Results and Performance Reports, and Quality Assurance reports. The Committee also reviewed and approved BIA's Audit Charter.
At the end of the year, the Committee approved the 2022 Audit Plan, detailing the number of audits to be undertaken in 2022 and the focus areas. It noted the deliverables and level of resources to be allocated in respect of internal audit execution and delivery, data analytics, diversity and leadership as well as governance and management information.

External auditThe work and performance of KPMG.
The Committee:
met with key members of the KPMG audit team to discuss the 2021 Audit Plan and KPMG’s areas of focus
assessed regular reports from KPMG on the progress of the 2021 audit and any material accounting and control issues identified
discussed KPMG’s feedback on Barclays’ critical accounting estimates and judgements
discussed KPMG’s draft report on certain control areas and the control environment ahead of the 2021 year end
received a report on KPMG’s audit quality initiatives and key interventions in the audit cycles
considered the draft SOx control report and the draft audit opinion.
The Committee approved the 2021 Audit Plan and the main areas of focus for the year.
The Committee approved the appointment of a new lead audit engagement partner.
Read more about the Committee’s role in assessing the performance, effectiveness and independence of the external auditor below.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
28

Directors’ report: Board Audit Committee report continued
External auditor
Following an external audit tender in 2015, KPMG was appointed as Barclays’ Statutory Auditor with effect from the 2017 financial year. Michelle Hinchliffe of KPMG is Barclays’ lead audit engagement partner and was appointed to this role with effect from the 2018 financial year. As noted above, Michelle Hinchliffe will be retiring from the role in 2022. Following detailed discussions with KPMG and the Committee's approval, Michelle's successor, Stuart Crisp, will be taking over from her as lead audit engagement partner with effect from February 2022.
Assessing external auditor effectiveness, objectivity and independence and non-audit services
The Committee is responsible for assessing the effectiveness, objectivity and independence of the Group’s auditor, KPMG. This responsibility was discharged by the Committee throughout the year at formal meetings, during private meetings with KPMG and through discussions with key Group executives. In addition to the matters noted above, the Committee also:
approved the terms of the audit engagement letter and associated fees, on behalf of the Board
discussed the Group policy on the Provision of Services by the Group Statutory Auditor (the Policy) and reviewed regular reports from management on the non-audit services provided by KPMG to Barclays
evaluated and approved revisions to the Group policy on Engagement of Employees and Workers of the Statutory Auditor and ensured compliance with the policy by regularly assessing reports from management detailing any appointments made
was briefed by KPMG on critical accounting judgements and estimates and internal controls over financial reporting
assessed any potential threats to independence that were self-identified and reported by KPMG.
In previous years, the FRC's Audit Quality Review (AQR) team had identified areas for improvement in KPMG’s audit work, particularly in relation to its bank audits, and its documented audit approach and guidance for auditing the requirements of IFRS 9 including the minimum procedures to be performed. As noted last year, KPMG had invested significantly in this area and considered that, based on the steps it had already taken, it would be able to demonstrate improvements in its future year-end audits.
The AQR did not review KPMG's audit of Barclays for the year ended 31 December 2020 but the FRC did walk through certain elements of KPMG's IFRS 13 audit work in connection with an assessment of progress against audit quality improvement action plans. The FRC walkthrough was not graded and while some areas for further enhancement were identified, improvements were noted as compared to previous AQR inspections. We welcome this constructive engagement between the FRC and KPMG.
The Committee had been satisfied with the degree of work that KPMG had proposed to undertake, noting incremental testing, particularly in areas identified as key audit matters. Further to this, KPMG informed us that, as a consequence of the FRC’s observations in the aforementioned walkthrough, they have made additional improvements to their firm methodologies which have been applied to the current year’s audit of Barclays.
KPMG’s performance, independence and objectivity during 2021 were also formally assessed at the beginning of 2022 by way of a questionnaire completed by key stakeholders across the Group, including the chairs of the Board Audit Committees of the Group’s main operating companies (BBUKPLC, Barclays US LLC and Barclays Bank Ireland PLC). The questionnaire was designed to evaluate KPMG’s audit process and addressed matters such as the quality of planning and communication, technical knowledge, the level of scrutiny and challenge applied and KPMG’s understanding of the business.
In addition, as in 2020, KPMG nominated a senior partner of the audit team reporting to the lead audit engagement partner to have specific responsibility for ensuring audit quality. The Committee therefore met with the partner concerned, without the lead audit engagement partner present, to receive a report on his assessment of audit quality.
Taking into account the result of all of the above, the Committee considered that KPMG maintained its independence and objectivity and that the audit process was effective.
Non-audit services
In order to safeguard the auditor’s independence and objectivity, Barclays has in place the Policy setting out the circumstances in which the auditor may be engaged to provide services other than those covered by the Group audit. The Policy applies to all Barclays’ subsidiaries and other material entities over which Barclays has significant influence. The core principle of the Policy is that non-audit services (other than those legally required to be carried out by the Group’s auditor) should be performed by the auditor only in certain controlled circumstances. The Policy sets out those types of services that are permitted (Permitted services). A summary of the Policy can be found at home.barclays/who-we-are/our-governance/auditor-independence/
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
29

Directors’ report: Board Audit Committee report continued
The Policy is reviewed on an annual basis to ensure that it is fit for purpose and that it reflects applicable rules and guidelines. The Policy is aligned with both the FRC’s requirements and KPMG’s own internal policy on non-audit services for FTSE 350 companies which broadly restricts non-audit work to services that are ‘closely related’ to the audit. During 2021, the Committee reviewed and approved the Policy in its current form on the basis it continued to reflect current applicable rules and guidelines and met the needs of the business. Any changes to the Policy are required to be approved at a Group level by the Committee. This is in accordance with laws applicable in the UK and FRC guidance, pursuant to which audit committees of Public Interest Entities (such as Barclays) are required to approve non-audit services provided by their auditors to such entities; and subsidiary Public Interest Entities in the UK – such as BBUKPLC and BBPLC – can rely on the approval of non-audit services by the ultimate parent’s Board Audit Committee. Pursuant to the Policy, audit services and the fee cap are monitored by the relevant Board Audit Committee, as appropriate.
Under the Policy, except for specific categories of Permitted services that require explicit Committee approval, the Committee has pre-approved all Permitted services for which fees are less than £100,000. However, all proposed work, regardless of the amount of the fees, must be sponsored by a senior executive and recorded on a centralised online system, with a detailed explanation of the clear commercial benefit arising from engaging the auditor over other potential service providers. The lead audit engagement partner must also confirm that the engagement has been approved in accordance with the auditor’s own internal ethical standards and does not pose any threat to the auditor’s independence or objectivity. All requests to engage the auditor are assessed by independent management (who are not involved in any work to which the proposed engagement relates) before work can commence. Requests for Permitted service types in respect of which the fees are expected to meet or exceed the above threshold but expected to be less than £250,000 must be approved by the Chair of the Committee (or an appropriate alternate) before work is permitted to begin. Services where the fees are expected to be £250,000 or higher must be approved by the Committee as a whole. All expenses and disbursements must be included in the fees calculation.
During 2021, all engagements for which expected fees met or exceeded the above thresholds were evaluated by either the Committee Chair or the Committee members as a whole, who, before confirming any approval, assured themselves that there was justifiable reason for engaging the auditor and that its independence and objectivity would not be threatened. No requests to use KPMG were declined by the Committee in 2021 (2020: none). On a quarterly basis, the Committee scrutinised details of individually approved and pre-approved services undertaken by KPMG in order to satisfy itself that they posed no risk to independence, either in isolation or on an aggregated basis.
For the purposes of the Policy, the Committee has determined that any pre-approved service of a value of under £50,000 is to be regarded as trivial in terms of its impact on Barclays' financial statements and has required the Group Financial Controller to specifically review and confirm to the Committee that any pre-approved service with a value of between £50,000 and £100,000 may be regarded as such. The Committee undertook a review of pre-approved services at its meeting in December 2021.
The fees payable to KPMG for the year ended 31 December 2021 amounted to £62m (2020: £59m), of which £12m (2020: £12m) was payable in respect of non-audit services. A breakdown of the fees payable to the auditor for statutory audit and non-audit work can be found in Note 40 of the financial statements. Of the £12m of non-audit services provided by KPMG during 2021, the significant categories of engagement, i.e. services where the fees amounted to more than £500,000, included:
audit-related services: services in connection with CASS audits
other services in connection with regulatory, compliance and internal control reports and specific audit procedures, required by law or regulation to be provided by the statutory auditor
other attestation and assurance services, such as ongoing attestation and assurance services for treasury and capital markets transactions to meet regulatory requirements, including regular reporting obligations and verification reports.
The Statutory Audit Services for Large Companies Market Investigation (Mandatory Use of Competitive Tender Processes and Audit Committee Responsibilities) Order 2014
An external audit tender was conducted in 2015 and the decision was made to appoint KPMG as Barclays’ external auditor with effect from the 2017 financial year, with PwC resigning as the Group’s statutory auditor at the conclusion of the 2016 audit.
Barclays is in compliance with the requirements of The Statutory Audit Services for Large Companies Market Investigation (Mandatory Use of Competitive Tender Processes and Audit Committee Responsibilities) Order 2014, which relates to the frequency and governance of tenders for the appointment of the external auditor and the setting of a policy on the provision of non-audit services.
As explained in previous Committee reports, provided that KPMG continues to maintain its independence and objectivity, and the Committee remains satisfied with its performance, the Group has no intention of tendering for an alternative external auditor before the end of the current required period of 10 years. Accordingly, any tender would be in respect of the 2027 financial year onwards and is likely to take place in 2025. The Committee believes it would not be appropriate to tender before this date as it recognises that whilst it is important to ensure the audit firm remains objective and does not become overly familiar with management, there is an important balance to be struck with the investment of time required both from management and any completely new audit team for them to gain sufficient understanding of such a large complex organisation to ensure a top quality audit. The Committee is also conscious that the lead engagement partner will have changed twice since KPMG's tenure and that there have also been significant changes of senior management – both of which serve to reduce any threat of overfamiliarity. The Committee will give further consideration over the next two years to its audit tendering strategy to take account, as appropriate, of the outcome of the UK audit reform proposals.


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
30


Directors’ report: Board Risk Committee report
Remaining watchful of the wider global implications of the COVID-19 pandemic, alongside other macro themes.
Responsible risk management

Dear Fellow Shareholders
Much like 2020, 2021 has presented a number of challenges for risk management. 2021 started with the UK having just entered its second lockdown as cases of COVID-19 continued to rise, ahead of the vaccine roll-out which shifted sentiment towards a return to economic activity by the middle of 2021. Large stimulus measures such as UK furlough schemes and the corporate and SME loan schemes were extended into 2021, with the Committee keeping a close eye on the risks inherent with a tapering of these as well as the significant monetary stimulus provided by central banks. The Risk Committee remained watchful of the wider global implications of the COVID-19 pandemic, alongside other macro themes, including the consequences of the UK’s withdrawal from the EU, the risk of a disorderly market correction, the evolving interest rate environment, US/China political tensions and other potential policy and geopolitical developments following the US Presidential election at the end of 2020.
Climate risk
The risks associated with climate change are increasingly well understood and, reflecting the importance of this global issue, Climate risk has been elevated to become a Principal Risk within our ERMF from 1 January 2022. The Committee began the year with a detailed training session on the financial and operational risks of climate change to enable the Committee to deepen its understanding of this complex and evolving risk. The training session covered Barclays’ governance in this space, progress made over the preceding 12 months and areas of key focus for 2021 and beyond. The Committee considered both the scenarios and models used for the Climate Internal Stress Test. The training session assisted with the Committee’s discussions around the methodology to be used for the BoE's industry-wide Climate Biennial Exploratory Scenario (CBES), the results of which were approved by the Committee in September.
Financial risk
The Committee continued to monitor closely developments related to the COVID-19 pandemic, including the changes in transmission of the virus and associated variants and the positive effects of the vaccine programme roll-outs. The extension of government support schemes and stimulus measures assisted with a return to economic activity but the Committee monitored their removal carefully noting that this would be a risk to growth.
The Committee considered a broad range of potential impacts including evolving inflation expectations, unemployment rates, delayed defaults as support measures were withdrawn, and longer- term structural risks, including the significant increase in global indebtedness in response to the COVID-19 pandemic. During the second half of the year, the Committee focused on the continued improvement in the global economic outlook while considering the risks to the recovery from supply chain constraints and bouts of rising infection rates amid new strains of the virus. The Committee reviewed and approved the Group’s Internal Capital Adequacy Assessment Process (ICAAP) and Internal Liquidity Adequacy Assessment Process (ILAAP) during the course of 2021, concluding that the Group was appropriately capitalised and had adequate liquidity resources. Economic conditions were such that no out-of-cycle refresh of either the ICAAP or the ILAAP was required.
The Committee monitored the risks associated with the Government loan schemes and the withdrawal of those schemes, including the potential for fraud and the risks linked to collection and recoveries.
The Committee continued to review the evolving interest rate environment on the Group, receiving detailed updates on the Group's preparedness both operationally and financially for the potential for negative interest rates in response to regulatory requests. As sentiment pivoted towards the recovery and whether rising inflation was transitory or more structural given the combination of pent-up corporate and consumer demand and supply bottlenecks, the Committee shifted its focus to the risks of a more disorderly normalisation of policy rates.
The Committee remained vigilant to the continued economic uncertainty of the UK’s withdrawal from the EU following the end of the transition period on 31 December 2020. The Committee considered event risks that remained despite a trade deal being reached. It also considered the resulting fragility of the UK economy given the combination of macroeconomic factors, including the COVID-19 pandemic, as well as more idiosyncratic risks, including trade relations with the EU and beyond, as well as the potential for another independence referendum in Scotland.
The Committee continued to monitor geopolitical risks, including in the Eurozone, as well as in China, in particular the market implications for the deteriorating relations between the US and China. These risks present a threat to global growth recovery efforts.
Conduct risk
The Committee continued to focus on Conduct risk, with key areas of focus including the heightened inherent risk associated with the impact of the COVID-19 pandemic (for example, Markets traders working from home), the impact of the transition away from LIBOR and adapting the Group's practices to comply with regulatory change. In addition to focusing on the Conduct risk profile of the Group’s core businesses, the Committee also received reports on ‘Lessons Learned’ as a result of industry developments and events.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
31

Directors’ report: Board Risk Committee report continued
Operational risk
Operational risk remained heightened in 2021 due to the impact of the COVID-19 pandemic. The Committee considered closely operational resilience, with a teach-in dedicated to the Group’s approach to resilience and increased regulatory scrutiny and regulator expectations. The Committee also received briefings on the Group’s approach to identifying important business services and their associated impact tolerances in advance of their final approval, expected in early 2022.
During the year, the Committee continued to monitor and challenge the progress being made in the identification, assessment and management of Operational risk. The primary risk management tools used by management are the RCSAs.
The RCSAs give ‘day-to-day’ coverage of the risk and control environment of the Group. They are built on a foundation of the actual processes the Group employs and the risks it faces from its activities. This approach enables management to improve identification and management of Operational risks going forward and also to review in detail risk events that have occurred in order to identify root causes.
During the year the Committee received detailed updates on key risk areas including cyber risk and the risk associated with the use of cryptocurrency to strengthen the Committee’s understanding of the potential these risks pose and to understand how the Group continued to strengthen its oversight in these areas.
Risk appetite and risk models
One of the most important roles of the Committee is to recommend to the Board an appropriate risk appetite for the Group. This represents the amount of risk the Group is able to take to earn an appropriate return while meeting minimum internal and regulatory capital requirements in a severe but plausible stress environment. The Committee analyses Barclays’ performance in both its internally generated stress tests and those developed externally by such bodies as the BoE and the Federal Reserve Board (FRB) in the US and, following such analysis, may recommend adjustments to the Group’s overall risk profile.
For the Group’s internal stress test, the Committee received a detailed briefing on the methodology approach and approved the internally generated scenario narrative theme and the macroeconomic projections that informed the scenario severity. The Committee was satisfied that the Group would meet internal and regulatory requirements for capital and liquidity in such a scenario.
The Committee continued to oversee model risk management and the ongoing validation of the Group’s models. The Group’s models are the core foundation upon which the majority of its internal assessment processes run. The Committee noted the continued progress made during 2021 to embed the Model risk management framework as evidenced by an increasingly stable model inventory and further improvements in documentation and control. However, models remain a key risk area for the Group and the Committee is closely monitoring the development of the Group’s approach and its regulators’ expectations in this regard.
Risk function
The Committee is responsible for ensuring the independence and effectiveness of the Risk function, whose primary role is the oversight and challenge of risk taking as the second line of defence. It accomplishes this by establishing the policies, limits, rules and constraints under which activities of the first line of defence shall be performed, consistent with the Group’s risk appetite and through monitoring the adherence of the first line of defence against these policies, limits and constraints. The Committee’s responsibilities include (i) designing a consistent classification of the risks faced by the Group in order to organise their management and reporting, (ii) designing and operating the process of setting risk appetite and material limits for the Group as a whole and its main entities, (iii) setting or approving strategies for approvals of transactions, and those significant individual agreements, as well as (iv) establishing key controls requirements to which customer-facing areas of Barclays must adhere in the conduct of their businesses.
The Committee reviewed the Risk function’s own assessment of its capability in late 2021 which showed that the function continues to meet expectations in providing effective and independent oversight and identified areas for enhancement.
Compliance function
The purpose of the Compliance function is to strengthen the culture of Barclays by providing oversight of the management of Conduct risk. Compliance participates in the prevention, detection and management of breaches of applicable laws, rules, regulations and procedures and has a key role in helping Barclays achieve the right Conduct outcomes and evolve a conduct-focused culture. The Committee maintains oversight of the Compliance function, and supports the independence of the function from the operational functions to ensure that Compliance has sufficient authority, stature, resources and access to the management body.
The Committee monitored the delivery of, and approved updates to, the Compliance function's Annual Plan for 2021 and approved the Annual Compliance Plan for 2022.
Committee effectiveness
The 2021 Committee effectiveness review was externally facilitated, as required by the Code. The review is an important part of the way Barclays monitors and improves Committee performance and effectiveness, maximising strengths and highlighting areas for further development.
The Board appointed CSA to facilitate the review. As part of the review, CSA conducted one-on-one interviews with each member of the Committee, the Group Chief Risk Officer, Group Finance Director, Group Chief Operating Officer, Group Chief Compliance Officer and Group Chief Internal Auditor. CSA also observed the September and October 2021 Committee meetings.
Feedback from the review confirms that the Committee is operating effectively, considering Barclays’ risk appetite and risk profile in a thoughtful and forensic way, with its core mandate well understood by its members and proactive challenge of management. It was noted that more recent additions to the Committee in 2019 and 2020 brought valuable markets insight and experience.
A continued focus on the split of work between the Board and the Committee, and potential overlap between the work of the Committee and the subsidiary Board Risk Committees, was considered to be beneficial. Feedback noted that there was no undue duplication between the Committee and the Board Audit Committee.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
32

Directors’ report: Board Risk Committee report continued
The review suggested that there may be benefit in the Committee taking time to reflect further upon likely major risk themes in the macro environment over the next three to five years, and how future Committee agendas might be shaped towards bigger picture issues.
Changes to Committee composition
Following his appointment to the Board on 8 February 2022, Robert Berry will succeed me as Chair of this Committee with effect from 1 March 2022 (subject to regulatory approval). Robert will bring to the Committee robust risk management expertise, and you can read more about his appointment on pages 17 and 18, and you can find details of his skills and experience in his biography on page 5.




Tim Breedon
Chair, Board Risk Committee
22 February 2022
Committee meetings
During 2021, the Committee met 11 times (including two ad hoc meetings) and the attendance by members at these meetings is shown on this page. As well as its members, Committee meetings were attended by representatives from management including the Group Chief Executive, Group Finance Director, Group Chief Internal Auditor, Group Chief Risk Officer, Group Treasurer, Group Chief Compliance Officer and Group General Counsel, as well as representatives from the businesses and additional members from the Risk function. The Committee held a number of sessions with the Group Chief Risk Officer and the Group Chief Compliance Officer, which were not attended by management. The lead audit engagement partner of KPMG, Michelle Hinchliffe, also attended all of the Committee meetings. Michelle Hinchliffe is standing down as lead audit engagement partner following the conclusion of the most recent audit. Stuart Crisp of KPMG has been appointed as the new lead engagement partner.
Committee roles and responsibilities
The Committee is responsible for reviewing on behalf of the Board management’s recommendations on the Principal Risks as set out in the Group’s ERMF with the exception of Reputation risk, which is a matter reserved to the Board, and in particular:
reviewing, on behalf of the Board, the management of those Principal Risks in the ERMF
considering and recommending to the Board the Group’s risk appetite and tolerances for those Principal Risks
reviewing, on behalf of the Board, the Group’s risk profile for those Principal Risks
commissioning, receiving and considering reports on key risk issues
safeguarding the independence, and overseeing the performance, of Barclays’ Risk and Compliance functions.
The Committee’s terms of reference are available at home.barclays/who-we-are/our-governance/board-committees

bcs-20211231_g8.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
33

Directors’ report: Board Risk Committee report continued
Primary activities
The Committee has diligently discharged its responsibilities in 2021, reviewing Group exposures in the context of the current and emerging risks facing Barclays. The Committee has sought to promote a strong culture of disciplined risk management.
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Risk appetite and stress testing
i.e. the level of risk the Group chooses to take in pursuit of its business objectives, including testing whether the Group’s financial position and risk profile provide sufficient resilience to withstand the impact of severe economic scenarios.
The risk context to the MTP, the financial parameters and constraints and mandate and scale limits for specific business risk exposures; the Group’s internal stress testing exercises, including scenario selection and financial constraints, stress testing themes and the results and implications of stress tests, including those run by the BoE.
To advise the Board on the appropriate risk appetite and tolerance for the Principal Risks, including the proposed overall Group risk appetite and limits.
To discuss and agree stress loss and mandate and scale limits for Credit risk, Market risk and Treasury and Capital risk.
To consider and approve internal stress test themes, and consider the financial constraints and scenarios, for stress testing risk appetite for the MTP.
To evaluate the results of the BoE’s annual cyclical stress test and the BoE’s Biennial Exploratory Scenario.
To consider the feedback from the FRB on the Barclays US LLC’s Comprehensive Capital Analysis and Review (CCAR) following the submission of the CCAR stress test results.
In early 2021, the Committee reviewed and recommended the proposed operational risk appetite statement to the Board for approval. The Committee also discussed and approved the mandate and scale limits for the Group during 2021, with subsequent changes to these limits being reviewed and approved later in the year.
In the first half of the year, the Committee received a briefing on Stress Tests, which provided an overview of the Stress Testing schedule for 2021.
The Committee reviewed proposed enhancements to the Group’s stress testing processes and models such as an update to Model risk tolerances. During 2021, Committee members attended briefings on stress testing and risk appetite and limit setting (which was also attended by Board members).
In response to the COVID-19 pandemic, the BoE temporarily changed its approach to stress testing and introduced a 2021 Solvency Stress Test. The approach to this test, along with the final results were reviewed and approved by the Committee, along with the results of the Reverse Internal Stress Test. The Committee also reviewed an assessment of actual macroeconomic variables against the Internal Stress Test scenarios and reviewed the Internal Stress Test scenario theme and severity for 2021 to ensure that they remained appropriate for risk appetite and capital adequacy and approved the Internal Stress Test narrative theme.
The Committee received and discussed the results of an internal Climate Stress Test. This assisted in deepening Barclays' understanding of climate risks, as did the Committee’s discussion about the scenarios for the CBES and Barclays’ approach to climate-specific modelling. The Committee subsequently discussed and approved the results of the CBES.
The Committee received updates on the CCAR submission to the FRB, including an assessment of the models used and overlays applied in the 2021 CCAR submission. The updates covered both the quantitative and qualitative results of the submission.
As part of the Group's strategic planning process, the Committee recommended to the Board for approval the risk appetite statement consisting of both quantitative and qualitative statements. This included a constraint and qualitative statement for Climate risk (which became a Principal Risk in 2022).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
34

Directors’ report: Board Risk Committee report continued
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Capital and funding
i.e. having sufficient capital and financial resources to meet the Group’s regulatory requirements and its obligations as they fall due, to maintain its credit rating, to support growth and strategic options.
The trajectory to achieving required regulatory and internal targets and capital and leverage ratios.
To review, on a regular basis, capital performance against plan, tracking the capital trajectory, any challenges and opportunities and regulatory policy developments.
To assess, on a regular basis, liquidity performance against both internal and regulatory requirements.
To monitor capital and funding requirements.
The Committee received a preliminary assessment of the ICAAP and the ILAAP in January. This was followed by a series of individual meetings between management and Committee members. The Committee subsequently discussed and approved the Group's 2021 ICAAP and the Group's 2021 ILAAP prior to its submission to the PRA.
The Committee continued to oversee improvements to the Liquidity Risk Appetite frameworks, as well as a review of the ICAAP framework with a focus on internal modelling approaches. Regulatory feedback on the ICAAP and ILAAP was noted throughout the year. During the course of the year, although monitored, no additional updates were required to the ICAAP and ILAAP following the changes that had been made in 2020.
The Committee reviewed the forecast capital and funding trajectory and the actions identified by management to manage the Group's capital position, taking into account macroeconomic factors including the ongoing COVID-19 pandemic.
The Committee challenged, reviewed and recommended to the Board for approval the Group Recovery Plan, which forms a part of the Group’s capital and liquidity risk management framework.
The Committee also discussed and recommended to the Board for approval its first Group Resolvability Self-Assessment which is the final major aspect to the BoE’s resolution regime for banks.
The Committee received updates on the progress of the global transition to alternative risk-free rates, including on preparations by the LIBOR Transition Programme to manage and mitigate the financial and non-financial risks associated with transition.
The Committee also considered the structural hedge programme and reviewed and discussed management’s hedging strategy proposals.
Political and economic risk
i.e. the impact on the Group’s risk profile of political and economic developments and macroeconomic conditions.
The potential impact on the Group’s risk profile of geopolitical developments, as well as continuing to monitor the political and economic impact of post-Brexit transition period scenarios.
To consider the ongoing impact of COVID-19 on the business directly and indirectly.
To consider trends in the UK and US economies.
To assess the geopolitical tensions in both the Eurozone and China.
To review potential consequences of the BoE statement regarding negative interest rates.
To review exposures to emerging markets.
To review and discuss plans for the impacts of Brexit post-transition.
To establish and examine key risk themes in order to monitor the evolving risk environment in which Barclays operates, the response of management, and the changing risk profile of the Group.
The Committee continued to monitor the Group's performance throughout the year with respect to the ongoing COVID-19 pandemic, taking into account the end of furlough in the UK, and the roll off of other UK government support schemes and the impact of other support measures from central banks and regulators. The Committee also received updates on the impact of vaccination roll-outs across the key markets in which the Group operates.
Whilst the risk of negative rates has receded during the course of 2021, the Committee continued to have regard to the evolving interest rate environment, reviewing in particular operational readiness and any potential impact to the Group's capital and liquidity positions.
The Committee monitored the Group's performance in light of geopolitical risks including tensions in the Eurozone related to both Brexit and COVID-19, and also in China in connection with technology, human rights and territorial claims and US/China political relations.
The Committee also considered the risk management implications of growth initiatives in emerging markets.
During the first part of the year, the Committee continued to monitor any potential post-Brexit risk impacts which might still remain even following the trade deal being reached, as well as monitoring the US political landscape following the Presidential election.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
35

Directors’ report: Board Risk Committee report continued
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Credit risk
i.e. the potential for financial loss if customers, clients or counterparties fail to fully honour their obligations.
Conditions in the UK housing market; levels of UK consumer indebtedness;
unemployment levels in the US and UK; and the performance of the UK and US cards businesses, including levels of impairment.
To assess conditions in the UK property market and monitor signs of stress.
To monitor management’s tracking and responding to persistent rising levels of consumer indebtedness, particularly unsecured credit in both the UK and US.
To monitor unemployment trends and COVID-19 pandemic financial support incentives, particularly in both the UK and US.
To review leveraged finance portfolios in order to assess maintenance within risk appetite and manageable limits.
To review business development activities in the CIB.
The Committee considered the risk with the Group's support of customers through the COVID-19 pandemic including the changes that were taking place to government schemes such as the end of payment holidays, replacement of existing loan schemes with the new Recovery Loan Scheme, and the launch of the new Help to Buy 2. The Committee monitored the key portfolio metrics including impairment as Barclays' key markets emerged from the COVID-19 pandemic, noting that the underlying portfolio performance remained resilient with limited migration to Watch List.
The Committee discussed reports from management on the risks arising from Barclays' participation in Government loan schemes in the UK, including a deep-dive on the risk position of the BBLS. The Committee discussed the legal risk position of the BBLS, the probability of high levels of default as well as potential fraud, credit, conduct, reputational and operational risks. The Committee reviewed reports on the leveraged finance business, taking into account the overall risk profile of the business. The Committee received regular reports on the risks from the CIB and has continued to oversee improvements to the risk and control environment in the Markets business.
Operational risk
i.e. the risk of loss arising from inadequate or failed processes and systems, human factors or due to external events.
The Group’s operational risk capital requirements and any material changes to the Group’s operational risk profile and performance of specific operational risks against agreed risk appetite.
To track operational risk key indicators.
To consider specific areas of operational risks, including fraud, conduct risk, cyber risk, execution risk, technology and data, including the controls that had been put in place for managing and avoiding such risks.
To review Barclays’ approach to scenario analyses as a risk management tool.
The Committee approved and recommended to the Board the 2021 Operational Risk Appetite Statement. The Operational risk profile of the Group remained heightened due to the ongoing COVID-19 pandemic.
The Committee was briefed by management on a variety of topical Operational risks including those relating to transactional operations risk, climate change, colleagues and their wellbeing (particularly in light of the ongoing COVID-19 pandemic), fraud, erroneous payments, cybersecurity and the use of cloud platforms.
The Committee continued to monitor enhancements that were made to the processes for new and amended product approvals for subsidiaries within the Group.
The Committee also considered closely Operational resilience, with a teach-in dedicated to the Group’s approach to resilience and regulatory expectations including with respect to identifying important business services and impact tolerances.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
36

Directors’ report: Board Risk Committee report continued
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
Model risk
i.e. the potential for adverse consequences from decisions based on incorrect or misused model outputs and reports.
Model risk governance.
To evaluate the appropriateness of the Model risk management framework and monitor progress on the implementation of an enhanced modelling framework, including receiving updates on findings in relation to specific modelling processes.
The Committee reviewed and approved changes to the Model risk tolerances which were described through a set of qualitative statements and associated metrics that would monitor the completeness and effectiveness of the Control Framework.
In addition, the Committee reviewed and discussed regular updates on Model risk including progress made against the multi-year enhancement plan to the risk management framework, as well as details on the approach being taken to develop regulatory models.
The Committee monitored and discussed the scope of the Model risk management implementation including scrutinising which models had been brought into governance and the rationale for exclusion of models.
To support the regulatory requirements in this area, the Committee discussed the remit of the independent Model Strategy and Oversight Team which was being formed to provide oversight on strategic modelling decisions.
Risk framework and governanceThe frameworks, policies and tools in place to support effective risk management and oversight.
To track the progress of significant risk management projects, achieving compliance with the Basel Committee for Banking Supervision (BCBS239) risk data aggregation principles and the RCSA process across the Group.
To assess risk management matters raised by Barclays’ regulators and the actions being taken by management to respond.
To review the design of the ERMF.
The Committee discussed the annual refresh of the Principal Risk Frameworks as well as recommending the updated ERMF to the Board for approval. This year, the Committee reviewed the first Climate Risk Framework to support Climate risk becoming a Principal Risk within the ERMF in 2022.
The Committee continued to oversee management's progress towards achieving full compliance with all aspects of BCBS239, receiving regular reports on levels of compliance and expected milestones.
The Committee reviewed reports from management on guidance, letters and reviews received from regulators. The Committee examined management's responses to the matters raised and monitored remediation programmes.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
37

Directors’ report: Board Risk Committee report continued
Areas of focusMatters addressedRole of CommitteeConclusion/action taken
RemunerationThe scope of any risk adjustments to be taken into account by the Board Remuneration Committee when making remuneration decisions for 2021.
To debate the Risk function’s view of performance, making a recommendation to the Board Remuneration Committee on the financial and operational risk factors to be taken into account in remuneration decisions for 2021.
The Committee considered the report of the Group Chief Risk Officer and considered the 2021 ex-ante risk adjustment methodology.
Conduct Risk
i.e. the risk of poor outcomes to customers, clients and markets, arising from the delivery of the Group's products and services.
Conduct robust reviews of any current and emerging risks arising from the delivery of Barclays' products and services.
To receive updates from management on Conduct risk and consider performance against key Conduct risk indicators and the status of initiatives in place to address those risks to further strengthen the culture of the business.
To review the effectiveness of the Conduct risk framework.
To review the Compliance function’s Annual Compliance Plan.
During 2021, the Committee was provided with regular updates on Conduct Risk, including a continued focus on COVID-19 and its impacts, and the assessments of potential risks to the Group following market events. The Committee also received updates on lessons learned reviews, undertaken in response to industry developments and events, and continued to monitor ongoing remediation activities.
The Committee discussed with management the Conduct and Risk culture of the Group both in the context of the Barclays’ Values and Mindset and from a colleague wellbeing perspective.
During the year, the Committee reviewed the Compliance function's effectiveness and performance of activities against its Compliance Plan for 2021, and towards year end approved the Annual Compliance Plan for 2022.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
38


Directors’ report: How we comply
For the year ended 31 December 2021, and as at the date of this report, Barclays PLC has complied in full with the Code’s principles and provisions.
Reporting against the Code's principles and provisions

The UK Corporate Governance Code
As a company listed on the London Stock
Exchange, Barclays PLC applies the
principles and provisions of the Code.
A copy of the Code can be found
at frc.org.uk. For the year ended
31 December 2021
, and as at the date
of this report, we are pleased to confirm
that Barclays PLC has complied in full
with the requirements of the Code.
This section sets out how we comply
with the Code.
Disclosure Guidance and Transparency Rules
By virtue of the information included in
this Governance section of the Annual
Report, we comply with the corporate
governance statement requirements of
the FCA’s DTRs. Certain additional
information that is required to be
disclosed pursuant to DTR7.2.6
can be found on pages 47 to 52.
New York Stock Exchange (NYSE)
Barclays is permitted by NYSE rules to follow UK corporate governance practices instead of those applied in the US and any significant variations are explained on page 319.

Board leadership and company purpose
Role of the Board
Our governance is designed to deliver an effective and entrepreneurial Board which:
is effective in providing challenge, advice and support to management
provides checks and balances and encourages constructive challenge
drives informed, collaborative and accountable decision-making
creates long-term sustainable value for our shareholders, having regard to the interests of all our other stakeholders.
You can read more about our governance in the context of the Board, including our Group-wide governance framework and how the Board discharged its responsibilities during 2021, on pages 8 to 14.
Culture
The Barclays Way sets out our Purpose, Values and Mindset, and is the Code of Conduct for everyone working at Barclays, providing a clear path for achieving a dynamic and positive culture within the Group.
The Board is fully supportive of The Barclays Way and our Purpose, Values and Mindset, and you can read more about Board's role in this area, including how the Board receives feedback on our culture through a number of channels to ensure it is aligned to our Purpose, Values and Mindset, on page 11.
Our Group Whistleblowing Standard enables employees to raise any matters of concern anonymously and is embedded into our business. You can read more about the role of the Board Audit Committee in reviewing and monitoring the Group's Whistleblowing policies on page 28.
Relations with shareholders and stakeholders
Considering the views and interests of our stakeholders is an important part of the way in which the Board makes decisions and provides oversight and challenge.
Our comprehensive investor relations engagement helps to inform the Board about investors’ views on Barclays, which are communicated regularly to the Board; and our Chairman engages with shareholders on governance and related matters. Our Investor Relations programme returned to a more normalised process in 2021, combining both virtual and in-person formats, as we adapted to new ways of working, allowing high-quality interaction in the ways our investors prefer.
Our shareholder communication guidelines are available on our website at home.barclays/investor-relations/shareholder-information/.
Institutional investors
In 2021, the Directors, in conjunction with the senior executive team and Investor Relations colleagues, were able to participate in investor meetings, seminars and conferences across many locations, increasingly in person. We held conference calls and webcasts for our quarterly results briefings for both our equity and fixed income investors, and look forward to continuing this engagement through 2022.
During 2021, discussions with investors included, but were not limited to:
the impact of the COVID-19 pandemic on Barclays, including macroeconomic effects of higher inflation and interest rates
opportunities arising from the subsequent reopening of global economies, and the recovery in consumer and corporate activity
drivers of sustained double-digit Group return on average tangible shareholders' equity (RoTE) post-COVID-19 pandemic
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
39

Directors’ report: How we comply continued
Group Chief Executive succession and its impact on the Group’s strategic priorities and targets over the medium term
capital allocation and shareholder distributions, while managing capital towards our target range
the advance of the climate agenda and furtherance of the Barclays’ climate strategy.
Private shareholders
During 2021, we continued to actively communicate with our private shareholders through shareholder mailings, information available on our website and at our AGM. Our Private Shareholder Relations team is also available to support with any feedback or questions from shareholders. You can read more about our 2021 AGM on this page.
The Group issues regulatory announcements via the Regulatory News Service (RNS) and shareholders can subscribe to receive notifications of such announcements via our website home.barclays/investor-relations/investor-news/regulatory-news-email-alerts/.
More information for shareholders is available on pages 310 to 311 , which includes details on signing up to Shareview (which enables shareholders to easily manage their shareholdings and personal information online), receiving dividends electronically, how we return unclaimed funds to shareholders and useful contacts.
The 2021 AGM
The Board shared the frustration of our shareholders that, like our 2020 AGM, the 2021 AGM was impacted by the COVID-19 pandemic and shareholders were unable to attend in person. The Board and the senior executive team consider our AGM to be an important event in our corporate calendar, providing a key opportunity for shareholder engagement, particularly with our private shareholders, and for shareholders to ask questions of the Board.
In order to maximise shareholder engagement whilst respecting the COVID-19 restrictions and guidance in place at the time, in 2021 we held the AGM as a combined physical and electronic meeting (a ‘hybrid’ AGM) for the first time. This enabled shareholders to attend the 2021 AGM virtually using electronic facilities and to vote and raise questions in real time, either by telephone or using the electronic facilities. In addition to raising questions at the 2021 AGM itself, shareholders were able to submit questions to the Board in advance of the meeting, as in previous years. All questions received ahead of the 2021 AGM were answered individually and answers to frequently asked questions were published on our website ahead of the meeting.
Voting on all of the resolutions at the 2021 AGM was conducted by way of a poll, thereby giving weight to the number of shares held by shareholders rather than simply attributing a notional one vote to each shareholder voting. With the exception of the shareholder requisitioned Resolution 29, all resolutions were passed with votes ‘For’ ranging from 91.54% to 99.97% of the total votes cast.
Shareholders voted in favour of amending our Articles of Association (Articles) at the 2021 AGM to include, amongst other changes, specific provisions on how a hybrid general meeting can be conducted, to allow for maximum flexibility in how we might convene and conduct AGMs in future years.
A climate change resolution (Resolution 29) was requisitioned by a group of shareholders co-ordinated by Market Forces. The Board did not consider Resolution 29 to be in the best interests of BPLC and its shareholders as a whole, and recommended that shareholders vote against Resolution 29 for the following reasons (as detailed in the 2021 Notice of AGM available at home.barclays/investor-relations/reports-and-events/general-meetings/):
firstly, our new climate change strategy was adopted in 2020 to align Barclays to the goals of the Paris Agreement
secondly, meaningful progress in the 12 months leading to the 2021 AGM had been made to design, refine and embed our detailed approach across Barclays
thirdly, the Board continued to believe that Barclays can make the greatest difference by supporting the transition to a low-carbon economy, rather than by simply phasing out support for some of the clients who are most engaged in it.
Resolution 29, which was not supported by the Board, was not passed, and the level of shareholder support for it fell well short of the 75% majority required for it to pass. Only 14.04% of the votes cast were cast ‘For’ Resolution 29, representing 8.92% of the register.
In line with Barclays' announcement at the 2021 AGM to offer shareholders a 'Say on Climate', shareholders will be asked to vote on Barclays' climate strategy at the 2022 AGM. Further details of the 'Say on Climate' vote will be set out in the 2022 Notice of AGM.
The 2022 AGM
Looking ahead to the 2022 AGM, the Board currently intends to hold the AGM in Manchester on 4 May 2022 at 11:00am as a combined physical and electronic meeting, to allow for shareholders to attend and vote in person or virtually using electronic facilities, should they prefer.
Our plans remain, of course, subject to the ongoing COVID-19 pandemic and any UK Government guidance or restrictions in place at the relevant time, but the Board very much hopes to be able to welcome shareholders to the 2022 AGM in person. Further details will be provided in our 2022 Notice of AGM.
As stated in our 2021 Notice of AGM, it is the Board’s intention on an annual basis to alternate AGM venues between London and a venue other than London where Barclays has a significant business or customer presence.
Stakeholder engagement
Seeking to understand all stakeholders’ views, and the impact of our behaviour and business on our customers and clients, colleagues, suppliers, communities and society more broadly, is a key part of how the Board makes decisions and provides oversight and challenge. Accordingly, the Board monitors key indicators across areas such as culture, citizenship, conduct, and customer and client satisfaction on an ongoing basis.
We engaged extensively with shareholders and other stakeholders (including proxy advisory agencies and investor associations) in 2021 on key topics including strategic priorities, governance and succession planning, as well as further engagement on Barclays' climate strategy.
Throughout 2021, we have engaged with our stakeholders through a variety of means including surveys, participation in forums and global and regional industry initiatives.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
40

Directors’ report: How we comply continued
Colleague engagement
Our colleagues are critical to our success, and the Board recognises that our continued investment in them protects and strengthens our culture.
Barclays has a long-standing commitment to the importance and value of colleague engagement, and in 2021 we continued to listen to colleagues and keep them informed in a number of ways. This included conducting regular 'Here to Listen' employee surveys, first launched in 2020, to make sure we were staying abreast of colleague feedback during the COVID-19 pandemic, as well as our annual 'Your View' employee survey.
You can read more about our commitment to our colleagues and our workforce engagement, including survey results and how we continue to support our colleagues, in the Our people and culture section on pages 92 to 97.
Conflicts of interest
In accordance with the Companies Act 2006 and BPLC Articles, the Board has the authority to authorise conflicts of interest and this ensures that the influence of third parties does not compromise the independent judgement of the Board. Directors are required to declare any potential or actual conflicts of interest that could interfere with their ability to act in the best interests of the Group.
The Group Company Secretary maintains a conflicts register, which is a record of actual and potential conflicts, together with any Board authorisation of the conflicts. The authorisations are for an indefinite period but are reviewed annually by the Nominations Committee, which also considers the effectiveness of the process for authorising Directors’ conflicts of interest. The Board retains the power to vary or terminate these authorisations at any time.
Division of responsibilities
Roles on the Board
Executive and Non-Executive Directors share the same duties. However, in line with the principles of the Code, a clear division of responsibilities has been established.
The Chair is responsible for:
leading the Board and its overall effectiveness
demonstrating objective judgement
promoting a culture of openness and constructive challenge and debate between all Directors
facilitating constructive board relations and the effective contribution of all Non-Executive Directors
ensuring Directors receive accurate, clear and timely information.
Responsibility for the day-to-day management of the Group is delegated to the Group Chief Executive, who is supported in this role by the ExCo. You can find further information on the membership of the ExCo on page 7.
As a Board we have set out our expectations of each Director in Barclays’ Charter of Expectations. This includes role profiles and the behaviours and competencies required for each role on the Board, namely the Chair, Deputy Chair (to the extent one is required), the SID, Non-Executive Directors, Executive Directors and Committee Chairs.
Our Non-Executive Directors provide effective oversight and scrutiny, strategic guidance and constructive challenge, holding the Executive Directors to account against their agreed performance objectives. The Non-Executive Directors, led by the Nominations Committee, have primary responsibility for the appointment and removal of the Executive Directors.
The SID provides a sounding board for the Chair, acting as an intermediary for the other Directors when necessary. Our SID is available to shareholders should they have concerns that have not been addressed through the normal engagement channels.
The Charter of Expectations is reviewed annually to ensure it remains relevant and accurately reflects the requirements of the Code, the Regulations and industry best practice.
A copy of the Charter of Expectations can be found at home.barclays/who-we-are/our-governance/board-responsibilities
Information provided to the Board
It is the responsibility of the Chair to set the Board agenda, primarily focused on strategy, performance, value creation, culture, stakeholders and accountability, and to ensure that Board members receive timely and high-quality information to enable them to make sound decisions and promote the success of BPLC. Working in collaboration with the Chair, the Group Company Secretary is responsible for ensuring good governance and information flow, to ensure an effective Board.
Throughout the year, both the Executive Directors and senior executives kept the Board informed of key business developments through regular updates. These are in addition to the presentations that the Board and Board Committees receive as part of their formal meetings. Where required to enable them to fulfil their obligations as members of the Board, Directors are able to seek independent and professional advice at Barclays’ expense.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
41

Directors’ report: How we comply continued
Attendance
Directors are expected to attend every Board meeting. In 2021, attendance was very strong both at scheduled meetings and the ad hoc meeting (called at short notice), as reflected in the table below. The Chairman met privately, on a quarterly basis, with each Non-Executive Director. If, owing to exceptional circumstances, a Director was not able to attend a Board meeting, the relevant Director ensured that their views were made known to the Chairman in advance of the meeting. The attendance record of Directors at scheduled and ad hoc meetings during 2021 is a testament to the commitment of each of our current Directors.
Board attendance in 2021Independent/ExecutiveScheduled Meetings eligible to attendScheduled Meetings attended% attendanceAd hoc Meetings eligible to attendAd hoc Meetings attended
Chairman
Nigel Higgins
On appointmenta
1414100 %11
Executive Directors
C.S. Venkatakrishnan Executive Director44100 %00
Tushar MorzariaExecutive Director1414100 %00
Non-Executive Directorsb
Mike AshleyIndependent1414100 %11
Tim BreedonIndependent141393 %11
Mohamed A. El-ErianIndependent1414100 %11
Dawn FitzpatrickIndependent1414100 %11
Mary FrancisIndependent1414100 %11
Crawford GilliesIndependent1414100 %11
Brian Gilvary
SIDc
1414100 %11
Diane SchuenemanIndependent 1414100 %11
Julia WilsonIndependent1212100 %11
Former Directors
Jes StaleyExecutive Director1010100 %00
Sir Ian CheshireIndependent33100 %00
Notes
a     As required by the Code, the Chairman was independent on appointment.
b Robert Berry did not join the Board until 8 February 2022.
c Brian Gilvary succeeded Crawford Gillies as SID on 1 January 2021.

Board Committee cross-membership
The table below shows the number of cross-memberships of the Non-Executive Directors across the Board Committees as at 31 December 2021.
bcs-20211231_g9.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
42

Directors’ report: How we comply continued
Composition of the Board
In line with the requirements of the Code, a majority of the Board is comprised of independent Non-Executive Directors. The independence of our Non-Executive Directors is considered by the Nominations Committee on an annual basis, having regard to the independence criteria set out in the Code. As part of this process, our Nominations Committee keeps under review the length of tenure of all Directors, which can affect independence, and makes any recommendations to the Board accordingly.
The independence of Mike Ashley, Crawford Gillies and Diane Schueneman, all of whom have served on the Board for more than six years, and Tim Breedon who has served on the Board for more than nine years, was subjected to a more rigorous review. The Nominations Committee remains satisfied that the lengths of their tenure have no impact on their respective levels of independence or the effectiveness of their contributions. The Nominations Committee and the Board consider all of the Non-Executive Directors to be independent.
In the case of Tim Breedon, having undertaken a rigorous review of his performance as a Non-Executive Director and taking into account other relevant factors that might be considered likely to impair, or could appear to impair, independence including as set out in Provision 10 of the Code, the Nominations Committee and the Board consider Tim to be independent.
During 2021, both Jes Staley and Sir Ian Cheshire stepped down from the Board. Neither raised any concerns about the operation of the Board or management.
You can read more about changes to Board composition and steps taken to further strengthen the Board and consideration of Non-Executive Director independence, including the Nomination Committee's review of Tim Breedon's independence and the appointment of Robert Berry in 2022, in the report of our Nominations Committee on pages 15 to 21.
Time commitment
All potential new Directors are asked to disclose their other significant commitments. The Nominations Committee then takes this into account when considering a proposed appointment to ensure that Directors can discharge their responsibilities to Barclays effectively. This means not only attending and preparing for formal Board and Board Committee meetings, but also making time to understand the business and to undertake training. The time commitment is agreed with each Non-Executive Director on an individual basis.
In addition, all Directors must seek approval (providing an indication of expected time commitments) before accepting any significant new commitment outside of Barclays. Prior to approving any significant new external commitment for a Director, the Board undertakes a review of all relevant facts and circumstances, including the role and time commitment involved and the nature of the external organisation. In 2021, all external appointment requests were approved on the basis that the Board was comfortable with any actual or potential conflicts and the Board was confident that the Director in question remained able to devote such time necessary to discharge their duties to Barclays effectively.
Set out on this page is the average time commitment expected for the role of Non-Executive Directors and the other Non-Executive positions on the Board.
Expected time commitment
RoleExpected time commitment
ChairEquivalent of up to 80% of full-time position.
Senior Independent DirectorAs required to fulfil the role.
Non-Executive Director35-40 days per year (membership of one Board Committee included, increasing to 50 days a year if member of two Board Committees).
Committee ChairsAt least 80 days per year (including Non-Executive Director time commitment) for Audit and Risk Committee Chairs and at least 60 days for the Remuneration Committee Chair.
Where circumstances require it, all Directors are expected to commit additional time as necessary to their work on the Board. The Group Company Secretary maintains a record of each Director’s commitments. For the year ended 31 December 2021 and as at the date of publication, the Board is satisfied that none of the Directors is over-committed and that each of the Directors allocates sufficient time to their role in order to discharge their responsibilities effectively.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
43

Directors’ report: How we comply continued
Composition, succession and evaluation
We have a Nominations Committee, the purpose and activities of which are contained in the report of our Nominations Committee on pages 15 to 21.
Board appointments
All Board and senior management appointments are viewed through a diversity lens and are based on merit and objective criteria, which focus on the skills and experience required for the Board’s effectiveness and the delivery of the Group strategy. Board appointments are made following a rigorous and transparent process facilitated by the Nominations Committee, with the aid of external search consultancy firms.
The Board adopted a revised version of the Board Diversity Policy on 9 February 2021, re-affirming the existing gender diversity target (33% female) and adopting a new ethnic diversity target aligned with the Parker Review on the ethnic diversity of UK Boards (at least one Board member to be a Person of Colour). The Board reconfirmed its commitment to these targets on 9 February 2022.
You can read more about diversity at Board level in the report of our Nominations Committee on page 18, and about Barclays' continued commitment to diversity and inclusion in Our people and culture section on pages 92 to 97.
The composition of the Board, Board Committees and the ExCo is regularly reviewed by the Nominations Committee. It frequently considers the skills required for the Board, Board Committees and the ExCo, identifying the core competencies, diversity and experience required. This, along with the annual effectiveness evaluation, helps to refresh the thinking on Board, Board Committee and ExCo composition and to determine a timeline for proposed new appointments. For the Board, it is standard practice to appoint any new Non-Executive Director or Chair for an initial three-year term, subject to annual re-election at the AGM, which may be extended for up to a further three-year term. As such, Non-Executive Directors typically serve up to a minimum of six years but this period may be extended where the Nominations Committee considers it appropriate.
All Directors are subject to election or re-election (as appropriate) each year by shareholders at the AGM.
Each year, we carry out an effectiveness review in order to evaluate our performance, as a Board, as well as the performance of each of the Board Committees and individual Directors. You can read more about the 2021 Board, Board Committee and Individual Effectiveness review, which was externally facilitated (as required by the Code), in the report of our Nominations Committee on pages 20 to 21.
You can find biographies for each member of the Board, including details of their relevant skills, experience and contribution, Board Committee memberships and other principal appointments on pages 3 to 6. Details of changes to the Board in 2021 and up to the date of this report, together with details of Board appointments, tenure, independence and succession planning are disclosed in the report of our Nominations Committee on pages 15 to 21.
The service contracts for the Executive Directors and the letters of appointment for the Group Chairman and Non-Executive Directors are available for inspection at our registered office and at the AGM.
Induction
On appointment to the Board, all Directors receive a comprehensive induction that is tailored to the new Director’s individual requirements. The induction schedule is designed to provide the new Director with an understanding of how the Group works and the key issues that it faces. The Group Company Secretary consults the Chair when designing a bespoke induction schedule, taking into account the particular needs of a new Director. When a Director is joining a Board Committee, the schedule includes an induction to the operation of that committee.
Following their appointments to the Board in 2021, Venkat and Julia Wilson each received tailored inductions. Robert Berry’s induction is in progress, following his appointment to the Board on 8 February 2022. You can read more about their inductions, Dawn Fitzpatrick's induction to the Board Remuneration Committee and Brian Gilvary's briefings in relation to his role as Board Remuneration Committee Chair and responsibilities as SID in the report of our Nominations Committee on page 19.
Training and development
In order to support the effective contribution by Board and Board Committee members, we regularly provide Directors with the opportunity to take part in ongoing training and development. Directors can also request specific training, as required.
Whilst opportunities for in-person Director training remained limited in 2021 due to the impact of the COVID-19 pandemic and ongoing social distancing guidance, training and development was supported through the Board deep dives, briefings for Board members on key risk topics, and Function reviews described on page 13.
The Board also received an annual briefing on regulatory responsibilities, including the Senior Managers Regime and on Barclays’ conduct and financial crime policies and standards.
The Nominations Committee supports the Chair in developing and monitoring effective induction, training and development for the Board, and you can read more on pages 19 to 20.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
44

Directors’ report: How we comply continued
Audit, Risk and
Internal Control
Accountability
Internal governance processes have been developed to ensure the effective operation of the individual Boards and Board Committees of each of BPLC, BBUKPLC and BBPLC respectively, in recognition of the fact that this is key to the development and execution of the Group’s strategy. Generally, there is one set of rules for the Group. Group-wide frameworks, policies and standards are adopted throughout the Group unless local laws or regulations (for example, the ring-fencing obligations applicable to BBUKPLC) require otherwise, or the ExCo decides otherwise in a particular instance.
The Board has a Board Audit Committee and a Board Risk Committee. The purposes and activities of the Board Audit and Board Risk Committees are contained within their respective reports on pages 22 and 31 respectively.
Internal and external audit functions
The Board, together with the Board Audit Committee, is responsible for ensuring the independence and effectiveness of the internal and external audit functions. For this reason, the Board Audit Committee members met regularly with the Group Chief Internal Auditor and the KPMG lead audit engagement partner, without management present. The appointment and removal of the Group Chief Internal Auditor is a matter reserved to the Board Audit Committee and the appointment, and removal, of the external auditor, is a matter reserved to the Board. Neither task is delegated to management. More detail is provided on pages 28 to 30 of the Board Audit Committee report.
Company’s position and prospects
The Board, together with the Board Audit Committee, is responsible for ensuring the integrity of this Annual Report and that the financial statements as a whole present a fair, balanced and understandable assessment of our performance, position and prospects. This is explained in detail on page 25 of the Board Audit Committee report.
Risk management and internal control
The Directors are responsible for ensuring that management maintains an effective system of risk management and internal control and for assessing its effectiveness. Such a system is designed to identify, evaluate and manage, rather than eliminate, the risk of failure to achieve business objectives and can only provide reasonable, and not absolute, assurance against material misstatement or loss.
The Group is committed to operating within a strong system of internal control. Barclays has an overarching framework that sets out the approach of the Group to internal governance, The Barclays Guide. This establishes the mechanisms, principles and processes through which management implements the strategy set by the Board.
Processes are in place for identifying, evaluating and managing the Principal Risks facing the Group in accordance with the ‘Guidance on Risk Management, Internal Control and Related Financial and Business Reporting’, published by the FRC. A key component of The Barclays Guide is the ERMF. The purpose of the ERMF is to identify and set minimum requirements in respect of the main risks to the strategic objectives of the Group. There are nine Principal Risks under the ERMF: Credit risk, Market risk, Treasury and Capital risk, Operational risk, Climate risk, Model risk, Reputation risk, Conduct risk and Legal risk. The system of risk management and internal control is set out in the risk frameworks relating to each of our nine Principal Risks and the Barclays Control Framework, which details requirements for the delivery of control responsibilities. Group-wide frameworks, policies and standards enable Barclays to meet regulators’ expectations relating to internal control and assurance.
Effectiveness of internal controls
Key controls are assessed on a regular basis for both design and operating effectiveness. Issues arising out of these assessments, where appropriate, are reported to the Board Audit Committee. The Board Audit Committee oversees the control environment (and remediation of related issues) and you can read more about its work on pages 22 to 30. The Board Audit Committee also reviews annually the risk management and internal control system, which includes the ERMF. It has concluded that, throughout the year ended 31 December 2021 and to date, the Group has operated a sound system of internal control that provides reasonable assurance of financial and operational controls and compliance with laws and regulations. For more details on that evaluation and its conclusions please see page 28.
The review of the effectiveness of the system of risk management and internal control is achieved through reviewing the effectiveness of the frameworks, principles and processes contained within The Barclays Guide, the ERMF and the Barclays Control Framework.
Regular reports are made by management to the Board Risk Committee and the Board covering significant risks, measurement methodologies and appropriate risk appetite for the Group.
Further details of risk management procedures and material existing and emerging risks are given in the Risk review and Risk management sections on pages 98 to 192.
Controls over financial reporting
A framework of disclosure controls and procedures is in place to support the approval of the financial statements of the Group.
Specific governance committees are responsible for examining the financial reports and disclosures to ensure that they have been subject to adequate verification and comply with applicable standards and legislation.
Where appropriate, these committees report their conclusions to the Board Audit Committee, which debates such conclusions and provides further challenge. Finally, the Board scrutinises and approves results announcements and the Annual Report and ensures that appropriate disclosures have been made. This governance process ensures that both management and the Board are given sufficient opportunity to debate and challenge the financial statements of the Group and other significant disclosures before they are made public.
Management’s report on internal control over financial reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting under the supervision of the principal executive and financial officers, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements, in accordance with (a) UK-adopted international accounting standards; and (b) International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB), including interpretations issued by the IFRS Interpretations Committee.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
45

Directors’ report: How we comply continued
Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail:
accurately and fairly reflect transactions and dispositions of assets
provide reasonable assurances that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS and that receipts and expenditures are being made only in accordance with authorisations of management and the respective Directors
provide reasonable assurance regarding prevention or timely detection of unauthorised acquisition, use or disposition of assets that could have a material effect on the financial statements.
Internal control systems, no matter how well designed, have inherent limitations and may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that internal controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.
Management has assessed the internal control over financial reporting as at 31 December 2021. In making its assessment, management utilised the criteria set out in the 2013 COSO framework and concluded that, based on its assessment, the internal control over financial reporting was effective as at 31 December 2021.
The system of internal financial and operational controls is also subject to regulatory oversight in the UK and overseas. Further information on supervision by the financial services regulators is provided under Supervision and Regulation in the Risk review section on pages 187 to 192.
Changes in internal control over financial reporting
There have been no changes that occurred during the period covered by this report, which have materially affected or are reasonably likely to materially affect the Group’s internal control over financial reporting.
Remuneration
We have a Board Remuneration Committee, the purpose and activities of which are described in the Remuneration report on pages 54 to 91.
The Board has delegated responsibility for the consideration and approval of the remuneration arrangements of the Chairman, the Executive Directors, other senior executives and certain Group employees to the Board Remuneration Committee. The Board Remuneration Committee, when considering the remuneration policies and practices, seeks to ensure that they support our strategy and promote the long-term success of the business and that they are aligned to the successful delivery of the Group’s strategy.
All executive and senior management remuneration policies are developed in accordance with the Group’s formal and transparent procedures (ensuring that no Director is involved in deciding their own remuneration outcome) and having regard to workforce remuneration and related policies and the alignment of incentives and rewards with culture.
All Board Remuneration Committee members demonstrate independent judgement and discretion when determining and approving remuneration outcomes. The Board as a whole, with the Non-Executive Directors abstaining, considers annually the fees paid to Non-Executive Directors.
You can find further information on the purpose of the Board Remuneration Committee and its activities in 2021 in the Remuneration report on pages 54 to 91.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
46


Directors’ report: Other statutory information
The Directors present their report together with the audited accounts for the year ended 31 December 2021.
Other statutory information

Other information that is relevant to the Directors’ report, and which is incorporated by reference into this report, can be located as follows:
Page
Remuneration policy, including details of the remuneration of each Director and Directors’ interests in shares62
Governance Statement2
Risk review98
Disclosures required pursuant to Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 as updated by Companies (Miscellaneous Reporting) Regulations 2018 can be found on the following pages:
Page
Engagement with employees (Sch. 7, Para 11 and 11A 2008/2018 Regs)92 to 97
Policy concerning the employment of disabled persons (Sch. 7, para 10 2008 Regs)97
Engagement with suppliers, customers and others in a business relationship (Sch. 7, Para 11 B 2008/2018 Regs)48
Financial instruments (Sch. 7, para 6 2008 Regs)244
Hedge accounting policy (Sch. 7, para 6 2008 Regs)247
Disclosures required pursuant to Listing Rule 9.8.4R can be found on the following pages:
Page
Long-term incentive schemes64
Waiver of Director emoluments91
Allotment for cash of equity securities282
Waiver of dividends47


Profit and dividends
Statutory profit after tax for 2021 was £7,226m (2020: £2,461m). The 2021 full year dividend of 4.0p per ordinary share will be paid on 5 April 2022 to shareholders whose names are on the Register of Members at the close of business on 4 March 2022. With the 2021 half year dividend totalling 2.0p per ordinary share, paid in September 2021, the total distribution for 2021 is 6.0p (2020: nil) per ordinary share. The half year and full year dividends for 2021 amounted to £512m (2020: nil). BPLC also completed share buy-back programmes during 2021, further details of which can be found on page 52.
Shareholders may have their dividends reinvested in Barclays by joining the Barclays DRIP. Further details regarding the DRIP can be found at home.barclays/dividends and shareview.co.uk/info/drip
The nominee company of certain Barclays’ employee benefit trusts holding shares in Barclays in connection with the operation of our share plans has lodged evergreen dividend waivers on shares held by it that have not been allocated to employees. The total amount of dividends waived during the year ended 31 December 2021 was £1.02m (2020: nil).
Board of Directors
The names of the current Directors of BPLC, along with their biographical details, are set out on pages 3 to 6 and are incorporated into this Directors’ report by reference. Changes to Directors during the year and up to the date of this report are set out below.
.
NameRoleEffective date
Julia WilsonNon- Executive DirectorAppointed 1 April 2021
Sir Ian CheshireNon-Executive DirectorStepped down 5 May 2021
Jes StaleyExecutive DirectorStepped down 31 October 2021
C.S. VenkatakrishnanExecutive DirectorAppointed 1 November 2021
Robert Berry
Non-Executive Director
Appointed 8 February 2022





















Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
47

Directors’ report: Other statutory information continued
Appointment and retirement of Directors
The appointment and retirement of Directors is governed by our Articles, the Code, the Companies Act 2006 and related legislation.
The Articles may be amended only by a special resolution of the shareholders. The Board has the power to appoint additional Directors or to fill a casual vacancy among the Directors and any Director so appointed holds office only until the next AGM and may offer himself/herself for re-election. The Code recommends that all directors of FTSE 350 companies should be subject to annual re-election. All Directors who will be continuing in office, and Anna Cross in her capacity as a Director from 23 April 2022, intend to offer themselves for election or re-election (as appropriate) at the 2022 AGM.
Directors’ indemnities
‘Qualifying third party indemnity’ provisions (as defined by section 234 of the Companies Act 2006) were in force during the course of the financial year ended 31 December 2021 for the benefit of the then Directors of the Company and the then Directors of certain of the Company's subsidiaries and, at the date of this report, are in force for the benefit of the Directors of the Company and the Directors of certain of the Company's subsidiaries in relation to certain losses and liabilities which they may incur (or have incurred) in connection with their duties, powers or office. The Group also maintains Directors’ & Officers’ Liability Insurance which gives appropriate cover for legal action brought against its Directors.
Qualifying pension scheme indemnity provisions (as defined by section 235 of the Companies Act 2006) were in force during the course of the financial year ended 31 December 2021 for the benefit of the then directors, and at the date of this report are in force for the benefit of directors of Barclays Pension Funds Trustees Limited as trustee of the Barclays Bank UK Retirement Fund, and Barclays Executive Schemes Trustees Limited as Trustee of Barclays Capital International Pension Scheme (No.1) and Barclays PLC Funded Unapproved Retirement Benefits Scheme. The directors of the trustees are indemnified against liability incurred in connection with the trustees’ activities in relation to the Barclays Bank UK Retirement Fund, Barclays Capital International Pension Scheme (No.1) and Barclays PLC Funded Unapproved Retirement Benefits Scheme.
Political donations
The Group did not give any money for political purposes in the UK or outside the UK, nor did it make any political donations to political parties or other political organisations or to any independent election candidates, nor did it incur any political expenditure during the year. In accordance with the US Federal Election Campaign Act, Barclays provides administrative support to a federal Political Action Committee (PAC) in the US, funded by the voluntary political contributions of eligible employees. The PAC is not controlled by Barclays and all decisions regarding the amounts and recipients of contributions are directed by a steering committee comprising employees eligible to contribute to the PAC. Contributions to political organisations reported by the PAC during the calendar year 2021 totalled $29,000 (2020 $113,500).
Country-by-Country reporting
The Capital Requirements (Country-by-Country reporting) Regulations 2013 require the Company to publish additional information in respect of the year ended 31 December 2021. This information is available on the Barclays website: home.barclays/annualreport.
Supporting our suppliers
Our engagement with suppliers is important and we engage with them regularly to ensure adherence to the Barclays’ Supplier Code of Conduct and Supply Control obligations. As part of the bank’s ESG strategy, we are focused on environmental and social responsibility in our supply chain, initially across three pillars of diversity and inclusion, the environment and modern slavery.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
48

Directors’ report: Other statutory information continued
Environment
As part of its ambition to be a net zero bank by 2050, Barclays is working to achieving net zero operations1 and supply chain emissions. Barclays has been carbon neutral for its Scope 12, Scope 23 and Scope 3 (business travel)4 emissions since 2020. We are defining net zero operations as the state in which we will achieve a greenhouse gas (GHG) reduction of our scope 1 and scope 2 emissions by at least 90%, against a 2018 baseline, and use carbon removals to eliminate any residual operational emissions that we cannot yet abate. We are defining carbon neutral as first reducing carbon dioxide emissions then counterbalancing carbon dioxide emissions for scope 1, scope 2 and scope 3 business travel with carbon offsets.
In 2020, we disclosed that we were already net zero from our own operations, based on the common understanding at that time, that ‘net zero’ and ‘carbon neutral’ were interchangeable terms. To reflect the most recent interpretations of both of these terms in public discourse, we will make a distinction between net zero operations and carbon neutral in our disclosures from now on. The standards available to understand and define net zero are rapidly evolving. We will continue to review and develop our own approach to net zero operations as this subject area matures.
We have been carbon neutral since 2020 by reducing or eliminating sources of carbon dioxide emissions associated with our operations and business travel and by compensating any remaining emissions by purchasing carbon credits under the Verified Carbon Standard (VCS). We intend to remain carbon neutral, while investing in the continued decarbonisation of our operations and in the development of a net zero pathway for the emissions from our supply chain.
In line with our commitment to offer shareholders a ‘Say on Climate’, we will be publishing an update on our climate strategy, targets and methodology in advance of the 2022 AGM. This will include 2030 targets for two new sectors, Cement and Metals (Steel). Further details of the 'Say on Climate' vote will be set out in the 2022 Notice of AGM.
Progress to date
We are transforming the way we operate by switching to renewable energy sources, increasing energy efficiency, adopting new ways of working and removing fossil fuels from our campuses. In 2021, 94% of the electricity used across our global property portfolio came from renewable sources. The transition to renewable sources of energy contributed to Barclays exceeding its target of 80% GHG emissions reduction for scope 1 and scope 2 (market-based) emissions by achieving an 86% reduction in 2021. At the same time as continuing our transition to renewable electricity, we intend to decarbonise our global property portfolio by progressively eliminating the use of fossil fuels currently used to heat and cool our buildings. We will continue removing the use of natural gas in our buildings, replacing gas boilers with carbon-free heating technologies when feasible. We will also continue to embed circular economy principles to reduce waste in our buildings and support the regeneration of natural systems.
We have disclosed global GHG emissions and energy use data as required by the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008. See the ESG Data Hub for further details on our annual operational GHG emissions since 2018, including our scope 1, scope 2 and scope 3 business travel location-based and market-based emissions. We further provide insights on our annual waste production, energy and water consumption and renewable electricity consumption by country. You may find extensive information relating to how we track our operational footprint at: home.barclays/sustainability/esg-resource-hub/
1     Operations include company cars, offices, retail branches and data centres where Barclays have operational control.
2     Scope 1 emissions include our direct GHG emissions from natural gas, fuel oil, company cars and HFC refrigerants.
3     Scope 2 emissions include our indirect GHG emissions from purchased electricity and purchased steam and chilled water.
4     Scope 3 business travel emissions are our indirect emissions from commercial air travel and other transport.



Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
49

Directors’ report: Other statutory information continued
GHG Emissions Table and Notes
Current Reporting Year
2021a
Previous Reporting Year
2020
UK &
Offshore Area
Global
GHG Emissions
UK &
Offshore Area
Global
GHG Emissions
Group GHG Emissionsb
Total CO2e (tonnes)85,313 148,618 107,157 189,304 
Scope 1 CO2e emissions (tonnes)c
15,684 21,986 15,339 21,512 
Scope 2 CO2e emissions (tonnes)d
68,710 124,226 83,252 148,658 
Scope 3 CO2e emissions (tonnes)e
919 2,406 8,566 19,134 
Energy consumption used to calculate above Scope 1 and 2 emissions (kWh)370,497,921 553,048,003 396,436,272 598,036,644 
Intensity Ratio
Total Full-Time Employees (FTE)44,100 81,600 47,700 83,000 
Total CO2e per FTE (tonnes)f
1.93 1.822.25 2.28 
Market-based emissions
Scope 2 CO2e market-based emissions (tonnes)d
3,767 13,400 6,400 48,192 
Total gross Scopes 1 and 2 (market-based) emissions (tonnes)19,451 35,386 21,739 69,704 
Notes
a    The carbon reporting year for our GHG emissions is 1 October to 30 September. The carbon reporting year is not fully aligned to the financial reporting year covered by this Directors’ Report. Details of our approach to assurance over the data is set out in the 2021 Barclays Strategic Report.
b    The methodology used to calculate our GHG emissions follows the 'Greenhouse Gas Protocol (GHG): A Corporate Accounting and Reporting Standard (Revised Edition)', defined by the World Resources Institute/World Business Council for Sustainable Development (WRI/WBCSD). We have adopted the operational control approach to define our reporting boundary. Emissions from leased buildings where Barclays do not manage the utility are excluded. Where Barclays is responsible for the utility costs, these emissions are included. Estimating the GHG emissions of working from home is a new activity with little or no precedent and with no common standard which is why we have not yet included it in our annual GHG inventory. We are evaluating different methodologies to estimate our remote working emissions moving forward. For 2021, we have applied the latest emission factors available at the time of reporting. We continuously review and update our performance data based on updated carbon emission factors, improvements in data quality and updates to estimates previously applied. We have recalculated this information from our previous 2020 reporting year. Where the recalculation of our performance using updated carbon emissions factors and improvements in data quality and estimates has resulted in a change of more than 5% we have represented these figures in the table above. In 2021, we conducted a review of our GHG emissions inventory for scope 1 and scope 2 to improve the transparency of our public emissions disclosure. Historically, Barclays have chosen to account for third party managed data centres under Scope 1 and Scope 2. Based on our review, and with due regard to the GHG Protocol Guidelines and Operational Control definitions, we have updated our GHG accounting policy and reallocated the emissions of third party managed data centres under scope 3 ‘downstream leased assets’, which will be reported in future. This reallocation is reflective of our limited control over energy sources at third party managed data centres. We have therefore re-baselined our historic emissions for 2018 and updated our reported figures for subsequent years. The previously reported scope 2 (location based) emissions were: 2018 (203,100 tCO2e), 2019 (182,000 tCO2e) and 2020 (159,500 tCO2e). In addition, a correction to underlying fugitive consumption data was identified, which has resulted in an adjustment to 2018-2020 fugitives emissions. The previously reported scope 1 emissions were: 2018 (25,900 tCO2e), 2019 (23,800 tCO2e) and 2020 (18,800 tCO2e).
c    Scope 1 emissions include our direct GHG emissions from natural gas, fuel oil, company cars and HFC refrigerants. In the case of company-owned vehicles, emissions are limited to UK vehicles only as this is the only country in which the Group owns vehicles.
d    Scope 2 GHG emissions include our direct GHG emissions from purchased electricity, purchased heat, cooling and steam . Market-based emissions have been reported for 2020 and 2021. We have used a zero emission factor where we have green tariffs or energy attribute certificates in place in the UK, US, Hong Kong, Japan, India Singapore and Continental Europe. Where we are not consuming renewable electricity we have used the appropriate residual mix factor for the country in question.
e    Scope 3 covers indirect emissions from business travel only. Business travel for these purposes compromises of: global flights and ground transport within the UK, US and India, however, in the case of the US and India ground transport covers onwards car hire only which has been provided directly by the supplier). Ground transportation data (excluding Scope 1 emissions from company-owned vehicles) covers only countries where robust data is available directly from the supplier.
f    Intensity ratio calculations have been calculated using location-based emission factors only.
g    Energy consumption data is captured through utility billing; meter reads or estimates. Principal measures we have undertaken in 2021 to improve energy efficiency include the following:
we have reduced our Group energy consumption by 7.5% versus 2020 due to reduced operating hours of our offices as our global workforce continued to work remotely as a result of COVID-19 in addition to a number of energy optimisation and efficiency initiatives in 2021, achieving a total reduction of 1.4 GWh since implementation.
our energy efficiency measures for 2021 can be broken down by principal categories such as end of life asset replacement projects saving 46 MWh; a 760 MWh saving from building optimisation projects; 397 MWh saving from adjusting our HVAC systems to align with reduced operational hours of our buildings globally; a 52 MWh saving from the installation of our brand new solar self-generation plant in Pune, India and installation of LED lighting together with power optimisation activities in select buildings which have achieved a combined 171 MWh saving.
Research and development
In the ordinary course of business, the Group develops new products and services in each of its business divisions.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
50

Directors’ report: Other statutory information continued
Share capital
Share capital structure
The Company has ordinary shares in issue. The Company’s Articles also allow for the issuance of sterling, US dollar, euro and yen preference shares (preference shares). No preference shares have been issued as at 21 February 2022 (the latest practicable date for inclusion in this report). Ordinary shares therefore represent 100% of the total issued share capital as at 31 December 2021 and as at 21 February 2022 (the latest practicable date for inclusion in this report).
Details of the movement in ordinary share capital during the year can be found in Note 28 on page 282.
Voting
Every member who is present in person or represented at any general meeting of the Company, and who is entitled to vote, has one vote on a show of hands. Every proxy present has one vote. The proxy will have one vote for, and one vote against, a resolution if he/she has been instructed to vote for, or against, the resolution by different members or in one direction by a member while another member has permitted the proxy discretion as to how to vote.
On a poll, every member who is present or represented and who is entitled to vote has one vote for every share held. In the case of joint holders, only the vote of the senior holder (as determined by the order in the share register) or his/her proxy may be counted. If any sum payable remains unpaid in relation to a member’s shareholding, that member is not entitled to vote that share or exercise any other right in relation to a meeting of the Company unless the Board otherwise determines.
If any member, or any other person appearing to be interested in any of the Company’s ordinary shares, is served with a notice under section 793 of the Companies Act 2006 and does not supply the Company with the information required in the notice, then the Board, in its absolute discretion, may direct that that member shall not be entitled to attend or vote at any meeting of the Company. The Board may further direct that, if the shares of the defaulting member represent 0.25% or more of the issued shares of the relevant class, dividends or other monies payable on those shares shall be retained by the Company until the direction ceases to have effect and no transfer of those shares shall be registered (other than certain specified ‘excepted transfers’). A direction ceases to have effect seven days after the Company has received the information requested, or when the Company is notified that an excepted transfer of all of the relevant shares to a third party has occurred, or as the Board otherwise determines.
Transfers
Ordinary shares may be held in either certificated or uncertificated form. Certificated ordinary shares may be transferred in writing in any usual or other form approved by the Group Company Secretary and executed by or on behalf of the transferor. Transfers of uncertificated ordinary shares must be made in accordance with the Companies Act 2006 and the CREST Regulations.
The Board is not bound to register a transfer of partly paid ordinary shares or fully paid shares in exceptional circumstances approved by the FCA. The Board may also decline to register an instrument of transfer of certificated ordinary shares unless it is (i) duly stamped, deposited at the prescribed place and accompanied by the share certificate(s) and such other evidence as reasonably required by the Board to evidence right to transfer, (ii) it is in respect of one class of shares only, and (iii) it is in favour of a single transferee or not more than four joint transferees (except in the case of executors or trustees of a member).
In accordance with the provisions of section 84 of the Small Business, Enterprise and Employment Act 2015, preference shares may be issued only in registered form. Preference shares shall be transferred in writing in any usual or other form approved by the Group Company Secretary and executed by or on behalf of the transferor. The Company’s registrar shall register such transfers of preference shares by making the appropriate entries in the register of preference shares. Each preference share shall confer, in the event of a winding up or any return of capital by reduction of capital (other than, unless otherwise provided by their terms of issue, a redemption or purchase by the Company of any of its issued shares, or a reduction of share capital), the right to receive out of the surplus assets of the Company available for distribution among the members and in priority to the holders of the ordinary shares and any other shares in the Company ranking junior to the relevant series of preference shares and pari passu with any other class of preference shares (other than any class of shares then in issue ranking in priority to the relevant series of preference shares), repayment of the amount paid up or treated as paid up in respect of the nominal value of the preference share together with any premium which was paid or treated as paid when the preference share was issued in addition to an amount equal to accrued and unpaid dividends.
The Company is not aware of any agreements between holders of securities that may result in restrictions on the transfer of securities or voting rights.
Variation of rights
The rights attached to any class of shares may be varied either with the consent in writing of the holders of at least 75% in nominal value of the issued shares of that class, or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class. The rights of shares shall not (unless expressly provided by the rights attached to such shares) be deemed varied by the creation of further shares ranking equally with them or subsequent to them.
Limitations on foreign shareholders
There are no restrictions imposed by the Articles or (subject to the effect of any economic sanctions that may be in force from time to time) by current UK laws which relate only to non-residents of the UK and which limit the rights of such non-residents to hold or (when entitled to do so) vote the ordinary shares.
Exercisability of rights under an employee share scheme
Employee Benefit Trusts (EBTs) operate in connection with certain of the Group’s Employee Share Plans (Plans). The trustees of the EBTs may exercise all rights attached to the shares in accordance with their fiduciary duties other than as specifically restricted in the documents governing the Plans. The trustees of the EBTs have informed the Company that their normal policy is to abstain from voting in respect of the Barclays shares held in trust. The trustees of the Global Sharepurchase EBT and UK Sharepurchase EBT may vote in respect of Barclays shares held in the EBTs, but only as instructed by participants in those Plans in respect of their partnership shares and (when vested) matching and dividend shares. The trustees will not otherwise vote in respect of shares held in the Sharepurchase EBTs.
Special rights
There are no persons holding securities that carry special rights with regard to the control of the Company.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
51

Directors’ report: Other statutory information continued
Major shareholders
Major shareholders do not have different voting rights from those of other shareholders. Information provided to the Company by substantial shareholders (holding voting rights of 3% or more in the financial instruments of the Company) pursuant to the DTRs are published via a Regulatory Information Service and is available on the Company’s website. As at 31 December 2021, the Company had been notified under Rule 5 of the DTRs of the following holdings of voting rights in its shares.
Person interestedNumber of
Barclays
Shares
% of total voting rights
attaching to issued
share capitala
Nature of holding (direct or indirect)
BlackRock Incb
944,022,209 5.78 indirect
Qatar Holding LLCc
1,017,455,690 5.99 direct
Notes
a    The percentage of voting rights detailed above was calculated at the time of the relevant disclosures made in accordance with Rule 5 of the DTRs.
b    Total shown includes 6,687,206 contracts for difference to which voting rights are attached. Part of the holding is held as American Depositary Receipts. On 8 February 2022, BlackRock, Inc. disclosed by way of a Schedule 13G filed with the SEC beneficial ownership of 1,401,752,691 ordinary shares of the Company as at 31 December 2021, representing 8.4% of that class of shares.
c    Qatar Holding LLC is wholly owned by Qatar Investment Authority. On 2 February 2022, Qatar Investment Authority disclosed by way of a Schedule 13G filed with the SEC beneficial ownership of 847,620,690 ordinary shares of the Company as at 31 December 2021, representing 5.06% of that class of shares.

Between 31 December 2021 and 21 February 2022 (the latest practicable date for inclusion in this report), the Company has not received any additional notifications pursuant to Rule 5 of the DTRs.
Powers of Directors to issue or buy back the Company’s shares
The powers of the Directors are determined by the Companies Act 2006 and the Company’s Articles. The Directors are authorised to issue and allot shares and to buy back shares subject to annual shareholder approval at the AGM. Such authorities were granted by shareholders at the 2021 AGM. It will be proposed at the 2022 AGM that the Directors be granted new authorities to allot and buy back shares.
Repurchase of shares
On 19 March 2021 and 2 August 2021 the Company commenced share buy-back programmes to purchase its ordinary shares of £0.25p each up a maximum consideration of £700m and £500m, respectively, The first share bu-yback programme concluded on 23 April 2021 and the second share buy-back programme concluded on 30 November 2021. The Company repurchased 377,356,751 ordinary shares at a volume weighted average price of 185.5008 pence per share during the first buy-back programme and 266,987,647 ordinary shares at a volume weighted average price of 187.2746 pence per share during the second buy-back programme. The purpose of the buy-back programmes was to reduce the Company’s number of outstanding ordinary shares.
In aggregate, the Company purchased 644,344,398 ordinary shares during 2021 with a nominal value of £161m (this represented 3.84% of the Company's issued share capital as at 31 December 2021) for an aggregate consideration of £1,200m excluding taxes and expenses. All of the repurchased ordinary shares have been cancelled.
No further shares have been repurchased since the completion of the second share buyback programme on 30 November 2021. The maximum number of ordinary shares which could be repurchased by the Company as part of any share buy-back under the authority for on-market share buy-backs granted at the 2021 AGM is 1,469,543,259 ordinary shares (being 1,736,530,906 less the 266,987,647 shares repurchased as part of the second share buy-back programme).
Distributable Reserves
As at 31 December 2021, the distributable reserves of the Company were £20,750m (2020: £24,386m).
Change of control
There are no significant agreements to which the Company is a party that are affected by a change of control of the Company following a takeover bid. There are no agreements between the Company and its Directors or employees providing for compensation for loss of office or employment that occurs because of a takeover bid.
Disclosure of information to the auditor
Each Director confirms that, so far as he/she is aware, there is no relevant audit information of which our auditor is unaware and that each of the Directors has taken all the steps that he/she ought to have taken as a Director to make himself/herself aware of any relevant audit information and to establish that our auditor is aware of that information. This confirmation is given pursuant to section 418 of the Companies Act 2006 and should be interpreted in accordance with, and subject to, those provisions.
Directors’ responsibilities
The following statement, which should be read in conjunction with the Auditor’s report set out on pages 213 to 214, is made with a view to distinguishing for shareholders the respective responsibilities of the Directors and of the auditor in relation to the accounts.
Going concern
The Group’s business activities and factors likely to affect its future development and performance are disclosed in the Strategic report and Risk Review sections of this report. The financial performance is disclosed within the Financial Review with funding, liquidity and capital details contained within the Risk Performance section. The Group’s objectives and policies in managing the financial risks to which it is exposed are discussed in the Risk Management section.
The Directors considered it appropriate to prepare the financial statements on a going concern basis.
In preparing each of the Group and Parent company financial statements, the Directors are required to:
assess the Group and Parent company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern;
use the going concern basis of accounting unless they either intend to liquidate the Group or the Parent company or to cease operations, or have no realistic alternative but to do so.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
52

Directors’ report: Other statutory information continued
Preparation of accounts
The Directors are required by the Companies Act 2006 to prepare Group and Company accounts for each financial year and, with regard to Group accounts, in accordance with UK-adopted international accounting standards. The Directors have prepared these accounts in accordance with (a) UK-adopted international accounting standards; and (b) IFRS as issued by the IASB, including interpretations issued by the IFRS Interpretations Committee. Pursuant to the Companies Act 2006, the Directors must not approve the accounts unless they are satisfied that they give a true and fair view of the state of affairs of the Group and the Company and of their profit or loss for that period.
The Directors consider that, in preparing the financial statements, the Group and the Company have used appropriate accounting policies, supported by reasonable judgements and estimates, and that all accounting standards which they consider to be applicable have been followed.
The Directors are satisfied that the Annual Report and financial statements, taken as a whole, are fair, balanced and understandable, and provide the information necessary for shareholders to assess the Group and Company’s position and performance, business model and strategy.
The Directors are responsible for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
Directors’ responsibility statement
The Directors have responsibility for ensuring that the Company and the Group keep accounting records which disclose with reasonable accuracy the financial position of the Company and the Group and which enable them to ensure that the accounts comply with the Companies Act 2006.
The Directors are also responsible for preparing a Strategic report, Directors’ report, Directors’ Remuneration report and Corporate Governance Statement in accordance with applicable law and regulations.
The Directors are responsible for the maintenance and integrity of the Annual Report and Financial Statements as they appear on our website. Legislation in the UK governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
The Directors have a general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the Group and to prevent and detect fraud and other irregularities.
The Directors, whose names and functions are set out on pages 3 to 6, confirm to the best of their knowledge that:
(a) the financial statements, prepared in accordance with (a) UK-adopted international accounting standards; and (b) IFRS as issued by the IASB, including interpretations issued by the IFRS Interpretations Committee, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole; and
(b) the management report, on pages 8 to 14, which is incorporated in the Directors’ report, includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the Principal Risks and uncertainties that they face.
Auditor’s report
The Auditor’s report on the Financial Statements of Barclays PLC for the year ended 31 December 2021 was unmodified and its statement under section 496 of the Companies Act 2006 was also unmodified.
By order of the Board



Stephen Shapiro
Company Secretary
22 February 2022
Registered in England. Company No. 48839
Registered office: 1 Churchill Place,
London E14 5HP
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
53



Remuneration report
Annual Statement from the Chair of
the Board Remuneration Committee

Contents
Annual statement
54
Remuneration philosophy
59
Fair Pay at a glance
61
Employee remuneration policy summary
62
Directors’ remuneration policy summary
63
Annual report on Directors’ remuneration
67
Remuneration Committee
MemberMeetings attended/eligible to attend (including ad hoc meetings)
Brian Gilvary7/7
Crawford Gillies2/2
(1 Jan 2021–28 Feb 2021)
Dawn Fitzpatrick 3/3
(from 1 July 2021 onwards)
Mary Francis7/7
Tim Breedon 5/5
(1 Jan 2021–31 Oct 2021)
You can find more information on our approach to pay fairness in our Fair Pay Report at home.barclays/annualreport
Our UK pay gap figures for 2021 and narrative explaining them are available at home.barclays/diversity
Dear Fellow Shareholders
On behalf of the Board, I am pleased to present the Remuneration report for 2021, my first as Chair of the Remuneration Committee.
We have had a number of changes to the Committee since last year's Remuneration report. I would like to thank my predecessor, Crawford Gillies, for his significant contribution over almost seven years on the Committee. I would also like to thank Tim Breedon for his contribution over eight years on the Committee, and to welcome Dawn Fitzpatrick.
Thanks too to shareholders for the support shown at our last Annual General Meeting for how we implemented our Directors' remuneration policy (DRP) during 2020, under Crawford's leadership.
As the Group Chief Executive sets out in his review, we have a robust strategy in place. Our universal banking model and diversified income have provided resilience, despite the ongoing impact of the COVID-19 pandemic, and we have delivered a record profit before tax in 2021, enabling us to announce a return of over £2.5bn of capitala to shareholders.
As always, the Committee has taken a number of important considerations into account when making remuneration decisions in respect of 2021 performance. We have looked carefully at Barclays’ financial and non-financial performance, in both absolute and relative terms. We have considered delivery of our strategy, as well as risk and conduct. We have also considered the competitive market for hiring and retaining talent. We have weighed the views and expectations of you as shareholders, of our customers and clients, of our colleagues and of our stakeholders in wider society. Our Fair Pay agenda continues to underpin all of our remuneration decisions. That means ensuring that we are recognising the contributions of all our colleagues, junior and senior, supporting and paying all colleagues fairly for the work they do. You can read more in our annual Fair Pay Report, published alongside this Annual Report. We have also published our UK pay gap figures and a narrative explaining them.
With these considerations in mind, allow me to set out the key decisions taken this year and our focus for 2022.
Jes Staley
As outlined in the Nominations Committee Report, the Board agreed with Jes Staley that he would step down from his role as Group Chief Executive and as an Executive Director of Barclays PLC (BPLC) and Barclays Bank PLC (BBPLC) with immediate effect on 31 October 2021. The treatment of his remuneration on stepping down was set out in the announcement of those Board changes on 1 November 2021 and is in line with the DRP. He is legally and contractually entitled to 12 months' notice, during which he continues to receive his Fixed Pay, pension allowance and other benefits, and to receive repatriation costs to the US.
Since Mr Staley was appointed, in 2015, only 16% of his variable remuneration has vestedb. A similar portion has lapsed without vesting. The significant majority, almost 70%, remains unvested, comprising a combination of deferred bonus and Long Term Incentive Plan (LTIP) awards. Subsequent to the Board changes that were announced in November, in line with its normal procedures, the Committee exercised its discretion to suspend the vesting of all of Mr Staley's unvested awards, pending further developments in respect of the regulatory and legal proceedings related to the ongoing FCA and PRA investigation regarding Mr Staley.
No further remuneration decisions have been made in respect of Mr Staley. The Committee will consider these matters further, in conjunction with the BPLC and BBPLC Boards, as and when it considers appropriate but does not currently expect to make further decisions on this until the conclusion of those regulatory and legal proceedings. Any such decisions in the future will be disclosed in future remuneration reports.
Notes
a    Includes total dividend for 2021 of 6.0p per share and total share buybacks announced in relation to 2021 of £1.5bn.
b    At the Q4 2021 average share price.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
54


Performance
Our commitment, as ever, is to a remuneration approach that rewards sustainable performance.
Our financial performance during 2021 continued to benefit from the diversification that is inherent in our universal banking model. The Corporate and Investment Bank continued to perform well, with record levels of profitability, offsetting some of the challenges brought by the COVID-19 pandemic and the low interest rate environment.
Barclays UK and Consumer, Cards and Payments benefited from the ongoing economic recovery, and are well positioned. Cost discipline kept Group base costsa flat, with efficiency savings reinvested to drive income growth.
We remain well capitalised, with a CET1 ratio of 15.1%, and have delivered a full year Return on Tangible Equity of 13.4%, meeting our greater-than-10% target. Consequently, we were able to meaningfully increase returns to our shareholders, announcing over £2.5bn of capital returned in respect of 2021, via a total dividend of 6p per share and £1.5bn of announced share buybacks. This is equivalent to a total payout of 15p per share. As the Group Chief Executive sets out in his review, continuing to return capital to shareholders on a consistent basis remains important to Barclays.
In parallel, the Committee continues to work on ensuring that we are rewarding performance that is sustainable. This year marked an important step forward in that effort, with the launch of the Barclays’ Mindset. The Mindset acts as an operating manual for how to get things done at Barclays, focusing on three key elements that are core to our success – Empower, Challenge and Drive. These in turn help drive ‘The Power of One Barclays’, our effort to bring our organisation closer together to create synergies and deliver more value for our stakeholders. This way of thinking is embedded in the organisation and initial feedback suggests that it resonates with colleagues as a way of driving long-term success. Over time, we believe it will provide a means of helping us to continue delivering sustainable performance.




Notes
a    Excluding performance costs and structural cost actions.
b    Determined by Barclays using the Massachusetts Institute of Technology Living Wage Calculator, a well-established market-based approach for determining living wages in the US.
c    On a comparable basis, period covering 2014-2021. Pre 2014 financials were not restated following re-segmentation in 2016.

Colleague remuneration
Paying at least a living wage to all our colleagues is at the heart of our Fair Pay agenda. For all our locations, we continue to ensure that we at least meet living wage benchmarks for each country and we have also been cognisant of the inflationary pressures in many jurisdictions. We worked closely with Unite the Union to agree a 2022 UK pay deal for c.43,000 employees with a total salary increase budget of 4.25%, and in addition increased anyone paid below £11 per hour to that amount, or more in London, exceeding the benchmarks set by the Living Wage Foundation. In the US, we made increases to bring lower-paid colleagues at least into alignment with the MIT living wageb, and in India our salary increase budget was over 10% in order to keep pace with local market pressures. Across our business, we targeted the salary spend so there are higher average increases for the most junior colleagues. Due to the pandemic, we accelerated the roll-out of remote access to medical support to colleagues in a number of our key locations during 2021. In India, we provided salary advances and supplemented medical cover to support colleagues through the devastating impact of the Delta variant of COVID-19. Our Fair Pay Report brings together the different ways we think about fair pay at Barclays and provides an update on our progress in putting fairness at the heart of the way we pay our people.
This year’s incentive pool reflects the consideration of all the elements set out at the start of this statement, including financial and non-financial performance, delivery of our strategy, risk, conduct, expectations of stakeholders and our commitment to fair pay.
In particular, the Committee wanted to take into account that all three of our main lines of business – Barclays UK, Consumer, Cards and Payments and the Corporate and Investment Bank – have performed well in 2021, with all three demonstrating robust profitability and delivering double-digit returns on equity.
The Committee took into account the strong performance in the Corporate and Investment Bank, where our colleagues continued to make a significant contribution to the global recovery through the economic activity they have facilitated. Record Investment Banking fees and Equities income were achievedc and this has had a material impact on the overall success of the Group.
At the same time, the Committee recognised the progress made in the delivery of our strategic digital agenda, including the ongoing transformation of Barclays UK, with an acute focus on improving customer and client experiences. Consistent with our approach last year, we were also mindful of the fact that it is often more junior employees who have been on the front line, directly supporting customers and clients during the pandemic. The Committee felt it appropriate to continue to reward those efforts.
Group income
£21,940m
2020: £21,766m
Group profit before tax
£8,414m
2020: £3,065m
Group RoTE
13.4%
2020: 3.2%
Cost: income ratio
66%
2020: 64%
CET1 ratio
15.1%
2020: 15.1%
Group compensation to income ratio
34.7%
2020: 34.2%
Group incentive pool
£1,945m
2020: £1,580m

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
55


Finally, we felt it important to recognise the huge effort made across the firm to maintain operational resilience throughout the COVID-19 pandemic, to enable the continued support of our customers and clients, driven in particular by colleagues in Barclays Execution Services (BX).
Taking all of this into account, the Committee has approved a Group incentive pool of £1.945bn. This represents an increase that recognises the strong performance across all businesses, following reductions in the incentive pool across many areas of the Group last year.
This level of incentive funding has enabled us to respond to the extremely competitive global market for talent, as well as the need to ensure our pay remains competitive to help attract and retain the talent required to deliver against our near-term and longer-term objectives. In areas where we had concerns that compensation might be becoming uncompetitive in comparison with our peers, we were able to take steps to address that.
We believe that this level of incentive funding is appropriate given what has been delivered and that it is consistent with our philosophy of rewarding sustainable performance, which in turn supports our long-term strategy of delivering continued strong returns to shareholders. In considering the incentive pool, we sought to strike an appropriate balance between a range of complex and at times conflicting factors. We recognise the strong performance that has been achieved, and the need to appropriately reward the teams and individuals responsible for that performance. At the same time, we were cognisant of the importance of maintaining cost discipline and not paying more than is necessary. The importance of reflecting performance is key, and both the Committee and management are clear that if performance falls in future years then the pool will reduce as appropriate.
As always, a significant portion of the pool is delivered in shares, most of which will be deferred over a number of years, ensuring alignment with shareholders. Those deferrals are subject to malus conditions. For Material Risk Takers, including the Executive Directors, deferrals and the upfront elements of incentive awards are also subject to clawback conditions, which may apply in a broad set of circumstances including individual misbehaviour and/ or material failures of risk management.
Executive Director remuneration
Implementing Fixed Pay increases
The DRP that shareholders approved in May 2020 included plans to increase Fixed Pay for Tushar Morzaria and Jes Staley. As reported last year, at the request of the Executive Directors, those increases were postponed in light of the prevailing external environment at that time. As a result of improvements in the economic environment since then, in July 2021 the Committee implemented those delayed increases.
Setting Venkat's remuneration on his appointment as Group Chief Executive
C.S. Venkatakrishnan (known as Venkat) was appointed Group Chief Executive with effect from 1 November 2021. The remuneration arrangements that the Committee agreed on his appointment reflect his role and responsibilities and are in accordance with the DRP.
Venkat’s Fixed Pay was set at £2.7m, delivered 50% in cash and 50% in shares. Fixed Pay shares are delivered quarterly, subject to a holding period with restrictions lifting over five years. This level of Fixed Pay was a reduction from that for his previous role as Head of Global Markets and Co-President of Barclays Bank PLC. Venkat also receives cash payments in lieu of pension in line with the DRP, equal to 5% of his Fixed Pay (equivalent to 10% of Fixed cash), which totalled £135,000 per annum on appointment. He receives standard benefits, including medical cover and life assurance, and is eligible to receive relocation support in line with our standard approach, including temporary accommodation in London, in accordance with the DRP. On an annual basis, Venkat is eligible to be considered for a discretionary incentive award and LTIP award in line with the DRP, up to a maximum value of 93% of Fixed Pay for bonus and up to 140% of Fixed Pay for the LTIP.
Determining Executive Director pay outcomes
In the context of the Group’s strong performance in 2021, the Committee considered the Executive Directors’ bonus and LTIP outcomes.
For 2021, Venkat was awarded a pro-rata discretionary incentive award for his part-year performance as Group Chief Executive, following his appointment. Although Venkat has started his new role as Group Chief Executive well, with real purpose, we did not consider it realistic to set strategic personal objectives and assess performance against those objectives after only two months in post. As a result, this bonus decision was based on the financial and non-financial measures only, scaling up the weighting of each to cover the entire bonus opportunity without any element based on personal objectives. Venkat received a separate discretionary incentive award in respect of the portion of 2021 when he was Head of Markets and Co-President of Barclays Bank PLC, which is not included within this report as it does not relate to his time as an Executive Director. For Tushar, his annual bonus was assessed against the financial, strategic and personal measures that were set out in the 2020 Remuneration report.
On the financial bonus measures, profit before tax significantly exceeded the level required to trigger a 100% outcome for that element of the bonus. Profit before tax for 2021 reached record levels, and higher than the top of the profit before tax target range for all previous bonus cycles. This, combined with a cost: income ratio also ahead of the maximum target and with good performance against the strategic non-financial measures, resulted in a 2021 bonus outcome equal to 94.4% of maximum for Venkat, and 94.5% of maximum for Tushar after factoring in his performance against his personal objectives. The outcome for the 2019-2021 LTIP was lower, at 55%, impacted by the performance challenges resulting from the COVID-19 pandemic, particularly during 2020.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
56


The Committee reflected on the appropriateness of these outcomes, for both the 2021 bonus and 2019-2021 LTIP. We reviewed the underlying financial health of the Group, which is strong and well-capitalised. We considered the bonus outcomes in the context of the bonus outcomes for the wider workforce, ensuring appropriate alignment both this year and over a multi-year period, and also compared to historical outcomes for the Executive Directors in the context of performance each year. We concluded that the outcomes are appropriate in the context of the performance achieved and that no discretionary adjustment was warranted.
No changes were made to any in-flight LTIP awards and the performance measures and targets for those awards have not been altered.
The Committee decided to grant awards under the 2022-2024 LTIP cycle with a face value at grant of 140% of Fixed Pay for Venkat and 134% of Fixed Pay for Tushar, reflecting strong 2021 performance.
The Executive Directors' pay in 2022
An annual review of Fixed Pay for the Executive Directors, in the same way and at the same time as for the wider workforce, was introduced as a feature of the DRP in 2020 but had not been operated to date due to the COVID-19 pandemic. In February 2022, the Committee reviewed the level of Fixed Pay for Venkat and Tushar in line with that approach and we will do this annually in the future. The maximum total compensation opportunity for both Venkat and Tushar is driven by their level of Fixed Pay, and for both of them is materially behind market when compared to the equivalent opportunity for comparable roles at our international banking peers. Given this relative market positioning, the Committee agreed to increase Fixed Pay by 3% for Venkat and 3% for Tushar, resulting in Fixed Pay of £2,780,000 and £1,775,000 respectively from 1 March 2022. This percentage increase is lower than the average increase across the wider workforce, including the 4.25% 2022 UK pay deal agreed with Unite. Even after these Fixed Pay increases, the total compensation opportunity that results for each
Executive Director remains well behind our international banking peers.
The Committee carefully considered the performance measures for the 2022 bonus and the 2022-2024 LTIP. The bonus measures for 2022 are in line with those for 2021, with one key amendment. For 2022, we have increased the weighting of the Strategic non-financial element from 20% to 25%, with a corresponding reduction to the weighting of the Personal objectives from 20% to 15%, to enable a greater focus on climate-related measures. Within the Strategic non-financial element, the Customers and clients and Colleagues sections are retained, and are each weighted at 7.5%, with a new Climate and sustainability section in place of the Society section, weighted at 10%. This section now primarily focuses on climate-related measures, including progress towards our green financing commitments and reducing our own carbon footprint, as well as delivering the strategy to achieve our ambition to be a net zero bank by 2050. This reflects the focus and importance that we attach to the Group's delivery on its climate objectives. The other bonus measures remain substantially unchanged.
For the 2022-2024 LTIP, changes have been made to align more closely with the evolution of the bonus measures. The strategic non-financial element of this LTIP cycle will include a Climate and sustainability category, in place of the standalone Climate measure, with a weighting of 10%. The other measures are largely unchanged.
Shareholder alignment
Total variable pay (annual bonus and LTIP) for the Executive Directors will be delivered primarily in shares that must be retained for a period of between one and eight years from award, aligning the Executive Directors' interests more closely to the shareholder experience. Venkat already has a significant shareholding and will continue building this over the coming years towards the level stipulated under the personal shareholding requirements, while Tushar continues to hold substantial shareholdings over and above the required level.
Group Finance Director succession
As indicated in the letters from the Chairman and Group Chief Executive introducing this Annual Report, on 22 February 2022 Tushar Morzaria informed the Board of his intention to retire from the Board and as Group Finance Director, and the Board has agreed that this will take effect on 22 April 2022. The remuneration details in connection with his retirement and for his successor, Anna Cross, will be set out in a separate announcement to the market on 23 February 2022, and are not reflected in this Remuneration report.
Looking ahead
Our current DRP, approved by shareholders at the 2020 AGM for a period of three years, is nearing its end. As we move into 2022, the Committee will be reviewing our DRP and considering how it should evolve. We will also discuss this with stakeholders, including our largest institutional shareholders, to understand their perspectives.
Beyond this, the Committee will continue its focus on rewarding sustainable performance. We are pleased with Barclays’ performance this year and the progress made over recent years to transform the bank. We remain committed to making sure that the way we pay our people continues to support the long-term health and success of the Group.




Brian Gilvary
Chair, Board Remuneration Committee
February 2022


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
57


bcs-20211231_g10.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
58


Remuneration report
Remuneration philosophy

To attract and retain the people who can best deliver for our customers and clients, we must pay fairly and appropriately – balancing the interests of all our stakeholders. Our policies and practices are transparently communicated and
enable us to reward sustainable performance in line with our Values, Mindset and risk expectations. This is our remuneration philosophy.

Philosophy
Attract and retain talent needed to deliver Barclays’ strategyLong-term success depends on the talent of our employees. This means attracting and retaining an appropriate range of talent to deliver against our strategy, and paying the right amount for that talent.
Align pay with investor and other stakeholder interestsRemuneration should be designed with appropriate consideration of the views, rights and interests of stakeholders. This means listening to our shareholders, other investors, regulators, government, customers and employees and ensuring their views are appropriately represented in remuneration decision-making.
Reward sustainable performanceSustainable performance means making a positive and enduring difference to investors, customers and communities, taking pride in leaving things better than we found them and playing a valuable role in society.
Support Barclays’ Values and cultureResults must be achieved in a manner consistent with our Values. Our Values, culture and Mindset should drive the way that business is conducted.
Align with risk appetite, risk exposure and conduct expectationsDesigned to reward employees for achieving results in line with the Group’s risk appetite and conduct expectations.
Be fair, transparent and as simple as possibleWe are committed to ensuring pay is fair, simple and transparent for all our stakeholders. All employees and stakeholders should understand how we reward our employees and fairness should be a lens through which we make remuneration decisions.
    

Our philosophy in action
Our remuneration philosophy applies to all of our employees globally, including our Executive Directors. The pay decisions set out in this report are a result of the application of our remuneration philosophy during 2021.
Our philosophy and the way that we approach remuneration is designed to be as simple and clear as possible, while ensuring strong alignment with risk and conduct as well as our Values and Mindset. It is closely aligned with Provision 40 of the FRC’s UK Corporate Governance Code, as shown in the table that follows, and we have continued to be transparent on the resulting outcomes in this report.
We consider the views of all of our stakeholders in remuneration decision-making. In 2021, we achieved this by meeting with institutional shareholders to understand their views on our 2020 pay outcomes, engaging extensively with our regulators to ensure appropriate compliance with new regulatory requirements, and continuing our partnership with Unite the Union in the UK to understand the views of their members and agree a new pay deal. We used our 2020 Fair Pay Report and internal
communication channels to share information on our approach to pay with colleagues, including how executive remuneration aligns with the wider company pay policy, and are now publishing our fourth Fair Pay Report to help do the same for 2021.
Specifically relating to our Executive Directors, we review the performance measures for the forward-looking incentives each year to ensure that we maintain alignment with our strategic priorities and KPIs, and to ensure that the measures we select continue to be appropriate in light of current circumstances and challenges. Alongside our key financial measures, our strategic non-financial performance objectives will ensure that the link between individual incentive outcomes and the delivery of our strategy, and the achievement of sustainable long-term performance, continues to be reinforced. The alignment of executive pay to our culture is further enhanced by the inclusion of the responsibility to embed our Mindset across the organisation and continue to develop a high-performing culture in line with our Values in the personal objectives for our Group Chief Executive.


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
59

Remuneration report
Remuneration philosophy continued
Alignment with Provision 40 of the UK Corporate Governance Code
Code requirementsHow the Committee has addressed the requirement
Clarity – remuneration arrangements should be transparent and promote effective engagement with shareholders and the workforce
Developed a clear remuneration philosophy with aligned policies and practices for Executive Directors and the wider workforce
Our Fair Pay Report, which sets out how pay fairness is central to what we stand for, is used to engage with our shareholders and our colleagues
Regular consultation on remuneration with our largest institutional shareholders
Simplicity – remuneration structures should avoid complexity and their rationale and operation should be easy to understand
Clear disclosure of rationale for and operation of each element of the DRP
Executive Directors incentivised via annual bonus with deferral and LTIP
Prospective disclosure of bonus metrics and LTIP targets, and full retrospective disclosure of outcomes against financial and non-financial targets and criteria, with full supporting commentary
Risk – remuneration arrangements should ensure reputational and other risks from excessive rewards, and behavioural risks that can arise from target-based incentive plans, are identified and mitigated
Assessment of 'What' and 'How' performance is achieved
Ex-ante and ex-post risk factored into the assessment of business performance
Significant deferral into shares, to align with shareholder experience
Committee discretion to adjust all variable remuneration outcomes
Malus and clawback provisions apply to all elements of variable remuneration
Predictability – the range of possible values of rewards to individual Directors and any other limits or discretions should be identified and explained at the time of approving the policy
Regulatory caps on incentive outcomes
Scenario charts illustrate potential pay-outs under each element of the DRP
Key areas of Committee discretion clearly outlined in the DRP
Proportionality – the link between individual awards, the delivery of strategy and the long-term performance of the company should be clear. Outcomes should not reward poor performance
Annual bonus and LTIP measures reviewed each year to maintain alignment to strategic priorities / KPIs
Significant deferral into shares, to align with shareholder experience
Committee discretion, malus and clawback provisions apply to all elements of variable remuneration, to ensure risk-alignment for the Executive Directors
Alignment to culture – incentive schemes should drive behaviours consistent with company purpose, values and strategy
The Committee reviews all policies and practices, including incentive schemes, ensuring alignment to the Group's Purpose, Values, Mindset and conduct expectations
Key aspect of remuneration philosophy is rewarding sustainable performance
Executive Directors' bonus and LTIP based on a balanced scorecard of financial and non-financial measures, with financial measures aligned to external financial targets and non financial measures aligned to supporting Customers and clients, Colleagues and Society
Commitment to pay fairness across the workforce
Executive Director remuneration outcomes considered in the context of outcomes across the wider workforce
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
60

Remuneration report
Remuneration philosophy continued
Fair pay at a glance
We have developed our approach over a number of years in making sure that fairness is a key, and explicit, consideration in the way we make all our pay decisions.
Our approach to fair pay helped guide our remuneration decision- making in 2021.
We have developed our approach over a number of years. Since we first published our ‘Fair Pay Agenda’ in 2018, we have made good progress in making sure that fairness is a key, and explicit, consideration in the way we make all our pay decisions.
This year, we published additional fair pay communications material to our employees to explain how the pay and performance approach aligns to the Fair
Pay agenda. The employee materials also include a description of the alignment between the wider workforce and Executive Directors' pay policies and practices. Colleagues can provide real-time feedback to help us identify if there is a need for additional information or explanation.
We also use our Fair Pay Report to engage with our shareholders and other external stakeholders on pay, explaining our approach to fair pay, including the alignment of the Executive Directors’ and employee pay. We encourage you to read the full Fair Pay Report.

Fair pay for
the lowest paid
Paying fairly for work done, in a simple and transparent way.
Continued to progress our work on global living wages, reviewing all our locations around the world to ensure we pay a living wage, and increasing minimum pay in the UK and US above local living wage levels.
Provided salary advances and supplemented medical cover to support colleagues in India through the devastating impact of the Delta variant of COVID-19.
Simplified incentives for colleagues in US contact centres by replacing four historical plans with a single, consistent and more transparent approach.
Enhanced medical benefits in the UK and US, and offered at a lower cost for junior colleagues in the US.

Equal pay
commitment
Rewarding employees fairly for their contribution and making sure pay and performance decisions never take into account any protected characteristics.
Explicit communication to managers that pay decisions must not take into account gender, age, ethnicity, disability, sexual orientation, religion, marital status, pregnancy, maternity, parental leave or any other protected characteristic.
All grievances raised by employees, including any issues relating to pay, are investigated.

Equal opportunities
to progress
Providing equal employment opportunities to all, so everyone can enjoy a successful career at Barclays.
Published Race at Work Ambitions in the UK and US to increase the number of colleagues from underrepresented ethnic minorities.
Introduced granular ethnicity pay gap reporting in the UK, separating out the differences in pay between Black, Asian and Multiracial colleagues compared to white colleagues.
Achieved our 2021 female senior leadership (Managing Directors and Directors) target of 28%, up from 24% at the end of 2018 when the target was set.
Published our new Gender Ambition to increase the proportion of female senior leaders to 33% by the end of 2025.
Alignment of employee and
Executive Director pay
Linking both Executive and employee pay to sustainable business performance.
Our pay policies are strongly aligned across the wider workforce, senior employees and Executive Directors of Barclays PLC.
Where pay policies differ, this is aligned to differences in seniority and ability to influence business performance.
Pay outcomes continue to be aligned with financial and non-financial performance .


Listening to
our colleagues
Engaging with colleagues to understand their views on the culture of the organisation and enabling the representation of employees in remuneration decision-making.
The Inclusion Index score measures how included our colleagues feel. For 2021 it is 79%, up from 76% in 2020.
Launched our Wellbeing Index, to measure the wellbeing of colleagues and how it changes over time.
Engaged with Unite the Union on a range of topics including fair pay, the UK pay deal and employee wellbeing.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
61


Remuneration report
Employee remuneration policy summary
As outlined earlier, Barclays has a clearly articulated remuneration philosophy. This continues to drive our thinking in how we structure and determine remuneration for all employees from the most senior (including our Executive Directors) to our new apprentices and graduates. As part of our annual review we assessed our remuneration policies and practices for alignment with Barclays’ Purpose, Values and Mindset, our remuneration philosophy and our Fair Pay agenda, including ensuring appropriate alignment between the Directors’ remuneration policy and remuneration approaches for senior management and the wider workforce.
We continue to ensure that we comply with all prevailing regulations. We identify individuals whose roles may expose Barclays to material risk, and assess and structure their pay in a way which encourages alignment of their interests with those of Barclays and our shareholders.
The table below provides a summary of the remuneration approach for employees below Board level.
Summary remuneration policy – employees below Board level
ElementOperation
Salary
Salaries reflect individuals’ skills and experience and are reviewed annually.
They are increased where justified by role change, increased responsibility or a change in the appropriate market rate. Salaries may also be increased in line with local statutory requirements and in line with union and works council commitments.
We have been a real living wage employer in the UK since 2013, and continue to work with the Fair Wage Network to complete an annual review of our pay levels against living wage benchmarks across locations globally.
Role Based Pay (RBP)A small number of senior employees (c.1% UK employees) receive a class of Fixed Pay called RBP to recognise the seniority, scale and complexity of their role. This may change where justified by role or responsibility change or a change in the appropriate market rate.
Pension and benefits
The provision of a competitive package of benefits is important to attracting and retaining the talent needed to deliver Barclays’ strategy. Employees have access to a range of country-specific company-funded benefits, including pension schemes, healthcare, life assurance and other voluntary employee-funded benefits.
Employer pension contributions for the UK workforce are at least at the level of those for the Executive Directors, and are set at a minimum of 10% of salary (a minimum of 12% for more junior colleagues).
Annual bonus
Annual bonuses incentivise and reward the achievement of Group, business and individual objectives, and reward employees for demonstrating individual behaviours in line with Barclays’ Values and Mindset. All employees are considered, subject to eligibility criteria.
For senior employees, an appropriate proportion of their annual bonus is deferred to future years. Deferred bonuses are generally delivered in equal portions as deferred cash and shares. They are subject to either a three, four, five or seven-year deferral period (and for MRTs further holding periods of six or 12 months for deferrals in shares) in line with regulatory requirements.
Consistent with regulation, the remuneration of MRTs is subject to the 2:1 maximum ratio of variable to fixed remuneration.
Share plansWe encourage wider employee share ownership through the all-employee share plans, with plans available to 99% of colleagues globally.
Performance managementPerformance assessment is based on two core dimensions: ‘what’ has been delivered against agreed individual, team and business objectives, as well as ‘how’ this has been achieved in line with our Barclays’ Values and Mindset. Both dimensions are assessed and rated independently of each other with no requirement to have an overall rating. This reinforces the equal importance of the ‘what’ and ‘how’.
Risk and conduct
Risk and conduct is taken seriously at Barclays and the Committee ensures that there are in-year adjustments, malus or clawback applied to individual remuneration, where appropriate.
In addition to individual adjustments, the Committee considers collective adjustments to the incentive pool for risk and conduct. For 2021, the total impact of risk and conduct-related collective adjustments is a reduction of c.£95m.
More information on our approach to performance management, and risk and conduct, as well as information in relation to Material Risk Takers (MRTs), including the number of MRTs by remuneration band paid over €1m, are set out in Appendix E of the Barclays PLC 2021 Pillar 3 Report.

Barclays PLC 2021 Pillar 3 Report can be found online at home.barclays/annualreport
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
62


Remuneration report
Directors’ remuneration policy summary
The forward-looking remuneration policy for Executive Directors and Non-Executive Directors was approved at the AGM held on 7 May 2020 and applies for three years from that date. A summary of the policy, including key remuneration
elements, is set out below and is provided for information only. The full policy can be found on pages 93 to 103 of the 2019 Annual Report.
Summary remuneration policy – Executive Directors
Element and purposeOperation
Fixed Pay
Fixed Pay is determined based on the individual’s role, skills and experience with reference to market practice and market data (on which the Committee receives independent advice).
Delivered 50% in cash (paid monthly) and 50% in shares. The shares are delivered quarterly and are subject to a holding period with restrictions lifting over five years (20% each year). As the Executive Directors beneficially own the shares, they will be entitled to any dividends paid on those shares.
Increases will normally be aligned to the annual increase for UK employees, and will take into account changes in responsibilities and market conditions.
To reward skills and experience appropriate for the scale, complexity and responsibilities of the role and to provide the basis for a competitive remuneration package
Pension
Delivered as an annual cash allowance in lieu of participation in a pension arrangement.
The maximum annual cash allowance is 5% of Fixed Pay (equivalent to 10% of fixed cash).
To enable Executive Directors to build long-term retirement savings
Benefits
A number of benefits are provided including, but not restricted to, private medical cover, annual health check, life and ill health income protection, and use of a Company vehicle and driver when required for business purposes (including any tax liabilities that may arise from this benefit).
The maximum value of benefits is determined by the nature of the benefit itself and costs of provision may depend on external factors, e.g. insurance costs.
To provide a competitive and cost-effective benefits package appropriate to the role and location
All-employee share plans
Executive Directors are entitled to participate in:
(i) Barclays Sharesave under which they can make monthly savings out of post-tax pay over a period of three or five years linked to the grant of an option over Barclays’ shares which can be at a discount of up to 20% on the share price set at the start.
(ii) Barclays Sharepurchase under which they can make contributions (monthly or lump sum) out of pre-tax pay (if based in the UK) which are used to acquire Barclays’ shares.
To provide an opportunity for Executive Directors to voluntarily invest in the Company through UK HMRC employee tax advantaged share schemes
Annual bonus
The maximum annual bonus opportunity is 93% of Fixed Pay (cash and shares) for the Group Chief Executive and 90% of Fixed Pay (cash and shares) for the Group Finance Director.
Individual bonuses are entirely discretionary (any amount may be awarded from zero to the maximum value) and decisions are based on the Committee’s judgement of Executive Directors’ performance in the year, measured against Group and personal objectives.
Delivered as a combination of cash and shares, a proportion of which may be deferred and/or subject to a holding period. Deferral proportions and vesting profiles will be structured so that, in combination with any LTIP award, the proportion of variable pay that is deferred is no less than that required by regulations (currently 60%).
Non-deferred cash components of any bonus are paid following the performance year to which they relate, normally in March. Non-deferred share bonuses are subject to a holding period (after the payment of tax) in line with regulations and with release no faster than permitted by regulations (currently one year).
Deferred share bonuses are structured so that no deferred shares vest faster than permitted by regulations. Vesting is also subject to the provisions of the plan rules including employment and the malus and clawback provisions. Any shares that vest are subject to an additional holding period (after payment of tax) in line with regulations and release no faster than permitted by regulations (currently one year).
The Committee will consider the previously disclosed financial and non-financial (including personal objectives) measures in determining the annual bonus for the Executive Directors. Financial factors will guide at least 60% of the bonus opportunity.
The Committee has the discretion to vary the measures and their respective weightings within each category. The measures and weightings will be disclosed annually as part of the annual report on Directors’ remuneration, at the beginning of the performance year (typically February).
To reward delivery of short-term financial targets set each year, the individual performance of the Executive Directors in achieving those targets, and their contribution to delivering Barclays’ strategic objectives
Delivery in part in shares with holding period increases alignment with shareholders
Deferred bonuses encourage longer-term focus and retention
Barclays PLC 2019 Annual Report can be found online at home.barclays/annualreport
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
63


Element and purposeOperation
Long Term Incentive Plan (LTIP) award
The maximum annual LTIP award for the Group Chief Executive is 140% of Fixed Pay (cash and shares) and 134% of Fixed Pay (cash and shares) for the Group Finance Director. LTIP awards are made by the Committee following discussion of recommendations made by the Chairman (for the Group Chief Executive’s LTIP award) and by the Group Chief Executive (for other Executive Directors’ LTIP awards) based on satisfactory performance over the prior year.
LTIP awards are structured so that when combined with the annual bonus the proportion of variable pay that is deferred is no less than that required by regulations (currently 60%).
No award vests before the third anniversary of grant and an award vests no faster than permitted by regulations (currently in five equal tranches with the first tranche vesting on or around the third anniversary of grant and the last tranche vesting on or around the seventh anniversary of the grant date). Any shares that vest are subject to an additional holding period (after payment of tax) in line with regulations, with restrictions lifting no faster than permitted by regulations (currently one year).
Vesting is dependent on performance measures and service. Forward-looking performance measures will be based on financial performance and other long-term strategic measures. Measures and weightings will be set in advance of each grant. The Committee has discretion to change the weightings but financial measures will be at least 70% of the total opportunity.
The Committee has discretion, and in line with the plan rules approved by shareholders, in exceptional circumstances to amend targets, measures, or the number of awards if an event happens (for example, a major transaction) that, in the opinion of the Committee, causes the original targets or measures to be no longer appropriate or such adjustment to be reasonable. The Committee also has the discretion to reduce the vesting of any award, including to nil, if it deems that the outcome is not consistent with performance delivered.
To incentivise execution of Barclays’ strategy over a multi-year period.
Long-term performance measurement, deferral and holding periods encourage a long-term view and align Executive Directors’ interests with those of shareholders
Risk and conduct adjustment, malus and clawback
Any bonus or LTIP awarded is subject to malus and clawback provisions. The malus provisions enable the Committee to reduce the amount of unvested bonus or LTIP (including to nil) prior to vesting in specified circumstances, including, but not limited to:
Malus and clawback provisions discourage excessive risk taking and inappropriate behaviours
a participant deliberately misleading Barclays, the market and/or shareholders in relation to the financial performance of the Barclays Group
a participant causing harm to Barclays’ reputation or where his/her actions have amounted to misconduct, incompetence or negligence
a material restatement of the financial statements of the Barclays Group or any subsidiary, or the Group or any business unit suffering a material downturn in its financial performance
a material failure of risk management in the Barclays Group
a significant deterioration in the financial health of the Barclays Group.
The clawback provisions enable amounts to be recovered after they have vested (for a period of seven years from grant/10 years in circumstances where a relevant investigation is ongoing at the end of the initial seven-year period) where (i) a participant’s actions or omissions have amounted to misbehaviour or material error and/or (ii) Barclays or the relevant business unit has suffered a material failure of risk management.
Shareholding requirement
Executive Directors have a contractual obligation to build up a shareholding equivalent to the maximum variable pay opportunity within five years from the date of appointment as Executive Director. Executive Directors will have a reasonable period to build up to this requirement again if it is not met because of a significant share price depreciation. Executive Directors also have a contractual obligation to maintain their shareholding for two years following the last day of active service.
Shares that count towards the requirement are beneficially owned shares including any vested share awards subject only to holding periods (including vested LTIPs, vested deferred share bonuses, Fixed Pay shares, and any legacy RBP shares). Shares from unvested deferred share bonuses and unvested LTIPs do not count towards the requirement during employment, but will count towards post-termination requirements (net of tax) provided that there are no remaining untested performance conditions.
Shareholding requirement for the Group Chief Executive is a minimum of 233% of Fixed Pay and for the Group Finance Director is 224% of Fixed Pay.
To further enhance the alignment of shareholders’ and Executive Directors’ interests in long-term value creation
Outside appointments
Executive Directors may accept one Non-Executive Director Board appointment in another listed company. The Chairman’s approval must be sought before accepting an appointment. Fees may be retained by the Executive Director.
To encourage self-development
Discretion
In addition to the various operational discretions that the Committee can exercise in the performance of its duties (including those discretions set out in the Company’s share plans), the Committee reserves the right to make either minor or administrative amendments to the policy to benefit its operation or to make more material amendments in order to comply with new laws, regulations and/or regulatory guidance. The Committee would only exercise this right if it believed it was in the best interests of the Company to do so and where it is not possible, practicable or proportionate to seek or await shareholder approval in a General Meeting.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
64


Summary remuneration policy – Executive Directors recruitment
Approval of the remuneration packages offered on appointment to any new Executive Director is a specific requirement of the Committee’s Terms of Reference. The terms of such packages must be approved by the Committee in consultation with the Chairman and (except for the terms of his own remuneration) the Group Chief Executive. Any new Executive Director’s package would include the same elements as those of the existing Executive Directors, as shown below. Where a senior executive is promoted to the Board, his or her existing contractual commitments agreed prior to his or her appointment may still be honoured in accordance with the terms of the relevant commitment, including the continued vesting of any pre-existing deferred bonus or long-term incentive awards.
ElementOperation
Fixed Pay
Determined by skills and experience appropriate for the scale, complexity and responsibilities of the role, and by market practice, market conditions and ability to recruit.
In line with financial regulations, Fixed Pay is a derivative of total compensation opportunity. Executive Directors’ total compensation is benchmarked against comparable roles in the following banks: Bank of America, BNP Paribas, Citigroup, Credit Suisse, Deutsche Bank, HSBC, JP Morgan Chase & Co, Lloyds, Morgan Stanley, Standard Chartered and UBS. The Committee may amend the list of comparator companies to ensure it remains relevant to Barclays or if circumstances make this necessary (for example, as a result of takeovers or mergers).
Fixed Pay will only exceed amounts paid to current Executive Directors, as considered reasonable by the Committee, by reference to these factors. Once appointed, increases will normally be aligned to the annual increase for UK employees, and will take into account changes in responsibilities and market conditions.
Determined by skills, experience, market practice, market conditions and ability to recruit
PensionIn line with policy.
BenefitsIn line with policy.
Annual bonusIn line with policy.
LTIP awardIn line with policy.
Summary remuneration policy – Executive Directors payment for loss of office
The Committee's approach to payments in the event of termination is to take account of the individual circumstances including the reason for termination, individual performance, contractual obligations and the terms of the deferred bonus plans and LTIPs in which the Executive Director participates.
ElementOperation
Notice period in Executive Directors' service contractsFor existing Executive Directors, 12 months' notice from the Company and six months' notice from the Executive Director. For new Executive Director hires, six months’ notice from the Company and six months’ notice from the Executive Director. Executive Directors may be required to work during the notice period or may be placed on garden leave or, if not required to work the full notice period, may be provided with pay in lieu of notice (subject to mitigation where relevant).
Pay during notice period or payment in lieu of notice per service contractsFixed Pay payable and continuation of pension allowance and other contractual benefits while an employee during notice period.
Treatment of annual bonus on terminationNo automatic entitlement to bonus on termination, but may be considered at the Committee’s discretion, pro-rated for service, and subject to performance measures being met. No bonus would be payable in the case of gross misconduct or resignation.
Treatment of unvested deferred bonus awards
In the case of death or if the Executive Director is an ‘eligible leaver’ the Executive Director would continue to be eligible to be considered for unvested portions of deferred awards, subject to the rules of the relevant plan, unless the Committee determines otherwise in exceptional circumstances. ‘Eligible leaver’ is defined as leaving due to injury, disability or ill health, retirement, redundancy, the business or company which employs the Executive Director ceasing to be part of the Group or the employer terminating employment, other than in circumstances which amount to gross misconduct or dismissal for cause. In addition, the Committee will apply its discretion to treat resignation on or after the fifth anniversary of the date of grant as ‘eligible leaver’ status. Outstanding deferred bonus awards would lapse if the Executive Director leaves by reason of resignation prior to the fifth anniversary, is terminated for gross misconduct or cause, or is otherwise not designated an ‘eligible leaver’.
Deferred awards are subject to malus provisions which enable the Committee to reduce the vesting level of deferred bonuses (including to nil) and once vested are subject to clawback provisions (as described above).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
65


ElementOperation
Treatment of unvested awards under the LTIP
In the case of death or if the Executive Director is an ‘eligible leaver’ the Executive Director would continue to be entitled to be considered for an award. ‘Eligible leaver’ is defined as leaving due to injury, disability or ill health, retirement, redundancy, the business or company which employs the Executive Director ceasing to be part of the Group or for any other reason if the Committee decides at its discretion. In addition, the Committee will apply its discretion to treat resignation on or after the fifth anniversary of the date of grant as ‘eligible leaver’ status.
In an ‘eligible leaver’ situation, awards may be considered for release on the scheduled release date. On death, awards are accelerated. In both cases, awards are pro-rated for time (over the whole performance period, including the assessment period prior to grant) and performance, subject to the Committee’s discretion to determine otherwise, in accordance with the plan rules, as amended from time to time. After release, the shares are subject to an additional holding period to the extent required by regulations (currently a minimum 12-month holding period applies). Outstanding unvested awards under the LTIP would lapse if the Executive Director leaves by reason of resignation prior to the fifth anniversary, is terminated for gross misconduct, or is otherwise not designated an ‘eligible leaver’.
Awards are subject to malus provisions which enable the Committee to reduce the vesting level of awards (including to nil) and once vested, awards are subject to clawback provisions (as described above).
RepatriationExcept in the case of gross misconduct or resignation, where an Executive Director has been relocated at the commencement of employment, the Company may pay for the Executive Director’s repatriation costs in line with Barclays’ general employee mobility policy including temporary accommodation, payment of removal costs and relocation flights for the Executive Director, spouse and children. The Company will pay the Executive Director’s tax on the relocation costs but will not tax equalise and will also not pay tax on his or her other income relating to the termination of employment.
OtherExcept in the case of gross misconduct or resignation, the Company may pay for the Executive Director’s legal fees and tax advice relating to the termination of employment and provide outplacement services. The Company may pay the Executive Director’s tax on these particular costs.

Summary remuneration policy – Non-Executive Directors
Element and purposeOperation
Fees
Reflect individual responsibilities and membership of Board Committees and are set to attract Non-Executive Directors who have relevant skills and experience to oversee the implementation of our strategy
The Chair is paid an all-inclusive fee for all Board responsibilities. The Chair has a time commitment equivalent of up to 80% of a full-time role. The other Non-Executive Directors receive a basic Board fee, with additional fees payable where individuals serve as a member or Chair of a Committee of the Board and some Non-Executive Directors may also receive fees as directors of subsidiary companies of Barclays PLC.
Fees are periodically reviewed by the Board against those for Non-Executive Directors in companies of similar size and complexity.
Benefits
The Chair is provided with private medical cover subject to the terms of the Barclays’ scheme rules from time to time, and is provided with the use of a Company vehicle and driver when required for business purposes (including settlement of any tax liabilities that may arise from this benefit). Benefits which are minor in nature and in any event do not exceed a cost of £500 may be provided to Non-Executive Directors in specific circumstances. Non-Executive Directors are not eligible to join Barclays’ pension plans.
To provide a competitive and cost-effective benefits package appropriate to the role and location
Shareholding requirement
Per annum £100,000 of the Chair’s and £30,000 for each of the Non-Executive Directors’ gross fees (before deduction of tax and other statutory deductions) are used to purchase Barclays’ shares which are retained on the Non-Executive Director’s behalf until they retire from the Board.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
66


Remuneration report
Annual report on Directors’ remuneration
This section explains how our Directors’ remuneration policy was implemented for 2021

Executive Directors
Single total figure for 2021 remuneration (audited)
The following table shows a single total figure for 2021 remuneration in respect of qualifying service for each Executive Director together with comparative figures for 2020.

1) Fixed Pay
£000

2) Pension
 £000
3) Taxable benefits
£000
Total
Fixed Pay
£000
4) Annual
bonus
£000

5) LTIP
£000
Total variable pay
£000

Total
£000
C.S. Venkatakrishnana
2021450236479395
b
395874
2020
Tushar Morzaria20211,68884521,8241,467
1,902c
3,3695,193
2020
1,650d
123581,831573
504e
1,0772,908
Jes Staleyf
20211,97599472,121
g
g
g
2,121
2020
2,350d
215642,629
843g
748e,g
1,591g
4,220
Notes
a    C. S. Venkatakrishnan was appointed as Group Chief Executive on 1 November 2021. The remuneration included in the table above for 2021 is in respect of his services as an Executive Director during 2021.
b The LTIP amount for 2021 relates to awards granted in 2019. No LTIP award was granted to C.S. Venkatakrishnan in 2019 as he was not an Executive Director at that time.
c    The LTIP amount for 2021 relates to awards granted in 2019, with vesting based on performance measured over 2019 to 2021. The value shown includes a 56% share price appreciation between the date of grant and the vesting date of the first tranche, estimated based on the Q4 2021 average share price of £1.91, as the 2021 Annual Report was finalised prior to the vesting date.
d    Fixed Pay for 2020 is shown before contributions made by Tushar Morzaria and Jes Staley to COVID-19 charitable causes, equal to one-third of Fixed Pay for six months.
e    The LTIP amounts for 2020 relate to awards granted in 2018, with vesting based on performance measured over 2018 to 2020. The values shown include a 1% share price depreciation between the date of grant and the vesting date, based on the share price on the vesting date of the first tranche, which was £1.75. The 2020 LTIP values disclosed in the 2020 Remuneration report were estimates, based on the Q4 2020 average share price, as the 2020 Annual Report was finalised prior to the vesting date.
f    Jes Staley stepped down as Group Chief Executive and an Executive Director on 31 October 2021. The remuneration included in the table above for 2021 is in respect of his services as an Executive Director during 2021.
g    The Committee has made no decisions in respect of Mr Staley's remuneration for his performance during 2021, and has suspended the vesting of all of Mr Staley's unvested deferred remuneration awards, including the LTIP award granted to him in March 2019 that normally would have been shown in the table above, as explained earlier in this Remuneration report.


Additional information in respect of each element
of pay for the Executive Directors (audited)
1) Fixed Pay
Fixed Pay is delivered 50% in cash, paid monthly, and 50% in shares, delivered quarterly. The shares are subject to a holding period, with restrictions lifting over five years, 20% each year.
During 2020, in response to the pandemic, Tushar Morzaria and Jes Staley asked to postpone increases to their Fixed Pay that shareholders had approved at the 2020 AGM as part of the new DRP. The economic environment improved in 2021 and the postponed Fixed Pay increases were implemented with effect from 1 July 2021. Fixed Pay for Tushar Morzaria increased from £1,650,000 to £1,725,000 and for Jes Staley increased from £2,350,000 to £2,400,000. On appointment as Group Chief Executive, Fixed Pay for C.S. Venkatakrishnan was set at £2,700,000, to deliver an appropriate starting total compensation opportunity, in line with the DRP. This is lower than his Fixed Pay in his previous role, as Head of Global Markets and Co-President of Barclays Bank PLC. More information on Fixed Pay is set out on page 78.
2) Pension
Executive Directors are paid cash in lieu of pension contributions equal to 5% of their Fixed Pay (equivalent to 10% of fixed cash). The pension cash allowance paid during 2021 was £22,500 for C.S. Venkatakrishnan and £98,750 for Jes Staley, for the respective periods they each served as Group Chief Executive during the year, and £84,375 for Tushar Morzaria. No other benefits were received by Executive Directors from any Barclays' pension plan.
3) Taxable benefits
Taxable benefits include private medical cover, life assurance, income protection, tax advice, car allowance and the use of a Company vehicle and driver when required for business purposes. For C.S. Venkatakrishnan, the benefits figure also includes the cost to the Company during 2021 of providing him with temporary accommodation in London, following his appointment as Group Chief Executive, which was c.£5,500. Under the terms of his relocation to London, temporary accommodation in London will be provided to him for a period of up to two years following his appointment, the annualised cost of which including tax gross up is expected to be c.£190,000.
4) 2021 annual bonus
The bonus amount included in the single total figure is the value awarded or scheduled to be awarded in Q1 following the financial year to which it relates.
In determining the bonus in respect of 2021 performance, the Committee considered the performance achieved against the Financial and Strategic non-financial performance measures that had been set to reflect Company priorities for 2021. A summary of the assessment of performance and resulting annual bonus outcomes for C.S. Venkatakrishnan and Tushar Morzaria is provided in the table that follows.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
67

Remuneration report
Annual report on Directors’ remuneration continued

For C.S. Venkatakrishnan, while he is considered to have performed well in his first two months as Group Chief Executive, the Committee determined that it was not realistic to set strategic personal objectives for those two months. As a result, his bonus in respect of that period was determined by increasing the weightings of the Financial and Strategic non-financial performance measures to cover the entire bonus opportunity, resulting in weightings of 75% and 25% respectively, while pro-rating the bonus opportunity for the proportion of 2021 that he served as Group Chief Executive. In 2022, the standard weighting to Personal objectives will apply.
For Tushar Morzaria, performance against the Personal objectives set for him, and the shared Personal objectives set for him and Jes Staley, was assessed in the normal way. Financial measures were weighted at 60%, Strategic non-financial weighted at 20% and Personal objectives weighted at 20%.
For Jes Staley, the Committee has not made any remuneration decisions at this stage and will consider these matters further as and when it considers appropriate but does not currently expect to make further decisions on this until the conclusion of the regulatory and legal proceedings related to the ongoing FCA and PRA investigation regarding Mr Staley.
2021 annual bonus outcomes
ThresholdMaximum2021 ActualC.S. VenkatakrishnanTushar Morzaria
Weighting2021 OutcomeWeighting2021 Outcome
Profit before tax (excluding material items), with CET1 ratio underpin£3.2bn£6.0bn
£9.1bna
62.5 %62.5 %50.0 %50.0 %
Cost: income ratio (excluding material items)68.0 %63.0 %
62.9%a
12.5 %12.5 %10.0 %10.0 %
Strategic non-financialPerformance against strategic measures, organised around three main categories: Customers and clients, Colleagues and Society25.0 %19.4 %20.0 %15.5 %
PersonalIndividual performance against each of the Executive Director's personal objectives assessed by the Committeen/an/a20.0 %19.0 %
Total100.0 %94.4 %100.0 %94.5 %
Final 2021 annual bonus outcome following Committee discretion94.4 %94.5 %
Notes
a    £648m of structural cost actions treated as material items and excluded from 2021 profit before tax and cost: income ratio. Structural cost actions primarily relate to the real estate review in Q221 and Barclays UK transformation costs.

Based on the Financial and Strategic non-financial assessment outlined above, for C.S. Venkatakrishnan the Committee determined an overall formulaic bonus outcome of 94.4% of the maximum opportunity. This equates to £395,000, after pro-rating the bonus opportunity for the proportion of 2021 that he served as Group Chief Executive and an Executive Director, of which 83% will be deferred under the Share Value Plan. For Tushar Morzaria, the Committee also recognised his outstanding performance against his individual and shared Personal objectives during 2021, assessing that an outcome of 19% out of a maximum of 20% was appropriate in that respect, which resulted in an overall formulaic outcome for Tushar of 94.5%. This equates to £1,467,000, of which 73% will be deferred under the Share Value Plan.
The Committee reflected on the appropriateness of these outcomes for the 2021 bonus, in the context of the performance achieved against the Financial measures, Strategic non-financial measures and, where applicable, Personal objectives. The Committee considered the underlying financial health of the Group, which is strong and well-capitalised. The outcomes for the Financial measures adjust for structural cost actions, which include costs in support of the BUK transformation. The Committee satisfied itself that the portion of these costs relating to colleague redundancy was appropriate to be excluded, as this part of the transformation is in response to changing customer behaviours and the broader evolution of the UK retail banking environment and not a result of the COVID-19 pandemic (and similarly for the Financial measures for the 2019-2021 LTIP). Consideration was also given to the strong start that C.S. Venkatakrishnan made during 2021 as he commenced his new role as Group Chief Executive, and the performance of Tushar Morzaria during 2021 against the Personal objectives set at the beginning of the year. The bonus outcomes were considered in the context of the bonus outcomes for the wider workforce, ensuring appropriate alignment both this year and over a multi-year period, and also by comparing to historical outcomes for the Executive Directors in the context of performance year on year. The Committee believes that the overall 2021 bonus outcomes above are aligned appropriately with stakeholder considerations and with the performance achieved. Based on this, the Committee concluded that no discretionary adjustment was warranted.
In line with the DRP, and due to the regulations prohibiting dividend equivalents being paid on unvested deferred share awards, the number of shares awarded to each Executive Director under the Share Value Plan will be calculated using a share price at the date of award, discounted to reflect the absence of dividend equivalents during the vesting period. The valuation will be aligned to IFRS 2, with the market expectations of dividends during the deferral period being assessed by an independent adviser. The shares will vest in tranches over years one to seven (subject to the rules of the Share Value Plan as amended from time to time) such that vesting, in combination with the LTIP, is no faster than pro-rata. As a result, all of the shares for C.S. Venkatakrishnan and the majority of shares for Tushar Morzaria in respect of the 2021 performance year will vest in two equal tranches on the first and second anniversary of grant. All shares (whether deferred or not) are subject to a further one-year holding period from the point of release. 2021 bonuses are subject to clawback provisions and the deferred elements of 2021 bonuses are subject to malus provisions, which enable the Committee to delay or reduce the vesting of unvested deferred bonuses (including to nil).
Further detail follows on the assessment of the Strategic non-financial measures, and performance against Personal objectives where applicable.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
68

Remuneration report
Annual report on Directors’ remuneration continued

Assessment of the Strategic non-financial measures for the 2021 annual bonus
Progress in relation to each of the Strategic non-financial measures, organised around three equally weighted categories, was assessed by the Committee. Within each of the three categories, the overall outcome was assessed based on the following scale: 0% to 1% Behind track on most measures, 1.5% to 3% Slightly behind track on most measures, 3.5% to 5.5% On track or slightly ahead of track for most measures, and 6% or 7% Ahead of track on most measures.
On this basis, the Committee agreed an overall outcome for the Strategic non-financial measures of 15.5% out of a maximum of 20%, which is the outcome reflected in the table above for Tushar Morzaria. The equivalent outcome for C.S. Venkatakrishnan, after scaling up the weighting of the Strategic non-financial measures from 20% to 25%, is 19.4% out of 25%. The detail supporting this assessment is provided in the table that follows.
The measures used in the Strategic non-financial assessment for bonus reflect key strategic priorities of the Bank. Most outcomes are either measured by an external provider (such as NPS or Investment Banking and Global Markets rank and fee share data) or are subject to independent ‘limited assurance’, including all Society measures with the exception of the Unreasonable Impact measure (which is delivered in partnership with the Unreasonable Group).
Customers and clients
MeasureCriteriaPerformanceCommentaryOutcome
Investment Banking fee ranking and shareMaintain client rankings and market share
6th (up from 7th in 2020)
Fee share increased to 3.7% (up from 3.6% in 2020)
Improved position from 7th to 6th with a small improvement in global fee share
Improved performance in both of key focus areas of M&A and ECM. Global M&A fee rank improved by two places to 8th, and gained 110bps in IPO fee share
(Source: Dealogic for the period covering 1 January 2020 to 31 December 2021)
Ahead of track
Global Markets revenue ranking and share
6th (maintained since 2020)
Revenue share decreased to 4.6% (down from 4.8% in 2020)
Global revenue ranking maintained at 6th. Largest non-US bank
(Source: Coalition Greenwich, Preliminary FY21 Competitor Analysis. Market share represents Barclays share of the Global Industry Revenue Pool. Analysis is based on Barclays internal business structure and internal revenues. Rank result is against the Coalition Index Banks. FY20 market share has been restated from last year’s published value based on latest analysis)
On track
Net promoter scores® (NPS)
Improve
Barclays UK: +11 (2020: +15)
Barclaycard UK: +4 (2020: +8)
US Consumer Bank: +37 (2020: +35)
NPS scores declined for Barclays UK and Barclaycard, driven partly by softening of NPS scores across the sector and partly through a decline in our service due to resource demand trade-offs
Relative positioning in comparison to peers was maintained at 3rd for Barclaycard and reverted back to 2019 levels for BUK (2021: 7th; 2020: 5th; 2019: 7th)
The NPS for the US Consumer Bank improved to +37 in 2021 from +35 in 2020
Slightly behind track
ComplaintsReduce BUK customer complaints and improve resolution timeBUK Total Complaints (Excl PPI): -17%
Significant reduction in customer complaints, driven by robust management actions and increased customer preference to use digital channels. This is despite an increase in customer transactions and interactions in 2021
Improvement in the number of complaints resolved within 3 days (53% in 2020 to 60% in 2021)
Ahead of track
DigitalIncrease digital engagement
Barclays App active users: 9.7m (2020: 9.2m)
Consumer, Cards & Payments US digital engagement: 71.8% (2020: 71.4%)
Barclays App registrations continue to increase. Reached 10m Barclays App registrations, 9.7m active users and exceeded 3 billion logins
Made significant improvements to our Barclays App, including functionality enabling eligible Barclaycard customers in financial difficulty to set up a repayment plan within the app
The US Consumer business continued to invest in the digital servicing model, partner app functionalities and expanding the product range. Digital active user rate increased slightly from 2020
On track
Total Customers and clients: 5.0%
Refer to home.barclays/sustainability/esg-resource-hub/ for more information on the ESG measures.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
69

Remuneration report
Annual report on Directors’ remuneration continued

Colleagues
MeasureCriteriaPerformanceCommentaryOutcome
Diversity28% females at Managing Director and Director level by 2021
28% in 2021, increasing from 26.5%a in 2020
Achieved our target by the end of 2021
For the UK, the equivalent was 30% at the end of 2021
On track
InclusionImprove inclusion indicatorsInclusion Index from Your View survey 79% (2020: 76%)
88% of colleagues told us that they feel included in their team (2020: 89%)
82% of colleagues told us they believe that senior leaders are truly committed to building a diverse workforce (2020: 82%)
Slightly ahead of track
EngagementMaintain engagement at healthy levels
Employee Engagement score from Your View survey 82% (2020: 83%)
83% of colleagues believe they have been able to balance their personal and work-life demands, up 5 percentage points on last year (2020: 78%)
Overall Wellbeing Index score of 84% (new for 2021), while 88% of colleagues said that their line managers are supporting their efforts to maintain their wellbeing (2020: 88%)
83% of employees would recommend Barclays as a good place to work (2020: 87%)
On track
Conduct and CultureMaintain culture and conduct indicators
92% of employees in Your View survey believe that they and their team role model the Values (2020: 94%)
89% of employees in Your View survey believe that they and their team role model the Mindset (new for 2021)
Slight improvement in percentage of employees who said they feel it is “safe to speak up at Barclays”, up one percentage point on 2020
Vast majority of colleagues believe that they and their teams role-model the Values and Mindset every day
On track
Supporting Colleagues during COVID-19Put financial resilience to use in supporting colleaguesSupported colleagues with full pay for COVID-related absence and enhanced medical support
Provided salary advances and supplemented medical cover to support colleagues in India through the impact of COVID-19
In the US, ensured that any treatments related to COVID-19 were 100% covered under medical insurance
Enhanced medical benefits in the US, and offered medical insurance at a lower cost for junior colleagues in the US
Ahead of track
Total Colleagues: 4.5%
Note
a    Represented to 1 decimal place as per the 2020 Remuneration report. Rounded in the Strategic Report to 26%; actual outcome 26.46%.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
70

Remuneration report
Annual report on Directors’ remuneration continued

Society
MeasureCriteriaPerformanceCommentaryOutcome
Green financingProgress towards our commitment to facilitate £100bn of green financing by 2030£29.8bn (£17.6bn in 2020)
Significant increase in green financing, up 69% from 2020, with a total of £62.2bn of green financing facilitated since 2018 against our 2030 target of £100bn
Social, Environment and Sustainability linked financing commitment of £150bn for 2018-2025 delivered four years early in 2021. On a cumulative basis, £193.3bn facilitated from 2018 to the end of 2021
Invested £30m in sustainability-focused start-ups through our Sustainable Impact Capital programme
Ahead of track
Emissions financing
Deliver against our near-term financing emissions targets (2025)
30% reduction in power portfolio emissions intensity
15% reduction in energy portfolio absolute emissions
Power portfolio emissions intensity (in KgCO2/MWh): 8% down versus 2020
Energy portfolio absolute emissions (in MtCO2): 22% down versus 2020
First year of measuring the reduction in client emissions that we finance using our BlueTrack™ methodology (launched in late 2020)
Currently ahead of target for Energy and on-track for Power, though progress is likely to be non-linear and will be reflective of the specific pathways that companies take
On track
Global greenhouse gas (GHG) emissions reduction in our operationsGHG scope 1 and 2 emissions (market-based) reduced against 2018 baseline by 80% by 2021 86% reduction against 2018 baseline
Exceeded our target of 80% reduction in our GHG scope 1 and 2 emissions (market-based)
Carbon neutral since 2020, compensating any remaining emissions by purchasing carbon credits
Ahead of track
Renewable electricity90% renewable electricity by 2021; 100% by 2030 at the latest94% (2020: 79%)
Surpassed our target of procuring 90% of our electricity from renewable sources by 2021
Slightly ahead of track
LifeSkills – people upskilled 10 million people upskilled (2018-2022)2.9 million people upskilled in 2021 (2020: 2.3million)
Strong progress in 2021. 9.8m people upskilled since 2018 against a 10m target by the end of 2022
Ahead of track
LifeSkills – people placed into work250,000 people placed into work (2019-2022)77,100 people placed into work in 2021 (2020: 49,700)
Strong progress in 2021. 193,400 people placed into work since 2019 against a 250,000 target by the end of 2022
Slightly ahead of track
Unreasonable Impact (partnership with the Unreasonable Group)250 businesses solving social and environmental challenges to be supported (2016-2022)216 growth-stage ventures had joined the programme by end of 2021
Good progress in 2021
Barclays and Unreasonable Group celebrated five years of partnership, with Unreasonable Impact now supporting 216 growth-stage ventures solving social and environmental challenges and collectively supporting thousands of jobs across the world
On track
Total Society: 6.0%
Overall strategic non-financial outcome for C.S. Venkatakrishnan (scaled up to be out of a maximum possible 25%)19.4%
Overall strategic non-financial outcome for Tushar Morzaria (out of a maximum possible 20%)15.5%
Further details on our approach to Key Performance Indicators are included in the Strategic report.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
71

Remuneration report
Annual report on Directors’ remuneration continued

Assessment of performance against the Personal objectives set for the 2021 annual bonus (20% weighting for Tushar Morzaria)
The individual performance of Tushar Morzaria was assessed by the Committee, against both the Personal objectives set for him and the shared Personal objectives set for him and Jes Staley in early 2021 (as set out on page 131 of the 2020 Annual Report).
As stated earlier, for C.S. Venkatakrishnan the Committee determined his bonus in respect of the portion of 2021 that he served as Group Chief Executive by increasing the weightings of the financial and strategic non-financial performance measures to cover the entire bonus opportunity. As a result, personal objectives for this two-month period were not set and performance against such objectives was not assessed. For Jes Staley, the Committee has not made any remuneration decisions at this stage, as explained earlier in this Remuneration report.
The table below summarises performance against the Personal objectives that Tushar Morzaria shared with Jes Staley.
Shared objectives for
Tushar Morzaria and Jes Staley
Outcomes
Deliver improving shareholder returns, with a focus on RoTE
Benefits of Barclays’ diversified business model continue to be demonstrated and all operating divisions delivered double-digit returns
Delivered a record Group profit before tax of £8.4bn (2020: £3.1bn) and achieved a Group RoTE of 13.4% (2020: 3.2%) aligned with our medium-term target of greater than 10%
Substantially increased returns to shareholders, equivalent to 15.0p per share, consisting of a total dividend of 6.0p per share and £1.5bn announced share buybacks in respect of 2021
Maintain robust capital ratios across the Group and within the main operating entities
Strong capital position has been maintained, with the Group’s CET1 ratio 15.1% at year end (2020: 15.1%)
Similarly strong capital ratios prevail in all main operating entities: at 31 December 2021, Barclays Bank PLC’s CET1 ratio was 13.0% and Barclays Bank UK PLC’s CET1 ratio was 15.2%, in each case exceeding regulatory minimums
Seek opportunities for further cost efficiencies, enabling reinvestment into strategic priorities and growth initiatives
Strong control of costs; total operating expenses were flat at £12.0bn excluding structural cost actions and performance costs. This has enabled investment spend on: strategic investments; technology and digital; cyber, fraud and regulatory controls; and amortisation of capitalised costs
Efficiency savings were achieved in 2021 from: technology productivity; process optimisation; smart procurement; and the real estate strategy
Structural cost actions in 2021 totalled £648m, with cost savings expected to be realised from 2023 onwards
Optimise partnerships within the Group to deliver the whole of Barclays to our clients
The Power of One Barclays is about colleagues uniting across businesses to put our clients' needs, opportunities and experience first. For example, the Green Structured Notes programme, launched as a partnership between Equities and Treasury, embodies the Power of the One Barclays philosophy to expand our green product offering for clients
The Group Chief Executive was involved in a number of key Power of One Barclays client meetings and client pitches, which assisted in securing new client business including one of the largest IPOs within the Financial Institutions Group in 2021
Continue to drive our technology agenda across the Group to support improving customer and client experience
The continuing shift towards digital adoption and demand for digital financial services has helped accelerate our digital agenda, and our focus on creating new business models built around digital customer engagement
We continued to enhance the Barclays App, reaching 10m registrations and over 3 billion logins. Customers cannot only transact and pay in the App but can complete hundreds of journeys end-to-end digitally, e.g. card management ‘on-the-go’ and ‘in-app support’ for those requiring assistance making credit card repayments
During 2021, we launched a first-of-its-kind payment option, known as Instalments for Amazon, allowing UK consumers to access a line of credit for their basket of purchases following a simple and quick, one-time application process
Drive growth in fee-based, technology-led annuity businesses with lower capital intensity
Good progress had been made in leveraging the investment we have made in our payments capabilities, and our aim is to deliver an additional £900m of income from payments activity by 2023
Successfully established new partnerships, including a long-term partnership agreement with Gap Inc., significant new client relationships, with Center Parcs and the UK Ministry of Defence, and expanded our relationship with Amazon
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
72

Remuneration report
Annual report on Directors’ remuneration continued

The table below summarises Tushar Morzaria’s performance against the objectives specific to him.
Tushar Morzaria’s objectivesOutcomes
Continue to optimise financial management and reporting (particularly through technology) to drive benefits across the Group
Significant efficiency gains achieved by leveraging data science and advanced analytics, resulting in more resilient, scalable processes, strengthened controls and accelerated financial reporting
Migration of key reporting to a leading cloud-based reporting platform, for production of external reports, system-based document editing and enhanced version control, driving efficiency and control
Empowered and upskilled colleagues using streamlined reporting and innovative technology, e.g. digital dashboards
Further improve capital productivity through enhancing capital allocation and the measurement of capital returns
Barclays’ diversified business model delivered a record profit before tax of £8.4bn (2020: £3.1bn), attributable profit of £6.4bn (2020: £1.5bn), a RoTE of 13.4% (2020: 3.2%) and EPS of 37.5p (2020: 8.8p)
The Group Capital Returns Forum was integrated into the Treasury Committee during the year, creating greater alignment and enabling further progress on our capital productivity, measurement and allocation goals
Oversee the effective management of the risk and controls agenda across Group Finance, Strategy, Tax and Treasury
Control Environment and Management Control Approach overall rated satisfactory for 2021
Liquidity transformation programme on track and full BCBS compliance is planned for the end of 2022
Retain focus on colleague agenda across Group Finance, Strategy, Tax and Treasury
High levels of colleague engagement were maintained across Finance, at 82% (2020: 82%)
Strong progress again this year against three key areas of people focus: Skills for the Future; Wellbeing; and Diversity & Inclusion
Effectively manage relationships with key external stakeholders including regulators and investors
Continued to maintain effective and open relationships with regulators and the investment community
High level of credibility with regulators, investors, analysts and rating agencies
5) Vesting of the 2019-2021 LTIP cycle
The LTIP value included in the single total figure for 2021 for Tushar Morzaria is based on the amount that will be released on 9 March 2022 in relation to the 2019-2021 LTIP award granted in 2019. The value that will vest has been estimated using the Q4 2021 average share price of £1.9144. Release is dependent on, among other things, performance over the period from 1 January 2019 to 31 December 2021, with straight-line vesting applied between the threshold and maximum points for the financial measures.
The performance achieved against the performance targets is shown in the table that follows.
No LTIP award was granted to C.S. Venkatakrishnan in 2019 as he was not an Executive Director at that time. For Jes Staley, the Committee exercised its discretion to suspend the vesting of all of his unvested awards, including the LTIP award granted in 2019, as explained earlier in this Remuneration report. No decision has been taken as to any potential vesting of this award for Mr Staley.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
73

Remuneration report
Annual report on Directors’ remuneration continued

2019-2021 LTIP outcomes
Performance measureWeightingThresholdMaximum vestingActual% of award vesting
Average return on tangible equity (RoTE) (excluding litigation and conduct and other material items)a, b
50%10% of award vests for RoTE of 8.5%

A CET1 underpin also applied
50% of award vests for RoTE of 10.5%9.6%32.0%
2021 Cost: income ratio (excluding litigation and conduct and other material items)c
20%4% of award vests for average cost: income ratio of 60%20% of award vests for Cost: income ratio of 58.5%62.1%0.0%
Risk scorecard
(detailed below)
15%The Risk scorecard captures a range of risks and is aligned with the annual incentive risk alignment framework reviewed with the regulators. The current framework measures performance against three broad categories – Capital and liquidity, Control environment and Conduct – using a combination of quantitative and qualitative metrics11.5%
Strategic non-financial
(detailed on pages
69 and 70)
15%Performance is measured against the Strategic non-financial measures. The Committee determined the percentage of the award that may vest between 0% and 15%. The measures are organised around three equally weighted categories: Customers and clients, Colleagues and Society11.5%
Total55.0%
Final 2019-2021 LTIP vesting outcome approved by the Committee55.0%
Notes
a     Based on adjusting tangible equity to be consistent with a CET1 ratio that aligns with the assumptions the Group uses for capital planning purposes (13.0% to 13.5% over the performance period and broadly in line with the Group CET1 ratio target).
b    RoTE excludes material items and litigation & conduct. Material items for 2021 consist of structural cost actions (£648m, or £489m post-tax) and a tax benefit (£462m) due to the remeasurement of UK deferred tax assets. Material items for 2020 consist of structural cost actions (post-tax £268m) and Barclays’ COVID -19 Community Aid package (post-tax £66m). Structural cost actions for 2021 primarily relate to the real estate review in Q221 and Barclays UK transformation costs.
c     2021 CIR excludes material items and litigation & conduct. Material items for 2021 consist of structural cost actions (£648m). Structural cost actions primarily relate to the real estate review in Q221 and Barclays UK transformation costs.

Assessment of the Risk scorecard for the 2019-2021 LTIP
A summary of the Committee’s assessment against the Risk scorecard performance measure over the three-year performance period is provided below. Each category was equally weighted at 5%.
CategoryPerformanceOutcome
Capital and liquidity
Group CET1 ratio grew from 13.2% to 15.1% over the period, and remained comfortably above the regulatory minimum throughout
Stress tests show that the bank is positioned to withstand a period of deteriorating economic imbalances due to post COVID-19 heightened demand and climate transition pressures
Our Liquidity Coverage Ratio was significantly above the 100% regulatory requirement throughout the period
4.5%
Control environment
The internal control environment continued to be strengthened, with most of the Group's operations achieving a ‘Satisfactory’ rating
Fraud, Transaction Operations, Information Security and Technology continue to be highlighted as key operational risk exposures
3.0%
Conduct
Barclays overall operated within Conduct Risk tolerance throughout the period
Trading Entity conduct risk dashboards continued to evolve, to allow effective oversight and decision-making
The Group remains focused on the continuous improvements being made to manage risk effectively with an emphasis on enhancing governance and management information to identify risk at earlier stages
4.0%
Overall Risk scorecard outcome for the 2019-2021 LTIP11.5%
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
74

Remuneration report
Annual report on Directors’ remuneration continued

Assessment of the Strategic non-financial measures for the 2019-2021 LTIP
A summary of the Committee’s assessment against the Strategic non-financial performance measures over the three-year performance period follows. Each category was equally weighted at 5%.
CategoryMeasureCriteriaPerformanceOutcome
Customers and clients
Investment Banking ranking
Investment Banking fee share
Maintain client ranking and increase market share
There was an increase in our Global Banking Fee Rank from 7th in 2018 to 6th in 2021, although fee share was down over the period
(Source: Dealogic for the period covering 1 January 2018 to 31 December 2021)
3.5%
Global Markets ranking
Global Markets revenue share
Global Markets ranking has improved from 7th in 2018 to 6th in 2021
Fee share has increased across the performance period
(Source: Coalition Greenwich, Preliminary FY21 Competitor Analysis. Market share represents Barclays share of the Global Industry Revenue Pool. Analysis is based on Barclays internal business structure and internal revenues. Rank result is against the Coalition Index Banks. FY20 market share has been restated from last year’s published value based on latest analysis)
Barclays UK NPS®
Barclaycard UK NPS®
US Consumer Bank NPS®
Improve (consider both absolute and relative performance)
Barclays UK and Barclaycard UK NPS rankings have remained relatively consistent over the period, between 5th and 7th for Barclays UK (ending at 7th) and between 3rd and 4th for Barclaycard UK (ending at 3rd)
Although the absolute NPS score of BUK improved initially, it subsequently reduced in line with what has been observed for UK peers over the COVID-19 pandemic. Likewise, Barclaycard UK absolute NPS scores remained positive but reduced over 2020 and 2021 in line with peers
US consumer NPS reduced at the beginning of the period, improving over 2020 and 2021
Barclays UK complaints reduction (ex PPI)
Reduce complaints
Solid progress in complaints reduction in Barclays UK since 2018
In 2021, reduction in customer complaints despite increase in customer transactions and interactions
Active App users (Barclays & Barclaycard)
Digitally active customers
CCP US Customer Digital Engagement
Increase digital engagement
Significant increase in number of Barclays App users over the period from 6.2m in 2018 to 9.7m in 2021, with new features introduced throughout this period
Steady increase in BUK digitally active customers over the period
CCP US Customer Digital Engagement increased to 71.8%
Colleagues
Diversity
% of females at Managing Director and Director level
2021 target of 28%
Achieved our women in senior leadership (Managing Directors and Directors) target of 28% for 2021, with steady increases each year, from 24% in 2018
Equivalent figure for the UK is 30%
3.5%
Inclusion
"I would recommend Barclays as a good place to work"
Maintain at healthy levels
The percentage of colleagues who would recommend Barclays as a good place to work has remained at healthy levels throughout the period, 80% or above in each year
The Inclusion Index is at 79% for 2021 up from 76% in 2020, the first year it was introduced
By 2021, 92% of colleagues believed that they and their teams do a good job of role-modelling the Barclays Values every day – above 90% scored throughout the period
Employee engagementMaintain at healthy levels
Engagement levels across Barclays are now at 82%, up 3% percentage points on 2018
87% of colleagues believe strongly in the goals and objectives of Barclays
"My team actively seeks feedback to understand customer and client expectations"Maintain at healthy levels
The percentage of colleagues who believe that their team actively seeks feedback to understand customer and client expectations has been maintained at a strong level (above 80%) throughout the period
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
75

Remuneration report
Annual report on Directors’ remuneration continued

CategoryMeasureCriteriaPerformanceOutcome
SocietySocial, environmental and sustainability-linked financing
Facilitate £150bn over 2018-2025
On a cumulative basis, a total of £193.3bn of social, environmental and sustainability-linked financing facilitated between 2018 and the end of 2021, exceeding the target four years early
Environmental financing increased year on year during the period
4.5%
GHG emissions reduction in our operations
GHG scope 1 and 2 emissions (market-based) reduced by 80% by 2021 against a 2018 baseline
Renewable electricity to 90% by 2021
GHG scope 1 and 2 emissions (market-based) reduced each year of the performance period. The overall reduction exceeded the target for progress by 2021
Significant increase in renewable electricity use over the period, with 94% of electricity now coming from renewable sources, 4 percentage points above the 2021 target of 90%
LifeSkills
Upskill 10 million people from 2018-2022
Place 250,000 people into work from 2019-2022
9.8m people upskilled between 2018 and 2021, making excellent progress towards our aspiration of helping 10m people by 2022
Good progress toward LifeSkills – placed into work target, with more than 193,400 people placed into work since 2019, despite the challenges of the pandemic in 2020 and 2021. On track to achieve 2022 target
Overall Strategic non-financial outcome for the 2019-2021 LTIP11.5%
The LTIP award is also subject to a discretionary underpin whereby the Committee must be satisfied with the underlying financial health of the Group. The Committee was satisfied that this underpin was met, and accordingly determined that the award held by Tushar Morzaria should vest at 55% of the maximum number of shares under the total award, to be released in five equal tranches annually, starting from March 2022. After release, the shares are subject to an additional 12-month holding period.
LTIP awards granted during 2021
An award was granted to each of Tushar Morzaria and Jes Staley on 8th March 2021 under the 2021-2023 LTIP, based on a value per share of £1.43938, which was derived from the share price less a discount to reflect the absence of dividends or equivalents during the vesting period, in accordance with the DRP. This is the value used to calculate the number of shares below.
For Jes Staley, the Committee exercised its discretion to suspend the vesting of all of his unvested awards, including the LTIP award granted on 8 March 2021, as explained earlier in this Remuneration report. No LTIP award was granted to C.S. Venkatakrishnan in March 2021 as he was not an Executive Director at that time.
% of Fixed PayNumber of sharesFace value at grantPerformance period
Tushar Morzaria134%1,536,078£2,211,0002021-2023
Jes Staley140%2,285,706£3,290,0002021-2023


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
76

Remuneration report
Annual report on Directors’ remuneration continued

The performance measures for the 2021-2023 LTIP awards are as follows:
Performance measureWeightingThreshold Maximum vesting
2023 return on tangible equity (RoTE) (excluding material items)a
25%0% of award vests for RoTE of 6.0%, rising on a straight-line basis25% of award vests for RoTE of 12.0%
Average cost: income ratio (excluding material items)10%0% of award vests for average cost: income ratio of 65.0%, rising on a straight-line basis10% of award vests for average cost: income ratio of 62.0%
Maintain CET 1 ratio within the target range10%
If CET1 is below MDA hurdleb +180bps during the period, the Committee will consider what portion of this element should vest, based on the causes of the CET1 reduction.
If CET1 is above MDA hurdle +280bps but does not make progress towards the range over the period, the Committee will consider what portion of this element should vest, based on the reasons for the elevated levels of CET1 versus target range and the associated impacts.
CET1 ratio between 180bps and 280bps above MDA hurdle throughout the period, or CET1 ratio more than 280bps above MDA hurdle but making progress towards the target range during the period.
Relative Total Shareholder Return (TSR)25%
6.25% of award vests for performancec at median of the peer groupd rising on a straight-line basis
25% of award vests for performance at or above the upper quartile
Risk scorecard10%The Risk scorecard captures a range of risks and is aligned with the annual incentive risk alignment framework shared with regulators. The current framework measures performance against three broad categories – Capital and liquidity, Control environment and Conduct – using a combination of quantitative and qualitative metrics. The framework may be updated from time to time in line with the Group’s risk strategy. Specific targets within each of the categories are deemed to be commercially sensitive. Retrospective disclosure will be made in the 2023 Remuneration Report, subject to commercial sensitivity no longer remaining.
Climate10%The evaluation will focus on progress towards our ambition to be a net zero bank by 2050 including:
our commitment to align our financing with the goals of the Paris Climate Agreement
our commitment to facilitate £100bn of green financing by 2030.
There will be detailed retrospective narrative on progress over the period, including consideration of progress towards other relevant targets. Performance will be assessed by the Committee to determine the percentage of the award that may vest, between 0% and 10%.
Strategic non-financial10%The evaluation will focus on key performance measures from the Performance Measurement Framework, with a detailed retrospective narrative on progress throughout the period against each category. Performance against the strategic non-financial measures will be assessed by the Committee to determine the percentage of the award that may vest between 0% and 10%. The measures are organised around three main categories: Customers and clients, Colleagues and Society (Citizenship). Each of the three main categories has equal weighting. Measures will likely include, but not be limited to, the following:
Customers and clients
Drive world-class outcomes for customers and clients and continue to support them through the pandemic: improve Net Promoter Scores, reduce BUK customer complaints and improve resolution time, maintain client ranking and market share within CIB, increase digital engagement.
Colleagues
Protect and strengthen our culture through our Purpose, Values and Mindset: continue to improve diversity in leadership roles, improve inclusion indicators, maintain engagement at healthy levels and maintain culture and conduct indicators.
Society (Citizenship)
Drive a focus on the sustainable impact of our business: continue investing in our communities, including LifeSkills – upskilled in the UK, LifeSkills – placed into work globally and Unreasonable Impact.
Notes
a    Based on an assumed CET1 ratio at the mid-point of the Group target range, 13-14%.
b    Currently 11.1%.
c    Performance assessed over the period from 1 January 2021 to 31 December 2023. Start and end TSR data will be the Q4 average for 2020 and 2023 respectively and will be measured in GBP for each company.
d    The peer group is comprised of multinational banks in Europe and North America of comparable size to Barclays and whose weekly returns have a high degree of correlation with Barclays'. The constituents of the comparator group are reviewed annually, prior to each new LTIP grant. The peer group for the 2021-2023 LTIP award is: Banco Santander, Bank of America, BBVA, BNP Paribas, Citigroup, Credit Agricole, Credit Suisse, Deutsche Bank, HSBC, ING Groep, Lloyds Banking Group, Morgan Stanley, NatWest Group, Societe Generale, Standard Chartered, UBS, Unicredit.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
77

Remuneration report
Annual report on Directors’ remuneration continued

Executive Directors:
Statement of implementation of remuneration policy in 2022
An overview of how the DRP will be implemented for Executive Directors in 2022 is set out in the subsequent sections. The following chart illustrates how 2022 remuneration will be delivered to the Executive Directors.
2022202320242025202620272028202920302031Implementation in 2022
Fixed payCash
C.S. Venkatakrishnan £2,780,000
Tushar Morzaria £1,775,000
SharesRestrictions lifting over 5 years
PensionCash in lieu of pension
C.S. Venkatakrishnan £139,000
Tushar Morzaria £88,750
Annual bonusPerformance periodCash
C.S. Venkatakrishnan up to 93% of Fixed Pay
Tushar Morzaria up to 90% of Fixed Pay
SharesHolding period
SharesHolding period
SharesHolding period
LTIPPreliminary performance periodPerformance periodSharesHolding period
C.S. Venkatakrishnan up to 140% of Fixed Pay
Tushar Morzaria up to 134% of Fixed Pay
SharesHolding period
SharesHolding period
SharesHolding period
SharesHolding period
2022 Fixed Pay and market competitiveness of the Executive Directors’ total compensation opportunity
Immediately prior to C.S. Venkatakrishnan’s appointment as Group Chief Executive, effective from 1 November 2021, the Committee considered the level of Fixed Pay he should receive, taking into consideration the role, his skills and experience and pay levels at other comparable firms (on which the Committee receives independent advice), in the context of wider workforce pay levels and the experience of our stakeholders. Pay benchmarking data is used as a reference point to ensure that the total compensation opportunity provided to the Executive Directors is competitive compared to other large and complex international banks. Banking regulation in the UK and Europe caps variable pay as a percentage of Fixed Pay for senior roles including the Executive Directors and so providing a competitive level of total compensation within the constraint of those regulations is a key driver of the Executive Directors’ Fixed Pay levels.
The Committee determined the level of Fixed Pay for C.S. Venkatakrishnan on appointment as Group Chief Executive as £2,700,000 per annum. In doing so, they concluded that the total compensation opportunity that this provides was an appropriate starting point, while noting that it was low compared with international banking peers and that this should be kept under review each year. This level of Fixed Pay was lower than he received for his previous role, as Head of Global Markets and Co-President of Barclays Bank PLC, though it was more than his predecessor as Group Chief Executive received.
The regulatory limit on the level of variable pay relative to fixed pay in banks results in the need to provide both Executive Directors with a level of Fixed Pay that is higher than the Committee might otherwise choose, to ensure the total compensation opportunity is competitive. To mitigate some of the impacts of that higher Fixed Pay, it is delivered half in cash, paid monthly via payroll in a similar way to salary for other employees, and half in shares, which are granted quarterly and released in instalments over 5 years, creating significant alignment with shareholder interests over the longer term.
An annual review of the Executive Directors' Fixed Pay, in the same way and at the same time as for the wider workforce, is a feature of the DRP approved by shareholders in 2020, but was not undertaken in 2021 due to the COVID-19 pandemic. In February 2022, the Committee reviewed the Fixed Pay for each Executive Director as part of the year-end payround process for colleagues across the Group. The Committee considered the maximum total compensation opportunity of each Executive Director, driven by their respective levels of Fixed Pay, and noted that in each case the opportunity is materially less than that at most other comparable international banks. As a result, the Committee determined that Fixed Pay would be increased to £2,780,000 for C.S. Venkatakrishnan, a 3% increase, and to £1,775,000 for Tushar Morzaria, also a 3% increase, effective 1 March 2022. The Committee noted that these are lower percentage increases than the average fixed pay increase for the wider workforce, and in particular for other UK colleagues, given the 4.25% salary spend agreed as part of the 2022 UK pay deal with Unite.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
78

Remuneration report
Annual report on Directors’ remuneration continued

Since the introduction of the DRP in the 2019 Annual Report, approved by shareholders at the AGM in 2020, Tushar’s Fixed Pay has increased once, by 4.5% in July 2021 (the implementation of Fixed Pay increases postponed from 2020 at the request of the Executive Directors). Combining that with the 2022 payround increase, the total Fixed Pay increase he has received since 2019 is 7.6%. Across our Unite-recognised colleagues in the UK, the compound average salary increase over the same period was 9.1%. For C.S. Venkatakrishnan, the Committee also considered whether a Fixed Pay increase in March 2022, following the determination of his current level of Fixed Pay on his appointment as Group Chief Executive, was appropriate, and confirmed that this is not out of line with the treatment of other colleagues who were promoted during the year, if their pay rates are below the benchmark.
The charts that follow compare each Executive Director's maximum total compensation opportunity for 2022 against the equivalent opportunity across international banking peers. This shows that even after these Fixed Pay increases the maximum total compensation opportunity is significantly behind international banking peers, falling in the lower part of the third quartile for both C.S. Venkatakrishnan and Tushar Morzaria.
The charts also show a comparison of the maximum total compensation opportunity of each Executive Director with the equivalent roles at the companies that make up the FTSE 30 (i.e. the 30 largest FTSE 100 constituents by market capitalisation). This shows that the Executive Directors’ maximum total compensation opportunity is more competitive, but not inappropriate, compared to the FTSE 30 group. The Committee noted that it would be unlikely for the Group to fill either of the Executive Director roles by recruiting from the other FTSE 30 companies, recognising the necessity for candidates for these roles to have the right breadth and depth of banking knowledge and experience, particularly given Barclays’ diversified business model including significant corporate banking, investment banking and global markets businesses. However, this comparison is provided alongside the international banking peer group to provide additional UK context.
Executive Director total maximum compensation opportunity relative to market benchmarks
bcs-20211231_g11.jpg

Notes:
Barclays and market benchmark data reflects maximum total compensation opportunity, excluding pensions and benefits
Benchmark data for the international banking peer group and FTSE 30 was provided by Willis Towers Watson, based on publicly disclosed data in respect of each firm's 2020 or 2020/21 financial years, incorporating assumptions where companies do not disclose a maximum total compensation opportunity
Barclays’ current peer group comprises the following international banks: Bank of America, BNP Paribas, Citigroup, Credit Suisse Group, Deutsche Bank, HSBC Holdings, JP Morgan Chase & Co, Lloyds Banking Group, Morgan Stanley, Standard Chartered and UBS Group, which is unchanged from the group set out in the DRP

2022 annual bonus performance measures
Performance measures with appropriately stretching targets have been selected to cover a range of financial and non-financial goals that support the key strategic objectives of the Company. The bonus measures for 2022 are in line with those for 2021, with one key amendment. For 2022, the weighting of the Strategic non-financial element has been increased from 20% to 25%, with a corresponding reduction to the weighting of the Personal objectives from 20% to 15%, to enable a greater focus on climate-related measures. Within the Strategic non-financial element, the Customers and clients and Colleagues sections are retained, and are each weighted at 7.5%, with a new Climate and sustainability section in place of the Society section, weighted at 10%. This section primarily focuses on climate-related measures, including progress towards our green financing commitments and reducing our own carbon footprint, as well as delivering the strategy to achieve our ambition to be a net zero bank by 2050. This change in bonus measures reflects the focus and importance attached to the Group's delivery on its climate objectives. For the Group Chief Executive, although for 2021 the bonus was determined solely based on the Financial and Strategic non-financial elements, for 2022 assessment against Personal objectives will also apply, in the usual way.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
79

Remuneration report
Annual report on Directors’ remuneration continued

Performance measureWeightingMetrics
Profit before tax (excluding material items)50%A performance target range has been set for this financial measure, which will be disclosed in the next Remuneration report. Pay-out of this element will also depend on the CET1 ratio at the end of the performance year. In line with regulatory requirements, if the CET1 ratio is below the MDR hurdle at the end of the performance year, the Committee will consider what part if any of this element should pay out.
Cost: income ratio (excluding material items)10%A performance target range has been set for this financial measure, which will be disclosed in the next Remuneration report.
Strategic non-financial

The evaluation will focus on a range of key metrics across stakeholder groups, with a detailed retrospective narrative on progress against each category throughout the period. Performance against the measures will be assessed by the Committee to determine the percentage of the award that may vest between 0% and 25%. Each of the three main categories is weighted as shown.
25%
The measures are organised around three main categories and measures will likely include, but not be limited to, the following:
Customers and clients (weighted 7.5%) – drive world class outcomes for customers and clients:
Improve Net Promoter Scores
Reduce BUK customer complaints and improve resolution time
Maintain client ranking and market share within CIB
Increase digital engagement
Colleagues (weighted 7.5%) – protect and strengthen our culture through our Purpose, Values and Mindset:
Continue to improve diversity in leadership positions
Improve inclusion indicators
Maintain engagement at healthy levels
Maintain culture and conduct indicators
Climate and sustainability (weighted 10%) – progress to be measured against four key objectives:
Progress towards our green financing commitments
Reduce operational and supply chain carbon footprint and increase use of renewable energy
Deliver the strategy to achieve our ambition to be a net zero bank by 2050 and to align our financing with the Paris Agreement
Continue to invest in our communities
Personal15%
Joint personal objectives:
Deliver improving shareholder returns, with a focus on RoTE
Maintain robust capital ratios across the Group and within the main operating entities
Actively deploy the range of Barclays' businesses and capabilities to support customers and clients as we collectively transition to a low carbon economy
Continue to deliver sustainable growth in the Corporate and Investment Bank
Continue to drive our technology agenda across the Group to support improving customer and client services and experience

C.S. Venkatakrishnan:
Ensure a continued focus on customer and client outcomes
Continue to embed the Mindset across the organisation in support of our Purpose
Continue to develop a high-performing culture in line with our Values, with a focus on employee engagement, succession planning, talent and diversity
Empower the effective management of the risk and controls agenda
Effectively manage relationships with key external stakeholders and society more broadly

Tushar Morzaria:
Continue to optimise financial management and reporting (particularly through technology) to drive benefits across the Group
Continue to progress the transformation of the Treasury function, including strategic treasury and liquidity platforms
Oversee the effective management of the risk and controls agenda across Group Finance, Strategy, Tax and Treasury
Retain focus on the colleague agenda across Group Finance, Strategy, Tax and Treasury, driving employee engagement, continuing to improve diversity, developing senior talent and succession planning
Effectively manage relationships with key external stakeholders including regulators and investors
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
80

Remuneration report
Annual report on Directors’ remuneration continued

2022-2024 LTIP awards and performance measures
The Committee decided to grant awards under the 2022-2024 LTIP cycle to C.S. Venkatakrishnan and Tushar Morzaria with face values at grant equal to 140% and 134% of Fixed Pay respectively, which will be based on Fixed Pay before applying the 1 March 2022 increases outlined earlier in this Remuneration report. Those maximum award multiples were determined following a detailed review of their individual performance throughout 2021 and recognising their significant personal contributions. This share-based award ensures alignment with future performance over the three-year assessment period, as well as shareholder alignment over the long release period (up to eight years from initial award).
For the 2022-2024 LTIP, changes have been made to align more closely with the evolution of the strategic non-financial measures. The strategic non-financial element of this LTIP cycle will include a ‘Climate and sustainability’ category, in place of the standalone Climate measure, with a weighting of 10%. The other measures are largely unchanged.
The 2022-2024 LTIP award will be subject to the following forward-looking performance measures.
Performance measureWeightingThresholdMaximum vesting
Average return on tangible equity (RoTE) (excluding material items)a
25%0% of award vests for RoTE of 7.0%, rising on a straight-line basis25% of award vests for RoTE of 11.0% or higher
Average cost: income ratio (excluding material items)10%0% of award vests for average cost: income ratio of 65.0%, rising on a straight-line basis10% of award vests for average cost: income ratio of 59.0% or lower
Maintain CET1 ratio within the target range10%
If CET1 is below the MDA hurdleb + 190 bps during the period, the Committee will consider what portion of this element should vest, based on the reasons for the CET1 shortfall
If CET1 is above MDA hurdle + 290bps but does not make progress towards the range over the period, the Committee will consider what portion of the element should vest, based on the reasons for the elevated levels of CET1 versus target range and the associated impacts
If CET1 is between 190bps and 290bps above the MDA hurdle throughout the period
or
If CET1 is above the MDA hurdle +290bps but making progress towards the target range
Relative Total Shareholder Return (TSR)c
25%
6.25% vests for performance at the median of the peer groupd, rising on a straight-line basis
25% of award vests for performance at or above the peer group upper quartile
Strategic non-financials20%
The evaluation will focus on key performance measures from the Performance Measurement Framework, with a detailed retrospective narrative on progress against each category throughout the period. Performance against the strategic non-financial measures will be assessed by the Committee to determine the percentage of the award that may vest between 0% and 20%. The measures are organised around three main categories and measures will likely include, but not be limited to, the following:
Customers and clients (weighted 5%) – drive world class outcomes for customers and clients:
Improve Net Promoter Scores; reduce BUK customer complaints and improve resolution time; maintain client rankings and market share within CIB; and increase digital engagement.
Colleagues (weighted 5%) – protect and strengthen our culture through our Purpose, Values and Mindset:
Continue to improve diversity in leadership roles; improve inclusion indicators; maintain engagement at healthy levels; and maintain culture and conduct indicators.
Climate and sustainability (weighted 10%) – progress to be measured against four key objectives:
Progress towards our green financing commitments; reduce operational and supply chain carbon footprint and increase use of renewable energy; progress towards achieving our ambition to be a net zero bank by 2050; and aligning our financing with the Paris Agreement, and continue to invest in our communities.
Risk scorecard10%The Risk scorecard captures a range of risks and is aligned with the annual incentive risk alignment framework shared with the regulators. The current framework measures performance against three broad categories – Capital and liquidity, Control environment and Conduct – using a combination of quantitative and qualitative metrics. The framework may be updated from time to time in line with the Group’s risk strategy. Specific targets within each of the categories are deemed to be commercially sensitive. Retrospective narrative on performance will be disclosed in the 2024 Remuneration report, subject to commercial sensitivity no longer remaining.
Notes
a     Based on an assumed CET1 ratio at the mid-point of the Group target range, 13-14%.
b     Currently 11.1%.
c     Performance assessed over the period from 1 January 2022 to 31 December 2024. Start and end TSR data will be the Q4 average for 2021 and 2024 respectively and will be measured in GBP for each company.
d     The peer group is comprised of multinational banks in Europe and North America of comparable size to Barclays and whose weekly returns have a high degree of correlation with Barclays’. The constituents of the comparator group are reviewed annually, prior to each new LTIP grant. The peer group for the 2022–2024 LTIP award is: Banco Santander, Bank of America, BBVA, BNP Paribas, Citigroup, Credit Agricole, Credit Suisse, Deutsche Bank, HSBC, ING Groep, Lloyds Banking Group, Morgan Stanley, NatWest Group, Societe Generale, Standard Chartered, UBS, Unicredit.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
81

Remuneration report
Annual report on Directors’ remuneration continued

Illustrative scenarios for Executive Directors’ total remuneration opportunity
The charts below show the potential value of the current Executive Directors’ 2022 total remuneration in three main scenarios: ‘Minimum’ (i.e. Fixed Pay, pension and benefits only, with no annual bonus award or LTIP), ‘Mid-point’ (i.e. Fixed Pay, pension, benefits and 50% of the maximum variable pay that may be awarded) and ‘Maximum’ (i.e. Fixed Pay, pension, benefits and the maximum variable pay that may be awarded). For the purposes of these charts, the value of benefits is based on an estimated annual value for 2022 regular contractual benefits. Additional ad hoc benefits may arise, for example, overseas relocation of Executive Directors, but will always be provided in line with the DRP.
A significant proportion of the potential remuneration of the Executive Directors is variable and is therefore performance related. It is also subject to deferral, additional holding periods, malus and clawback. In line with reporting requirements, we have provided an indication of the maximum remuneration receivable, assuming share price appreciation of 50% on the LTIP.


bcs-20211231_g12.jpg

Group Finance Director succession
As indicated in the letters from the Chairman and Group Chief Executive introducing this Annual Report, on 22 February 2022 Tushar Morzaria informed the Board of his intention to retire from the Board and as Group Finance Director, and the Board has agreed that this will take effect on 22 April 2022. The remuneration details in connection with his retirement and for his successor, Anna Cross, will be set out in a separate announcement to the market on 23 February 2022, and are not reflected in this Remuneration report.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
82

Remuneration report
Annual report on Directors’ remuneration continued

Additional remuneration disclosures
Group performance graph and Group Chief Executive remuneration
The performance graph below compares the total shareholder return of Barclays shares with the total shareholder return of the FTSE 100 index over the ten years ended 31 December 2021. The FTSE 100 index has been selected because it represents a cross-section of leading UK companies, of which Barclays is a long-standing constituent.
bcs-20211231_g13.jpg
Year2012201320142015201620172018201920202021
Group Chief ExecutiveRobert
Diamond
Antony
Jenkins
Antony
Jenkins
Antony
Jenkins
Antony
Jenkins
John McFarlaneJes
Staley
Jes
Staley
Jes
Staley
Jes
Staley
Jes
Staley
Jes
Staley
Jes
Staley
C.S.
Venkata-
krishnan
Single total remuneration
figure Group Chief Executive
1,892 529 1,602 
5,467a
3,399 305 277 4,233 3,873 3,362 5,929 
4,220b
2,121c
874d
Annual bonus award as a % of maximum0.0 %0.0 %0.0 %57.0 %48.0 %n/an/a60.0 %48.5 %48.3 %75.0 %38.6 %
n/ac
94.4 %
Long-term incentive plan vesting as a % of maximum0.0 %
n/ae
n/ae
30.0 %39.0 %
n/ae
n/ae
n/ae
n/ae
n/ae
48.5 %23 %
n/ac
n/ae
Notes
a    Antony Jenkins’ 2014 pay is higher than in earlier years since he declined a bonus in 2012 and 2013 and did not have LTIP vesting in those years.
b    2020 remuneration outcomes reflect 2018-2020 LTIP value restated for the actual share price on the date of vesting.
c    Jes Staley stepped down as Group Chief Executive on 31 October 2021. The remuneration shown for 2021 is in respect of his services as an Executive Director between 1 January 2021 and 31 October 2021. This figure does not include variable remuneration as the Committee has made no decisions in respect of Mr Staley's variable remuneration in respect of performance during 2021, and has suspended the vesting of all of his unvested deferred remuneration awards including the LTIP award granted to him in March 2019, as explained earlier in this Remuneration report.
d    C.S. Venkatakrishnan was appointed as Group Chief Executive on 1 November 2021. The remuneration shown for 2021 is in respect of his services as an Executive Director between 1 November 2021 and 31 December 2021.
e    Not applicable as the individual was not a participant in a long-term incentive award that vested in the period.



Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
83

Remuneration report
Annual report on Directors’ remuneration continued

Group Chief Executive pay ratio
The table below shows the ratios of the Group Chief Executive’s total remuneration to the total remuneration of UK employees since 2018. The change in the pay ratios for 2021 is explained in more detail below.
Option25th percentileMedian75th percentile
2021a
A95 x62 x35 x
2020b
A144 x95 x53 x
2019A213 x140 x77 x
2018A126 x85 x45 x
Notes
a    2021 Group Chief Executive pay ratio figures are calculated using the sum of 2021 remuneration for C.S. Venkatakrishnan and Jes Staley (as per the single total figure for remuneration table) in respect of their periods of service as Group Chief Executive in 2021.
b    2020 Group Chief Executive pay ratio figures have been updated to reflect the restatement of the 2018-2020 LTIP value based on the share price at the time of vesting.

The regulations provide three options which may be used to calculate total pay for the employees at the 25th percentile, median and 75th percentile. Following guidance issued by some proxy advisers and institutional shareholders, we have selected Option A to calculate total pay for each calendar year, each year using the employee population on 31 December.
Option A calculates total pay for all employees on the same basis that the single total figure for remuneration is calculated for Executive Directors. Total pay for each employee includes earned fixed pay, which is made up of salary, Role Based Pay and relevant allowances, annual incentives awarded for the 2021 calendar year, and an estimate of pension and benefits for 2021. Other elements of pay such as overtime and shift allowances have been excluded. The estimate of pension for each employee is based on the percentage currently available to new hires in the UK (10% of salary for the more senior and 12% for the more junior corporate grades). The estimate of benefits is based on the cost of core benefits available at each corporate grade, including private medical insurance, income protection and life assurance. Calculations use full-time equivalent pay data taken from our HR systems for all UK employees.
Total pay and fixed pay for the employees at the 25th percentile, median and 75th percentile are set out in the table below.
25th percentileMedian75th percentile
Total payFixed PayTotal payFixed PayTotal payFixed Pay
2021£31,404£26,035£48,253£39,461£85,407£67,408
2020£29,380£24,706£44,631£37,460£79,324£64,272
2019£27,875£23,348£42,362£35,158£77,488£62,263
2018£26,587£21,899£39,390£32,202£74,685£60,000
The Group Chief Executive pay ratios have decreased between 2020 and 2021, largely due to a decrease in the Group Chief Executive remuneration, which is calculated using the sum of 2021 remuneration for C.S. Venkatakrishnan and Jes Staley for their respective periods of service as Group Chief Executive in the year, as per the single total figure for 2021 remuneration table. Over the same time period, employee total pay increased by 7% at the lower quartile and by 8% at each of the median and upper quartile, also contributing to the decrease in pay ratios. The increases in median fixed pay and bonus between 2020 and 2021 are explained in more detail in the section that follows, which covers the annual percentage change in remuneration of Directors and employees.
The decrease in the Group Chief Executive single total figure for remuneration from 2020 to 2021 is due to two factors. Firstly, C.S. Venkatakrishan’s remuneration for his two months of service as Group Chief Executive during 2021 does not include any value in respect of LTIP, as no 2019-2021 LTIP award was granted to him given that he was not an Executive Director at the time of grant. Secondly, Jes Staley's 2021 single total figure for the 10 months of 2021 that he served as Group Chief Executive does not include any bonus or LTIP value, as no remuneration decisions have been made in respect of Mr Staley, and his unvested LTIP and deferred bonus awards have been suspended, as explained earlier in this Remuneration report.
Barclays remuneration philosophy is set out earlier in this report, and all remuneration decisions for Executive Directors and the wider workforce are made within this framework. The Group Chief Executive pay ratio is one of the outcomes of all of these decisions, which are explained in more detail in the Committee Chair’s annual statement.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
84

Remuneration report
Annual report on Directors’ remuneration continued

Annual percentage change in remuneration of Directors and employees
The table below shows the percentage change in the Executive Directors’ Fixed Pay, benefits and bonus each year between 2019 and 2021 compared with the percentage change in each of those components of pay for UK-based employees of Barclays Group and for employees of the Barclays PLC (BPLC), the parent company of the Group.
Fixed payBenefitsAnnual bonus
2020/2021
C.S. Venkatakrishnana
n/an/an/a
Tushar Morzaria%-10%156 %
Jes Staleyb
%-12%n/a
Median UK employee%%42 %
Median employee of BPLCc
11 %38 %
2019/2020Tushar Morzaria%-49 %
Jes Staley10 %-49 %
Median UK employee%20 %-16 %
Median employee of BPLCc
%26 %-16 %
Notes
a    C.S. Venkatakrishnan was appointed as Group Chief Executive on 1 November 2021. No percentage change figures can be calculated for 2020/21 as C.S. Venkatakrishnan did not receive any remuneration in respect of services provided as an Executive Director in 2020.
b    Jes Staley's remuneration figures for 2021 are pro-rated up for the purpose of this comparison. The Committee has not made any remuneration decisions at this stage, as explained earlier in this Remuneration report.
c    The BPLC comparison is included because this is a statutory requirement, though BPLC employs only a very small number of Head Office employees (45 for 2021).

For the Executive Directors, percentage change figures for 2020 to 2021 are calculated using the single total figure for the 2021 remuneration table.
For Fixed Pay, the increases from 2020 to 2021 for Jes Staley and Tushar Morzaria reflect the increases approved by shareholders at the 2020 AGM, which were postponed at the request of the Executive Directors due to the COVID-19 pandemic, and only implemented with effect from 1 July 2021 as economic conditions improved. Their reductions in benefits over the same time period are largely due to reductions in tax compliance costs.
For bonus, in many parts of the Group bonuses were down in 2020 but the Committee chose to protect outcomes for junior colleagues, consistent with our Fair Pay agenda, and as a result the greatest reductions in incentives from 2019 to 2020 were seen for more senior colleagues. The incentive approach for the Executive Directors is significantly more structured than for most other employees, as required by institutional shareholders for Directors of UK-listed companies, and this more structured approach leads to greater year-on-year volatility in incentive outcomes, both up and down, for the Executive Directors compared to the norms for other colleagues. This can be seen in the much larger than average year-on-year reduction in bonus for Jes Staley and Tushar Morzaria from 2019 to 2020.
Moving from 2020 into 2021, the Group’s performance was significantly stronger, with record profit before tax in 2021 and all three main lines of business delivering double-digit returns on equity. The significant increase in Tushar Morzaria’s bonus reflects that stronger financial performance, which resulted in a maximum pay-out against the financial elements of the Executive Directors’ 2021 bonus measures, alongside an outstanding personal performance in 2021 and outcomes for the Strategic non-financial measures that were strong, comparable with 2020. Tushar Morzaria’s bonus paid out at 94.5% of maximum in 2021 and 38.6% of maximum in 2020.
In determining the 2021 bonus outcomes for the Executive Directors, the Committee considered the context of the bonus outcomes for the wider workforce, ensuring appropriate alignment both this year and over a multi-year period, and also compared to historical outcomes for the Executive Directors in the context of performance each year. They also reviewed the underlying financial health of the Group, which is strong and well-capitalised. They concluded that the outcomes were appropriate in the context of the performance achieved.
For the UK employees, the 5% increase in median fixed pay reflects increases awarded during 2021 in the normal course of business, and also a change in the make-up of the UK population. In 2021, as part of the broader BUK transformation, the profile of a number of customer facing roles changed. To support the new business model, over 2,000 branch colleagues developed new skills and were promoted to recognise their broader, more-complex customer support responsibilities. Their previous lower-graded roles were not replaced. This promotion of employees into more highly-skilled and more highly-paid roles also contributed to the upward shift in median fixed pay. The increase in median bonus for UK employees is driven in part by the same demographic shift in the population, but mainly as a result of the increase in bonus pool from 2020 to 2021, reflecting improved organisational performance.
BPLC only employs a very small number of Head Office employees (45 for 2021) and there is frequent movement of employees between BPLC and other entities within the Barclays Group. In order to make a meaningful year-on-year comparison, the figures are therefore based on all individuals employed by BPLC in both years (39 individuals). The fixed pay increase for this population of 11%, which is higher than that for the median UK employee Group-wide, is driven by a few market adjustments in this small population. The bonus increase is broadly in line with the increase for the median employee across the UK workforce and is largely due to the year-on-year increase in bonus pool reflecting business performance.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
85

Remuneration report
Annual report on Directors’ remuneration continued

The table below shows the percentage change in fees each year between 2019 and 2021 for the Chairman and the Non-Executive Directors serving on Barclays' Board during 2021. Non-Executive Directors who joined on or after 1 January 2021 are not included. The percentage change in fees between 2020 and 2021 relate to set fees for additional responsibilities taken on by the Non-Executive Directors. Increases in fees between 2019 and 2020 are largely attributable to the increase in Non-Executive Director basic Board and Committee fees effective 1 January 2020, as set out in the 2019 Remuneration report.
2020 / 2021 Fees2019 / 2020 Fees
Nigel Higgins%
0%a
Mike Ashley%19 %
Tim Breedon
64%b
24 %
Mohamed A. El-Erian11 %n/a
Dawn Fitzpatrick14 %
36%a
Mary Francis%-3 %
Crawford Gillies
108%c
%
Brian Gilvary
95%a,d
n/a
Diane Schueneman-4 %%
Sir Ian Cheshire
‑82%a,e
%
Notes
a     For those who were appointed during 2019 or 2020 or those who stood down during 2021, fees are pro-rated up for the relevant year for the purpose of this comparison.
b    The increase in fees from 2020 to 2021 is primarily due to Tim Breedon's appointment as Chair of Barclays Bank Ireland PLC with effect from 16 April 2021.
c    The increase in fees from 2020 to 2021 is primarily due to Crawford Gillies' additional responsibilities following his appointment as Chair of Barclays Bank UK PLC with effect from 1 January 2021, for which he receives an annual fee of £400,000.
d     The increase in fees from 2020 to 2021 is due to Brian Gilvary's additional responsibilities in 2021, including becoming Senior Independent Director with effect from 1 January 2021, Chair of the Remuneration Committee with effect from 1 March 2021 and joining the Risk and Nominations Committees with effect from 1 January 2021.
e     Sir Ian Cheshire stepped down as Chair of Barclays Bank UK PLC with effect from 31 December 2020 but remained on the Board of Barclays PLC until the conclusion of the 2021 AGM on 5 May 2021. For his service in 2021, he received a fee of £90,000 pro-rata, which is reflected in his change in fees from 2020 to 2021.

Relative importance of spend on pay
A year-on-year comparison of Group compensation costs and of distributions to shareholders is shown below. The distributions shown relate to dividends paid and share buyback programmes completed during the year. The distributions for 2021 do not include the dividends and share buyback programme announced on 23 February 2022.
bcs-20211231_g14.jpg

Notes
a    Relates to costs arising from salaries and other elements of fixed pay, social security costs, post-retirement benefits and other compensation costs.
b    The chart shows dividends paid and share buyback programmes completed during the year, i.e. for 2021, the figure represents the 2020 full year dividend paid in April 2021, the share buyback programme announced with the 2020 results, which concluded on 23 April 2021, the 2021 half year dividend paid in September 2021, and the share buyback programme announced with the half year results, which concluded on 30 November 2021. The dividends and share buyback programme announced on 23 February 2022 are not reflected in this chart.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
86

Remuneration report
Annual report on Directors’ remuneration continued

Chairman and Non-Executive Directors
Remuneration for Non-Executive Directors reflects their responsibilities, time commitment and the level of fees paid to Non-Executive Directors of comparable major UK companies. Fees are pro-rated for periods of service.
Non-Executive Directors are reimbursed expenses that are incurred for business reasons. Any tax that arises on these reimbursed expenses is paid by Barclays.
Chairman and Non-Executive Directors: Single total figure for 2021 remuneration (audited)
Feesa
BenefitsTotal
202120202021202020212020
£000£000£000£000£000£000
Chairman
Nigel Higginsb
80080086808806
Non-Executive Directors
Mike Ashley265265265265
Tim Breedonc
483295483295
Mohamed A. El-Erian150135150135
Dawn Fitzpatrick170150170150
Mary Francis162150162150
Crawford Gilliesd
502241502241
Brian Gilvarye
234108234108
Diane Schueneman374390374390
Julia Wilsonf
9090
Former Directors
Sir Ian Cheshireg
3149031490
Total3,2613,024863,2693,030
Notes
a    The annual fees received in 2021 by each Non-Executive Director include fees for Board Committee memberships and/or subsidiary Board positions. Fees shown in the table above are pro-rated (where appropriate) for periods of service. Key changes in appointments during 2021 are identified in notes c to g below.
b    Nigel Higgins does not receive a fee in respect of his role as Chairman of Barclays Bank PLC.
c    Tim Breedon was appointed Chair of Barclays Bank Ireland PLC with effect from 16 April 2021. The 2021 figure includes €330,000 (£284,000) for this appointment (pro-rata for service in 2021).
d     Crawford Gillies was appointed as Chair of Barclays Bank UK PLC with effect from 1 January 2021. The 2021 figure includes £400,000 for this appointment.
e     Brian Gilvary succeeded Crawford Gillies as Senior Independent Director with effect from 1 January 2021 and as Chair of the Remuneration Committee with effect from 1 March 2021. The 2021 figure includes £36,000 and £70,000 (pro-rata for service in 2021) respectively, for these appointments.
f    Julia Wilson was appointed to the Board and as a member of the Audit Committee with effect from 1 April 2021. The 2021 figure includes £90,000 and £30,000 respectively, for these appointments (pro-rata for service in 2021).
g    Sir Ian Cheshire stepped down as Chair of Barclays Bank UK PLC with effect from 31 December 2020, but remained on the Board of Barclays PLC until the conclusion of the 2021 AGM on 5 May 2021. The 2021 figure includes £90,000 for this appointment (pro-rata for service in 2021).
Chairman and Non-Executive Directors: Statement of implementation of remuneration policy in 2022
Fees for the Chairman and Non-Executive Directors for 2022 are shown below. The fees were last reviewed in 2019 and revised for 2020, since then there have been no subsequent amendments.
1 January 20221 January 2021
£000£000
Chairmana
800 800 
Board member9090 
Additional responsibilities
Senior Independent Director3636 
Chairman of Board Audit or Risk Committee8080 
Chairman of the Board Remuneration Committee7070 
Membership of Board Audit, Remuneration or Risk Committee3030 
Membership of Board Nominations Committee1515 
Note
a    The Chairman does not receive any fees in addition to the Chairman fees.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
87

Remuneration report
Annual report on Directors’ remuneration continued

Directors’ shareholdings and share interests
Interests in Barclays PLC shares (audited)
The table below shows the number of shares owned beneficially by each person who served as a Director during 2021 (including any shares owned beneficially by their connected persons). For the Executive Directors, it shows the number of shares over which each holds awards that are subject to either deferral terms or to deferral terms plus performance measures, and the number of shares owned outright includes shares purchased by the Director as well as shares received in relation to remuneration. The numbers shown for shares that are subject to performance measures represent the maximum number of shares that may be released if those performance measures were to be satisfied in full.
The total share interests at 21 February 2022 were the same as shown below for all Directors in service as at 31 December 2021.
Owned outright as at 31 December 2021 (or date of retirement from the Board, if earlier)UnvestedTotal as at 31 December 2021 (or date of retirement from the Board, if earlier)
Subject to performance measuresNot subject to performance measures
Executive Directors
C.S. Venkatakrishnana
1,324,2552,515,4053,839,660 
Tushar Morzaria4,709,1256,116,6621,261,54512,087,332 
Chairman
Nigel Higgins1,580,995 1,580,995 
Non-Executive Directors
Mike Ashley369,863 369,863 
Tim Breedon189,664 189,664 
Mohamed A. El-Erian129,881 129,881 
Dawn Fitzpatrick933,596 933,596 
Mary Francis55,696 55,696 
Crawford Gillies209,282 209,282 
Brian Gilvary173,080 173,080 
Diane Schueneman89,430 89,430 
Julia Wilsonb
12,094 12,094 
Former Directors
Jes Staleyc
6,778,0269,084,7792,139,67418,002,479 
Sir Ian Cheshired
122,449 122,449 
Notes
a    C.S. Venkatakrishnan was appointed to the Board with effect from 1 November 2021.
b    Julia Wilson was appointed to the Board with effect from 1 April 2021.
c    Jes Staley stepped down as an Executive Director with effect from 31 October 2021 and as a result his shareholdings are shown as at that date. The Committee has exercised its discretion to suspend the vesting of all of Mr Staley's unvested awards, as explained earlier in this Remuneration report.
d    Sir Ian Cheshire stepped down as a Non-Executive Director with effect from 5 May 2021 and as a result his shareholdings are shown as at that date.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
88

Remuneration report
Annual report on Directors’ remuneration continued

Executive Directors’ shareholdings and share interests (audited)
The charts below show the value of Barclays shares held beneficially as at 31 December 2021 by C.S. Venkatakrishnan and Tushar Morzaria, or as at 31 October 2021 for Jes Staley, being his last day of active service, in each case using the Q4 2021 average Barclays’ ordinary share price of £1.9144.
The shareholding requirement is 233% of year-end Fixed Pay for C.S. Venkatakrishnan and 224% of year-end Fixed Pay for Tushar Morzaria. C.S. Venkatakrishnan has five years from 1 November 2021, his date of appointment as Group Chief Executive, to meet this requirement. Barclays shares held beneficially by each Executive Director count towards the shareholding requirement.
For Jes Staley, the shareholding requirement is 233% of his Fixed Pay on his last day of active service as an Executive Director and the requirement continues to apply for two years following his last day of active service. As he has stepped down as an Executive Director, in addition to the shares that he beneficially owns counting towards the requirement, shares from unvested deferred share bonuses and unvested LTIPs (net of tax) can also be counted, provided that there are no remaining untested performance conditions. The chart below includes only the beneficially owned shares.
bcs-20211231_g15.jpg

Service contracts and letters of appointment
Each Executive Director has a service contract, whereas the Chairman and Non-Executive Directors each have a letter of appointment. Copies of the service contracts and letters of appointment are available for inspection at the Company’s registered office. The effective dates of the current Directors’ appointments disclosed in their service contracts or letters of appointment are shown in the table below.
As stated in the letters of appointment, the Chairman and Non-Executive Directors are appointed for an initial term of three years and are subject to annual re-election by shareholders. On expiry of the initial term and subject to the needs of the Board, Non-Executive Directors may be invited to serve a further three years. Non-Executive Directors appointed beyond six years will be at the discretion of the Board Nominations Committee.
Effective date of appointment
Chairman
Nigel Higgins1 March 2019 (as a Non-Executive Director)
2 May 2019 (as Chairman)
Executive Directors
C.S. Venkatakrishnan1 November 2021
Tushar Morzaria15 October 2013
Non-Executive Directors
Mike Ashley18 September 2013
Robert Berry8 February 2022
Tim Breedon1 November 2012
Mohamed A. El-Erian1 January 2020
Dawn Fitzpatrick25 September 2019
Mary Francis1 October 2016
Crawford Gillies1 May 2014
Brian Gilvary1 February 2020
Diane Schueneman25 June 2015
Julia Wilson1 April 2021

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
89

Remuneration report
Annual report on Directors’ remuneration continued

Payments to former Directors (audited)
Former Group Chief Executive: Jes Staley
On stepping down from his role as Group Chief Executive and as an Executive Director of Barclays PLC, on 31 October 2021, Mr Staley was entitled to 12 months' notice from Barclays, under his contract of employment. During his notice period, he continues to receive his Fixed Pay (£2.4m per annum delivered half in cash, paid monthly, and half in Barclays shares, awarded each quarter), pension allowance (£120,000 per annum, paid monthly) and other benefits, in line with the DRP. The amounts that he received during 2021, after stepping down, amounted to Fixed Pay in cash of £200,000, Fixed Pay in shares of £200,000, pension allowance of £20,000 and other benefits with a value of approximately £6,000. He is also contractually entitled to receive repatriation costs to the US, in line with the DRP, though these have not yet been incurred. No decisions have yet been made in respect of any further remuneration payments to be made to Mr Staley, as outlined in the annual statement from the Chair of the Remuneration Committee.
Former Group Finance Director: Chris Lucas
In 2021, Chris Lucas continued to be eligible to receive life assurance cover, private medical cover and payments under the Executive Income Protection Plan (EIPP). Full details of his eligibility under the EIPP were disclosed in the 2013 Remuneration report (page 115 of the 2013 Annual Report). Chris Lucas did not receive any other payment or benefit in 2021.
Former Chairs or Non-Executive Directors
No payments were made to former Chairs or Non-Executive Directors during 2021.
Previous AGM voting outcomes
The table below shows the shareholder voting result in respect of our 2020 Remuneration report (approved by shareholders at the AGM held on 5 May 2021) and Directors’ remuneration policy (approved by shareholders at the AGM held on 7 May 2020).
For % of votes cast
Number
Against % of votes cast
Number
Withheld Number
Vote on the 2020 Remuneration Report at the 2021 AGM99.25 %0.75 %
11,981,557,90490,709,782222,296,011
Vote on the Directors’ remuneration policy at the 2020 AGM96.29 %3.71 %
11,308,670,932436,091,600201,020,969
At the AGM held on 24 April 2014, 96.02% (10,364,453,159 votes) of shareholders of Barclays PLC voted for the resolution in respect of a fixed to variable remuneration ratio of 1:2 for ‘Remuneration Code Staff ’ (now known as MRTs). On 14 December 2017, the Board of Barclays PLC as shareholder of Barclays Bank PLC approved the resolution that Barclays Bank PLC and any of its current and future subsidiaries be authorised to apply a ratio of the fixed to variable components of total remuneration of their MRTs that exceeds 1:1, provided the ratio does not exceed 1:2. On 15 November 2018, the Board of Barclays PLC as shareholder of Barclays Bank UK PLC approved an equivalent resolution in relation to MRTs within Barclays Bank UK PLC and any of its subsidiaries.
Barclays Board Remuneration Committee
The Committee is responsible for overseeing Barclays’ remuneration as described in more detail below.
Terms of Reference
The role of the Committee is to:
set the overarching principles and parameters of remuneration policy across the Group;
consider and approve the remuneration arrangements of (i) the Chairman, (ii) the Executive Directors, (iii) members of the Barclays Group Executive Committee and any other senior executives specified by the Committee from time to time, and (iv) all other Group employees whose total annual compensation exceeds an amount determined by the Committee from time to time; and
exercise oversight for remuneration issues.
The Committee considers the overarching objectives, principles and parameters of remuneration policy across the Group to ensure it is adopting a coherent approach in respect of all employees. In discharging this responsibility, the Committee seeks to ensure that the policy is fair and transparent, avoids complexity and assesses, among other things, the impact of pay arrangements in supporting the Group’s culture, Values and strategy and on all elements of risk management. The Committee also approves incentive pools for each of the Group, Barclays Bank PLC, Barclays Bank UK PLC and BX, periodically reviews (at least annually) all material matters of retirement benefit design and governance, and exercises judgement in the application of remuneration policies to promote the long-term success of the Group for the benefit of shareholders. The Committee and its members work as necessary with other Board Committees, and the Committee is authorised to select and appoint its own advisers as required.

The Committee’s terms of reference are available at home.barclays/who-we-are/our-governance/board-committees
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
90

Remuneration report
Annual report on Directors’ remuneration continued

Advisers to the Committee
The Committee appointed PricewaterhouseCoopers (PwC) as the independent adviser in October 2017. The Committee considered the advice provided by PwC to the Committee during the year and was satisfied that the advice is independent and objective. PwC is a signatory to the voluntary code of conduct in relation to executive remuneration consulting in the UK.
PwC was paid £125,000 (excluding VAT) in fees for their advice to the Committee in 2021 relating to the Executive Directors (either exclusively or along with other employees within the Committee’s Terms of Reference). In addition to advising the Committee, PwC provided unrelated consulting advice to the Group in respect of strategic advice on business, regulation, operational models and cost, corporate taxation, technology, pensions and HR issues.
Throughout 2021, Willis Towers Watson (WTW) provided the Committee with market data on compensation as context when considering incentive levels and remuneration packages. WTW were paid £85,000 (excluding VAT) in fees for their services. In addition to the services provided to the Committee, WTW also provides pensions and benefits advice and insurance brokerage services to Barclays Group, and pensions advice and administration services to a number of the Group's pension funds.
In the course of its deliberations, the Committee also considers the views of the Group Chairman, the Group Chief Executive, the Group Human Resources Director and the Group Reward and Performance Director. The Group Finance Director and the Group Chief Risk Officer provide regular updates on Group and business financial performance and risk profiles, respectively. The Head of Corporate Communications attended when requested to advise on reward communications and disclosures. The Group General Counsel and Company Secretary advised on legal and governance-related matters.
No Barclays employee or Director participates in discussions with, or decisions of, the Committee relating to his or her own remuneration. No other advisers provided services to the Committee in the year.
Committee effectiveness in 2021
The 2021 Committee effectiveness review was externally facilitated, as required by the Code. The review is an important part of the way Barclays monitors and improves Committee performance and effectiveness, maximising strengths and highlighting areas for further development.
The Board appointed Christopher Saul Associates (CSA) to facilitate the review. As part of its review, CSA conducted one-on-one interviews with each member of the Committee and the Group Human Resources Director. CSA also observed the November 2021 Committee meeting.
Feedback from the review confirms that the Committee is operating effectively, with constructive engagement with management and appropriate challenge observed in meetings, coupled with balanced contributions from Committee members during meetings. Feedback also highlights that the Committee is able to make important decisions at pace. In addition, feedback noted that consideration was still being given to adding an additional member to the Committee in light of Crawford Gillies having stepped down in February 2021.
Committee activity in 2021
The following provides a summary of the Committee’s activity during 2021 and at the January and February 2022 meetings at which 2021 remuneration decisions were finalised. The Committee is also provided with updates at each scheduled meeting on: operation of the Committee’s Control Framework on hiring, retention and termination, headcount and employee attrition, and extant LTIP performance.
January 2021February 2021June
2021
November 2021December 2021January 2022February 2022
Overall remunerationFinance and Risk updates
Incentive funding proposals including risk adjustments
2020 Remuneration Report
Group Fixed Pay budgets
Wider workforce considerations
Incentive funding approach
Barclays’ Fair Pay agenda and Report
2021 Remuneration Report
Executive Directors’ and senior executives’ remunerationExecutive Directors’ and senior executives’ bonus outcomes
Annual bonus and LTIP performance measures and target calibration
GovernanceRegulatory and stakeholder matters
Discussion with independent adviser
Remuneration Review Panel update
Review of Committee effectiveness
There were two additional Committee meetings, one each in April and October 2021, the first to consider remuneration for a number of senior positions and the second to consider the remuneration aspects related to the Group Chief Executive succession.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
91


Our people and culture
We want to recruit, retain and engage the talented people that Barclays needs to succeed, providing an environment that enables them to build their careers and achievements.
A culture of
togetherness
Our colleagues are critical to our success. We know that the past two years have been challenging for a lot of our people, in different ways, impacting both our personal and professional lives. We are proud of the way colleagues responded to these challenges, and for the way they have continued to support our customers and clients around the world. We have learnt a lot about ourselves over this period, and we have invested in supporting people in a number of ways. In particular, our focus has been on culture, mindset, wellbeing and development. As ever, our approach is informed by the latest thinking in behavioural and data science, and our ability to track effectiveness and progress over time.
Measuring
where we are
Colleague engagement
82%
2020: 83%
Females at Managing Director and Director level
28%
2020: 26%
“I would recommend Barclays as a good place to work”
83%
2020: 87%
“I believe that my team and I do a good job of role modelling Values every day”
92%
2020: 94%
“I believe my team and I do a good job of role modelling our Mindset every day”
September 2021:
89%
April 2021: 88%
The Barclays Mindset
At the beginning of the COVID-19 pandemic, we observed a number of improvements in the way people were working at Barclays. We reflected on how we could capture these positive developments for the long term and responded this year by launching the Barclays Mindset.
Our Mindset acts as an operating manual for how to get things done at Barclays. It focuses on three key elements that are core to our success – Empower, Challenge and Drive. Our research shows that when we demonstrate behaviours aligned to these three elements, outcomes are better, colleagues are more engaged and they are more likely to stay longer to build their career at Barclays.
We have worked hard to encourage this new way of thinking across our organisation, including in the way we hire people, manage performance and recognise success. We have established a global network of over 330 Mindset Champions, working to support its rollout and communicate with colleagues. We have also developed a Mindset Dashboard to measure impact and to help leaders identify where we need to do more to embed this way of thinking.
Initial findings suggest our Mindset resonates with colleagues, with 83% telling us they believe it is the right Mindset to drive success at Barclays, and 89% of colleagues saying they believe their teams do a good job of role modelling our Mindset every day.
Hiring great people
We are focused on hiring people with the skills and capabilities to support our strategy. At the heart of our hiring approach is a focus on strengthening our relationships with local talent pools in the areas within which we are hiring, including reaching out to local communities and upskilling local students. For example, our partnerships with universities in Glasgow have been important in developing a robust pipeline of apprentices and graduates at the global campus we officially opened there this year. Our other global campuses in Whippany and Pune leverage similar local hiring arrangements.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
92

Our people and culture continued
The COVID-19 pandemic has required us to adapt to changes in hiring demands and volumes. This has been particularly important in customer-facing areas where we know it is critical that we are providing support to our customers. We have also taken steps to enhance our candidate assessment processes, including factoring in the new Barclays Mindset so we can ensure we're attracting and hiring candidates with the capability to Empower, Challenge and Drive.
People with different perspectives and life experiences make our organisation stronger, so we are committed to attracting, developing and retaining a workforce that is as diverse and inclusive as possible. We are an equal opportunities employer and give full and fair consideration to all populations based on their competencies, strengths and potential. You can find more information in our Diversity and Inclusion Report at home.barclays/annualreport.
We retain an emphasis on hiring from within. This year, we filled 39% of vacancies internally and added a further 851 graduates to our internal pipeline of future leaders. We also continue to invest in our flagship career development programmes, including our AFTER programme to support those who have been in the armed forces. After a period of in-depth research, we launched new global programmes this year, managing 2,039 graduates, interns and apprentices.
Our Glasgow campus
Our Glasgow campus is a 500,000 square foot site on the banks of the river Clyde. This is a brownfield area transformed into a new city centre park and is the first Barclays campus to implement a zero waste strategy.
The campus will house Technology, Operations, and Functions teams – bringing new high-value roles to the city. Barclays has grown its workforce in Glasgow by over 90% in the last four years and is on track to have around 5,000 employees on campus by 2023.
One of the top priorities while developing the site was to create a world class accessible workspace. We wanted to create a welcoming, inclusive environment for people with physical, cognitive and sensory disabilities, incorporating design for neurodiversity and including people on the autism spectrum. The project team commissioned accessible design specialists, Motionspot, and embarked upon a two-year partnership with Scottish Autism to ensure they met this crucial objective.
As the world of work transforms in the wake of the pandemic, the Glasgow campus will enable a hybrid approach to office working, striking the right balance between collaboration and flexibility.
Beyond the highly-skilled new roles being created within Barclays, the campus is rooted in the local community and economy, with a focus on using local suppliers and contractors wherever possible.
This is the latest step in Barclays’ global location strategy which is focused on bringing teams closer together to drive innovation and collaboration.
Developing people for the future
At Barclays, we believe that everyone has the potential to continuously grow. We are committed to cultivating a culture of lifelong learning and our development proposition is designed to support colleagues at every stage of their career.
A wide range of development opportunities are available to help colleagues build their careers, delivered through our digital learning platform, Learning Lab.
This year we launched a new partnership with LinkedIn Learning, providing extensive digital development to all colleagues globally. We also have a number of corporate memberships with industry experts, allowing our colleagues to remain up to date with the latest developments and trends. In line with our professional qualification guidance, Barclays encourages colleagues to study for degree programmes and professional qualifications that benefit the business and support their development.
We are also committed to cultivating leadership skills among colleagues, whether they are in a leadership role or not. The Barclays Leadership Framework provides a guide to support colleagues with their own leadership development, and applies across all levels – from new line managers to our Group Executive Committee. We also continue to operate three flagship leadership development programmes: our Enterprise Leaders Summit, our Strategic Leaders Programme and Aspire.
We measure the success of our development offering through our colleague surveys, Your View and Here to Listen, tracking the progression of participants from our leadership development programmes, as well as tracking our levels of retention, and internal mobility. These measures feed into our training and development approach, enabling us to focus action on the right areas for our workforce.
Notes
a     With the appointment of Robert Berry (effective 8 February 2022), the percentage of females on the BPLC Board of Directors decreased to 31%. You can read more about gender diversity on the Board in the report of the Board Nominations Committee on page 15.
bcs-20211231_g16.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
93

Our people and culture continued
Highlights
Graduate hires
851
2020: 961
Average training days per annum per employee (payroll)
2
2020: 1.7
Average training hours per annum per employee (payroll)
15
2020: 13
Voluntary employee turnover
11%
2020: 6%
Employee turnover
14%
2020: 9%
We promote a culture of continuous feedback, encouraging all colleagues to have regular performance conversations with their line manager throughout the year. This happens in addition to the annual performance review process that applies to all permanent employees. In these conversations, both ‘what’ has been achieved as well as ‘how’ it has been achieved are reviewed. This ensures our colleagues are able to keep broadening their skills, emphasising their personal development and working in a way that reflects our Values and Mindset.
We also want to help colleagues balance their work life with their personal commitments, supporting career development opportunities at each life stage. We offer enhanced maternity, paternity, adoption and shared parental entitlements in all our major jurisdictions.
NOTE:
Under the Companies Act 2006 (the 'Companies Act'), Barclays is required to report on the gender breakdown of our employees, ‘senior managers’, and the Board of Barclays PLC's Directors. The Group’s global workforce was 88,565 (48,453 male, 40,058 female, 54 unavailable), with 434 senior managers (342 male, 92 female), and the Board of Barclays PLC had 12 directors (8 male, 4 female) as at 31 December 2021. This is on a headcount basis, including colleagues on long-term leave. Unavailable refers to colleagues who do not record their gender in our systems. The ‘male’ and ‘female’ gender splits disclosed in this paragraph are based on Companies Act disclosure requirements and numbers are taken from our employee records which are maintained pursuant to applicable rules and regulations on employee record keeping. For further information on the Group’s approach to building a more inclusive company, including a broader range of gender data and characteristics please see our voluntary disclosures included in our Diversity & Inclusion report, published on our website at home.barclays/annualreport. ‘Senior managers’ is defined by the Companies Act, and is different to both our Senior Managers under the FCA and PRA Senior Managers regime, and our Director and Managing Director corporate grades. It includes Barclays PLC Group Executive Committee members, their direct reports and directors on the boards of undertakings of the Group, but excludes Directors on the Board of Barclays PLC. Where such persons hold multiple directorships across the Group they are only counted once. The definition of 'senior managers' within this disclosure has a narrower scope than the Managing Director and Director female representation data provided.
Building a supportive and inclusive culture
Building a supportive and inclusive culture is not only the right thing to do, but also what is best for our business. It creates a sense of belonging and enables colleagues to perform to their highest capability.
We focus on six areas of diversity and inclusion: disability, gender, LGBT+, multicultural, multigenerational and socioeconomic inclusion. We have Employee Resource Groups in place across each of these areas to provide support and advice, create development opportunities and raise awareness of issues and challenges. Membership of our Employee Resource Groups is at an all-time high, with over 25,000 colleagues now involved in one or more. Their insight and experiences help influence our people policies and inform the commitments and actions we take as an organisation to give our people the support they need to succeed.
We strive to embed a culture of inclusion through our allyship initiatives, encouraging colleagues to become allies and to focus on understanding and eliminating barriers faced by underrepresented groups. We provide a toolkit for these colleagues to help them take conscious, positive steps to make everyone feel that they belong. In our Your View survey, 79% of colleagues told us they believe we are all in this together at Barclays, while 82% say they believe leaders are committed to building a diverse workforce.
We remain committed to improving the diversity of our leaders and to closing pay gaps at Barclays. We aim for diverse promotion assessors and panels, helping us to ensure the widest available pool of talent is considered for promotion. We actively provide development opportunities for leaders of the future such as ex-officio roles and places on our development programmes. As of the end of 2021, 28% of our global Managing Directors and Directors were female, and 30% of our UK Managing Directors and Directors were female.
bcs-20211231_g17.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
94

Our people and culture continued
bcs-20211231_g18.jpg
Digital Unleashed
Digital Unleashed is Barclays flagship digital and technology speaker series, open to every colleague in the bank. It is delivered virtually and in partnership with a network of internal and external industry thought leaders, and is sponsored by our global senior leadership. The event is designed to empower colleagues to build their digital skills and to help drive a culture of innovation. In 2021, the event combined 11 live sessions, with a range of podcasts and curated online learning resources, delivering a fully rounded learning experience for colleagues. Over 2,000 colleagues attended one or more of the live events, with more watching mobile enabled replays and accessing content through our digital learning platform, Learning Lab.
We closely track the ever-changing composition of our people through online dashboards that make sure our senior leaders understand the diverse makeup and needs of the organisation they lead. Our Inclusion Index, launched in 2020, continues to allow us to measure colleagues’ experience of how inclusive the Barclays culture is and gives us a benchmark for monitoring progress year on year. Our overall Inclusion Index score for 2021 is 79%, up from 76% last year. 88% of colleagues say they feel included in their team.
Through our Race at Work Action Plan, we are working to close the gaps in the UK and US where some ethnicities are significantly underrepresented at Barclays. We are focusing our efforts across four areas: increasing the number of underrepresented minority employees we hire; providing access to career and development opportunities; creating a culture of allyship across the organisation; and being transparent and measuring our outcomes, allowing us to see the impact our actions are having over time.
In the UK, we aim to increase the number of underrepresented minority employees by 25% by the end of 2025. This will take us to 5% overall. In the US, we aim to increase the number of underrepresented minority employees by 20% by the end of 2025. This will take us to 21% overall. In the UK and the US, we aim to at least double the number of Black employees at Managing Director and Director level by the end of 2022, which we are on track to meet.
This year, we continued to review the provision of Workplace Adjustments for colleagues with disabilities to further our strategy for a more globally consistent and supportive experience. We encourage managers to check in regularly with their teams and to emphasise the importance of safe working and appropriate workstation setup. As part of the UK Government Disability Confident scheme, we encourage applications from people with a disability, or a physical or mental health condition. We require managers to give full and fair consideration to those with a disability on the basis of strengths, potential and ability, both when hiring and managing. We also ensure opportunities for training, career development and promotion are available to all.
Mental health and wellbeing continues to be a major focus, with 88% of colleagues telling us their manager supports their efforts to maintain wellbeing. Through our Be Well programme, we continue to provide expert advice and guidance on the practical steps colleagues can take to look after their physical and mental health. In 2021, we focused on three key areas in particular: a continued commitment to make Barclays a ‘mental health confident’ organisation, further development of our supportive culture and a renewed emphasis on sustainable working.
This year, we launched a new Wellbeing Index, with a starting score of 84%, giving us a metric for measuring the wellbeing of colleagues and informing the Be Well programme. We are very pleased to see colleagues’ ability to balance their personal and work demands has improved from 78% in 2020 to 83% in 2021. In time, it will mean we can better understand the impact of particular activities on colleagues wellbeing and continue to evolve the Be Well programme offering.
We continue to promote our wellbeing offerings, including the global Be Well portal, with 43% of colleagues registered. Throughout the year, we executed leader-led campaigns to offer practical guidance on looking after physical and mental health, enhancing wellbeing and resilience and a continued focus on safe working. We also focused on stress manageability through ongoing campaigns, and the promotion of Health and Wellbeing workshops. We launched Developing our supportive culture e-learning with 89% completion. We were one of the first businesses to sign up to the Mental Health at Work Commitment and we continue to deploy Mental Health Awareness as required e-learning.
You can find more information in our Diversity & Inclusion Report available at home.barclays/annualreport
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
95

Our people and culture continued
bcs-20211231_g19.jpg
Beyond the pandemic
We continue to follow government guidance relating to COVID-19 in all the jurisdictions we operate in, taking a prudent and considered approach to return to office that prioritises the health, safety and wellbeing of colleagues.
Where possible, and in line with local government guidance, we have undertaken a programme to gradually increase the number of colleagues returning to working in the office at least some of the time.
Throughout the pandemic, we have kept our buildings operating safely for key workers by maintaining health and safety measures. In advance of colleagues returning, we risk-assessed all our buildings and provided training to colleagues on the safety measures that would be in place as they returned. We continue to evaluate and adjust these measures in accordance with government guidance and the latest epidemiology.
In the early stages of the pandemic, Barclays put in place a set of global principles to ensure we were doing as much as possible to support our colleagues. We have kept these principles in place and evolved them with the changing nature of the pandemic. The principles and provisions have helped colleagues cope with some of the personal challenges the pandemic has created, including offering additional paid leave to support self-quarantine, isolation, vaccination, sickness or care for dependants and advice made available to help support physical and mental health. Colleagues who have returned to on-site working did so on a voluntary basis and we have worked closely with any colleagues who have concerns about returning, to understand those concerns and support them.
We are also thinking carefully about the future of work at Barclays. We want to balance the best of the past with the best of what we have proved possible during the pandemic. We have adopted the principle that the optimal physical location for a role is largely determined by the nature and requirements of that role. At the same time, it is important to us that everyone at Barclays, no matter what their role, maintains a strong connection to their colleagues at a Barclays site.
In support of our approach to future ways of working, we have revised and relaunched our principles, process and guidance on Working Flexibly. At Barclays, we encourage colleagues to work flexibly to balance and integrate their work and other life commitments, enhance their wellbeing and effectiveness at work and feel included, irrespective of personal circumstances. We have expanded the opportunity for many colleagues to work in a hybrid pattern, spending part of their time working from a Barclays site and part of their time working from home. Over the course of the year, colleagues have begun to transition to this new, hybrid way of working. We are taking a test and learn approach, and ways of working will continue to iterate into 2022 as we focus on balancing the benefits of working on site with more flexible solutions.
bcs-20211231_g20.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
96

Our people and culture continued
Listening to colleagues and keeping
them informed
We think colleague engagement should be a two-way exercise, with equal weight placed on listening to our people and on keeping them informed. We want to be able to consider our colleagues’ perspective when we make decisions, including at the most senior level.
Our Your View survey is the primary mechanism for how we track engagement and monitor our culture. In addition, this year we continued to run regular Here to Listen surveys, first launched in 2020, to make sure we're staying abreast of colleague feedback during the COVID-19 pandemic. Results from these regular surveys are shared directly with leadership, so action can be taken to continue to provide the appropriate support for colleagues.
The results from our surveys are also an important part of the conversations our Board and Executive Committee have about our culture and how we run Barclays. These survey results help our Board and Executive Committee take into account our colleagues' views in their decision-making. We update the Board and its relevant sub-committees throughout the year and in addition, our leaders engage regularly with colleagues to hear what they think, visiting branches, trading floors and offices as well as hosting virtual forums. Direct engagement, a comprehensive reporting approach and dedicated time at Board meetings, enables the Board to determine that our workforce engagement approach is effective. We make sure we are keeping everyone up to date on the strategy, performance and progress of the organisation, through a combination of leader-led engagement, digital and print communication, blogs, vlogs and podcasts.
Our people are also encouraged to seek the views of colleagues with different perspectives and experiences via a series of monthly events and podcasts called Courageous Conversations that provides a platform for meaningful conversations on diversity, equity and inclusion topics.
We engage with our people collectively through a strong and effective partnership with Unite, as well as the Barclays Group European Forum, representing colleagues within the European Union, and other colleague forums. We regularly brief our union partners on the strategy and progress of the business, seeking their input on ways in which we can improve the colleague experience of working for Barclays. The collective bargaining coverage of Unite in the UK represents 84% of our UK workforce and 48% of our global workforce. We consult in detail with colleague representatives on major change programmes affecting our people. We do this to help us minimise compulsory job losses, including through voluntary redundancy and redeployment, with a focus on reskilling.
We maintain an engagement approach that is in line with the UK’s Financial Reporting Council (FRC) governance recommendations. This extends to those who work for us indirectly as well, such as contractors. As of 2021, the Barclays Third Party Supplier Code of Conduct states that all third parties with greater than 250 employees must demonstrate through annual reporting that effective workforce engagement mechanisms are in place to provide channels for the workforce to share ideas and concerns with senior management and the board.
Our policies
Our people policies are designed to recruit the best people, provide equal opportunities and create an inclusive culture, in line with our Values and in support of our long-term success. They also reflect relevant employment law, including the provisions of the Universal Declaration of Human Rights and International Labour Organisation (ILO) Declaration on the Fundamental Principles and Rights at Work.
We expect our people to treat each other with dignity and respect, and do not tolerate discrimination, bullying, harassment or victimisation on any grounds.
We are committed to paying our people fairly and appropriately relative to their role, skills, experience and performance – in a way that balances the needs of all our stakeholders. That means our remuneration policies reward sustainable performance that is in line with our Purpose and Values, as well as our risk expectations.
You can find more information in our Fair Pay Report at home.barclays/annualreport
We encourage our people to benefit from Barclays’ performance by enrolling in our share ownership plans, further strengthening their commitment to the organisation.
You can find out more information in the Directors’ Remuneration Report in this Report.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
97


Risk review
The management of risk is a critical underpinning to the execution of Barclays’ strategy. The material risks and uncertainties the Group faces across its business and portfolios are key areas of management focus.
Annual ReportPillar 3 Report
Risk management strategy
Enterprise Risk Management Framework (ERMF)
100150
Overview of Barclays’ approach to risk management. A detailed overview together with more specific information on policies that the Group determines to be of particular significance in the current operating environment can be found in the Barclays PLC Pillar 3 Report 2021 or at barclays.com
Segregation of duties – the ‘Three Lines of Defence’ model
100150
Principal risks
101151
Risk appetite for the principal risks
101151
Risk committees
101152
Frameworks, policies and standards
n/a153
Assurance
n/a153
Effectiveness of risk management arrangements
n/a153
Learning from our mistakes
n/a154
Barclays’ risk culture
101154
Group-wide risk management tools
n/a154
Risk management in the setting of strategy
n/a158
Material existing and emerging risks
Material existing and emerging risks potentially impacting more than one principal risk
102n/a
Insight into the level of risk across our business and portfolios, the material existing and emerging risks and uncertainties we face and the key areas of management focus.
Climate risk
106n/a
Credit risk
107n/a
Market risk
108n/a
Treasury and capital risk
108n/a
Operational risk
109n/a
Model risk
111n/a
Conduct risk
112n/a
Reputation risk
112n/a
Legal risk and legal, competition and regulatory matters
113n/a
Principal risk management
Climate risk management
114n/a
Barclays’ approach to risk management for each principal risk with focus on organisation and structure and roles and responsibilities.
Credit risk management
116159
Management of credit risk mitigation techniques and counterparty credit risk
n/a177
Market risk management
117180
Management of securitisation exposures
n/a189
Treasury and capital risk management
118193
Operational risk management
119201
Model risk management
120205
Conduct risk management
121208
Reputation risk management
121210
Legal risk management
121212
Risk performance
Credit risk overview and summary of performance
123n/a
Credit risk: The risk of loss to the Group from the failure of clients, customers or counterparties, including sovereigns, to fully honour their obligations to the Group, including the whole and timely payment of principal, interest, collateral and other receivables.
Maximum exposure and effects of netting, collateral and risk transfer
123n/a
Expected Credit Losses
126n/a
Movements in gross exposure and impairment allowance including provisions for loan commitments and financial guarantees
130n/a
Management adjustments to models for impairment
135n/a
Measurement uncertainty and sensitivity analysis
137n/a
Analysis of the concentration of credit risk
146n/a
The Group’s approach to management and representation of credit quality
148n/a
Analysis of specific portfolios and asset types
152n/a
Forbearance
155n/a
Analysis of debt securities
157n/a
Analysis of derivatives
158n/a
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
98


Annual ReportPillar 3 Report
Market risk: The risk of loss arising from potential adverse changes in the value of the Group’s assets and liabilities from fluctuation in market variables including, but not limited to, interest rates, foreign exchange, equity prices, commodity prices, credit spreads, implied volatilities and asset correlations.
Market risk overview and summary of performance
159125
Balance sheet view of trading and banking books
n/a126
Review of management measures
159127
Review of regulatory measures
n/a128
Treasury and capital risk – Liquidity: The risk that the Group is unable to meet its contractual or contingent obligations or that it does not have the appropriate amount, tenor and composition of funding and liquidity to support its assets.
Liquidity risk overview and summary of performance
161n/a
Liquidity risk stress testing
163n/a
Liquidity pool
165n/a
Funding structure and funding relationships
166n/a
Contractual maturity of financial assets and liabilities
169n/a
Asset encumbrance
n/a221
Treasury and capital risk – Capital: The risk that the Group has an insufficient level or composition of capital to support its normal business activities and to meet its regulatory capital requirements under normal operating environments and stressed conditions (both actual and as defined for internal planning or regulatory testing purposes). This also includes the risk from the Group’s pension plans.
Capital risk overview and summary of performance
173n/a
Regulatory minimum capital and leverage requirements
1738
Analysis of capital resources
17417
Analysis of risk-weighted assets
17625
Analysis of leverage ratio and exposures
17730
Minimum requirement for own funds and eligible liabilities
178n/a
Foreign exchange risk
17941
Pension risk review
18042
Treasury and capital risk – Interest rate risk in the banking book: The risk that the Group is exposed to capital or income volatility because of a mismatch between the interest rate exposures of its (non-traded) assets and liabilities.
Interest rate risk in the banking book overview and summary of performance
18243
Net interest income sensitivity
18243
Analysis of equity sensitivity
18344
Volatility of the fair value through other comprehensive income (FVOCI) portfolio in the liquidity pool
18344
Operational risk: The risk of loss to the Group from inadequate or failed processes or systems, human factors or due to external events (for example, fraud) where the root cause is not due to credit or market risks.
Operational risk overview and summary of performance
184145
Operational risk profile
184147
Model risk: The potential for adverse consequences from decisions based on incorrect or misused model outputs and reports.
Model risk overview and summary of performance
186n/a
Conduct risk: The risk of poor outcomes for, or harm to, customers, clients and markets, arising from the delivery of the Group’s products and services.
Conduct risk overview and summary of performance
186n/a
Reputation risk: The risk that an action, transaction, investment, event, decision, or business relationship will reduce trust in the Group’s integrity and/or competence.
Reputation risk overview and summary of performance
186n/a
Legal risk: The risk of loss or imposition of penalties, damages or fines from the failure of the Group to meet its legal obligations, including regulatory or contractual requirements.
Legal risk overview and summary of performance
186n/a
Supervision and regulation
Supervision of the Group
187n/a
The Group’s operations, including its overseas offices, subsidiaries and associates, are subject to a significant body of rules and regulations.
Global regulatory developments
187n/a
Financial regulatory framework
188n/a
Pillar 3 Report
Notes on basis of preparation
n/a5
Contains extensive information on risk as well as capital management.
Scope of application of Basel rules
n/a6
Risk and capital position review: Provides a detailed breakdown of Barclays’ regulatory capital adequacy and how this relates to Barclays’ risk management.
Group capital resources, requirements, leverage and liquidity
n/a15
Analysis of credit risk
n/a46
Analysis of counterparty credit risk
n/a109
Analysis of market risk
n/a125
Analysis of securitisation exposures
n/a132
Analysis of operational risk
n/a145
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
99


Risk review
Risk management
Barclays’ risk management strategy
This section introduces the Group’s approach to managing and identifying risks, and for fostering a strong risk culture.
Enterprise Risk Management Framework (ERMF)
The ERMF outlines the highest level principles for risk management by setting out standards, objectives and key responsibilities of different groups of employees of the Group.
It is then approved by the Barclays PLC Board on recommendation of the Group Board Risk Committee and the Group Chief Risk Officer.
The ERMF sets out:
principal risks faced by the Group which guides the organisation of the risk management function
risk appetite requirements. This helps define the level of risk we are willing to undertake in our business
Risk Management and Segregation of duties: The ERMF defines a Three Lines of Defence model
Roles and responsibilities for key risk management and governance structure: The accountabilities of the Group CEO, Group CRO and other senior managers, as well as overview of Barclays PLC committees.
The ERMF is complemented by frameworks, policies and standards which are mainly aligned to individual principal risks:
frameworks cover the management processes for a collection of related activities and define the associated policies used to govern them
policies set out principles, control objectives and other core requirements for the activities of the Group. Policies describe ‘what’ must be done
standards set out the key control requirements that describe 'how' the requirements set out in the policy are met.
Segregation of duties –
the ‘Three Lines of Defence’ model
The ERMF sets out a clear lines of defence model. All colleagues are responsible for understanding and managing risks within the context of their individual roles and responsibilities, as set out below.
The First line comprises all employees engaged in the revenue-generating and client-facing areas of the Group and all associated support functions, including Finance, Operations, Treasury, and Human Resources. The first line is responsible for identifying and managing the risks in which they are engaged in, developing a control framework, and escalating risk events to Risk and Compliance.
The Second line is comprised of the Risk and Compliance functions. The role of the second line is to establish the limits, rules and constraints, policies and standards under which first line activities shall be performed, consistent with the risk appetite of the Group, and to monitor the performance of the first line against these limits, rules and constraints. Controls for first line activities, especially those related to operational risk, will ordinarily be established by the control officers operating within the control framework of the firm. These will remain subject to supervision by the second line.
The Third line of defence is Internal Audit, who are responsible for providing independent assurance over the effectiveness of governance, risk management and control over current, systemic and evolving risks.
The Legal function provides support to all areas of the bank and is not formally part of any of the three lines, however, it is subject to second line oversight with respect to operational and conduct risks.

bcs-20211231_g21.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
100

Risk review
Risk management continued
Principal risks
The ERMF identifies nine principal risks namely: credit risk, market risk, treasury and capital risk, climate risk, operational risk, model risk, conduct risk, reputation risk and legal risk. Note that climate risk was added in January 2022; see page 114 for more information.
Each of the principal risks is overseen by an accountable executive within the Group who is responsible for the framework, policies and standards that set out associated responsibilities and expectations and detail the related requirements around risk management. In addition, certain risks span across more than one principal risk .
Risk appetite
Risk appetite is defined as the level of risk which the Group is prepared to accept in the conduct of their activities. It provides a basis for ongoing dialogue between management and Board with respect to the Group’s current and evolving risk profile, allowing strategic and financial decisions to be made on an informed basis.
Risk appetite is approved by the Barclays PLC Board in aggregate and disseminated across legal entities and businesses, supported by limits to enable and control specific exposures and activities that have material concentration risk implications.
Risk committees
Barclays product/risk type committees consider risk matters relevant to their business, and escalate as required to the Group Risk Committee (GRC), whose Chairman, in turn, escalates to the Barclays PLC Board Committees and the Barclays PLC Board.
In addition to setting the risk appetite of the Group, the Board is responsible for approving the ERMF, and reviewing all reputation risk matters. It receives regular information on the risk profile of the Group, and has ultimate responsibility for risk appetite and capital plans.
Further, there are two Board-level committees which oversee the application of the ERMF and implementation of key aspects, the Barclays PLC Board Risk Committee (BRC) and the Barclays PLC Board Audit Committee (BAC). Additionally, the Barclays PLC Board Remuneration Committee oversee pay practices focusing on aligning pay to sustainable performance.
The Barclays PLC Board Risk Committee (BRC): the BRC monitors the Group’s risk profile against the agreed appetite. Where actual performance differs from expectations, the actions taken by management are reviewed to ascertain that the BRC is comfortable with them. The BRC also reviews certain key risk methodologies, the effectiveness of risk management, and the Group’s risk profile, including the material issues affecting each business portfolio and forward risk trends. The committee also commissions in-depth analysis of significant risk topics, which are presented by the Group CRO or senior risk managers.
The Barclays PLC Board Audit Committee (BAC): the BAC receives regular reports on the effectiveness of internal control systems, quarterly reports on material control issues of significance, quarterly papers on accounting judgements (including impairment), and a quarterly review of the adequacy of impairment allowances, relative to the risk inherent in the portfolios, the business environment, and Barclays policies and methodologies.
The Barclays PLC Board Remuneration Committee (RemCo): the RemCo receives proposals on ex-ante and ex-post risk adjustments to variable remuneration based on risk management performance including events, issues and the wider risk profile. These inputs are considered in the setting of performance incentives.
The terms of reference and additional details on membership and activities for each of the principal Board committees are available from the corporate governance section of the Barclays website at: home.barclays/who-we-are/our-governance/board-committees/
The GRC is the most senior executive body responsible for reviewing and monitoring the risk profile of the Group. This includes coverage of all principal risks, and any other material risks, to which the Group is exposed. The GRC reviews and recommends the proposed risk appetite and relative limits to the BRC. The committee covers all business units and legal entities of the Group and incorporates specific coverage of Barclays Bank Group.
Barclays’ risk culture
Risk culture can be defined as the norms, attitudes and behaviours related to risk awareness, risk taking and risk management. This is reflected in how the Group identifies, escalates and manages risk matters.
Barclays is committed to maintaining a robust risk culture in which:
management expect, model and reward the right behaviours from a risk and control perspective
colleagues identify, manage and escalate risk and control matters, and meet their responsibilities around risk management.
The Group CEO works with the Executive Management to embed a strong risk culture within the firm, with particular regard to the identification, escalation and management of risk matters, in accordance with the ERMF. Specifically, all employees regardless of their positions, functions or locations must play their part in the Group’s risk management. Employees are required to be familiar with risk management policies which are relevant to their responsibilities, know how to escalate actual or potential risk issues, and have a role-appropriate level of awareness of the risk management process as defined by the ERMF.
Our Code of Conduct – the Barclays Way
Globally, all colleagues must attest to the ‘Barclays Way’, our Code of Conduct, and comply with all frameworks, policies and standards applicable to their roles. The Code of Conduct outlines the Purpose, Values and Mindset which govern our ‘Barclays Way’ of working across our business globally. It constitutes a reference point covering all aspects of colleagues’ working relationships, and provides guidance on working with other Barclays employees, customers and clients, governments and regulators, business partners, suppliers, competitors and the broader community.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
101


Risk review
Material existing and emerging risks
Material existing and emerging risks to the Group’s future performance
The Group has identified a broad range of risks to which its businesses are exposed. Material risks are those to which senior management pay particular attention and which could cause the delivery of the Group’s strategy, results of operations, financial condition and/or prospects to differ materially from expectations. Emerging risks are those which have unknown components, the impact of which could crystallise over a longer time period. In addition, certain other factors beyond the Group’s control, including escalation of terrorism or global conflicts, natural disasters, pandemics and similar events, although not detailed below, could have a similar impact on the Group.
Material existing and emerging risks potentially impacting more than one principal risk
i) Risks relating to the impact of COVID-19
The COVID-19 pandemic has had, and continues to have, a material impact on businesses around the world and the economic environments in which they operate. Additionally, the impacts of the economic downturn resulting from the COVID-19 pandemic and post-recovery environment, from a commercial, regulatory and risk perspective could be significantly different to past crises and persist for a prolonged period. As a result, there are a number of factors associated with the COVID-19 pandemic and its impact on global economies that have had and could continue to have a material adverse effect on the profitability, capital and liquidity of the Group.
The COVID-19 pandemic has caused disruption to the Group’s customers, suppliers and staff globally. Most jurisdictions in which the Group operates, implemented severe restrictions on the movement of their respective populations, with a resultant significant impact on economic activity in those jurisdictions. While a number of restrictions have been eased with the roll-out of COVID-19 vaccination programmes, others still remain in place and future developments are highly uncertain. In some jurisdictions, restrictions that had been previously lifted were re-imposed in response to a resurgence in cases. These decisions are being taken by the governments of individual jurisdictions (including through the implementation of emergency powers) and impacts (including any subsequent lifting, extension or reimposition of restrictions) may vary from jurisdiction to jurisdiction and/or within jurisdictions. It remains unclear how the COVID-19 pandemic will evolve through 2022 (including whether there will be further waves of the COVID-19 pandemic, whether COVID-19 vaccines continue to prove effective, whether further new strains of COVID-19 will emerge and whether, and in what manner, additional restrictions will be imposed and/or existing restrictions extended) and the Group continues to monitor the situation closely.
However, despite the COVID-19 contingency plans established by the Group, the ability to conduct business may be adversely affected by disruptions to infrastructure and supply chains, business processes and technology services, resulting from the unavailability of staff due to illness or the failure of third parties to supply services. This may cause significant customer detriment, costs to reimburse losses incurred by the Group’s customers, potential litigation costs (including regulatory fines, penalties and other sanctions), and reputational damage.
In many of the jurisdictions in which the Group operates, schemes were initiated by central banks, national governments and regulators to provide financial support to parts of the economy most impacted by the COVID-19 pandemic. The rapid introduction and varying nature of these support schemes, as well as customer expectations, required the Group to implement large-scale changes in a short period of time, leading to an increase in certain risks faced by the Group, including operational risk, conduct risk, reputation risk and fraud risk. These risks are likely to be heightened further as and when those government and other support schemes expire, are withdrawn or are no longer supported. Furthermore, the impact from participating in government and central bank-supported loan and other financing schemes may be exacerbated if the Group is required by any government or regulator to offer forbearance or additional financial relief to borrowers or if the Group is unable to rely on guarantees provided by governments in connection with financial support schemes.
As these schemes and other financial support schemes provided by national governments (such as job retention and furlough schemes, payment deferrals and mass lending schemes) expire, are withdrawn or are no longer supported, there is a risk that economic growth and employment may be negatively impacted which may, in turn, impact the Group’s results of operations and profitability. In addition, the Group may experience a higher volume of defaults and delinquencies in certain portfolios which may negatively impact the Group’s RWAs, level of impairment and, in turn, capital position, and may initiate collection and enforcement actions to recover defaulted debts. The inception of large-scale collections and recovery programmes (including the use of third party debt collection agents) may also create significant risk if (because of the complexity, speed and scale of these programmes) defaulting borrowers are harmed by the Group’s conduct, which may also give rise to civil legal proceedings, including class actions, regulatory censure, potentially significant fines and other sanctions, and reputational damage. Other legal disputes may also arise between the Group and defaulting borrowers relating to matters such as breaches or enforcement of legal rights or obligations arising under loan and other credit agreements. Adverse findings in any such matters may result in the Group’s rights not being enforced as intended.
Changes in macroeconomic variables such as gross domestic product (GDP) and unemployment have a significant impact on the modelling of expected credit losses (ECLs) by the Group. As a result, the Group experienced higher ECLs in 2020 compared to prior periods though this trend was reversed in 2021 as economic conditions partially recovered. The economic environment remains uncertain and future impairment charges may be subject to further volatility (including from changes to macroeconomic variable forecasts) depending on the longevity of the COVID-19 pandemic and related containment measures and the continued efficacy of any COVID-19 vaccines, as well as the longer- term effectiveness of central bank, government and other support measures. For further details on macroeconomic variables used in the calculation of ECLs, refer to the credit risk performance section. In addition, ECLs may be adversely impacted by increased levels of default for single name exposures in certain sectors directly impacted by the COVID-19 pandemic (such as the retail, airline, and hospitality and leisure sectors).
Furthermore, the Group relies on models to support a broad range of business and risk management activities, including informing business decisions and strategies, measuring and limiting risk, valuing exposures (including the calculation of impairment), conducting stress testing and assessing capital adequacy. Models are, by their nature, imperfect and incomplete representations of reality because they rely on assumptions and inputs, and so they may be subject to errors affecting the accuracy of their outputs and/or misused. This may be exacerbated when dealing with unprecedented scenarios, such as the COVID-19 pandemic, due to the lack of reliable historical reference points and data. For further details on model risk, refer to ‘vi) Model risk’ below.
There can be no assurance that economic activity will return to pre-pandemic levels and, accordingly, there could be further adverse impacts on the Group’s income and profitability caused by lower lending and transaction volumes due to volatility or weakness in the capital markets. Furthermore, in order to support lending activity to promote economic growth, governments and/or regulators may limit management’s flexibility in managing its business, require the deployment of capital in particular business lines or otherwise restrict or limit capital distributions and capital allocation.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
102

Risk review
Material existing and emerging risks continued
Any and all such events mentioned above could have a material adverse effect on the Group’s business, results of operations, financial condition, prospects, liquidity, capital position and credit ratings (including potential credit rating agency changes of outlooks or ratings), as well as on the Group’s customers, employees and suppliers.
ii) Business conditions, general economy and geopolitical issues
The Group’s operations are subject to potentially unfavourable global and local economic and market conditions, as well as geopolitical developments, which may have a material effect on the Group’s business, results of operations, financial condition and prospects.
A deterioration in global or local economic and market conditions may lead to (among other things): (i) deteriorating business, consumer or investor confidence and lower levels of fixed asset investment and productivity growth, which in turn may lead to lower client activity, including lower demand for borrowing from creditworthy customers; (ii) higher default rates, delinquencies, write-offs and impairment charges as borrowers struggle with the burden of additional debt; (iii) subdued asset prices and payment patterns, including the value of any collateral held by the Group; (iv) mark-to-market losses in trading portfolios resulting from changes in factors such as credit ratings, share prices and solvency of counterparties; and (v) revisions to calculated ECLs leading to increases in impairment allowances. In addition, the Group’s ability to borrow from other financial institutions or raise funding from external investors may be affected by deteriorating economic conditions and market disruption.
Geopolitical events may lead to further financial instability and affect economic growth. In particular:
Global GDP growth recovered in 2021 from the severe contraction in 2020 as a result of the COVID-19 pandemic. While government support packages, accommodative monetary policy and the lifting of certain restrictions on movement bolstered economic growth and confidence in 2021, the global outlook remains highly uncertain, especially regarding: (a) ongoing concerns about how the COVID-19 pandemic may develop; (b) the disruptive impact of the COVID-19 pandemic on supply chains; and (c) how long inflationary pressures will persist and whether central banks will succeed in normalising monetary policy. These factors could adversely affect economic growth, affect specific industries or countries or affect the Group’s employees and business operations in affected countries. Refer to 'i) Risks relating to the impact of COVID-19' above for further details.
In the UK, the UK Government's subsidised job retention and furlough schemes, which were implemented as a response to the COVID-19 pandemic, came to an end on 30 September 2021. Prior to the end of the job retention and furlough schemes, the UK labour market performed more favourably than initially predicted at the start of the COVID-19 pandemic, with low unemployment rates and the number of employees on UK company payrolls surpassing pre-pandemic levels. However, the end of the job retention and furlough schemes, exacerbated by further uncertainty arising from the impact of new strains of COVID-19 (including the Omicron variant), may cause upward pressure on unemployment which may result in higher impairment charges.
Recent increases in inflation have been partly driven by a rebalancing of supply and demand, following the relaxation of restrictions on movement that were imposed during the COVID-19 pandemic. Monetary policy remains highly accommodative, increasing the risk that more abrupt government action will be necessary later if inflation does not prove transitory. A prolonged period of rising inflation may develop into slow or stagnant economic growth if combined with slowing economic expansion and elevated unemployment. Inflation may be further driven by supply chain disruptions and labour shortages, the imposition of further restrictions on movement due to the failure to contain the spread of COVID-19 and structural changes in the UK economy after the UK's exit from the European Union.
A significant proportion of the Group’s portfolio is located in the US, including a major credit card portfolio and a range of corporate and investment banking exposures. The possibility of significant continued changes in US policy in certain sectors (including trade, healthcare and commodities) may have an impact on the Group’s associated portfolios. Stress in the US economy, weakening GDP and the associated exchange rate fluctuations, heightened trade tensions (such as between the US and China), an unexpected rise in unemployment and/or an increase in interest rates could lead to increased levels of impairment, which may have a material adverse effect on the Group's results of operations and profitability.
An escalation in geopolitical tensions or increased use of protectionist measures may have a material adverse effect on the Group’s business in the affected regions.
In China the pace of credit growth remains a concern, given the high level of leverage and despite government and regulatory action. A stronger than expected slowdown could result if authorities fail to manage growth appropriately during the transition from manufacturing towards services and the end of the investment and credit-led boom. Deterioration in emerging markets could have a material adverse effect on the Group's results of operations if contagion results in higher impairment charges via sovereign or counterparty defaults.
Trading disruption between the EU and the UK may have a significant impact on economic activity in the EU and the UK which, in turn, could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects. Unstable economic conditions could result in (among other things):
a recession in the UK and/or one or more member states of the EEA in which it operates, with lower growth, higher unemployment and falling property prices, which could lead to increased impairments in relation to a number of the Group’s portfolios (including, but not limited to, its UK mortgage portfolio, unsecured lending portfolio (including credit cards) and commercial real estate exposures)
increased market volatility (in particular in currencies and interest rates), which could impact the Group’s trading book positions and affect the underlying value of assets in the banking book and securities held by the Group for liquidity purposes
a credit rating downgrade for one or more members of the Group (either directly or indirectly as a result of a downgrade in the UK sovereign credit ratings), which could significantly increase the Group’s cost of and/or reduce its access to funding, widen credit spreads and materially adversely affect the Group’s interest margins and liquidity position and/or
a widening of credit spreads more generally or reduced investor appetite for the Group’s debt securities, which could negatively impact the Group’s cost of and/or access to funding.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
103

Risk review
Material existing and emerging risks continued
iii) The impact of interest rate changes on the Group’s profitability
Changes to interest rates are significant for the Group, especially given the uncertainty as to the direction of interest rates and the pace at which they may change, particularly in the Group’s main markets of the UK and the US.
A period of low interest rates and flat yield curves, including any rate cuts and/or negative interest rates, may affect and put pressure on the Group’s net interest margins (the difference between its lending income and borrowing costs) and could adversely affect the profitability and prospects of the Group.
Interest rate rises could positively impact the Group’s profitability as retail and corporate business income increases due to margin decompression. However, further increases in interest rates, if larger or more frequent than expected, could lead to generally weaker than expected growth, reduced business confidence and higher unemployment. This, combined with the impact interest rate rises may have on the affordability of loan arrangements for borrowers, could cause stress in the lending portfolio and underwriting activity of the Group with resultant higher credit losses driving an increased impairment charge which would most notably impact retail unsecured portfolios and wholesale non-investment grade lending and could have a material effect on the Group’s business, results of operations, financial condition and prospects.
In addition, changes in interest rates could have an adverse impact on the value of the securities held in the Group’s liquid asset portfolio. Consequently, this could create more volatility than expected through the Group’s Fair Value through Other Comprehensive Income (FVOCI) reserve.
iv) Competition in the banking and financial services industry
The Group operates in a highly competitive environment (in particular, in the UK and US) in which it must evolve and adapt to the significant changes as a result of financial regulatory reform, technological advances, increased public scrutiny and prevailing economic conditions. The Group expects that competition in the financial services industry will continue to be intense and may have a material adverse effect on the Group’s future business, results of operations, financial condition and prospects.
New competitors in the financial services industry continue to emerge. Technological advances and the growth of ecommerce have made it possible for non- banks to offer products and services that traditionally were banking products such as electronic securities trading, payments processing and online automated algorithmic-based investment advice. Furthermore, payments processing and other services could be significantly disrupted by technologies, such as blockchain (used in cryptocurrency systems) and 'buy now pay later' lending, both of which are currently subject to lower levels of regulatory oversight. Furthermore, the introduction of Central Bank Digital Currencies could potentially have significant impacts on the banking system and the role of commercial banks within it by disrupting the current provision of banking products and services. It could allow new competitors, some previously hindered by banking regulation (such as FinTechs), to provide customers with access to banking facilities and increase disintermediation of banking services.
New technologies have required and could require the Group to spend more to modify or adapt its products or make additional capital investments in its businesses to attract and retain clients and customers or to match products and services offered by its competitors, including technology companies.
Ongoing or increased competition and/or disintermediation of banking services may put pressure on the pricing for the Group’s products and services, which could reduce the Group’s revenues and profitability, or may cause the Group to lose market share, particularly with respect to traditional banking products such as deposits, bank accounts and mortgage lending. This competition may be on the basis of quality and variety of products and services offered, transaction execution, innovation, reputation and price. The failure of any of the Group’s businesses to meet the expectations of clients and customers, whether due to general market conditions, underperformance, a decision not to offer a particular product or service, changes in client and customer expectations or other factors, could affect the Group’s ability to attract or retain clients and customers. Any such impact could, in turn, reduce the Group’s revenues.
v) Regulatory change agenda and impact on business model
The Group remains subject to ongoing significant levels of regulatory change and scrutiny in many of the countries in which it operates (including, in particular, the UK and the US). As a result, regulatory risk will remain a focus for senior management. Furthermore, a more intensive regulatory approach and enhanced requirements together with the potential lack of international regulatory co-ordination as enhanced supervisory standards are developed and implemented may adversely affect the Group’s business, capital and risk management strategies and/or may result in the Group deciding to modify its legal entity, capital and funding structures and business mix, or to exit certain business activities altogether or not to expand in areas despite otherwise attractive potential.
There are several significant pieces of legislation and areas of focus which will require considerable management attention, cost and resource, including:
Changes in prudential requirements may impact minimum requirements for own funds and eligible liabilities (MREL) (including requirements for internal MREL), leverage, liquidity or funding requirements, applicable buffers and/or add-ons to such minimum requirements and risk weighted assets calculation methodologies all as may be set by international, EU or national authorities. This includes the upcoming implementation of the remaining Basel III reforms, as well as the expected incorporation of risks associated with climate change into the prudential framework and increased scrutiny of firms’ governance and risk management frameworks (including in respect of climate change and Environmental, Social and Governance ( ESG ) risks). Such or similar changes to prudential requirements or additional supervisory and prudential expectations, as well as requirements imposed by the Group's regulators under the resolution framework, either individually or in aggregate, may result in, among other things, a need for further management actions to meet the changed requirements, such as:
increasing capital, MREL or liquidity resources, reducing leverage and risk weighted assets
modifying the terms of outstanding capital instruments
modifying legal entity structure (including with regard to issuance and deployment of capital, MREL and funding)
changing the Group’s business mix or exiting other businesses and/or
undertaking other actions to strengthen the Group’s position or resolvability.
The derivatives market has been the subject of particular focus for regulators in recent years across the G20 countries and beyond, with regulations introduced which require the on-venue trading and clearing of standardised over the counter (OTC) derivatives and the mandatory margining of non-cleared OTC derivatives. These regulations may increase costs for market participants, as well as reduce liquidity in the derivatives markets, in particular, if there are areas of overlapping or conflicting regulation. More broadly, changes to the regulatory framework could entail significant costs for market participants and may have a significant impact on certain markets in which the Group operates.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
104

Risk review
Material existing and emerging risks continued
The Group and certain of its members are subject to supervisory stress testing exercises in a number of jurisdictions. These exercises currently include the programmes of the Bank of England, the European Banking Authority (EBA) and the Federal Reserve Board (FRB). Failure to meet the requirements of regulatory stress tests, or the failure by regulators to approve the stress test results and capital plans of the Group, could result in the Group or certain of its members being required to enhance their capital position, limit capital distributions or position additional capital in specific subsidiaries.
As a result of the on-shoring of EU legislation in the UK, UK-based entities within the Group are currently subject to substantially the same rules and regulations as prior to the UK’s withdrawal from the EU. It is the UK’s intention to recast on-shored EU legislation as part of UK legislation and PRA and FCA rules, which could result in changes to regulatory requirements in the UK. If the regulatory regimes for EU and UK financial services change further, the provision of cross-border banking and investment services across the Group may become more complex and costly which could have a material adverse effect on the Group’s business and results of operations and could result in the Group modifying its legal entity, capital and funding structures and business mix, exiting certain business activities altogether or not expanding in areas despite otherwise attractive potential returns. This may also be exacerbated if Barclays Bank Ireland PLC expands further and, as a result of its growth and importance to the Group and the EEA banking system as a whole, Barclays Bank Ireland PLC is made subject to higher capital requirements or restrictions are imposed by regulators, on capital allocation and capital distributions by Barclays Bank Ireland PLC.
For further details on the regulatory supervision of, and regulations applicable to, the Group, refer to the Supervision and regulation section.
vi) Impact of benchmark interest rate reforms on the Group
Global regulators and central banks in the UK, US and EU have been driving international efforts to reform key benchmark interest rates and indices, such as the London Interbank Offered Rate (LIBOR), which are used to determine the amounts payable under a wide range of transactions and make them more reliable and robust. These benchmark reforms have resulted in significant changes to the methodology and operation of certain benchmarks and indices, the adoption of alternative risk-free reference rates (RFRs), the discontinuation of certain reference rates (including LIBOR), and the introduction of implementing legislation and regulations. Specifically, regulators in the UK, US and EU directed that certain non-US dollar LIBOR tenors would cease at the end of 2021. Furthermore, certain US dollar LIBOR tenors are to cease by the end of June 2023, and restrictions have been imposed on new use of US dollar LIBOR. Notwithstanding these developments, given the unpredictable consequences of benchmark reform, any of these developments could have an adverse impact on market participants, including the Group, in respect of any financial instruments linked to, or referencing, any of these benchmark interest rates. Uncertainty associated with such potential changes, including the availability and/or suitability of alternative RFRs, the participation of customers and third party market participants in the transition process, challenges with respect to required documentation changes, and impact of legislation to deal with certain legacy contracts that cannot convert into or add fall-back RFRs before cessation of the benchmark they reference, may adversely affect a broad range of transactions (including any securities, loans and derivatives which use LIBOR or any other affected benchmark to determine the interest payable which are included in the Group’s financial assets and liabilities) that use these reference rates and indices, and present a number of risks for the Group, including but not limited to:
Conduct risk: in undertaking actions to transition away from using certain reference rates (such as LIBOR) to new alternative RFRs, the Group faces conduct risks. These may lead to customer complaints, regulatory sanctions or reputational impact if the Group is considered to be (among other things): (i) undertaking market activities that are manipulative or create a false or misleading impression; (ii) misusing sensitive information or not identifying or appropriately managing or mitigating conflicts of interest; (iii) providing customers with inadequate advice, misleading information, unsuitable products or unacceptable service; (iv) not taking a consistent approach to remediation for customers in similar circumstances; (v) unduly delaying the communication and migration activities in relation to client exposure, leaving them insufficient time to prepare; or (vi) colluding or inappropriately sharing information with competitors.
Litigation risk: members of the Group may face legal proceedings, regulatory investigations and/or other actions or proceedings regarding (among other things): (i) the conduct risks identified above, (ii) the interpretation and enforceability of provisions in LIBOR-based contracts, and (iii) the Group’s preparation and readiness for the replacement of LIBOR with alternative RFRs.
Financial risk: the valuation of certain of the Group’s financial assets and liabilities may change. Moreover, transitioning to alternative RFRs may impact the ability of members of the Group to calculate and model amounts receivable by them on certain financial assets and determine the amounts payable on certain financial liabilities (such as debt securities issued by them) because certain alternative RFRs (such as the Sterling Overnight Index Average (SONIA) and the Secured Overnight Financing Rate (SOFR)) are look-back rates whereas term rates (such as LIBOR) allow borrowers to calculate at the start of any interest period exactly how much is payable at the end of such interest period. This may have a material adverse effect on the Group’s cash flows.
Pricing risk: changes to existing reference rates and indices, discontinuation of any reference rate or indices and transition to alternative RFRs may impact the pricing mechanisms used by the Group on certain transactions.
Operational risk: changes to existing reference rates and indices, discontinuation of any reference rate or index and transition to alternative RFRs may require changes to the Group’s IT systems, trade reporting infrastructure, operational processes, and controls. In addition, if any reference rate or index (such as LIBOR) is no longer available to calculate amounts payable, the Group may incur additional expenses in amending documentation for new and existing transactions and/or effecting the transition from the original reference rate or index to a new reference rate or index.
Accounting risk: an inability to apply hedge accounting in accordance with IAS 39 could lead to increased volatility in the Group’s financial results and performance.
Any of these factors may have a material adverse effect on the Group’s business, results of operations, financial condition, prospects and reputation.
For further details on the impacts of benchmark interest rate reforms on the Group, refer to Note 41.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
105

Risk review
Material existing and emerging risks continued
vii) Change delivery and execution risks
The Group will need to adapt and/or transform the way it conducts business in response to changing customer behaviour and needs, technological developments, regulatory expectations, increased competition and cost management initiatives. Accordingly, effective management of transformation projects is required to successfully deliver the Group's strategic priorities, involving delivering both on externally driven programmes, as well as key business initiatives to deliver revenue growth, product enhancement and operational efficiency outcomes. The magnitude, complexity and, at times, concurrent demands of the projects required to meet these priorities can result in heightened execution risk.
The ability to execute the Group’s strategy may be limited by operational capacity and the increasing complexity of the regulatory environment in which the Group operates. In addition, whilst the Group continues to pursue cost management initiatives, they may not be as effective as expected and cost saving targets may not be met.
The failure to successfully deliver or achieve any of the expected benefits of these strategic initiatives and/or the failure to meet customer and stakeholder expectations could have a material adverse effect on the Group’s business, results of operations, financial condition, customer outcomes, prospects and reputation.
viii) Holding company structure of Barclays PLC and its dependency on distributions from its subsidiaries
Barclays PLC is a holding company and its principal sources of income are, and are expected to continue to be, distributions (in the form of dividends and interest payments) from operating subsidiaries which also hold the principal assets of the Group. As a separate legal entity, Barclays PLC relies on such distributions in order to be able to meet its obligations as they fall due (including its payment obligations with respect to its debt securities) and to create distributable reserves for payment of dividends to ordinary shareholders.
The ability of Barclays PLC’s subsidiaries to pay dividends and interest and Barclays PLC’s ability to receive such distributions from its investments in its subsidiaries and other entities will be subject not only to the financial performance of such subsidiaries and entities and prevailing macroeconomic conditions but also to applicable local laws, capital regulations (including internal MREL requirements) and other restrictions (including restrictions imposed by governments and/or regulators, which limit management’s flexibility in managing the business and taking action in relation to capital distributions and capital allocation). These laws and restrictions could limit the payment of dividends and distributions to Barclays PLC by its subsidiaries and any other entities in which it holds an investment from time to time, which could restrict Barclays PLC’s ability to meet its obligations and/or to pay dividends to ordinary shareholders.
ix) Application of resolution measures and stabilisation powers under the Banking Act
Under the Banking Act 2009, as amended (Banking Act), substantial powers are granted to the Bank of England (or, in certain circumstances, HM Treasury), in consultation with the PRA, the FCA and HM Treasury, as appropriate, as part of a special resolution regime (SRR). These powers enable the relevant UK resolution authority to implement resolution measures and stabilisation options with respect to a UK bank or investment firm and certain of its affiliates (currently including Barclays PLC) (each, a relevant entity) in circumstances in which the relevant UK resolution authority is satisfied that the resolution conditions are met.
The SRR consists of five stabilisation options: (i) private sector transfer of all or part of the business or shares of the relevant entity; (ii) transfer of all or part of the business of the relevant entity to a ‘bridge bank’ established by the Bank of England; (iii) transfer to an asset management vehicle wholly or partly owned by HM Treasury or the Bank of England; (iv) the cancellation, transfer or dilution of the relevant entities’ equity (including Barclays PLC’s ordinary share capital) and write-down or conversion of the relevant entity’s capital instruments and liabilities (the bail-in tool); and (v) temporary public ownership (i.e. nationalisation).
In addition, the relevant UK resolution authority may, in certain circumstances, in accordance with the Banking Act require the permanent write-down or conversion into equity of any outstanding Tier 1 capital instruments, Tier 2 capital instruments and internal MREL prior to, or together with, the exercise of any stabilisation option. Any such action could result in the dilution of Barclays PLC’s ordinary share capital, restrict Barclays PLC’s ability to meet its obligations and/or to pay dividends to ordinary shareholders.
Shareholders should assume that, in a resolution situation, public financial support will only be available to a relevant entity as a last resort after the relevant UK resolution authorities have assessed and used, to the maximum extent practicable, the resolution tools, including the bail-in tool (the Bank of England’s preferred approach for the resolution of the Group is a bail-in strategy with a single point of entry at Barclays PLC). The exercise of any of such powers under the Banking Act or any suggestion of any such exercise could materially adversely affect the value of Barclays PLC ordinary shares and could lead to shareholders losing some or all of their investment.
In addition, any safeguards within the Banking Act (such as the ‘no creditor worse off’ principle) may not result in compensation to shareholders that is equivalent to the full losses incurred by them in the resolution and there can be no assurance that shareholders would recover such compensation promptly.
Material existing and emerging risks impacting individual principal risks
i) Climate risk
The risks associated with climate change are subject to rapidly increasing societal, regulatory and political focus, both in the UK and internationally. Embedding climate risk into the Group’s risk framework in line with regulatory expectations and requirements, and adapting the Group’s operations and strategy to address the financial risks resulting from both: (i) the physical risk of climate change; and (ii) the risk from the transition to a low-carbon economy, could have a significant impact on the Group’s business, results of operations, financial condition and prospects, the Group's customers and clients and the creditworthiness of the Group's counterparties.
Physical risks from climate change arise from a number of factors and relate to specific weather events and longer-term shifts in the climate. The nature and timing of extreme weather events are uncertain but they are increasing in frequency and their impact on the economy is predicted to be more acute in the future.
The potential impact on the economy includes, but is not limited to, lower GDP growth, higher unemployment and significant changes in asset prices and profitability of industries. Damage to properties and operations of borrowers could impair asset values and the creditworthiness of customers leading to increased default rates, delinquencies, write-offs and impairment charges in the Group’s portfolios. In addition, the Group’s premises and resilience may also suffer physical damage due to weather events leading to increased costs for the Group.
As the economy transitions to a low-carbon economy, financial institutions such as the Group may face significant and rapid developments in stakeholder expectations, policy, law and regulation which could impact the lending activities the Group undertakes, as well as the risks associated with its lending portfolios, and the value of the Group’s financial assets. As sentiment towards climate change shifts and societal preferences change, the Group may face greater scrutiny of the type of business it conducts, adverse media coverage and reputational damage, which may in turn impact customer demand for the Group’s products, returns on certain business activities and the value of certain assets and trading positions resulting in impairment charges.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
106

Risk review
Material existing and emerging risks continued
In addition, the impacts of physical and transition climate risks can lead to second order connected risks, which have the potential to affect the Group’s retail and wholesale portfolios. The impacts of climate change may increase losses for those sectors sensitive to the effects of physical and transition risks. For example, the Group’s UK mortgage and agriculture portfolios are particularly exposed to both the physical and transition risks of climate change. The mortgage portfolio is affected by the risks of flooding, subsidence and energy efficiency performance requirements, all of which may impact property valuations, whilst the agriculture portfolio is exposed to flooding and drought, as well as the potential for legislative changes and changes in consumer behaviour. Furthermore, any subsequent increase in defaults and rising unemployment could create recessionary pressures, which may lead to wider deterioration in the creditworthiness of the Group’s clients, higher ECLs, and increased charge-offs and defaults among retail customers.
With effect from 1 January 2022, climate risk became one of the principal risks within the Group’s Enterprise Risk Management Framework. Failure to adequately embed risks associated with climate change into its risk framework to appropriately measure, manage and disclose the various financial and operational risks it faces as a result of climate change or failure to adapt the Group's strategy and business model to the changing regulatory requirements and market expectations on a timely basis, may have a material and adverse impact on the Group’s level of business growth, competitiveness, profitability, capital requirements, cost of funding, and financial condition.
In March 2020, the Group announced its ambition to become a net zero bank by 2050 and its commitment to align all of its financing activities with the goals and timelines of the Paris Agreement. In order to reach these ambitions and targets or any other climate-related ambitions or targets the Group may commit to in future, the Group will need to incorporate climate considerations into its strategy, business model, the products and services it provides to customers and its financial and non-financial risk management processes (including processes to measure and manage the various financial and non-financial risks the Group faces as a result of climate change). The Group also needs to ensure that its strategy and business model adapt to changing national and international standards, industry and scientific practices, regulatory requirements and market expectations regarding climate change, which remain under continuous development and are subject to different interpretations. There can be no assurance that these standards, practices, requirements and expectations will not be interpreted differently than what was the Group’s understanding when defining its climate-related ambitions and targets, or change in a manner that substantially increases the cost or effort for the Group to achieve such ambitions and targets. In addition, the Group’s ambitions and targets may prove to be considerably more difficult or even impossible to achieve under such changing circumstances. This may be exacerbated if the Group chooses or is required to accelerate its climate-related ambitions or targets as a result of (among other things) UK or international regulatory developments or stakeholder expectations. Achieving the Group’s climate-related ambitions and targets will also depend on a number of factors outside the Group’s control, including (among other things) availability of data to measure and assess the climate impact of the Group’s customers, advancements of low-carbon technologies and supportive public policies in the markets where the Group operates. If these external factors and other changes do not occur, or do not occur on a timely basis, the Group may fail to achieve its climate-related ambitions and targets and this could have a material adverse effect on the Group’s business, results of operations, financial condition, prospects and reputation.
For further details on the Group’s approach to climate change, refer to the climate change risk management section.
ii) Credit risk
Credit risk is the risk of loss to the Group from the failure of clients, customers or counterparties, including sovereigns, to fully honour their obligations to members of the Group, including the whole and timely payment of principal, interest, collateral and other receivables.
a) Impairment
Impairment is calculated in line with the requirements of IFRS9 which results in recognition of loss allowances, based on ECLs, on a forward-looking basis using a broad scope of financial instruments. Measurement involves complex judgement and impairment charges are potentially volatile, particularly under stressed conditions, which could have a material adverse effect on the Group's business, results of operations, financial condition and prospects.
For further details, refer to Note 7.
b) Specific sectors and concentrations
The Group is subject to risks arising from changes in credit quality and recovery rates of loans and advances due from borrowers and counterparties in any specific portfolio. Any deterioration in credit quality could lead to lower recoverability and higher impairment in a specific sector. The following are areas of uncertainties to the Group’s portfolio which could have a material impact on performance:
UK retail, hospitality and leisure: softening demand, rising costs and a structural shift to online shopping, which have been exacerbated due to restrictions imposed during the COVID-19 pandemic and changes in consumer behaviour, continue to pressurise the UK High Street and other sectors heavily reliant on consumer discretionary spending. As these sectors continue to reposition themselves, the trend represents a potential risk in the Group’s UK corporate portfolio as a higher probability of default exists for retailers, hospitality providers and their landlords while this transition takes place.
Consumer affordability: this has remained a key area of focus, particularly in unsecured lending. Macroeconomic factors, such as unemployment, higher interest rates or broader inflationary pressures, that impact a customer’s ability to service debt payments could lead to increased arrears in both unsecured and secured products.
UK real estate market: UK property represents a significant portion of the overall Group retail and corporate credit exposure. In 2021, property prices rose, particularly in the residential property market where customers took advantage of temporary changes in stamp duty rates or sought more space as home working became more prevalent during the COVID-19 pandemic. However, there can be no assurance that house price growth will continue in 2022. House price growth and fewer new high loan-to-value (LTV) mortgages in 2020 and the beginning of 2021 have diluted the Group’s high LTV stock to very low levels but there is potential for house prices to fall, especially in London and the South East of the UK where the Group has a high exposure. In addition, small segments of the housing market could be subject to specific valuation impacts (for example, certain properties within the Group's residential loan portfolio may be subject to remediation activities relating to fire safety standards). The Group’s corporate exposure is vulnerable to the impacts of the ongoing COVID-19 stress, with particular weakness in retail property as a result of reduced rent collections and residential development constrained by supply chain issues. The Group remains at risk of increased impairment from a material fall in property prices.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
107

Risk review
Material existing and emerging risks continued
Leverage finance underwriting: the Group takes on sub-investment grade underwriting exposure, including single name risk, particularly in the US and Europe. The Group is exposed to credit events and market volatility during the underwriting period. Any adverse events during this period may potentially result in loss for the Group, or an increased capital requirement should there be a need to hold the exposure for an extended period.
Oil & Gas sector: the Group’s corporate credit exposure includes companies whose performance is dependent on the oil and gas sector. Whilst market prices have recovered in 2021, a sustained period of lower energy prices in recent years has led to the erosion of balance sheet strength, particularly for higher cost producers and those businesses which supply goods and services to the oil and gas sector. In the longer term, costs associated with the transition towards renewable sources of energy may place greater financial demands on companies that the Group has exposure to globally. These factors could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects through increased impairment charges.
Air travel: the COVID-19 pandemic has caused a significant reduction in demand for air travel as both the willingness and ability to travel have reduced, impacting revenues of the Group’s clients and their ability to service their debt obligations. While the situation is expected to improve as travel restrictions are eased, changes in consumer behaviour both due to COVID-19 and climate change create uncertainty for the sector. Furthermore, the possibility of further global and regional pandemics pose additional risks for the sector.
The Group also has large individual exposures to single name counterparties, both in its lending activities and in its financial services and trading activities, including transactions in derivatives and transactions with brokers, central clearing houses, dealers, other banks, mutual and hedge funds and other institutional clients. The default of such counterparties could have a significant impact on the carrying value of these assets. In addition, where such counterparty risk has been mitigated by taking collateral, credit risk may remain high if the collateral held cannot be monetised, or has to be liquidated at prices which are insufficient to recover the full amount of the loan or derivative exposure. Any such defaults could have a material adverse effect on the Group’s results due to, for example, increased credit losses and higher impairment charges.
For further details on the Group’s approach to credit risk, refer to the credit risk management and credit risk performance sections.
iii) Market risk
Market risk is the risk of loss arising from potential adverse changes in the value of the Group’s assets and liabilities from fluctuation in market variables including, but not limited to, interest rates, foreign exchange, equity prices, commodity prices, credit spreads, implied volatilities and asset correlations.
Economic and financial market uncertainties remain elevated, as the path of the COVID-19 pandemic is inherently difficult to predict. Further waves of the COVID-19 pandemic, a disruptive adjustment to monetary policy normalisation, intensifying social unrest that weighs on market sentiment, and deteriorating trade and geopolitical tensions are some of the factors that could heighten market risks for the Group’s portfolios.
In addition, the Group’s trading business is generally exposed to a prolonged period of elevated asset price volatility, particularly if it adversely affects market liquidity. Such a scenario could impact the Group’s ability to execute client trades and may also result in lower client flow-driven income and/or market-based losses on its existing portfolio of market risks. These can include higher hedging costs from rebalancing risks that need to be managed dynamically as market levels and their associated volatilities change.
It is difficult to predict changes in market conditions, and such changes could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
For further details on the Group’s approach to market risk, refer to the market risk management and market risk performance sections.
iv) Treasury and capital risk
There are three primary types of treasury and capital risk faced by the Group:
a) Liquidity risk
Liquidity risk is the risk that the Group is unable to meet its contractual or contingent obligations or that it does not have the appropriate amount, tenor and composition of funding and liquidity to support its assets. This could cause the Group to fail to meet internal and/or regulatory liquidity requirements, make repayments as they fall due or be unable to support day-to-day banking activities. Key liquidity risks that the Group faces include:
Stability of the Group’s deposit funding profile: deposits which are payable on demand or at short notice could be affected by the Group failing to preserve the current level of customer and investor confidence.
Ongoing access to wholesale funding: the Group regularly accesses the money and capital markets to provide short-term and long-term unsecured and secured funding to support its operations. A loss of counterparty confidence, or adverse market conditions could lead to a reduction in the tenor, or an increase in the costs, of the Group’s unsecured and secured wholesale funding.
Impacts of market volatility: adverse market conditions, with increased volatility in asset prices can negatively impact the Group’s liquidity position through increased derivative margin requirements and/or wider haircuts when monetising liquidity pool securities, and make it more difficult to execute secured financing transactions.
Intraday liquidity usage: increased collateral requirements at payments and securities settlement systems could negatively impact the Group’s liquidity position, as cash and liquid assets required for intraday purposes are unavailable to meet other outflows.
Off-balance sheet commitments: deterioration in economic and market conditions could cause customers to draw on off-balance sheet commitments provided to them, for example revolving credit facilities, negatively affecting the Group’s liquidity position.
Credit rating changes and the impact on funding costs: any reductions in a credit rating (in particular, any downgrade below investment grade) may affect the Group’s access to the money or capital markets and/or terms on which the Group is able to obtain market funding (for example, this could lead to increased costs of funding and wider credit spreads, the triggering of additional collateral or other requirements in derivative contracts and other secured funding arrangements, or limits on the range of counterparties who are willing to enter into transactions with the Group).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
108

Risk review
Material existing and emerging risks continued
b) Capital risk
Capital risk is the risk that the Group has an insufficient level or composition of capital to support its normal business activities and to meet its regulatory capital requirements under normal operating environments and stressed conditions (both actual and as defined for internal planning or regulatory stress testing purposes). This also includes the risk from the Group’s pension plans. Key capital risks that the Group faces include:
Failure to meet prudential capital requirements: this could lead to the Group being unable to support some or all of its business activities, a failure to pass regulatory stress tests, increased cost of funding due to deterioration in investor appetite or credit ratings, restrictions on distributions including the ability to meet dividend targets, and/or the need to take additional measures to strengthen the Group’s capital or leverage position.
Adverse changes in FX rates impacting capital ratios: the Group has capital resources, risk weighted assets and leverage exposures denominated in foreign currencies. Changes in foreign currency exchange rates may adversely impact the sterling equivalent value of these items. As a result, the Group’s regulatory capital ratios are sensitive to foreign currency movements. Failure to appropriately manage the Group’s balance sheet to take account of foreign currency movements could result in an adverse impact on the Group’s regulatory capital and leverage ratios.
Adverse movements in the pension fund: adverse movements in pension assets and liabilities for defined benefit pension schemes could result in deficits on a technical provision and/or IAS 19 accounting basis. This could lead to the Group making substantial additional contributions to its pension plans and/or a deterioration in its capital position. Under IAS 19, the liabilities discount rate is derived from the yields of high-quality corporate bonds. Therefore, the valuation of the Group’s defined benefits schemes would be adversely affected by a prolonged fall in the discount rate due to a persistent low interest rate and/or credit spread environment. Inflation is another significant risk driver to the pension fund as the liabilities are adversely impacted by an increase in long-term inflation expectations.
c) Interest rate risk in the banking book
Interest rate risk in the banking book is the risk that the Group is exposed to capital or income volatility because of a mismatch between the interest rate exposures of its (non-traded) assets and liabilities. The Group’s hedging programmes for interest rate risk in the banking book rely on behavioural assumptions and, as a result, the effectiveness of the hedging strategy cannot be guaranteed. A potential mismatch in the balance or duration of the hedging assumptions could lead to earnings deterioration. A decline in interest rates in sterling, US dollars or euros may also compress net interest margin on retail and corporate portfolios. In addition, the Group’s liquid asset portfolio is exposed to potential capital and/or income volatility due to movements in market rates and prices which may have a material adverse effect on the capital position of the Group.
For further details on the Group’s approach to treasury and capital risk, refer to the treasury and capital risk management and treasury and capital risk performance sections.
v) Operational risk
Operational risk is the risk of loss to the Group from inadequate or failed processes or systems, human factors or due to external events where the root cause is not due to credit or market risks. Examples include:
a) Operational resilience
The Group functions in a highly competitive market, with market participants that expect consistent and smooth business processes. The loss of or disruption to business processing is a material inherent risk within the Group and across the financial services industry, whether arising through impacts on the Group’s technology systems, real estate services including its retail branch network, or availability of personnel or services supplied by third parties. Failure to build resilience and recovery capabilities into business processes or into the services of technology, real estate or suppliers on which the Group’s business processes depend, may result in significant customer detriment, costs to reimburse losses incurred by the Group’s customers, and reputational damage.
b) Cyberattacks
Cyberattacks continue to be a global threat that is inherent across all industries, with the number and severity of attacks continuing to rise. The financial sector remains a primary target for cybercriminals, hostile nation states, opportunists and hacktivists. The Group, like other financial institutions, experiences numerous attempts to compromise its cybersecurity.
The Group dedicates significant resources to reducing cybersecurity risks, but it cannot provide absolute security against cyberattacks. Malicious actors are increasingly sophisticated in their methods, seeking to steal money, gain unauthorised access to, destroy or manipulate data, and disrupt operations, and some of their attacks may not be recognised until launched, such as zero-day attacks that are launched before patches and defences can be readied. Cyberattacks can originate from a wide variety of sources and target the Group in numerous ways, including attacks on networks, systems, or devices used by the Group or parties such as service providers and other suppliers, counterparties, employees, contractors, customers or clients, presenting the Group with a vast and complex defence perimeter. Moreover, the Group does not have direct control over the cybersecurity of the systems of its clients, customers, counterparties and third party service providers and suppliers, limiting the Group’s ability to effectively defend against certain threats. Some of the Group’s third party service providers and suppliers have experienced successful attempts to compromise their cybersecurity. These included ransomware attacks that disrupted the service providers’ or suppliers’ operations and, in some cases, had a limited impact on the Group’s operations. Such cyberattacks are likely to continue.
A failure in the Group’s adherence to its cybersecurity policies, procedures or controls, employee malfeasance, and human, governance or technological error could also compromise the Group’s ability to successfully defend against cyberattacks. Furthermore, certain legacy technologies that are at or approaching end-of-life may not be able to maintain acceptable levels of security. The Group has experienced cybersecurity incidents and near-misses in the past, and it is inevitable that additional incidents will occur in the future. Cybersecurity risks will continue to increase, due to factors such as the increasing demand across the industry and customer expectations for continued expansion of services delivered over the internet; increasing reliance on internet-based products, applications and data storage; and changes in ways of working by the Group’s employees, contractors, and third party service providers and suppliers and their subcontractors as a potentially long-term consequence of the COVID-19 pandemic. Bad actors have taken advantage of remote working practices and modified customer behaviours that have taken hold during the COVID-19 pandemic, exploiting the situation in novel ways that may elude defences.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
109

Risk review
Material existing and emerging risks continued
Common types of cyberattacks include deployment of malware to obtain covert access to systems and data; ransomware attacks that render systems and data unavailable through encryption; denial of service and distributed denial of service (DDoS) attacks; infiltration via business email compromise; social engineering, including phishing, vishing and smishing; automated attacks using botnets; and credential validation or stuffing attacks using login and password pairs from unrelated breaches. A successful cyberattack of any type has the potential to cause serious harm to the Group or its clients and customers, including exposure to potential contractual liability, litigation, regulatory or other government action, loss of existing or potential customers, damage to the Group’s brand and reputation, and other financial loss. The impact of a successful cyberattack is also likely to include operational consequences (such as unavailability of services, networks, systems, devices or data), remediation of which could come at significant cost.
Regulators worldwide continue to recognise cybersecurity as an increasing systemic risk to the financial sector and have highlighted the need for financial institutions to improve their monitoring and control of, and resilience to cyberattacks. A successful cyberattack may, therefore, result in significant regulatory fines for the Group.
For further details on the Group’s approach to cyberattacks, refer to the operational risk performance section. For further details on cyber security regulation applicable to the Group, refer to the Supervision and regulation section.
c) New and emergent technology
Technology is fundamental to the Group’s business and the financial services industry. Technological advancements present opportunities to develop new and innovative ways of doing business across the Group, with new solutions being developed both in-house and in association with third party companies. For example, payment services and securities, futures and options trading are increasingly occurring electronically, both on the Group’s own systems and through other alternative systems, and becoming automated. Whilst increased use of electronic payment and trading systems and direct electronic access to trading markets could significantly reduce the Group’s cost base, it may, conversely, reduce the commissions, fees and margins made by the Group on these transactions which could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
Introducing new forms of technology, however, has the potential to increase inherent risk. Failure to evaluate, actively manage and closely monitor risk exposure during all phases of business development could introduce new vulnerabilities and security flaws and have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
d) External fraud
The nature of fraud is wide-ranging and continues to evolve, as criminals continually seek opportunities to target the Group’s business activities and exploit changes to customer behaviour and product and channel use (such as the increased use of digital products and enhanced online services) or exploit new products. Fraud attacks can be very sophisticated and are often orchestrated by highly organised crime groups who use ever more sophisticated techniques to target customers and clients directly to obtain confidential or personal information that can be used to commit fraud. The UK market has also seen significant growth in ‘scams’ where the Group takes increased levels of liability as part of a voluntary code to provide additional safeguards to customers and clients who are tricked into making payments to fraudsters. The impact from fraud can lead to customer detriment, financial losses (including the reimbursement of losses incurred by customers), loss of business, missed business opportunities and reputational damage, all of which could have a material adverse impact on the Group’s business, results of operations, financial condition and prospects.
e) Data management and information protection
The Group holds and processes large volumes of data, including personal information, intellectual property, and financial data and the Group’s businesses are subject to complex and evolving laws and regulations governing the privacy and protection of personal information of individuals. The protected parties can include: (i) the Group’s clients and customers, and prospective clients and customers; (ii) clients and customers of the Group’s clients and customers; (iii) employees and prospective employees; and (iv) employees of the Group’s suppliers, counterparties and other external parties. The international nature of both the Group’s business and its IT infrastructure also means that personal information may be available in countries other than those from where it originated. Accordingly, the Group needs to ensure that its collection, use, transfer and storage of personal information complies with all applicable laws and regulations in all relevant jurisdictions (including as such new and existing regulations continue to be implemented, interpreted and applied), which could: (i) increase the Group’s compliance and operating costs, particularly in the context of ensuring that adequate data protection and data transfer mechanisms are in place; (ii) impact the development of new products or services, impact the offering of existing products or services, or affect how products and services are offered to clients and customers; (iii) demand significant oversight by the Group’s management; and (iv) require the Group to review some elements of the structure of its businesses, operations and systems in less efficient ways. Concerns regarding the effectiveness of the Group’s measures to safeguard personal information, or even the perception that those measures are inadequate, could expose the Group to the risk of loss or unavailability of data or data integrity issues and/or cause the Group to lose existing or potential clients and customers, and thereby reduce the Group’s revenues. Furthermore, any failure or perceived failure by the Group to comply with applicable privacy or data protection laws and regulations (and the evolving standards imposed by data protection authorities in connection therewith) may subject it to potential contractual liability, litigation, regulatory or other government investigation or action (including significant regulatory fines) and require changes to certain operations or practices which could also inhibit the Group’s development or marketing of certain products or services, or increase the costs of offering them to customers. Any of these events could damage the Group’s reputation, subject the Group to material fines or other monetary penalties, make the Group liable to the payment of compensatory damages, divert management's time and attention, lead to enhanced regulatory oversight and otherwise materially adversely affect its business, results of operations, financial condition and prospects.
For further details on data protection regulation applicable to the Group, refer to the supervision and regulation section.
f) Algorithmic trading
In some areas of the investment banking business, trading algorithms are used to price and risk manage client and principal transactions. An algorithmic error could result in erroneous or duplicated transactions, a system outage, or impact the Group’s pricing abilities, which could have a material adverse effect on the Group’s business, results of operations, financial condition, prospects and reputation.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
110

Risk review
Material existing and emerging risks continued
g) Processing errors
The Group’s businesses are highly dependent on its ability to process and monitor, on a daily basis, a very large number of transactions, many of which are highly complex and occur at high volumes and frequencies, across numerous and diverse markets in many currencies. As the Group’s customer base and geographical reach expand and the volume, speed, frequency and complexity of transactions, especially electronic transactions (as well as the requirements to report such transactions on a real-time basis to clients, regulators and exchanges) increase, developing, maintaining and upgrading operational systems and infrastructure becomes more challenging, and the risk of systems or human error in connection with such transactions increases, as well as the potential consequences of such errors due to the speed and volume of transactions involved and the potential difficulty associated with discovering errors quickly enough to limit the resulting consequences. Furthermore, events that are wholly or partially beyond the Group’s control, such as a spike in transaction volume, could adversely affect the Group’s ability to process transactions or provide banking and payment services.
Processing errors could result in the Group, among other things: (i) failing to provide information, services and liquidity to clients and counterparties in a timely manner; (ii) failing to settle and/or confirm transactions; (iii) causing funds transfers, capital markets trades and/or other transactions to be executed erroneously, illegally or with unintended consequences; and (iv) adversely affecting financial, trading or currency markets. Any of these events could materially disadvantage the Group’s customers, clients and counterparties (including them suffering financial loss) and/or result in a loss of confidence in the Group which, in turn, could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
h) Supplier exposure
The Group depends on suppliers for the provision of many of its services and the development of technology. Whilst the Group depends on suppliers, it remains fully accountable for any risk arising from the actions of suppliers. The dependency on suppliers and sub-contracting of outsourced services introduces concentration risk where the failure of specific suppliers could have an impact on the Group’s ability to continue to provide material services to its customers. Failure to adequately manage supplier risk could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
i) Estimates and judgements relating to critical accounting policies and regulatory disclosures
The preparation of financial statements requires the application of accounting policies and judgements to be made in accordance with IFRS. Regulatory returns and capital disclosures are prepared in accordance with the relevant capital reporting requirements and also require assumptions and estimates to be made. The key areas involving a higher degree of judgement or complexity, or areas where assumptions are significant to the consolidated and individual financial statements, include credit impairment provisions, taxes, fair value of financial instruments, goodwill and intangible assets, pensions and post-retirement benefits, and provisions including conduct and legal, competition and regulatory matters (refer to the notes to the audited financial statements for further details). There is a risk that if the judgement exercised, or the estimates or assumptions used, subsequently turn out to be incorrect, this could result in material losses to the Group, beyond what was anticipated or provided for. Further development of accounting standards and regulatory interpretations could also materially impact the Group’s results of operations, financial condition and prospects.
j) Tax risk
The Group is required to comply with the domestic and international tax laws and practice of all countries in which it has business operations. There is a risk that the Group could suffer losses due to additional tax charges, other financial costs or reputational damage as a result of failing to comply with such laws and practice, or by failing to manage its tax affairs in an appropriate manner, with much of this risk attributable to the international structure of the Group. In addition, increasing tax authority focus on reporting and disclosure requirements around the world and the digitisation of the administration of tax has potential to increase the Group’s tax compliance obligations further. For example, the OECD and G20 Inclusive Framework on Base Erosion and Profit Shifting has announced plans to introduce a global minimum tax from 2023 which, if enacted, will increase the Group’s tax compliance obligations. In addition, the proposed Build Back Better Act includes proposals to implement changes to US international tax provisions which may require systems and process changes if enacted. Any systems and process changes associated with these changes introduce additional operational risk.
k) Ability to hire and retain appropriately qualified employees
As a regulated financial institution, the Group requires diversified and specialist skilled colleagues. The Group’s ability to attract, develop and retain a diverse mix of talent is key to the delivery of its core business activity and strategy. This is impacted by a range of external and internal factors, such as potential effects on employee engagement and wellbeing from long-term periods of working remotely. Failure to attract or prevent the departure of appropriately qualified and skilled employees could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects. Additionally, this may result in disruption to service which could in turn lead to disenfranchising certain customer groups, customer detriment and reputational damage.
For further details on the Group’s approach to operational risk, refer to the operational risk management and operational risk performance sections.
vi) Model risk
Model risk is the potential for adverse consequences from decisions based on incorrect or misused model outputs and reports. The Group relies on models to support a broad range of business and risk management activities, including informing business decisions and strategies, measuring and limiting risk, valuing exposures (including the calculation of impairment), conducting stress testing, assessing capital adequacy, supporting new business acceptance and risk and reward evaluation, managing client assets, and meeting reporting requirements.
Models are, by their nature, imperfect representations of reality and have some degree of uncertainty because they rely on assumptions and inputs, and so are subject to intrinsic uncertainty, errors and inappropriate use affecting the accuracy of their outputs. This may be exacerbated when dealing with unprecedented scenarios, such as the COVID-19 pandemic, due to the lack of reliable historical reference points and data. For instance, the quality of the data used in models across the Group has a material impact on the accuracy and completeness of its risk and financial metrics. Model uncertainty, errors and inappropriate use may result in (among other things) the Group making inappropriate business decisions and/or inaccuracies or errors in the Group’s risk management and regulatory reporting processes. This could result in significant financial loss, imposition of additional capital requirements, enhanced regulatory supervision and reputational damage, all of which could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
For further details on the Group’s approach to model risk, refer to the model risk management and model risk performance sections.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
111

Risk review
Material existing and emerging risks continued
vii) Conduct risk
Conduct risk is the risk of poor outcomes for, or harm to, customers, clients and markets, arising from the delivery of the Group's products and services. This risk could manifest itself in a variety of ways, including:
a) Market integrity
The Group’s businesses are exposed to risk from potential non-compliance with its policies and standards and instances of wilful and negligent misconduct by employees, all of which could result in potential customer and client detriment, enforcement action (including regulatory fines and/or sanctions), increased operation and compliance costs, redress or remediation or reputational damage which in turn could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects. Examples of employee misconduct which could have a material adverse effect on the Group’s business include: (i) employees improperly selling or marketing the Group’s products and services; (ii) employees engaging in insider trading, market manipulation or unauthorised trading; or (iii) employees misappropriating confidential or proprietary information belonging to the Group, its customers or third parties. These risks may be exacerbated in circumstances where the Group is unable to rely on physical oversight and supervision of employees (such as during the COVID-19 pandemic where employees have worked remotely).
b) Customer protection
The Group must ensure that its customers, particularly those that are vulnerable, are able to make well-informed decisions on how best to use the Group’s financial services and understand that they are appropriately protected if something goes wrong. Poor customer outcomes can result from the failure to: (i) communicate fairly and clearly with customers; (ii) provide services in a timely and fair manner; (iii) handle and protect customer data appropriately; and (iv) undertake appropriate activity to address customer detriment, including the adherence to regulatory and legal requirements on complaint handling. The Group is at risk of financial loss and reputational damage as a result.
c) Product design and review risk
Products and services must meet the needs of clients, customers, markets and the Group throughout their life cycle, However, there is a risk that the design and review of the Group’s products and services fail to reasonably consider and address potential or actual negative outcomes, which may result in customer detriment, enforcement action (including regulatory fines and/or sanctions), redress and remediation and reputational damage. Both the design and review of products and services are a key area of focus for regulators and the Group.
d) Financial crime
The Group may be adversely affected if it fails to effectively mitigate the risk that third parties or its employees facilitate, or that its products and services are used to facilitate, financial crime (money laundering, terrorist financing, breaches of economic and financial sanctions, bribery and corruption, and the facilitation of tax evasion). UK and US regulations covering financial institutions continue to focus on combating financial crime. Failure to comply may lead to enforcement action by the Group’s regulators, including severe penalties, which may have a material adverse effect on the Group’s business, financial condition and prospects.
e) Regulatory focus on culture and accountability
Regulators around the world continue to emphasise the importance of culture and personal accountability and enforce the adoption of adequate internal reporting and whistleblowing procedures to help to promote appropriate conduct and drive positive outcomes for customers, colleagues, clients and markets. The requirements and expectations of the UK Senior Managers Regime, Certification Regime and Conduct Rules have reinforced additional accountabilities for individuals across the Group with an increased focus on governance and rigour, with similar requirements also introduced in other jurisdictions globally. Failure to meet these requirements and expectations may lead to regulatory sanctions, both for the individuals and the Group.
For further details on the Group’s approach to conduct risk, refer to the conduct risk management and conduct risk performance sections.
viii) Reputation risk
Reputation risk is the risk that an action, transaction, investment, event, decision or business relationship will reduce trust in the Group’s integrity and/or competence.
Any material lapse in standards of integrity, compliance, customer service or operating efficiency may represent a potential reputation risk. Stakeholder expectations constantly evolve, and so reputation risk is dynamic and varies between geographical regions, groups and individuals. A risk arising in one business area can have an adverse effect upon the Group’s overall reputation and any one transaction, investment or event (in the perception of key stakeholders) can reduce trust in the Group’s integrity and competence. The Group’s association with sensitive topics and sectors has been, and in some instances continues to be, an area of concern for stakeholders, including: (i) the financing of, and investments in, businesses which operate in sectors that are sensitive because of their relative carbon intensity or local environmental impact; (ii) potential association with human rights violations (including combating modern slavery) in the Group’s operations or supply chain and by clients and customers; and (iii) the financing of businesses which manufacture and export military and riot control goods and services.
Reputation risk could also arise from negative public opinion about the actual, or perceived, manner in which the Group (including its employees, clients and other associations) conducts its business activities, or the Group’s financial performance, as well as actual or perceived practices in banking and the financial services industry generally. Modern technologies, in particular, online social media channels and other broadcast tools that facilitate communication with large audiences in short time frames and with minimal costs, may significantly enhance and accelerate the distribution and effect of damaging information and allegations. Negative public opinion may adversely affect the Group’s ability to retain and attract customers, in particular, corporate and retail depositors, and to retain and motivate staff, and could have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
In addition to the above, reputation risk has the potential to arise from operational issues or conduct matters which cause detriment to customers, clients, market integrity, effective competition or the Group (refer to ‘v) Operational risk’ above).
For further details on the Group’s approach to reputation risk, refer to the reputation risk management and reputation risk performance sections.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
112

Risk review
Material existing and emerging risks continued
ix) Legal risk and legal, competition and regulatory matters
The Group conducts activities in a highly regulated global market which exposes it and its employees to legal risk arising from: (i) the multitude of laws and regulations that apply to the businesses it operates, which are highly dynamic, may vary between jurisdictions and/or conflict, and are often unclear in their application to particular circumstances especially in new and emerging areas; and (ii) the diversified and evolving nature of the Group’s businesses and business practices. In each case, this exposes the Group and its employees to the risk of loss or the imposition of penalties, damages or fines from the failure of members of the Group to meet their respective legal obligations, including legal or contractual requirements. Legal risk may arise in relation to any number of the material existing and emerging risks identified above.
A breach of applicable legislation and/or regulations by the Group or its employees could result in criminal prosecution, regulatory censure, potentially significant fines and other sanctions in the jurisdictions in which the Group operates. Where clients, customers or other third parties are harmed by the Group’s conduct, this may also give rise to civil legal proceedings, including class actions. Other legal disputes may also arise between the Group and third parties relating to matters such as breaches or enforcement of legal rights or obligations arising under contracts, statutes or common law. Adverse findings in any such matters may result in the Group being liable to third parties or may result in the Group’s rights not being enforced as intended.
Details of legal, competition and regulatory matters to which the Group is currently exposed are set out in Note 26. In addition to matters specifically described in Note 26, the Group is engaged in various other legal proceedings which arise in the ordinary course of business. The Group is also subject to requests for information, investigations and other reviews by regulators, governmental and other public bodies in connection with business activities in which the Group is, or has been, engaged and may (from time to time) be subject to legal proceedings and other investigations relating to financial and non-financial disclosures made by members of the Group (including, but not limited to, in relation to ESG disclosures). Additionally, due to the increasing number of new climate and sustainability-related laws and regulations (or laws and regulatory processes seeking to protect the energy sector from any risks of divestment or challenges in accessing finance), growing demand from investors and customers for environmentally sustainable products and services, and regulatory scrutiny, financial institutions, including the Group, may through their business activities face increasing litigation, conduct, enforcement and contract liability risks related to climate change, environmental degradation and other social, governance and sustainability-related issues. Furthermore, there is a risk that shareholders, campaign groups, customers and other interest groups could seek to take legal action against the Group for financing or contributing to climate change and environmental degradation.
The outcome of legal, competition and regulatory matters, both those to which the Group is currently exposed and any others which may arise in the future, is difficult to predict. In connection with such matters, the Group may incur significant expense, regardless of the ultimate outcome, and any such matters could expose the Group to any of the following outcomes: substantial monetary damages, settlements and/or fines; remediation of affected customers and clients; other penalties and injunctive relief; additional litigation; criminal prosecution; the loss of any existing agreed protection from prosecution; regulatory restrictions on the Group’s business operations including the withdrawal of authorisations; increased regulatory compliance requirements or changes to laws or regulations; suspension of operations; public reprimands; loss of significant assets or business; a negative effect on the Group’s reputation; loss of confidence by investors, counterparties, clients and/or customers; risk of credit rating agency downgrades; potential negative impact on the availability and/or cost of funding and liquidity; and/or dismissal or resignation of key individuals. In light of the uncertainties involved in legal, competition and regulatory matters, there can be no assurance that the outcome of a particular matter or matters (including formerly active matters or those arising after the date of this Annual Report) will not have a material adverse effect on the Group’s business, results of operations, financial condition and prospects.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
113


Risk review
Climate change risk management
Climate risk management
The impact on Financial and Operational Risks arising from climate change through, physical risks, risks associated with transitioning to a lower-carbon economy and connected risks arising as a result of second order impacts on portfolios of these two drivers.
Overview
Given the increasing risks associated with climate change, and to support the Group’s ambition to be a net zero bank by 2050, it was agreed that climate risk would become a principal risk from 2022. To support this decision, in 2021 the Group delivered a Climate Risk Integration Plan with three overarching objectives:
1.     Governance Framework: Develop a Principal Risk Framework and Risk Appetite Statement and integrate climate drivers into limit setting.
2.     Scenario Analysis: Refine methodologies used for the 2020 scenario analysis to support the Bank of England Biennial Exploratory Scenario on climate change, with specific focus on wholesale credit and physical risk modelling.
3.     Carbon Modelling: Enhance the BlueTrackTM model to further develop the approach for the Energy sector, expand coverage to Cement and Metals and consider the overall net zero ambition of the Group.
For more detail on how climate risks arise and their impact on the Group, refer to the ‘material existing and emerging risks’ section.

Organisation and structure
On behalf of the Board, the BRC reviews and approves the Group’s approach to managing the financial and operational risks associated with climate change. Reputation risk is the responsibility of the Board, which directly handles the most material issues facing the Group. Broader sustainability matters and other reputation risk issues associated with climate change are co-ordinated by the Sustainability team.
In 2021 the Head of Climate Risk took the role of Climate Principal Risk owner, reporting directly to the Group Chief Risk Officer.
To support the oversight of Barclays Group climate risk profile a Climate Risk Committee (CRC) has been established. The CRC is a sub-committee of the Group Risk Committee (GRC), the most senior executive body responsible for review and challenge of risk practices and risk profile, for climate risk and other principal risk types. The authority of the CRC is delegated by the GRC. The management of climate risk is supported by working groups established by Barclays Bank Group and Barclays Bank UK Group.
bcs-20211231_g22.jpg
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
114

Risk review
Principal risk management continued
The Climate Risk Framework (CRF) was developed in 2021 to support the Enterprise Risk Management Framework and outlines the key principles for managing climate risk.
Climate risk across certain other Principal Risk types is managed via a ‘Climate Change Financial Risk and Operational Risk Policy’, which is embedded in each of the following Principal Risk Frameworks and contains key principles for identifying and quantifying climate risk, with supporting reporting and governance.
Risk TypeRisk IdentificationRisk Measurement
Credit risk
Identified as part of sovereign, portfolio and obligor credit annual reviews.

Measured using a Credit Risk Materiality Matrix completed for obligor/obligee groups with elevated exposure to climate change risk. Retail portfolios are monitored through regular reporting of climate metrics and are assessed against mandate triggers where appropriate.
Market risk
Identified using stress tests, aggregate market risk exposures from climate-related risks.
Measured by using adverse multi-asset stress scenarios applied to individual risk factors reflecting climate change risks across sectors, countries and regions.
Treasury and capital risk
Identified using stress tests and analysis to assess the exposures which may be impacted by climate-related risks.
Measured as part of stress testing and key risk indicator monitoring.
Operational risk
Confirmed operational risks associated with climate change are included in the Bank’s Operational Risk Taxonomy. Climate risk included within the Strategic Risk Assessment process.
Established reporting on internal and external climate related risk events to the Operational Risk Committee. Risk tolerances for premises and resilience risks are reviewed so these adequately capture climate-related risk drivers.
-
Risks resulting from climate change aligned to Model, Conduct, Reputation and Legal Principal Risks are out of the scope of the CRF and continue to be managed under their respective Principal Risk Frameworks. As climate risk continues to evolve, the effect upon these risks may change. Specific consideration of the impact of these changes will be covered as part of these frameworks.
A Climate Risk Appetite at Barclays Group level was introduced in line with the Barclays Group’s risk appetite approach. It establishes a direct link between strategic plans and risk appetite, supporting Barclays’ ambition to be a net zero bank by 2050.
Linking with ESG and Reputation Risk:
Barclays has published a Climate Change Statement, which sets out the strategic ambition to support economies and clients through the net zero transition, as well as appetite for conducting business with particularly sensitive energy sub-sectors. It is supported by an internal Climate Change Standard, which outlines the controls and approach to these sectors in more detail, including requirements for enhanced due diligence for restricted activities (such as outlined in the Group Forestry & Palm Oil Standard). These standards are enforced through an existing transaction origination, review and approval process.
A dedicated Sustainability team considers how the Group approaches wider sustainability and environmental, social and governance (ESG) matters, working closely with the Environmental Risk Management function.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
115

Risk review
Principal risk management continued
Risk review
Principal risk management
Credit risk management (audited)
The risk of loss to the Group from the failure of clients, customers or counterparties, including sovereigns, to fully honour their obligations to the Group, including the whole and timely payment of principal, interest, collateral and other receivables.
Overview
The credit risk that the Group faces arises from wholesale and retail loans and advances together with the counterparty credit risk arising from derivative contracts with clients; trading activities, including: debt securities, settlement balances with market counterparties, FVOCI (Fair Value through Other Comprehensive Income) assets and reverse repurchase loans.
Credit risk management objectives are to:
maintain a framework of controls to oversee credit risk
identify, assess and measure credit risk clearly and accurately across the Group and within each separate business, from the level of individual facilities up to the total portfolio
control and plan credit risk taking in line with external stakeholder expectations and avoiding undesirable concentrations
monitor credit risk and adherence to agreed controls.
Organisation, roles and responsibilities
The first line of defence has primary responsibility for managing credit risk within the risk appetite and limits set by the Risk function, supported by a defined set of policies, standards and controls. In the entities, business risk committees (attended by the first line) monitor and review the credit risk profile of each business unit where the most material issues are escalated to the Retail Credit Risk Management Committee, Wholesale Credit Risk Management Committee and Group Risk Committee.
Wholesale and retail portfolios are managed separately to reflect the differing nature of the assets; wholesale balances tend to be larger and are managed on an individual basis, while retail balances are greater in number but lesser in value and are, therefore, managed in aggregated segments.
The responsibilities of the credit risk management teams in the businesses, the sanctioning team and other shared services include: sanctioning new credit agreements (principally wholesale); setting strategies for approval of transactions (principally retail); setting risk appetite; monitoring risk against limits and other parameters; maintaining robust processes, data gathering, quality, storage and reporting methods for effective credit risk management; performing effective turnaround and workout scenarios for wholesale portfolios via dedicated restructuring and recoveries teams; maintaining robust collections and recovery processes/units for retail portfolios; and review and validation of credit risk measurement models. The credit risk management teams in each legal entity are accountable to the relevant Legal Entity CRO, who reports to the Group CRO.
For wholesale portfolios, credit risk managers are organised in sanctioning teams by geography, industry and/or product. In wholesale portfolios, credit risk approval is undertaken by experienced credit risk professionals operating within a clearly defined delegated authority framework, with only the most senior credit officers assigned the higher levels of delegated authority. The largest credit exposures, which are outside the Risk Sanctioning Unit or Risk Distribution Committee authority, require the support of a legal entity Senior Credit Officer. For exposures in excess of the legal entity Senior Credit Officer’s authority, approval by Group Senior Credit Officer/Board Risk Committee is also required. The Group Credit Risk Committee, attended by legal entity Senior Credit Officers, provides a formal mechanism for the Group Senior Credit Officer to exercise the highest level of credit authority over the most material Group single name exposures.
Credit risk mitigation
The Group employs a range of techniques and strategies to actively mitigate credit risks. These can broadly be divided into three types:
netting and set-off
collateral
risk transfer.
Netting and set-off
Credit risk exposures can be reduced by applying netting and set-off. For derivative transactions, the Group’s normal practice is, on a legal entity basis, to enter into standard master agreements with counterparties (e.g. ISDAs). These master agreements typically allow for netting of credit risk exposure to a counterparty resulting from derivative transactions against the obligations to the counterparty in the event of default, and so produce a lower net credit exposure. These agreements may also reduce settlement exposure (e.g. for foreign exchange transactions) by allowing payments on the same day in the same currency to be set-off against one another.
Collateral
The Group has the ability to call on collateral in the event of default of the counterparty, comprising:
home loans: a fixed charge over residential property in the form of houses, flats and other dwellings
wholesale lending: a fixed charge over commercial property and other physical assets, in various forms
other retail lending: includes charges over motor vehicles and other physical assets; second lien charges over residential property; and finance lease receivables
derivatives: the Group also often seeks to enter into a margin agreement (e.g. Credit Support Annex) with counterparties with which the Group has master netting agreements in place. These annexes to master agreements provide a mechanism for further reducing credit risk, whereby collateral (margin) is posted on a regular basis (typically daily) to collateralise the mark to market exposure of a derivative portfolio measured on a net basis
reverse repurchase agreements: collateral typically comprises highly liquid securities which have been legally transferred to the Group subject to an agreement to return them for a fixed price
financial guarantees and similar off-balance sheet commitments: cash collateral may be held against these arrangements.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
116

Risk review
Principal risk management continued
Risk transfer
A range of instruments including guarantees, credit insurance, credit derivatives and securitisation can be used to transfer credit risk from one counterparty to another. These mitigate credit risk in two main ways:
if the risk is transferred to a counterparty which is more creditworthy than the original counterparty, then overall credit risk is reduced
where recourse to the first counterparty remains, both counterparties must default before a loss materialises. This is less likely than the default of either counterparty individually so credit risk is reduced.
Detailed policies are in place to appropriately recognise and record credit risk mitigation. For more information, refer to pages 177 to 179 of the Barclays PLC Pillar 3 Report 2021 (unaudited).
Governance and oversight of ECLs under IFRS 9
The Group’s organisational structure and internal governance processes oversee the estimation of ECL across several areas, including: i) setting requirements in policy, including key assumptions and the application of key judgements; ii) the design and execution of models; and iii) review of ECL results.
i) Impairment policy requirements are set and reviewed regularly, at a minimum annually, to maintain adherence to accounting standards. Key judgements inherent in policy, including the estimated life of revolving credit facilities and the quantitative criteria for assessing the significant increase in credit risk (SICR), are separately supported by analytical study. In particular, the quantitative thresholds used for assessing SICR are subject to a number of internal validation criteria, particularly in retail portfolios where thresholds decrease as the origination Probability of Default (PD) of each facility increases. Key policy requirements are also typically aligned to the Group’s credit risk management strategy and practices, for example, wholesale customers that are risk managed on an individual basis are assessed for ECL on an individual basis upon entering Stage 3; furthermore, key internal risk management indicators of high risk are used to set SICR policy, for example, retail customers identified as high risk account management are automatically deemed to have met the SICR criteria.
ii) ECL is estimated in line with internal policy requirements using models which are validated by a qualified independent party to the model development area, the Independent Validation Unit (IVU), before first use and at a minimum annually thereafter. Each model is designated an owner who is responsible for:
model maintenance: monitoring of model performance including backtesting by comparing predicted ECL versus flow into stage 3 and coverage ratios; proposing material changes for independent IVU approval; and recalibrating model parameters on more timely data
proposing post-model adjustments (PMA) to address model weaknesses or to account for situations where known or expected risk factors and information have not been considered in the modelling process. All PMAs relating to model deficiencies, regardless of value are approved by IVU for a set time period. PMAs representing Expert Judgement are validated by Risk, as the second line of defence and approved for a set time period. The most material PMAs are also approved by the CRO.
Models must also assess ECL across a range of future economic conditions. These economic scenarios are generated via an independent model and ultimately set by the Senior Scenario Review Committee. Economic scenarios are regenerated at a minimum twice annually but more frequently if deemed appropriate, and also to align with the Group’s medium term planning exercise. Each model used in the estimation of ECL, including key inputs, are governed by a series of internal controls, which include the validation of completeness and accuracy of data in golden source systems, documented data transformations and documented lineage of data transfers between systems.
i) The Group Impairment Committee, formed of members from both Finance and Risk and attended by both the Group Finance Director and the Group CRO, is responsible for overseeing impairment policy and practice across the Group and will approve impairment results. Reported results and key messages are communicated to the BAC, which has an oversight role and provides challenge of key assumptions, including the basis of the scenarios adopted. Impairment results are then factored into management decision making, including but not limited to, business planning, risk appetite setting and portfolio management.
Market risk management (audited)
The risk of loss arising from potential adverse changes in the value of the Group’s assets and liabilities from fluctuation in market variables including, but not limited to, interest rates, foreign exchange, equity prices, commodity prices, credit spreads, implied volatilities and asset correlations.
Overview
Market risk arises primarily as a result of client facilitation in wholesale markets, involving market-making activities, risk management solutions and execution of syndications. Upon execution of a trade with a client, the Group will look to hedge against the risk of the trade moving in an adverse direction. Mismatches between client transactions and hedges result in market risk due to changes in asset prices, volatility or correlations.
Organisation, roles and responsibilities
Market risk in the businesses resides primarily in Barclays International and Treasury. These businesses have the mandate to assume market risk. The front office and Treasury trading desks are responsible for managing market risk on a day-to-day basis, where they are required to understand and adhere to all limits applicable to their businesses. The Market Risk team supports the trading desks with the day-to-day limit management of market risk exposures through governance processes which are outlined in supporting market risk policies and standards.
Market risk oversight and challenge is provided by business committees and Group committees, including the Market Risk Committee (MRC).
The objectives of market risk management are to:
identify, understand and control market risk by robust measurement, limit setting, reporting and oversight
facilitate business growth within a controlled and transparent risk management framework
control market risk in the businesses according to the allocated appetite.
To meet the above objectives, a governance structure is in place to manage these risks consistent with the ERMF.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
117

Risk review
Principal risk management continued
The BRC recommends market risk appetite to the Board for their approval. The Market Risk Principal Risk Lead (PR Lead) is responsible for the Market Risk Control Framework and, under delegated authority from the Group CRO, agrees with the business CROs a limit framework within the context of the approved market risk appetite.
The MRC reviews and makes recommendations concerning the group-wide market risk profile. This includes overseeing the operation of the Market Risk Framework and associated standards and policies; reviewing market or regulatory issues and limits and utilisation. The committee is chaired by the PR Lead and attendees include the business heads of market risk and business aligned market risk managers.
In addition to MRC, the Corporate and Investment Bank Risk Committee (‘CIBRC’) is the main forum in which market risk exposures are discussed and reviewed with senior business heads. The Committee is chaired by the CRO of Barclays International and meets weekly, covering current market events, notable market risk exposures, and key risk topics. New business initiatives are generally socialised at CIBRC before any changes to risk appetite or associated limits are considered in other governance committees.
The head of each business is accountable for all market risks associated with its activities, while the head of the market risk team covering each business is responsible for implementing the risk control framework for market risk.
For more information on market risk management, refer to the Barclays PLC Pillar 3 Report 2021 (unaudited).
Management value at risk (VaR)
VaR is an estimate of the potential loss arising from unfavourable market movements if the current positions were to be held unchanged for one business day. For internal market risk management purposes, a historical simulation methodology with a one-year equally weighted historical period, at the 95% confidence level is used for all trading books and some banking books.
Limits are applied at the total level as well as by risk factor type, which are then cascaded down to particular trading desks and businesses by the market risk management function.
See the market risk performance section for a review of management VaR.

Treasury and capital risk management
This comprises:
Liquidity risk: The risk that the Group is unable to meet its contractual or contingent obligations or that it does not have the appropriate amount, tenor and composition of funding and liquidity to support its assets.
Capital risk: The risk that the Group has an insufficient level or composition of capital to support its normal business activities and to meet its regulatory capital requirements under normal operating environments and stressed conditions (both actual and as defined for internal planning or regulatory testing purposes). This also includes the risk from the Group’s pension plans.
Interest rate risk in the banking book: The risk that the Group is exposed to capital or income volatility because of a mismatch between the interest rate exposures of its (non-traded) assets and liabilities.
The Treasury function manages treasury and capital risk exposure on a day-to-day basis with the Group Treasury Committee acting as the principal management body. The Treasury and Capital Risk function is responsible for oversight and provide insight into key capital, liquidity, interest rate risk in the banking book (IRRBB) and pension risk management activities.
Liquidity risk management (audited)
Overview
The efficient management of liquidity is essential to the Group in order to retain the confidence of the financial markets and maintain the sustainability of the business. Treasury and Capital Risk have created a framework to manage all liquidity risk exposures under both normal and stressed conditions. The framework is designed to maintain liquidity resources that are sufficient in amount, quality and funding tenor profile to remain within the liquidity risk appetite as expressed by the Barclays PLC Board. The liquidity risk appetite is monitored against both internal and regulatory liquidity metrics.
Organisation, roles and responsibilities
Treasury has the primary responsibility for managing liquidity risk within the set risk appetite. Both Risk and Treasury contribute to the production of the Internal Liquidity Adequacy Assessment Process (ILAAP). The Treasury and Capital Risk function is responsible for the management and governance of the liquidity risk mandate, as defined by the Board.
The framework established by treasury and capital risk is designed to deliver the appropriate term and structure of funding, consistent with the liquidity risk appetite set by the Board. The framework incorporates a range of ongoing business management tools to monitor, limit and stress test the Group’s balance sheet, contingent liabilities and the recovery plan. Limit setting and transfer pricing are tools that are designed to control the level of liquidity risk taken and drive the appropriate mix of funds. Together, these tools reduce the likelihood that a liquidity stress event could lead to an inability to meet Group’s obligations as they fall due.
The Board approves the Group funding plan, internal stress tests, regulatory stress test results, recovery plan and liquidity risk appetite. The Group Treasury Committee is responsible for monitoring and managing liquidity risk in line with the Group’s funding management objectives, funding plan and risk appetite. The Treasury and Capital Risk Committee monitors and reviews the liquidity risk profile and control environment, providing second line oversight of the management of liquidity risk. The Board Risk Committee reviews the risk profile, and reviews liquidity risk appetite at least annually and the impact of stress scenarios on the Group funding plan/forecast in order to agree the Group’s projected funding abilities.
Capital risk management (audited)
Overview
Capital risk is managed through ongoing monitoring and management of the capital position, regular stress testing and a robust capital governance framework. The objectives of the framework are to maintain adequate capital for the Group and legal entities to withstand the impact of the risks that may arise under normal and stressed conditions, and maintain adequate capital to cover current and forecast business needs and associated risks to provide a viable and sustainable business offering.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
118

Risk review
Principal risk management continued
Organisation, roles and responsibilities
Treasury has the primary responsibility for managing and monitoring capital adequacy. The Treasury and Capital Risk function provides oversight of capital risk. Production of the Barclays PLC Internal Capital Adequacy Assessment Process (ICAAP) is the responsibility of Treasury.
Capital risk management is underpinned by a control framework and policy. The capital management strategy, outlined in the Group and legal entity capital plans, is developed in alignment with the control framework and policy for capital risk, and is implemented consistently in order to deliver on the Group’s objectives.
The Board approves the Group capital plan, internal stress tests and results of regulatory stress tests, and the Group recovery plan. The Group Treasury Committee is responsible for monitoring and managing capital risk in line with the Group’s capital management objectives, capital plan and risk frameworks. The Treasury and Capital Risk Committee monitors and reviews the capital risk profile and control environment, providing second line oversight of the management of capital risk. The BRC reviews the risk profile, and reviews risk appetite at least annually and the impact of stress scenarios on the Group capital plan/forecast in order to agree the Group’s projected capital adequacy.
Local management assures compliance with an entity’s minimum regulatory capital requirements by reporting to local Asset and Liability Committees (ALCOs) with oversight by the Group Treasury Committee, as required. In 2021, Barclays complied with all regulatory minimum capital requirements.
Pension risk
The Group maintains a number of defined benefit pension schemes for past and current employees. The ability of schemes to meet pension payments is achieved with investments and contributions.
Pension risk arises because the market value of pension fund assets might decline; investment returns might reduce; or the estimated value of pension liabilities might increase. The Group monitors the pension risks arising from its defined benefit pension schemes and works with the relevant pension fund’s trustees to address shortfalls. In these circumstances, the Group could be required or might choose to make extra contributions to the pension fund. The Group’s main defined benefit scheme was closed to new entrants in 2012.
Interest rate risk in the banking book management (IRRBB)
Overview
Interest rate risk in the banking book is driven by customer deposit taking and lending activities, investments in the liquid asset portfolio and funding activities. As per the Group’s policy to remain within the defined risk appetite, hedging strategies are executed to mitigate the various IRRBB risks that result from these activities. However, the Group remains susceptible to interest rate risk and other non-traded market risks from the following key sources:
Interest rate and repricing risk: the risk that net interest income could be adversely impacted by a change in interest rates, differences in the timing of interest rate changes between assets and liabilities, and other constraints on interest rate changes as per product terms and conditions.
Customer behavioural risk: the risk that net interest income could be adversely impacted by the discretion that customers and counterparties may have in respect of being able to vary their contractual obligations with Barclays. This risk is often referred to by industry regulators as ‘embedded option risk’.
Investment risks in the liquid asset portfolio: the risk that the fair value of assets held in the liquid asset portfolio and associated risk management portfolios could be adversely impacted by market volatility, creating volatility in capital directly.
Organisation, roles and responsibilities
The entity ALCOs and/or treasury committees, together with the Group Treasury Committee, are responsible for monitoring and managing IRRBB risk in line with the Group’s management objectives and risk frameworks. The GRC and Treasury and Capital Risk Committee monitors and reviews the IRRBB risk profile and control environment, providing second line oversight of the management of IRRBB. The BRC reviews the interest rate risk profile, including review of the risk appetite at least annually and the impact of stress scenarios on the interest rate risk of the Group’s banking books.
In addition, the Group’s IRRBB policy sets out the processes and key controls required to identify all IRRBB risks arising from banking book operations, to monitor the risk exposures via a set of metrics with a frequency in line with the risk management horizon, and to manage these risks within agreed risk appetite and limits.
Operational risk management
The risk of loss to the Group from inadequate or failed processes or systems, human factors or due to external events (for example, fraud) where the root cause is not due to credit or market risks.
Overview
The management of operational risk has three key objectives:
deliver an operational risk capability owned and used by business leaders to enable sound risk decisions over the long term
provide the frameworks, policies and standards to enable management to meet their risk management responsibilities while the second line of defence provides robust, independent, and effective oversight and challenge
deliver a consistent and aggregated measurement of operational risk that will provide clear and relevant insights, so that the right management actions can be taken to keep the operational risk profile consistent with the Group’s strategy, the stated risk appetite and stakeholder needs.
The Group operates within a system of internal controls that enables business to be transacted and risk taken without exposing it to unacceptable potential losses or reputational damages.
Organisation, roles and responsibilities
The prime responsibility for the management of operational risk and the compliance with control requirements rests within the business and functional units where the risk arises. The operational risk profile and control environment is reviewed by management through business risk committees and control committees. Operational risk issues escalated from these meetings are considered through the second line of defence review meetings. Depending on their nature, the outputs of these meetings are presented to the Operational Risk Profile Forum, the Operational Risk Committee, the BRC or the BAC. In addition, specific reports are prepared by Operational Risk on a regular basis for the GRC and the BRC.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
119

Risk review
Principal risk management continued
Legal entities, businesses and functions are required to report their operational risks on both a regular and an event-driven basis. The reports include a profile of the material risks that may threaten the achievement of their objectives and the effectiveness of key controls, operational risk events and a review of scenarios.
The Group Head of Operational Risk is responsible for establishing, owning and maintaining an appropriate group-wide Operational Risk Framework and for overseeing the portfolio of operational risk across the Group.
The Operational Risk function acts in a second line of defence capacity, and is responsible for defining and overseeing the implementation of the framework and monitoring the Group’s operational risk profile. The Operational Risk function alerts management when risk levels exceed acceptable tolerance in order to drive timely decision- making and actions by the first line of defence.
Operational risk categories
Operational risks are grouped into risk categories to support effective risk management, measurement and reporting. These comprise: Data Management Risk; Financial Reporting Risk; Fraud Risk; Information Security Risk; Operational Resilience Planning Risk; Payments Process Risk; People Risk; Premises Risk; Physical Security Risk; Strategic Investment Change Management Risk; Supplier Risk; Tax Risk; Technology Risk; and Transaction Operations Risk.
In addition to the above, operational risk encompasses risks associated with prudential regulation. This includes the risk of failing to: adhere to prudential regulatory requirements; provide regulatory submissions; or monitor and manage adherence to new prudential regulatory requirements.
Risk themes
Barclays also recognises that there are certain threats/risk drivers that are more thematic and have the potential to impact the Group’s strategic objectives. These are risk themes which require an overarching and integrated risk management approach. The Group’s risk themes include Cyber, Data, and Resilience.
For definitions of the Group’s operational risk categories and risk themes, refer to the management of operational risk section in the Barclays PLC Pillar 3 Report 2021.
Model risk management
The potential for adverse consequences from decisions based on incorrect or misused model outputs and reports.
Overview
The Group uses models to support a broad range of activities, including informing business decisions and strategies, measuring and limiting risk, valuing exposures, conducting stress testing, assessing capital adequacy, managing client assets, and meeting reporting requirements.
Organisation, roles and responsibilities
The Group has a dedicated Model Risk Management (MRM) function that consists of four teams: (i) Independent Validation Unit (IVU), responsible for model validation and approval; (ii) Model Governance (MG), responsible for model risk governance, controls and reporting, including ownership of the Model Risk Framework, the Group Model Risk Policy and the associated standards; (iii) Strategy and Transformation responsible for inventory, strategy, communications and business management; and (iv) Model Risk Measurement and Quantification (MRMQ), responsible for the design of the framework and methodology to measure and, where possible, quantify model risk. It is also responsible for the strategic Validation Centre of Excellence (VCoE), which is an independent quality assurance function within MRM with the mandate to review and challenge validation outcomes.
The model risk management framework consists of the model risk policy and standards. The policy prescribes Group-wide, end-to-end requirements for the identification, measurement and management of model risk, covering model documentation, development, monitoring, annual review, independent validation and approval, change and reporting processes. The policy is supported by global standards covering model inventory, documentation, validation, complexity and materiality, testing and monitoring, overlays, risk appetite, as well as vendor models and stress testing challenger models.
The function reports to the Group CRO and operates a global framework. Implementation of best practice standards is a central objective of the Group.
The key model risk management activities include:
Correctly identifying models across all relevant areas of the Group, and recording models in the Group Models Database (GMD), the Group-wide model inventory.
Enforcing that every model has a model owner who is accountable for the model. The model owner must sign off models prior to submission to IVU for validation and maintain that the model presented to IVU is and remains fit for purpose.
Overseeing that every model is subject to validation and approval by IVU, prior to being used and on a continual basis.
Defining model risk appetite in terms of risk tolerance, and qualitative metrics which are used to track and report model risk.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
120

Risk review
Principal risk management continued

Conduct Risk management
The risk of poor outcomes for, or harm to, customers, clients and markets, arising from the delivery of the Group’s products and services.
Overview
The Group defines, manages and mitigates conduct risk with the objective of providing good customer and client outcomes, protecting market integrity and promoting effective competition.
Conduct risk incorporates market integrity, customer protection, financial crime and product design and review risks.
Organisation, roles and responsibilities
The Conduct Risk Management Framework (CRMF) outlines how the Group manages and measures its conduct risk profile. The Group Chief Compliance Officer is accountable for developing, maintaining and overseeing the CRMF. This includes defining and owning the relevant conduct risk policies which detail the control objectives, principles and other core requirements for the activities of the Group. It is the responsibility of the first line of defence to establish controls to manage its performance and assess conformance to these policies and controls.
Senior managers are accountable within their areas of responsibility for owning and managing conduct risk in accordance with the CRMF, as defined within their regulatory Statement of Responsibilities.
Compliance as an independent second line function helps to prevent, detect and manage breaches of applicable laws, rules, regulations and procedures and has a key role in helping Barclays achieve the right conduct outcomes and evolve a conduct-focused culture.
The governance of conduct risk within the Group is fulfilled through management committees and forums operated by the first and second lines of defence with clear escalation and reporting lines to the Board. The Barclays Group and Barclays Bank Group Risk Committee and the Barclays Bank UK Group Risk Committee are the primary second line governance committees for the oversight of the Conduct Risk Profile. The risk committees’ responsibilities include the identification and discussion of any emerging conduct risks exposures in their respective entities.

Reputation Risk management
The risk that an action, transaction, investment, event, decision, or business relationship will reduce trust in the Group’s integrity and/or competence.
Overview
A reduction of trust in the Group’s integrity and competence may reduce the attractiveness of the Group to stakeholders and could lead to negative publicity, loss of revenue, regulatory or legislative action, loss of existing and potential client business, reduced workforce morale and difficulties in recruiting talent. Ultimately it may destroy shareholder value.
Organisation, roles and responsibilities
Barclays PLC Board is the most senior body responsible for reviewing and monitoring the effectiveness of the Group’s management of reputation risk.
The Group Chief Compliance Officer is accountable for developing a Reputation Risk Management Framework (RRMF), and the Group Head of Public Policy and Corporate Responsibility is responsible for developing a reputation risk policy and associated standards, including tolerances against which data is monitored, reported on and escalated, as required. The RRMF sets out what is required to manage reputation risk across the Group.
The primary responsibility for identifying and managing reputation risk and adherence to the control requirements sit with the business and support functions where the risk arises.
Barclays Bank Group and Barclays Bank UK Group are required to operate within established reputation risk appetite, and their component businesses prepare reports highlighting their most significant current and potential reputation risks and issues and how they are being managed. These reports are a key internal source of information for the quarterly reputation risk reports which are prepared for Barclays Group ExCo and the Board.
The Group Reputation Risk Committee is a sub-committee of the Group Executive Committee, authorised to manage material reputation risks and issues as they are brought to the attention of the committee via relevant reputation risk assessment and escalation processes.

Legal Risk management
The risk of loss or imposition of penalties, damages or fines from the failure of the Group to meet its legal obligations, including regulatory or contractual requirements.
Overview
The Group has no tolerance for wilful breaches of laws, regulations or other legal obligations. However, the multitude of laws and regulations across the globe are highly dynamic and their application to particular circumstances is often unclear. This results in a high level of inherent legal risk which the Group seeks to mitigate through the operation of a Group-wide legal risk management framework, including the implementation of Group-wide legal risk policies requiring the engagement of legal professionals in situations that have the potential for legal risk. Notwithstanding these mitigating actions, the Group operates with a level of residual legal risk, for which the Group has limited tolerance.
Organisation, roles and responsibilities
The Group's businesses and functions have primary responsibility for identifying and escalating legal risk in their area as well as responsibility for adherence to minimum control requirements.
The Legal Function organisation and coverage model aligns legal expertise to businesses, functions, products, activities and geographic locations so that the Group receives support from appropriate legal professionals, working in partnership to manage legal risk. The senior management of the Legal Function oversees, challenges and monitors the legal risk profile and effectiveness of the legal risk control environment across the Group. The Legal Function does not sit in any of the Three Lines of Defence but supports them all.
The Group General Counsel is responsible for developing and maintaining a Group-wide legal risk management framework. This includes defining the relevant legal risk policies, developing Group-wide risk appetite for legal risk, and oversight of the implementation of controls to manage and escalate legal risk.
The legal risk profile and control environment is reviewed by management through business risk committees and control committees. The Group Risk Committee is the most senior executive body responsible for reviewing and monitoring the effectiveness of risk management across the Group. Escalation paths from this committee exist to the Barclays PLC Board Risk Committee.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
121


Risk review: Credit risk
Risk performance
Credit risk: summary of contents
Page
Credit risk represents a significant risk and mainly arises from exposure to wholesale and retail loans and advances together with the counterparty credit risk arising from derivative contracts entered into with clients.
Credit risk overview and summary of performance
123
Maximum exposure and effects of netting, collateral and risk transfer
124
This section outlines the expected credit loss allowances, the movements in allowances during the period, material management adjustments to model output and measurement uncertainty and sensitivity analysis.
Expected Credit Losses
126
Loans and advances at amortised cost by stage
126
Loans and advances at amortised cost by product
128
Movement in gross exposure and impairment allowance for loans and advances at amortised cost
130
Stage 2 decomposition
134
Stage 3 decomposition
134
Management adjustments to models for impairment
135
Measurement uncertainty and sensitivity analysis
137
The Group reviews and monitors risk concentrations in a variety of ways. This section outlines performance against key concentration risks.
Analysis of the concentration of credit risk
146
Geographic concentrations
146
Industry concentrations
146
Approach to management and representation of credit quality
148
Asset credit quality
148
Debt securities
148
Balance sheet credit quality
148
Credit exposures by internal PD grade
150
Credit risk monitors exposure performance across a range of significant portfolios.
Analysis of specific portfolios and asset types
152
Secured home loans
152
Credit cards, unsecured loans and other retail lending
153
Government supported loans
154
The Group monitors exposures to assets where there is a heightened likelihood of default and assets where an actual default has occurred. From time to time, suspension of certain aspects of client credit agreements are agreed, generally during temporary periods of financial difficulties where the Group is confident that the client will be able to remedy the suspension. This section outlines the current exposure to assets with this treatment.
Forbearance
155
Retail forbearance programmes
156
Wholesale forbearance programmes
157
This section provides an analysis of credit risk on debt securities and derivatives.
Analysis of debt securities
157
Analysis of derivatives
158


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
122

Risk review: Credit risk
Risk performance continued
Credit risk
All disclosures in this section are unaudited unless otherwise stated.
Overview
Credit risk represents a significant risk to the Group and mainly arises from exposure to wholesale and retail loans and advances together with the counterparty credit risk arising from derivative contracts entered into with clients.
Credit risk disclosures include many of the recommendations of the Taskforce on Disclosures about Expected Credit Losses (DECL) and it is expected that relevant disclosures will continue to be developed in future periods.
The continued impact of the COVID-19 pandemic has meant that management was required to monitor economic uncertainty judgement over the course of 2021. Customer and client default rates have remained relatively stable despite the impact of the pandemic and volatile macroeconomic environment.
In retail cards, credit profiles did not show material deterioration due to continued government support measures in some geographies and customer deleveraging. In wholesale, watch list balances continue to improve. However, the degree of economic uncertainty remains relatively high: credit deterioration may still occur when support measures are fully withdrawn across geographies; emerging supply chain disruption and inflationary pressures may challenge economic stability. Given this backdrop, management has maintained economic uncertainty adjustments to modelled outputs to address these sources of uncertainties and ensure that the potential impact of stress are provided for. This uncertainty continues to be captured in two distinct ways: firstly, the identification of customers and clients who may be more vulnerable to the withdrawal of support and emerging economic instability and secondly, model uncertainty which does not capture certain macroeconomic and risk parameter uncertainties which are applied at a portfolio level. Refer to the Management adjustment to models for impairment section on page 237 for further details.
Further detail can be found in the Financial statements section in Note 7 Credit impairment charges. Descriptions of terminology can be found in the glossary, available at home.barclays/annualreport.
Key metrics
Decrease in impairment allowances of
£3,115m
Impairment allowances on loans and advances at amortised cost including off-balance sheet elements of the allowance, decreased by £3,115m to £6,284m (2020: £9,399m). The decrease is driven by Barclays International £1,801m, Barclays UK £1,252m, and Head Office £62m. Refer to the Expected Credit Losses section for further details.


Summary of performance in the period
Credit impairment release of £(653)m (2020: £4,838m charge) due to the improved macroeconomics outlook and reduced unsecured lending balances and low delinquency. Economic uncertainty adjustments have been maintained in respect of customers and clients considered to be potentially more vulnerable as government and other support schemes have started to reduce.
Refer to the credit risk management section for details of governance, policies and procedures.

Maximum exposure and effects of netting, collateral and risk transfer
Basis of preparation
The following tables present a reconciliation between the Group's maximum exposure and its net exposure to credit risk, reflecting the financial effects of risk mitigation reducing the Group's exposure.
For financial assets recognised on the balance sheet, maximum exposure to credit risk represents the balance sheet carrying value after allowance for impairment. For off-balance sheet guarantees, the maximum exposure is the maximum amount that the Group would have to pay if the guarantees were to be called upon. For loan commitments and other credit related commitments that are irrevocable over the life of the respective facilities, the maximum exposure is the full amount of the committed facilities.
This and subsequent analyses of credit risk exclude other financial assets not subject to credit risk, mainly equity securities. For off-balance sheet exposures certain contingent liabilities not subject to credit risk such as performance guarantees are excluded.
The Group mitigates the credit risk to which it is exposed through netting and set-off, collateral and risk transfer. Further detail on the Group’s policies to each of these forms of credit enhancement is presented on pages 177 to 179 of the Barclays PLC Pillar 3 Report 2021 (unaudited).
Overview
As at 31 December 2021, the Group’s net exposure to credit risk, after taking into account credit risk mitigation, increased 4% to £912bn (2020: £877bn). Overall, the extent to which the Group holds mitigation against its total exposure slightly decreased to 44% (2020: 46%).
Of the unmitigated on balance sheet exposure, a significant portion relates to cash held at central banks, cash collateral and settlement balances, and debt securities issued by governments all of which are considered to be lower risk. The increase in the Group’s net exposure to credit risk is mainly driven by increases in cash held at central banks and off-balance sheet loan commitments. Trading portfolio liability positions, which to a significant extent economically hedge trading portfolio assets but which are not held specifically for risk management purposes, are excluded from the analysis. The credit quality of counterparties to derivatives, financial investments and wholesale loan assets are predominantly investment grade. Further analysis on the credit quality of assets is presented in the approach to management and representation of credit quality section.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
123

Risk review: Credit risk
Risk performance continued
Collateral obtained
Where collateral has been obtained in the event of default, the Group does not, ordinarily, use such assets for its own operations and they are usually sold on a timely basis. The carrying value of assets held by the Group as at 31 December 2021, as a result of the enforcement of collateral, was £22m (2020: £6m).
Maximum exposure and effects of netting, collateral and risk transfer (audited)
Maximum exposureNetting and set-offCash collateralNon-cash collateralRisk transferNet exposure
As at 31 December 2021£m£m£m£m£m£m
On-balance sheet:
Cash and balances at central banks238,574     238,574 
Cash collateral and settlement balances92,542     92,542 
Loans and advances at amortised cost:
Home loans169,205  (339)(168,627)(146)93 
Credit cards, unsecured loans and other retail lending41,793  (1,050)(4,560)(252)35,931 
Wholesale loans150,453 (5,001)(128)(42,691)(23,104)79,529 
Total loans and advances at amortised cost361,451 (5,001)(1,517)(215,878)(23,502)115,553 
Of which credit-impaired (Stage 3):
Home loans1,725  (11)(1,714)  
Credit cards, unsecured loans and other retail lending828  (29)(229)(3)567 
Wholesale loans2,161  (1)(717)(765)678 
Total credit-impaired loans and advances at amortised cost4,714  (41)(2,660)(768)1,245 
Reverse repurchase agreements and other similar secured lending3,227   (3,227)  
Trading portfolio assets:
Debt securities50,864   (461) 50,403 
Traded loans12,525   (268) 12,257 
Total trading portfolio assets63,389   (729) 62,660 
Financial assets at fair value through the income statement:
Loans and advances38,667   (31,263) 7,404 
Debt securities2,305   (319) 1,986 
Reverse repurchase agreements145,014  (1,428)(143,057) 529 
Other financial assets111     111 
Total financial assets at fair value through the income statement186,097  (1,428)(174,639) 10,030 
Derivative financial instruments262,572 (202,519)(34,598)(5,887)(5,738)13,830 
Financial assets at fair value through other comprehensive income60,851   (53)(1,164)59,634 
Other assets1,212     1,212 
Total on-balance sheet1,269,915 (207,520)(37,543)(400,413)(30,404)594,035 
Off-balance sheet:
Contingent liabilities21,346  (906)(1,367)(256)18,817 
Loan commitments345,711  (141)(44,777)(1,668)299,125 
Total off-balance sheet367,057  (1,047)(46,144)(1,924)317,942 
Total 1,636,972 (207,520)(38,590)(446,557)(32,328)911,977 
Off-balance sheet exposures are shown gross of provisions of £542m (2020: £1,064m). See Note 25 for further details. In addition to the above, the Group holds forward starting reverse repos with notional contract amounts of £39.3bn (2020: £34.6bn). These balances are fully collateralised. Wholesale loans and advances at amortised cost include £11.4bn (2020: £12.2bn) of BBLs, CBILs and CLBILs supported by UK government guarantees of £11.0bn (2020: £11.7bn), which are included within the Risk transfer column in the table. For further information on credit risk mitigation techniques, refer to the Credit risk management section.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
124

Risk review: Credit risk
Risk performance continued
Maximum exposure and effects of netting, collateral and risk transfer (audited)
Maximum exposureNetting and set-offCash collateralNon-cash collateralRisk transferNet exposure
As at 31 December 2020£m£m£m£m£m£m
On-balance sheet:
Cash and balances at central banks191,127 — — — — 191,127 
Cash collateral and settlement balances101,367 — — — — 101,367 
Loans and advances at amortised cost:
Home loans159,647 — (284)(159,203)(85)75 
Credit cards, unsecured loans and other retail lending40,813 — (967)(3,825)(195)35,826 
Wholesale loans142,172 (6,988)(62)(37,103)(23,963)74,056 
Total loans and advances at amortised cost342,632 (6,988)(1,313)(200,131)(24,243)109,957 
Of which credit-impaired (Stage 3):
Home loans1,813 — (14)(1,796)— 
Credit cards, unsecured loans and other retail lending921 — (14)(237)(2)668 
Wholesale loans2,525 — (4)(872)(232)1,417 
Total credit-impaired loans and advances at amortised cost5,259 — (32)(2,905)(234)2,088 
Reverse repurchase agreements and other similar secured lending9,031 — — (9,031)— — 
Trading portfolio assets:
Debt securities56,482 — — (391)— 56,091 
Traded loans8,348 — — (374)— 7,974 
Total trading portfolio assets64,830 — — (765)— 64,065 
Financial assets at fair value through the income statement:
Loans and advances30,879 — (9)(23,677)— 7,193 
Debt securities1,693 — — (292)— 1,401 
Reverse repurchase agreements137,616 — (672)(136,537)— 407 
Other financial assets343 — — — — 343 
Total financial assets at fair value through the income statement170,531 — (681)(160,506)— 9,344 
Derivative financial instruments302,446 (233,080)(43,291)(4,773)(6,409)14,893 
Financial assets at fair value through other comprehensive income77,927 — — (106)(1,385)76,436 
Other assets850 — — — — 850 
Total on-balance sheet1,260,741 (240,068)(45,285)(375,312)(32,037)568,039 
Off-balance sheet:
Contingent liabilities21,609 — (1,095)(2,135)(282)18,097 
Loan commitments333,049 — (128)(40,714)(1,520)290,687 
Total off-balance sheet354,658 — (1,223)(42,849)(1,802)308,784 
Total 1,615,399 (240,068)(46,508)(418,161)(33,839)876,823 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
125

Risk review: Credit risk
Risk performance continued
Expected Credit Losses
Loans and advances at amortised cost by stage
The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 31 December 2021. Also included are off-balance sheet loan commitments and financial guarantee contracts by gross exposure and impairment allowance and coverage ratio by stage allocation as at 31 December 2021.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure as ECL is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision.
Loans and advances at amortised cost by stage (audited)
Gross exposureImpairment allowanceNet exposure
Stage 1Stage 2 Stage 3TotalStage 1Stage 2 Stage 3Total
As at 31 December 2021£m£m£m£m£m£m£m£m£m
Barclays UK160,695 22,779 2,915 186,389 261 949 728 1,938 184,451 
Barclays International25,981 2,691 1,566 30,238 603 795 858 2,256 27,982 
Head Office3,735 429 705 4,869 2 36 347 385 4,484 
Total Barclays Group retail190,411 25,899 5,186 221,496 866 1,780 1,933 4,579 216,917 
Barclays UK35,571 1,917 969 38,457 153 43 111 307 38,150 
Barclays International92,341 13,275 1,059 106,675 187 192 458 837 105,838 
Head Office542 2 21 565   19 19 546 
Total Barclays Group wholesalea
128,454 15,194 2,049 145,697 340 235 588 1,163 144,534 
Total loans and advances at amortised cost318,865 41,093 7,235 367,193 1,206 2,015 2,521 5,742 361,451 
Off-balance sheet loan commitments and financial guarantee contractsb
312,142 34,815 1,298 348,255 217 302 23 542 347,713 
Totalc
631,007 75,908 8,533 715,448 1,423 2,317 2,544 6,284 709,164 
Loan impairment charge and loan loss rate
Coverage ratio Loan impairment charge/(release)Loan loss rate
Stage 1Stage 2 Stage 3Total
As at 31 December 2021%%%%£mbps
Barclays UK0.2 4.2 25.0 1.0 (227) 
Barclays International2.3 29.5 54.8 7.5 181 60 
Head Office0.1 8.4 49.2 7.9   
Total Barclays Group retail0.5 6.9 37.3 2.1 (46) 
Barclays UK0.4 2.2 11.5 0.8 122 32 
Barclays International0.2 1.4 43.2 0.8 (197) 
Head Office  90.5 3.4   
Total Barclays Group wholesalea
0.3 1.5 28.7 0.8 (75) 
Total loans and advances at amortised cost0.4 4.9 34.8 1.6 (121) 
Off-balance sheet loan commitments and financial guarantee contractsb
0.9 1.8 0.2 (514)
Other financial assets subject to impairmentc
(18)
Total0.2 3.1 29.8 0.9 (653)
Notes
a    Includes Wealth and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures, including BBLs of £9.4bn that are managed on a collective basis and reported within BUK Retail. The net impact is a difference in total exposure of £5,994m of balances reported as wholesale loans in the Loans and advances at amortised cost by product disclosure.
b    Excludes loan commitments and financial guarantees of £18.8bn carried at fair value.
c    Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn and impairment allowance of £114m. This comprises £6m ECL on £154.9bn Stage 1 assets, £1m on £157m Stage 2 fair value through other comprehensive income assets, other assets, cash collateral and settlement assets and £107m on £110m Stage 3 other assets.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
126

Risk review: Credit risk
Risk performance continued
Loans and advances at amortised cost by stage (audited)
Gross exposureImpairment allowanceNet exposure
Stage 1Stage 2 Stage 3TotalStage 1Stage 2 Stage 3Total
As at 31 December 2020£m£m£m£m£m£m£m£m£m
Barclays UK153,250 23,896 2,732 179,878 332 1,509 1,147 2,988 176,890 
Barclays Internationala
21,048 5,500 1,992 28,540 396 1,329 1,205 2,930 25,610 
Head Office4,267 720 844 5,831 51 380 435 5,396 
Total Barclays Group retail178,565 30,116 5,568 214,249 732 2,889 2,732 6,353 207,896 
Barclays UK31,918 4,325 1,126 37,369 13 129 116 258 37,111 
Barclays Internationala
79,911 16,565 2,270 98,746 288 546 859 1,693 97,053 
Head Office570 — 33 603 — — 31 31 572 
Total Barclays Group wholesaleb
112,399 20,890 3,429 136,718 301 675 1,006 1,982 134,736 
Total loans and advances at amortised cost290,964 51,006 8,997 350,967 1,033 3,564 3,738 8,335 342,632 
Off-balance sheet loan commitments and financial guarantee contractsc
289,939 52,891 2,330 345,160 256 758 50 1,064 344,096 
Totald
580,903 103,897 11,327 696,127 1,289 4,322 3,788 9,399 686,728 
Loan impairment charge and loan loss rate
Coverage ratio Loan impairment chargeLoan loss rate
Stage 1Stage 2 Stage 3Total
As at 31 December 2020%%%%£mbps
Barclays UK0.2 6.3 42.0 1.7 1,070 59
Barclays Internationala
1.9 24.2 60.5 10.3 1,680 589
Head Office0.1 7.1 45.0 7.5 91 156
Total Barclays Group retail0.4 9.6 49.1 3.0 2,841 133
Barclays UK— 3.0 10.3 0.7 154 41
Barclays Internationala
0.4 3.3 37.8 1.7 914 93
Head Office— — 93.9 5.1 — 
Total Barclays Group wholesaleb
0.3 3.2 29.3 1.4 1,068 78
Total loans and advances at amortised cost0.4 7.0 41.5 2.4 3,909 111
Off-balance sheet loan commitments and financial guarantee contractsc
0.1 1.4 2.1 0.3 776 
Other financial assets subject to impairmentd
153 
Totale
0.2 4.2 33.4 1.4 4,838 
Notes
a    Private Banking have refined the methodology to classify £5bn of their exposure between Wholesale and Retail during the year.
b    Included in the above analysis are Wealth and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,551m of balances reported as wholesale loans in the Loans and advances at amortised cost by product disclosure.
c    Excludes loan commitments and financial guarantees of £9.5bn carried at fair value.
d    Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn and impairment allowance of £165m. This comprises £11m ECL on £175.7bn Stage 1 assets £9m on £4.4bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £145m on £154m Stage 3 other assets.
e    The loan loss rate is 138bps after applying the total impairment charge of £4,838m.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
127

Risk review: Credit risk
Risk performance continued
Loans and advances at amortised cost by product (audited)
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.
Loans and advances at amortised cost by product (audited)
Stage 2
As at 31 December 2021Stage 1Not past due<=30 days past due>30 days past dueTotalStage 3Total
Gross exposure£m£m£m£m£m£m£m
Home loans148,058 17,133 1,660 707 19,500 2,122 169,680 
Credit cards, unsecured loans and other retail lending37,840 5,102 300 248 5,650 2,332 45,822 
Wholesale loans 132,967 15,246 306 391 15,943 2,781 151,691 
Total318,865 37,481 2,266 1,346 41,093 7,235 367,193 
Impairment allowance
Home loans19 46 6 7 59 397 475 
Credit cards, unsecured loans and other retail lending824 1,493 85 123 1,701 1,504 4,029 
Wholesale loans 363 248 4 3 255 620 1,238 
Total1,206 1,787 95 133 2,015 2,521 5,742 
Net exposure
Home loans148,039 17,087 1,654 700 19,441 1,725 169,205 
Credit cards, unsecured loans and other retail lending37,016 3,609 215 125 3,949 828 41,793 
Wholesale loans 132,604 14,998 302 388 15,688 2,161 150,453 
Total317,659 35,694 2,171 1,213 39,078 4,714 361,451 
Coverage ratio%%%%%%%
Home loans0.30.41.00.318.70.3
Credit cards, unsecured loans and other retail lending2.229.328.349.630.164.58.8
Wholesale loans 0.31.61.30.81.622.30.8
Total0.44.84.29.94.934.81.6
As at 31 December 2020
Gross exposure£m£m£m£m£m£m£m
Home loans138,639 16,651 1,785 876 19,312 2,234 160,185 
Credit cards, unsecured loans and other retail lending33,021 9,470 544 306 10,320 3,172 46,513 
Wholesale loans 119,304 19,501 1,097 776 21,374 3,591 144,269 
Total290,964 45,622 3,426 1,958 51,006 8,997 350,967 
Impairment allowance
Home loans33 57 13 14 84 421 538 
Credit cards, unsecured loans and other retail lending680 2,382 180 207 2,769 2,251 5,700 
Wholesale loans 320 650 50 11 711 1,066 2,097 
Total1,033 3,089 243 232 3,564 3,738 8,335 
Net exposure
Home loans138,606 16,594 1,772 862 19,228 1,813 159,647 
Credit cards, unsecured loans and other retail lending32,341 7,088 364 99 7,551 921 40,813 
Wholesale loans 118,984 18,851 1,047 765 20,663 2,525 142,172 
Total289,931 42,533 3,183 1,726 47,442 5,259 342,632 
Coverage ratio%%%%%%%
Home loans0.30.71.60.418.80.3
Credit cards, unsecured loans and other retail lending2.125.233.167.626.871.012.3
Wholesale loans 0.33.34.61.43.329.71.5
Total0.46.87.111.87.041.52.4
The increase in coverage on Credit cards, unsecured loans and other retail lending Stage 2 not past due is driven by a reduction in balances and the economic uncertainty adjustments held for specific customers and clients who may be more vulnerable to the full withdrawal of support and emerging economic uncertainty.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
128

Risk review: Credit risk
Risk performance continued
Loans and advances at amortised cost by selected sectors
The table below presents a breakdown of drawn exposure and impairment allowance for loans and advances at amortised cost , with stage allocation for selected industry sectors within the wholesale loans portfolio. The industry sectors have been selected based upon the level of management focus they have received following the onset of the COVID-19 pandemic. The credit risk industry concentration disclosure in the analysis of the concentration of credit risk section represents all the industry categories and the below only covers a subset of that table.
The gross loans and advances to selected sectors have decreased over the year driven by repayments and lower drawdowns. The reduction in provisions is informed by the improved macroeconomic outlook over the course of 2021, partially offset by management judgements to reflect the risk of uncertainty still prevailing within these sectors. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against systemic losses. An additional £0.1bn (2020: £0.1bn) impairment allowance has been applied to the undrawn exposures not included in the table below
Loans and advances at amortised cost by selected sectors
Gross exposureImpairment allowance
Stage 1Stage 2 Stage 3TotalStage 1Stage 2 Stage 3Total
As at 31 December 2021£m£m£m£m£m£m£m£m
Air travel232 201 94 527 9 5 37 51 
Hospitality and leisure4,898 986 377 6,261 26 19 45 90 
Oil and gas1,765 576 62 2,403 14 9 21 44 
Retail3,901 780 192 4,873 38 14 39 91 
Shipping382 201 25 608 9 8 0 17 
Transportation1,166 417 156 1,739 18 9 29 56 
Total12,344 3,161 906 16,411 114 64 171 349 
Total of wholesale exposures (%)9 %20 %33 %11 %31 %25 %28 %28 %
Gross exposureImpairment allowance
Stage 1Stage 2 Stage 3TotalStage 1Stage 2 Stage 3Total
As at 31 December 2020£m£m£m£m£m£m£m£m
Air travel367 525 56 948 27 23 59 
Hospitality and leisure4,440 2,387 313 7,140 53 115 61 229 
Oil and gas1,754 854 465 3,073 31 27 140 198 
Retail3,907 1,153 283 5,343 78 51 108 237 
Shipping308 389 12 709 30 33 
Transportation1,148 253 125 1,526 19 10 57 86 
Total11,924 5,561 1,254 18,739 192 260 390 842 
Total of wholesale exposures (%)10 %26 %35 %13 %60 %37 %37 %40 %
The coverage ratio for selected sectors has decreased from 4.5% as at 31 December 2020 to 2.1% as at 31 December 2021 due to improved macroeconomic outlook. Non Default coverage remains elevated as compared to Pre COVID level.
Exposure to UK Commercial Real Estate £8.5bn (2020: £9.9bn) remained stable and is predominantly in Stage1 82% (2020: 83%). The loan portfolio is well collateralised, hence a low coverage of 1% (ECL: £0.1bn). Exposure included in Stage 3 is 4% (2020: 4%) having a coverage ratio of 17% (2020: 20%).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
129

Risk review: Credit risk
Risk performance continued
Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees
The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the methodology used to determine credit impairment provisions is included in Note 7. Transfers between stages in the tables have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 12-month period.
Loans and advances at amortised cost (audited)
Stage 1Stage 2Stage 3Total
Gross exposureECLGross exposureECLGross exposureECLGross exposureECL
£m£m£m£m£m£m£m£m
Home loans
As at 1 January 2021138,639 33 19,312 84 2,234 421 160,185 538 
Transfers from Stage 1 to Stage 2(7,672)(2)7,672 2     
Transfers from Stage 2 to Stage 15,336 32 (5,336)(32)    
Transfers to Stage 3(282) (469)(9)751 9   
Transfers from Stage 335 1 203 5 (238)(6)  
Business activity in the yeara
32,744 7 1,243 5 4  33,991 12 
Refinements to models used for calculationb
   (4) 38  34 
Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes(8,131)(50)(1,090)12 (216)(26)(9,437)(64)
Final repayments(12,039)(2)(2,009)(4)(392)(18)(14,440)(24)
Disposalsc
(572) (26)   (598) 
Write-offsd
    (21)(21)(21)(21)
As at 31 December 2021e
148,058 19 19,500 59 2,122 397 169,680 475 
Credit cards, unsecured loans and other retail lending
As at 1 January 202133,021 680 10,320 2,769 3,172 2,251 46,513 5,700 
Transfers from Stage 1 to Stage 2(1,894)(78)1,894 78     
Transfers from Stage 2 to Stage 14,717 1,174 (4,717)(1,174)    
Transfers to Stage 3(529)(22)(790)(370)1,319 392   
Transfers from Stage 355 26 32 19 (87)(45)  
Business activity in the yeara
7,842 119 257 62 42 19 8,141 200 
Refinements to models used for calculationb
 (5) (33) 14  (24)
Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changesf
(2,793)(1,030)(848)389 (165)620 (3,806)(21)
Final repayments(2,579)(40)(498)(39)(212)(92)(3,289)(171)
Disposalsc
    (287)(205)(287)(205)
Write-offsd
    (1,450)(1,450)(1,450)(1,450)
As at 31 December 2021e
37,840 824 5,650 1,701 2,332 1,504 45,822 4,029 
Wholesale loans
As at 1 January 2021119,304 320 21,374 711 3,591 1,066 144,269 2,097 
Transfers from Stage 1 to Stage 2(6,115)(19)6,115 19     
Transfers from Stage 2 to Stage 19,137 257 (9,137)(257)    
Transfers to Stage 3(804)(4)(377)(21)1,181 25   
Transfers from Stage 3580 23 410 22 (990)(45)  
Business activity in the yeara
34,804 95 1,774 18 283 50 36,861 163 
Refinements to models used for calculationb
 8  11    19 
Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes(417)(268)721 (68)(211)67 93 (269)
Final repayments(22,219)(34)(4,734)(174)(545)(131)(27,498)(339)
Disposalsc
(1,303)(15)(203)(6)(163)(47)(1,669)(68)
Write-offsd
    (365)(365)(365)(365)
As at 31 December 2021e
132,967 363 15,943 255 2,781 620 151,691 1,238 
Notes
a    Business activity in the year does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'.
b    Refinements to models used for calculation include a £34m movement in Home loans, £24m in Credit cards, unsecured loans and other retail lending and £19m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
130

Risk review: Credit risk
Risk performance continued
c    The £598m disposals reported within Home loans relate to transfer of facilities to a non-consolidated special purpose vehicle for the purpose of securitisation. The £287m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relate to debt sales undertaken during the year. The £1.7bn disposal reported within Wholesale loans includes a £1.0bn sale of Barclays Asset Finance and a £0.7bn of debt sales.
d    In 2021, gross write-offs amounted to £1,836m (2020: £1,964m) and post write-off recoveries amounted to £66m (2020: £35m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,770m (2020: £1,929m).
e    Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £6m ECL (December 2020: £11m) on £154.9bn Stage 1 assets (December 2020: £175.7bn), £1m (December 2020: £9m) on £157m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2020: £4.4bn) and £107m (December 2020: £145m) on £110m Stage 3 other assets (December 2020: £154m).
f    Transfers and risk parameters change include a £0.3bn (2020: £0.6bn) net release in ECL arising from reclassification of £1.9bn (2020: £2.0bn) gross loans and advances from Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending. The reclassification followed a review of back-testing of results which indicated that accuracy of origination probability of default characteristics require management adjustments to correct and was first established in Q220.

Reconciliation of ECL movement to credit impairment (release)/charge for the period£m
Home loans(42)
Credit cards, unsecured loans and other retail lending(16)
Wholesale loans(426)
ECL movement excluding assets derecognised due to disposals and write-offs(484)
Recoveries and reimbursementsa
240 
Exchange and other adjustmentsb
123 
Credit impairment release on loan commitments and financial guarantees(514)
Credit impairment release on other financial assetsc
(18)
Credit impairment release for the year(653)
Notes
a    Recoveries and reimbursements includes a net reduction in amounts recoverable from financial guarantee contracts held with third parties of £306m and cash recoveries of previously written off amounts of £66m.
b    Includes foreign exchange and interest and fees in suspense.
c    Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £6m ECL (December 2020: £11m) on £154.9bn Stage 1 assets (December 2020: £175.7bn), £1m (December 2020: £9m) on £157m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2020: £4.4bn) and £107m (December 2020: £145m) on £110m Stage 3 other assets (December 2020: £154m).

Loan commitments and financial guarantees (audited)
Stage 1Stage 2Stage 3Total
Gross exposureECLGross exposureECLGross exposureECLGross exposureECL
£m£m£m£m£m£m£m£m
Home loans
As at 1 January 202111,861  516  5  12,382  
Net transfers between stages(131) 124  7    
Business activity in the year7,034      7,034  
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes(7,556) (64) (4) (7,624) 
Limit management and final repayments(375) (44) (5) (424) 
As at 31 December 202110,833  532  3  11,368  
Credit cards, unsecured loans and other retail lending
As at 1 January 2021114,371 55 12,117 305 229 23 126,717 383 
Net transfers between stages5,769 206 (6,379)(213)610 7   
Business activity in the year11,206  430  2  11,638  
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes(742)(207)217 (24)(526)(10)(1,051)(241)
Limit management and final repayments(7,785)(4)(667)(7)(97) (8,549)(11)
As at 31 December 2021122,819 50 5,718 61 218 20 128,755 131 
Wholesale loans
As at 1 January 2021163,707 201 40,258 453 2,096 27 206,061 681 
Net transfers between stages8,227 221 (7,174)(215)(1,053)(6)  
Business activity in the year44,085 14 4,658 102 10  48,753 116 
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes8,819 (229)(151)7 515 (11)9,183 (233)
Limit management and final repayments(46,348)(40)(9,026)(106)(491)(7)(55,865)(153)
As at 31 December 2021178,490 167 28,565 241 1,077 3 208,132 411 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
131

Risk review: Credit risk
Risk performance continued
Loans and advances at amortised cost (audited)
Stage 1Stage 2Stage 3Total
Gross exposureECLGross exposureECLGross exposureECLGross exposureECL
£m£m£m£m£m£m£m£m
Home loans
As at 1 January 2020135,713 22 17,043 64 2,155 346 154,911 432 
Transfers from Stage 1 to Stage 2(8,724)(1)8,724 — — — — 
Transfers from Stage 2 to Stage 14,618 14 (4,618)(14)— — — — 
Transfers to Stage 3(308)— (420)(10)728 10 — — 
Transfers from Stage 347 219 (266)(3)— — 
Business activity in the yeara
22,548 714 — 23,266 
Refinements to models used for calculationb
— — — — — — — — 
Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes(6,195)(9)(841)42 (57)105 (7,093)138 
Final repayments(9,060)(1)(1,509)(3)(308)(15)(10,877)(19)
Disposalsc
— — — — — — — — 
Write-offsd
— — — — (22)(22)(22)(22)
As at 31 December 2020e
138,639 33 19,312 84 2,234 421 160,185 538 
Credit cards, unsecured loans and other retail lending
As at 1 January 202046,012 542 10,759 2,007 3,409 2,335 60,180 4,884 
Transfers from Stage 1 to Stage 2(6,571)(134)6,571 134 — — — — 
Transfers from Stage 2 to Stage 13,080 482 (3,080)(482)— — — — 
Transfers to Stage 3(712)(25)(1,162)(398)1,874 423 — — 
Transfers from Stage 376 39 67 12 (143)(51)— — 
Business activity in the yeara
5,598 67 324 83 59 28 5,981 178 
Refinements to models used for calculationb
— 13 — 296 — — — 309 
Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changesf
(9,678)(229)(2,706)1,174 (10)1,353 (12,394)2,298 
Final repayments(3,291)(67)(270)(37)(204)(84)(3,765)(188)
Disposalsc
(1,493)(8)(183)(20)(204)(144)(1,880)(172)
Write-offsd
— — — — (1,609)(1,609)(1,609)(1,609)
As at 31 December 2020e
33,021 680 10,320 2,769 3,172 2,251 46,513 5,700 
Wholesale loans
As at 1 January 2020117,541 143 10,432 302 2,359 547 130,332 992 
Transfers from Stage 1 to Stage 2(12,531)(35)12,531 35 — — — — 
Transfers from Stage 2 to Stage 14,121 40 (4,121)(40)— — — — 
Transfers to Stage 3(1,137)(4)(875)(58)2,012 62 — — 
Transfers from Stage 3471 22 247 13 (718)(35)— — 
Business activity in the yeara
27,863 46 2,336 149 634 85 30,833 280 
Refinements to models used for calculationb
— — — — — — — — 
Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes13,828 130 3,811 339 (64)799 17,575 1,268 
Final repayments(28,458)(22)(2,977)(29)(299)(59)(31,734)(110)
Disposalsc
(2,394)— (10)— — — (2,404)— 
Write-offsd
— — — — (333)(333)(333)(333)
As at 31 December 2020e
119,304 320 21,374 711 3,591 1,066 144,269 2,097 
Notes
a    Business activity in the year does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'.
b    Refinements to models used for calculation include a £309m adjustment which largely represents model remediation for over recovery of debt in UK unsecured lending. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses.
c    The £1.9bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio includes £1.7bn sale of motor financing business within the Barclays Partner Finance business and £0.2bn relate to debt sales undertaken during the year. The £2.4bn disposal reported within Wholesale loans include sale of debt securities as part of the Group Treasury operations.
d     In 2020, gross write-offs amounted to £1,964m (2019: £1,883m) and post write-off recoveries amounted to £35m (2019: £124m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,929m (2019: £1,759m).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
132

Risk review: Credit risk
Risk performance continued
e    Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn (December 2019: £149.3bn) and impairment allowance of £165m (December 2019: £24m). This comprises £11m ECL (December 2019: £12m) on £175.7bn Stage 1 assets (December 2019: £148.5bn), £9m (December 2019: £2m) on £4.4bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2019: £0.8bn) and £145m (December 2019: £10m) on £154m Stage 3 other assets (December 2019: £10m).
f    Transfers and risk parameter changes has seen an ECL increase which is materially driven by stage migration in response to the macroeconomic scenario updates, partially offset by a net release in ECL of £0.6bn due to a reclassification of £2.0bn gross loans and advances from Stage 2 to Stage 1 in credit cards and unsecured loans. The reclassification followed a review of back-testing of results which indicated that origination probability of default characteristics were unnecessarily moving Stage 1 accounts into Stage 2.

Reconciliation of ECL movement to credit impairment charge/(release) for the period£m
Home loans128 
Credit cards, unsecured loans and other retail lending2,597 
Wholesale loans1,438 
ECL movement excluding assets derecognised due to disposals and write-offs4,163 
Recoveries and reimbursementsa
(399)
Exchange and other adjustmentsb
145 
Credit impairment charge on loan commitments and financial guarantees776 
Credit impairment charge on other financial assetsc
153 
Credit impairment charge for the year4,838 
Notes
a    Recoveries and reimbursements includes £364m for reimbursements expected to be received under the arrangement where Group has entered into financial guarantee contracts which provide credit protection over certain loan assets with third parties. Cash recoveries of previously written off amounts to £35m.
b    Includes foreign exchange and interest and fees in suspense.
c    Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn (December 2019: £149.3bn) and impairment allowance of £165m (December 2019: £24m). This comprises £11m ECL (December 2019: £12m) on £175.7bn Stage 1 assets (December 2019: £148.5bn), £9m (December 2019: £2m) on £4.4bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2019: £0.8bn) and £145m (December 2019: £10m) on £154m Stage 3 other assets (December 2019: £10m).

Loan commitments and financial guarantees (audited)
Stage 1Stage 2Stage 3Total
Gross exposureECLGross exposureECLGross exposureECLGross exposureECL
£m£m£m£m£m£m£m£m
Home loans
As at 1 January 20209,542 — 500 — — 10,046 — 
Net transfers between stages(82)— 78 — — — — 
Business activity in the year7,975 — — — — — 7,975 — 
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes(5,332)— (27)— (2)— (5,361)— 
Limit management and final repayments(242)— (35)— (1)— (278)— 
As at 31 December 202011,861 — 516 — — 12,382 — 
Credit cards, unsecured loans and other retail lending
As at 1 January 2020125,759 35 6,238 71 250 14 132,247 120 
Net transfers between stages(5,477)43 4,725 (40)752 (3)— — 
Business activity in the year5,214 158 5,374 
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes1,298 (22)1,636 272 (671)15 2,263 265 
Limit management and final repayments(12,423)(3)(640)(1)(104)(4)(13,167)(8)
As at 31 December 2020114,371 55 12,117 305 229 23 126,717 383 
Wholesale loans
As at 1 January 2020185,839 62 12,447 99 681 41 198,967 202 
Net transfers between stages(28,325)67 27,319 (72)1,006 — — 
Business activity in the year42,917 32 4,708 102 774 48,399 136 
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes13,637 47 (44)338 (69)(20)13,524 365 
Limit management and final repayments(50,361)(7)(4,172)(14)(296)(1)(54,829)(22)
As at 31 December 2020163,707 201 40,258 453 2,096 27 206,061 681 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
133

Risk review: Credit risk
Risk performance continued
Stage 2 decomposition
Loans and advances at amortised costa
20212020
Gross exposureImpairment allowanceGross exposureImpairment allowance
As at 31 December£m £m£m £m
Quantitative test29,096 1,612 36,754 3,252 
Qualitative test10,891 372 11,865 273 
30 days past due backstop1,106 31 2,387 39 
Total Stage 241,093 2,015 51,006 3,564 
Note
a    Where balances satisfy more than one of the above three criteria for determining a significant increase in credit risk, the corresponding gross exposure and ECL has been assigned in order of categories presented.
Stage 2 exposures are predominantly identified using quantitative tests where the lifetime PD has deteriorated more than a pre-determined amount since origination during the year driven by changes in macroeconomic variables. This is augmented by inclusion of accounts meeting the designated high risk criteria (including watchlist) for the portfolio under the qualitative test. Qualitative tests predominantly include £8.3bn (2020: £8.5bn) in Barclays UK of which £6.8bn (2020: £7.1bn) relates to UK Home Finance, £1.0bn (2020: £1.0bn) relates to Business Banking and £0.2bn (2020: £0.1bn) relates to Barclaycard UK. A further £2.6bn (2020: £3.3bn) relates to Barclays International of which £1.4bn (2020: £2.0bn) relates to Corporate and Investment Bank and £1.1bn (2020: £1.0bn) relates to Consumer, Cards and Payments.
A small number of other accounts (2% of impairment allowances and 3% of gross exposure) are included in Stage 2. These accounts are not otherwise identified by the quantitative or qualitative tests but are more than 30 days past due. The percentage triggered by these backstop criteria is a measure of the effectiveness of the Stage 2 criteria in identifying deterioration prior to delinquency. These balances include items in the Corporate and Investment Bank for reasons such as outstanding interest and fees rather than principal balances.
For further detail on the three criteria for determining a significant increase in credit risk required for Stage 2 classification, refer to Note 7.
Stage 3 decomposition
Loans and advances at amortised cost
20212020
Gross exposureImpairment allowanceGross exposureImpairment allowance
As at 31 December£m £m£m £m
Exposures not charged-off including within cure perioda
3,894 657 3,773 831 
Exposures individually assessed or in recovery bookb
3,341 1,864 5,224 2,907 
Total Stage 37,235 2,521 8,997 3,738 
Notes
a    Includes £2.9bn (2020: £2.6bn) of gross exposure in a cure period that must remain in Stage 3 for a minimum of 12 months before moving to Stage 2.
b    Exposures individually assessed or in recovery book cannot cure out of Stage 3.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
134

Risk review: Credit risk
Risk performance continued
Management adjustments to models for impairment (audited)
Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end. Management adjustments are reviewed and incorporated into future model development where applicable.
Total management adjustments to impairment allowance are presented by product below:
Overview of management adjustments to models for impairment allowance (audited)a
20212020
Management adjustments to impairment allowancesProportion of total impairment allowancesManagement adjustments to impairment allowancesProportion of total impairment allowances
As at 31 December£m%£m%
Home loans10321.7 13124.3 
Credit cards, unsecured loans and other retail lending1,36232.7 1,23420.3 
Wholesale loans211.3 230.8 
Total1,48623.6 1,38814.8 
Note
a    Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance.

Management adjustments to models are presented by product below: (audited)a
Impairment allowance pre management adjustmentsb
Economic uncertainty adjustments(a)
Other adjustments(b)
Total adjustments(a+b)
Total impairment allowancec
As at 31 December 2021£m£m£m£m£m
Home loans372 72 31 103 475 
Credit cards, unsecured loans and other retail lending2,798 1,217 145 1,362 4,160 
Wholesale loansd
1,628 403 (382)21 1,649 
Total4,798 1,692 (206)1,486 6,284 
As at 31 December 2020£m£m£m£m£m
Home loans407 21 110 131 538 
Credit cards, unsecured loans and other retail lending4,849 1,625 (391)1,234 6,083 
Wholesale loansd
2,755 421 (398)23 2,778 
Total8,011 2,067 (679)1,388 9,399 
Notes
a    Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance.
b    Includes £4.1bn (2020: £6.8bn) of modelled ECL, £0.5bn (2020: £0.9bn) of individually assessed impairments and £0.2bn (2020: £0.3bn) ECL from non-modelled exposures.
c    Total impairment allowance consist of ECL stock on drawn and undrawn exposure.
d    Other adjustments include £(0.4)bn related to Bounce Back Loan government guarantees in 2021. In the prior year, the adjustment was £(0.1)bn) and was presented under economic uncertainty.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
135

Risk review: Credit risk
Risk performance continued
Economic uncertainty adjustments
Throughout the COVID-19 pandemic in 2020 and 2021, macroeconomic forecasts anticipated lasting impacts to unemployment levels and customer and client stress. More recent macroeconomic forecasts indicated that the outlook has improved, with measures of government and bank support having tapered down and no material deterioration in customer delinquencies observed to date. However, the degree of economic uncertainty remains relatively high: credit deterioration may still occur when support measures are fully withdrawn across geographies; emerging supply chain disruption and inflationary pressures may challenge economic stability; and economic consensus may not capture the range of economic uncertainty associated with fast moving new COVID-19 variants such as Omicron.
Given this backdrop, management has recognised economic uncertainty adjustments to modelled outputs to address these sources of uncertainties and ensure that the potential impacts of stress are provided for. This uncertainty continues to be captured in two distinct ways. Firstly, customer uncertainty: the identification of customers and clients who may be more vulnerable to the withdrawal of support schemes and emerging economic instability; and secondly, model uncertainty: to capture the impact from model limitations and sensitivities to specific macroeconomic parameters which are applied at a portfolio level.
The economic uncertainty adjustments of £1.7bn (2020: £2.1bn) includes customer and client uncertainty provisions of £1.5bn (2020: £1.7bn) and model uncertainty provisions of £0.2bn (2020: £0.4bn).
Customer uncertainty provisions comprises:
a. An adjustment of £0.4bn (2020: £0.7bn) to adjust the probability of default (PDs) to pre-COVID-19 levels to offset the temporary improvement to PDs in light of reduced customer spend behaviour and support measures. The decrease of £0.3bn is primarily driven by some normalisation of customer spending behaviour during the year resulting in a partial release of the PMA.
b. A vulnerable customer adjustment of £1.1bn (2020: £1.0bn) has been applied to customers and clients considered potentially vulnerable to the withdrawal of support schemes and emerging economic instability against which lifetime coverage is applied. This is split between credit cards, unsecured loans and other retail lending of £0.8bn (2020: £0.8bn) and wholesale loans of £0.3bn (2020: £0.2bn). The latter includes an adjustment of £0.1bn (2020: nil) to reflect possible cross default risk on Barclays lending in respect of clients who have taken bounce back loans.
Model uncertainty provisions reduced by £0.2bn reflecting an update in adjustment in response to the modelled provisions following the update in the Q421 scenarios.
Other adjustments
Other adjustments are operational in nature and are expected to remain in place until they can be corrected in the underlying models. These adjustments result from data limitations and model performance related issues identified through established governance processes. The quantum of adjustments reduced in response to the Q421 scenarios as well as model enhancements made during the year. Material adjustments consists of the following:
Home loans: The low average LTV nature of the UK Home Loans portfolio means that modelled ECL estimates are low and do not reflect the tail risk with severe economic stress. An adjustment is made to maintain an appropriate level of ECL informed by model monitoring.
Credit cards, unsecured loans and other retail lending: Includes an adjustment for model inaccuracies informed by model monitoring and a reclassification of loans and advances from Stage 2 to Stage 1 in credit cards. The reclassification followed a review of back-testing results which indicated that accuracy of origination probability of default characteristics require management adjustments to correct and was first established in Q220. This adjustment has reduced driven by the improved macroeconomic scenarios in Q421 and the reduction in exposure on this portfolio.
Wholesale loans: Materially comprises of an adjustment applied on bounce back loans of £(0.4)bn to reverse out the modelled charge which does not consider the government guarantee when calculating the ECL.
Management adjustments of £(0.4)bn within wholesale loans in 2020 primarily comprised an adjustment to offset modelled ECL output in the Investment Bank to limit excessive ECL sensitivity to the macroeconomic variable for Federal Tax Receipts.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
136

Risk review: Credit risk
Risk performance continued
Measurement uncertainty and sensitivity analysis
Management has applied economic uncertainty and other adjustments to modelled ECL outputs. Economic uncertainty adjustments reflect the potential vulnerability of specific customers and clients who may be more vulnerable to the full withdrawal of support and emerging economic instability and the degree to which economic consensus may not have captured the range of economic uncertainty associated with new variants of COVID-19. As a result, ECL is higher than would be the case if it were based on forecast economic scenarios alone.
The measurement of modelled ECL involves complexity and judgement, including estimation of probabilities of default (PD), loss given default (LGD), a range of unbiased future economic scenarios, estimation of expected lives, estimation of exposures at default (EAD) and assessing significant increases in credit risk. The Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices), which forms the Baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated to a broadly similar severity to Barclays’ internal stress tests and stress scenarios provided by regulators whilst also considering IFRS 9 specific sensitivities and non-linearity. The favourable scenarios are designed to reflect plausible upside risks to the Baseline scenario which are broadly consistent with the economic narrative approved by the Senior Scenario Review Committee. All scenarios are regenerated at a minimum semi-annually. The scenarios include eight key economic variables (GDP, unemployment, House Price Index (HPI) and base rates in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed to evolve over a five-year stress horizon, with all five scenarios converging to a steady state after approximately eight years.
Scenarios used to calculate the Group’s ECL charge were reviewed and updated regularly throughout 2021, following the continuation of the COVID-19 pandemic throughout the year, including the emergence of the Omicron variant and the global vaccination rollout. The current Baseline scenario reflects the latest consensus economic forecasts; the steady recovery in GDP in both the UK and US continues with UK GDP returning to pre-COVID-19 pandemic levels by Q222. UK unemployment peaks at 5.0% in Q122 and US unemployment continues to decline. In the Downside 2 scenario, inflation continues to accelerate and the UK bank rate is increased to 4.0% and the US federal funds rate is increased to 3.5%, by the end of 2022, leading to a further downturn in GDP until Q323. Unemployment peaks in Q323 at 9.2% in the UK and 9.5% in the US. In the Upside 2 scenario, inflation expectations and global energy prices stabilise and GDP growth rises as COVID-19 risks continue to decline helping to release more of the pent-up demand and accumulated household savings into the economy. Unemployment rates decline gradually.
The methodology for estimating probability weights used in calculating ECL involves simulating a range of future paths for UK and US GDP using historical data. The five scenarios are mapped against the distribution of these future paths, with the median centred around the Baseline such that scenarios further from the Baseline attract a lower weighting. A single set of five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The same scenarios and weights that are used in the estimation of expected credit losses are also used for Barclays' internal planning purposes. The impacts across the portfolios are different because of the sensitivities of each of the portfolios to specific macroeconomic variables, for example, mortgages are highly sensitive to house prices, credit cards and unsecured consumer loans are highly sensitive to unemployment.
The changes to the scenario weights in 2021 primarily reflect changes made to the severity of the scenarios. The Downside 2 scenario has been aligned with the internal stress test, which is informed by a weaker GDP outlook. The effect of this is to move the Downside 2 scenario further away from the Baseline, resulting in a lower weighting. For further details see page 140..
Although the macroeconomic outlook has improved, the level of uncertainty remains relatively high. A key judgement is the extent to which economic uncertainty experienced throughout the COVID-19 pandemic now reflects additional challenges, namely inflationary pressures and global supply chain disruptions. Inflationary headwinds have yet to materially impact customer affordability and corporate profitability data. A balanced approach has therefore been adopted in the sizing of expert judgements as we move away from a period characterised by significant customer support.
The economic uncertainty adjustments of £1.7bn (2021: £2.1bn) have been applied as overlays to the modelled ECL output. These adjustments consist of a customer and client uncertainty provision of £1.5bn (2021: £1.7bn) and a model uncertainty provision of £0.2bn (2021: £0.4bn). For further details see pages 135 to 136.
The tables below show the key macroeconomic variables used in the five scenarios (5 year annual paths), the probability weights applied to each scenario and the macroeconomic variables by scenario using ‘specific bases’ i.e. the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios and the lowest unemployment for upside scenarios. 5-year average tables and movement over time graphs provide additional transparency. Annual paths show quarterly averages for the year (unemployment and base rate) or change in the year (GDP and HPI).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
137

Risk review: Credit risk
Risk performance continued
Baseline average macroeconomic variables used in the calculation of ECL
20212022202320242025
As at 31 December 2021 % % % % %
UK GDPa
6.2 4.9 2.3 1.9 1.7 
UK unemploymentb
4.8 4.7 4.5 4.3 4.2 
UK HPIc
4.7 1.0 1.9 1.9 2.3 
UK bank rate0.1 0.8 1.0 1.0 0.8 
US GDPa
5.5 3.9 2.6 2.4 2.4 
US unemploymentd
5.5 4.2 3.6 3.6 3.6 
US HPIe
11.8 4.5 5.2 4.9 5.0 
US federal funds rate0.2 0.3 0.9 1.2 1.3 
20202021202220232024
As at 31 December 2020 % % % % %
UK GDPa
(10.1)6.3 3.3 2.6 2.0 
UK unemploymentb
4.5 6.7 6.4 5.8 5.1 
UK HPIc
6.1 2.4 2.3 5.0 2.4 
UK bank rate0.2 0.0 (0.1)0.0 0.1 
US GDPa
(4.4)3.9 3.1 2.9 2.9 
US unemploymentd
8.4 6.9 5.7 5.6 5.6 
US HPIe
2.3 2.8 4.7 4.7 4.7 
US federal funds rate0.5 0.3 0.3 0.3 0.4 

Downside 2 average macroeconomic variables used in the calculation of ECL
20212022202320242025
As at 31 December 2021 % % % % %
UK GDPa
6.2 0.2 (4.0)2.8 4.3 
UK unemploymentb
4.8 7.2 9.0 7.6 6.3 
UK HPIc
4.7 (14.3)(21.8)11.9 15.2 
UK bank rate0.1 2.2 3.9 3.1 2.2 
US GDPa
5.5 (0.8)(3.5)2.5 3.2 
US unemploymentd
5.5 6.4 9.1 8.1 6.4 
US HPIe
11.8 (6.6)(9.0)5.9 6.7 
US federal funds rate0.2 2.1 3.4 2.6 2.0 
20202021202220232024
As at 31 December 2020 % % % % %
UK GDPa
(10.1)(3.9)6.5 2.6 1.4 
UK unemploymentb
4.5 8.0 9.3 7.8 6.3 
UK HPIc
6.1 (13.6)(10.8)0.5 1.5 
UK bank rate0.2 (0.2)(0.2)(0.1)(0.1)
US GDPa
(4.4)(2.4)3.6 2.1 2.0 
US unemploymentd
8.4 13.4 11.9 10.1 8.2 
US HPIe
2.3 (17.2)(0.7)0.6 1.3 
US federal funds rate0.5 0.3 0.3 0.3 0.3 
Notes
a    Average Real GDP seasonally adjusted change in year.
b    Average UK unemployment rate 16-year+.
c    Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
d    Average US civilian unemployment rate 16-year+.
e    Change in year end US HPI = FHFA house price index, relative to prior year end.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
138

Risk review: Credit risk
Risk performance continued
Downside 1 average macroeconomic variables used in the calculation of ECL
20212022202320242025
As at 31 December 2021 % % % % %
UK GDPa
6.2 2.8 (0.7)2.3 2.9 
UK unemploymentb
4.8 6.2 6.8 6.0 5.3 
UK HPIc
4.7 (6.8)(10.5)6.9 8.6 
UK bank rate0.1 1.6 2.7 2.3 1.6 
US GDPa
5.5 1.6 (0.4)2.4 2.7 
US unemploymentd
5.5 5.4 6.6 6.1 5.2 
US HPIe
11.8 (1.2)(2.1)4.8 5.2 
US federal funds rate0.2 1.3 2.3 2.1 1.8 
20202021202220232024
As at 31 December 2020 % % % % %
UK GDPa
(10.1)0.1 6.6 3.2 1.8 
UK unemploymentb
4.5 7.3 8.0 6.9 5.8 
UK HPIc
6.1 (6.7)(3.5)1.7 2.0 
UK bank rate0.2 (0.1)(0.1)0.0 0.0 
US GDPa
(4.4)0.4 3.6 2.3 2.2 
US unemploymentd
8.4 11.0 8.9 6.9 6.1 
US HPIe
2.3 (5.9)1.8 2.6 3.6 
US federal funds rate0.5 0.3 0.3 0.3 0.3 

Upside 2 average macroeconomic variables used in the calculation of ECL
20212022202320242025
As at 31 December 2021 % % % % %
UK GDPa
6.2 7.2 4.0 2.7 2.1 
UK unemploymentb
4.8 4.5 4.1 4.0 4.0 
UK HPIc
4.7 8.5 9.0 5.2 4.2 
UK bank rate0.1 0.2 0.5 0.5 0.3 
US GDPa
5.5 5.3 4.1 3.5 3.4 
US unemploymentd
5.5 3.9 3.4 3.3 3.3 
US HPIe
11.8 10.6 8.5 7.2 6.6 
US federal funds rate0.2 0.3 0.4 0.7 1.0 
20202021202220232024
As at 31 December 2020 % % % % %
UK GDPa
(10.1)12.2 5.3 3.9 2.9 
UK unemploymentb
4.5 6.2 5.5 4.8 4.4 
UK HPIc
6.1 6.6 10.4 10.8 7.3 
UK bank rate0.2 0.1 0.3 0.3 0.5 
US GDPa
(4.4)7.1 4.6 4.0 3.5 
US unemploymentd
8.4 5.5 4.3 4.1 4.1 
US HPIe
2.3 8.8 9.1 8.9 7.5 
US federal funds rate0.5 0.3 0.4 0.6 0.9 
Notes
a    Average Real GDP seasonally adjusted change in year.
b    Average UK unemployment rate 16-year+.
c    Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
d    Average US civilian unemployment rate 16-year+.
e    Change in year end US HPI = FHFA house price index, relative to prior year end.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
139

Risk review: Credit risk
Risk performance continued
Upside 1 average macroeconomic variables used in the calculation of ECL
20212022202320242025
As at 31 December 2021 % % % % %
UK GDPa
6.2 6.0 3.1 2.3 1.9 
UK unemploymentb
4.8 4.6 4.3 4.2 4.1 
UK HPIc
4.7 5.0 5.0 3.9 3.3 
UK bank rate0.1 0.6 0.8 0.8 0.5 
US GDPa
5.5 4.6 3.4 2.9 2.9 
US unemploymentd
5.5 4.0 3.5 3.5 3.5 
US HPIe
11.8 8.3 7.0 6.0 5.7 
US federal funds rate0.2 0.3 0.6 1.0 1.1 
20202021202220232024
As at 31 December 2020 % % % % %
UK GDPa
(10.1)9.3 3.9 3.4 2.5 
UK unemploymentb
4.5 6.4 6.0 5.2 4.7 
UK HPIc
6.1 4.6 6.1 6.1 4.7 
UK bank rate0.2 0.1 0.1 0.3 0.3 
US GDPa
(4.4)5.5 4.0 3.7 3.3 
US unemploymentd
8.4 6.0 4.8 4.6 4.6 
US HPIe
2.3 6.8 6.7 6.3 5.6 
US federal funds rate0.5 0.3 0.3 0.5 0.8 
Notes
a    Average Real GDP seasonally adjusted change in year.
b    Average UK unemployment rate 16-year+.
c    Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
d    Average US civilian unemployment rate 16-year+.
e    Change in year end US HPI = FHFA house price index, relative to prior year end.

Scenario probability weighting (audited)
Upside 2Upside 1BaselineDownside 1Downside 2
%%%%%
As at 31 December 2021
Scenario probability weighting20.9 27.2 30.1 14.8 7.0 
As at 31 December 2020
Scenario probability weighting20.2 24.2 24.7 15.5 15.4 
Specific bases shows the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start point in the 20 quarter period.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
140

Risk review: Credit risk
Risk performance continued
Macroeconomic variables (specific bases)a
Upside 2Upside 1BaselineDownside 1Downside 2
As at 31 December 2021 % % % % %
UK GDPb
21.4 18.3 3.4 (1.6)(1.6)
UK unemploymentc
4.0 4.1 4.5 7.0 9.2 
UK HPId
35.7 23.8 2.4 (12.7)(29.9)
UK bank rate0.1 0.1 0.7 2.8 4.0 
US GDPb
22.8 19.6 3.4 1.5 (1.3)
US unemploymentc
3.3 3.5 4.1 6.8 9.5 
US HPId
53.3 45.2 6.2 2.2 (5.0)
US federal funds rate0.1 0.1 0.8 2.3 3.5 
As at 31 December 2020
UK GDPb
14.2 8.8 0.7 (22.1)(22.1)
UK unemploymentc
4.0 4.0 5.7 8.4 10.1 
UK HPId
48.2 30.8 3.6 (4.5)(18.3)
UK bank rate0.1 0.1 0.0 0.6 0.6 
US GDPb
15.7 12.8 1.6 (10.6)(10.6)
US unemploymentc
3.8 3.8 6.4 13.0 13.7 
US HPId
42.2 30.9 3.8 (3.7)(15.9)
US federal funds rate0.1 0.1 0.3 1.3 1.3 
Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively.
Macroeconomic variables (5 year averages)a
Upside 2Upside 1BaselineDownside 1Downside 2
As at 31 December 2021 % % % % %
UK GDPe
4.4 3.9 3.4 2.7 1.8 
UK unemploymentf
4.3 4.4 4.5 5.8 7.0 
UK HPIg
6.3 4.4 2.4 0.3 (2.0)
UK bank rate0.3 0.5 0.7 1.7 2.3 
US GDPe
4.4 3.9 3.4 2.4 1.3 
US unemploymentf
3.9 4.0 4.1 5.7 7.1 
US HPIg
8.9 7.7 6.2 3.6 1.4 
US federal funds rate0.5 0.6 0.8 1.5 2.1 
As at 31 December 2020
UK GDPe
2.5 1.6 0.7 0.1 (0.9)
UK unemploymentf
5.0 5.3 5.7 6.5 7.2 
UK HPIg
8.2 5.5 3.6 (0.2)(3.6)
UK bank rate0.3 0.2 0.0 0.0 (0.1)
US GDPe
2.9 2.4 1.6 0.8 0.1 
US unemploymentf
5.3 5.7 6.4 8.3 10.4 
US HPIg
7.3 5.5 3.8 0.8 (3.0)
US federal funds rate0.5 0.5 0.3 0.3 0.3 
Notes
a    UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA house price index. 20 quarter period starts from Q121 (2020: Q120).
b    Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year yearly average CAGR in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios.
c    Lowest quarter in Upside scenarios; 5-year average in Baseline; highest quarter in Downside scenarios. Period based on 20 quarters from Q121 (2020: Q120).
d    Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios.
e    5-year yearly average CAGR, starting 2020 (2020: 2019).
f    5-year average, Period based on 20 quarters from Q121 (2020: Q120).
g    5-year quarter end CAGR, starting Q420 (2020: Q419).

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
141

Risk review: Credit risk
Risk performance continued
The graphs below plot the historical data for GDP growth rate and unemployment rate in the UK and US as well as the forecasted data under each of the five scenarios.
bcs-20211231_g23.jpg
GDP growth based on year on year growth each quarter (Q/(Q-4)).

ECL under 100% weighted scenarios for modelled portfolios (audited)
The table below shows the ECL assuming scenarios have been 100% weighted. Model exposures are allocated to a stage based on the individual scenario rather than through a probability-weighted approach as required for Barclays reported impairment allowances. As a result, it is not possible to back solve to the final reported weighted ECL from the individual scenarios as a balance may be assigned to a different stage dependent on the scenario. Model exposure uses exposure at default (EAD) values and is not directly comparable to gross exposure used in prior disclosures. For Credit cards, unsecured loans and other retail lending, an average EAD measure is used (12-month or lifetime, depending on stage allocation in each scenario). Therefore, the model exposure movement into Stage 2 is higher than the corresponding Stage 1 reduction.
All ECL using a model is included, with the exception of Treasury assets (£3.9m of ECL). Non-modelled exposures and management adjustments are excluded. For information on management adjustments, please see pages 135 to 136.
Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on observable evidence of default as at 31 December 2021 and not on macroeconomic scenarios.
The Downside 2 scenario represents a severe global recession with substantial falls in both UK and US GDP. Unemployment in UK markets rises towards 9.2% and US markets rises towards 9.5% and there are substantial falls in asset prices including housing. Under the Downside 2 scenario, model exposure moves between stages as the economic environment weakens. This can be seen in the movement of £23.6bn of model exposure into Stage 2 between the Weighted and Downside 2 scenario. ECL increases in Stage 2 predominantly due to unsecured portfolios as economic conditions deteriorate.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
142

Risk review: Credit risk
Risk performance continued
Scenarios
As at 31 December 2021WeightedUpside 2Upside 1BaselineDownside 1Downside 2
Stage 1 Model exposure (£m)
Home loans137,279 139,117 138,424 137,563 135,544 133,042 
Credit cards, unsecured loans and other retail lending45,503 46,170 45,963 45,751 43,131 38,820 
Wholesale loans174,249 177,453 176,774 175,451 169,814 161,998 
Stage 1 Model ECL (£m)
Home loans4 2 2 3 6 14 
Credit cards, unsecured loans and other retail lending324 266 272 279 350 418 
Wholesale loans290 240 262 286 327 350 
Stage 1 Coverage (%)
Home loans      
Credit cards, unsecured loans and other retail lending0.7 0.6 0.6 0.6 0.8 1.1 
Wholesale loans0.2 0.1 0.1 0.2 0.2 0.2 
Stage 2 Model exposure (£m)
Home loans22,915 21,076 21,769 22,631 24,649 27,151 
Credit cards, unsecured loans and other retail lending7,200 6,260 6,521 6,795 9,708 14,290 
Wholesale loans32,256 29,052 29,732 31,054 36,692 44,507 
Stage 2 Model ECL (£m)
Home loans15 10 11 12 22 47 
Credit cards, unsecured loans and other retail lending1,114 925 988 1,058 1,497 3,295 
Wholesale loans572 431 467 528 851 1,510 
Stage 2 Coverage (%)
Home loans0.1  0.1 0.1 0.1 0.2 
Credit cards, unsecured loans and other retail lending15.5 14.8 15.2 15.6 15.4 23.1 
Wholesale loans1.8 1.5 1.6 1.7 2.3 3.4 
Stage 3 Model exposure (£m)
Home loans1,724 1,724 1,724 1,724 1,724 1,724 
Credit cards, unsecured loans and other retail lending1,922 1,922 1,922 1,922 1,922 1,922 
Wholesale loansa
1,811 1,811 1,811 1,811 1,811 1,811 
Stage 3 Model ECL (£m)
Home loans303 292 295 299 320 346 
Credit cards, unsecured loans and other retail lending1,255 1,236 1,245 1,255 1,277 1,297 
Wholesale loansa
323 321 322 323 326 332 
Stage 3 Coverage (%)
Home loans17.6 16.9 17.1 17.3 18.6 20.1 
Credit cards, unsecured loans and other retail lending65.3 64.3 64.8 65.3 66.4 67.5 
Wholesale loansa
17.8 17.7 17.8 17.8 18 18.3 
Total Model ECL (£m)
Home loans322 304 308 314 348 407 
Credit cards, unsecured loans and other retail lending2,693 2,427 2,505 2,592 3,124 5,010 
Wholesale loansa
1,185 992 1,051 1,137 1,504 2,192 
Total ECL4,200 3,723 3,864 4,043 4,976 7,609 
Note
a    Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £524m is reported as individually assessed impairments in the table below.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
143

Risk review: Credit risk
Risk performance continued
Reconciliation to total ECL£m
Total model ECL4,200 
ECL from individually assessed impairments524 
ECL from non-modelled and other management adjustmentsa
1,560 
Total ECL6,284 
Note
a    Includes £1.5bn of post model adjustments, of which £0.2bn is included as part of total model ECL and £0.2bn ECL from non-modelled exposures.
The dispersion of results around the Baseline is an indication of uncertainty around the future projections. The disclosure highlights the results of the alternative scenarios enabling the reader to understand the extent of the impact on exposure and ECL from the upside/downside scenarios. Consequently, the use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 3.9%, largely driven by credit card losses which have more linear loss profiles than UK home loans and wholesale loan positions.
Home loans: Total weighted ECL of £322m represents a 2.5% increase over the Baseline ECL (£314m), and coverage ratios remain steady across the Upside scenarios, Baseline and Downside 1 scenario. However, total ECL increases in the Downside 2 scenario to £407m, driven by a significant fall in UK HPI (29.9%) reflecting the non-linearity of the UK portfolio.
Credit cards, unsecured loans and other retail lending: Total weighted ECL of £2,693m represents a 3.9% increase over the Baseline ECL (£2,592m) reflecting the range of economic scenarios used, mainly impacted by Unemployment and other key retail variables. Total ECL increases to £5,010m under the Downside 2 scenario, mainly driven by Stage 2, where coverage rates increase to 23.1% from a weighted scenario approach of 15.5% and circa £7.1bn increase in model exposure that meets the Significant Increase in Credit Risk criteria and transitions from Stage 1 to Stage 2.
Wholesale loans: Total weighted ECL of £1,185m represents a 4.2% increase over the Baseline ECL (£1,137m) reflecting the range of economic scenarios used, with exposures in the Investment Bank particularly sensitive to the Downside 2 scenario.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
144

Risk review: Credit risk
Risk performance continued
Scenarios
As at 31 December 2020WeightedUpside 2Upside 1BaselineDownside 1Downside 2
Stage 1 Model exposure (£m)
Home loans131,422 134,100 133,246 132,414 130,547 128,369 
Credit cards, unsecured loans and other retail lending51,952 53,271 52,932 51,995 50,168 48,717 
Wholesale loans149,099 155,812 154,578 152,141 144,646 131,415 
Stage 1 Model ECL (£m)
Home loans14 42 
Credit cards, unsecured loans and other retail lending392 316 340 372 415 415 
Wholesale loans262 242 258 249 278 290 
Stage 1 Coverage (%)
Home loans— — — — — — 
Credit cards, unsecured loans and other retail lending0.8 0.6 0.6 0.7 0.8 0.9 
Wholesale loans0.2 0.2 0.2 0.2 0.2 0.2 
Stage 2 Model exposure (£m)
Home loans19,180 16,502 17,356 18,188 20,055 22,233 
Credit cards, unsecured loans and other retail lending13,399 10,572 11,579 13,176 16,477 19,322 
Wholesale loans32,677 25,963 27,198 29,635 37,130 50,361 
Stage 2 Model ECL (£m)
Home loans37 31 32 33 42 63 
Credit cards, unsecured loans and other retail lending2,207 1,618 1,837 2,138 2,865 3,564 
Wholesale loans1,410 952 1,047 1,223 1,771 2,911 
Stage 2 Coverage (%)
Home loans0.2 0.2 0.2 0.2 0.2 0.3 
Credit cards, unsecured loans and other retail lending16.5 15.3 15.9 16.2 17.4 18.4 
Wholesale loans4.3 3.7 3.8 4.1 4.8 5.8 
Stage 3 Model exposure (£m)
Home loans1,778 1,778 1,778 1,778 1,778 1,778 
Credit cards, unsecured loans and other retail lending2,585 2,585 2,585 2,585 2,585 2,585 
Wholesale loansa
2,211 2,211 2,211 2,211 2,211 2,211 
Stage 3 Model ECL (£m)
Home loans307 282 286 290 318 386 
Credit cards, unsecured loans and other retail lending2,003 1,947 1,972 2,001 2,055 2,078 
Wholesale loansa
146 128 134 141 157 184 
Stage 3 Coverage (%)
Home loans17.3 15.9 16.1 16.3 17.9 21.7 
Credit cards, unsecured loans and other retail lending77.5 75.3 76.3 77.4 79.5 80.4 
Wholesale loansa
6.6 5.8 6.1 6.4 7.1 8.3 
Total Model ECL (£m)
Home loans350317323329374491
Credit cards, unsecured loans and other retail lending4,6023,8814,1494,5115,3356,057
Wholesale loansa
1,8181,3221,4391,6132,2063,385
Total ECL6,7705,5205,9116,4537,9159,933
Note
a    Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £902m is reported as individually assessed impairments in the table below.
Reconciliation to total ECLa
£m
Total model ECL6,770 
ECL from individually assessed impairments902 
ECL from non-modelled and other management adjustments1,727 
Total ECL9,399 
Note
a    Includes £1.4bn of post-model adjustment and £0.3bn ECL from non-model exposures.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
145

Risk review: Credit risk
Risk performance continued
Analysis of the concentration of credit risk
A concentration of credit risk exists when a number of counterparties are located in a common geographical region or are engaged in similar activities and have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions. The Group implements limits on concentrations in order to mitigate the risk. The analyses of credit risk concentrations presented below are based on the location of the counterparty or customer or the industry in which they are engaged. Further detail on the Group policies with regard to managing concentration risk is presented in the Barclays PLC Pillar 3 Report 2021 (unaudited).

Geographic concentrations
As at 31 December 2021, the geographic concentration of the Group’s assets remained broadly consistent with 2020. Exposure is concentrated in the UK 40% (2020: 39%), in the Americas 35% (2020: 33%) and in Europe 19% (2020: 21%).
Credit risk concentrations by geography (audited)
United
Kingdom
AmericasEuropeAsiaAfrica and Middle EastTotal
£m£m£m£m£m£m
As at 31 December 2021
On-balance sheet:
Cash and balances at central banks114,959 38,735 76,846 7,789 245 238,574 
Cash collateral and settlement balances34,249 28,469 21,822 7,260 742 92,542 
Loans and advances at amortised cost270,261 51,599 24,352 11,039 4,200 361,451 
Reverse repurchase agreements and other similar secured lending9 123 401 2,508 186 3,227 
Trading portfolio assets12,926 29,539 15,092 4,943 889 63,389 
Financial assets at fair value through the income statement28,737 95,478 30,083 21,800 9,999 186,097 
Derivative financial instruments78,710 92,010 75,247 14,709 1,896 262,572 
Financial assets at fair value through other comprehensive income7,661 27,391 19,235 6,164 400 60,851 
Other assets949 223 39 1  1,212 
Total on-balance sheet548,461 363,567 263,117 76,213 18,557 1,269,915 
Off-balance sheet:
Contingent liabilities5,527 10,328 3,957 1,131 403 21,346 
Loan commitments105,844 192,303 40,523 5,104 1,937 345,711 
Total off-balance sheet111,371 202,631 44,480 6,235 2,340 367,057 
Total659,832 566,198 307,597 82,448 20,897 1,636,972 
As at 31 December 2020
On-balance sheet:
Cash and balances at central banks66,459 36,063 69,963 17,987 655 191,127 
Cash collateral and settlement balances33,893 27,287 30,121 9,558 508 101,367 
Loans and advances at amortised cost262,231 41,094 24,949 10,728 3,630 342,632 
Reverse repurchase agreements and other similar secured lending10 152 373 8,285 211 9,031 
Trading portfolio assets9,829 31,000 17,107 5,948 946 64,830 
Financial assets at fair value through the income statement34,229 88,327 25,709 14,742 7,524 170,531 
Derivative financial instruments93,430 90,801 101,102 14,532 2,581 302,446 
Financial assets at fair value through other comprehensive income10,672 27,504 28,607 11,006 138 77,927 
Other assets608 185 57 — — 850 
Total on-balance sheet511,361 342,413 297,988 92,786 16,193 1,260,741 
Off-balance sheet:
Contingent liabilities5,876 10,122 3,809 1,222 580 21,609 
Loan commitments112,561 175,926 38,836 4,169 1,557 333,049 
Total off-balance sheet118,437 186,048 42,645 5,391 2,137 354,658 
Total629,798 528,461 340,633 98,177 18,330 1,615,399 
Industry concentrations
The concentration of the Group’s assets by industry remained broadly consistent year on year. As at 31 December 2021, total assets concentrated in banks and other financial institutions was 38% (2020: 40%), predominantly within derivative financial instruments. The proportion of the overall balance concentrated in governments and central banks was 23% (2020: 21%), cards, unsecured loans and other personal lending was 10% (2020: 10%) and in home loans remained stable at 11% (2020: 11%). Further details on material and emerging risks can be found on pages 102 to 113.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
146

Risk review: Credit risk
Risk performance continued
Credit risk concentrations by industry (audited)
BanksOther financial
insti-
tutions
Manu-
facturing
Const-
ruction
and
property
Govern-
ment and central bank
Energy
and
water
Whole-
sale
and retail distri-
bution
 and leisure
Business
and other
services
Home
loans
Cards,
unsecured
loans and
other personal
lending
OtherTotal
£m£m£m£m£m£m£m£m£m£m£m£m
As at 31 December 2021
On-balance sheet:
Cash and balances at central banks52 74   238,448       238,574 
Cash collateral and settlement balances 14,811 61,581 320 79 14,526 390 60 366  68 341 92,542 
Loans and advances at amortised cost8,519 32,332 6,701 25,722 30,827 4,345 11,455 19,113 169,205 42,198 11,034 361,451 
Reverse repurchase agreements and other similar secured lending645 2,049   533       3,227 
Trading portfolio assets2,586 8,817 4,881 1,097 32,574 4,043 1,734 4,716   2,941 63,389 
Financial assets at fair value through the income statement26,074 131,264 771 7,999 13,945 87 181 3,753 1,595  428 186,097 
Derivative financial instruments120,666 117,400 4,169 1,898 7,233 3,544 1,172 2,696   3,794 262,572 
Financial assets at fair value through other comprehensive income14,441 4,274  662 40,872   455   147 60,851 
Other assets618 450 1 3 8  2 104  21 5 1,212 
Total on-balance sheet188,412 358,241 16,843 37,460 378,966 12,409 14,604 31,203 170,800 42,287 18,690 1,269,915 
Off-balance sheet:
Contingent liabilities1,006 5,356 3,080 1,341 1,682 3,284 1,209 2,518  73 1,797 21,346 
Loan commitments1,395 55,071 42,587 16,673 1,362 26,461 16,299 25,682 11,656 121,680 26,845 345,711 
Total off-balance sheet2,401 60,427 45,667 18,014 3,044 29,745 17,508 28,200 11,656 121,753 28,642 367,057 
Total190,813 418,668 62,510 55,474 382,010 42,154 32,112 59,403 182,456 164,040 47,332 1,636,972 
As at 31 December 2020
On-balance sheet:
Cash and balances at central banks56 84   190,981   6    191,127 
Cash collateral and settlement balances17,986 67,305 375 35 13,946 871 30 575   244 101,367 
Loans and advances at amortised cost8,133 22,062 8,142 26,125 28,445 4,722 12,569 19,538 159,647 41,312 11,937 342,632 
Reverse repurchase agreements and other similar secured lending706 7,964   361       9,031 
Trading portfolio assets2,743 11,464 4,104 516 35,902 3,052 1,883 2,625   2,541 64,830 
Financial assets at fair value through the income statement21,824 131,943 608 5,668 5,530 13 64 3,712 971  198 170,531 
Derivative financial instruments155,767 116,526 4,126 2,725 11,649 3,288 1,235 2,361  0 4,769 302,446 
Financial assets at fair value through other comprehensive income18,829 5,843 1 425 51,955   733   141 77,927 
Other assets439 224 6 12 1 10 18 98  34 8 850 
Total on-balance sheet226,483 363,415 17,362 35,506 338,770 11,956 15,799 29,648 160,618 41,346 19,838 1,260,741 
Off-balance sheet:
Contingent liabilities1,150 5,501 3,187 1,260 1,678 3,223 1,005 2,283  155 2,167 21,609 
Loan commitments1,813 53,936 39,638 14,002 1,398 25,780 17,165 24,554 12,385 119,807 22,571 333,049 
Total off-balance sheet2,963 59,437 42,825 15,262 3,076 29,003 18,170 26,837 12,385 119,962 24,738 354,658 
Total229,446 422,852 60,187 50,768 341,846 40,959 33,969 56,485 173,003 161,308 44,576 1,615,399 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
147

Risk review: Credit risk
Risk performance continued
The approach to management and representation of credit quality
Asset credit quality
The credit quality distribution is based on the IFRS 9 12-month probability of default (PD) at the reporting date to ensure comparability with other ECL disclosures in the Expected Credit Losses section.
The following internal measures are used to determine credit quality for loans:
Default GradeRetail and Wholesale lending
Probability of default
Credit Quality Description
1-30.0 to <0.05%Strong
4-50.05 to <0.15%
6-80.15 to <0.30%
9-110.30 to <0.60%
12-140.60 to <2.15%Satisfactory
15-192.15 to <10%
1910 to <11.35%
20-2111.35 to <100%Higher Risk
22100%Credit Impaired
For retail clients, a range of analytical tools is used to derive the probability of default of clients at inception and on an ongoing basis.
For loans that are not past due, these descriptions can be summarised as follows:
Strong: there is a very high likelihood of the asset being recovered in full.
Satisfactory: while there is a high likelihood that the asset will be recovered and therefore, of no cause for concern to the Group, the asset may not be collateralised, or may relate to unsecured retail facilities. At the lower end of this grade there are customers that are being more carefully monitored, for example, corporate customers which are indicating some evidence of deterioration, home loans with a high loan to value, and unsecured retail loans operating outside normal product guidelines.
Higher risk: there is concern over the obligor’s ability to make payments when due. However, these have not yet converted to actual delinquency. There may also be doubts over the value of collateral or security provided. However, the borrower or counterparty is continuing to make payments when due and is expected to settle all outstanding amounts of principal and interest.
Loans that are past due are monitored closely, with impairment allowances raised as appropriate and in line with the Group’s impairment policies.
Debt securities
For assets held at fair value, the carrying value on the balance sheet will include, among other things, the credit risk of the issuer. Most listed and some unlisted securities are rated by external rating agencies. The Group mainly uses external credit ratings provided by Standard & Poor’s, Fitch or Moody’s. Where such ratings are not available or are not current, the Group will use its own internal ratings for the securities.
Balance sheet credit quality
The following tables present the credit quality of the Group’s assets exposed to credit risk.
Overview
As at 31 December 2021, the ratio of the Group’s on-balance sheet assets classified as strong (0.0 to <0.60%) remained stable at 87% (2020: 87%) of total assets exposed to credit risk. Further analysis of debt securities by issuer and issuer type and netting and collateral arrangements on derivative financial instruments is presented in the Analysis of debt securities section and Analysis of derivatives section.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
148

Risk review: Credit risk
Risk performance continued
Balance sheet credit quality (audited)
PD rangeTotalPD rangeTotal
0.0 to <0.60%0.60 to <11.35%11.35 to 100%0.0 to <0.60%0.60 to <11.35%11.35 to 100%
£m£m£m£m%%%%
As at 31 December 2021
Cash and balances at central banks238,574   238,574 100   100 
Cash collateral and settlement balances83,257 9,275 10 92,542 90 10  100 
Loans and advances at amortised cost:
Home loans161,314 5,547 2,344 169,205 96 3 1 100 
Credit cards, unsecured loans and other retail lending25,664 14,293 1,836 41,793 62 34 4 100 
Wholesale loans104,823 40,437 5,193 150,453 70 27 3 100 
Total loans and advances at amortised cost291,801 60,277 9,373 361,451 80 17 3 100 
Reverse repurchase agreements and other similar secured lending3,141 86  3,227 97 3  100 
Trading portfolio assets:
Debt securities44,652 5,735 477 50,864 88 11 1 100 
Traded loans2,172 10,144 209 12,525 17 81 2 100 
Total trading portfolio assets46,824 15,879 686 63,389 74 25 1 100 
Financial assets at fair value through the income statement:
Loans and advances19,642 18,979 46 38,667 51 49  100 
Debt securities1,389 864 52 2,305 61 37 2 100 
Reverse repurchase agreements108,437 36,047 530 145,014 75 25  100 
Other financial assets93 18  111 84 16  100 
Total financial assets at fair value through the income statement129,561 55,908 628 186,097 70 30  100 
Derivative financial instruments246,628 15,678 266 262,572 94 6  100 
Financial assets at fair value through other comprehensive income60,845 6  60,851 100   100 
Other assets1,155 55 2 1,212 95 5  100 
Total on-balance sheet1,101,786 157,164 10,965 1,269,915 87 12 1 100 
As at 31 December 2020
Cash and balances at central banks191,127 — — 191,127 100 — — 100 
Cash collateral and settlement balances90,633 10,725 101,367 89 11 — 100 
Loans and advances at amortised cost:— — — — 
Home loans150,748 6,310 2,589 159,647 94 100 
Credit cards, unsecured loans and other retail lending15,870 22,427 2,516 40,813 39 55 100 
Wholesale loans105,968 31,538 4,666 142,172 75 22 100 
Total loans and advances at amortised cost272,586 60,275 9,771 342,632 79 18 100 
Reverse repurchase agreements and other similar secured lending9,019 12 — 9,031 100 — — 100 
Trading portfolio assets:
Debt securities51,395 4,871 216 56,482 91 — 100 
Traded loans704 5,107 2,537 8,348 61 30 100 
Total trading portfolio assets52,099 9,978 2,753 64,830 81 15 100 
Financial assets at fair value through the income statement:
Loans and advances16,467 14,369 43 30,879 53 47 — 100 
Debt securities1,126 521 46 1,693 66 31 100 
Reverse repurchase agreements95,376 41,566 674 137,616 70 30 — 100 
Other financial assets330 13 — 343 96 — 100 
Total financial assets at fair value through the income statement113,299 56,469 763 170,531 67 33 — 100 
Derivative financial instruments282,617 19,352 477 302,446 94 — 100 
Financial assets at fair value through other comprehensive income77,919 — 77,927 100 — — 100 
Other assets778 68 850 92 — 100 
Total on-balance sheet1,090,077 156,887 13,777 1,260,741 87 12 100 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
149

Risk review: Credit risk
Risk performance continued
Credit exposures by internal PD grade
The below tables represent credit risk profile by PD grade for loans and advances at amortised cost, contingent liabilities and loan commitments.
Stage 1 higher risk assets, presented gross of associated collateral held, are of weaker credit quality but have not significantly deteriorated since origination.
IFRS 9 Stage 1 and Stage 2 classification is not dependent solely on the absolute probability of default but on elements that determine a Significant Increase in Credit Risk (see Note 7), including relative movement in probability of default since initial recognition. There is therefore no direct relationship between credit quality and IFRS 9 stage classification.
Credit risk profile by internal PD grade for loans and advances at amortised cost (audited)
Gross carrying amountAllowance for ECLNet exposureCoverage ratio
GradingPD rangeCredit quality descriptionStage 1Stage 2Stage 3TotalStage 1Stage 2Stage 3Total
%£m£m£m£m£m£m£m£m£m%
As at 31 December 2021
1 - 30.0 to <0.05%Strong95,795 1,554  97,349 283 8  291 97,058 0.3 
4 - 50.05 to <0.15%Strong83,818 3,584  87,402 19 3  22 87,380  
6 - 80.15 to <0.30%Strong58,409 9,722  68,131 41 12  53 68,078 0.1 
9 - 110.30 to <0.60%Strong35,794 3,649  39,443 129 29  158 39,285 0.4 
12 - 140.60 to <2.15%Satisfactory30,654 7,090  37,744 326 264  590 37,154 1.6 
15 - 192.15 to <10%Satisfactory7,977 6,645  14,622 230 780  1,010 13,612 6.9 
1910 to <11.35%Satisfactory5,572 4,364  9,936 99 326  425 9,511 4.3 
20 - 2111.35 to <100%Higher Risk846 4,485  5,331 79 593  672 4,659 12.6 
22100%Credit Impaired  7,235 7,235   2,521 2,521 4,714 34.8 
Total318,865 41,093 7,235 367,193 1,206 2,015 2,521 5,742 361,451 1.6 
As at 31 December 2020
1 - 30.0 to <0.05%Strong82,312 3,095  85,407 6 35  41 85,366  
4 - 50.05 to <0.15%Strong101,309 9,715  111,024 34 25  59 110,965 0.1 
6 - 80.15 to <0.30%Strong30,697 6,263  36,960 47 64  111 36,849 0.3 
9 - 110.30 to <0.60%Strong34,601 5,093  39,694 120 168  288 39,406 0.7 
12 - 140.60 to <2.15%Satisfactory29,498 8,399  37,897 379 593  972 36,925 2.6 
15 - 192.15 to <10%Satisfactory8,125 9,136  17,261 302 1,283  1,585 15,676 9.2 
1910 to <11.35%Satisfactory3,505 4,437  7,942 73 195  268 7,674 3.4 
20 - 2111.35 to <100%Higher Risk917 4,868  5,785 72 1,201  1,273 4,512 22.0 
22100%Credit Impaired  8,997 8,997   3,738 3,738 5,259 41.5 
Total290,964 51,006 8,997 350,967 1,033 3,564 3,738 8,335 342,632 2.4 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
150

Risk review: Credit risk
Risk performance continued
Credit risk profile by internal PD grade for contingent liabilities (audited)a
Gross carrying amountAllowance for ECLNet exposureCoverage ratio
GradingPD rangeCredit quality descriptionStage 1Stage 2Stage 3TotalStage 1Stage 2Stage 3Total
%£m£m£m£m£m£m£m£m£m%
As at 31 December 2021
1 - 30.0 to <0.05%Strong6,389 172  6,561 8 1  9 6,552 0.1 
4 - 50.05 to <0.15%Strong2,929 503  3,432 2 2  4 3,428 0.1 
6 - 80.15 to <0.30%Strong1,996 199  2,195 2 2  4 2,191 0.2 
9 - 110.30 to <0.60%Strong2,794 216  3,010 4 1  5 3,005 0.2 
12 - 140.60 to <2.15%Satisfactory1,990 287  2,277 19 8  27 2,250 1.2 
15 - 192.15 to <10%Satisfactory817 479  1,296 5 10  15 1,281 1.2 
1910 to <11.35%Satisfactory607 254  861 21 42  63 798 7.3 
20 - 2111.35 to <100%Higher Risk141 1,162  1,303 3 77  80 1,223 6.1 
22100%Credit Impaired  180 180   2 2 178 1.1 
Total17,663 3,272 180 21,115 64 143 2 209 20,906 1.0 
As at 31 December 2020
1 - 30.0 to <0.05%Strong6,178 189  6,367 1   1 6,366  
4 - 50.05 to <0.15%Strong2,765 428  3,193 3 2  5 3,188 0.2 
6 - 80.15 to <0.30%Strong1,468 165  1,633 3 3  6 1,627 0.4 
9 - 110.30 to <0.60%Strong3,524 552  4,076 5 33  38 4,038 0.9 
12 - 140.60 to <2.15%Satisfactory2,712 546  3,258 8 25  33 3,225 1.0 
15 - 192.15 to <10%Satisfactory305 398  703 7 21  28 675 4.0 
1910 to <11.35%Satisfactory264 423  687 17 83  100 587 14.6 
20 - 2111.35 to <100%Higher Risk40 769  809  61  61 748 7.5 
22100%Credit Impaired  654 654   10 10 644 1.5 
Total17,256 3,470 654 21,380 44 228 10 282 21,098 1.3 
Credit risk profile by internal PD grade for loan commitments (audited)a
Gross carrying amountAllowance for ECLNet exposureCoverage ratio
GradingPD rangeCredit quality descriptionStage 1Stage 2Stage 3TotalStage 1Stage 2Stage 3Total
%£m£m£m£m£m£m£m£m£m%
As at 31 December 2021
1 - 30.0 to <0.05%Strong104,204 3,034  107,238 6 4  10 107,228  
4 - 50.05 to <0.15%Strong68,986 5,524  74,510 10 5  15 74,495  
6 - 80.15 to <0.30%Strong30,968 2,387  33,355 8 6  14 33,341  
9 - 110.30 to <0.60%Strong40,539 2,524  43,063 8 6  14 43,049  
12 - 140.60 to <2.15%Satisfactory30,065 4,713  34,778 81 30  111 34,667 0.3 
15 - 192.15 to <10%Satisfactory7,091 3,516  10,607 21 37  58 10,549 0.5 
1910 to <11.35%Satisfactory10,407 3,091  13,498 8 13  21 13,477 0.2 
20 - 2111.35 to <100%Higher Risk2,219 6,754  8,973 11 58  69 8,904 0.8 
22100%Credit Impaired  1,118 1,118   21 21 1,097 1.9 
Total294,479 31,543 1,118 327,140 153 159 21 333 326,807 0.1 
As at 31 December 2020
1 - 30.0 to <0.05%Strong60,525 5,525  66,050 4 2  6 66,044  
4 - 50.05 to <0.15%Strong74,860 6,322  81,182 12 16  28 81,154  
6 - 80.15 to <0.30%Strong51,255 6,719  57,974 17 47  64 57,910 0.1 
9 - 110.30 to <0.60%Strong43,650 6,950  50,600 17 72  89 50,511 0.2 
12 - 140.60 to <2.15%Satisfactory30,994 9,908  40,902 119 131  250 40,652 0.6 
15 - 192.15 to <10%Satisfactory5,702 4,971  10,673 27 113  140 10,533 1.3 
1910 to <11.35%Satisfactory4,886 5,129  10,015 11 25  36 9,979 0.4 
20 - 2111.35 to <100%Higher Risk811 3,897  4,708 5 124  129 4,579 2.7 
22100%Credit Impaired  1,676 1,676   40 40 1,636 2.4 
Total272,683 49,421 1,676 323,780 212 530 40 782 322,998 0.2 
Note
a    Excludes loan commitments and financial guarantees of £18.8bn (2020: £9.5bn) carried at fair value.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
151

Risk review: Credit risk
Risk performance continued
Analysis of specific portfolios and asset types
This section provides an analysis of principal portfolios and businesses, in particular, home loans, credit cards, unsecured loans and other retail lending and a summary of government supported loans.
Secured home loans
The UK home loans portfolio comprises first lien home loans and accounts for 93% (2020: 93%) of the Group’s total home loan balances.
Home loans principal portfolios
Barclays UK
As at 31 December20212020
Gross loans and advances (£m)158,192148,343
>90 day arrears, excluding recovery book (%)0.10.2
Annualised gross charge-off rates – 180 days past due (%)0.50.6
Recovery book proportion of outstanding balances (%)0.60.6
Recovery book impairment coverage ratio (%)4.23.2
Within the UK home loans portfolio:
gross loans and advances increased by £9.8bn (6.6%) following an increase in Residential (7.8%), while Buy to Let (BTL) remained broadly stable
owner-occupied interest-only home loans comprised 19.0% (2020: 22.1%) of total balances. The average balance weighted LTV on owner occupied loans increased to 50.3% (2020: 49.9%)
BTL home loans comprised 13.1% (2020: 14.0%) of total balances. In BTL, the average balance weighted LTV dropped to 53.4% (2020: 55.3%).

Home loans principal portfolios - distribution of balances by LTVa
Distribution of balancesDistribution of impairment allowanceCoverage ratio
Stage 1Stage 2Stage 3TotalStage 1Stage 2Stage 3TotalStage 1Stage 2Stage 3Total
Barclays UK%%%%%%%%%%%%
As at 31 December 2021
<=75%77.211.30.789.28.317.731.957.9 0.12.4 
>75% and <=90%9.30.6 9.94.810.711.727.2 1.022.60.1
>90% and <=100%0.9  0.90.91.02.94.80.11.987.50.3
>100%    0.21.08.910.10.46.4100.014.1
As at 31 December 2020
<=75%75.711.60.687.917.915.019.051.9 0.11.8 
>75% and <=90%10.80.8 11.69.714.87.632.10.11.216.00.2
>90% and <=100%0.4  0.40.81.52.24.50.12.635.70.7
>100%0.1  0.10.73.47.411.50.710.369.18.0
Note
a    Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI available as at 31 December 2021.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
152

Risk review: Credit risk
Risk performance continued
Home loans principal portfolios – average LTV
Barclays UK
As at 31 December20212020
Overall portfolio LTV (%):
Balance weighted %50.7 50.7
Valuation weighted %37.5 37.6
For >100% LTVs:
Balances £m58129
Marked to market collateral £m47112
Average LTV: Balance weighted %160.9138.2
Average LTV: Valuation weighted %129.1120.6
% of balances in recoveries14.510.8

Home loans principal portfolios - new lending
Barclays UK
As at 31 December 202120212020
New home loan bookings (£m)33,94522,776
New home loan proportion above 90% LTV (%)1.92.6
Average LTV on new home loan: balance weighted (%)69.567.5
Average LTV on new home loan: valuation weighted (%)61.959.6

New bookings: The increased level of new business in 2021 was driven by elevated demand in the house purchase market supported by government intervention including stamp duty relief. Barclays maintained its share of the market, supported by re-introduction of HLTV (> 85% LTV) products and reversal of some policy tightening introduced in 2020.
Head Office: Italian home loans and advances at amortised cost reduced to £4.7bn (2020: £5.7bn) and continue to run-off since new bookings ceased in 2016. The portfolio is secured on residential property with an average balance weighted mark to market LTV of 60.4% (2020: 62.1%). 90-day arrears decreased to 1.3% (2020: 1.7%) and gross charge-off rate decreased to 0.3% (2020: 1.0%) due to continuous reduction of delinquent balances.

Credit cards, unsecured loans and other retail lending
The principal portfolios listed below accounted for 82% (2020: 84%) of the Group’s total credit cards, unsecured loans and other retail lending.
Credit cards and unsecured loans principal portfolios
Gross exposure30 day arrears rate, excluding recoveries book90 day arrears rate, excluding recoveries bookAnnualised gross write-off ratesAnnualised net write-off rates
£m%%%%
As at 31 December 2021
Barclays UK
    UK cards9,9331.00.24.14.0
    UK personal loans4,0111.50.73.53.2
    Barclays Partner Finance2,4710.40.21.41.4
Barclays International
    US cards17,7791.60.84.34.2
    Germany consumer lending3,5591.50.70.90.8
As at 31 December 2020
Barclays UK
    UK cards11,9111.70.82.92.9
    UK personal loans4,5912.31.23.43.1
    Barclays Partner Finance2,4690.50.31.11.1
Barclays International
    US cards16,8452.51.45.65.6
    Germany consumer lending3,4581.90.81.21.1

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
153

Risk review: Credit risk
Risk performance continued
UK cards: 30 and 90 day arrears rates reduced significantly to 1.0% (2020: 1.7%) and 0.2% (2020: 0.8%) respectively, with balances reducing by £2.0bn. Whilst performance had been on an improving trend as a result of reduced spend and increased repayments due to government support as a response to COVID-19 and lower flows into delinquency, the main driver was a change in the point of charge off from 180 days to 120 days past due. Higher write offs primarily reflected a higher level of debt sales.
UK personal loans: 30 and 90 day arrears rates reduced significantly to 1.5% (2020: 2.3%) and 0.7% (2020: 1.2%) respectively, with balances reducing by £0.6bn. Similar to UK cards, the main driver was a change in the point of charge off from 180 days to 120 days past due. Higher write offs primarily reflected a higher level of debt sales. Barclays Partner Finance: 30 and 90 day arrears rates both reduced by 0.1% as a result of slightly lower entry rates and flows through the delinquency cycles.
US cards: 30 and 90 day arrears rates improved and remain below pre-pandemic levels due to continued benefit from government support schemes throughout the pandemic and industry payment deferrals that were made available to consumers.
Germany consumer lending: 30 and 90 day arrears rates reduced in 2021 due to improved payment behaviour of formerly high-risk customers as unemployment eased, and the benefit from government support in the local market continued.
Government supported loans
Throughout the COVID-19 pandemic Barclays has supported its customers and clients by participating in the UK Government's Bounce Back Loan Scheme (BBLs), Coronavirus Business Interruption Loan Scheme (CBILs), Coronavirus Large Business Interruption Loan Scheme (CLBILs) and the Recovery Loan Scheme (RLS).
Government supported loans
Gross exposureImpairment allowanceImpairment coverageGovernment guaranteed exposure
Stage 1Stage 2 Stage 3TotalModelled impairmentManagement adjustmentImpairment post management adjustmentPre management adjustmentPost management adjustmentTotal
£m£m£m£m£m£m£m%%£m
As at 31 December 2021
Barclays UK
BBLs7,8817977049,382396(380)164.20.29,366
CBILs900110471,05712(7)51.10.5845
RLSs111122.72.710
Barclays International
CBILs6191466771550.60.6617
CLBILs163562221110.40.4177
RLSs114.74.71
Total9,5751,10976011,444414(387)273.60.211,016
As at 31 December 2020
Barclays UK
BBLs9,4133731309,91668(68)19,916
CBILs1,04237201,0996611879
RLSs
Barclays International
CBILs8461121959121211768
CLBILs1842382152211171
RLSs
Total11,48554515912,18988(68)20111,734

The BBLs and CBILs schemes were launched to provide financial support to smaller and medium-sized businesses and CLBILs for larger businesses in the UK who may experience financial difficulties as a result of the COVID-19 outbreak. The RLS aims to help UK businesses access finance as they recover and grow following the COVID-19 pandemic. These loans are guaranteed by the Government at 100% for BBLs and 80% for CBILs, CLBILs and RLS as at the balance sheet date.
Management adjustments of £(380)m and £(7)m are applied as the underlying ECL models do not currently fully recognise the 100% and 80% government guarantee against BBLs and CBILs exposure within BUK Business Banking. In instances where Barclays has assessed the BBLs exposure to have not met strict assessment criteria, no claim has been made against the government guarantee resulting in an impairment allowance against these loans of £16m at the year-end.
Additionally, while the government supported loans are covered by guarantees, many BBLs customers have other financing arrangements with Barclays which are not covered by the government guarantee. Noting the elevated levels of delinquency across the BBLs population, Barclays has applied an adjustment of £0.1bn to the £2.5bn gross exposure to BBLs customers outside the scheme.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
154

Risk review: Credit risk
Risk performance continued
Forbearance
Forbearance measures consist of concessions towards a debtor that is experiencing or about to experience difficulties in meeting their financial commitments (‘financial difficulties’).
Analysis of forbearance programmes
BalancesImpairment allowance
Stage 1Stage 2Stage 3TotalStage 1Stage 2Stage 3Total
£m£m£m£m£m£m£m£m
As at 31 December 2021
Barclays UK1401407371,017246284332
Barclays International132442481152153
Head Office1161161515
Total retail1411431,0971,381247451500
Barclays UK597649462924850
Barclays International1,0519612,01238321359
Head Office
Total wholesale591,1271,4552,64140369409
Group total2001,2702,5524,022287820909
As at 31 December 2020
Barclays UK59144374577377106186
Barclays International123503531198199
Head Office1261261818
Total retail601468501,056378322403
Barclays UK4853458235457
Barclays International1,3731,4602,83386564650
Head Office
Total wholesale1,4211,9943,41589618707
Group total601,5672,8444,47131679401,110
Retail balances on forbearance increased 31%, reflecting an increase in Barclays UK due to the application of EBA's definition of forbearance across the Group to standardise reporting.
Wholesale balances subject to forbearance decreased to £2.6bn (2020: £3.4bn) with reduced exposure in Corporate Bank and Investment Bank of £400m and £238m respectively. Impairment allowances reduced to £409m (2020: £707m) with balance reductions driving lower ECL, a range of cases returning from forbearance and one notable write off. Barclays International accounted for 76% of wholesale forbearance with corporate cases representing 84% of these balances.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
155

Risk review: Credit risk
Risk performance continued
Retail forbearance programmes
Forbearance on the Group’s principal retail portfolios is presented below. The principal portfolios account for 99% (2020: 100%) of total retail forbearance balances.
Analysis of key portfolios in forbearance programmes
Balances on forbearance programmesMarked to market LTV of forbearance balances: balance weightedMarked to market LTV of forbearance balances: valuation weightedImpairment allowances marked against balances on forbearance programmesTotal balances on forbearance programmes coverage ratio
Total% of gross retail loans and advances
£m£m%%£m%
As at 31 December 2021
Barclays UK
UK home loans2930.242.230.03 1.0
UK cards5775.8n/an/a242 41.9
UK personal loans1203.0n/an/a69 57.9
Barclays Partner Finance15 0.6n/an/a9 61.6
Barclays International
US cards196 1.1n/an/a122 62.2
Germany consumer lending51 1.4n/an/a31 60.7
Head Office
Italian home loans1162.458.441.91513.2
As at 31 December 2020
Barclays UK
UK home loans1350.140.229.021.4
UK cards3843.2n/an/a15139.3
UK personal loans541.2n/an/a3157.6
Barclays Partner Finance40.1n/an/a249.0
Barclays International
US cards2861.7n/an/a15554.2
Germany consumer lending671.9n/an/a4465.0
Head Office
Italian home loans1262.259.243.21814.5
UK home loans: Forbearance balances increased to £293m (2020: £135m) including £91m due to a standardisation of the definition of forbearance to comply with EBA Reporting rules. On a like for like basis, the increase of £67m was driven by extended periods of support to COVID-19 payment holiday exits during H1. Forbearance flow is now back to pre COVID-19 levels.
UK cards: Gross balances on forbearance programmes increased to £577m (2020: £384m), reflecting an increase of £423m due to a standardisation of the definition of forbearance to comply with EBA Reporting rules. On a like for like basis, the decrease of £230m was driven by the reduced asset base as well as fewer customers requiring support compared to the peak of the COVID-19 pandemic.
UK personal loans: Gross balances on forbearance programmes increased to £120m (2020: £54m), reflecting an increase of £114m due to a standardisation of the definition of forbearance to comply with EBA Reporting rules. On a like for like basis, the decrease of £48m was due to the reduced asset base as well as fewer customers requiring support compared to the peak of the COVID-19 pandemic.
Barclays Partner Finance: The increase in gross balances on forbearance programmes reflected standardisation of the definition of forbearance to comply with EBA Reporting rules.
US cards: Forbearance balances decreased to £196m (2020: £286m) due to the impact of lower delinquency driving fewer forbearance enrollments.
Germany consumer lending: Forbearance balances decreased to £51m (2020: £67m) due to lower customer demand.
Italian home loans: Forbearance balances reduced to £116m (2020: £126m) due to a natural exit from forbearance status as the portfolio is in run-off and reduction in the volumes of new concessions.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
156

Risk review: Credit risk
Risk performance continued
Wholesale forbearance programmes
The table below details balance information for wholesale forbearance cases.
Analysis of wholesale balances in forbearance programmes
Balances on forbearance programmesImpairment allowances marked against balances on forbearance programmesTotal balances on forbearance programmes coverage ratio
Total balances% of gross wholesale loans and advances
£m%£m%
As at 31 December 2021
Barclays UK6291.6507.9
Barclays International2,0121.935917.8
Total2,6411.840915.5
As at 31 December 2020
Barclays UK5821.6579.8
Barclays International2,8332.965022.9
Total3,4152.570720.7
Analysis of debt securities
Debt securities include government securities held as part of the Group’s treasury management portfolio for liquidity and regulatory purposes, and are for use on a continuing basis in the activities of the Group.
The following tables provide an analysis of debt securities held by the Group for trading and investment purposes by issuer type, and where the Group held government securities exceeding 10% of shareholders’ equity. Further information on the credit quality of debt securities is presented in the Balance sheet credit quality section.
Debt securities
20212020
As at 31 December£m%£m%
Of which issued by:
Governments and other public bodies94,730 65.0 105,496 66.0 
Corporate and other issuers36,916 25.3 39,733 24.9 
US agency4,364 3.0 8,742 5.5 
Mortgage and asset backed securities9,788 6.7 5,745 3.6 
Total145,798 100.0159,716 100.0 

Government securities
Fair value
20212020
As at 31 December£m£m
United States30,023 30,363 
United Kingdom27,409 23,873 
Japan8,555 16,258 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
157

Risk review: Credit risk
Risk performance continued
Analysis of derivatives
The tables below set out the fair values of the derivative assets together with the value of those assets subject to enforceable counterparty netting arrangements for which the Group holds offsetting liabilities and eligible collateral.
Derivative assets (audited)
20212020
Balance sheet
assets
Counterparty
netting
Net
exposure
Balance sheet
assets
Counterparty
netting
Net
exposure
As at 31 December£m£m£m£m£m£m
Foreign exchange76,975 60,525 16,450 85,115 68,108 17,007 
Interest rate125,905 92,669 33,236 172,334 128,072 44,262 
Credit derivatives5,682 4,525 1,157 4,605 3,584 1,021 
Equity and stock index51,723 43,084 8,639 38,972 32,183 6,789 
Commodity derivatives2,287 1,717 570 1,420 1,133 287 
Total derivative assets262,572 202,520 60,052 302,446 233,080 69,366 
Cash collateral held34,598 43,291 
Net exposure less collateral25,454 26,075 
Derivative asset exposures would be £237bn (2020: £276bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds cash collateral. Similarly, derivative liabilities would be £(235)bn (2020: £(276)bn) lower reflecting counterparty netting and collateral placed. In addition, non-cash collateral of £6bn (2020: £5bn) was held in respect of derivative assets. The Group received collateral from clients in support of over the counter derivative transactions. These transactions are generally undertaken under International Swaps and Derivative Association (ISDA) agreements governed by either UK or New York law.
The table below sets out the fair value and notional amounts of OTC derivative instruments by type of collateral arrangement.
Derivatives by collateral arrangement
20212020
Notional contract
amount
Fair valueNotional contract
amount
Fair value
AssetsLiabilitiesAssetsLiabilities
£m£m£m£m£m£m
Unilateral in favour of Barclays
Foreign exchange26,905 437 (635)28,431 618 (532)
Interest rate6,790 816 (6)6,580 982 (10)
Credit derivatives1,200 24 (202)227 — 
Equity and stock index245 33 (4)860 17 (77)
Total unilateral in favour of Barclays35,140 1,310 (847)36,098 1,619 (619)
Unilateral in favour of counterparty
Foreign exchange22,987 385 (883)16,420 545 (1,003)
Interest rate36,230 3,162 (3,684)36,973 3,524 (4,543)
Credit derivatives152 1  287 — — 
Equity and stock index507 159 (21)451 146 (22)
Total unilateral in favour of counterparty59,876 3,707 (4,588)54,131 4,215 (5,568)
Bilateral arrangement
Foreign exchange5,261,708 71,624 (68,186)5,154,176 79,337 (77,919)
Interest rate13,956,001 116,656 (108,723)13,267,129 161,909 (155,453)
Credit derivatives570,968 3,635 (4,190)365,757 3,348 (3,490)
Equity and stock index259,066 12,749 (15,965)453,990 15,376 (18,399)
Commodity derivatives4,485 54 (102)4,235 89 (100)
Total bilateral arrangement20,052,228 204,718 (197,166)19,245,287 260,059 (255,361)
Uncollateralised derivatives
Foreign exchange403,523 4,348 (4,526)269,417 4,277 (4,589)
Interest rate227,093 3,244 (1,759)250,857 4,583 (2,131)
Credit derivatives34,184 347 (360)18,629 324 (419)
Equity and stock index18,865 5,881 (8,478)10,850 3,268 (7,596)
Commodity derivatives185 2 (5)— (10)
Total uncollateralised derivatives683,850 13,822 (15,128)549,762 12,452 (14,745)
Total OTC derivative assets/(liabilities)20,831,094 223,557 (217,729)19,885,278 278,345 (276,293)
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
158

Risk review: Market risk
Risk performance continued
Summary of contents
Page
Outlines key measures used to summarise the market risk profile of the bank such as value at risk (VaR).
Market risk overview and summary of performance
159
The Group discloses details on management measures of market risk. Total management VaR includes all trading positions and is presented on a diversified basis by risk factor.
This section also outlines the macroeconomic conditions modelled as part of the Group’s risk management framework.
Traded market risk
159
Review of management measures
160
The daily average, maximum and minimum values of management
160
Business scenario stresses VaR
160
Market risk
All disclosures in this section are unaudited unless otherwise stated.
Overview
This section contains key statistics describing the market risk profile of the Group. The market risk management section provides a description of management VaR.
Measures of market risk in the Group and accounting measures
Traded market risk measures such as VaR and balance sheet exposure measures have fundamental differences:
balance sheet measures show accruals-based balances or marked to market values as at the reporting date;
VaR measures also take account of current marked to market values, but in addition hedging effects between positions are considered;
market risk measures are expressed in terms of changes in value or volatilities as opposed to static values.
For these reasons, it is not possible to present direct reconciliations of traded market risk and accounting measures.
Summary of performance in the period
Average management VaR decreased by 41% to £19m in 2021 (2020: £32m), driven by reduced risk taking, lower market volatility and the impact of a methodology update in March 2021 which changed the historical lookback period of the VaR model from two years to one year. The methodology change has increased the responsiveness of the model to changes over time in volatility levels in the lookback period.
Traded market risk review
Review of management measures
The following disclosures provide details on management measures of market risk. Refer to the market risk management section of the Barclays PLC Pillar 3 Report 2021 (unaudited) for more detail on management measures and the differences when compared to regulatory measures.
The table below shows the total management VaR on a diversified basis by risk factor. Total management VaR includes all trading positions in CIB and Treasury and it is calculated with a one-day holding period.
Limits are applied against each risk factor VaR as well as total management VaR, which are then cascaded further by risk managers to each business.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
159

Risk review: Market risk
Risk performance continued
The daily average, maximum and minimum values of management VaR
Management VaR (95%, one day) (audited)
20212020
Average
Higha
Lowa
Average
Higha
Lowa
For the year ended 31 December£m£m£m£m£m£m
Credit risk 14307203810
Interest rate risk 715410176
Equity risk 929413356
Basis risk 610310167
Spread risk 463593
Foreign exchange risk 4161572
Commodity risk 111
Inflation risk 352231
Diversification effecta
(28)n/an/a(34)n/an/a
Total management VaR19366325718
Note
a    Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table.

bcs-20211231_g24.jpg
Business scenario stresses
As part of the Group’s risk management framework, on a regular basis the performance of the trading business in hypothetical scenarios characterised by severe macroeconomic conditions is modelled. Up to seven global scenarios are modelled on a regular basis, for example, a sharp deterioration in liquidity, a slowdown in the global economy, global recession, and a sharp increase in economic growth.
In 2021, the scenario analyses showed that the largest market risk related impacts would be due to a severe deterioration in financial liquidity and an associated global recession.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
160

Risk review: Treasury and Capital risk
Risk performance continued
Treasury and Capital risk: summary of contents
Page
Liquidity risk performance
The risk that the firm is unable to meet its contractual or contingent obligations or that it does not have the appropriate amount, tenor and composition of funding and liquidity to support its assets.
This section provides an overview of the Group’s liquidity risk.
Liquidity overview and summary of performance
163
Liquidity risk stress testing
163
Liquidity risk appetite
163
Liquidity regulation
164
Liquidity coverage ratio
164
The liquidity pool is held unencumbered and is intended to offset stress outflows.
Liquidity pool
165
Composition of the liquidity pool
165
Liquidity pool by currency
165
Management of the liquidity pool
165
Contingent liquidity
165
The basis for sound liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an inability to meet funding obligations as they fall due.
Funding structure and funding relationships
166
Deposit funding
166
Wholesale funding
167
Provides details on the contractual maturity of all financial instruments and other assets and liabilities.
Contractual maturity of financial assets and liabilities
169
Capital risk performance
Capital risk is the risk that the firm has an insufficient level or composition of capital to support its normal business activities and to meet its regulatory capital requirements under normal operating environments or stressed conditions (both actual and as defined for internal planning or regulatory testing purposes). This also includes the risk from the firm’s pension plans.
This section details the Group’s capital position providing information on both capital resources and capital requirements. It also provides details of the leverage ratios and exposures.
Capital risk overview and summary of performance
173
Regulatory minimum capital, leverage and MREL requirements
173
Capital
173
Leverage
173
This section outlines the Group’s capital ratios, capital composition, and provides information on significant movements in CET1 capital during the year.
Analysis of capital resources
174
Capital ratios
174
Capital resources
174
Movement in CET1 capital
175
This section outlines risk weighted assets by risk type, business and macro drivers.
Analysis of risk weighted assets
176
Risk weighted assets by risk type and business
176
Movement analysis of risk weighted assets
176
This section outlines the Group’s leverage ratios, leverage exposure composition, and provides information on significant movements in the IFRS and leverage balance sheet.
Analysis of leverage ratios and exposures
177
Leverage ratios and exposures
177
This section outlines the Group’s Minimum requirement for own funds and Eligible Liabilities (MREL) position and ratios.
Minimum requirement for own funds and eligible liabilities
178
This section outlines the impact of regulatory changes as implemented by the Prudential Regulation Authority on the Group's capital and leverage ratios, indicative as at 01.01.22
Regulatory changes as implemented by the Prudential Regulation Authority
178
The Group discloses the two sources of foreign exchange risk that it is exposed to.
Foreign exchange risk
179
Transactional foreign currency exposure
179
Translational foreign exchange exposure
179
Functional currency of operations
179
A review focusing on the UK retirement fund, which represents the majority of the Group’s total retirement benefit obligation.
Pension risk review
180
Assets and liabilities
180
IAS 19 position
180
Risk measurement
181
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
161

Risk review: Treasury and Capital risk
Risk performance continued
Interest rate risk in the banking book performance
A description of the non-traded market risk framework is provided.
The Group discloses a sensitivity analysis on pre-tax net interest income for non-trading financial assets and liabilities. The analysis is carried out by business unit and currency.
The Group measures some non-traded market risks, in particular prepayment, recruitment, and residual risk using an economic capital methodology.
The Group discloses the overall impact of a parallel shift in interest rates on other comprehensive income and cash flow hedges.
The Group measures the volatility of the value of the FVOCI instruments in the liquidity pool through non-traded market risk VaR.
Net interest income sensitivity
182
by business unit
182
by currency
183
Analysis of equity sensitivity
183
Volatility of the FVOCI portfolio in the liquidity pool
183

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
162

Risk review: Treasury and Capital risk
Risk performance continued
Liquidity risk
All disclosures in this section are unaudited unless otherwise stated.
Overview
The Group has a liquidity risk control framework that meets the PRA standards and is designed to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is appropriate to meet the Group’s Liquidity Risk Appetite (LRA). The Liquidity Framework is delivered via a combination of policy formation, review and governance, analysis, stress testing, limit setting and monitoring.
This section provides an analysis of the Group’s: (i) summary of performance, (ii) liquidity risk stress testing, iii) liquidity pool, (iv) funding structure and funding relationships, (v) credit ratings, and (vi) contractual maturity of financial assets and liabilities.
For further detail on liquidity risk governance and framework, refer to page195 to 200 of the Barclays PLC Pillar 3 Report 2021 (unaudited).
Key metrics
Liquidity Coverage Ratio
168%
Summary of performance
The liquidity pool at £291bn (December 2020: £266bn) reflects the Group’s prudent approach to liquidity management. The Liquidity Coverage Ratio (LCR) remained well above the 100% regulatory requirement at 168% (December 2020: 162%), equivalent to a surplus of £116bn (December 2020: £99bn). The increase in the liquidity pool, LCR and surplus over the year was driven by continued deposit growth, borrowing from the Bank of England's Term Funding Scheme with additional incentives for SMEs (TFSME) and an increase in wholesale funding, which were partly offset by an increase in business funding consumption .
During the year, the Group issued £11bn of minimum requirement for own funds and eligible liabilities (MREL) instruments in a range of tenors and currencies.
Barclays Bank PLC continued to issue in the shorter-term and medium-term markets and Barclays Bank UK PLC continued to issue in the shorter-term markets and maintain active secured funding programmes. This funding capacity enables the respective entities maintain their stable and diversified funding bases.
The Group’s reliance on short-term wholesale funding, as measured by the proportion of wholesale funding maturing in less than one year increased year-on-year. At 31 December 2021, it was 36% (December 2020: 29%).
Liquidity risk stress testing
Under the Liquidity Framework, the Group has established a liquidity risk appetite (LRA) together with the appropriate limits for the management of the liquidity risk. This is the level of liquidity risk the Group chooses to take in pursuit of its business objectives and in meeting its regulatory obligations. The Group sets its internal liquidity risk appetite based on internal liquidity risk assessments and, external regulatory requirements namely the Liquidity Coverage Ratio (LCR).
Liquidity risk appetite
The liquidity risk assessment measures the potential contractual and contingent stress outflows under a range of stress scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated outflows should a stress occur.
As part of the LRA, the Group runs three short-term liquidity stress scenarios, aligned to the PRA’s prescribed stresses:
90 days market-wide stress event
30 days Barclays-specific stress event
combined 30 days market-wide and Barclays-specific stress event


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
163

Risk review: Treasury and Capital risk
Risk performance continued
Key LRA assumptions
For the year ended 31 December 2021
Drivers of Liquidity RiskLRA Combined stress – key assumptions
Wholesale Secured and Unsecured Funding Risk
Zero rollover of maturing wholesale unsecured funding
Loss of repo capacity on non-extremely liquid repos at contractual maturity date
 Roll of repo for extremely liquid repo at wider haircut at contractual maturity date
Withdrawal of contractual buyback obligations, excess client futures margin, Prime Brokerage (PB) client cash and overlifts
Haircuts applied to the market value of marketable assets held in the liquidity buffer
Retail and Corporate Funding Risk
Retail and Corporate deposit outflows as counterparties seek to diversify their deposit balances
Intraday Liquidity Risk
Liquidity held to meet increased intraday liquidity usage due to payment and receipts volatility, loss of unsecured credit lines and haircuts applied to collateral values used to back secured creditlines, in a stress
Intra-Group Liquidity Risk
Liquidity support for material subsidiaries. Surplus liquidity held within certain subsidiaries is not taken as a benefit to the wider Group
Cross-Currency Liquidity Risk
Deterioration in FX market capacity that may result in restriction in net currency positions
Off-Balance Sheet Liquidity Risk
Drawdown on committed facilities based on facility and counterparty type
Collateral outflows due to a two-notch credit rating downgrade
Increase in the Group's initial margin requirement across all major exchanges
Variation margin outflows from collateralised risk positions
Outflow of collateral owing but not called
Loss of internal sources of funding within the PB synthetics business
Franchise-Viability Risk
Liquidity held to enable the firm to meet select non-contractual obligations to ensure market confidence in the firm is maintained, including debt buy-backs, swap tear-ups and increased prime brokerage margin debits
Funding Concentration Risk
Liquidity held against largest wholesale funding counterparty refusing to roll
As at 31 December 2021, the Group held eligible liquid assets well in excess of 100% of net stress outflows of the 30 days combined scenario, which has the highest net outflows of the three short-term liquidity stress scenarios.
The Group also runs a long term liquidity stress test, which measures the anticipated outflows over a 12 months market-wide scenario. As at 31 December 2021, the Group remained compliant with this internal metric.
Liquidity regulation
Certain Basel III standards including those relating to the introduction of the liquidity adequacy requirement measured through the LCR were implemented in EU law through CRR, as amended by CRRII, and the Capital Requirements Directive IV. These standards were retained in the UK regulatory framework via a series of onshoring instruments as part of the UK’s withdrawal from the EU. In October 2021, the PRA published the final policy statement setting out its planned implementation of supplementary Basel III standards, including the Net Stable Funding Ratio (NSFR). These came into effect in the UK on 1 January 2022 from which date the Group monitors its position against both the LCR and NSFR.
The LCR is designed to promote short-term resilience of a bank’s liquidity risk profile by holding sufficient High Quality Liquid Assets (HQLA) to survive an acute stress scenario lasting for 30 days. The NSFR has been developed to promote a sustainable and stable structure of assets and liabilities. Barclays is compliant with the NSFR requirement in effect from 1 January 2022.
As a result of the UK’s withdrawal from the EU, EEA government bonds and central bank exposures no longer automatically qualify as Level 1 HQLA. This would impact both the LCR and NSFR metrics. In December 2021, following its consultation process on implementing CRR II in the UK, the PRA introduced a modification by consent (MBC) which would allow for the ongoing recognition of EEA government and central bank assets as Level 1 HQLA for the purposes of the LCR and NSFR. Barclays applied for this MBC which was granted by the PRA in December 2021.
Liquidity coverage ratio
The external LCR requirement is prescribed by the regulator taking into account the relative stability of different sources of funding and potential incremental funding requirements in a stress.
20212020
As at 31 December£bn£bn
Eligible liquidity buffer285 258 
Net stress outflows(169)(159)
Surplus116 99 
Liquidity coverage ratio168 %162 %
As part of the LRA, Barclays also establishes the minimum LCR limit. The Group plans to maintain its surplus to the internal and regulatory stress requirements at an efficient level, while continuously assessing risks to market funding conditions and its liquidity position and taking actions to manage the size of the liquidity pool as appropriate.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
164

Risk review: Treasury and Capital risk
Risk performance continued
Liquidity pool
The Group liquidity pool as at 31 December 2021 was £291bn (2020: £266bn). During 2021, the month-end liquidity pool ranged from £290bn to £337bn (2020: £218bn to £332bn), and the month-end average balance was £303bn (2020: £287bn). The liquidity pool is held unencumbered and is intended to offset stress outflows. It comprises the following cash and unencumbered assets.
Composition of the Group liquidity pool as at 31 December 2021
Liquidity pool of which CRR LCR eligiblec
2020
Liquidity poolCashLevel 1Level 2ALiquidity pool
£bn£bn£bn£bn£bn
Cash and deposits with central banksa
245 243   197 
Government bondsb
AAA to AA-26  23  31 
A+ to A-2   2 13 
BBB+ to BBB-    
Total government bonds28  23 2 45 
Other
Government guaranteed issuers, PSEs and GSEs 6  5 1 10 
International organisations and MDBs5  5  
Covered bonds 6  4 2 
Other1    — 
Total other18  14 3 24 
Total as at 31 December 2021291 243 37 5 266 
Total as at 31 December 2020266 192 55 11 
Notes
a    Includes cash held at central banks and surplus cash at central banks related to payment schemes. Of which over 99% (2020: over 98%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.
b    Of which over 82% (2020: over 78%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.
c    The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR (as amended by CRR II) qualifying assets that are not eligible under Barclays’ internal risk appetite.
The Group liquidity pool is well diversified by major currency and the Group monitors LRA stress scenarios for major currencies.
Liquidity pool by currency
USDEURGBPOther Total
£bn£bn£bn£bn£bn
Liquidity pool as at 31 December 202159 52 132 48 291 
Liquidity pool as at 31 December 202060 50 80 76 266 
Management of the liquidity pool
The composition of the liquidity pool is subject to limits set by the Board and the independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration risk by issuer, currency and asset type. Given the returns generated by these highly liquid assets, the risk and reward profile is continuously managed.
As at 31 December 2021, 58% (2020: 64%) of the liquidity pool was located in Barclays Bank PLC, 30% (2020: 23%) in Barclays Bank UK PLC and 7% (2020: 7%) in Barclays Bank Ireland PLC. The residual portion of the liquidity pool is held outside of these entities, predominantly in the US subsidiaries, to meet entity-specific stress outflows and local regulatory requirements. To the extent the use of this portion of the liquidity pool is restricted due to local regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR.
Contingent liquidity
In addition to the Group liquidity pool, the Group has access to other unencumbered assets which provide a source of contingent liquidity. While these are not relied on in the Group’s LRA, a portion of these assets may be monetised in a stress to generate liquidity through their use as collateral for secured funding or through outright sale.
In a Barclays-specific, market-wide or combined liquidity stress, liquidity available via market sources could be severely disrupted. In circumstances where market liquidity is unavailable or available only at significantly elevated prices, the Group could generate liquidity via central bank facilities. To this end, as at 31 December 2021, the Group had £93.3bn (December 2020: £99.2bn) of assets positioned at various central banks.
For more detail on the Group’s other unencumbered assets, see pages 221 to 223 of the Barclays PLC Pillar 3 Report 2021 (unaudited).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
165

Risk review: Treasury and Capital risk
Risk performance continued
Funding structure and funding relationships
The basis for sound liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an inability to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified funding base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to provide protection against unexpected fluctuations, while minimising the cost of funding.
Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched. A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual assets.
These funding relationships are summarised below:
2021202020212020
Assets£bn£bnLiabilities£bn£bn
Loans and advances at amortised costa
358 335 Deposits at amortised cost519 481 
Group liquidity pool291 266 <1 Year wholesale funding61 43 
>1 Year wholesale funding107 102 
Reverse repurchase agreements, trading portfolio assets, cash collateral and settlement balances388 376 Repurchase agreements, trading portfolio liabilities, cash collateral and settlement balances330 324 
Derivative financial instruments263 302 Derivative financial instruments257 301 
Other assetsb
84 71 Other liabilities40 32 
Equity70 67 
Total assets1,384 1,350 Total liabilities1,384 1,350 
Notes
a    Adjusted for liquidity pool debt securities reported at amortised costs of £3bn (December 2020: £8bn).
b    Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.
Deposit funding (audited)
20212020
Funding of loans and advancesLoans and advances at amortised costDeposits at amortised cost
Loan: deposit
ratioa
Loan: deposit
ratio
As at 31 December 2021£bn£bn%%
Barclays UK222 260 85 %89 %
Barclays International134 259 52 %51 %
Head Office5  
Barclays Group361 519 70 %71 %
Note
a    The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.

As at 31 December 2021, £222bn (2020: £209bn) of total customer deposits were insured through the UK Financial Services Compensation Scheme (FSCS) and other similar schemes. In addition to these customer deposits £1.3bn (2020: £2bn) of other liabilities are insured by other governments.
Contractually current accounts are repayable on demand and savings accounts at short notice. In practice, their observed maturity is typically longer than their contractual maturity. Similarly, repayment profiles of certain types of assets e.g. mortgages, overdrafts and credit card lending, differ from their contractual profiles. The Group therefore assesses the behavioural maturity of both customer assets and liabilities to identify structural balance sheet funding gaps. In doing so, it applies quantitative modelling and qualitative assessments which take into account historical experience, current customer composition, and macroeconomic projections.
The Group’s broad base of customers, numerically and by depositor type, helps protect against unexpected fluctuations in balances and hence provides a stable funding base for the Group’s operations and liquidity needs.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
166

Risk review: Treasury and Capital risk
Risk performance continued
Wholesale funding
Barclays Bank Group and Barclays Bank UK Group maintain access to a variety of sources of wholesale funds in major currencies, including those available from term investors across a variety of distribution channels and geographies, short-term funding markets and repo markets.
Barclays Bank Group has direct access to US, European and Asian capital markets through its global investment banking operations and to long-term investors through its clients worldwide. Key sources of wholesale funding include money markets, certificates of deposit, commercial paper, medium term issuances (including structured notes) and securitisations.
Key sources of wholesale funding for Barclays Bank UK Group include money markets, certificates of deposit, commercial paper, covered bonds and other securitisations.
The Group expects to continue issuing public wholesale debt from Barclays PLC (the Parent company), in order to maintain compliance with indicative MREL requirements and maintain a stable and diverse funding base by type, currency and market. During the year, the Group issued £11.0bn of MREL instruments from Barclays PLC (the Parent company) in a range of different currencies and tenors.
Barclays Bank PLC continued to issue in the shorter-term markets and maintain active medium-term notes programmes. Barclays Bank UK PLC continued to issue in the shorter-term markets and maintain active secured funding programmes. This funding capacity enables the respective entities to maintain their stable and diversified funding bases.
As at 31 December 2021, the Group’s total wholesale funding outstanding (excluding repurchase agreements) was £167.5bn (2020: £145.0bn), of which £16.6bn (2020: £17.1bn) was secured funding and £150.9bn (2020: £127.9bn) unsecured funding. Unsecured funding includes £59.7bn (2020: £54.8bn) of privately placed senior unsecured notes issued through a variety of distribution channels including intermediaries and private banks.
Wholesale funding of £60.7bn (2020: £42.7bn) matures in less than one year, representing 36% (December 2020: 29%) of total wholesale funding outstanding. This includes £18.9bn (2020: £20.3bn) related to term fundingb. Although not a requirement, the liquidity pool exceeded the wholesale funding maturing in less than one year by £230bn (2020: £223bn).
Barclays Bank Group and Barclays Bank UK Group also support various central bank monetary initiatives, such as the Bank of England’s Term Funding Scheme with additional incentives for SMEs (TFSME), and the European Central Bank’s Targeted Long-Term Refinancing Operations (TLTRO). These are reported under ‘repurchase agreements and other similar secured borrowing’ on the balance sheet.
In 2021, Barclays repaid £1.4bn of Term Funding Scheme (TFS) drawings early, reducing the outstanding drawn balance under TFS to £0.0bn as at 31 December 2021. In addition, Barclays drew an additional £15.4bn under the TFSME and an additional £0.5bn under the TLTRO; £22.0bn TFSME and £2.7bn TLTRO balances were outstanding at the year-end.
Maturity profile of wholesale fundinga,b
<1 month1-3 months3-6 months6-12 months<1 year1-2 years2-3 years3-4 years4-5 years>5 yearsTotal
£bn£bn£bn£bn£bn£bn£bn£bn£bn£bn£bn
Barclays PLC (the Parent company)
Senior unsecured (Public benchmark) 0.8   0.8 7.4 5.5 5.5 5.8 15.6 40.6 
Senior unsecured (Privately placed)     0.1 0.1   1.0 1.2 
Subordinated liabilities      0.9  1.5 6.8 9.2 
Barclays Bank PLC (including subsidiaries)
Certificates of deposit and commercial paper0.7 11.2 10.2 9.0 31.1 0.2 0.1    31.4 
Asset backed commercial paper2.3 4.2 0.6  7.1      7.1 
Senior unsecured (Public benchmark)  1.3  1.3  0.9   0.4 2.6 
Senior unsecured (Privately placed)c1.2 2.1 3.1 5.3 11.7 7.1 8.6 4.6 4.0 22.5 58.5 
Asset backed securities0.1   0.5 0.6 0.1 2.0 0.1 0.3 1.4 4.5 
Subordinated liabilities 1.0  1.3 2.3  0.1  0.4 0.8 3.6 
Barclays Bank UK PLC (including subsidiaries)
Certificates of deposit and commercial paper2.9 0.2 0.5  3.6      3.6 
Senior unsecured (Public benchmark)         0.2 0.2 
Covered bonds 2.2   2.2 1.8    1.0 5.0 
Total as at Total as at 31 December 217.2 21.7 15.7 16.1 60.7 16.7 18.2 10.2 12.0 49.7 167.5 
Of which secured2.4 6.4 0.6 0.5 9.9 1.9 2.0 0.1 0.3 2.4 16.6 
Of which unsecured4.8 15.3 15.1 15.6 50.8 14.8 16.2 10.1 11.7 47.3 150.9 
Total as at Total as at 31 December 205.7 15.4 9.5 12.1 42.7 15.6 16.7 12.3 10.2 47.5 145.0 
Of which secured2.3 5.0 0.7 0.5 8.5 3.1 2.2 0.5 0.2 2.6 17.1 
Of which unsecured3.4 10.4 8.8 11.6 34.2 12.5 14.5 11.8 10.0 44.9 127.9 
Notes
a    The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.
b    Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the original maturity of the instrument was more than one year.
c    Includes structured notes of £50.1bn, of which £10.9bn matures within one year.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
167

Risk review: Treasury and Capital risk
Risk performance continued
Currency composition of wholesale debt
As at 31 December 2021, the proportion of wholesale funding by major currencies was as follows:
Currency composition of wholesale funding
USDEURGBPOther
%%%%
Certificates of deposit and commercial paper50 43 6 1 
Asset backed commercial paper82 13 5  
Senior unsecured (Public benchmark)57 21 14 8 
Senior unsecured (Privately placed)65 15 9 11 
Covered bonds / Asset backed securities48 22 30  
Subordinated liabilities66 24 7 3 
Total as December 31, 202159 24 11 6 
Total as December 31, 202061 20 13 
To manage cross currency refinancing risk, the Group manages to currency mismatch limits, which limit risk at specific maturities.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
168

Risk review: Treasury and Capital risk
Risk performance continued
Contractual maturity of financial assets and liabilities
The table below provides detail on the contractual maturity of all financial instruments and other assets and liabilities. Derivatives (other than those designated in a hedging relationship) and trading portfolio assets and liabilities are included in the ‘on demand’ column at their fair value. Liquidity risk on these items is not managed on the basis of contractual maturity since they are not held for settlement according to such maturity and will frequently be settled before contractual maturity at fair value. Derivatives designated in a hedging relationship are included according to their contractual maturity.
Contractual maturity of financial assets and liabilities (audited)
As at 31 December 2021 On
demand
 Not more
than three
months
 Over three
months but
not more
than six
months
 Over six
months but
not more
than nine months
 Over nine
months but
not more
than one year
 Over one
year
but not
more than
two years
 Over two
years but
not more
than three
years
 Over three
years but
not more
than five
years
 Over five
years but
not more
than ten
years
 Over ten
years
 Total
 £m  £m  £m  £m  £m  £m  £m  £m  £m  £m  £m
Assets
Cash and balances at central banks238,369 205         238,574 
Cash collateral and settlement balances2,807 89,735         92,542 
Loans and advances at amortised cost19,749 8,670 8,879 5,291 10,192 23,716 26,037 47,614 39,822 171,481 361,451 
Reverse repurchase agreements and other similar secured lending58 2,984    184    1 3,227 
Trading portfolio assets147,035          147,035 
Financial assets at fair value through the income statement24,257 127,085 9,281 7,042 3,451 5,889 5,394 2,590 2,564 4,419 191,972 
Derivative financial instruments261,678 58 48   82 145 537 15 9 262,572 
Financial assets at fair value through other comprehensive income 4,280 1,488 1,245 1,419 3,834 8,205 13,188 18,226 9,868 61,753 
Other financial assets707 474 26 2  1   1 2 1,213 
Total financial assets694,660 233,491 19,722 13,580 15,062 33,706 39,781 63,929 60,628 185,780 1,360,339 
Other assets23,946 
Total assets1,384,285 
Liabilities
Deposits at amortised cost454,961 40,755 13,524 2,994 3,724 2,025 433 241 545 231 519,433 
Cash collateral and settlement balances2,983 76,388         79,371 
Repurchase agreements and other similar secured borrowing20 6,621    2,195 8,925 10,504  87 28,352 
Debt securities in issue 24,399 12,606 5,845 3,254 9,792 8,957 12,948 12,218 8,848 98,867 
Subordinated liabilities 1,007  74 1,218 27 1,063 1,885 5,603 1,882 12,759 
Trading portfolio liabilities54,169          54,169 
Financial liabilities designated at fair value14,342 158,059 17,065 10,557 3,909 7,861 9,185 8,558 7,746 13,678 250,960 
Derivative financial instruments255,747 4 22 18 5 124 177 302 122 362 256,883 
Other financial liabilities184 4,331 43 42 40 691 145 266 420 139 6,301 
Total financial liabilities782,406 311,564 43,260 19,530 12,150 22,715 28,885 34,704 26,654 25,227 1,307,095 
Other liabilities6,979 
Total liabilities1,314,074 
Cumulative liquidity gap(87,746)(165,819)(189,357)(195,307)(192,395)(181,404)(170,508)(141,283)(107,309)53,244 70,211 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
169

Risk review: Treasury and Capital risk
Risk performance continued
Contractual maturity of financial assets and liabilities (audited)
As at 31 December 2020 On
demand
 Not more
than three
months
 Over three
months but
not more
than six
months
 Over six
months but
not more
than nine
months
 Over nine
months but
not more
than one
year
 Over one
year
but not
more than
two years
 Over two
years but
not more
than three
years
 Over three
years but
not more
than five
years
 Over five
years but
not more
than ten
years
 Over ten
years
 Total
 £m  £m  £m  £m  £m  £m  £m  £m  £m  £m  £m
Assets
Cash and balances at central banks190,347 182 598        191,127 
Cash collateral and settlement balances1,177 100,190         101,367 
Loans and advances at amortised cost14,098 11,970 8,388 4,956 5,234 25,392 22,133 36,286 47,944 166,231 342,632 
Reverse repurchase agreements and other similar secured lending150 8,698     183    9,031 
Trading portfolio assets127,950          127,950 
Financial assets at fair value through the income statement17,377 123,044 7,548 6,960 4,151 4,911 1,346 2,431 2,345 5,038 175,151 
Derivative financial instruments301,880 23    70 55 310 87 21 302,446 
Financial assets at fair value through other comprehensive income 9,655 3,517 1,393 948 6,469 5,566 17,552 24,450 9,138 78,688 
Other financial assets357 451 19 22  1     850 
Total financial assets653,336 254,213 20,070 13,331 10,333 36,843 29,283 56,579 74,826 180,428 1,329,242 
Other assets20,272 
Total assets1,349,514 
Liabilities
Deposits at amortised cost410,894 41,468 15,886 5,073 3,082 2,264 625 601 764 379 481,036 
Cash collateral and settlement balances1,900 83,523         85,423 
Repurchase agreements and other similar secured borrowing4 3,276    1,400 2,329 7,073  92 14,174 
Debt securities in issue 16,344 4,048 5,100 1,937 5,780 10,402 13,608 12,721 5,856 75,796 
Subordinated liabilities 1,589 3,209 294  2,192 14 989 6,915 1,139 16,341 
Trading portfolio liabilities47,405          47,405 
Financial liabilities designated at fair value15,555 172,153 8,677 5,067 2,938 8,594 6,939 8,580 8,344 12,918 249,765 
Derivative financial instruments299,795 1 49   79 67 185 196 403 300,775 
Other financial liabilities101 2,915 49 46 45 738 156 273 436 210 4,969 
Total financial liabilities775,654 321,269 31,918 15,580 8,002 21,047 20,532 31,309 29,376 20,997 1,275,684 
Other liabilities6,948 
Total liabilities1,282,632 
Cumulative liquidity gap(122,318)(189,374)(201,222)(203,471)(201,140)(185,344)(176,593)(151,323)(105,873)53,558 66,882 
Expected maturity date may differ from the contractual dates, to account for:
trading portfolio assets and liabilities and derivative financial instruments, which may not be held to maturity as part of the Group’s trading strategies
corporate and retail deposits, reported under deposits at amortised cost, are repayable on demand or at short notice on a contractual basis. In practice, their behavioural maturity is typically longer than their contractual maturity, and therefore these deposits provide stable funding for the Group’s operations and liquidity needs because of the broad base of customers, both numerically and by depositor type
loans to corporate and retail customers, which are included within loans and advances at amortised cost and financial assets at fair value, may be repaid earlier in line with terms and conditions of the contract
debt securities in issue, subordinated liabilities, and financial liabilities designated at fair value, may include early redemption features.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
170

Risk review: Treasury and Capital risk
Risk performance continued
Contractual maturity of financial liabilities on an undiscounted basis
The table below presents the cash flows payable by the Group under financial liabilities by remaining contractual maturities at the balance sheet date. The amounts disclosed in the table are the contractual undiscounted cash flows of all financial liabilities (i.e. nominal values).
The balances in the below table do not agree directly to the balances in the consolidated balance sheet as the table incorporates all cash flows, on an undiscounted basis, related to both principal as well as those associated with all future coupon payments.
Derivative financial instruments held for trading and trading portfolio liabilities are included in the on demand column at their fair value.
Contractual maturity of financial liabilities - undiscounted (audited)
 On
demand
 Not more
than three
months
 Over three
months but
not more
than six
months
 Over six
months but
not more
than one year
 Over one
year
but not
more than
three years
 Over three
years but
not more
than five
years
 Over five
years but
not more
than ten
years
 Over ten
years
 Total
 £m  £m  £m  £m  £m  £m  £m  £m  £m
As at 31 December 2021
Deposits at amortised cost454,961 40,755 13,524 6,718 2,461 239 559 261 519,478 
Cash collateral and settlement balances2,983 76,388       79,371 
Repurchase agreements and other similar secured borrowing20 6,621   11,356 10,885  146 29,028 
Debt securities in issue 24,450 12,625 9,075 19,225 14,060 14,147 13,690 107,272 
Subordinated liabilities 1,063  1,379 1,213 2,316 6,627 2,867 15,465 
Trading portfolio liabilities54,169        54,169 
Financial liabilities designated at fair value14,342 158,094 17,096 14,558 17,445 8,908 7,949 22,062 260,454 
Derivative financial instruments255,747 5 22 24 305 316 134 449 257,002 
Other financial liabilities184 4,344 57 111 932 327 502 162 6,619 
Total financial liabilities782,406 311,720 43,324 31,865 52,937 37,051 29,918 39,637 1,328,858 
As at 31 December 2020
Deposits at amortised cost410,894 41,468 15,886 8,156 2,893 599 768 385 481,049 
Cash collateral and settlement balances1,900 83,523 — — — — — — 85,423 
Repurchase agreements and other similar secured borrowing3,276 — — 3,729 7,089 — 154 14,252 
Debt securities in issue— 16,368 4,058 7,061 16,684 14,715 14,882 9,852 83,620 
Subordinated liabilities— 1,597 3,328 311 2,498 1,152 8,578 1,587 19,051 
Trading portfolio liabilities47,405 — — — — — — — 47,405 
Financial liabilities designated at fair value15,555 172,186 8,683 8,007 15,604 8,586 8,369 20,835 257,825 
Derivative financial instruments299,795 49 — 147 187 204 443 300,826 
Other financial liabilities101 2,929 62 116 981 338 557 248 5,332 
Total financial liabilities775,654 321,348 32,066 23,651 42,536 32,666 33,358 33,504 1,294,783 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
171

Risk review: Treasury and Capital risk
Risk performance continued
Maturity of off-balance sheet commitments received and given
The table below presents the maturity split of the Group’s off-balance sheet commitments received and given at the balance sheet date. The amounts disclosed in the table are the undiscounted cash flows (i.e. nominal values) on the basis of earliest opportunity at which they are available.
Maturity analysis of off-balance sheet commitments received (audited)
On
demand
Not more than three months  Over three months but not more than six months  Over six months but not more than nine months  Over nine months but not more than one year  Over one year but not more than two years  Over two years but not more than three years  Over three years but not more than five years  Over five years but not more than ten years  Over ten years  Total
 £m  £m  £m  £m  £m  £m  £m  £m  £m  £m  £m
As at 31 December 2021
Guarantees, letters of credit and credit insurance25,613 31 21 10 12 4 12 83 65 19 25,870 
Other commitments received455          455 
Total off-balance sheet commitments received26,068 31 21 10 12 4 12 83 65 19 26,325 
As at 31 December 2020
Guarantees, letters of credit and credit insurance26,368 86 37 68 8 18 14 47 40 25 26,711 
Other commitments received92          92 
Total off-balance sheet commitments received26,460 86 37 68 8 18 14 47 40 25 26,803 

Maturity analysis of off-balance sheet commitments given (audited)
 On
demand
 Not more than three months  Over three months but not more than six months  Over six months but not more than nine months  Over nine months but not more than one year  Over one year but not more than two years  Over two years but not more than three years  Over three years but not more than five years  Over five years but not more than ten years  Over ten years  Total
 £m  £m  £m  £m  £m  £m  £m  £m  £m  £m  £m
As at 31 December 2021
Contingent liabilities21,207 135 4        21,346 
Documentary credits and other short-term trade related transactions1,582 2         1,584 
Standby facilities, credit lines and other commitments344,055     72     344,127 
Total off-balance sheet commitments given366,844 137 4   72     367,057 
As at 31 December 2020
Contingent liabilities21,307 213 57 6 1 25     21,609 
Documentary credits and other short-term trade related transactions1,084 1 1        1,086 
Standby facilities, credit lines and other commitments330,499 564 93 123 95 160 199 202 21 7 331,963 
Total off-balance sheet commitments given352,890 778 151 129 96 185 199 202 21 7 354,658 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
172

Risk review: Treasury and Capital risk
Risk performance continued
Capital risk
All disclosures in this section are unaudited unless otherwise stated.
Overview
The CET1 ratio, among other metrics, is a measure of the capital strength and resilience of Barclays. Maintenance of our capital resources is vital in order to meet the overall regulatory capital requirement, to withstand the impact of the risks that may arise under normal and stressed conditions, and to cover current and forecast business needs and associated risks to provide a viable and sustainable business offering.
This section provides an overview of the Group’s: (i) CET1 capital, leverage and own funds and eligible liabilities requirements; (ii) capital resources; (iii) risk weighted assets (RWAs); (iv) leverage ratios and exposures; and (v) own funds and eligible liabilities.
More details on monitoring and managing capital risk may be found in the risk management sections of the Barclays PLC Pillar 3 Report 2021 (unaudited).
Key metrics
Common Equity Tier 1 ratio
15.1%
Average UK leverage ratio
4.9%
UK leverage ratio
5.3%
Own funds and eligible liabilities ratio as a percentage of CRR leverage exposuresa,b
8.0%

Notes
a    Fully loaded CRR leverage exposure is calculated without applying the transitional arrangements of the CRR as amended by CRR II.
b    Excludes subsidiary issuances which cannot be counted towards the Group’s MREL from 1 January 2022. The own funds and eligible liabilities ratio including subsidiary issuances was 8.1%.
Summary of performance in the period
The Group continues to be in excess of overall capital, leverage and MREL regulatory requirements.
CET1 capital increased by £1.2bn to £47.5bn as profit before tax of £8.4bn was partially offset by share buybacks, 2021 dividends and equity coupons paid and foreseen as well as pensions deficit contribution payments.
RWAs increased £7.9bn to £314.1bn primarily resulting from the recalibration of the modelled market risk stress period, increased client and trading activity within CIB and growth in mortgages within Barclays UK, partially offset by lower unsecured balances.
The average UK leverage ratio decreased to 4.9% (December 2020: 5.0%). The average leverage exposure increased by £80.2bn to £1,227.1bn largely driven by an increase in securities financing transactions (SFTs), potential future exposure (PFE) on derivatives and trading portfolio assets (TPAs) .
As at 31 December 2021, Barclays PLC (the Parent company) had £108.2bn of own funds and eligible liabilities equating to 8% of CRR leverage exposures. This was in excess of the Group’s MREL requirement to hold £93.9bn of own funds and eligible liabilities, equating to 6.9% of CRR leverage exposures.
Minimum capital requirements
The Group’s Overall Capital Requirement for CET1 is 11.1% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.6% Pillar 2A requirement and a 0% Countercyclical Capital Buffer (CCyB).
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11 March 2020, the Financial Policy Committee (FPC) set the CCyB rate for UK exposures at 0% with immediate effect. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0% CCyB for the Group. On 13 December 2021, the FPC announced that a CCyB rate of 1% for UK exposures has been re-introduced and will be applicable from 13 December 2022.
As at 31 December 2021, the Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement was set as a nominal amount. When expressed as a percentage of RWAs this was 4.6% of which at least 56.25% needed to be met with CET1 capital, equating to approximately 2.6% of RWAs. The Pillar 2A requirement is subject to at least annual review and is based on a point in time assessment.
Minimum leverage requirements
The Group is subject to a leverage ratio requirement of 3.8% as at 31 December 2021. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer of 0.0%. Although the leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.0bn.
Minimum requirements for own funds and eligible liabilities
As at 31 December 2021, the Group was required to meet the higher of: (i) the MREL set by the Bank of England (BoE); and (ii) the requirements in CRR as amended by CRR II, both of which have RWA and leverage measures.
CET1 capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be applied above MREL requirements.
Significant regulatory updates in the period
Following the withdrawal of the UK from the EU, any references to CRR as amended by CRR II mean, unless otherwise specified, CRR as amended by CRR II, as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018 and subject to the temporary transitional powers (TTP) available to UK regulators to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022, as at the applicable reporting date.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
173

Risk review: Treasury and Capital risk
Risk performance continued
Capital resources
Capital ratiosa,b,c
As at 31 December20212020
CET115.1 %15.1 %
Tier 1 (T1)19.2 %19.0 %
Total regulatory capital22.3 %22.1 %
Capital resources (audited)
20212020
As at 31 December£m£m
Total equity excluding non-controlling interests per the balance sheet69,222 65,797 
Less: other equity instruments (recognised as AT1 capital)(12,259)(11,172)
Adjustment to retained earnings for foreseeable ordinary share dividends (666)(174)
Adjustment to retained earnings for foreseeable repurchase of shares — 
Adjustment to retained earnings for foreseeable other equity coupons(32)(30)
Other regulatory adjustments and deductions
Additional value adjustments (PVA)(1,585)(1,146)
Goodwill and intangible assets(6,804)(6,914)
Deferred tax assets that rely on future profitability excluding temporary differences(1,028)(595)
Fair value reserves related to gains or losses on cash flow hedges852 (1,575)
Gains or losses on liabilities at fair value resulting from own credit892 870 
Defined benefit pension fund assets(2,619)(1,326)
Direct and indirect holdings by an institution of own CET1 instruments(50)(50)
Adjustment under IFRS 9 transitional arrangements1,229 2,556 
Other regulatory adjustments345 55 
CET1 capital47,497 46,296 
AT1 capital
Capital instruments and related share premium accounts12,259 11,172 
Qualifying AT1 capital (including minority interests) issued by subsidiaries 637 646 
Other regulatory adjustments and deductions(80)(80)
AT1 capital12,816 11,738 
T1 capital60,313 58,034 
T2 capital
Capital instruments and related share premium accounts8,713 7,836 
Qualifying T2 capital (including minority interests) issued by subsidiaries1,113 1,893 
Credit risk adjustments (excess of impairment over expected losses)73 57 
Other regulatory adjustments and deductions(160)(160)
Total regulatory capital70,052 67,660 
Total RWAs314,136 306,203 
Notes
aCET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.
bThe fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 14.7%, with £46.3bn of CET1 capital and £313.9bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.
cThe Group’s CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was 15.1%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II, including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December 2017.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
174

Risk review: Treasury and Capital risk
Risk performance continued
Movement in CET1 capital
2021
£m
Opening balance as at 1 January 202146,296 
Profit for the period attributable to equity holders7,179 
Own credit relating to derivative liabilities16 
Ordinary share dividends paid and foreseen(1,004)
Purchased and foreseeable share repurchase(1,200)
Other equity coupons paid and foreseen(806)
Increase in retained regulatory capital generated from earnings4,185 
Net impact of share schemes187 
Fair value through other comprehensive income reserve(288)
Currency translation reserve(131)
Other reserves(2)
Decrease in other qualifying reserves(234)
Pension remeasurements within reserves643 
Defined benefit pension fund asset deduction(1,293)
Net impact of pensions(650)
Additional value adjustments (PVA)(439)
Goodwill and intangible assets110 
Deferred tax assets that rely on future profitability excluding those arising from temporary differences(433)
Adjustment under IFRS 9 transitional arrangements(1,327)
Other regulatory adjustments(11)
Decrease in regulatory capital due to adjustments and deductions(2,100)
Closing balance as at 31 December 202147,497 
CET1 capital increased £1.2bn to £47.5bn (December 2020: £46.3bn).
£7.2bn of capital generated from profits were partially offset by distributions of £3bn comprising:
£1bn of dividends paid and foreseen for ordinary shares, which includes £0.3bn half year dividend and a £0.7bn accrual towards the 2021 full year dividend
£1.2bn for share buybacks made up of £0.7bn for the share buyback announced with FY20 results and £0.5bn for the share buyback announced with H121 results; and
£0.8bn of equity coupons paid
Other significant movements in the period were:
A £1.3bn decrease in IFRS 9 transitional relief, after tax, primarily due to credit impairment releases, impairment migrations from Stage 2 to Stage 3 and a decrease to the amount of relief applied to the pre-2020 impairment charge reducing to 50% in 2021 from 70% in 2020
A £0.7bn decrease as a result of movements relating to pensions, largely due to deficit contribution payments of £0.35bn in April 2021 and September 2021
A £0.4bn increase in the PVA deduction due to the reversal of temporary COVID-19 relief measures which increased diversification factors applied to certain additional valuation adjustments during 2020

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
175

Risk review: Treasury and Capital risk
Risk performance continued
Risk weighted assets
Risk weighted assets (RWAs) by risk type and business
Credit riskCounterparty credit riskMarket riskOperational riskTotal RWAs
StdIRBStdIRBSettlement riskCVAStdIMA
As at 31 December 2021£m£m£m£m£m£m£m£m£m£m
Barclays UK7,195 53,408 426   138 100  11,022 72,289 
Corporate and Investment Bank29,420 64,416 15,223 19,238 105 2,289 17,306 27,308 25,359 200,664 
Consumer, Cards and Payments20,770 2,749 215 18  21  57 6,391 30,221 
Barclays International50,190 67,165 15,438 19,256 105 2,310 17,306 27,365 31,750 230,885 
Head Office4,733 7,254       (1,025)10,962 
Barclays Group62,118 127,827 15,864 19,256 105 2,448 17,406 27,365 41,747 314,136 
As at 31 December 2020
Barclays UK7,360 54,340 394   136 72  11,359 73,661 
 Corporate and Investment Bank24,660 73,792 12,047 20,280 246 2,351 13,123 22,363 23,343 192,205 
 Consumer, Cards and Payments19,754 3,041 177 45  31  71 6,996 30,115 
Barclays International44,414 76,833 12,224 20,325 246 2,382 13,123 22,434 30,339 222,320 
Head Office4,153 6,869       (800)10,222 
Barclays Group55,927 138,042 12,618 20,325 246 2,518 13,195 22,434 40,898 306,203 

Movement analysis of risk weighted assets
Credit risk Counterparty credit riskMarket riskOperational riskTotal RWAs
Risk weighted assets£m£m£m£m£m
As at 31 December 2020193,969 35,707 35,629 40,898 306,203 
Book size(1,106)1,838 1,295 849 2,876 
Acquisitions and disposals(1,095)   (1,095)
Book quality175 (102)  73 
Model updates(950)(186)6,927  5,791 
Methodology and policy(345)416 920  991 
Foreign exchange movement a
(703)   (703)
Total RWA movements(4,024)1,966 9,142 849 7,933 
As at 31 December 2021189,945 37,673 44,771 41,747 314,136 
Note
a    Foreign exchange movement does not include foreign exchange for counterparty credit risk, market risk or operational risk.
Overall RWAs increased £7.9bn to £314.1bn (December 2020: £306.2bn). Significant movements in the period were:
Credit risk RWAs decreased £4.0bn:
A £1.1bn decrease in book size mainly driven by lower lending, partially offset by growth in mortgages within Barclays UK
A £1.1bn decrease in acquisitions and disposals mainly driven by disposal of wholesale loans during the year
A £1.0bn decrease in model updates primarily due to modelled risk weight recalibrations
Counterparty credit risk RWAs increased £2.0bn:
A £1.8bn increase in book size primarily due to an increase in client and trading activities within SFTs, partially offset by a reduction in derivatives
Market risk RWAs increased £9.1bn:
A £1.3bn increase in book size primarily due to an increase in client and trading activities
A £6.9bn increase in model updates driven by an increase in Stressed Value at Risk (SVaR) due to a model adjustment to reflect market movements during the COVID-19 stressed period following recalibration of the period, which was delayed until 2021 as a result of COVID-19 relief measures afforded by the PRA
A £0.9bn increase in methodology and policy driven by the application of Pillar 1 Structural FX charge, partially offset by a change in the historical lookback period of the VaR model from two years to one year


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
176

Risk review: Treasury and Capital risk
Risk performance continued
Leverage ratios and exposures
The Group is required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter. The Group is also required to disclose a UK leverage ratio based on capital and exposure on the last day of the quarter.
Leverage ratiosa,b
20212020
As at 31 December£m£m
Average UK leverage ratio4.9 %5.0 %
Average T1 capitalc
59,79657,069
Average UK leverage exposure1,227,1341,146,919
UK leverage ratio5.3 %5.3 %
CET1 capital47,49746,296
AT1 capital12,17911,092
T1 capitalc
59,67657,388
UK leverage exposure1,135,9971,090,907
UK leverage exposure
20212020
As at 31 December£m£m
Accounting assets
Derivative financial instruments262,572302,446
Derivative cash collateral58,17764,798
Securities financing transactions170,853164,034
Loans and advances and other assets892,683818,236
Total IFRS assets1,384,2851,349,514
Regulatory consolidation adjustments(3,665)(1,144)
Derivatives adjustments
Derivatives netting(236,881)(272,275)
Adjustments to collateral(50,929)(57,414)
Net written credit protection15,50914,986
Potential future exposure on derivatives137,291117,010
Total derivatives adjustments(135,010)(197,693)
SFTs adjustments24,54421,114
Regulatory deductions and other adjustments(20,219)(17,469)
Weighted off-balance sheet commitments113,140113,704
Qualifying central bank claims(210,134)(155,890)
Settlement netting(16,944)(21,229)
UK leverage exposure1,135,9971,090,907
Notes
a    Fully loaded average UK leverage ratio was 4.8%, with £58.5bn of T1 capital and £1,225.8bn of leverage exposure. Fully loaded UK leverage ratio was 5.2%, with £58.4bn of T1 capital and £1,134.8bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II.
b    Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.
c    The T1 capital is calculated in line with the PRA Handbook.
The average UK leverage ratio decreased to 4.9% (December 2020: 5.0%). The average leverage exposure increased by £80.2bn to £1,227.1bn (December 2020: £1,146.9bn) largely driven by balance sheet increases in SFTs and TPAs as well as, PFE on derivatives.
The UK leverage ratio remained stable at 5.3% (December 2020: 5.3%) primarily driven by a £2.3bn increase in T1 capital offset by a £45.1bn increase in UK leverage exposure. The UK leverage exposure increase to £1,136.0bn (December 2020: £1,090.9bn) was primarily driven by a £20.3bn increase in PFE on derivatives, a £19.1bn increase in TPAs due to increased trading activity in CIB, £18.8bn increase in loans and advances at amortised cost, and a £6.8bn increase in SFTs, offset by a £16.9bn decrease in assets at fair value through other comprehensive income due to disposals.
The Group also discloses a CRR leverage ratioa within its additional regulatory disclosures prepared in accordance with EBA guidelines on disclosure under Part Eight of the CRR (see Barclays PLC Pillar 3 Report 2021, due to be published on 23 February 2022 and which will be available at home.barclays/investor-relations/reports-and-events/annual-reports).
Note
a    CRR leverage ratio as amended by CRR II.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
177

Risk review: Treasury and Capital risk
Risk performance continued
Minimum requirement for own funds and eligible liabilities
MREL requirements including buffersa,b
Requirement (£m):Requirement (%):
As at 31.12.2021As at 30.09.2021As at 31.12.2020As at 31.12.2021As at 30.09.2021As at 31.12.2020
Requirement based on RWAs77,302 76,174 75,918 24.6 %24.8 %24.8 %
Requirement based on CRR leverage exposure (minimum requirement)93,861 94,438 87,529 6.9 %6.9 %7.0 %
Own funds and eligible liabilitiesa,b
£m£m£m
CET1 capital47,49747,30246,296
AT1 capital instruments and related share premium accountsc
12,17912,17211,092
T2 capital instruments and related share premium accountsc
8,6268,8657,733
Eligible liabilities39,88938,78735,086
Total Barclays PLC (the Parent company) own funds and eligible liabilities108,191107,126100,207
Total RWAs314,136307,464306,203
Total CRR leverage exposure1,354,2841,368,2591,254,157
Own funds and eligible liabilities ratios as a percentage of:As at 31.12.2021As at 30.09.2021As at 31.12.2020
Total RWAs34.4 %34.8 %32.7 %
Total CRR leverage exposure8.0 %7.8 %8.0 %
Notes
a    CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.
b    As at 31 December 2021, Own funds and eligible liabilities including instruments issued by subsidiaries was £109.9bn.
c    Includes other AT1 capital regulatory adjustments and deductions of £80m (December 2020: £80m), and other T2 credit risk adjustments and deductions of £87m (December 2020: £103m).

Regulatory changes as implemented by the Prudential Regulation Authority
The PRA has implemented several regulatory changes impacting the calculation of the CET1 ratio within the UK. Changes have also been implemented following the review of the UK Leverage framework and the setting of MREL requirements. All changes took effect from 1 January 2022.
Capital and RWAs
On 19 July 2019, the EBA published a report on the implementation of IRB roadmap changes. These have subsequently been implemented by the PRA via several Policy Statements. Key changes include revisions to the criteria for definition of default, PD and LGD estimation to ensure supervisory consistency and increase transparency of IRB models.
On 14 October 2021, the PRA finalised their implementation of Basel standards through Policy Statement 22/21. The finalised requirements included the introduction of the Standardised Approach for Counterparty Credit Risk (SA-CCR) which replaces the Current Exposure Method (CEM) for Standardised derivative exposures as a more risk sensitive approach. The PRA also confirmed the intention to revert to the previous treatment of 100% CET1 capital deduction for qualifying software assets, meaning the c.35bps benefit in the CET1 ratio will be reversed.
UK Leverage Ratio Framework
On 8 October 2021, the PRA published its Policy Statement on the UK leverage ratio framework. The Policy Statement confirms that UK banks will be subject to a single UK leverage ratio requirement meaning that the CRR leverage ratio will no longer apply for UK banks. Whilst largely upholding the existing framework, technical changes generally align to the Basel III standards with the exception of the qualifying claims on central banks exemption. Central bank claims can be excluded from the UK leverage ratio measure as long as they are matched by qualifying liabilities (rather than deposits). Minimum requirements for the Group remain the same with minimum requirements also expected to be applied at the individual level from 1 January 2023. Individual requirements may be replaced with a sub-consolidated measure, subject to permission from the PRA.
MREL requirements
On 3 December 2021 the BoE set new MREL requirements via an updated Statement of Policy removing the requirements under CRR, meaning that from 1 January 2022 the Group will be required to meet the higher of (i) 2 times 8% Pillar 1 and 4.6% Pillar 2A requirement; and (ii) 6.75% of UK leverage exposure. Using the rebased 1 January 2022 RWAs and UK leverage exposure, the MREL requirement is expected to be £93.6bn based on RWAs. The Group currently holds £108.2bn of own funds and eligible liabilities which is above the expected 2022 minimum requirement. The Statement of Policy also confirmed that own funds instruments issued by subsidiaries cannot count towards the Group's MREL from 1 January 2022.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
178

Risk review: Treasury and Capital risk
Risk performance continued
Barclays has calculated RWAs, Leverage exposures and Capital and Leverage ratios reflecting our interpretation of the latest rules and guidance.
Impacts due to implementation of regulatory changes - indicative as at 01.01.22As at
31.12.21
Rebased as at
01.01.22
£bn£bn
CET1 ratio15.1 %14.3 %
CET1 capital
47.545.8
Total RWAsa,b
314.1320.5
UK leverage ratio5.3 %5.3 %
T1 capital59.758.0
UK leverage exposure1,136.01,102.1
MREL requirement based on UK leverage exposuresc
87.3
MREL requirement based on RWAs (minimum requirement)c
93.6
Notes
a Includes expected impact on CVA of roll out of SA-CCR across 60 day average period..
b IRB roadmap impact based on latest available data by portfolio, majority is based on 31 December 2021..
c MREL requirement for 31 December 2021 was £93.9bn based on CRR leverage exposures which no longer apply for UK banks from 1 January 2022..

Barclays CET1 ratio is expected to decrease by c.80bps as a result of the regulatory changes which took effect from 1 January 2022, due to the reversal of the software intangibles benefit, implementation of IRB roadmap changes, introduction of SA-CCR and amortisation of IFRS 9 transitional relief.
The UK Leverage ratio is expected to remain broadly stable following the introduction of SA-CCR and exclusion of central bank claims matched by qualifying liabilities, partially offset by the reversal of the software intangibles benefit.
Foreign exchange risk (audited)
The Group is exposed to two sources of foreign exchange risk.
a) Transactional foreign currency exposure
Transactional foreign currency exposures represent exposure on banking assets and liabilities, denominated in currencies other than the functional currency of the transacting entity.
The Group’s risk management policies are designed to prevent the holding of significant open positions in foreign currencies outside the trading portfolio managed by Barclays International which is monitored through VaR.
Banking book transactional foreign exchange risk outside of Barclays International is monitored on a daily basis by the market risk function and minimised by the businesses.
b) Translational foreign exchange exposure
The Group’s investments in overseas subsidiaries and branches create capital resources denominated in foreign currencies, principally USD and EUR. Changes in the GBP value of the net investments due to foreign currency movements are captured in the currency translation reserve, resulting in a movement in CET1 capital.
The Group’s strategy is to minimise the volatility of the capital ratios caused by foreign exchange movements, by matching the CET1 capital movements to the revaluation of the Group’s foreign currency RWA exposures.
Functional currency of operations (audited)
Foreign currency net investmentsBorrowings which hedge the net investmentsDerivatives which hedge the net investmentsStructural currency exposures pre-economic hedgesEconomic hedgesRemaining structural currency exposures
£m£m£m£m£m£m
As at 31 December 2021
USD25,958 (7,707)(2,356)15,895 (7,389)8,506 
EUR8,453 (3,408)(3)5,042 (268)4,774 
JPY614 (97) 517  517 
Other currencies2,448  (64)2,384  2,384 
Total37,473 (11,212)(2,423)23,838 (7,657)16,181 
As at 31 December 2020
USD24,204 (7,666)(764)15,774 (6,193)9,581 
EUR5,275 (952)(3)4,320 (286)4,034 
JPY582 — — 582 — 582 
Other currencies2,020 (42)(24)1,954 — 1,954 
Total32,081 (8,660)(791)22,630 (6,479)16,151 
Economic hedges relate to exposures arising on foreign currency denominated preference share and AT1 instruments. These are accounted for at historical cost under IFRS and do not qualify as hedges for accounting purposes. The gain or loss arising from changes in the GBP value of these instruments is recognised on redemption in retained earnings.
During 2021, total structural currency exposure net of hedging instruments remained stable at £16.2bn (2020: £16.2bn). Foreign currency net investments increased by £5.4bn to £37.5bn (2020: £32.1bn) driven predominantly by a £3.2bn increase in EUR, £1.7bn increase in USD and £0.5bn increase in other currencies. The hedges associated with these investments increased by £4.1bn to £13.6bn (2020: £9.5bn).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
179

Risk review: Treasury and Capital risk
Risk performance continued
Pension risk review
The UK Retirement Fund (UKRF) represents approximately 97% (2020: 97%) of the Group’s total retirement benefit obligations globally. As such this risk review section focuses exclusively on the UKRF. The UKRF is closed to new entrants and there is no new final salary benefit being accrued. Existing active members accrue a combination of a cash balance benefit and a defined contribution element. Pension risk arises as the market value of the pension fund assets may decline, investment returns may reduce or the estimated value of the pension liabilities may increase.
Refer to the Management of pension risk section in the Barclays PLC Pillar 3 Report 2021 (unaudited) for more information on how pension risk is managed.
Assets
The Trustee Board of the UKRF defines its overall long-term investment strategy with investments across a broad range of asset classes. This results in an appropriate mix of return seeking assets as well as liability matching assets to better match future pension obligations. The two largest market risks within the asset portfolio are interest rates and equities. The split of scheme assets is shown within Note 33 to the financial statements. The fair value of the UKRF assets was £34.7bn as at 31 December 2021 (2020: £33.9bn).
Liabilities
The UKRF retirement benefit obligations are a series of future cash flows with relatively long duration. On an IAS 19 basis these cash flows are sensitive to changes in the expected long-term price inflation rate (RPI) and the discount rate (GBP AA corporate bond yield):
An increase in long-term expected inflation corresponds to an increase in liabilities;
A decrease in the discount rate corresponds to an increase in liabilities.
Pension risk is generated through the Group’s defined benefit schemes and this risk is set to reduce over time as the main defined benefit scheme is closed to new entrants. The chart below outlines the shape of the UKRF’s liability cash flow profile as at 31 December 2021 that takes account of the future inflation indexing of payments to beneficiaries. The majority of the cash flows (approximately 95%) fall between 0 and 40 years, peaking between 11 and 20 years and reducing thereafter. The shape may vary depending on changes to inflation and longevity expectations and any members who elect to transfer out. Transfers out will bring forward the liability cash flows.
For more detail on the UKRF’s financial and demographic assumptions, see Note 33 to the financial statements.

Proportion of liability cash flows
%
bcs-20211231_g25.jpg    
Net IAS 19 position
£bn
bcs-20211231_g26.jpg
The graph above shows the evolution of the UKRF’s net IAS 19 position over the last two years. During 2021 the increase in the IAS 19 pension surplus was driven by high asset returns and scheduled deficit reduction contributions. Higher realised inflation over the year had a negative impact by increasing the projected liabilities, which was partially offset by updates to the demographic assumptions.
Refer to Note 33 to the financial statements for the sensitivity of the UKRF to changes in key assumptions.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
180

Risk review: Treasury and Capital risk
Risk performance continued
Risk measurement
In line with Barclays’ risk management framework the assets and liabilities of the UKRF are modelled within a VaR framework to show the volatility of the pension position at a total portfolio level. This enables the risks, diversification and liability matching characteristics of the UKRF obligations and investments to be adequately captured. VaR is measured and monitored on a monthly basis. Risks are reviewed and reported regularly at forums including the Board Risk Committee, the Group Risk Committee, the Pensions Management Group and the Pension Executive Board. The VaR model takes into account the valuation of the liabilities on an IAS 19 basis (see Note 33 to the financial statements). The Trustee receives quarterly VaR measures on a funding basis.
The pension liability is also sensitive to post-retirement mortality assumptions which are reviewed regularly (See Note 33 to the financial statements). To mitigate part of this risk the UKRF has entered into a longevity swap hedging approximately a quarter of current pensioner liabilities.
In addition, the impact of pension risk to the Group is taken into account as part of the stress testing process. Stress testing is performed internally on at least an annual basis. The UKRF exposure is also included as part of regulatory stress tests.
Barclays defined benefit pension schemes affects capital in two ways:
An IAS 19 deficit is treated as a liability on the Group’s balance sheet. Movement in a deficit due to remeasurements, including actuarial losses, are recognised immediately through Other Comprehensive Income and as such reduces shareholders’ equity and CET1 capital. An IAS 19 surplus is treated as an asset on the balance sheet and increases shareholders’ equity; however, it is deducted for the purposes of determining CET1 capital.
In the Group’s statutory balance sheet an IAS 19 surplus or deficit is partially offset by a deferred tax liability or asset respectively. These may or may not be recognised for calculating CET1 capital depending on the overall deferred tax position of the Group at the particular time.
Pension risk is taken into account in the Pillar 2A capital assessment undertaken by the PRA at least annually. The Pillar 2A requirement forms part of the Group’s Overall Capital Requirement for CET1 capital, Tier 1 capital and total capital. More detail on minimum regulatory requirements can be found in the Overall capital requirements section.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
181

Risk review: Treasury and Capital risk
Risk performance continued
Interest rate risk in the banking book
All disclosures in this section are unaudited unless otherwise stated.
Overview
The treasury and capital risk framework covers interest rate sensitive exposures held in the banking book, mostly relating to accrual accounted and FVOCI instruments. The potential volatility of net interest income is measured by an Annual Earnings at Risk (AEaR) metric which is monitored regularly and reported to senior management and the Barclays PLC Board Risk Committee as part of the limit monitoring framework.
For further detail on the interest rate risk in the banking book governance and framework refer to pages 199 to 200 of the Barclays PLC Pillar 3 Report 2021 (unaudited).
Key metrics
AEaR
-£158m
AEaR across the Group from a -25bps shock to forward interest rate curves.
Summary of performance in the period
NII sensitivity to a -25bp shock to rates has decreased year on year due to reduced margin compression exposure driven by actual and expected central bank rate increases. In the +25bp shocks, the decompression of margins in the base scenario reduces sensitivity to further up shocks.
Net interest income sensitivity
The table below shows a sensitivity analysis on pre-tax net interest income for non-traded financial assets and liabilities, including the effect of any hedging. This analysis is not a forward guidance on NII and is intended as a quantification of risk exposure utilising the AEaR metric as described on page 200 of the Barclays PLC Pillar 3 Report 2021 (unaudited). Note that this metric assumes an instantaneous parallel change to forward interest rate curves. The model does not apply floors to shocked market rates, but does recognise contractual product specific interest rate floors where relevant.
The main model assumptions are: (i) one-year ahead time horizon; (ii) balance sheet is held constant; (iii) balances are adjusted for customer behaviour (i.e. considers that customers may prepay before the contractual maturity or withdraw their deposits); and (iv) behavioural assumptions are kept unchanged in all rate scenarios.

Net interest income sensitivity (AEaR) by business unit (audited)
Barclays UKBarclays InternationalHead OfficeTotal
As at 31 December£m£m£m£m
2021
+25bps(2)68 5 71 
-25bps(54)(99)(5)(158)
2020
+25bps10 86 100 
-25bps(141)(263)(4)(408)
Note
+25bps AEaR in Barclays International reflects refined modelling of pricing assumptions for 2021. Based on these assumptions, the 2020 scenario would have shown an AEaR of £121m.
The Group’s customer banking book hedging activity is risk reducing from an NII sensitivity perspective. The hedges in place remove interest rate risk and smooth income over the medium term. The NII sensitivity for the Group at 31 December 2021 without hedging in place for +/-25bp rate shocks would be £218m/£305m respectively.

NII asymmetry arises due to the current low interest rate levels and the effect of embedded floors in customer products. NII sensitivity to a -25bp shock to rates has decreased year on year due to reduced margin compression exposure driven by actual and expected central bank rate increases. NII sensitivity to a +25bps shock has similarly decreased year on year driven by the expectation of rate rises in the outlook and the decompression of product margins in the base case.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
182

Risk review: Treasury and Capital risk
Risk performance continued
Net interest income sensitivity (AEaR) by currency (audited)
As at 31 December
20212020
+25 basis points-25 basis points+25 basis points-25 basis points
£m£m£m£m
GBP14 (85)48 (313)
USD58 (62)48 (63)
EUR5 (15)10 (34)
Other currencies(6)4 (6)
Total71 (158)100 (408)
Note
+25bps AEaR in Barclays International reflects refined modelling of pricing assumptions for 2021. Based on these assumptions, the 2020 scenario would have shown a GBP AEaR of £83m.

Analysis of equity sensitivity
Equity sensitivity measures the overall impact of a +/-25bps movement in interest rates on retained earnings, FVOCI, cash flow hedge reserves and pensions. For non-NII items a DV01 metric is used, which is an indicator of the shift in value for a 1bp movement in the yield curve.
Analysis of equity sensitivity (audited)
As at 31 December20212020
+25 basis
points
-25 basis
points
+25 basis
points
-25 basis
points
£m£m£m£m
Net interest income71 (158)100 (408)
Taxation effects on the above(15)33 (27)110 
Effect on profit for the year56 (125)73 (298)
As percentage of net profit after tax0.8 %(1.7 %)3.0 %(12.1 %)
Effect on profit for the year (per above)56 (125)73 (298)
Fair value through other comprehensive income reserve(479)408 (437)453 
Cash flow hedge reserve(859)859 (570)570 
Taxation effects on the above361 (342)272 (276)
Effect on equity(921)800 (662)449 
As percentage of equity(1.3 %)1.2 %(1.0 %)0.7 %
Note
+25bps AEaR in Barclays International reflects refined modelling of pricing assumptions for 2021. Based on these assumptions, the 2020 scenario would have shown an effect on equity of £(636)m.

VaR remained broadly within a £10m range in H1 2021. The range widened in H2 2021 reflecting outright interest rates risk positioning, which was initially reduced before subsequently being increased. The portfolio de-risked in both outright and asset swap in Q4 which caused a downward trend in VaR.

Volatility of the FVOCI portfolio in the liquidity pool
Changes in value of FVOCI exposures flow directly through capital via the FVOCI reserve. The volatility of the value of the FVOCI investments in the liquidity pool is captured and managed through a value measure rather than an earning measure, i.e. non-traded market risk VaR.
Although the underlying methodology to calculate the non-traded VaR is identical to the one used in traded management VaR, the two measures are not directly comparable. The non-traded VaR represents the volatility to capital driven by the FVOCI exposures. These exposures are in the banking book and do not meet the criteria for trading book treatment.
Analysis of volatility of the FVOCI portfolio in the liquidity pool
20212020
AverageHighLowAverageHighLow
For the year ended 31 December£m£m£m£m£m£m
Non-traded market value at risk (daily, 95%)51 62 34 52 68 36 
VaR trend remained in ~£10m range in H1 2021. The range widened in H2 and was generally driven by outright interest rates risk positioning, which was initially reduced before subsequently being increased. The portfolio de-risked in both outright and asset swap in Q4 which caused a downward trend in VaR.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
183

Risk review: Operational risk
Risk performance continued
Operational risk
All disclosures in this section are unaudited unless otherwise stated.
Overview
Operational risks are inherent in the Group’s business activities and it is not cost effective or possible to attempt to eliminate all operational risks. The Operational Risk Framework is therefore focused on identifying operational risks, assessing them and managing them within the Group’s approved risk appetite.
The Operational Risk principal risk comprises the following risks: Data Management Risk; Financial Reporting Risk; Fraud Risk; Information Security Risk, Operational Recovery Planning Risk, Payments Process Risk; People Risk; Physical Security Risk; Premises Risk; Risk Reporting; Strategic Investment Change Management Risk; Supplier Risk; Tax Risk; Technology Risk and Transaction Operations Risk. The operational risk profile is also informed by a number of risk themes: Cyber, Data, and Resilience. These represent threats to the Group that extend across multiple risk types, and therefore require an integrated risk management approach.
For definitions of these risks refer to pages 201 to 204 of the Barclays PLC Pillar 3 Report 2021. In order to provide complete coverage of the potential adverse impacts on the Group arising from operational risk, the operational risk taxonomy extends beyond the risks listed above to cover operational risks associated with other principal risks too.
This section provides an analysis of the Group’s operational risk profile, including events above the Group’s reportable threshold, which have had a financial impact in 2021. The Group’s operational risk profile is informed by bottom-up risk assessments undertaken by each business unit and top-down qualitative review for each risk type. Fraud, Transaction Operations, Information Security and Technology continue to be highlighted as key operational risk exposures.
For information on conduct risk events, see the conduct risk section.
Key metrics
84%
of the Group’s net reportable operational risk events had a loss value of £50,000 or less
84%
of events by number are due to External Fraud
51%
of losses are from events aligned to External Fraud
48%
of losses are from events aligned to Execution, Delivery and Process Management

Summary of performance in the period
During 2021, total operational risk lossesa decreased to £157m (2020: £217m) while the number of recorded events for 2021 (2,722) increased from the level for 2020 (2,258). The total operational risk losses for the year were mainly driven by events falling within the Execution, Delivery & Process Management and External Fraud categories, which tend to be high volume but low impact events.

Operational risk profile
Within operational risk, there are a large number of smaller value risk events. In 2021, 84% (2020: 78%) of the Group’s reportable operational risk events by volume had a value of less than £50,000 each. Cumulatively, events under this £50,000 threshold accounted for only 29% (2020: 16%) of the Group’s total net operational risk losses. A small proportion of operational risk events have a material impact on the financial results of the Group.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
184

Risk review: Operational risk
Risk performance continued
The analysis below presents the Group’s operational risk events by Basel event category:
bcs-20211231_g27.jpg

Note
a    The data disclosed includes operational risk losses for reportable events impacting the Barclays Bank UK Group business areas, having impact of > £10,000 and excludes events that are conduct or legal risk, aggregate and boundary events. A boundary event is an operational risk event that results in a credit risk impact. Due to the nature of risk events that keep evolving, prior year losses are updated.

External Fraud remains the category with the highest frequency of events at 84% of total events in 2021 (2020: 71%). Impacts from events arising from External Fraud increased in 2021 to £79m (2020: £51m) and accounted for 51% of total 2021 losses (2020: 23%). In this category, high volume, low value events are driven by transactional fraud often related to debit and credit card usage.
Execution, Delivery and Process Management impacts fell to £75m (2020: £152m) and accounted for 48% (2020: 70%) of total operational risk losses. The events in this category are typical of the banking industry as a whole where high volumes of transactions are processed on a daily basis, mapping mainly to Barclays Transaction Operations risk type. The overall frequency of events in this category also decreased to 14% of total events by volume (2020: 25%).
Investment continues to be made in improving the control environment across the Group. Particular areas of focus include new and enhanced fraud prevention systems and tools to combat the increasing level of fraud attempts being made whilst minimising disruption to genuine transactions. Fraud remains an industry wide threat and the Group continues to work closely with external partners on various prevention initiatives.
Operational Resilience remains a key area of focus for the Group. The COVID-19 pandemic is the most severe global health emergency the World Health Organization (WHO) has ever declared. While overall, the Group has continued to prove resilient and actual losses have not materially increased due to the effects of the pandemic, the COVID-19 pandemic has caused disruption to the Group’s customers, suppliers, and staff globally. The COVID-19 pandemic has reinforced our continued focus on resilience and the Group continues to monitor potential operational disruptions associated with both the Group's and its suppliers' transition to a Work-from-Home environment and in response to initially high market volatility. The Group continues to strengthen its resilience approach across its most important business services to improve recoverability and assurance thereof.
Operational risk associated with cybersecurity remains a top focus for the Group. The sophistication of threat actors continues to grow as noted by multiple external risk events observed throughout the year. Ransomware attacks across the global Barclays supplier base were observed and we worked closely with the affected suppliers to manage potential impacts to the Group and its clients and customers. The Group’s cybersecurity events were managed within its risk tolerances and there were no material loss events associated with cybersecurity recorded within the event categories above.
For further information, refer to the operational risk management section.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
185

Risk review: Model risk, Conduct risk, Reputation risk and Legal risk
Model risk, Conduct risk, Reputation risk and Legal risk
All disclosures in this section are unaudited unless otherwise stated.
Model risk
Barclays is committed to continuously improving model risk management and made a number of enhancements in 2021, including:
strengthening the periodic assessment of the design and operating effectiveness of model risk controls to ensure adherence to model risk framework, policies and standards across the model risk lifecycle
enhancing model risk assessment and appetite management with the design of a new Model Risk Uncertainty Assessment to measure and report model uncertainty, enabling risk-based decision making and remediation prioritisation
improving model risk governance through the implementation and embedment of MRM led forums
expanding its quality assurance function and its operating model to improve consistency and quality of the challenges raised, assess the relevance and soundness of the responses received from model owners, and continue to review the rationale for decisions made by validators
improving model inventory data quality through enhanced platform controls and related processes
In 2022, MRM will continue to focus on the validation of additional low materiality models, embedding of validation and governance activities , further roll-out of Model Risk Uncertainty Assessment across the model population and expanding the coverage of the MRM framework to new /emerging model types.
Conduct risk
Barclays is committed to continuing to drive the right culture throughout all levels of the organisation. The Group will continue to enhance effective management of conduct risk and appropriately consider the relevant tools, governance and management information in decision-making processes. Focus on management of conduct risk is ongoing and, alongside other relevant business and control management information, the Trading Entity conduct risk dashboard is a key component of this.
The Group continues to review the role and impact of conduct risk events and issues in remuneration decisions at both the individual and business level.
Throughout 2021, the Group maintained focus on the new and heightened inherent conduct risks created by the coronavirus pandemic and continues to monitor these on an ongoing basis.
Businesses have continued to assess the potential customer, client and market impacts of strategic change. As part of the 2021 medium- term planning process, material conduct risks associated with strategic and financial plans were assessed.
Throughout 2021, conduct risks were raised by each business area for consideration by relevant Board level committees. These committees reviewed the risks raised and whether management’s proposed actions were appropriate to mitigate the risks effectively.
The Group continued to incur costs in relation to litigation and conduct matters, refer to Note 26 Legal, competition and regulatory matters and Note 24 Provisions for further details. Costs include customer redress and remediation, as well as fines and settlements. Resolution of these matters remains a necessary and important part of delivering the Group’s strategy and an ongoing commitment to improve oversight of culture and conduct.
Trading Entity conduct risk dashboards, setting out key indicators in relation to conduct and risk, are provided to the respective Board Risk Committees and senior management. These continue to be evolved and enhanced to allow effective oversight and decision-making. Barclays has operated at the overall set tolerance for conduct risk throughout 2021. The tolerance adherence is assessed by the business areas through key indicators and reported to the relevant Trading Entity Board Committees as part of the conduct risk dashboards.
The Group remains focused on the continuous improvements being made to manage risk effectively with an emphasis on enhancing governance and management information to identify risk at earlier stages.
Reputation risk
Barclays is committed to identifying reputation risks and issues as early as possible and managing them appropriately. At a Group level throughout 2021, reputation risks and issues were overseen by the Board which reviews the processes and policies which Barclays identifies and manages reputation risk. Within the Barclays Bank UK Group and the Barclays Bank Group reputation risks and issues were overseen by the respective risk and Board risk committees. The top live and emerging reputation risks and issues within the Barclays Bank UK Group and the Barclays Bank Group are included within an over-arching quarterly report at the respective Board level.
The Board reviewed risks escalated by the businesses and considered whether management’s proposed actions, for example attaching conditions to proposed client transactions or increased engagement with impacted stakeholders, were appropriate to mitigate the risks effectively. The Board also received regular updates with regard to key reputation risks and issues, including: Barclays’ response to the pandemic; Barclays’ association with sensitive sectors; access to banking; lending practices and the resilience of key Barclays systems and processes.
The Group continued to incur costs in relation to litigation and conduct matters, refer to Note 26 Legal, competition and regulatory matters and Note 24 Provisions for further details. Costs include customer redress and remediation, as well as fines and settlements. Resolution of these matters remains an ongoing commitment to improve oversight of culture and conduct and management of reputation risks.
As part of Barclays 2021 Medium Term Planning process, material reputation risks associated with strategic and financial plans were also assessed.
Legal risk
The Group remains committed to continuous improvements in managing legal risk effectively. During 2021, improvements included a refresh of the Group-wide legal risk management framework and a review and update of the supporting legal risk policies, standards and mandatory training, reinforced by ongoing engagement with and education of the Group’s businesses and functions by Legal Function colleagues. Legal risk tolerances and legal risk appetite have also been reviewed.
Throughout 2021, the Group has operated within set tolerances for legal risk. Tolerances adherence is assessed through key indicators, which are also used to evaluate the legal risk profile and are reviewed, at least annually, through the relevant risk and control committees. Minimum mandatory controls to manage legal risks are set out in the legal risk standards and are subject to ongoing monitoring.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
186


Risk review
Supervision and regulation
Supervision of the Group
The Group’s operations, including its overseas branches, subsidiaries and associates, are subject to a large number of rules and regulations that are a condition for authorisation to conduct banking and financial services business in each of the jurisdictions in which the Group operates. These apply to business operations, impact financial returns and include capital, leverage and liquidity requirements, authorisation, registration and reporting requirements, restrictions on certain activities, conduct of business regulations and many others.
Regulatory developments impact the Group globally. We focus particularly on UK, US and EU regulation due to the location of the Group’s principal areas of business. Regulations elsewhere may also have a significant impact on the Group due to the location of its branches, subsidiaries and, in some cases, clients. For more information on the risks related to the supervision and regulation of the Group, including regulatory change, see the material existing and emerging risk entitled ‘Regulatory Change agenda and impact on Business Model’ in the Material existing and emerging risks section.
Supervision in the UK
In the UK, day-to-day regulation and supervision of the Group is divided between the Prudential Regulation Authority (PRA) (a division of the Bank of England (BoE)) and the Financial Conduct Authority (FCA). In addition, the Financial Policy Committee (FPC) of the BoE has influence on the prudential requirements that may be imposed on the banking system through its powers of direction and recommendation. The Group is also subject to regulatory initiatives undertaken by the UK Payment Systems Regulator (PSR), as a participant in payment systems regulated by the PSR.
Barclays Bank PLC and Barclays Bank UK PLC are authorised credit institutions and subject to prudential supervision by the PRA and subject to conduct regulation and supervision by the FCA. The Group is also subject to prudential supervision by the PRA on a group consolidated basis. Barclays PLC has submitted an application for approval by the PRA as a financial holding company. Barclays Capital Securities Limited is authorised and supervised by the PRA as a PRA-designated investment firm and subject to conduct regulation and supervision by the FCA. Barclays Execution Services Limited is an appointed representative of Barclays Bank PLC, Barclays Bank UK PLC and Clydesdale Financial Services Limited.
The PRA’s supervision of the Group is conducted through a variety of regulatory tools, including the collection of information by way of prudential returns or cross-firm reviews, reports obtained from skilled persons, regular supervisory visits to firms and regular meetings with management and directors to discuss issues such as strategy, governance, financial resilience, operational resilience, risk management, and recovery and resolution.
Both the PRA and the FCA apply standards that either anticipate or go beyond requirements established by global or EU standards, whether in relation to capital, leverage and liquidity, resolvability and resolution or matters of conduct.
The FCA’s supervision of the UK firms in the Group is carried out through a combination of proactive engagement, regular thematic work and project work based on the FCA’s sector assessments, which analyse the different areas of the market and the risks that may lie ahead.
The FCA and the PRA also apply the Senior Managers and Certification Regime (the SMCR) which imposes a regulatory approval, individual accountability and fitness and propriety framework in respect of senior or key individuals within relevant firms.
FCA supervision has focused on conduct risk and customer/client outcomes, including product design, customer behaviour, market operations, fair pricing, affordability, access to cash, and fair treatment of vulnerable customers.
PRA supervision has focused on financial resilience, credit risk management, Board effectiveness, operational resilience, climate risk and resolvability, where resolvability is reviewed in conjunction with the Resolution Directorate (a separate division of the BoE).
Both the PRA and the FCA have assessed the impact of COVID-19 and Brexit on UK financial markets and customers as well as the orderly transition away from LIBOR.
Supervision in the EU
The Group’s operations in Europe are authorised and regulated by a combination of its home regulators and host regulators in the European countries where the Group operates.
Barclays Bank Ireland PLC is licensed as a credit institution by the Central Bank of Ireland (CBI) and is designated as a significant institution falling under direct supervision on a solo basis by the European Central Bank (ECB) for prudential purposes. Barclays Bank Ireland PLC’s EU branches are supervised by the ECB and are also subject to direct supervision for local conduct purposes by national supervisory authorities in the jurisdictions where they are established. Barclays Bank Ireland PLC is also subject to supervision by the CBI as home state or competent authority under various EU financial services directives and regulations.
The Group provides the majority of its cross-border banking and investment services to EEA clients via Barclays Bank Ireland PLC. Additionally, in certain EEA Member States, Barclays Bank PLC and Barclays Capital Securities Limited (BCSL) have cross-border licences to enable them to continue to conduct a limited range of activities, including accessing EEA trading venues and interdealer trading. Barclays Bank PLC also has a Paris branch (to facilitate access to Target 2), which is regulated by the ACPR.
Supervision in the US
Barclays PLC, Barclays Bank PLC and its New York branch, and Barclays Bank PLC’s US subsidiaries are subject to a comprehensive regulatory framework involving numerous statutes, rules and regulations in the US. For example, the Group’s US activities and operations are subject to supervision and regulation by the Board of Governors of the Federal Reserve System (FRB), as well as additional supervision, requirements and restrictions imposed by other federal and state regulators and self-regulatory organisations (SROs). In some cases, US requirements may impose restrictions on the Group’s global activities, in addition to its activities in the US.
Barclays PLC, Barclays Bank PLC, Barclays US Holdings Limited (BUSHL), Barclays US LLC (BUSL), and Barclays Group US Inc. (BGUS) are regulated as bank holding companies (BHCs) by the FRB. BUSL is the Group’s top-tier US holding company that holds substantially all of the Group’s US subsidiaries (including Barclays Capital Inc. and Barclays Bank Delaware). BUSL is subject to requirements in respect of capital adequacy, capital planning and stress testing, risk management and governance, liquidity, leverage limits, large exposure limits, activities restrictions and financial regulatory reporting. Barclays Bank PLC’s New York branch is also subject to enhanced prudential standards relating to, among other things, liquidity and risk management.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
187

Risk review
Supervision and regulation continued
Barclays PLC, Barclays Bank PLC, BUSHL and BUSL have financial holding company (FHC) status under the Bank Holding Company Act of 1956. FHC status allows these entities to engage in a variety of financial and related activities, directly or through subsidiaries, including underwriting, dealing and market making in securities. Failure to maintain FHC status could result in increasingly stringent penalties and, ultimately, in the closure or cessation of certain operations in the US.
In addition to oversight by the FRB, Barclays Bank PLC’s New York branch and many of the Group’s subsidiaries are regulated by additional authorities based on the location or activities of those entities. The New York branch of Barclays Bank PLC is subject to supervision and regulation by the New York State Department of Financial Services (NYSDFS). Barclays Bank Delaware, a Delaware chartered bank, is subject to supervision and regulation by the Delaware Office of the State Bank Commissioner, the Federal Deposit Insurance Corporation (FDIC), the FRB and the Consumer Financial Protection Bureau (CFPB). The deposits of Barclays Bank Delaware are insured by the FDIC. Barclays PLC, Barclays Bank PLC, BUSHL, BUSL, and BGUS are required to act as a source of strength for Barclays Bank Delaware. This could, among other things, require these entities to inject capital into Barclays Bank Delaware if it fails to meet applicable regulatory capital requirements.
The Group’s US securities broker/dealer and investment banking operations, are conducted primarily through Barclays Capital Inc., and are also subject to ongoing supervision and regulation by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA) and other government agencies and SROs under US federal and state securities laws. BCI is also registered as Futures Commission Merchant with the Commodity Futures Trading Commission (CFTC), through which the Group conducts its US futures and options on futures business, including client clearing operations, which are subject to ongoing supervision and regulation by the CFTC, the National Futures Association and other SROs.
Under the US framework for regulating swaps and security-based swaps established under Title VII of the Dodd-Frank Act, the Commodity Futures Trading Commission (CFTC) has regulatory authority over swaps, the SEC has regulatory authority over security-based swaps, and the Commissions jointly regulate mixed swaps. Accordingly, the Group’s US swaps and security-based swaps related activities are conducted by Barclays Bank PLC and are subject to ongoing supervision and regulation by, the CFTC and the National Futures Association, and the SEC and FINRA, respectively. Barclays Bank PLC is provisionally registered as a Swap Dealer with the CFTC and conditionally registered as a Security-based Swap Dealer with the SEC. Barclays Bank PLC is also subject to the FRB swaps rules with respect to margin and capital requirements.
Supervision in Asia Pacific
The Group’s operations in Asia Pacific are supervised and regulated by a broad range of national banking and financial services regulators.
Prudential regulation
Certain Basel III standards were implemented in EU law through the Capital Requirements Regulation (CRR) and the Capital Requirements Directive IV (CRD IV), as amended by CRR II and CRD V. These standards were retained in the UK regulatory framework via a series of onshoring instruments as part of the UK’s withdrawal from the European Union. Beyond the minimum standards required by CRR, the PRA has expected the Group, in common with other major UK banks and building societies, to meet a 7% Common Equity Tier 1 (CET1) ratio at the level of the consolidated group since 1 January 2016.
Global systemically important banks (G-SIBs), such as the Barclays Group, are subject to a number of additional prudential requirements, including the requirement to hold additional loss-absorbing capacity and additional capital buffers above the level required by Basel III standards. The level of the G-SIB buffer is set by the Financial Stability Board (FSB) according to a bank’s systemic importance and can range from 1% to 3.5% of risk-weighted assets (RWAs). The G-SIB buffer must be met with CET1. In November 2021, the FSB published an update to its list of G-SIBs, maintaining the 1.5% G-SIB buffer that applies to the Group.
The Group is also subject to a ‘combined buffer requirement’ consisting of (i) a capital conservation buffer, and (ii) a countercyclical capital buffer (CCyB). The CCyB is based on rates determined by the regulatory authorities in each jurisdiction in which the Group maintains exposures. In March 2020, the FPC cut the UK CCyB rate to 0% with immediate effect in order to support the supply of credit expected as a result of the COVID-19 pandemic. At its meeting in December 2021, the FPC agreed that it would raise the UK CCyB rate to 1% with effect from 13 December 2022.
The PRA requires UK firms to hold additional capital to cover risks which the PRA assesses are not fully captured by the Pillar 1 capital requirement. The PRA sets this additional capital requirement (Pillar 2A) at least annually, derived from each firm’s individual capital guidance. Under current PRA rules, the Pillar 2A must be met with at least 56.25% CET1 capital and no more than 25% tier 2 capital. In addition, the capital that firms use to meet their minimum requirements (Pillar 1 and Pillar 2A) cannot be counted towards meeting the combined buffer requirement.
As part of its approach to ring fencing, the FPC established a framework to apply a firm-specific systemic risk buffer (SRB) which could be set between 0% and 3% of RWAs and which had to be met solely with CET1 capital. The purpose of the SRB was to increase the capacity of ring-fenced bodies, such as Barclays Bank UK PLC, to absorb stress. The buffer rate applicable to the Group’s ring-fenced sub-group was set at 1% with effect from August 2019. With the implementation of CRD V, the Other Systemically Important Institutions Buffer (O-SII buffer) replaced the SRB. As part of the implementation of CRD V, the PRA and FPC confirmed that the Barclays Bank UK PLC O-SII buffer would be held at the historic SRB rate of 1% until reassessment in December 2021. On 8 October 2021, the PRA extended the O-SII buffer rate of 1% for a further year, with any future adjustment to the O-SII buffer applicable from January 2024.
The PRA may also impose a 'PRA buffer' to cover risks over a forward looking planning horizon, including with regard to firm-specific stresses or management and governance weaknesses. If the PRA buffer is imposed on a specific firm, it must be met separately to the combined buffer requirement, and must be met fully with CET1 capital.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
188

Risk review
Supervision and regulation continued
In July 2021 and October 2021, the PRA, respectively, published a policy statement and confirmation, setting out its planned implementation of certain Basel III standards, including the net stable funding ratio (NSFR), the new counterparty credit risk standard (SA-CCR) and rules on large exposures. As part of this policy statement, the PRA also confirmed that it would maintain its approach of requiring the deduction of software assets from capital. The PRA will consult shortly on the implementation of the remaining Basel III standards, which include a revised standardised approach for credit risk, the elimination of modelled approaches for certain credit risk exposure categories, a new standardised approach for operational risk, a new market risk approach and the implementation of an output floor requiring reported RWAs calculated under standardised and modelled approaches to be a minimum of 72.5% of fully standardised calculations. The EU has also launched its legislative process for implementing these remaining Basel III reforms. In October 2021, the FPC and PRA published a policy statement setting out changes to the leverage ratio framework, including applying the leverage ratio requirement on an individual basis and making sub-consolidation available as an alternative to individual application where a firm has subsidiaries that can be consolidated.
In the US, in October 2019, the FRB and other US regulatory agencies released final rules to tailor the applicability of prudential requirements for large domestic US banking organisations, foreign banking organisations and their intermediate holding companies (IHCs), including BUSL. BUSL is a “Category III” IHC. BUSL (and Barclays Bank Delaware) is therefore subject to reduced (calibrated at 85%) standardised liquidity requirements, including the liquidity coverage ratio and NSFR.
In June 2018 and October 2019, the FRB finalised rules regarding single counterparty credit limits (SCCL). The SCCL apply to the largest US BHCs and foreign banks’ (including the Group’s) US operations. The SCCL creates two separate limits for foreign banks, the first on combined US operations (CUSO) and the second on the US IHC (BUSL). The SCCL for US BHCs, including BUSL, requires that exposure to an unaffiliated counterparty of BUSL not exceed 25% of BUSL’s tier 1 capital. With respect to the CUSO, the SCCL rule allows certification to the FRB that a foreign bank complies with comparable home country regulation.
Barclays Bank PLC was not required to comply with the CUSO requirement until 1 January 2022, with the first certification applicable for Q1 2022 results.
Stress testing
The Group and certain of its members are subject to supervisory stress testing exercises in a number of jurisdictions, designed to assess the resilience of banks to adverse economic or financial developments and ensure that they have robust, forward-looking capital planning processes that account for the risks associated with their business profile. Assessment by regulators is on both a quantitative and qualitative basis, the latter focusing on such elements as data provision, stress testing capability including model risk management and internal management processes and controls.
Recovery and Resolution
Stabilisation and resolution framework
The UK framework for recovery and resolution was established by the Banking Act 2009, as amended. The EU framework was established by the 2014 Bank Recovery and Resolution Directive (BRRD), as amended by BRRD II.
The BoE, as the UK resolution authority, has the power to resolve a UK financial institution that is failing or likely to fail by exercising several stabilisation options, including transferring such institution’s business or securities to a commercial purchaser or a ‘bridge bank’ owned by the BoE or transferring the institution into temporary public ownership. When exercising any of its stabilisation powers, the BoE must generally provide that shareholders bear first losses, followed by creditors in accordance with the priority of their claims in insolvency.
In order to enable the exercise of its stabilisation powers, the BoE may impose a temporary stay on the rights of creditors to terminate, accelerate or close out contracts, or override events of default or termination rights that might otherwise be invoked as a result of a resolution action and modify contractual arrangements in certain circumstances (including a variation of the terms of any securities). HM Treasury may also amend the law for the purpose of enabling it to use its powers under this regime effectively, potentially with retrospective effect.
In addition, the BoE has the power to permanently write-down, or convert into equity, tier 1 capital instruments, tier 2 capital instruments and internal eligible liabilities at the point of non-viability of the bank.
The BoE’s preferred approach for the resolution of the Group is a bail-in strategy with a single point of entry at Barclays PLC. Under such a strategy, Barclays PLC’s subsidiaries would remain operational while Barclays PLC’s capital instruments and eligible liabilities would be written down or converted to equity in order to recapitalise the Group and allow for the continued provision of services and operations throughout the resolution. The order in which the bail-in tool is applied reflects the hierarchy of capital instruments under CRD IV and otherwise respecting the hierarchy of claims in an ordinary insolvency. Accordingly, the more subordinated the claim, the more likely losses will be suffered by owners of the claim.
The PRA has made rules that require authorised firms to draw up recovery plans and resolution packs, as required by the BRRD. Recovery plans are designed to outline credible actions that authorised firms could implement in the event of severe stress in order to restore their business to a stable and sustainable condition. Removal of potential impediments to an orderly resolution of a banking group or one or more of its subsidiaries is considered as part of the BoE’s and PRA’s supervisory strategy for each firm, and the PRA can require firms to make significant changes in order to enhance resolvability. The Group currently provides the PRA with a recovery plan annually and with a resolution pack as requested.
Under the Resolvability Assessment Framework (RAF) firms are required to have in place capabilities covering three resolvability outcomes: (i) adequate financial resources; (ii) being able to continue to do business through resolution and restructuring; and (iii) being able to communicate and co-ordinate within the firm and with authorities. The first self-assessment report on these capabilities was submitted by the Group to the PRA/BoE in 2021 with public disclosures required by both firms and the PRA/BoE in June 2022 (and every two years thereafter).
While regulators in many jurisdictions have indicated a preference for single point of entry resolution for the Group, additional resolution or bankruptcy provisions may apply to certain Group entities or branches.
In the US, BUSL is subject to the Orderly Liquidation Authority established by Title II of the Dodd-Frank Act (DFA), a regime for the orderly liquidation of systemically important financial institutions by the FDIC, as an alternative to proceedings under the US Bankruptcy Code. In addition, the licensing authorities of Barclays Bank PLC New York branch and of Barclays Bank Delaware have the authority to take possession of the business and property of the applicable branch or entity they license and/or to revoke or suspend such licence.
In the US, Title I of the DFA, as amended, and the implementing regulations issued by the FRB and the FDIC require each bank holding company with assets of $250bn or more, including those within the Group, to prepare and submit a plan for the orderly resolution of subsidiaries and operations in the event of future material financial distress or failure. The Group submitted a “targeted plan” in December 2021. The Group’s next submission of the US Resolution Plan in respect of its US operations will be a “full plan” due in 2024.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
189

Risk review
Supervision and regulation continued
Barclays Bank Ireland PLC, as a significant institution under the Single Resolution Mechanism Regulation (SRMR), is subject to the powers of the Single Resolution Board (SRB) as the Eurozone resolution authority. The CBI and the ECB require Barclays Bank Ireland PLC to submit a standalone BRRD-compliant recovery plan on an annual basis. The SRB has the power to require data submissions specific to Barclays Bank Ireland PLC under powers conferred upon it by the BRRD and the SRMR. The SRB will exercise these powers to determine the optimal resolution strategy for Barclays Bank Ireland PLC in the context of the BoE’s preferred resolution strategy of single point of entry with bail-in at Barclays PLC. The SRB also has the power under the BRRD and the SRMR to develop a resolution plan for Barclays Bank Ireland PLC.
TLAC and MREL
The Group is subject to a Minimum Requirement for own funds and Eligible Liabilities (MREL), which includes a component reflecting the FSB’s standards on total loss absorbency capacity (TLAC).
The MREL requirements were fully implemented by 1 January 2022, at which time G-SIBs with resolution entities incorporated in the UK will be required to meet an MREL equivalent to the higher of: (i) two times the sum of their Pillar 1 and Pillar 2A requirements; or (ii) the higher of two times their leverage ratio or 6.75% of leverage exposures. Internal MREL for operating subsidiaries is subject to a scalar in the 75-90% range of the external requirement that would apply to the subsidiary if it were a resolution entity. The starting point for the scalar is 90% for ring-fenced bank sub-groups.
Barclays Bank Ireland PLC is subject to the SRB’s MREL policy, as issued in May 2021, in respect of the internal MREL that it will be required to issue to the Group. The SRB’s current calibration of internal MREL for non-resolution entities is expressed as two ratios that have to be met in parallel: (a) two times the sum of: (i) the firm’s Pillar 1 requirement; (ii) its Pillar 2 requirement; and (b) two times the leverage ratio. The SRB’s policy does not envisage the application of any scalar in respect of the internal MREL requirement.
In the US, the FRB’s TLAC rule includes provisions that require BUSL to have: (i) a specified outstanding amount of eligible long-term debt; (ii) a specified outstanding amount of TLAC (consisting of common and preferred equity regulatory capital plus eligible long-term debt); and (iii) a specified common equity buffer. In addition, the FRB’s TLAC rule prohibits BUSL, for so long as the Group’s overall resolution plan treats BUSL as a non-resolution entity, from issuing TLAC to entities other than those within the Group.
Bank Levy and FSCS
The BRRD established a requirement for EU member states to set up a pre-funded resolution financing arrangement with funding equal to 1% of covered deposits by 31 December 2024 to cover the costs of bank resolutions. The UK has implemented this requirement by way of a tax on the balance sheets of banks known as the ‘Bank Levy’.
In addition, the UK has a statutory compensation fund called the Financial Services Compensation Scheme (FSCS), which is funded by way of annual levies on most authorised financial services firms.
Structural reform
In the UK, the Financial Services (Banking Reform) Act 2013 put in place a framework for ring-fencing certain operations of large banks. Ring-fencing requires, among other things, the separation of the retail and smaller deposit-taking business activities of UK banks into a legally distinct, operationally separate and economically independent entity, which is not permitted to undertake a range of activities.
US regulation places further substantive limits on the activities that may be conducted by banks and holding companies, including foreign banking organisations such as the Group. The ‘Volcker Rule’, which was part of the DFA and which came into effect in the US in 2015, prohibits banking entities from undertaking certain proprietary trading activities and limits such entities’ ability to sponsor or invest in certain private equity funds and hedge funds (in each case broadly defined). As required by the rule, the Group has developed and implemented an extensive compliance and monitoring programme addressing proprietary trading and covered fund activities (both inside and outside of the US).
Market infrastructure regulation
In recent years, regulators as well as global-standard setting bodies such as the International Organisation of Securities Commissions (IOSCO) have focused on improving transparency and reducing risk in markets, particularly risks related to over-the-counter (OTC) transactions. This focus has resulted in a variety of new regulations across the G20 countries and beyond that require or encourage on-venue trading, clearing, posting of margin and disclosure of pre-trade and post-trade information.
The European Market Infrastructure Regulation (EMIR) has introduced requirements designed to improve transparency and reduce the risks associated with the derivatives market. EMIR has potential operational and financial impacts on the Group, including by imposing new collateral requirements on a broader range of market participants from 2022. If not extended, the EU’s equivalence decision for UK Central Clearing Counterparties (CCPs), and exemption for certain intragroup transactions from the EMIR derivatives clearing and margin obligations, both due to expire at the end of June 2022, could also have operational and financial impacts on the Group.
The Markets in Financial Instruments Directive and Markets in Financial Instruments Regulation (collectively referred to as MiFID II) have affected many of the markets in which the Group operates, the instruments in which it trades and the way it transacts with market counterparties and other customers. MiFID II is currently undergoing a review process in both the EU and the UK, including as part of the EU’s ongoing focus on the development of a stronger Capital Markets Union and the UK’s Wholesale Markets Review.
The EU Regulation on Sustainability-Related Disclosures introduces disclosure obligations requiring financial institutions to explain how they integrate environmental, social and governance factors in their investment decisions for certain financial products. In addition, the EU Taxonomy Regulation provides for a general framework for the development of an EU-wide classification system for environmentally sustainable economic activities. In the UK, the FCA has announced that the UK Green Taxonomy Technical Screening Criteria will be finalised by the end of 2022. Reporting against the Taxonomy will form part of the UK’s new Sustainability Disclosure Requirements (SDR). Certain companies will be required to disclose which portion of their activities are Taxonomy-aligned. The structure of the Taxonomy draws on the EU approach and has six environmental objectives (climate change mitigation, climate change adaptation, sustainable use and protection of water and marine resources, transition to a circular economy, pollution prevention and control and protection and restoration of biodiversity). The UK regulators are also consulting on a new SDR Framework for firms as well as investment product disclosures, including a new sustainable investment labelling regime.
The EU and UK Benchmarks Regulation apply to the administration, contribution and use of benchmarks within the EU and the UK, respectively. Financial institutions within the EU or the UK, as applicable, are prohibited from using benchmarks unless their administrators are authorised, registered or otherwise recognised in the EU or the UK, respectively. The FCA has stated that it does not intend to support LIBOR after the end of 2021. Global regulators in conjunction with the industry have developed and are continuing to develop alternative benchmarks and risk-free rate fallback arrangements, including updates to existing, as well as new, applicable legislation.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
190

Risk review
Supervision and regulation continued
US regulators have imposed similar rules as the EU with respect to the mandatory on-venue trading and clearing of certain derivatives, and post-trade transparency, as well as in relation to the margining of OTC derivatives. US regulators have finalised certain aspects of their rules with respect to their application on a cross-border basis, including with respect to their registration requirements in relation to non-US swap dealers and security-based swap dealers. The regulators may adopt further rules, or provide further guidance, regarding cross-border applicability. In December 2017, the CFTC and the European Commission recognised the trading venues of each other’s jurisdiction to allow market participants to comply with mandatory on-venue trading requirements while trading on certain venues recognised by the other jurisdiction. In November 2021, the CFTC extended temporary relief that would permit trading venues and market participants located in the UK to continue to rely on this mutual recognition framework following the withdrawal of the UK from the EU.
Certain participants in US swap markets are required to register with the CFTC as ‘swap dealers’ or ‘major swap participants’ and with the SEC as ‘security-based swap dealers’ or ‘major security-based swap participants’. Such registrants are subject to CFTC and SEC regulation and oversight. Entities required to register as swap dealers and security-based swap dealers are subject to business conduct, record-keeping and reporting requirements under both CFTC and SEC rules. Barclays Bank PLC is also subject to regulation by the FRB, and is both provisionally registered with the CFTC as a swap dealer and conditionally registered with the SEC as a security-based swap dealer.
Accordingly, Barclays Bank PLC is subject to CFTC rules on business conduct, record-keeping and reporting and to FRB rules on capital and margin. The CFTC has approved certain comparability determinations that permit substituted compliance with non-US regulatory regimes for certain swap regulations. Substituted compliance is permitted for certain transaction-level requirements, where applicable, only with respect to transactions between a non-US swap dealer and certain non-US counterparties, whereas entity-level determinations generally apply on an entity-wide basis regardless of counterparty status. In November 2021, the CFTC extended temporary relief that would permit swap dealers located in the UK to continue to rely on existing CFTC substituted compliance determinations with respect to EU requirements in the event of a withdrawal of the UK from the EU. In July 2020 the CFTC adopted no-action relief from application of CFTC transaction level requirements to transactions between a non-US swap dealer and a non-US counterparty that are “arranged, negotiated or executed” by personnel of the swap dealer or its agent in the US. The final rules also codify certain aspects of the CFTC’s current cross-border framework with respect to internal and external business conduct requirements.
As of 1 November 2021, Barclays Bank PLC became conditionally registered as a security-based swap dealer with the SEC and subject to SEC rules on business conduct, recordkeeping and reporting, similar to the CFTC rules noted above. The SEC approved certain comparability determinations that permit conditional substituted compliance with non-US regulatory regimes for certain security-based swap regulations. Due to the conditionality of the determinations Barclays Bank PLC is relying on substituted compliance only with respect to a few entity-wide regulations. Many of the regulations under the CFTC and SEC regimes are complementary, however, the SEC does require non-US security-based swap dealers to comply with certain SEC rules in connection with transactions that are “arranged, negotiated or executed” from the US expanding the scope and impact of the SEC regime to transactions with a greater number of non-US counterparties. As noted above, Barclays Bank PLC is subject to FRB rules on capital and margin.
Other regulation
Consumer protection, culture, and diversity and inclusion
In May 2021, the FCA published a consultation paper proposing the imposition of a new consumer duty on firms. The duty looks to set higher expectations for the standard of care that firms provide to customers and will impact all aspects of Barclays' retail businesses, including every customer journey, product and service as well as our relationships with partners, suppliers and third parties. This will result in significant implementation costs and there will also be higher ongoing costs for the industry as a result of extensive monitoring and evidential requirements. Final rules are due to be published by July 2022.
Our regulators have enhanced their focus on the promotion of cultural values as a key area for banks, although they generally view the responsibility for reforming culture as primarily sitting with the industry. The UK regulators have also begun focusing on diversity and inclusion in financial services firms, with the Bank of England, PRA and FCA having published a joint discussion paper and the FCA having published a consultation paper on this topic in July 2021.
Data protection and PSD2
Most countries where the Group operates have comprehensive laws requiring openness and transparency about the collection and use of personal information, and protection against loss and unauthorised or improper access. Regulations regarding data protection are increasing in number, as well as levels of enforcement, as manifested in increased amounts of fines and the severity of other penalties. We expect that personal privacy and data protection will continue to receive attention and focus from regulators, as well as public scrutiny and attention.
The EU’s General Data Protection Regulation (GDPR) created a broadly harmonised privacy regime across EU member states, introducing mandatory breach notification, enhanced individual rights, a need to openly demonstrate compliance, and significant penalties for breaches. The extraterritorial effect of the GDPR means entities established outside the EU may fall within the Regulation’s ambit when offering goods or services to European based customers or clients. Following the UK’s withdrawal from the EU, the UK continues to apply the GDPR framework (as onshored into UK law and hence now referred to as the ‘UK GDPR’ - this sits alongside an amended version of the UK Data Protection Act 2018). The GDPR has become the global touchstone as countries around the world either usher in or contemplate similar data privacy laws, or align their existing legislation. In 2020, the European Court of Justice (CJEU) invalidated the EU-US Privacy Shield as a mechanism for transferring EU personal data to the US and placed additional requirements on the use of standard contractual clauses (SCCs) for transfers of personal information to third countries. In 2021, the European Commission published new SCCs to meet the requirements of GDPR and the CJEU decision, known as Schrems II. Implementing the new SCCs, which involve case-by-case transfer impact assessments and other safeguards, is likely to result in increased compliance costs for the Group. During 2020 and 2021 new privacy laws were passed in Switzerland, took effect in Brazil, Mainland China and Dubai, and were proposed in India. Noncompliance with any of these requirements could lead to regulatory fines and other penalties.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
191

Risk review
Supervision and regulation continued
In the US, Barclays US Consumer Bank is subject to the US Federal Gramm-Leach-Bliley Act (GLBA) the California Consumer Privacy Act of 2018, which came into effect on 1 January 2020 (CCPA) and the California Privacy Rights Act which was passed in November 2020 (CPRA) and will take effect in January 2023 with respect to data collected as early as January 2022. The GLBA limits the use and disclosure of non-public personal information to non-affiliated third parties and requires financial institutions to provide written notice of their privacy policies and practices and implement certain information security policies and practices. Any violations of the GLBA could subject the US Consumer Bank to additional reporting requirements or regulatory investigation or audits by the financial regulators. The CCPA applies to personal information that is not collected, processed, sold or disclosed pursuant to the GLBA, and it requires the US Consumer Bank to provide California consumers (as defined in the law) with additional disclosures regarding the collection, use and sharing of personal information, and grants California consumers access, deletion, and other rights with respect to their personal information, including the right to opt-out of certain sales or transfers of such personal information. The CCPA subjects the US Consumer Bank to enforcement penalties by the Attorney General of the State of California, and grants a private right of action with respect to certain data breaches. The CPRA significantly modifies the CCPA, including by imposing additional obligations on covered companies and expanding consumers’ rights with respect to certain sensitive personal information, and creates a new state agency that will be vested with authority to implement and enforce both the CCPA and the CPRA, potentially resulting in further uncertainty in the interpretation and enforcement of both laws. In addition, all 50 states have laws including obligations to provide notification of security breaches of computer databases that contain personal information to affected individuals, state officers and others.
In addition, in May 2020, the National People’s Congress of the PRC approved the PRC Civil Code, which took effect on 1 January 2021. Pursuant to the PRC Civil Code, the collection, storage, use, process, transmission, provision and disclosure of personal information shall follow the principles of legitimacy, properness and necessity.
From 2019, new rules apply under the revised Payment Services Directive (PSD2) that affect the way banks and other payment services providers check that the person requesting access to an account or trying to make a payment is permitted to do so. This is referred to as strong customer authentication (SCA). The deadline for implementing SCA for e-commerce has been extended by the FCA to 14 March 2022.
Cyber security and operational resilience
Regulators in the UK, the EU and the US continue to focus on cyber security risk management, organisational operational resilience and overall soundness across all financial services firms, with customer and market expectations of continuous access to financial services remaining at an all-time high.
The regulatory focus has been further heightened by the increasing number of high-profile ransomware and other supply chain attacks seen across the industry during the COVID-19 pandemic. This is evidenced by the continuing publication of proposed laws and changes to regulatory frameworks globally. For example, legislation has been introduced in the US that aims to expand cyber security notification requirements for critical infrastructure, whilst in the UK a new framework for operational resilience focused on the identification of, and setting impact tolerances for, important business services came into effect in March 2021. In 2022, the European Union’s Digital Operational Resilience Act (DORA) is expected to introduce comprehensive and sector specific regulation on ICT incident reporting, testing and third party risk management, and provide for direct oversight of critical third party ICT providers servicing the EU financial services sector. However, such measures are likely to result in increased technology and compliance costs for the Group.
Sanctions and financial crime
The UK Bribery Act 2010 introduced a new form of corporate criminal liability focused broadly on a company’s failure to prevent bribery on its behalf. The Criminal Finances Act 2017 introduced new corporate criminal offences of failing to prevent the facilitation of UK and overseas tax evasion. Both pieces of legislation have broad application and in certain circumstances may have extraterritorial impact on entities, persons or activities located outside the UK, including Barclays PLC’s subsidiaries outside the UK. The UK Bribery Act requires the Group to have adequate procedures to prevent bribery which, due to the extraterritorial nature of the Act, makes this both complex and costly. Additionally, the Criminal Finances Act requires the Group to have reasonable prevention procedures in place to prevent the criminal facilitation of tax evasion by persons acting for, or on behalf of, the Group.
The Sanctions and Anti-Money Laundering Act became law in the UK in 2018. The Act allows for the adoption of an autonomous UK sanctions regime, as well as a more flexible licensing regime post-Brexit. On 6 July 2020, the UK Government announced the first sanctions that have been implemented independently by the UK outside the auspices of the UN and EU. The autonomous UK sanctions regime came into force on 1 January 2021. The sanctions apply within the UK and in relation to the conduct of all UK persons wherever they are in the world; they also apply to overseas branches of UK companies.
In the US, the Bank Secrecy Act, the USA PATRIOT Act 2001, the Anti-Money Laundering Act of 2020 and regulations thereunder contain numerous anti-money laundering and anti-terrorist financing requirements for financial institutions. In addition, the Group is subject to the US Foreign Corrupt Practices Act, which prohibits, among other things, corrupt payments to foreign government officials. It is also subject to various economic sanctions laws, regulations and executive orders administered by the US government, which prohibit or restrict some or all business activities and other dealings with or involving certain individuals, entities, groups, countries and territories.
In some cases, US state and federal regulations addressing sanctions, money laundering and other financial crimes may impact entities, persons or activities located or undertaken outside the US, including Barclays PLC and its subsidiaries. US government authorities have aggressively enforced these laws against financial institutions in recent years. Failure of a financial institution to ensure compliance with such laws could have serious legal, financial and reputational consequences for the institution.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
192

Financial review
Contents
Financial review
A review of the Group’s performance, including the key performance indicators, and the contribution of each of our businesses to the overall performance of the Group.
Financial review
Key performance indicators
194
Consolidated summary income statement
196
Income statement commentary
197
Consolidated summary balance sheet
198
Balance sheet commentary
199
Analysis of results by business
200
Non-IFRS performance measures
207
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
193


Financial review
Key performance indicators
In assessing the financial performance of the Group, management uses a range of KPIs which focus on the Group’s financial strength, the delivery of sustainable returns and cost management. Barclays continues to target RoTE of greater than 10% over the medium term. Cost discipline remains a priority and management continues to target a cost: income ratio below 60%.
Non-IFRS performance measures
The Group’s management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group.
They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the non-IFRS performance measures section for further information and calculations of non-IFRS performance measures included throughout this section and the most directly comparable IFRS measures.
DefinitionWhy is it important and how the Group performed
Common Equity Tier 1 (CET1) ratio
The Group’s capital management objective is to maximise shareholder value by prudently managing the level and mix of its capital to: ensure the Group and all of its subsidiaries are appropriately capitalised relative to their regulatory minimum and stressed capital requirements, support the Group’s risk appetite, growth and strategic options, while seeking to maintain a robust credit proposition for the Group and its subsidiaries.
The CET1 ratio was stable at 15.1% (2020: 15.1%). CET1 capital increased by £1.2bn to £47.5bn as profit before tax of £8.4bn was partially offset by share buybacks, 2021 dividends and equity coupons paid and foreseen, as well as pensions deficit contribution payments. RWAs increased £7.9bn to £314.1bn primarily resulting from the recalibration of the modelled market risk stress period, increased client and trading activity within CIB and growth in mortgages within Barclays UK, partially offset by lower unsecured balances.
Group target: a CET1 ratio in the range of 13-14%.
CET1 ratio
Capital requirements are part of the regulatory framework governing how banks and depository institutions are supervised. Capital ratios express a bank’s capital as a percentage of its RWAs as defined by the PRA.
CET1 ratio is a measure of capital that is predominantly common equity defined by the CRR, as retained in the UK regulatory framework through on-shoring instruments as part of the UK’s withdrawal from the European Union, and amended by CRR II with effect from 1 January 2022.
15.1%
2020: 15.1%
2019: 13.8%
Return on average shareholders’ equity
RoE is calculated as profit after tax attributable to ordinary shareholders, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments.
This measure indicates the return generated by the management of the business based on shareholders' equity. RoE for the Group was 11.5% (2020: 2.7%).
Group RoE
11.5%
2020: 2.7%
2019: 4.5%
Return on average tangible shareholders’ equity
This measure indicates the return generated by the management of the business based on shareholders’ tangible equity. Achieving a target RoTE demonstrates the organisation’s ability to execute its strategy and align management’s interests with the shareholders’. RoTE lies at the heart of the Group’s capital allocation and performance management process.
RoTE for the Group was 13.4% (2020: 3.2%) due to record profit before tax including a net credit impairment release and increased income, partially offset by higher operating expenses.
Group target: RoTE of greater than 10%.
RoTE based on a CET1 ratio of 13.5%, excluding litigation and conduct, structural cost actions and the re-measurement of UK DTA’s was 15.3% (2020: 4.4%)a. A CET1 ratio of 13.5% is used, which is the mid-point of the target range of 13%-14%.
Group RoTE
RoTE is calculated as profit after tax attributable to ordinary shareholders, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill.
13.4%
2020: 3.2%
2019: 5.3%
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
194


DefinitionWhy is it important and how the Group performed
Total operating expenses
Barclays views total operating expenses as a key strategic area for banks; those who actively manage costs and control them effectively will gain a strong competitive advantage.
Group total operating expenses increased 4% to £14.4bn, due to structural cost actions of £0.6bn primarily relating to the real estate review in Q221 and Barclays UK transformation costs in Q421, higher performance costs that reflect improved returns, and continued investment and business growth. This was partially offset by the benefit from the depreciation of average USD against GBP, efficiency savings and a lower UK bank levy charge, primarily due to the reduced rate.
Excluding structural cost actions and performance costs, Group total operating expenses were flat at £12.0bn, as efficiency saving were reinvested to drive income growth.
Excluding structural cost actions of £0.6bn (2020: £0.4bn), operating expenses would have been £13.8bn (2020: £13.5bn).
Total operating expensesb
£14.4bn
2020: £13.9bn
2019: £15.4bn
Cost: income ratio
This is a measure management uses to assess the productivity of the business operations. Managing the cost base is a key execution priority for management and includes a review of all categories of discretionary spending and an analysis of how we can run the business to ensure that costs increase at a slower rate than income.
The Group cost: income ratio was 66% (2020: 64%) as increased income was offset by higher operating expenses, including £0.6bn of structural cost actions.
The Group cost: income ratio, excluding structural cost actions of £0.6bn (2020: £0.4bn) was 63% (2020: 62%).
Group target: a cost: income ratio below 60%.
Cost: income ratio
Total operating expenses divided by total income.66%
2020: 64%
2019: 71%
Notes
a 2020 based on a 13.0% CET1 ratio, excluding litigation and conduct, structural cost actions and COVID-19 community aid package. Refer to the Non-IFRS performance measures section for further information and calculations.
b    Includes litigation and conduct, 2021: £177m, 2020: £153m and 2019: £1,849m, of which £1,400m relates to Payment Protection Insurance.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
195


Financial review
Consolidated summary income statement
20212020201920182017
For the year ended 31 December£m£m£m£m£m
Continuing operations
Interest income11,24011,89215,45614,54113,631
Interest expense(3,167)(3,770)(6,049)(5,479)(3,786)
Net interest income8,0738,1229,4079,0629,845
Fee and commission income9,8808,6419,1228,8938,751
Fee and commission expense(2,206)(2,070)(2,362)(2,084)(1,937)
Net fee and commission income7,6746,5716,7606,8096,814
Other income6,1937,0735,4655,2654,417
Total income21,94021,76621,63221,13621,076
Credit impairment releases/(charges)653(4,838)(1,912)(1,468)(2,336)
Operating costs(14,092)(13,434)(13,359)(13,627)(13,884)
UK bank levy (170)(299)(226)(269)(365)
GMP charge (140)
Litigation and conduct(177)(153)(1,849)(2,207)(1,207)
Total operating expenses(14,439)(13,886)(15,434)(16,243)(15,456)
Other net income260237169257
Profit before tax8,4143,0654,3573,4943,541
Tax charge(1,188)(604)(1,003)(911)(2,066)
Profit after tax in respect of continuing operations7,2262,4613,3542,5831,475
Loss after tax in respect of discontinued operation(2,195)
Non-controlling interests in respect of continuing operations(47)(78)(80)(234)(249)
Non-controlling interests in respect of discontinued operation(140)
Other equity instrument holders(804)(857)(813)(752)(639)
Attributable profit/(loss)6,3751,5262,4611,597(1,748)
Selected financial statistics
Basic earnings/(loss) per share37.5p8.8p14.3p9.4p(10.3p)
Diluted earnings/(loss) per share36.6p8.6p14.1p9.2p(10.1p)
Return on average shareholders’ equity11.5 %2.7 %4.5 %3.1 %(3.1 %)
Return on average tangible shareholders’ equity13.4%3.2%5.3%3.6%(3.6%)
Cost: income ratio66%64%71%77%73%
The financial information above is extracted from the published accounts. This information should be read together with the information included in the accompanying consolidated financial statements.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
196


Financial review
Income statement commentary
2021 compared to 2020a
Barclays’ diversified business model delivered a record profit before tax of £8,414m (2020: £3,065m), RoE of 11.5% (2020: 2.7%), RoTE of 13.4% (2020: 3.2%) and earnings per share (EPS) of 37.5p (2020: 8.8p).
Total income increased to £21,940m (2020: £21,766m). Barclays UK income increased 3%. Barclays International income decreased 2%, with CIB income down 1% and CC&P income down 3%. Excluding the impact of the 8% depreciation of average USD against GBP, total income was up, reflecting Barclays’ diversified income streams.
Credit impairment net release of £653m (2020: £4,838m charge). The net release included a reversal of £1.3bn in non-default charges, primarily reflecting the improved macroeconomic outlook. Excluding this reversal, the charge was £0.7bn, reflecting reduced unsecured lending balances and low delinquency. Economic uncertainty adjustments have been maintained firstly in respect of customers and clients who may be more vulnerable to the withdrawal of support schemes and emerging economic uncertainty, and secondly, model uncertainty which does not capture certain macroeconomic and risk parameter uncertainties. The reduction in unsecured lending balances and growth in secured balances have contributed to a decrease in the Group’s loan coverage ratio to 1.6% (December 2020: 2.4%). Coverage ratios in unsecured loan portfolios remained elevated compared to pre-COVID-19 pandemic levels.
Total operating expenses increased 4% to £14,439m, due to structural cost actions of £648m primarily relating to the real estate review in Q221 and Barclays UK transformation costs in Q421, higher performance costs that reflect improved returns, and continued investment and business growth. This was partially offset by the benefit from the depreciation of average USD against GBP, efficiency savings and a lower UK bank levy charge, primarily due to the reduced rate. This resulted in a cost: income ratio of 66% (2020: 64%). Excluding structural cost actions of £648m (2020: £368m), operating expenses would have been £13,791m (2020: £13,518m), resulting in a cost: income ratio of 63% (2020: 62%).
The effective tax rate was 14.1% (2020: 19.7%). This reflects a £462m tax benefit recognised for the re-measurement of the Group’s UK deferred tax assets (DTAs) as a result of the enactment in 2021 of a UK corporation tax rate increase from 19% to 25% effective from 1 April 2023.
Attributable profit was £6,375m (2020: £1,526m).
Please refer to the Financial review section in the Annual Report on Form 20-F 2020 for a comparative discussion of the 2020 financial results compared to 2019.
Note
a    The 8% depreciation of average USD against GBP adversely impacted income and profits and positively impacted total operating expenses.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
197


Financial review
Consolidated summary balance sheet
20212020201920182017
As at 31 December£m£m£m£m£m
Assets
Cash and balances at central banks238,574 191,127 150,258 177,069 171,082 
Cash collateral and settlement balances92,542 101,367 83,256 77,222 77,168 
Loans and advances at amortised cost361,451 342,632 339,115 326,406 324,048 
Reverse repurchase agreements and other similar secured lending3,227 9,031 3,379 2,308 12,546 
Trading portfolio assets147,035 127,950 114,195 104,187 113,760 
Financial assets at fair value through the income statement191,972 175,151 133,086 149,648 116,281 
Derivative financial instruments262,572 302,446 229,236 222,538 237,669 
Financial investments — — — 58,915 
Financial assets at fair value through other comprehensive income61,753 78,688 65,750 52,816 — 
Assets included in disposal groups classified as held for sale — — — 1,193 
Other assets25,159 21,122 21,954 21,089 20,586 
Total assets1,384,285 1,349,514 1,140,229 1,133,283 1,133,248 
Liabilities
Deposits at amortised cost519,433 481,036 415,787 394,838 398,701 
Cash collateral and settlement balances79,371 85,423 67,341 67,522 68,143 
Repurchase agreements and other similar secured borrowings28,352 14,174 14,517 18,578 40,338 
Debt securities in issuea
98,867 75,796 76,369 82,286 73,314 
Subordinated liabilities12,759 16,341 18,156 20,559 23,826 
Trading portfolio liabilities54,169 47,405 36,916 37,882 37,351 
Financial liabilities designated at fair value250,960 249,765 204,326 216,834 173,718 
Derivative financial instruments256,883 300,775 229,204 219,643 238,345 
Other liabilities13,280 11,917 11,953 11,362 13,496 
Total liabilities1,314,074 1,282,632 1,074,569 1,069,504 1,067,232 
Equity
Called up share capital and share premium4,536 4,637 4,594 4,311 22,045 
Other equity instruments12,259 11,172 10,871 9,632 8,941 
Other reserves1,770 4,461 4,760 5,153 5,383 
Retained earnings50,657 45,527 44,204 43,460 27,536 
Total equity excluding non-controlling interests69,222 65,797 64,429 62,556 63,905 
Non-controlling interests989 1,085 1,231 1,223 2,111 
Total equity70,211 66,882 65,660 63,779 66,016 
Total liabilities and equity1,384,285 1,349,514 1,140,229 1,133,283 1,133,248 
Net asset value per ordinary share340p315p309p309p322p
Tangible net asset value per share292p269p262p262p276p
Number of ordinary shares of Barclays PLC (in millions)16,752 17,359 17,322 17,133 17,060 
Year-end USD exchange rate1.35 1.37 1.32 1.28 1.35 
Year-end EUR exchange rate1.19 1.11 1.18 1.12 1.13 
Note
a    Debt securities in issue include covered bonds of £5.0bn (2020: £6.2bn).

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
198


Financial review
Balance sheet commentary
Total assets
Total assets increased £35bn to £1,384bn.
Cash and balances at central banks increased by £47bn to £239bn, predominantly driven by strong growth in customer deposits. Financial assets at fair value through other comprehensive income decreased £17bn to £62bn.
Derivative financial instrument assets decreased £40bn to £263bn, driven by an increase in major interest rate curves. Cash collateral and settlement balances decreased by £9bn to £93bn, predominantly due to reduced derivative balances.
Loans and advances at amortised cost increased £19bn to £361bn, which reflected increased lending across Barclays UK and Barclays International, including £10bn of mortgage growth.
Trading portfolio assets increased £19bn to £147bn due to increased client activity and financial assets at fair value through the income statement increased £17bn to £192bn due to reverse repurchase agreements and similar secured lending.
Total liabilities
Total liabilities increased £31bn to £1,314bn.
Deposits at amortised cost increased £38bn to £519bn primarily due to clients increasing liquidity, and lower consumer spending levels.
Derivative financial instruments liabilities decreased £44bn to £257bn, driven by an increase in major interest rate curves. This is consistent with the movement in derivative financial instrument assets. Cash collateral and settlement balances decreased by £6bn to £79bn predominantly due to reduced mark-to-market balances.
Trading portfolio liabilities increased £7bn due to increased client activity to £54bn and financial liabilities designated at fair value increased £1bn to £251bn due to repurchase agreements and similar secured borrowing.
Total shareholders’ equity
Total shareholders’ equity increased £3.3bn to £70.2bn.
Other equity instruments increased £1.1bn to £12.3bn due to the issuance of a $1.5bn AT1 instrument. AT1 securities are perpetual subordinated contingent convertible securities structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date.
Other reserves decreased by £2.7bn, mainly due to a reduction in the cash flow hedging reserve of £2.4bn to £0.9bn debit, as a result of fair value movements on interest rate swaps held for hedging purposes due to an increase in major interest rate curves.
Retained earnings increased £5.1bn to £50.7bn, mainly due to profits of £6.4bn, offset by share repurchases of £1.2bn and dividends of £0.5bn.
Net asset value per share increased 25p to 340p. Tangible net asset value per share increased 23p to 292p as 38p earnings per share were offset by net negative reserve movements of 15p.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
199


Financial review
Analysis of results by business

Barclays UK
202120202019
£m£m£m
Income statement information
Net interest income5,2025,2345,888
Net fee, commission and other income1,3341,1131,465
Total income6,5366,3477,353
Credit impairment releases/(charges)365(1,467)(712)
Net operating income6,9014,8806,641
Operating costs (4,357)(4,270)(3,996)
UK bank levy(36)(50)(41)
Operating expenses(4,393)(4,320)(4,037)
Litigation and conduct(37)(32)(1,582)
Total operating expenses(4,430)(4,352)(5,619)
Other net income18
Profit before tax2,4715461,022
Attributable profit1,756325281
Balance sheet information
Loans and advances to customers at amortised cost£208.8bn£205.4bn£193.7bn
Total assets£321.2bn£289.1bn£257.8bn
Customer deposits at amortised cost£260.6bn£240.5bn£205.5bn
Loan: deposit ratio85%89%96%
Risk weighted assets£72.3bn£73.7bn£74.9bn
Key facts
Average LTV of mortgage portfolioa
51%51%51%
Average LTV of new mortgage lendinga
70%68%68%
Number of branches666859963
Mobile banking active customers9.7m9.2m8.4m
30 day arrears rate - Barclaycard Consumer UK1.0%1.7%1.7%
Number of employees (full time equivalent)b
7,10021,30021,400
Performance measures
Return on average allocated equity13.0%2.4%2.0%
Return on average allocated tangible equity17.6%3.2%2.7%
Average allocated equity£13.6 bn£13.7 bn£13.9 bn
Average allocated tangible equity£10.0bn£10.1bn£10.3bn
Cost: income ratio68%69 %76 %
Loan loss rate (bps)6836
Net interest margin 2.52%2.61%3.09%
Notes
a    Average Loan to Value of mortgages is balance weighted and reflects both residential and BTL mortgage portfolios within the Home Loans portfolio.
b    Barclays UK has transformed its business this year and consolidated all Customer Care employees, who directly serve customers, into Barclays Execution Services, within the Head Office segment, to improve customer service and experience. Costs are recharged, while FTE's are reported within Head Office, as at 31 December 2021 10,700 FTE were impacted by the move from Barclays UK to Head Office, prior years have not been restated.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
200

Financial review
Analysis of results by business continued
Analysis of Barclays UK
202120202019
£m£m£m
Analysis of total income
Personal Banking3,8833,5224,009
Barclaycard Consumer UK1,2501,5191,992
Business Banking1,4031,3061,352
Total income6,5366,3477,353
Analysis of credit impairment releases/(charges)
Personal Banking28(380)(195)
Barclaycard Consumer UK404(881)(472)
Business Banking(67)(206)(45)
Total credit impairment releases/(charges)365(1,467)(712)
Analysis of loans and advances to customers at amortised cost
Personal Banking£165.4bn£157.3bn£151.9bn
Barclaycard Consumer UK£8.7bn£9.9bn£14.7bn
Business Banking£34.7bn£38.2bn£27.1bn
Total loans and advances to customers at amortised cost£208.8bn£205.4bn£193.7bn
Analysis of customer deposits at amortised cost
Personal Banking£196.4bn£179.7bn£159.2bn
Barclaycard Consumer UK£0.1bn
Business Banking£64.2bn£60.7bn£46.3bn
Total customer deposits at amortised cost£260.6bn£240.5bn£205.5bn
2021 compared to 2020
Profit before tax increased to £2,471m (2020: £546m). RoE was 13.0% (2020: 2.4%). RoTE was 17.6% (2020: 3.2%) reflecting an improving UK operating environment.
Total income increased 3% to £6,536m. Net interest income reduced 1% to £5,202m with a net interest margin of 2.52% (2020: 2.61%) as strong customer retention and improved margins in mortgages were more than offset by lower unsecured lending balances. Net fee, commission and other income increased 20% to £1,334m, returning back towards pre-COVID-19 pandemic levels.
Personal Banking income increased 10% to £3,883m, reflecting strong growth in mortgages, alongside improved margins during the first three quarters, balance growth in deposits and the non-recurrence of COVID-19 customer support actions. This was partially offset by deposit margin compression from lower interest rates and lower unsecured lending balances.
Barclaycard Consumer UK income decreased 18% to £1,250m, as repayments by customers and reduced borrowing resulted in a lower level of IEL balances. However, IEL balances began to stabilise throughout the second half of 2021.
Business Banking income increased 7% to £1,403m due to lending and deposit balance growth from £12.1bn of government scheme lending and the non-recurrence of COVID-19 and related customer support actions, partially offset by deposit margin compression from lower interest rates.
Credit impairment net release of £365m (2020: £1,467m charge) was driven by an improved macroeconomic outlook and lower unsecured lending balances due to customer repayments and lower delinquencies. As at 31 December 2021, 30 and 90 day arrears rates in UK cards were 1.0% (Q420: 1.7%) and 0.2% (Q420: 0.8%) respectively.
Total operating expenses increased 2% to £4,430m primarily reflecting increased investment spend, including structural cost actions of £288m (2020: £150m). Excluding structural cost actions, operating expenses would have been broadly stable at £4,142m (2020: £4,202m), with higher operational and customer service costs, primarily driven by increased volumes, offset by efficiency savings.
Loans and advances to customers at amortised cost increased 2% to £208.8bn predominantly from £9.9bn of mortgage growth following a strong flow of new applications as well as strong customer retention. This was offset by a £2.2bn decrease in the Education, Social Housing and Local Authority (ESHLA) portfolio carrying value as interest rate yield curves steepened, £1.6bn lower unsecured lending balances and £1.3bn lower Business Banking balances as repayment of government scheme lending commences.
Customer deposits at amortised cost increased 8% to £260.6bn reflecting an increase of £16.7bn and £3.5bn in Personal Banking and Business Banking respectively, further strengthening the liquidity position and contributing to a loan: deposit ratio of 85% (December 2020: 89%).
RWAs decreased to £72.3bn (December 2020: £73.7bn) driven by a reduction in unsecured lending and the value of the ESHLA portfolio, partially offset by growth in mortgages.
Please refer to the Financial review section in the Annual Report on Form 20-F 2020 for a comparative discussion of the 2020 financial results compared to 2019.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
201

Financial review
Analysis of results by business continued
Barclays International
202120202019
£m£m£m
Income statement information
Net interest income3,2633,2823,941
Net trading income5,6936,9204,199
Net fee, commission and other income6,7095,7196,535
Total income15,66515,92114,675
Credit impairment releases/(charges)288(3,280)(1,173)
Net operating income15,95312,64113,502
Operating costs(9,076)(8,765)(9,163)
UK bank levy (134)(240)(174)
Litigation and conduct(125)(48)(116)
Total operating expenses(9,335)(9,053)(9,453)
Other net income402869
Profit before tax6,6583,6164,118
Attributable profit4,8172,2202,816
Balance sheet information
Loans and advances at amortised cost£133.8bn£122.7bn£132.8bn
Trading portfolio assets£146.9bn£127.7bn£113.3bn
Derivative financial instrument assets £261.5bn£301.8bn£228.9bn
Financial assets at fair value through the income statement£188.2bn£170.7bn£128.4bn
Cash collateral and settlement balances£88.1bn£97.5bn£79.4bn
Other assets£225.6bn£221.4bn£178.6bn
Total assets£1,044.1bn£1,041.8bn£861.4bn
Deposits at amortised cost£258.8bn£240.5bn£210.0bn
Derivative financial instrument liabilities£256.4bn£300.4bn£228.9bn
Loan: deposit ratio52%51%63%
Risk weighted assets£230.9bn£222.3bn£209.2bn
Key facts
Number of employees (full time equivalent)10,40010,80011,200
Performance measures
Return on average allocated equity14.5%6.9%8.7%
Return on average allocated tangible equity14.9%7.1%9.0%
Average allocated equity£33.1bn£32.1 bn£32.2 bn
Average allocated tangible equity£32.4bn£31.5bn£31.2bn
Cost: income ratio60 %57%64%
Loan loss rate (bps)25786
Net interest margin4.01%3.64%4.07%
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
202

Financial review
Analysis of results by business continued
Analysis of Barclays International
202120202019
Corporate and Investment Bank£m£m£m
Income statement information
Net interest income1,3511,0841,119
Net trading income5,6526,9754,413
Net fee, commission and other income5,3314,4174,699
Total income12,33412,47610,231
Credit impairment releases / (charges)473(1,559)(157)
Net operating income12,80710,91710,074
Operating costs(6,818)(6,689)(6,882)
UK bank levy(128)(226)(156)
Litigation and conduct(17)(4)(109)
Total operating expenses (6,963)(6,919)(7,147)
Other net income2628
Profit before tax5,8464,0042,955
Attributable profit4,2022,5541,980
Balance sheet information
Loans and advances at amortised cost£100.0bn£92.4bn£92.0bn
Trading portfolio assets£146.7bn£127.5bn£113.3bn
Derivative financial instrument assets£261.5bn£301.7bn£228.8bn
Financial assets at fair value through the income statement£188.1bn£170.4bn£127.7bn
Cash collateral and settlement balances£87.2bn£96.7bn£78.5bn
Other assets£195.8bn£194.9bn£155.3bn
Total assets£979.3bn£983.6bn£795.6bn
Deposits at amortised cost£189.4bn£175.2bn£146.2bn
Derivative financial instrument liabilities£256.4bn£300.3bn£228.9bn
Risk weighted assets£200.7bn£192.2bn£171.5bn
Performance measures
Return on average allocated equity14.8%9.4%7.6%
Return on average allocated tangible equity14.9%9.5%7.6%
Average allocated equity£28.3 bn£27.0 bn£25.9 bn
Average allocated tangible equity£28.3bn£27.0bn£25.9bn
Cost: income ratio56%55%70%
Analysis of total income
FICC3,4485,1383,364
Equities2,9672,4711,887
Global Markets6,4157,6095,251
Advisory921561776
Equity capital markets813473329
Debt capital markets1,9251,6971,430
Investment Banking fees3,6592,7312,535
Corporate lending588590765
Transaction banking1,6721,5461,680
Corporate2,2602,1362,445
Other
Total income12,33412,47610,231


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
203

Financial review
Analysis of results by business continued
Analysis of Barclays International continued
202120202019
Consumer, Cards and Payments£m£m£m
Income statement information
Net interest income1,9122,1982,822
Net fee, commission, trading and other income 1,4191,2471,622
Total income3,3313,4454,444
Credit impairment charges(185)(1,721)(1,016)
Net operating income3,1461,7243,428
Operating costs(2,258)(2,076)(2,281)
UK bank levy(6)(14)(18)
Litigation and conduct(108)(44)(7)
Total operating expenses(2,372)(2,134)(2,306)
Other net income382241
Profit/(loss) before tax812(388)1,163
Attributable profit/(loss)615(334)836
Balance sheet information
Loans and advances at amortised cost£33.8bn£30.3bn£40.8bn
Total assets£64.8bn£58.2bn£65.8bn
Deposits at amortised cost£69.4bn£65.3bn£63.8bn
Risk weighted assets£30.2bn£30.1bn£37.7bn
Key facts
30 day arrears rates - Barclaycard US1.6%2.5%2.7%
US cards customer FICO score distribution
<66010%13%14%
>66090%87%86%
Total number of Barclaycard payments clientsc.380,000c.365,000c.376,000
Value of payments processeda
£277bn£274bn£354bn
Performance measures
Return on average allocated equity12.8%(6.6)%13.3%
Return on average allocated tangible equity15.0%(7.5%)15.8%
Average allocated equity£4.8 bn£5.1 bn£6.3 bn
Average allocated tangible equity£4.1bn£4.5bn£5.3bn
Cost: income ratio71%62%52%
Loan loss rate (bps)51517234
Analysis of total income
International Cards and Consumer Bank2,0922,433
Private Bank781707
Unified Payments458305
Total income3,3313,445
Note
a    Includes £270bn (2020: £268bn; 2019: £272bn) of merchant acquiring payments.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
204

Financial review
Analysis of results by business continued
2021 compared to 2020
Profit before tax increased 84% to £6,658m with a RoE of 14.5% and a RoTE of 14.9% (2020: 7.1%), reflecting a RoE of 14.8% (2020: 9.4%) and RoTE of 14.9% (2020: 9.5%) in CIB and a RoE of 12.8% (2020: (6.6%)) and a RoTE of 15.0% (2020: (7.5)%) in CC&P.
The 8% depreciation of average USD against GBP adversely impacted income and profits and positively impacted total operating expenses.
Total income decreased to £15,665m (2020: £15,921m).
CIB income decreased 1% to £12,334m.
Global Markets income decreased 16% to £6,415m as a strong performance in Equities, representing the best full year on a comparable basisa, was more than offset by FICC. Equities income increased 20% to £2,967m driven by strong client activity in derivatives and increased client balances in financing. FICC income decreased 33% to £3,448m due to tighter spreads and the non-recurrence of prior year client activity levels.
Investment Banking fees income, representing the best full year on a comparable basisa, increased 34% to £3,659m driven by a strong performance in Advisory and Equity capital markets reflecting an increase in the fee pool and an increased market shareb.
Within Corporate, Transaction banking income increased 8% to £1,672m driven by deposits and higher payments volumes. Corporate lending income was stable at £588m (2020: £590m) driven by a current year fair value loan write-off on a single name and increased cost of hedging, whilst the prior year included net losses from the mark-to-market of lending and related hedge positions.
CC&P income decreased 3% to £3,331m.
International Cards and Consumer Bank income decreased 14% to £2,092m reflecting lower average cards balances whilst balances increased during the second half of 2021.

Private Bank income increased 10% to £781m, reflecting client balance growth and a gain on a property sale.
Unified Payments income increased 50% to £458m driven by the non-recurrence of a c.£100m valuation loss on Barclays’ preference shares in Visa Inc. in Q220, which have subsequently been fully disposed of in FY21, and merchant acquiring turnover growth following the easing of lockdown restrictions.
Credit impairment net release of £288m (2020: £3,280m charge) was driven by an improved macroeconomic outlook. CIB credit impairment net release of £473m (2020: £1,559m charge) was also supported by net single name wholesale loan releases and a benign credit environment. CC&P credit impairment charge of £185m (2020: £1,721m) was partially driven by lower delinquencies and higher customer repayments. As at 31 December 2021, 30 and 90 day arrears in US cards were 1.6% (Q420: 2.5%) and 0.8% (Q420: 1.4%) respectively.
Total operating expenses increased 3% to £9,335m. CIB total operating expenses increased 1% to £6,963m due to higher performance costs, that reflect an improvement in returns, partly offset by a lower bank levy charge, primarily due to the reduced rate. CC&P total operating expenses increased 11% to £2,372m driven by the impact of higher investment spend, including an increase in marketing and costs for existing and new partnerships, and customer remediation costs related to a legacy portfolio.
Loans and advances at amortised cost increased £11.1bn to £133.8bn due to increased lending across CIB and CC&P.
Trading portfolio assets increased £19.2bn to £146.9bn predominantly due to increased activity in Equities.
Derivative financial instruments assets decreased £40.3bn and liabilities decreased £44.0bn to £261.5bn and £256.4bn respectively, driven by an increase in major interest rate curves and reduced client activity in FICC.
Financial assets at fair value through the income statement increased £17.5bn to £188.2bn driven by increased secured lending.
Cash collateral and settlement balances decreased £9.4bn to £88.1bn.
Deposits at amortised cost increased £18.3bn to £258.8bn due to clients increasing liquidity.
RWAs increased to £230.9bn (December 2020: £222.3bn) primarily resulting from the recalibration of the modelled market risk stress period, and increased client and trading activity within CIB.
Please refer to the Financial review section in the Annual Report on Form 20-F 2020 for a comparative discussion of the 2020 financial results compared to 2019.
Notes
a    Period covering 2014 - 2021. Pre 2014 financials were not restated following re-segmentation in 2016.
b    Data source: Dealogic for the period covering 1 January to 31 December 2021.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
205

Financial review
Analysis of results by business continued
Head Office
202120202019
£m£m£m
Income statement information
Net interest income(392)(393)(422)
Net fee, commission and other income131(109)26
Total income(261)(502)(396)
Credit impairment charges(91)(27)
Net operating expenses(261)(593)(423)
Operating costs(659)(399)(200)
UK bank levy(9)(11)
Litigation and conduct(15)(73)(151)
Total operating expenses(674)(481)(362)
Other net income / (expenses)220(23)2
Loss before tax(715)(1,097)(783)
Attributable loss(198)(1,019)(636)
Balance sheet information
Total assets£19.0bn£18.6bn£21.0bn
Risk weighted assets£11.0bn£10.2bn£11.0bn
Key facts
Number of employees (full time equivalent)a
64,10050,90048,200
Performance measures
Average allocated equity£8.7bn£10.6bn£8.5bn
Average allocated tangible equity£5.0bn£6.7bn£5.1bn
Note
a    Barclays UK has transformed its business this year and consolidated all Customer Care employees, who directly serve customers, into Barclays Execution Services, within the Head Office segment, to improve customer service and experience. Costs are recharged, while FTE's are reported within Head Office, as at 31 December 2021 10,700 FTE were impacted by the move from Barclays UK to Head Office, prior years have not been restated.



2021 compared to 2020
Loss before tax was £715m (2020: £1,097m).
Total income was an expense of £261m (2020: £502m), which primarily reflected hedge accounting, funding costs on legacy capital instruments and treasury items, partially offset by mark-to-market gains on legacy investments and the recognition of dividends on Barclays’ stake in Absa Group Limited.
Total operating expenses were £674m (2020: £481m), which included £266m relating to structural cost actions taken as part of the real estate review in Q221, as well as costs associated with the discontinued use of software assets.
Other net income was £220m (2020: £23m expense) driven by a fair value gain on investments held by the Business Growth Fund in which Barclays has an associate interest.
RWAs were £11.0bn (December 2020: £10.2bn).
Please refer to the Financial review section in the Annual Report on Form 20-F 2020 for a comparative discussion of the 2020 financial results compared to 2019.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
206


Financial review
Non-IFRS performance measures
The Group’s management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group.
They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
Non-IFRS performance measures glossary
MeasureDefinition
Loan: deposit ratioLoans and advances at amortised cost divided by deposits at amortised cost. The components of the calculation have been included on page 166.
Period end allocated tangible equityAllocated tangible equity is calculated as 13.5% (2020 and 2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group’s tangible shareholders’ equity and the amounts allocated to businesses.
Average tangible shareholders’ equityCalculated as the average of the previous month’s period end tangible equity and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period.
Average allocated tangible equityCalculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.
Return on average tangible shareholders’ equityStatutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 208.
Return on average allocated tangible equityStatutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on page 208.
Cost: income ratioTotal operating expenses divided by total income.
Loan loss rateQuoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 126. Quoted as zero when credit impairment is a net release.
Net interest marginNet interest income divided by the sum of average customer assets. The components of the calculation have been included on page 208.
Tangible net asset value per shareCalculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 210.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
207

Financial review
Non-IFRS performance measures continued
Margins analysis
For the year ended 31 December20212020
Net interest incomeAverage customer assetsNet interest marginNet interest incomeAverage customer assetsNet interest margin
£m£m%£m£m%
Barclays UK5,202 206,628 2.52 5,234 200,317 2.61 
Barclays Internationala
3,149 78,530 4.01 3,382 92,909 3.64 
Total Barclays UK and Barclays International8,351 285,158 2.93 8,616 293,226 2.94 
Otherb
(278)(494)
Total Barclays Group8,073 8,122 
Notes
a    Barclays International margins include IEL balances within the corporate and investment banking business.
b    Other includes Head Office and non-lending related corporate and investment banking businesses not included in Barclays International margins.

The Group net interest margin remained stable with a 1bps decrease to 2.93%. Barclays UK net interest margin decreased 9bps to 2.52%, reflecting the impact of lower UK interest rates as well as the mix impact of strong mortgage growth and lower unsecured lending balances. Barclays International net interest margin increased 37bps to 4.01% reflecting the mix impact of lower average lending balances in the CIB.
The Group’s combined product and equity structural hedge notional as at 31 December 2021 was £228bn (December 2020: £188bn), with an average duration of close to 3 years (2020: average duration 2.5 to 3 years). Group net interest income includes gross structural hedge contributions of £1,415m (2020: £1,650m) and net structural hedge contributions of £1,187m (2020: £1,246m). Gross structural hedge contributions represent the absolute interest income earned from the fixed receipts on the basket of swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.
Returns
Return on average tangible equity is calculated as profit for the period attributable to ordinary equity holders of the parent as a proportion of average tangible equity for the period, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2020 and 2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group’s average tangible shareholders’ equity and the amounts allocated to businesses.
Profit/(loss) attributable to ordinary equity holders of the parentAverage
tangible
 equity
Return on
average
tangible
 equity
£m£bn%
For the year ended 31 December 2021
Barclays UK1,75610.017.6
    Corporate and Investment Bank4,20228.314.9
    Consumer, Cards and Payments6154.115.0
Barclays International4,81732.414.9
Head Office(198)5.0n/m
Barclays Group6,37547.413.4
For the year ended 31 December 2020
Barclays UK32510.13.2
    Corporate and Investment Bank2,55427.09.5
    Consumer, Cards and Payments(334)4.5(7.5)
Barclays International2,22031.57.1
Head Office(1,019)6.7n/m
Barclays Group1,52648.33.2
For the year ended 31 December 2019
Barclays UK28110.32.7
    Corporate and Investment Bank1,98025.97.6
    Consumer, Cards and Payments8365.315.8
Barclays International2,81631.29.0
Head Office(636)5.1n/m
Barclays Group2,46146.65.3
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
208

Financial review
Non-IFRS performance measures continued
Performance measures
For the year ended 31 December 2021
Return on average tangible shareholders' equityBarclays UKCorporate and Investment BankConsumer, Cards and PaymentsBarclays InternationalHead OfficeBarclays Group
£m£m£m£m£m£m
Attributable profit/(loss)1,7564,2026154,817(198)6,375
Average shareholders' equity £13.6bn£28.3bn£4.8bn£33.1bn£8.7bn£55.4bn
Average goodwill and intangibles£(3.6)bn£(0.7)bn£(0.7)bn£(3.7)bn£(8.0)bn
Average tangible shareholders' equity £10.0bn£28.3bn£4.1bn£32.4bn£5.0bn£47.4bn
Return on average tangible shareholders' equity17.6%14.9%15.0%14.9%n/m13.4%

For the year ended 31 December 2020
Return on average tangible shareholders' equityBarclays UKCorporate and Investment BankConsumer, Cards and PaymentsBarclays InternationalHead OfficeBarclays Group
£m£m£m£m£m£m
Attributable profit/(loss)3252,554(334)2,220(1,019)1,526
Average shareholders' equity £13.7bn£27.0bn£5.1bn£32.1bn£10.6bn£56.4bn
Average goodwill and intangibles(£3.6bn)(£0.6bn)(£0.6bn)(£3.9bn)(£8.1bn)
Average tangible shareholders' equity £10.1bn£27.0bn£4.5bn£31.5bn£6.7bn£48.3bn
Return on average tangible shareholders' equity3.2%9.5%(7.5%)7.1%n/m3.2%

For the year ended 31 December 2019
Return on average tangible shareholders' equityBarclays UKCorporate and Investment BankConsumer, Cards and PaymentsBarclays InternationalHead OfficeBarclays Group
£m£m£m£m£m£m
Attributable profit/(loss)2811,9808362,816(636)2,461
Average shareholders' equity £13.9bn£25.9bn£6.3bn£32.2bn£8.5bn£54.6bn
Average goodwill and intangibles(£3.6bn)(£1.0bn)(£1.0bn)(£3.4bn)(£8.0bn)
Average tangible shareholders' equity £10.3bn£25.9bn£5.3bn£31.2bn£5.1bn£46.6bn
Return on average tangible shareholders' equity2.7%7.6%15.8%9.0%n/m5.3%
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
209

Financial review
Non-IFRS performance measures continued
Return on average tangible shareholders’ equity, excluding litigation and conduct, structural cost actions and the re-measurement of UK DTAs
2021
Profit attributable to ordinary equity holders of the parent£m
Attributable profit6,375
Post-tax impact of litigation and conduct136
Post-tax impact of structural cost actions 489
Re-measurement of UK DTAs (462)
Profit attributable to ordinary equity holders of the parent, excluding litigation and conduct, structural cost actions and the re-measurement of UK DTAs 6,538
Barclays Group return on average tangible shareholders’ equity
Barclays Group average tangible shareholders’ equity£47.4bn
Barclays Group average tangible shareholders’ equity based on a CET1 ratio of 13.5%£42.7bn
Barclays Group return on average tangible shareholders’ equity based on a CET1 ratio of 13.5%14.9%
Barclays Group return on average tangible shareholders’ equity, excluding litigation and conduct, structural cost actions and the re-measurement of UK DTAs, based on a CET1 ratio of 13.5%15.3%

Return on average tangible shareholders’ equity, excluding litigation and conduct, structural cost actions and COVID-19 community aid package
2020
Profit attributable to ordinary equity holders of the parent£m
Attributable profit1,526
Post-tax impact of litigation and conduct112
Post-tax impact of structural cost actions268
Post-tax impact of COVID-19 community aid package 66
Profit attributable to ordinary equity holders of the parent, excluding litigation and conduct, structural cost actions and COVID-19 community aid package 1,972
Barclays Group return on average tangible shareholders’ equity
Barclays Group average tangible shareholders’ equity£48.3bn
Barclays Group average tangible shareholders’ equity based on a CET1 ratio of 13.0%£45.1bn
Barclays Group return on average tangible shareholders’ equity based on a CET1 ratio of 13.0%3.4%
Barclays Group return on average tangible shareholders’ equity, excluding litigation and conduct, structural cost actions and COVID-19 community aid package, based on a CET1 ratio of 13.0%4.4%

Tangible net asset value per share
202120202019
£m£m£m
Total equity excluding non-controlling interests69,22265,79764,429
Other equity instruments(12,259)(11,172)(10,871)
Shareholders' equity attributable to ordinary shareholders of the parent56,96354,62553,558
Goodwill and intangibles(8,061)(7,948)(8,119)
Tangible shareholders’ equity attributable to ordinary shareholders of the parent48,90246,67745,439
Shares in issue16,752m17,359m17,322m
Net asset value per share340p315p309p
Tangible net asset value per share292p269p262p
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
210

Financial review
Non-IFRS performance measures continued
Profit/(loss) attributable to ordinary equity holders of the parentAverage equityReturn on average equity
£mbn%
For the year ended 31 December 2021
Barclays UK1,756 13.6 13.0 
Corporate and Investment Bank4,202 28.3 14.8 
Consumer, Cards and Payments615 4.8 12.8 
Barclays International4,817 33.1 14.5 
Head Office(198)8.7 n/m
Barclays Group6,375 55.4 11.5 
For the year ended 31 December 2020
Barclays UK325 13.7 2.4 
Corporate and Investment Bank2,554 27.0 9.4 
Consumer, Cards and Payments(334)5.1 (6.6)
Barclays International2,220 32.1 6.9 
Head Office(1,019)10.6 n/m
Barclays Group1,526 56.4 2.7 
For the year ended 31 December 2019
Barclays UK281 13.9 2.0 
Corporate and Investment Bank1,980 25.9 7.6 
Consumer, Cards and Payments836 6.3 13.3 
Barclays International2,816 32.2 8.7 
Head Office(636)8.5 n/m
Barclays Group2,461 54.6 4.5 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
211

Financial statements

Financial statements
Detailed analysis of our statutory accounts, independently audited and providing in-depth disclosure on the financial performance of the Group.
Barclays has adopted the British Bankers’ Association (BBA) Code for Financial Reporting Disclosure as adopted by UK Finance in 2017 and has prepared the 2021 Annual Report in compliance with the BBA Code. Barclays is committed to continuously reflect the objectives of reporting set out in the BBA Code.
PageNote
Consolidated financial statements
Independent Auditor’s Report (Auditor number 1118)
213n/a
Consolidated income statement215n/a
Consolidated statement of comprehensive income216n/a
Consolidated balance sheet
217n/a
Consolidated statement of changes in equity218n/a
Consolidated cash flow statement220n/a
Parent company accounts221n/a

Notes to the financial statements
Significant accounting policies2241
Financial performance and returnsSegmental reporting2282
Net interest income2303
Net fee and commission income2314
Net trading income2335
Net investment income2336
Credit impairment charges2347
Operating expenses2388
Tax2389
Earnings per share24210
Dividends on ordinary shares24211
Assets and liabilities held at fair valueTrading portfolio24312
Financial assets at fair value through the income statement24313
Derivative financial instruments24414
Financial assets at fair value through other comprehensive income25215
Financial liabilities designated at fair value25216
Fair value of financial instruments25317
Offsetting financial assets and financial liabilities26318
Assets at amortised cost and other investmentsLoans and advances and deposits at amortised cost26419
Property, plant and equipment26420
Leases26621
Goodwill and intangible assets26822
Accruals, provisions, contingent liabilities and legal proceedingsOther liabilities27223
Provisions27224
Contingent liabilities and commitments27325
Legal, competition and regulatory matters27426
Capital instruments, equity and reservesSubordinated liabilities27927
Ordinary shares, share premium and other equity28228
Reserves28329
Non-controlling interests28430
Employee benefitsStaff costs28531
Share-based payments28632
Pensions and post-retirement benefits28833
Scope of consolidationPrincipal subsidiaries29334
Structured entities29435
Investments in associates and joint ventures29736
Securitisations29837
Assets pledged, collateral received and assets transferred29938
Other disclosure mattersRelated party transactions and Directors’ remuneration30139
Auditor’s remuneration30340
Interest rate benchmark reform30341
Barclays PLC (the Parent company)30842
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
212

Report of Independent Registered Public Accounting Firm
To the Shareholders and Board of Directors Barclays PLC:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying consolidated balance sheets of Barclays PLC and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated income statements, consolidated statements of comprehensive income, consolidated statements of changes in equity, and consolidated cash flow statements for each of the years in the three-year period ended December 31, 2021, and the related notes and specific disclosures described in Note 1 of the consolidated financial statements as being part of the consolidated financial statements (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2021, in conformity with International Financial Reporting Standards, as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s report on internal control over financial reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgements. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Impairment allowance for loans and advances at amortized cost, including off-balance sheet elements of the allowance
As discussed in the credit risk disclosures on pages 122 to 158, the Company’s impairment allowance for loans and advances, including off-balance sheet elements at amortized cost was £6.3bn as at 31 December 2021.
We identified the assessment of impairment allowance for loans and advances at amortized cost, including off balance sheet elements as a critical audit matter. A high degree of audit effort, including specialized skills and knowledge was required because it involved significant measurement uncertainty. Complex and subjective auditor judgement was required to assess the following:
Model estimations – Complex and subjective auditor judgement was applied in assessing the Company’s modelled estimations of Expected Credit Losses (“ECL”) due to the inherently judgemental nature of the underlying models and underlying assumptions, namely the IFRS 9 Probability of Default (“PD”) models, the Loss Given Default (“LGD”) models, the Probability of Survival (“PS”) models and the Exposure at Default (“EAD”) models. Certain IFRS 9 models and model assumptions are the key drivers of complexity and subjectivity, and minor changes to those models and model assumptions could have a significant effect on the Company’s calculation of the ECL estimate.
Economic scenarios – Complex and subjective auditor judgement was applied in assessing the forward-looking economic scenarios used by the Company, the probability weightings applied to them and the complexity of models used to derive the probability weightings.
Qualitative adjustments – Complex and subjective auditor judgement was applied in assessing qualitative adjustments to the model-driven impairment allowance due to the inherent estimation uncertainty associated with these adjustments, especially in relation to adjustments introduced to respond to the continuous impact of economic uncertainty.
In addition, auditor judgement was required to evaluate the sufficiency of audit evidence obtained.
The following are the primary procedures we performed to address this critical audit matter.
We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s process for estimating the impairment allowance for loans and advances at amortized cost, including off-balance sheet elements. This included controls relating to the (1) application of the staging criteria, (2) model validation, implementation and monitoring, (3) authorization and calculation of qualitative adjustments and management overlays, and (4) selection and implementation of economic variables and the controls over the economic scenario selection and probabilities.
We involved credit risk modelling professionals with specialized skills and knowledge, who assisted in the following:
evaluating the Company’s impairment methodologies for compliance with IFRS 9;
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
213

Report of Independent Registered Public Accounting Firm
inspecting model code for the calculation of certain components of the ECL model to assess its consistency with the Company’s approved staging criteria and the output of the model;
evaluating for a selection of models which were changed or updated during the year as to whether the changes (including the updated model code) were appropriate by assessing the updated model methodology against the applicable accounting standard;
reperforming the calculation of certain post model adjustments to assess consistency with the post model adjustment methodologies;
evaluating the model output for a selection of models by inspecting the corresponding model functionality and independently implementing the model by rebuilding the model code and comparing our independent output with management’s output; and
reperforming and assessing, for a selection of models, the reasonableness of the model predictions by comparing them against actual results and evaluating the resulting differences.
In addition, we involved economic professionals with specialized skills and knowledge, who assisted in:
assessing the reasonableness of the Company’s methodology and models used for determining the economic scenarios used and the probability weightings applied to them;
assessing key economic variables which included comparing a selection of economic variables to external sources;
assessing the overall reasonableness of the economic forecasts by comparing the Company’s forecasts to our own modelled forecasts; and
assessing the reasonableness of the Company’s qualitative adjustments by challenging key economic assumptions applied in their calculation based on external sources.
We evaluated the collective results of the procedures performed to assess the sufficiency of the audit evidence obtained related to the Company’s impairment allowance for loans and advances at amortized cost, including off-balance sheet elements of the allowance.
Valuation of certain difficult-to-value financial instruments recorded at fair value
As discussed in Note 17 to the Company’s consolidated financial statements, the balance of financial assets and liabilities recorded at fair value as at December 31, 2021 was £663bn and £562bn, respectively. Of these amounts, Level 3 assets (£16bn) and liabilities (£6.5bn) represented 2.4% of the Company’s financial assets carried at fair value and 1.2% of the Company’s financial liabilities carried at fair value. The Company has Level 2 financial assets at fair value of £533bn and financial liabilities at fair value of £521bn. Included in these amounts are certain difficult-to-value fair value financial instruments for which the Company is required to apply valuation techniques which often involve the exercise of significant judgement and the use of assumptions and valuation models.
We identified the valuation of certain difficult-to-value financial instruments recorded at fair value as a critical audit matter. This is because there was significant measurement uncertainty associated with the fair value estimates of these instruments and subjective auditor judgement, including specialized skills and knowledge, was required to evaluate pricing data inputs, valuation models and fair value adjustments (“FVA”), including portfolio-level FVAs related to credit and funding (commonly referred to as “XVAs”).
The following are the primary procedures we performed to address this critical audit matter:
We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s process to measure fair value of these portfolios. This included controls related to (1) the independent price verification (‘IPV’) of certain market pricing data inputs, (2) the determination or calculation of FVAs, including exit adjustments (to mark the portfolio to bid or offer prices), model shortcoming reserves to address model limitations and XVAs and (3) the validation, implementation and usage of valuation models including assessment of the impact of model limitations and assumptions;
For a selection of collateral disputes identified through management’s control we challenged management’s valuation where significant fair value differences were observable through comparison with the market participant’s valuation on the other side of the trade;
We performed a retrospective review by inspecting significant gains and losses on a selection of new trades, trade exits, novations and restructurings and evaluated whether these data points indicated elements of fair value not incorporated in the current valuation methodologies;
We inspected movements in certain unobservable inputs throughout the period to assess whether gains or losses generated were in line with the accounting standards;
We involved valuation professionals with specialized skills and knowledge who assisted in the following:
i.assessing the conceptual soundness of significant models and methodologies used in calculating fair values, risk exposures and in calculating FVAs;
ii.utilising collateral dispute data to identify fair value financial instruments with significant fair value differences against market counterparties and developing an independent estimate of the fair value of such financial instruments; and
iii.developing an independent estimate of fair value for a selection of trades from the above portfolios and challenging the Company where their valuations were outside our tolerance.
UK Pension Scheme – Defined Benefit Obligation (‘DBO’) assumptions
As discussed in Note 33 to the consolidated financial statements, the Company operates multiple defined benefit pension plans with the majority of the balance relating to the UKRF. The total fair value of the defined benefit pension obligation as of 31 December 2021 was £31.9bn. Of this amount, £30.9bn related to UKRF. The determination of the Company’s defined benefit pension obligation with respect to these plans is dependent on certain actuarial assumptions, including the discount rate, inflation rate (or retail price index) and mortality assumptions.
We identified the valuation of the defined benefit pension obligation in respect of UKRF as a critical audit matter. Subjective and complex auditor judgement, including specialized skills and knowledge, was required in evaluating the discount rates, retail price index (‘RPI’) and mortality assumptions used, as small changes would have a significant impact on the measurement of the defined benefit pension obligation.
The following are the primary procedures we performed to address this critical audit matter:
a.We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s defined benefit pension obligation process. This included controls related to management’s review of IAS19 assumptions including discount rate, RPI and mortality assumptions;
b.We involved actuarial professionals with specialized skills and knowledge who assisted in assessing the Company’s discount rate, RPI and mortality assumptions by evaluating those assumptions against expectations derived from external sources.





/s/ KPMG LLP
We have served as the Company’s auditor since 2017.
London, United Kingdom
February 22, 2022
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
214

Consolidated financial statements

Consolidated income statement
202120202019
For the year ended 31 DecemberNotes£m£m£m
Interest and similar income311,240 11,892 15,456 
Interest and similar expense3(3,167)(3,770)(6,049)
Net interest income8,073 8,122 9,407 
Fee and commission income49,880 8,641 9,122 
Fee and commission expense4(2,206)(2,070)(2,362)
Net fee and commission income7,674 6,571 6,760 
Net trading income55,794 7,029 4,235 
Net investment income6311 13 1,131 
Other income88 31 99 
Total income21,940 21,766 21,632 
Credit impairment releases/(charges)7653 (4,838)(1,912)
Net operating income22,593 16,928 19,720 
Staff costs31(8,511)(8,097)(8,315)
Infrastructure costs8(3,614)(3,323)(2,970)
Administration and general expenses8(2,137)(2,313)(2,300)
Litigation and conduct8(177)(153)(1,849)
Operating expenses8(14,439)(13,886)(15,434)
Share of post-tax results of associates and joint ventures260 61 
Profit on disposal of subsidiaries, associates and joint ventures 17 10 
Profit before tax 8,414 3,065 4,357 
Taxation9(1,188)(604)(1,003)
Profit after tax7,226 2,461 3,354 
Attributable to:
Equity holders of the parent 6,375 1,526 2,461 
Other equity instrument holders804 857 813 
Total equity holders of the parent7,179 2,383 3,274 
Non-controlling interests3047 78 80 
Profit after tax7,226 2,461 3,354 
Earnings per shareppp
Basic earnings per ordinary share1037.5 8.8 14.3 
Diluted earnings per share1036.6 8.6 14.1 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
215

Consolidated financial statements
Consolidated statement
of comprehensive income
202120202019
For the year ended December 31£m£m£m
Profit after tax7,226 2,461 3,354 
Other comprehensive income/(loss) that may be recycled to profit or loss:
Currency translation reserve
Currency translation differencesa
(131)(473)(544)
Fair value through other comprehensive income reserve movements relating to debt securities
Net (losses)/gains from changes in fair value(1,668)2,902 2,901 
Net gains transferred to net profit on disposal(305)(295)(502)
Net (gains)/losses relating to (releases of) impairment(8)
Net gains/(losses) due to fair value hedging1,354 (2,000)(2,172)
Other movements — (5)
Tax198 (155)(57)
Cash flow hedging reserve
Net gains/(losses) from changes in fair value(2,280)1,299 724 
Net gains transferred to net profit(1,173)(510)(277)
Tax1,025 (216)(105)
Other 16 
Other comprehensive (loss)/income that may be recycled to profit or loss(2,988)559 (20)
Other comprehensive income/(loss) not recycled to profit or loss:
Retirement benefit remeasurements1,298 (80)(280)
Fair value through other comprehensive income reserve movements relating to equity instruments141 (262)(95)
Own credit(106)(810)(316)
Tax(563)198 150 
Other comprehensive income/(loss) not recycled to profit or loss770 (954)(541)
Other comprehensive loss for the year(2,218)(395)(561)
Total comprehensive income for the year5,008 2,066 2,793 
Attributable to:
Equity holders of the parent4,961 1,988 2,713 
Non-controlling interests47 78 80 
Total comprehensive income for the year5,008 2,066 2,793 
Note
a    Includes £26m loss (2020: £17m gain; 2019: £15m loss) on recycling of currency translation differences to net profit.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
216

Consolidated financial statements
Consolidated balance sheet
20212020
As at December 31Notes£m£m
Assets
Cash and balances at central banks238,574 191,127 
Cash collateral and settlement balances92,542 101,367 
Loans and advances at amortised cost19 361,451 342,632 
Reverse repurchase agreements and other similar secured lending3,227 9,031 
Trading portfolio assets12 147,035 127,950 
Financial assets at fair value through the income statement13 191,972 175,151 
Derivative financial instruments 14 262,572 302,446 
Financial assets at fair value through other comprehensive income15 61,753 78,688 
Investments in associates and joint ventures36 999 781 
Goodwill and intangible assets22 8,061 7,948 
Property, plant and equipment20 3,555 4,036 
Current tax assets261 477 
Deferred tax assets4,619 3,444 
Retirement benefit assets33 3,879 1,814 
Other assets3,785 2,622 
Total assets1,384,285 1,349,514 
Liabilities
Deposits at amortised cost19 519,433 481,036 
Cash collateral and settlement balances79,371 85,423 
Repurchase agreements and other similar secured borrowing28,352 14,174 
Debt securities in issue98,867 75,796 
Subordinated liabilities27 12,759 16,341 
Trading portfolio liabilities12 54,169 47,405 
Financial liabilities designated at fair value16 250,960 249,765 
Derivative financial instruments14 256,883 300,775 
Current tax liabilities739 645 
Deferred tax liabilities37 15 
Retirement benefit liabilities33 311 291 
Other liabilities23 10,505 8,662 
Provisions24 1,688 2,304 
Total liabilities1,314,074 1,282,632 
Equity
Called up share capital and share premium28 4,536 4,637 
Other equity instruments28 12,259 11,172 
Other reserves29 1,770 4,461 
Retained earnings 50,657 45,527 
Total equity excluding non-controlling interests69,222 65,797 
Non-controlling interests30 989 1,085 
Total equity70,211 66,882 
Total liabilities and equity1,384,285 1,349,514 

The Board of Directors approved the financial statements on pages 215 to 309 on 22 February 2022.

Nigel Higgins
Group Chairman

C.S. Venkatakrishnan
Group Chief Executive

Tushar Morzaria
Group Finance Director
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
217

Consolidated financial statements
Consolidated statement
of changes in equity
Called up share capital and share premiuma
Other equity instrumentsa
Other reservesb
Retained earningsTotal equity excluding non-controlling interestsNon-controlling interestsTotal equity
£m£m£m£m£m£m£m
Balance as at 1 January 20214,637 11,172 4,461 45,527 65,797 1,085 66,882 
Profit after tax 804  6,375 7,179 47 7,226 
Currency translation movements  (131) (131) (131)
Fair value through other comprehensive income reserve  (288) (288) (288)
Cash flow hedges  (2,428) (2,428) (2,428)
Retirement benefit remeasurements   643 643  643 
Own credit reserve  (14) (14) (14)
Total comprehensive income for the year 804 (2,861)7,018 4,961 47 5,008 
Employee share schemes and hedging thereof60   235 295  295 
Issue and redemption of other equity instruments 1,078  6 1,084 (75)1,009 
Other equity instruments coupons paid (804)  (804) (804)
Increase in treasury shares  (240) (240) (240)
Vesting of shares under employee share schemes  241 (410)(169) (169)
Dividends paid   (512)(512)(44)(556)
Repurchase of shares(161) 161 (1,200)(1,200) (1,200)
Other reserve movements 9 8 (7)10 (24)(14)
Balance as at 31 December 20214,536 12,259 1,770 50,657 69,222 989 70,211 
Balance as at 1 January 20204,594 10,871 4,760 44,204 64,429 1,231 65,660 
Profit after tax— 857 — 1,526 2,383 78 2,461 
Currency translation movements— — (473)— (473)— (473)
Fair value through other comprehensive income reserve— — 192 — 192 — 192 
Cash flow hedges— — 573 — 573 — 573 
Retirement benefit remeasurements— — — (111)(111)— (111)
Own credit reserve— — (581)— (581)— (581)
Other— — — — 
Total comprehensive income for the year— 857 (289)1,420 1,988 78 2,066 
Employee share schemes and hedging thereof43 — — 303 346 — 346 
Issue and exchange of other equity instruments— 311 — (55)256 (158)98 
Other equity instruments coupons paid— (857)— — (857)— (857)
Increase in treasury shares— — (207)— (207)— (207)
Vesting of shares under employee share schemes— — 197 (347)(150)— (150)
Dividends paid— — — — — (79)(79)
Other reserve movements— (10)— (8)13 
Balance as at 31 December 20204,637 11,172 4,461 45,527 65,797 1,085 66,882 
Notes
a    For further details refer to Note 28.
b    For further details refer to Note 29.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
218

Consolidated financial statements
Called up share capital and share premiuma
Other equity instrumentsa
Other reservesb
Retained earningsTotal equity excluding non-controlling interestsNon-controlling interestsTotal equity
£m£m£m£m£m£m£m
Balance as at 1 January 20194,311 9,632 5,153 43,460 62,556 1,223 63,779 
Profit after tax— 813 — 2,461 3,274 80 3,354 
Currency translation movements— — (544)— (544)— (544)
Fair value through other comprehensive income reserve— — 71 — 71 — 71 
Cash flow hedges— — 342 — 342 — 342 
Retirement benefit remeasurements— — — (194)(194)— (194)
Own credit reserve— — (252)— (252)— (252)
Other— — — 16 16 — 16 
Total comprehensive income for the year— 813 (383)2,283 2,713 80 2,793 
Issue of new ordinary shares182 — 182 — 182 
Employee share schemes and hedges thereof101 — 478 579 — 579 
Issue and exchange of other equity instruments— 1,238 — (406)832 — 832 
Other equity instruments coupons paid— (813)— — (813)— (813)
Increase in treasury shares— — (224)— (224)— (224)
Vesting of shares under employee share schemes— — 214 (404)(190)— (190)
Dividends paid— — — (1,201)(1,201)(80)(1,281)
Other reserve movements— — (6)(5)
Balance as at 31 December 20194,594 10,871 4,760 44,204 64,429 1,231 65,660 
Notes
aFor further details refer to Note 28.
bFor further details refer to Note 29.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
219

Consolidated financial statements
Consolidated cash flow statement
202120202019
For the year ended 31 DecemberNotes£m£m£m
Reconciliation of profit before tax to net cash flows from operating activities:

Profit before tax8,414 3,065 4,357 
Adjustment for non-cash items:
Credit impairment (releases)/charges(653)4,838 1,912 
Depreciation, amortisation and impairment of property, plant, equipment and intangibles2,076 1,734 1,520 
Other provisions, including pensions248 1,365 2,336 
Net loss on disposal of investments and property, plant and equipment39 47 
Other non-cash movements including exchange rate movements3,093 (2,977)(280)
Changes in operating assets and liabilities
Net decrease/(increase) in cash collateral and settlement balances4,101 4,321 (6,436)
Net increase in loans and advances at amortised cost(10,728)(4,365)(2,255)
Net decrease/(increase) in reverse repurchase agreements and other similar secured lending5,804 (5,652)(1,071)
Net increase in deposits at amortised cost38,397 65,249 20,949 
Net increase/(decrease) in debt securities in issue18,131 (6,309)(9,911)
Net increase/(decrease) in repurchase agreements and other similar secured borrowing14,178 (343)(4,061)
Net (increase)/decrease in derivative financial instruments(4,018)(1,845)2,863 
Net increase in trading portfolio assets(19,085)(13,755)(10,008)
Net increase/(decrease) in trading portfolio liabilities6,764 10,489 (966)
Net (increase)/decrease in financial assets and liabilities at fair value through the income statement(15,626)3,374 4,054 
Net (increase)/decrease in other assets(2,133)452 (412)
Net increase/(decrease) in other liabilities1,252 (1,500)(2,872)
Corporate income tax paid(1,335)(683)(228)
Net cash from operating activities48,919 57,505 (502)
Purchase of debt securities at amortised cost(12,500)(14,671)(14,729)
Proceeds from sale or redemption of debt securities at amortised cost3,757 8,480 3,590 
Purchase of financial assets at fair value through other comprehensive income(75,673)(91,744)(92,365)
Proceeds from sale or redemption of financial assets at fair value through other comprehensive income89,342 80,895 81,202 
Purchase of property, plant and equipment and intangibles(1,720)(1,324)(1,793)
Proceeds from sale of property, plant and equipment and intangibles — 46 
Disposal of subsidiaries and associates, net of cash disposed1,057 — — 
Other cash flows associated with investing activities7 (12)84 
Net cash from investing activities4,270 (18,376)(23,965)
Dividends paid and other coupon payments on equity instruments(1,360)(936)(1,912)
Issuance of subordinated liabilities271,890 1,438 1,352 
Redemption of subordinated liabilities27(4,807)(3,258)(3,248)
Issue of shares and other equity instruments1,118 1,165 3,582 
Repurchase of shares and other equity instruments(1,275)(1,056)(2,668)
Issuance of debt securitiesa
8,415 5,736 3,994 
Redemption of debt securitiesa
(3,475)— — 
Net purchase of treasury shares (399)(357)(410)
Net cash from financing activities107 2,732 690 
Effect of exchange rates on cash and cash equivalents(4,232)1,668 (3,347)
Net increase/(decrease) in cash and cash equivalents49,064 43,529 (27,124)
Cash and cash equivalents at beginning of year210,142 166,613 193,737 
Cash and cash equivalents at end of year259,206 210,142 166,613 
Cash and cash equivalents comprise:
Cash and balances at central banks238,574 191,127 150,258 
Loans and advances to banks with original maturity less than three months6,488 5,955 8,021 
Cash collateral balances with central banks with original maturity less than three months13,532 12,204 7,854 
Treasury and other eligible bills with original maturity less than three months612 856 480 
Cash and cash equivalents at end of year259,206 210,142 166,613 
Note
a    Issuance of debt securities and Redemption of debt securities included in financing activities relate to instruments that qualify as eligible liabilities and satisfy regulatory requirements for MREL instruments which came into effect during 2019. Refer to Note 1, paragraph 4(vi), for further details.
Interest received was £17,194m (2020: £18,748m; 2019: £34,061m) and interest paid was £8,063m (2020: £9,577m; 2019: £23,186m). These amounts include interest paid and received arising from trading activities. Dividends received were £20m (2020: £37m; 2019: £76m). The Group is required to maintain balances with central banks and other regulatory authorities. These amounted to £4,750m (2020: £3,392m; 2019: £4,893m) and are included within the Cash and cash equivalents. For the purposes of the cash flow statement, cash comprises cash on hand and demand deposits and cash equivalents comprise highly liquid investments that are convertible into cash with an insignificant risk of changes in value with original maturities of three months or less. Repurchase and reverse repurchase agreements are not considered to be part of cash equivalents.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
220


Financial statements of Barclays PLC
Parent company accounts
Statement of comprehensive income
202120202019
For the year ended 31 DecemberNotes£m£m£m
Dividends received from subsidiary421,356 763 1,560 
Net interest (expense)/income(161)(175)214 
Other income42659 1,192 1,760 
Impairment reversal/(charge) of investment in subsidiary422,573 (2,573)— 
Operating expenses(160)(241)(267)
Profit/(loss) before tax4,267 (1,034)3,267 
Taxation76 16 (86)
Profit/(loss) after tax4,343 (1,018)3,181 
Other comprehensive income — — 
Total comprehensive income/(loss)4,343 (1,018)3,181 
Profit/(loss) after tax attributable to:
Ordinary equity holders3,539 (1,875)2,368 
Other equity instrument holders804 857 813 
Profit/(loss) after tax4,343 (1,018)3,181 
Total comprehensive income/(loss) attributable to:
Ordinary equity holders3,539 (1,875)2,368 
Other equity instrument holders804 857 813 
Total comprehensive income/(loss)4,343 (1,018)3,181 
For the year ended 31 December 2021, profit after tax was £4,343m (2020: loss £1,018m) and total comprehensive income was £4,343m (2020: loss £1,018m). The Company has 65 members of staff (2020: 60).
Balance sheet
20212020
As at 31 DecemberNotes£m £m
Assets
Investment in subsidiaries4262,528 58,886 
Loans and advances to subsidiaries4222,072 24,710 
Financial assets at fair value through the income statement 4225,091 17,521 
Derivative financial instruments4 
Other assets68 65 
Total assets109,763 101,189 
Liabilities
Deposits at amortised cost488 482 
Debt securities in issue4225,658 28,428 
Subordinated liabilities429,301 7,724 
Financial liabilities designated at fair value4216,319 9,507 
Derivative financial instruments43 — 
Other liabilities117 176 
Total liabilities51,926 46,317 
Equity
Called up share capital284,188 4,340 
Share premium account28348 297 
Other equity instruments2812,241 11,169 
Other reserves555 394 
Retained earnings40,505 38,672 
Total equity57,837 54,872 
Total liabilities and equity109,763 101,189 
The financial statements on pages 221 to 223 and the accompanying note on page 308 to 309 were approved by the Board of Directors on 22 February 2022 and signed on its behalf by:
Nigel Higgins
Group Chairman
C.S.Venkatakrishnan
Group Chief Executive
Tushar Morzaria
Group Finance Director
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
221

Financial statements of Barclays PLC
Statement of changes in equity
Called up share capital and share premiumOther equity instrumentsOther reservesRetained earningsTotal equity
Notes£m£m£m£m£m
Balance as at 1 January 2021
4,637 11,169 394 38,672 54,872 
Profit after tax and other comprehensive income 804  3,539 4,343 
Issue of shares under employee share schemes60   29 89 
Issue and exchange of other equity instruments 1,072   1,072 
Vesting of shares under employee share schemes   (18)(18)
Dividends paid11   (512)(512)
Other equity instruments coupons paid (804)  (804)
Repurchase of shares(161) 161 (1,200)(1,200)
Other reserve movements   (5)(5)
Balance as at 31 December 2021
4,536 12,241 555 40,505 57,837 
Balance as at 1 January 2020
4,594 10,865 394 40,614 56,467 
Profit/(loss) after tax and other comprehensive income— 857 — (1,875)(1,018)
Issue of new ordinary shares— — — — — 
Issue of shares under employee share schemes43 — — 20 63 
Issue and exchange of other equity instruments— 304 — (73)231 
Vesting of shares under employee share schemes— — — (14)(14)
Dividends paid11— — — — — 
Other equity instruments coupons paid— (857)— — (857)
Balance as at 31 December 2020
4,637 11,169 394 38,672 54,872 

Statement of changes in equity
Called up share capital and share premiumOther equity instrumentsOther reservesRetained earningsTotal equity
Notes£m£m£m£m£m
Balance as at 1 January 20194,311 9,633 394 39,842 54,180 
Profit after tax and other comprehensive income— 813 — 2,368 3,181 
Issue of new ordinary shares182 — — — 182 
Issue of shares under employee share schemes101 — — 20 121 
Issue and exchange of other equity instruments— 1,232 — (396)836 
Vesting of shares under employee share schemes— — — (19)(19)
Dividends paid11— — — (1,201)(1,201)
Other equity instruments coupons paid— (813)— — (813)
Balance as at 31 December 20194,594 10,865 394 40,614 56,467 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
222


Cash flow statement
2021
2020b
2019b
For the year ended 31 December£m£m£m
Reconciliation of profit before tax to net cash flows from operating activities:
Profit/(loss) before tax4,267 (1,034)3,267 
Adjustment for non-cash items:
Impairment (reversal)/charge of investment in subsidiary(2,573)2,573 
Other non-cash items383 528 (582)
Changes in operating assets and liabilities17 — 87 
Net cash generated from operating activities2,094 2,067 2,772 
Net increase in loans and advances to subsidiaries of the Parenta, b
(6,118)(4,732)(4,464)
Capital contribution to and investment in subsidiary(1,083)(393)(1,187)
Net cash used in investing activities(7,201)(5,125)(5,651)
Issue of shares and other equity instruments1,114 1,175 3,597 
Redemption of other equity instruments (898)(2,668)
Net increase in debt securities in issuec
4,939 3,720 2,588 
Proceeds of borrowings and issuance of subordinated debt1,579 158 1,194 
Repurchase of shares(1,200)— — 
Dividends paid(512)— (1,019)
Coupons paid on other equity instruments(804)(857)(813)
Net cash generated from financing activities5,116 3,298 2,879 
Net increase in cash and cash equivalents9 240 — 
Cash and cash equivalents at beginning of year240 — — 
Cash and cash equivalents at end of year249 240 — 
Net cash generated from operating activities includes:
Dividends received1,356 763 1,560 
Net interest (paid)/received(161)(175)214 
Notes
a    Includes financial assets at fair value through the income statement.
b    Following a review of the Barclays parent company cash flow statement, in order to make the cash flow statement more relevant, cash movements resulting from loans and advances to subsidiaries are now presented within investing activities, whereas previously they were presented in financing activities. Comparatives have been restated. The effect of this change was to increase the net cash outflow due to investing activities increased by £4,732m in 2020 and £4,464m in 2019, with the net cash inflow relating to financing activities increasing by the same amount .
c    Includes financial liabilities designated at fair value.
The Parent company’s principal activity is to hold the investment in its wholly-owned subsidiaries, Barclays Bank PLC, Barclays Bank UK PLC, Barclays Execution Services Limited and Barclays Principal Investments Limited. Dividends received are treated as operating income.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
223


Notes to the financial statements
For the year ended 31 December 2021
This section describes the Group’s significant policies and critical accounting estimates that relate to the financial statements and notes as a whole. If an accounting policy or a critical accounting estimate relates to a particular note, the accounting policy and/or critical accounting estimate is contained with the relevant note.
1 Significant accounting policies
1. Reporting entity
Barclays PLC is a public company limited by shares registered in England under company number 48839, having its registered office at 1 Churchill Place, London, E14 5HP.
These financial statements are prepared for Barclays PLC and its subsidiaries (the Group) under Section 399 of the Companies Act 2006. The Group is a major global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. In addition, separate financial statements have been presented for the holding company.
2. Compliance with International Financial Reporting Standards
The consolidated financial statements of the Group, and the separate financial statements of Barclays PLC, have been prepared in accordance with UK-adopted international accounting standards.
The consolidated financial statements of the Group, and the separate financial statements of Barclays PLC, have also been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB), including interpretations issued by the IFRS Interpretations Committee, as there are no applicable differences from IFRS as issued by the IASB for the periods presented.
The principal accounting policies applied in the preparation of the consolidated and separate financial statements are set out below, and in the relevant notes to the financial statements. These policies have been consistently applied, with the exception of the Interest Rate Benchmark Reform Phase 2 amendments (amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16) which were applied from 1 January 2020.
3. Basis of preparation
The consolidated and separate financial statements have been prepared under the historical cost convention modified to include the fair valuation of investment property, and particular financial instruments, to the extent required or permitted under IFRS as set out in the relevant accounting policies. These financial statements are stated in millions of pounds Sterling (£m), the functional currency of Barclays PLC.
The financial statements have been prepared for Barclays PLC and its subsidiaries (the Group) under Section 399 of the Companies Act 2006 as applicable to companies using IFRS. The financial statements are prepared on a going concern basis, as the Board is satisfied that the Group and the parent company have the resources to continue in business for a period of at least 12 months from approval of the financial statements.
In making this assessment, the Board has considered a wide range of information relating to present and future conditions and includes a review of a working capital report (WCR). The WCR is used by the Board to assess the future performance of the Group and that it has the resources in place that are required to meet its ongoing regulatory requirements. The assessment is based upon business plans which contain future projections of profitability taken from the Group’s medium-term plan as well as projections of regulatory capital requirements and business funding needs. The WCR also includes an assessment of the impact of internally generated stress testing scenarios on the liquidity and capital requirement forecasts. The stress tests used were based upon an assessment of reasonably possible downside economic scenarios that the Group could experience.
The WCR showed that the Group had sufficient capital and liquidity in place to support its future business requirements and remained above its regulatory minimum requirements in the stress scenarios. Accordingly, the Directors concluded that there was a reasonable expectation that the Group and parent company has adequate resources to continue as a Going Concern for a period of at least 12 months from the date of approval of the financial statements.
4. Accounting policies
The Group prepares financial statements in accordance with IFRS. The Group’s significant accounting policies relating to specific financial statement items, together with a description of the accounting estimates and judgements that were critical to preparing those items, are set out under the relevant notes. Accounting policies that affect the financial statements as a whole are set out below.
(i) Consolidation
The Group applies IFRS 10 Consolidated financial statements.
The consolidated financial statements combine the financial statements of Barclays PLC and all its subsidiaries. Subsidiaries are entities over which Barclays PLC has control. The Group has control over another entity when the Group has all of the following:
1)power over the relevant activities of the investee, for example through voting or other rights
2)exposure to, or rights to, variable returns from its involvement with the investee, and
3)the ability to affect those returns through its power over the investee.
The assessment of control is based on the consideration of all facts and circumstances. The Group reassesses whether it controls an investee if facts and circumstances indicate that there are changes to one or more of the three elements of control.
Intra-group transactions and balances are eliminated on consolidation. Consistent accounting policies are used throughout the Group for the purposes of the consolidation.
Changes in ownership interests in subsidiaries are accounted for as equity transactions if they occur after control has already been obtained and they do not result in loss of control.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
224

Notes to the financial statements
For the year ended 31 December 2021 continued
As the consolidated financial statements include partnerships where the Group member is a partner, advantage has been taken of the exemption under Regulation 7 of the Partnership (Accounts) Regulations 2008 with regard to preparing and filing of individual partnership financial statements.
Details of the principal subsidiaries are given in Note 34.
(ii) Foreign currency translation
The Group applies IAS 21 The Effects of Changes in Foreign Exchange Rates. Transactions in foreign currencies are translated into Sterling at the rate ruling on the date of the transaction. Foreign currency monetary balances are translated into Sterling at the period end exchange rates. Exchange gains and losses on such balances are taken to the income statement.  Non-monetary foreign currency balances in relation to items measured in terms of historical cost are carried at historical transaction date exchange rates. Non-monetary foreign currency balances in relation to items measured at fair value are translated using the exchange rate at the date when the fair value was measured.
The Group’s foreign operations (including subsidiaries, joint ventures, associates and branches) based mainly outside the UK may have different functional currencies. The functional currency of an operation is the currency of the main economy to which it is exposed.
Prior to consolidation (or equity accounting) the assets and liabilities of non-Sterling operations are translated at the period end exchange rate and items of income, expense and other comprehensive income are translated into Sterling at the rate on the date of the transactions. Exchange differences arising on the translation of foreign operations are included in currency translation reserves within equity. These are transferred to the income statement when the Group disposes of the entire interest in a foreign operation, when partial disposal results in the loss of control of an interest in a subsidiary, when an investment previously accounted for using the equity method is accounted for as a financial asset, or on the disposal of a foreign operation within a branch.
(iii) Financial assets and liabilities
The Group applies IFRS 9 Financial Instruments to the recognition, classification and measurement, and derecognition of financial assets and financial liabilities and the impairment of financial assets. The Group applies the requirements of IAS 39 Financial Instruments: Recognition and Measurement for hedge accounting purposes.
Recognition
The Group recognises financial assets and liabilities when it becomes a party to the terms of the contract. Trade date or settlement date accounting is applied depending on the classification of the financial asset.
Classification and measurement
Financial assets are classified on the basis of two criteria:
i)the business model within which financial assets are managed, and
ii)their contractual cash flow characteristics (whether the cash flows represent ‘solely payments of principal and interest’ (SPPI)).
The Group assesses the business model criteria at a portfolio level. Information that is considered in determining the applicable business model includes (i) policies and objectives for the relevant portfolio, (ii) how the performance and risks of the portfolio are managed, evaluated and reported to management, and (iii) the frequency, volume and timing of sales in prior periods, sales expectation for future periods, and the reasons for such sales.
The contractual cash flow characteristics of financial assets are assessed with reference to whether the cash flows represent SPPI. In assessing whether contractual cash flows are SPPI compliant, interest is defined as consideration primarily for the time value of money and the credit risk of the principal outstanding. The time value of money is defined as the element of interest that provides consideration only for the passage of time and not consideration for other risks or costs associated with holding the financial asset. Terms that could change the contractual cash flows so that it would not meet the condition for SPPI are considered, including: (i) contingent and leverage features, (ii) non-recourse arrangements and (iii) features that could modify the time value of money.
Financial assets are measured at amortised cost if they are held within a business model whose objective is to hold financial assets in order to collect contractual cash flows, and their contractual cash flows represent SPPI.
Financial assets are measured at fair value through other comprehensive income if they are held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets, and their contractual cash flows represent SPPI.
Other financial assets are measured at fair value through profit and loss. There is an option to make an irrevocable election on initial recognition for non traded equity investments to be measured at fair value through other comprehensive income, in which case dividends are recognised in profit or loss, but gains or losses are not reclassified to profit or loss upon derecognition, and the impairment requirements of IFRS 9 do not apply.
The accounting policy for each type of financial asset or liability is included within the relevant note for the item. The Group’s policies for determining the fair values of the assets and liabilities are set out in Note 17.
Derecognition
The Group derecognises a financial asset, or a portion of a financial asset, from its balance sheet where (i) the contractual rights to cash flows from the asset have expired, or (ii) the contractual rights to cash flows from the asset have been transferred (usually by sale) and with them either (a) substantially all the risks and rewards of the asset have been transferred, or (b) where neither substantially all the risks and reward have been transferred or retained, where control over the asset has been lost.
Financial liabilities are de-recognised when the liability has been settled, has expired or has been extinguished. An exchange of an existing financial liability for a new liability with the same lender on substantially different terms – generally a difference of 10% or more in the present value of the cash flows or a substantive qualitative amendment – is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
225

Notes to the financial statements
For the year ended 31 December 2021 continued
Transactions in which the Group transfers assets and liabilities, portions of them, or financial risks associated with them can be complex and it may not be obvious whether substantially all of the risks and rewards have been transferred. It is often necessary to perform a quantitative analysis. Such an analysis compares the Group’s exposure to variability in asset cash flows before the transfer with its retained exposure after the transfer.
A cash flow analysis of this nature may require judgement. In particular, it is necessary to estimate the asset’s expected future cash flows as well as potential variability around this expectation. The method of estimating expected future cash flows depends on the nature of the asset, with market and market-implied data used to the greatest extent possible. The potential variability around this expectation is typically determined by stressing underlying parameters to create reasonable alternative upside and downside scenarios. Probabilities are then assigned to each scenario. Stressed parameters may include default rates, loss severity, or prepayment rates.
Accounting for reverse repurchase and repurchase agreements including other similar lending and borrowing
Reverse repurchase agreements (and stock borrowing or similar transactions) are a form of secured lending whereby the Group provides a loan or cash collateral in exchange for the transfer of collateral, generally in the form of marketable securities subject to an agreement to transfer the securities back at a fixed price in the future. Repurchase agreements are where the Group obtains such loans or cash collateral, in exchange for the transfer of collateral.
The Group purchases (a reverse repurchase agreement) or borrows securities subject to a commitment to resell or return them. The securities are not included in the balance sheet as the Group does not acquire the risks and rewards of ownership. Consideration paid (or cash collateral provided) is accounted for as a loan asset at amortised cost, unless it is designated or mandatorily at fair value through profit and loss.
The Group may also sell (a repurchase agreement) or lend securities subject to a commitment to repurchase or redeem them. The securities are retained on the balance sheet as the Group retains substantially all the risks and rewards of ownership. Consideration received (or cash collateral provided) is accounted for as a financial liability at amortised cost, unless it is designated at fair value through profit and loss.
(iv) Issued debt and equity instruments
The Group applies IAS 32, Financial Instruments: Presentation, to determine whether funding is either a financial liability (debt) or equity.
Issued financial instruments or their components are classified as liabilities if the contractual arrangement results in the Group having an obligation to either deliver cash or another financial asset, or a variable number of equity shares, to the holder of the instrument. If this is not the case, the instrument is generally an equity instrument and the proceeds included in equity, net of transaction costs. Dividends and other returns to equity holders are recognised when paid or declared by the members at the Annual General Meeting and treated as a deduction from equity.
Where issued financial instruments contain both liability and equity components, these are accounted for separately. The fair value of the debt is estimated first and the balance of the proceeds is included within equity.
(v) Changes in the basis for determining contractual cash flows resulting from interest rate benchmark reform
A change in the basis of determining the contractual cash flows of a financial instrument that is required by interest rate benchmark reform is accounted for by updating the effective interest rate, without the recognition of an immediate gain or loss. This practical expedient is only applied where (1) the change to the contractual cash flows is necessary as a direct consequence of the reform and (2) the new basis for determining the contractual cash flows is economically equivalent to the previous basis. For changes made in addition to those required by the interest rate benchmark reform, the practical expedient is applied first, after which the normal IFRS 9 requirements for modifications of financial instruments is applied.
Refer to Note 14 for further details regarding hedge accounting policies in respect of interest rate benchmark reform.
Refer to Note 41 for further disclosure related to interest rate benchmark reform.
(vi) Cash flow statement
Cash comprises cash on hand and balances at central banks. Cash equivalents comprise loans and advances to banks, cash collateral balances with central banks related to payment schemes and treasury and other eligible bills, all with original maturities of three months or less. Repurchase and reverse repurchase agreements are not considered to be part of cash equivalents.
Investments in debt securities at amortised cost, presented within loans and advances on the balance sheet, are deemed to be investing activities for the purposes of the cash flow statement, except those instruments considered to be cash equivalents. 
Debt securities issued and redeemed are considered to be operating activities, except qualifying eligible liabilities that satisfy regulatory requirements for MREL instruments (or have previously satisfied these requirements since 2019 when they came into effect), which are considered to be financing activities.
5. New and amended standards and interpretations
The accounting policies adopted have been consistently applied, with the exception of the Interest Rate Benchmark Reform Phase 2 amendments (amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16) which were applied from 1 January 2020.
Future accounting developments
The following accounting standards have been issued by the IASB but are not yet effective:
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
226

Notes to the financial statements
For the year ended 31 December 2021 continued
IFRS 17 – Insurance contracts
In May 2017, the IASB issued IFRS 17 Insurance Contracts, a comprehensive new accounting standard for insurance contracts covering recognition and measurement, presentation and disclosure. Once effective, IFRS 17 will replace IFRS 4 Insurance Contracts that was issued in 2005.
IFRS 17 applies to all types of insurance contracts (i.e. life, non-life, direct insurance and re-insurance), regardless of the type of entities that issue them, as well as to certain guarantees and financial instruments with discretionary participation features. A few scope exceptions will apply.
In June 2020, the IASB published amendments to IFRS 17. The amendments that are relevant to the Group are the scope exclusion for credit card contracts and similar contracts that provide insurance coverage, the optional scope exclusion for loan contracts that transfer significant insurance risk, and the clarification that only financial guarantees issued are in scope of IFRS 9.
The amendments also defer the effective date of IFRS 17, including the above amendments, to annual reporting periods beginning on or after 1 January 2023.
IFRS 17, including the 2020 amendments to IFRS 17, has been endorsed by the EU. Following the UK’s withdrawal from the EU on 31 December 2020, the UK-adopted international accounting standards will be applicable. IFRS 17, including the amendments to IFRS 17, has not yet been endorsed by the UK. The Group does not expect the impact of IFRS 17 to be material.
Disclosure of Accounting Policies - Amendments to IAS 1 and IFRS Practice Statement 2
In February 2021 the IASB issued amendments to IAS 1 that require entities to disclose their material accounting policies rather than their significant accounting policies. The amendments to IFRS Practice Statement 2 provide guidance on the concept of materiality and its application to accounting policy information.
Under the amendments, accounting policy information is material if, when considered together with other information included in an entity’s financial statements, it can reasonably be expected to influence decisions that the primary users of general purpose financial statements make on the basis of those financial statements.
The amendments are effective for annual periods beginning on or after 1 January 2023, and will be applied from that date.
Definition of Accounting Estimate - Amendments to IAS 8
In February 2021 the IASB issued amendments to IAS 8 that replace the definition of a change in accounting estimates with a definition of accounting estimates.
Under the new definition, accounting estimates are clarified as monetary amounts in financial statements that are subject to measurement uncertainty. Where an entity's accounting policy requires an item to be measured at monetary amounts that cannot be observed directly, it should develop an accounting estimate to achieve this objective.
The amendments are effective for annual periods beginning on or after 1 January 2023, and will be applied from that date.
6. Critical accounting estimates and judgements
The preparation of financial statements in accordance with IFRS requires the use of estimates. It also requires management to exercise judgement in applying the accounting policies. The key areas involving a higher degree of judgement or complexity or areas where assumptions are significant to the consolidated and individual financial statements are highlighted under the relevant note. Critical accounting estimates and judgements are disclosed in:
Credit impairment charges on page 234
Tax on page 238
Fair value of financial instruments on page 253
Goodwill and intangible assets on page 268
Pensions and post-retirement benefits – obligations on page 288
Provisions including conduct and legal, competition and regulatory matters on page 272.
7. Other disclosures
To improve transparency and ease of reference, by concentrating related information in one place, certain disclosures required under IFRS have been included within the Risk review section as follows:
Credit risk on pages 116 to 117 and 123 to 158
Market risk on page 117 to 118 and 159 to 160
Treasury and capital risk – liquidity on pages 118 and 163 to 172
Treasury and capital risk – capital on pages 118 to 119 and 173 to 179.
These disclosures are covered by the Audit opinion (included on pages 213 to 214) where referenced as audited.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
227

Notes to the financial statements
For the year ended 31 December 2021 continued
Financial performance and returns
The notes included in this section focus on the results and performance of the Group. Information on the income generated, expenditure incurred, segmental performance, tax, earnings per share and dividends are included here. For further detail on performance, see income statement commentary within Financial review (unaudited).
2 Segmental reporting
Presentation of segmental reporting
The Group’s segmental reporting is in accordance with IFRS 8 Operating Segments. Operating segments are reported in a manner consistent with the internal reporting provided to the Executive Committee, which is responsible for allocating resources and assessing performance of the operating segments, and has been identified as the chief operating decision maker. All transactions between business segments are conducted on an arm’s-length basis, with intra-segment revenue and costs being eliminated in Head Office. Income and expenses directly associated with each segment are included in determining business segment performance.
The Group is a British universal bank diversified by business, geography and income type, serving consumer and wholesale customers and clients globally and for segmental reporting purposes it defines its two operating divisions as Barclays UK and Barclays International.
Barclays UK consists of our UK Personal Banking, UK Business Banking and Barclaycard Consumer UK businesses. These businesses are carried on by our UK ring-fenced bank (Barclays Bank UK PLC) and certain other entities within the Group.
Barclays International consists of our Corporate and Investment Bank and Consumer, Cards and Payments businesses. These businesses are carried on by our non ring-fenced bank (Barclays Bank PLC) and its subsidiaries, and certain other entities within the Group.
The below table also includes Head Office which comprises head office and legacy businesses, as well as the FTE employed by Barclays Execution Services.
Analysis of results by business
Barclays UK Barclays International Head OfficeGroup results
£m£m£m£m
For the year ended 31 December 2021
Total income6,53615,665(261)21,940
Credit impairment releases365288653
Net operating income/(expenses)6,90115,953(261)22,593
Operating costs(4,357)(9,076)(659)(14,092)
UK bank levy(36)(134)(170)
Litigation and conduct(37)(125)(15)(177)
Total operating expenses(4,430)(9,335)(674)(14,439)
Other net incomea
40220260
Profit/(loss) before tax 2,4716,658(715)8,414
Total assets (£bn)321.21,044.119.01,384.3
Number of employees (full time equivalent)b
7,10010,40064,10081,600
Average number of employees (full time equivalent)82,900
Notes
a    Other net income represents the share of post-tax results of associates and joint ventures, profit on disposal of subsidiaries, associates and joint ventures, and gains on acquisitions.
b    Barclays UK has transformed its business this year and consolidated all Customer Care employees, who directly serve customers, into Barclays Execution Services, within the Head Office segment, to improve customer service and experience. Costs are recharged, while FTE's are reported within Head Office, as at 31 December 2021 10,700 FTE were impacted by the move from Barclays UK to Head Office, prior years have not been restated.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
228

Notes to the financial statements
For the year ended 31 December 2021 continued
Barclays UKb
Barclays Internationalb
Head OfficeGroup results
£m£m£m£m
For the year ended 31 December 2020
Total income6,34715,921(502)21,766
Credit impairment charges(1,467)(3,280)(91)(4,838)
Net operating income/(expenses)4,88012,641(593)16,928
Operating costs(4,270)(8,765)(399)(13,434)
UK bank levy(50)(240)(9)(299)
Litigation and conduct(32)(48)(73)(153)
Total operating expenses(4,352)(9,053)(481)(13,886)
Other net income/(expenses)a
1828(23)23
Profit/(loss) before tax 5463,616(1,097)3,065
Total assets (£bn)289.11,041.818.61,349.5
Number of employees (full time equivalent)21,30010,80050,90083,000
Average number of employees (full time equivalent)81,800
Notes
a    Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint ventures, and gains on acquisitions.
b    On ### April 2020, assets of £2.2bn relating to the Barclays Partner Finance business were moved from Barclays International to Barclays UK, with net operating income of £19m and loss before tax of £5m subsequently recognised in Barclays UK for the rest of 2020. The 2019 comparative figures have not been restated.

Barclays UK Barclays International Head
 Office
Group results
£m£m£m£m
For the year ended 31 December 2019
Total income7,35314,675(396)21,632
Credit impairment charges(712)(1,173)(27)(1,912)
Net operating income/(expenses)6,64113,502(423)19,720
Operating costs(3,996)(9,163)(200)(13,359)
UK bank levy(41)(174)(11)(226)
Litigation and conduct(1,582)(116)(151)(1,849)
Total operating expenses(5,619)(9,453)(362)(15,434)
Other net incomea
69271
Profit/(loss) before tax1,0224,118(783)4,357
Total assets (£bn)257.8861.421.01,140.2
Number of employees (full time equivalent)21,40011,20048,20080,800
Average number of employees (full time equivalent)82,700
Note
a    Other net income represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint ventures, and gains on acquisitions.

Income by geographic regiona
202120202019
For the year ended 31 December£m£m£m
United Kingdom11,256 11,21111,809
Europe 2,372 2,0591,754
Americas 7,199 7,4257,064
Africa and Middle East45 3659
Asia 1,068 1,035946
Total21,940 21,76621,632
.
Income from individual countries which represent more than 5% of total incomea
202120202019
For the year ended 31 December£m£m£m
United Kingdom11,256 11,21111,809
United States 7,048 7,3186,939
Note
a    The geographical analysis is based on the location of the office where the transactions are recorded.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
229

Notes to the financial statements
For the year ended 31 December 2021 continued
3 Net interest income
Accounting for interest income and expenses
Interest income on loans and advances at amortised cost and financial assets at fair value through other comprehensive income, and interest expense on financial liabilities held at amortised cost, are calculated using the effective interest method which allocates interest, and direct and incremental fees and costs, over the expected lives of the assets and liabilities.
The effective interest method requires the Group to estimate future cash flows, in some cases based on its experience of customers’ behaviour, considering all contractual terms of the financial instrument, as well as the expected lives of the assets and liabilities.
The Group incurs certain costs to originate credit card balances with the most significant being co-brand partner fees. To the extent these costs are attributed to customers that continuously carry an outstanding balance (revolvers) and incremental to the origination of credit card balances, they are capitalised and subsequently included within the calculation of the effective interest rate. They are amortised to interest income over the period of expected repayment of the originated balance. Costs attributed to customers that settle their outstanding balances each period (transactors) are deferred on the balance sheet as a cost of obtaining a contract and amortised to fee and commission expense over the life of the customer relationship (refer to Note 4). There are no other individual estimates involved in the calculation of effective interest rates that are material to the results or financial position.
20212020
2019
£m£m£m
Cash and balances at central banks184 275 1,091 
Loans and advances at amortised cost9,540 10,180 12,450 
Fair value through other comprehensive income550 776 1,032 
Negative interest on liabilities248 68 13 
Other 718 593 870 
Interest and similar income11,240 11,892 15,456 
Deposits at amortised cost(561)(1,030)(2,449)
Debt securities in issuea
(1,340)(1,360)(1,906)
Subordinated liabilities(507)(670)(1,068)
Negative interest on assets(374)(344)(278)
Other(385)(366)(348)
Interest and similar expense(3,167)(3,770)(6,049)
Net interest income8,073 8,122 9,407 
Note
a    Barclays has amended the presentation of the premium paid for purchased financial guarantees which are embedded in notes it issues directly to the market. From 2020 onwards, the full note coupon is presented as interest expense within net interest income. The financial guarantee element of the coupon had previously been recognised in net investment income. The comparatives of £25m in 2019 have not been restated.

Interest and similar income presented above represents interest revenue calculated using the effective interest method. Costs to originate credit card balances of £652m (2020: £698m; 2019: £697m) have been amortised to interest and similar income during the year. Interest and similar income includes £37m (2020: £40m; 2019: £48m) accrued on impaired loans. Other interest expense includes £64m (2020: £70m; 2019:£76m) relating to IFRS 16 lease interest expenses.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
230

Notes to the financial statements
For the year ended 31 December 2021 continued
4 Net fee and commission income
Accounting for net fee and commission income
The Group applies IFRS 15 Revenue from Contracts with Customers. IFRS 15 establishes a five-step model governing revenue recognition. The five-step model requires the Group to (i) identify the contract with the customer, (ii) identify each of the performance obligations included in the contract, (iii) determine the amount of consideration in the contract, (iv) allocate the consideration to each of the identified performance obligations and (v) recognise revenue as each performance obligation is satisfied.
The Group recognises fee and commission income charged for services provided by the Group as the services are provided, for example, on completion of the underlying transaction. Where the contractual arrangements also result in the Group recognising financial instruments in scope of IFRS 9, such financial instruments are initially recognised at fair value in accordance with IFRS 9 before applying the provisions of IFRS 15.
Fee and commission income is disaggregated below by fee types that reflect the nature of the services offered across the Group and operating segments, in accordance with IFRS 15. The below table includes a total for fees in scope of IFRS 15. Refer to Note 2 for more detailed information about operating segments.
2021
Barclays UKBarclays InternationalHead OfficeTotal
£m£m£m£m
Fee type
Transactional871 2,572  3,443 
Advisory172 1,096 1 1,269 
Brokerage and execution228 1,135  1,363 
Underwriting and syndication 3,425  3,425 
Other74 182 3 259 
Total revenue from contracts with customers1,345 8,410 4 9,759 
Other non-contract fee income 121  121 
Fee and commission income1,345 8,531 4 9,880 
Fee and commission expense(218)(1,983)(5)(2,206)
Net fee and commission income1,127 6,548 (1)7,674 

2020
Barclays UKBarclays InternationalHead OfficeTotal
£m£m£m£m
Fee type
Transactional810 2,353 — 3,163 
Advisory159 693 854 
Brokerage and execution212 1,173 — 1,385 
Underwriting and syndication— 2,867 — 2,867 
Other71 173 253 
Total revenue from contracts with customers1,252 7,259 11 8,522 
Other non-contract fee income— 119 — 119 
Fee and commission income1,252 7,378 11 8,641 
Fee and commission expense(308)(1,754)(8)(2,070)
Net fee and commission income944 5,624 6,571 

2019
Barclays UKBarclays InternationalHead OfficeTotal
£m£m£m£m
Fee type
Transactional1,074 2,809 — 3,883 
Advisory177 903 — 1,080 
Brokerage and execution208 1,131 — 1,339 
Underwriting and syndication— 2,358 — 2,358 
Other92 242 12 346 
Total revenue from contracts with customers1,551 7,443 12 9,006 
Other non-contract fee income— 116 — 116 
Fee and commission income1,551 7,559 12 9,122 
Fee and commission expense(365)(1,990)(7)(2,362)
Net fee and commission income1,186 5,569 6,760 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
231

Notes to the financial statements
For the year ended 31 December 2021 continued
Fee types
Transactional
Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees. These include interchange and merchant fee income generated from credit and bank card usage. Transaction and processing fees are recognised at the point in time the transaction occurs or service is performed. Interchange and merchant fees are recognised upon settlement of the card transaction payment.
The Group incurs certain card related costs including those related to cardholder reward programmes and payments to co-brand partners. Cardholder reward programmes costs related to customers that settle their outstanding balance each period (transactors) are expensed when incurred and presented in fee and commission expense while costs related to customers that continuously carry an outstanding balance (revolvers) are included in the effective interest rate of the receivable (refer to Note 3). Payments to partners for new cardholder account originations related to transactor accounts are deferred as costs to obtain a contract under IFRS 15, while costs related to revolver accounts are included in the effective interest rate of the receivable (refer to Note 3). Those costs deferred under IFRS 15 are capitalised and amortised over the estimated life of the customer relationship. Payments to co-brand partners based on revenue sharing are presented as a reduction of fee and commission income while payments based on profitability are presented in fee and commission expense.
Advisory
Advisory fees are generated from wealth management services and investment banking advisory services related to mergers, acquisitions and financial restructurings. Wealth management advisory fees are earned over the period the services are provided and are generally recognised quarterly when the market value of client assets is determined. Investment banking advisory fees are recognised at the point in time when the services related to the transaction have been completed under the terms of the engagement. Investment banking advisory costs are recognised as incurred in fee and commission expense if direct and incremental to the advisory services or are otherwise recognised in operating expenses.
Brokerage and execution
Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter markets and assisting clients in clearing transactions. Brokerage and execution fees are recognised at the point in time the associated service has been completed which is generally the trade date of the transaction.
Underwriting and syndication
Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and administration of a loan syndication. This includes commitment fees to provide loan financing. Underwriting fees are generally recognised on trade date if there is no remaining contingency, such as the transaction being conditional on the closing of an acquisition or another transaction. Underwriting costs are deferred and recognised in fee and commission expense when the associated underwriting fees are recorded. Syndication fees are earned for arranging and administering a loan syndication; however, the associated fee may be subject to variability until the loan has been syndicated to other syndicate members or until other contingencies have been resolved and therefore the fee revenue is deferred until the uncertainty is resolved.
Included in the underwriting and syndication fees are loan commitment fees which are not presented as part of the carrying value of the loan in accordance with IFRS 9. Such commitment fees are recognised over time through to the contractual maturity of the commitment.
Contract assets and contract liabilities
The Group had no material contract assets or contract liabilities as at 31 December 2021 (2020: £nil; 2019: £nil).
Impairment of fee receivables and contract assets
During 2021, there have been no material impairments recognised in relation to fees receivable and contract assets (2020: £nil; 2019: £nil). Fees in relation to transactional business can be added to outstanding customer balances. These amounts may be subsequently impaired as part of the overall loans and advances balance.
Remaining performance obligations
The Group applies the practical expedient of IFRS 15 and does not disclose information about remaining performance obligations that have original expected durations of one year or less or because the Group has a right to consideration that corresponds directly with the value of the service provided to the client or customer.
Costs incurred in obtaining or fulfilling a contract
The Group expects that incremental costs of obtaining a contract such as success fee and commission fees paid are recoverable and therefore capitalised such contract costs. Capitalised contract costs net of amortisation as at 31 December 2021 is £154m (2020: £141m; 2019: £159m).
Capitalised contract costs are amortised based on the transfer of services to which the asset relates which typically ranges over the expected life of the relationship. In 2021, the amount of amortisation was £36m (2020: £36m; 2019: £30m) and there was no impairment loss recognised in connection with the capitalised contract costs (2020: £nil; 2019: £nil).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
232

Notes to the financial statements
For the year ended 31 December 2021 continued
5 Net trading income
Accounting for net trading income
In accordance with IFRS 9, trading positions are held at fair value, and the resulting gains and losses are included in the income statement, together with interest and dividends arising from long and short positions and funding costs relating to trading activities.
Income arises from both the sale and purchase of trading positions, margins which are achieved through market making and customer business and from changes in fair value caused by movements in interest and exchange rates, equity prices and other market variables.
Gains or losses on non-trading financial instruments designated or mandatorily at fair value with changes in fair value recognised in the income statement are included in net trading income where the business model is to manage assets and liabilities on a fair value basis which includes use of derivatives or where an instrument is designated at fair value to eliminate an accounting mismatch and the related instrument's gain and losses are reported in trading income.
202120202019
£m£m£m
Net gains on financial instruments held for trading3,992 5,342 2,941 
Net gains on financial instruments designated at fair value692 700 256 
Net gains on financial instruments mandatorily at fair value1,110 987 1,038 
Net trading income5,794 7,029 4,235 

6 Net investment income
Accounting for net investment income
Dividends are recognised when the right to receive the dividend has been established. Other accounting policies relating to net investment income are set out in Note 13 and Note 15.
202120202019
£m£m£m
Net gains/(losses) from financial instruments mandatorily at fair value 73 (50)510 
Net gains from disposal of debt instruments at fair value through other comprehensive income305 295 502 
Net gains/(losses) from disposal of financial assets and liabilities measured at amortised costa
114 (61)257 
Dividend income20 37 76 
Net (losses)/gains on other investmentsb
(201)(208)(214)
Net investment income311 13 1,131 
Notes
a    Included within the 2021 balance are gains of £83m relating to the sale of loans and advances at amortised cost. Included within the 2020 balance are losses of £115m relating to partial redemption of contingent capital notes.
b    Barclays has amended the presentation of the premium paid for purchased financial guarantees which are embedded in notes it issues directly to the market. From 2020 onwards, the full note coupon is presented as interest expense within net interest income. The financial guarantee element of the coupon had previously been recognised in net investment income. The comparative of £25m in 2019 has not been restated.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
233

Notes to the financial statements
For the year ended 31 December 2021 continued
7 Credit impairment charge/(release)
Accounting for the impairment of financial assets
Impairment
In accordance with IFRS 9, the Group is required to recognise expected credit losses (ECLs) based on unbiased forward-looking information for all financial assets at amortised cost, lease receivables, debt financial assets at fair value through other comprehensive income, loan commitments and financial guarantee contracts.
At the reporting date, an allowance (or provision for loan commitments and financial guarantees) is required for the 12 month (Stage 1) ECLs. If the credit risk has significantly increased since initial recognition (Stage 2), or if the financial instrument is credit impaired (Stage 3), an allowance (or provision) should be recognised for the lifetime ECLs.
The measurement of ECL is calculated using three main components: (i) probability of default (PD) (ii) loss given default (LGD) and (iii) the exposure at default (EAD).
The 12 month and lifetime ECLs are calculated by multiplying the respective PD, LGD and the EAD. The 12 month and lifetime PDs represent the PD occurring over the next 12 months and the remaining maturity of the instrument respectively. The EAD represents the expected balance at default, taking into account the repayment of principal and interest from the balance sheet date to the default event together with any expected drawdowns of committed facilities. The LGD represents expected losses on the EAD given the event of default, taking into account, among other attributes, the mitigating effect of collateral value at the time it is expected to be realised and the time value of money.
Determining a significant increase in credit risk since initial recognition:
The Group assesses when a significant increase in credit risk has occurred based on quantitative and qualitative assessments. The credit risk of an exposure is considered to have significantly increased when:
i) Quantitative test
The annualised lifetime PD has increased by more than an agreed threshold relative to the equivalent at origination.
PD deterioration thresholds are defined as percentage increases, and are set at an origination score band and segment level to ensure the test appropriately captures significant increases in credit risk at all risk levels. Generally, thresholds are inversely correlated to the origination PD, i.e. as the origination PD increases, the threshold value reduces.
The assessment of the point at which a PD increase is deemed ‘significant’, is based upon analysis of the portfolio’s risk profile against a common set of principles and performance metrics (consistent across both retail and wholesale businesses), incorporating expert credit judgement where appropriate. Application of quantitative PD floors does not represent the use of the low credit risk exemption as exposures can separately move into Stage 2 via the qualitative route described below.
Wholesale assets apply a 100% increase in PD and 0.2% PD floor to determine a significant increase in credit risk.
Retail assets apply bespoke relative increase and absolute PD thresholds based on product type and origination PD. Thresholds are subject to maximums defined by Group policy and typically apply minimum relative thresholds of 50-100% and a maximum relative threshold of 400%.
For existing/historical exposures where origination point scores or data are no longer available or do not represent a comparable estimate of lifetime PD, a proxy origination score is defined, based upon:
back-population of the approved lifetime PD score either to origination date or, where this is not feasible, as far back as possible (subject to a data start point no later than 1 January 2015); or
use of available historical account performance data and other customer information, to derive a comparable ‘proxy’ estimation of origination PD.
ii) Qualitative test
This is relevant for accounts that meet the portfolio’s ‘high risk’ criteria and are subject to closer credit monitoring.
High risk customers may not be in arrears but either through an event or an observed behaviour exhibit credit distress. The definition and assessment of high risk includes as wide a range of information as reasonably available, such as industry and Group-wide customer level data, including but not limited to bureau scores and high consumer indebtedness index, wherever possible or relevant.
Whilst the high risk populations applied for IFRS 9 impairment purposes are aligned with risk management processes, they are also regularly reviewed and validated to ensure that they capture any incremental segments where there is evidence of credit deterioration.
iii) Backstop criteria
This is relevant for accounts that are more than 30 calendar days past due. The 30 days past due criteria is a backstop rather than a primary driver of moving exposures into Stage 2.
The criteria for determining a significant increase in credit risk for assets with bullet repayments follows the same principle as all other assets, i.e. quantitative, qualitative and backstop tests are all applied.
Exposures will move back to Stage 1 once they no longer meet the criteria for a significant increase in credit risk. This means that, at a minimum all payments must be up-to-date, the PD deterioration test is no longer met, the account is no longer classified as high risk, and the customer has evidenced an ability to maintain future payments.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
234

Notes to the financial statements
For the year ended 31 December 2021 continued
Exposures are only removed from Stage 3 and re-assigned to Stage 2 once the original default trigger event no longer applies. Exposures being removed from Stage 3 must no longer qualify as credit impaired, and:
a)the obligor will also have demonstrated consistently good payment behaviour over a 12-month period, by making all consecutive contractual payments due and, for forborne exposures, the relevant EBA defined probationary period has also been successfully completed or;
b)(for non-forborne exposures) the performance conditions are defined and approved within an appropriately sanctioned restructure plan, including 12 months’ payment history have been met.
Management overlays and other exceptions to model outputs are applied only if consistent with the objective of identifying significant increases in credit risk.
Forward-looking information
The measurement of ECL involves complexity and judgement, including estimation of PD, LGD, a range of unbiased future economic scenarios, estimation of expected lives (where contractual life is not appropriate), and estimation of EAD and assessing significant increases in credit risk.
Credit losses are the expected cash shortfalls from what is contractually due over the expected life of the financial instrument, discounted at the original effective interest rate (EIR). ECLs are the unbiased probability-weighted credit losses determined by evaluating a range of possible outcomes and considering future economic conditions.
The Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices), which forms the baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated to a similar severity to internal stress tests, whilst also considering IFRS 9 specific sensitivities and non-linearity. Downside 2 is benchmarked to the Bank of England’s annual cyclical scenarios and to the most severe scenario from Moody’s inventory, but is not designed to be the same. The favourable scenarios are calibrated to be symmetric to the adverse scenarios, subject to a ceiling calibrated to relevant recent favourable benchmark scenarios. The scenarios include eight economic variables (GDP, unemployment, House Price Index (HPI) and base rates in both the UK and US markets) and expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed to evolve over a five-year stress horizon, with all five scenarios converging to a steady state after approximately eight years.
The methodology for estimating probability weights for each of the scenarios involves a comparison of the distribution of key historical UK and US macroeconomic variables against the forecast paths of the five scenarios. The methodology works such that the baseline (reflecting current consensus outlook) has the highest weight and the weights of adverse and favourable scenarios depend on the deviation from the baseline; the further from the baseline, the smaller the weight. A single set of five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The same scenarios and weights that are used in the estimation of expected credit losses are also used for the Group internal planning purposes. The impacts across the portfolios are different because of the sensitivities of each of the portfolios to specific macroeconomic variables, for example, mortgages are highly sensitive to house prices, and credit cards and unsecured consumer loans are highly sensitive to unemployment.
Definition of default, credit impaired assets, write-offs, and interest income recognition
The definition of default for the purpose of determining ECLs, and for internal credit risk management purposes, has been aligned to the Regulatory Capital CRR Article 178 definition of default, to maintain a consistent approach with IFRS 9 and associated regulatory guidance. The Regulatory Capital CRR Article 178 definition of default considers indicators that the debtor is unlikely to pay, includes exposures in forbearance and is no later than when the exposure is more than 90 days past due or 180 days past due in the case of UK mortgages. When exposures are identified as credit impaired at the time when they are purchased or originated interest income is calculated on the carrying value net of the impairment allowance.
An asset is considered credit impaired when one or more events occur that have a detrimental impact on the estimated future cash flows of the financial asset. This comprises assets defined as defaulted and other individually assessed exposures where imminent default or actual loss is identified.
Uncollectable loans are written off against the related allowance for loan impairment on completion of the Group’s internal processes and when all reasonably expected recoverable amounts have been collected. Subsequent recoveries of amounts previously written off are credited to the income statement. The timing and extent of write-offs may involve some element of subjective judgement. Nevertheless, a write-off will often be prompted by a specific event, such as the inception of insolvency proceedings or other formal recovery action, which makes it possible to establish that some or the entire advance is beyond realistic prospect of recovery.
Accounting for purchased financial guarantee contracts
The Group may enter into a financial guarantee contract which requires the issuer of such contract to reimburse the Group for a loss it incurs because a specified debtor fails to make payment when due in accordance with the terms of a debt instrument. For these separate financial guarantee contracts, the Group recognises a reimbursement asset aligned with the recognition of the underlying ECLs, if it is considered virtually certain that a reimbursement would be received if the specified debtor fails to make payment when due in accordance with the terms of the debt instrument.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
235

Notes to the financial statements
For the year ended 31 December 2021 continued
Loan modifications and renegotiations that are not credit-impaired
When modification of a loan agreement occurs as a result of commercial restructuring activity rather than due to the credit risk of the borrower, an assessment must be performed to determine whether the terms of the new agreement are substantially different from the terms of the existing agreement. This assessment considers both the change in cash flows arising from the modified terms as well as the change in overall instrument risk profile. In respect of payment holidays granted to borrowers which are not due to forbearance, if the revised cash flows on a present value basis (based on the original EIR) are not substantially different from the original cash flows, the loan is not considered to be substantially modified. 
Where terms are substantially different, the existing loan will be derecognised and a new loan will be recognised at fair value, with any difference in valuation recognised immediately within the income statement, subject to observability criteria.
Where terms are not substantially different, the loan carrying value will be adjusted to reflect the present value of modified cash flows discounted at the original EIR, with any resulting gain or loss recognised immediately within the income statement as a modification gain or loss.
Note 1 sets out details for changes in the basis of determining the contractual cash flows of a financial instrument that are required by interest rate benchmark reform.
Expected life
Lifetime ECLs must be measured over the expected life. This is restricted to the maximum contractual life and takes into account expected prepayment, extension, call and similar options. The exceptions are certain revolving financial instruments, such as credit cards and bank overdrafts, that include both a drawn and an undrawn component where the entity’s contractual ability to demand repayment and cancel the undrawn commitment does not limit the entity’s exposure to credit losses to the contractual notice period. For revolving facilities, expected life is analytically derived to reflect the behavioural life of the asset, i.e. the full period over which the business expects to be exposed to credit risk. Behavioural life is typically based upon historical analysis of the average time to default, closure or withdrawal of facility. Where data is insufficient or analysis inconclusive, an additional ‘maturity factor’ may be incorporated to reflect the full estimated life of the exposures, based upon experienced judgement and/or peer analysis. Potential future modifications of contracts are not taken into account when determining the expected life or EAD until they occur.
Discounting
ECLs are discounted at the EIR at initial recognition or an approximation thereof and consistent with income recognition. For loan commitments the EIR is the rate that is expected to apply when the loan is drawn down and a financial asset is recognised. Issued financial guarantee contracts are discounted at the risk free rate. Lease receivables are discounted at the rate implicit in the lease. For variable/floating rate financial assets, the spot rate at the reporting date is used and projections of changes in the variable rate over the expected life are not made to estimate future interest cash flows or for discounting.
Modelling techniques
The regulatory Basel Committee of Banking Supervisors (BCBS) ECL calculations are leveraged for IFRS 9 modelling but adjusted for key differences which include:
BCBS requires 12 month through the economic cycle losses whereas IFRS 9 requires 12 months or lifetime point in time losses based on conditions at the reporting date and multiple forecasts of the future economic conditions over the expected lives;
IFRS 9 models do not include certain conservative BCBS model floors and downturn assessments and require discounting to the reporting date at the original EIR rather than using the cost of capital to the date of default;
Management adjustments are made to modelled output to account for situations where known or expected risk factors and information have not been considered in the modelling process, for example forecast economic scenarios for uncertain political events; and
ECL is measured at the individual financial instrument level, however a collective approach where financial instruments with similar risk characteristics are grouped together, with apportionment to individual financial instruments, is used where effects can only be seen at a collective level, for example for forward-looking information.
For the IFRS 9 impairment assessment, the Group’s risk models are used to determine the PD, LGD and EAD. For Stage 2 and 3, the Group applies lifetime PDs but uses 12 month PDs for Stage 1. The ECL drivers of PD, EAD and LGD are modelled at an account level which considers vintage, among other credit factors. Also, the assessment of significant increase in credit risk is based on the initial lifetime PD curve, which accounts for the different credit risk underwritten over time.
Forbearance
A financial asset is subject to forbearance when it is modified due to the credit distress of the borrower. A modification made to the terms of an asset due to forbearance will typically be assessed as a non-substantial modification that does not result in derecognition of the original loan, except in circumstances where debt is exchanged for equity.
Both performing and non-performing forbearance assets are classified as Stage 3 except where it is established that the concession granted has not resulted in diminished financial obligation and that no other regulatory definition of default criteria have been triggered, in which case the asset is classified as Stage 2. The minimum probationary period for non-performing forbearance is 12 months and for performing forbearance, 24 months. Hence, a minimum of 36 months is required for non-performing forbearance to move out of a forborne state.
No financial instrument in forbearance can transfer back to Stage 1 until all of the Stage 2thresholds are no longer met and can only move out of Stage 3 when no longer credit impaired.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
236

Notes to the financial statements
For the year ended 31 December 2021 continued
Critical accounting estimates and judgements
IFRS 9 impairment involves several important areas of judgement, including estimating forward looking modelled parameters (PD, LGD and EAD), developing a range of unbiased future economic scenarios, estimating expected lives and assessing significant increases in credit risk, based on the Group’s experience of managing credit risk. The determination of expected life is most material for Barclays credit card portfolios which is obtained via behavioural life analysis to materially capture the risk of these facilities.
Within the retail and small businesses portfolios, which comprise large numbers of small homogenous assets with similar risk characteristics where credit scoring techniques are generally used, the impairment allowance is calculated using forward looking modelled parameters which are typically run at account level. There are many models in use, each tailored to a product, line of business or customer category. Judgement and knowledge is needed in selecting the statistical methods to use when the models are developed or revised. Management adjustments to impairment models, which contain an element of subjectivity, are applied in order to factor in certain conditions or changes in policy that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end. Management adjustments are reviewed and incorporated into future model development where appropriate. The impairment release reflected in the income statement for retail portfolios is £289m (2020: £3,116m charge; 2019: £1,696m charge) of the total impairment release on loans and advances and off balance sheet loan commitments and financial guarantee contracts.
For individually significant assets in Stage 3, impairment allowances are calculated on an individual basis and all relevant considerations that have a bearing on the expected future cash flows across a range of economic scenarios are taken into account. These considerations can be particularly subjective and can include the business prospects for the customer, the realisable value of collateral, the Group’s position relative to other claimants, the reliability of customer information and the likely cost and duration of the work-out process. The level of the impairment allowance is the difference between the value of the discounted expected future cash flows (discounted at the loan’s original effective interest rate), and its carrying amount. Furthermore, judgements change with time as new information becomes available or as work-out strategies evolve, resulting in frequent revisions to the impairment allowance as individual decisions are taken. Changes in these estimates would result in a change in the allowances and have a direct impact on the impairment charge. The impairment release reflected in the financial statements in relation to wholesale portfolios is £346m (2020: £1,569m charge; 2019: £208m release) of the total impairment release on loans and advances and off balance sheet loan commitments and financial guarantee contracts.
Further information on impairment allowances, impairment charges, management adjustments to models for impairment, measurement uncertainty, sensitivity analysis and related credit information is set out within the Credit risk performance section.
Temporary adjustments to calculated IFRS9 impairment allowances may be applied in limited circumstances to account for situations where known or expected risk factors or information have not been considered in the ECL assessment or modelling process. For further information please see page 135 in the credit risk performance section.
202120202019
Impairment charges
Recoveries and reimburse-mentsa
TotalImpairment charges
Recoveries and reimburse-mentsa
TotalImpairment charges
Recoveries and reimburse-mentsa
Total
£m£m£m£m£m£m£m£m£m
Loans and advances(361)240 (121)4,308 (399)3,909 1,957 (124)1,833 
Provision for undrawn contractually committed facilities and guarantees provided(514) (514)776 — 776 71 — 71 
Loans impairment(875)240 (635)5,084 (399)4,685 2,028 (124)1,904 
Cash collateral and settlement balances(4) (4)— — 
Financial assets at fair value through other comprehensive income(8) (8)— — 
Other financial assets measured at cost(6) (6)149 — 149 — 
Credit impairment (releases)/charges(893)240 (653)5,237 (399)4,838 2,036 (124)1,912 
Note
a    Recoveries and reimbursements includes a net reduction in amounts recoverable from financial guarantee contracts held with third parties of £306m (2020 gain: £364m) and cash recoveries of previously written off amounts of £66m (2020: £35m) .

Write-offs that can be subjected to enforcement activity
The contractual amount outstanding on financial assets that were written off during the year and that can still be subjected to enforcement activity is £1,190m (2020: £1,246m). This is lower than the write-offs presented in the movement in gross exposures and impairment allowance table due to assets sold during the year post write-offs and post write-off recoveries.
Modification of financial assets
Financial assets with a loss allowance measured at an amount equal to lifetime ECL of £3,446m (2020: £4,275m) were subject to non-substantial modification during the year, with a resulting loss of £11m (2020: £34m). The gross carrying amount of financial assets subject to non-substantial modification for which the loss allowance has changed to a 12 month ECL during the year amounts to £419m (2020: £1,194m).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
237

Notes to the financial statements
For the year ended 31 December 2021 continued
8 Operating expenses
202120202019
£m£m£m
Infrastructure costs
Property and equipment1,506 1,556 1,409 
Depreciation and amortisation1,673 1,539 1,487 
Lease payments32 34 41 
Impairment of property, equipment and intangible assets403 194 33 
Total infrastructure costs3,614 3,323 2,970 
Administration and general expenses
Consultancy, legal and professional fees610 567 590 
Marketing and advertising399 330 425 
UK bank levy170 299 226 
Other administration and general expenses958 1,117 1,059 
Total administration and general expenses2,137 2,313 2,300 
Staff costs8,511 8,097 8,315 
Provisions for litigation and conduct177 153 1,849 
Operating expensesa
14,439 13,886 15,434 
Note
a    Operating expenses includes £648m relating to structural cost actions of which £266m pertains to impairment of property taken as part of real estate review.

For further details on staff costs including accounting policies, refer to Note 31.
9 Tax
Accounting for income taxes
The Group applies IAS 12 Income Taxes in accounting for taxes on income. Income tax payable on taxable profits (current tax) is recognised as an expense in the periods in which the profits arise. Withholding taxes are also treated as income taxes. Income tax recoverable on tax allowable losses is recognised as a current tax asset only to the extent that it is regarded as recoverable by offsetting against taxable profits arising in the current or prior periods. Current tax is measured using tax rates and tax laws that have been enacted or substantively enacted at the balance sheet date.
Deferred tax assets are recognised to the extent that it is probable that taxable profit will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses can be utilised. Deferred tax liabilities are recognised for all taxable temporary differences except from the initial recognition of goodwill. Deferred tax is not recognised where the temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss. Deferred tax is determined using tax rates and legislation enacted or substantively enacted by the balance sheet date which are expected to apply when the deferred tax asset is realised or the deferred tax liability is settled. Deferred tax assets and liabilities are only offset when there is both a legal right to set-off and an intention to settle on a net basis.
The Group considers an uncertain tax position to exist when it considers that ultimately, in the future, the amount of profit subject to tax may be greater than the amount initially reflected in the Group’s tax returns. The Group accounts for provisions in respect of uncertain tax positions in two different ways.
A current tax provision is recognised when it is considered probable that the outcome of a review by a tax authority of an uncertain tax position will alter the amount of cash tax due to, or from, a tax authority in the future. From recognition, the current tax provision is then measured at the amount the Group ultimately expects to pay the tax authority to resolve the position. The accrual of interest and penalty amounts in respect of uncertain income tax positions is recognised as an expense within profit before tax.
Deferred tax provisions are adjustments made to the carrying value of deferred tax assets in respect of uncertain tax positions. A deferred tax provision is recognised when it is considered probable that the outcome of a review by a tax authority of an uncertain tax position will result in a reduction in the carrying value of the deferred tax asset. From recognition of a provision, measurement of the underlying deferred tax asset is adjusted to take into account the expected impact of resolving the uncertain tax position on the loss or temporary difference giving rise to the deferred tax asset.
The approach taken to measurement takes account of whether the uncertain tax position is a discrete position that will be reviewed by the tax authority in isolation from any other position, or one of a number of issues which are expected to be reviewed together concurrently and resolved simultaneously with a tax authority. The Group’s measurement of provisions is based upon its best estimate of the additional profit that will become subject to tax. For a discrete position, consideration is given only to the merits of that position. Where a number of issues are expected to be reviewed and resolved together, the Group will take into account not only the merits of its position in respect of each particular issue but also the overall level of provision relative to the aggregate of the uncertain tax positions across all the issues that are expected to be resolved at the same time. In addition, in assessing provision levels, it is assumed that tax authorities will review uncertain tax positions and that all facts will be fully and transparently disclosed.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
238

Notes to the financial statements
For the year ended 31 December 2021 continued
Critical accounting estimates and judgements
There are two key areas of judgement that impact the reported tax position. Firstly, the level of provisioning for uncertain tax positions; and secondly, the recognition and measurement of deferred tax assets.
The Group does not consider there to be a significant risk of a material adjustment to the carrying amount of current and deferred tax balances, including provisions for uncertain tax positions in the next financial year.  The provisions for uncertain tax positions cover a diverse range of issues and reflect advice from external counsel where relevant.  It should be noted that only a proportion of the total uncertain tax positions will be under audit at any point in time, and could therefore be subject to challenge by a tax authority over the next year.
Deferred tax assets have been recognised based on business profit forecasts. Details on the recognition of deferred tax assets are provided in this note.
202120202019
£m£m£m
Current tax charge/(credit)
Current year1,467 1,255 1,037 
Adjustments in respect of prior years317 31 (45)
1,784 1,286 992 
Deferred tax (credit)/charge
Current year(352)(830)86 
Adjustments in respect of prior years(244)148 (75)
(596)(682)11 
Tax charge1,188 604 1,003 
The table below shows the reconciliation between the actual tax charge and the tax charge that would result from applying the standard UK corporation tax rate to the Group’s profit before tax.
202120212020202020192019
£m%£m%£m%
Profit before tax8,414 3,065 4,357 
Tax charge based on the standard UK corporation tax rate of 19% (2020: 19%; 2019: 19% )
1,599 19.0 %582 19.0 %828 19.0 %
Impact of profits/losses earned in territories with different statutory rates to the UK (weighted average tax rate is 22.4% (2020: 25.1%; 2019: 24.2% ))
285 3.4 %188 6.1 %227 5.2 %
Recurring items:
Non-creditable taxes including withholding taxes134 1.6 %109 3.5 %150 3.4 %
Banking surcharge and other items83 1.0 %0.2 %57 1.3 %
Non-deductible expenses80 1.0 %48 1.6 %45 1.0 %
Adjustments in respect of prior years73 0.9 %179 5.8 %(120)(2.7 %)
Impact of UK bank levy being non-deductible32 0.4 %57 1.9 %43 1.0 %
Impact of Barclays Bank PLC's overseas branches being taxed both locally and in the UK25 0.3 %25 0.8 %15 0.3 %
Tax adjustments in respect of share-based payments(5)(0.1 %)26 0.8 %(6)(0.1 %)
Changes in recognition of deferred tax and effect of unrecognised tax losses(140)(1.7 %)(123)(4.0 %)(82)(1.9 %)
Tax relief on payments made under AT1 instruments(149)(1.8 %)(165)(5.4 %)(157)(3.6 %)
Non-taxable gains and income(367)(4.4 %)(208)(6.8 %)(260)(6.0 %)
Non-recurring items:
Remeasurement of UK deferred tax assets due to tax rate changes(462)(5.5 %)(118)(3.8 %)— — 
Non-deductible provisions for UK customer redress  (7)(0.2 %)263 6.1 %
Non-deductible provisions for investigations and litigation  0.2 %— — 
Total tax charge1,188 14.1 %604 19.7 %1,003 23.0 %
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
239

Notes to the financial statements
For the year ended 31 December 2021 continued
Factors driving the effective tax rate
The effective tax rate of 14.1% is lower than the UK corporation tax rate of 19% primarily due to adjustments for the remeasurement of UK deferred tax assets as a result of the enactment in 2021 of an increase in the UK corporation tax rate to 25% from 1 April 2023, the impact of non-taxable gains and income, tax relief on payments made under AT1 instruments and the use of unrecognised tax losses in the period. These factors, which have each decreased the effective tax rate, are partially offset by profits earned outside the UK being taxed at local statutory tax rates that are higher than the UK tax rate and non-creditable taxes.
The Group’s future tax charge will be sensitive to the geographic mix of profits earned, the tax rates in force and changes to the tax rules in the jurisdictions that the Group operates in. In its Budget held in October 2021, the UK Government announced that the banking surcharge rate will be reduced from 8% to 3% from 1 April 2023. This reduction in the banking surcharge rate was substantively enacted on 2 February 2022 and is a non-adjusting post balance sheet event. If the reduction in the banking surcharge rate had been substantively enacted at the balance sheet date then this would have resulted in the Group’s UK deferred tax assets being remeasured and decreasing with a tax charge in the income statement of £346m and tax credit within other comprehensive income of £87m.
In October 2021, the OECD and G20 Inclusive Framework on Base Erosion and Profit Shifting announced plans to introduce a global minimum tax rate of 15% from 2023. The model rules, which set out the scope of and the mechanism for calculating the global minimum tax, were released by the OECD on 20 December 2021. The Group is reviewing the model rules and awaiting the OECD’s anticipated publication of further guidance, as well as new legislation expected to be released by governments implementing this new tax regime, and will assess the potential impact of new legislation during 2022.
In the USA, a proposed Build Back Better Act has been passed by the House of Representatives but has not been passed by the Senate and at this time it is uncertain whether the Act will progress further. The proposed Act passed by the House of Representatives included proposals to implement material changes to international tax provisions, including amendments to the Base Erosion and Anti-Abuse Tax and the imposition of an alternative minimum tax based on accounting profits. It is unclear at this time whether any of these proposals could have a significant impact on the Group if enacted. The Group will continue to monitor developments and assess the potential impact of any future legislative changes ultimately enacted.
Tax in the consolidated statement of comprehensive income
The tax relating to each component of other comprehensive income can be found in the consolidated statement of comprehensive income which includes within Other a tax credit of £nil (2020: £5m). The total amount recognised in relation to the remeasurement of UK deferred tax through other comprehensive income was a £111m charge (2020: £52m).
Tax included directly in equity
Tax included directly in equity comprises a £58m credit (2020: £18m) relating to share-based payments and deductible costs on issuing other equity instruments.
Deferred tax assets and liabilities
The deferred tax amounts on the balance sheet were as follows:
20212020
£m£m
UK Tax Group2,183 886 
US Intermediate Holding Company Tax Group ('IHC Tax Group')1,004 1,001 
US Branch Tax Group1,002 1,048 
Other (outside the UK and US tax groups)430 509 
Deferred tax asset4,619 3,444 
Deferred tax liability(37)(15)
Net deferred tax4,582 3,429 
US deferred tax assets in the IHC and US Branch Tax Groups
The deferred tax asset in the IHC Tax Group of £1,004m (2020: £1,001m) includes £1m (2020: £nil) relating to tax losses, with the balance relating to temporary differences. The deferred tax asset in Barclays Bank PLC’s US Branch Tax Group of £1,002m (2020: £1,048m) relates entirely to temporary differences.
In relation to the IHC Tax Group, these temporary differences include £301m (2020: £330m) arising from New York State and City prior net operating loss conversion which can be carried forward and will expire in 2034. Business profit forecasts indicate these amounts will be fully recovered before expiry.
UK Tax Group deferred tax asset
The deferred tax asset in the UK Tax Group of £2,183m (2020: £886m) includes £1,098m (2020: £565m) relating to tax losses, with the balance relating to temporary differences. There is no time limit on utilisation of UK tax losses and business profit forecasts indicate that these losses will be fully recovered.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
240

Notes to the financial statements
For the year ended 31 December 2021 continued
Other deferred tax assets (outside the UK and US tax groups)
The deferred tax asset of £430m (2020: £509m) in other entities within the Group includes £121m (2020: £170m) relating to tax losses. These deferred tax assets relate to a number of different territories and their recognition is based on profit forecasts or local country law which indicate that it is probable that those deferred tax assets will be fully recovered.
Of the deferred tax asset of £430m (2020: £509m), an amount of £9m (2020: £8m) relates to entities which have suffered a loss in either the current or prior year and for which the utilisation of the deferred tax is dependent on future taxable profits. This has been taken into account in reaching the above conclusion that these deferred tax assets will be fully recovered in the future.
The table below shows movements on deferred tax assets and liabilities during the year. The amounts are different from those disclosed on the balance sheet and in the preceding table as they are presented before offsetting asset and liability balances where there is a legal right to set-off and an intention to settle on a net basis.
Fixed asset timing differencesFair value through other comprehensive incomeCash flow hedgesRetirement benefit obligationsLoan impairment allowanceOther provisionsShare-based payments and deferred compensationOther temporary differencesTax losses carried forwardTotal
£m£m£m£m£m£m£m£m£m£m
Assets1,465   43 666 143 363 1,564 735 4,979 
Liabilities(41)(38)(566)(826)   (79) (1,550)
As at 1 January 20211,424 (38)(566)(783)666 143 363 1,485 735 3,429 
Income statement184 (6) 5 39 7 12 (130)485 596 
Other comprehensive income and reserves 198 1,088 (855)  36 97  564 
Other movements(3)1 (1)(1)(12) 3 6  (7)
1,605 155 521 (1,634)693 150 414 1,458 1,220 4,582 
Assets1,647 155 521 40 693 150 414 1,524 1,220 6,364 
Liabilities(42)  (1,674)   (66) (1,782)
As at 31 December 20211,605 155 521 (1,634)693 150 414 1,458 1,220 4,582 
Assets1,338 119 — 38 501 128 344 1,458 523 4,449 
Liabilities(31)(18)(181)(640)— — — (312)— (1,182)
As at 1 January 20201,307 101 (181)(602)501 128 344 1,146 523 3,267 
Income statement129 — — 156 22 20 134 215 682 
Other comprehensive income and reserves— (137)(377)(191)— — 238 — (462)
Other movements(12)(2)(8)(7)(6)(33)(3)(58)
1,424 (38)(566)(783)666 143 363 1,485 735 3,429 
Assets1,465 — — 43 666 143 363 1,564 735 4,979 
Liabilities(41)(38)(566)(826)— — — (79)— (1,550)
As at 31 December 20201,424 (38)(566)(783)666 143 363 1,485 735 3,429 
Other movements include the impact of changes in foreign exchange rates as well as deferred tax amounts relating to acquisitions and disposals.
The amount of deferred tax assets expected to be recovered after more than 12 months is £5,886m (2020: £4,544m). The amount of deferred tax liability expected to be settled after more than 12 months is £1,778m (2020: £1,510m). These amounts are before offsetting asset and liability balances where there is a legal right to set-off and an intention to settle on a net basis.
Unrecognised deferred tax
Tax losses and temporary differences
Deferred tax assets have not been recognised in respect of gross deductible temporary differences of £110m (2020: £125m), unused tax credits of £283m (2020: £236m), and gross tax losses of £22,835m (2020: £20,913m). The tax losses include capital losses of £3,981m (2020: £3,947m). Of these tax losses, £63m (2020: £139m) expire within five years, £370m (2020: £236m) expire within six to ten years, £10,529m (2020: £7,271m) expire within 11 to 20 years and £11,873m (2020: £13,267m) can be carried forward indefinitely. Deferred tax assets have not been recognised in respect of these items because it is not probable that future taxable profits and gains will be available against which they can be utilised.
Group investments in subsidiaries, branches and associates
Deferred tax is not recognised in respect of the value of the Group's investments in subsidiaries, branches and associates where the Group is able to control the timing of the reversal of the temporary differences and it is probable that such differences will not reverse in the foreseeable future. The aggregate amount of these temporary differences for which deferred tax liabilities have not been recognised was £0.9bn (2020: £0.8bn).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
241

Notes to the financial statements
For the year ended 31 December 2021 continued
10 Earnings per share
202120202019
£m£m£m
Profit attributable to ordinary equity holders of the parent6,375 1,526 2,461 

202120202019
millionmillionmillion
Basic weighted average number of shares in issue16,985 17,300 17,200 
Number of potential ordinary shares435 368 282 
Diluted weighted average number of shares17,420 17,668 17,482 

Basic earnings per shareDiluted earnings per share
202120202019202120202019
 p  p  p  p  p  p
Earnings per ordinary share37.5 8.8 14.3 36.6 8.6 14.1 
The calculation of basic earnings per share is based on the profit attributable to equity holders of the parent and the basic weighted average number of shares excluding treasury shares held in employee benefit trusts or held for trading. When calculating the diluted earnings per share, the weighted average number of shares in issue is adjusted for the effects of all expected dilutive potential ordinary shares held in respect of Barclays PLC, totaling 435m (2020: 368m) shares. The total number of share options outstanding, under schemes considered to be potentially dilutive, was 688m (2020: 719m). These options have strike prices ranging from £0.84 to £1.66.
Of the total number of employee share options and share awards at 31 December 2021, 5m (2020: 69m) were anti-dilutive.
The 315m decrease (2020: 100m increase) in the basic weighted average number of shares is primarily due to the impact of the share buyback programmes completed in the year.
11 Dividends on ordinary shares
The Directors have approved a total dividend in respect of 2021 of 6p per ordinary share of 25p each. The full year dividend for 2021 of 4p per ordinary share will be paid on 5 April 2022 to shareholders on the Share Register on 4 March 2022. On 31 December 2021, there were 16,752m ordinary shares in issue. The financial statements for the year ended 31 December 2021 do not reflect this dividend, which will be accounted for in shareholders’ equity as an appropriation of retained profits in the year ending 31 December 2022.
The Directors have confirmed their intention to initiate a share buyback of up to £1.0bn after the balance sheet date. The share buyback is expected to commence in the first quarter of 2022. The financial statements for the year ended 31 December 2021 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are repurchased by the Company.
The 2021 financial statements include the 2021 half year dividend of £339m (2020: nil); a full year dividend declared in relation to 2020 of £173m (2020: nil) and two share buybacks, £700m completed in H1 2021 (2020: nil) and £500m completed in H2 2021 (2020: nil) . Dividends and share buybacks are funded out of distributable reserves.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
242

Notes to the financial statements
For the year ended 31 December 2021 continued
Assets and liabilities held at fair value
The notes included in this section focus on assets and liabilities the Group holds and recognises at fair value. Fair value refers to the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date, which may be an observable market price or, where there is no quoted price for the instrument, may be an estimate based on available market data. Detail regarding the Group’s approach to managing market risk can be found in the Market risk management section.
12 Trading portfolio
Accounting for trading portfolio assets and liabilities
In accordance with IFRS 9, all assets and liabilities held for trading purposes are held at fair value with gains and losses in the changes in fair value taken to the income statement in net trading income (Note 5).
Trading portfolio assetsTrading portfolio liabilities
2021202020212020
£m£m£m£m
Debt securities and other eligible bills50,864 56,482 (34,957)(30,102)
Equity securities83,113 62,192 (19,212)(17,303)
Traded loans12,525 8,348  — 
Commodities533 928  — 
Trading portfolio assets/(liabilities)147,035 127,950 (54,169)(47,405)
13 Financial assets at fair value through the income statement
Accounting for financial assets mandatorily at fair value
Financial assets that are held for trading are recognised at fair value through profit or loss. In addition, financial assets are held at fair value through profit or loss if they do not contain contractual terms that give rise on specified dates to cash flows that are SPPI, or if the financial asset is not held in a business model that is either (i) a business model to collect the contractual cash flows or (ii) a business model that is achieved by both collecting contractual cash flows and selling.
Accounting for financial assets designated at fair value
Financial assets, other than those held for trading, are classified in this category if they are so irrevocably designated at inception and the use of the designation removes or significantly reduces an accounting mismatch.
Subsequent changes in fair value for these instruments are recognised in the income statement in net investment income, except if reporting it in trading income reduces an accounting mismatch.
The details on how the fair value amounts are derived for financial assets at fair value are described in Note 17.
Designated at fair valueMandatorily at fair valueTotal
202120202021202020212020
£m£m£m£m£m£m
Loans and advances5,579 5,600 33,088 25,279 38,667 30,879 
Debt securities319 292 1,986 1,401 2,305 1,693 
Equity securities — 5,875 4,620 5,875 4,620 
Reverse repurchase agreements and other
similar secured lending
 19 145,014 137,597 145,014 137,616 
Other financial assets — 111 343 111 343 
Financial assets at fair value through the income statement5,898 5,911 186,074 169,240 191,972 175,151 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
243

Notes to the financial statements
For the year ended 31 December 2021 continued
Credit risk of financial assets designated at fair value and related credit derivatives
The following table shows the maximum exposure to credit risk, the changes in fair value attributable to changes in credit risk, and the cumulative changes in fair value since initial recognition for loans and advances. The table does not include debt securities and reverse repurchase agreements and other similar secured lending designated at FV as they have minimal exposure to credit risk. Reverse repurchase agreements are collateralised and debt securities are primarily relating to high quality sovereigns.
Maximum exposure as at 31 DecemberChanges in fair value during the year endedCumulative changes in fair value from inception
202120202021202020212020
£m£m£m£m£m£m
Loans and advances designated at fair value, attributable to credit risk5,579 5,600 5 (47)(19)(73)
Value mitigated by related credit derivatives 1,617 795 (3)(3)
14 Derivative financial instruments
Accounting for derivatives
Derivative instruments are contracts whose value is derived from one or more underlying financial instruments or indices defined in the contract. They include swaps, forward-rate agreements, futures, options and combinations of these instruments and primarily affect the Group’s net interest income, net trading income and derivative assets and liabilities. Notional amounts of the contracts are not recorded on the balance sheet. Derivatives are used to hedge interest rate, credit risk, inflation risk, exchange rate, commodity equity exposures, and exposures to certain indices such as house price indices and retail price indices related to non-trading positions.
All derivative instruments are held at fair value through profit or loss, except for derivatives that are in a designated cash flow or net investment hedge accounting relationship. Derivatives are classified as assets when their fair value is positive or as liabilities when their fair value is negative. This includes terms included in a contract or financial liability (the host), which, had it been a standalone contract, would have met the definition of a derivative. If these are separated from the host, i.e. when the economic characteristics of the embedded derivative are not closely related with those of the host contract and the combined instrument is not measured at fair value through profit or loss, then they are accounted for in the same way as derivatives. For financial assets, the requirements are whether the financial assets contain contractual terms that give rise on specified dates to cash flows that are SPPI, and consequently the requirements for accounting for embedded derivatives are not applicable to financial assets.
Hedge accounting
The Group applies the requirements of IAS 39 Financial Instruments: Recognition and Measurement for hedge accounting purposes. The Group applies hedge accounting to represent the economic effects of its interest rate, currency and contractually linked inflation risk management strategies. Where derivatives are held for risk management purposes, and when transactions meet the required criteria for documentation and hedge effectiveness, the Group applies fair value hedge accounting, cash flow hedge accounting, or hedging of a net investment in a foreign operation, as appropriate to the risks being hedged.
The Group applies the ‘Amendments to IFRS 9, IAS 39 and IFRS 7 Interest Rate Benchmark Reform’ issued in September 2019 (the Phase 1 amendments). The amendments provide temporary relief from applying specific hedge accounting requirements to hedging relationships directly affected by IBOR (‘Interbank Offered Rates’) reform. The reliefs have the effect that IBOR reform should not generally cause hedge accounting to terminate. However, any hedge ineffectiveness continues to be recorded in the income statement. Furthermore, the amendments set out triggers for when the reliefs will end, which include the uncertainty arising from interest rate benchmark reform no longer being present.
In summary, the reliefs provided by the Phase 1 amendments are:
When considering the ‘highly probable’ requirement, the Group has assumed that the IBOR interest rates upon which our hedged items are based do not change as a result of IBOR Reform.
In assessing whether the hedge is expected to be highly effective on a forward-looking basis the Group has assumed that the IBOR interest rates upon which the cash flows of the hedged items and the interest rate swaps that hedge them are based are not altered by IBOR reform.
The Group will not discontinue hedge accounting during the period of IBOR-related uncertainty solely because the retrospective effectiveness falls outside the required 80–125% range.
The Group has not recycled the cash flow hedge reserve relating to the period after the reforms are expected to take effect.
The Group has assessed whether the hedged IBOR risk component is a separately identifiable risk only when it first designates a hedged item in a fair value hedge and not on an ongoing basis.
The Group also applies the ‘Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 Interest Rate Benchmark Reform – Phase 2’ issued in August 2020. The Phase 2 amendments provide relief when changes are made to hedge relationships as a result of the interest rate benchmark reform.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
244

Notes to the financial statements
For the year ended 31 December 2021 continued
In summary, the reliefs provided by the Phase 2 amendments are:
Under a temporary exception, the Group has considered that changes to the hedge designation and hedge documentation due to the interest rate benchmark reform would not constitute the discontinuation of the hedge relationship nor the designation of a new hedging relationship.
In respect of the retrospective hedge effectiveness assessment, the Group may elect, on a hedge-by-hedge basis, to reset the cumulative fair value changes to zero when the exception to the retrospective assessment ends (Phase 1 relief). Any hedge ineffectiveness will continue to be measured and recognised in full in profit or loss.
The Group has deemed the amounts accumulated in the cash flow hedge reserve to be based on the alternative benchmark rate (on which the hedge future cash flows are determined) when there is a change in basis for determining the contractual cash flows.
For hedges of groups of items (such as those forming part of a macro cash flow hedging strategy), the amendments provide relief for items within a designated group of items that are amended for changes directly required by the reform.
In respect of whether a risk component of a hedged item is separately identifiable, the amendments provide temporary relief to entities to meet this requirement when an alternative risk free rate (RFR) financial instrument is designated as a risk component. These amendments allow the Group upon designation of the hedge to assume that the separately identifiable requirement is met if the Group reasonably expects the RFR risk will become separately identifiable within the next 24 months. The Group applies this relief to each RFR on a rate-by-rate basis and starts when the Group first designates the RFR as a non-contractually specified risk component.
Fair value hedge accounting
Changes in fair value of derivatives that qualify and are designated as fair value hedges are recorded in the income statement, together with changes in the fair value of the hedged asset or liability that are attributable to the hedged risk. The fair value changes adjust the carrying value of the hedged asset or liability held at amortised cost.
If hedge relationships no longer meet the criteria for hedge accounting, hedge accounting is discontinued. For fair value hedges of interest rate risk, the fair value adjustment to the hedged item is amortised to the income statement over the period to maturity of the previously designated hedge relationship using the effective interest method. If the hedged item is sold or repaid, the unamortised fair value adjustment is recognised immediately in the income statement. For items classified as fair value through other comprehensive income, the hedge accounting adjustment is included in other comprehensive income.
Cash flow hedge accounting
For qualifying cash flow hedges, the fair value gain or loss associated with the effective portion of the cash flow hedge is recognised initially in other comprehensive income, and then recycled to the income statement in the periods when the hedged item will affect profit or loss. Any ineffective portion of the gain or loss on the hedging instrument is recognised in the income statement immediately.
When a hedging instrument expires or is sold, or when a hedge no longer meets the criteria for hedge accounting, any cumulative gain or loss existing in equity at that time remains in equity and is recognised when the hedged item is ultimately recognised in the income statement. When a forecast transaction is no longer expected to occur, the cumulative gain or loss that was recognised in equity is immediately transferred to the income statement.
Hedges of net investments
The Group’s net investments in foreign operations, including monetary items accounted for as part of the net investment, are hedged for foreign currency risks using both derivatives and foreign currency borrowings. Hedges of net investments are accounted for similarly to cash flow hedges; the effective portion of the gain or loss on the hedging instrument is being recognised directly in other comprehensive income and the ineffective portion being recognised immediately in the income statement. The cumulative gain or loss recognised in other comprehensive income is recognised in the income statement on the disposal or partial disposal of the foreign operation, or other reductions in the Group’s investment in the operation.
Total derivatives
20212020
Notional contract amountFair valueNotional
contract
amount
Fair value
AssetsLiabilitiesAssetsLiabilities
£m£m£m£m£m£m
Total derivative assets/(liabilities) held for trading47,812,774 261,678 (255,747)43,169,971 301,880 (299,795)
Total derivative assets/(liabilities) held for risk management219,551 894 (1,136)189,784 566 (980)
Derivative assets/(liabilities)48,032,325 262,572 (256,883)43,359,755 302,446 (300,775)
As part of the industry wide IBOR transition during the year, interest rate swap contracts held with Central Clearing Counterparties (CCPs) have been converted to alternative benchmarks. Operationally, this involved the CCPs splitting each contract into multiple component operational parts in order to preserve accrued IBOR cash flows. Legally, Barclays remains party to only one contract, and as such all notional amounts quoted in this disclosure reflect the legal contract notional. In total, 'operational-only' trade notional amounts of £1,828bn primarily with London Clearing House & Japan Securities Clearing Corporation have been explicitly excluded from these disclosures.
Further information on netting arrangements of derivative financial instruments can be found within Note 18.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
245

Notes to the financial statements
For the year ended 31 December 2021 continued
The fair values and notional amounts of derivative instruments held for trading and held for risk management are set out in the following table:
Derivatives held for trading and held for risk management
20212020
Notional
contract
amount
Fair valueNotional
contract
amount
Fair value
AssetsLiabilitiesAssetsLiabilities
£m£m£m£m£m£m
Derivatives held for trading
Foreign exchange derivatives
OTC derivatives5,705,108 75,959 (74,226)5,461,057 84,401 (84,043)
Derivatives cleared by central counterparty99,664 171 (208)78,946 335 (335)
Exchange traded derivatives20,084 10 (3)14,034 (3)
Foreign exchange derivatives5,824,856 76,140 (74,437)5,554,037 84,739 (84,381)
Interest rate derivatives
OTC derivatives14,216,846 123,819 (113,051)13,547,990 170,808 (161,157)
Derivatives cleared by central counterparty19,398,748 1,122 (845)18,737,415 965 (885)
Exchange traded derivatives5,200,838 905 (907)2,971,966 371 (360)
Interest rate derivatives38,816,432 125,846 (114,803)35,257,371 172,144 (162,402)
Credit derivatives
OTC derivatives606,504 4,007 (4,752)384,900 3,674 (3,909)
Derivatives cleared by central counterparty665,600 1,675 (1,809)462,945 931 (1,095)
Credit derivatives1,272,104 5,682 (6,561)847,845 4,605 (5,004)
Equity and stock index derivatives
OTC derivatives278,683 18,822 (24,468)466,151 18,807 (26,094)
Exchange traded derivatives1,469,078 32,901 (33,174)927,114 20,165 (20,521)
Equity and stock index derivatives1,747,761 51,723 (57,642)1,393,265 38,972 (46,615)
Commodity derivatives
OTC derivatives4,670 56 (107)4,244 89 (110)
Exchange traded derivatives146,951 2,231 (2,197)113,209 1,331 (1,283)
Commodity derivatives151,621 2,287 (2,304)117,453 1,420 (1,393)
Derivative assets/(liabilities) held for trading47,812,774 261,678 (255,747)43,169,971 301,880 (299,795)
Total OTC derivatives20,811,811 222,663 (216,604)19,864,342 277,779 (275,313)
Total derivatives cleared by central counterparty20,164,012 2,968 (2,862)19,279,306 2,231 (2,315)
Total exchange traded derivatives6,836,951 36,047 (36,281)4,026,323 21,870 (22,167)
Derivative assets/(liabilities) held for trading47,812,774 261,678 (255,747)43,169,971 301,880 (299,795)
Derivatives held for risk management
Derivatives designated as cash flow hedges
OTC foreign exchange derivatives7,592 798  6,596 351 — 
OTC interest rate derivatives788  (3)2,433 35 — 
Interest rate derivatives cleared by central counterparty105,933   65,408 — — 
Derivatives designated as cash flow hedges114,313 798 (3)74,437 386 — 
Derivatives designated as fair value hedges
OTC interest rate derivatives8,480 59 (1,118)11,116 155 (980)
Interest rate derivatives cleared by central counterparty94,335  (11)103,440 — — 
Derivatives designated as fair value hedges102,815 59 (1,129)114,556 155 (980)
Derivatives designated as hedges of net investments
OTC foreign exchange derivatives2,423 37 (4)791 25 — 
Derivatives designated as hedges of net investments2,423 37 (4)791 25 — 
Derivative assets/(liabilities) held for risk management219,551 894 (1,136)189,784 566 (980)
Total OTC derivatives19,283 894 (1,125)20,936 566 (980)
Total derivatives cleared by central counterparty200,268  (11)168,848 — — 
Derivative assets/(liabilities) held for risk management219,551 894 (1,136)189,784 566 (980)
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
246

Notes to the financial statements
For the year ended 31 December 2021 continued
Hedge accounting
Hedge accounting is applied predominantly for the following risks:
Interest rate risk – arises due to a mismatch between fixed interest rates and floating interest rates. Interest rate risk also includes exposure to inflation risk for certain types of investments.
Currency risk – arises due to assets or liabilities being denominated in different currencies than the functional currency of the relevant entity. At a consolidated level, currency risk also arises when the functional currency of subsidiaries are different from the parent.
Contractually linked inflation risk – arises from financial instruments within contractually specified inflation risk. The Group does not hedge inflation risk that arises from other activities.
In order to hedge these risks, the Group uses the following hedging instruments:
Interest rate derivatives to swap interest rate exposures into either fixed or variable rates.
Currency derivatives to swap foreign currency exposures into the entity’s functional currency, and net investment exposure to local currency.
Inflation derivatives to swap inflation exposure into either fixed or variable interest rates.
In some cases, certain items which are economically hedged may be ineligible hedged items for the purposes of IAS 39, such as core deposits and equity. In these instances, a proxy hedging solution can be utilised whereby portfolios of floating rate assets are designated as eligible hedged items in cash flow hedges.
In some hedging relationships, the Group designates risk components of hedged items as follows:
Benchmark interest rate risk as a component of interest rate risk, such as the LIBOR or Risk Free Rate (RFR) component.
Inflation risk as a contractually specified component of a debt instrument.
Spot exchange rate risk for foreign currency financial assets or financial liabilities.
Components of cash flows of hedged items, for example certain interest payments for part of the life of an instrument.
Using the benchmark interest rate risk results in other risks, such as credit risk and liquidity risk, being excluded from the hedge accounting relationship. Following market-wide interest rate benchmark reform, sensitivity to risk-free rates is considered to be the predominant interest rate risk and therefore the hedged items (which often reference risk-free or similar 'overnight' rates) change in fair value on a proportionate basis with reference to this risk.
In respect of many of the Group’s hedge accounting relationships, the hedged item and hedging instrument change frequently due to the dynamic nature of the risk management and hedge accounting strategy. The Group applies hedge accounting to dynamic scenarios, predominantly in relation to interest rate risk, with a combination of hedged items in order for its financial statements to reflect as closely as possible the economic risk management undertaken. In some cases, if the hedge accounting objective changes, the relevant hedge accounting relationship is de-designated and is replaced with a different hedge accounting relationship.
Changes in the GBP value of net investments due to foreign currency movements are captured in the currency translation reserve, resulting in a movement in CET1 capital. The Group mitigates this by matching the CET1 capital movements to the revaluation of the foreign currency RWA exposures. Net investment hedges are designated where necessary to reduce the exposure to movement in a particular exchange rate to within limits mandated by Risk. As far as possible, existing external currency liabilities are designated as the hedging instruments.
The hedging instruments share the same risk exposures as the hedged items. Hedge effectiveness is determined with reference to quantitative tests, predominantly regression testing, but to the extent hedging instruments are exposed to different risks than the hedged items, this could result in hedge ineffectiveness or hedge accounting failures.
Sources of ineffectiveness include the following:
Mismatches between the contractual terms of the hedged item and hedging instrument, including basis differences.
Changes in credit risk of the hedging instruments.
If a hedging relationship becomes over-hedged, for example in hedges of net investments if the net asset value designated at the start of the period falls below the amount of the hedging instrument.
Cash flow hedges using external swaps with non-zero fair values.
The effects of the reforms to IBOR because these might take effect at a different time and have a different impact on hedged items and hedging instruments.
The Group's risk exposure continues, in part, to be affected by interest rate benchmark reform. In most cases, hedged items and hedging instruments are expected to transition to relevant risk-free rates at the end of their current cash flow period. For GBP LIBOR contracts, where uncertainty around the timing and effects of LIBOR reform continues beyond the end of the current cash flow period, financial instruments are generally expected to utilise 'synthetic LIBOR' (as permitted by the FCA on a temporary basis until their contracts are fully remediated). USD LIBOR linked hedge accounting relationships are still exposed to uncertainty regarding the precise timing and effects of benchmark reform. USD LIBOR benchmarks will cease to be published from 30 June 2023, but certain hedged items and hedging instruments continue to contractually reference these benchmarks beyond the cessation date.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
247

Notes to the financial statements
For the year ended 31 December 2021 continued
The following table summarises the significant hedge accounting exposures impacted by the IBOR reform (see Note 41 for further updates) as at 31 December 2021:
Current benchmark rateExpected convergence to RFRNominal amount of hedged items directly impacted by IBOR reform Nominal amount of hedging instruments directly impacted by IBOR reform
£m£m
GBP London Interbank Offered rate (LIBOR)Reformed Sterling Overnight Index Average (SONIA)10,032 200 
USD LIBORSecured Overnight Financing Rate (SOFR)25,744 25,288 
Singapore Swap Offered Rate (SOR)Singapore Overnight Rate Average (SORA)110 110 
Total35,886 25,598 

The disparity in outstanding GBP notionals between hedged items and hedging instruments results from a temporary timing mismatch where derivative contracts have been transitioned to SONIA prior to 31 December, whereas hedged items are expected to transition early 2022.
Hedged items in fair value hedges
Accumulated fair value adjustment included in carrying amount
Hedged item statement of financial position classification and risk categoryCarrying amountTotalOf which: Accumulated fair value adjustment on items no longer in a hedge relationshipChange in fair value used as a basis to determine ineffectiveness
Hedge ineffectiveness recognised in the income statementsa
£m£m£m£m£m
2021
Assets
Loans and advances at amortised cost
- Interest rate risk8,512 671 (642)(1,643)33 
- Inflation risk556 354  9  
Debt securities classified at amortised cost
- Interest rate risk1,378 (39) (75)(18)
- Inflation risk4,087 400  (16)(1)
Financial assets at fair value through other comprehensive income
- Interest rate risk31,485 (258)32 (1,436)39 
- Inflation risk9,066 470 (32)161 13 
Total assets55,084 1,598 (642)(3,000)66 
Liabilities
Debt securities in issue
- Interest rate risk(48,251)(1,084)86 1,606 (48)
Total liabilities(48,251)(1,084)86 1,606 (48)
Total hedged items6,833 514 (556)(1,394)18 
2020
Assets
Loans and advances at amortised cost
- Interest rate risk9,858 2,289 (638)1,583 111 
- Inflation risk545 345 — 25 
Debt securities classified at amortised cost
- Interest rate risk1,440 23 — 18 (7)
- Inflation risk4,071 (43)— 453 
Financial assets at fair value through other comprehensive income
- Interest rate risk41,544 1,284 351 825 (13)
- Inflation risk10,821 367 (9)307 
Total assets68,279 4,265 (296)3,211 98 
Liabilities
Debt securities in issue
- Interest rate risk(50,438)(2,859)(24)(1,466)(56)
Total liabilities(50,438)(2,859)(24)(1,466)(56)
Total hedged items17,841 1,406 (320)1,745 42 
Note
a    Hedge ineffectiveness is recognised in net interest income.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
248

Notes to the financial statements
For the year ended 31 December 2021 continued
For items classified as fair value through other comprehensive income, the hedge accounting adjustment is not included in the carrying amount, but rather adjusts other comprehensive income.
The following table shows the fair value hedging instruments which are carried on the Group’s balance sheet:
Carrying valueNominal amountChange in fair value used as a basis to determine ineffectivenessNominal amount directly impacted by IBOR reform
Derivative assets Derivative liabilitiesLoan liabilities
Hedge typeRisk category£m£m£m£m£m£m
As at 31 December 2021
Fair value Interest rate risk54 (11) 92,447 1,554 15,577 
Inflation risk5 (1,118) 10,368 (142)1,624 
Total59 (1,129) 102,815 1,412 17,201 
As at 31 December 2020
Fair value Interest rate risk120 (166)— 103,623 (925)30,072 
Inflation risk35 (815)— 10,933 (778)1,487 
Total155 (980)— 114,556 (1,703)31,559 
The following table profiles the expected notional values of current hedging instruments in future years:
2021202220232024202520262027 and later
As at 31 December£m£m£m£m£m£m£m
Fair value hedges of:
Interest rate risk (outstanding notional amount)92,447 87,025 79,475 67,206 55,080 44,801 37,652 
Inflation risk (outstanding notional amount)10,368 9,874 8,999 6,503 5,445 3,472 1,159 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
249

Notes to the financial statements
For the year ended 31 December 2021 continued
There are 1,782 (2020: 1,906) interest rate risk fair value hedges with an average fixed rate of 1.88% (2020: 1.87%) across the relationships and 96 (2020: 104) inflation risk fair value hedges with an average rate of 0.51% (2020: 0.63%) across the relationships.
Hedged items in cash flow hedges and hedges of net investments in foreign operations
Description of hedge relationship and hedged riskChange in value of hedged item used as the basis for recognising ineffectivenessBalance in cash flow hedging reserve for continuing hedgesBalance in currency translation reserve for continuing hedgesBalances remaining in cash flow hedging reserve for which hedge accounting is no longer appliedBalances remaining in currency translation reserve for which hedge accounting is no longer appliedHedging gains or losses recognised in other comprehensive income
Hedge ineffectiveness recognised in the income statementa
£m£m£m£m£m£m£m
2021
Cash flow hedge of:
Interest rate risk
Loans and advances at amortised cost2,465 1,536  (492) 2,465 (347)
Foreign exchange risk
Loans and advances at amortised cost(88)(16)   (88)1 
Debt securities classified at amortised cost(356)123    (356)1 
Inflation risk
Debt securities classified at amortised cost252 204  (12) 252 (22)
Total cash flow hedge2,273 1,847  (504) 2,273 (367)
Hedge of net investment in foreign operations
USD foreign operations138  943   138  
EUR foreign operations(117) 100   (117) 
Other foreign operations(3) 44  186 (3) 
Total foreign operations18  1,087  186 18  
2020
Cash flow hedge of:
Interest rate risk
Loans and advances at amortised cost(1,124)(598)— (1,370)— (1,124)27 
Foreign exchange risk
Loans and advances at amortised cost(70)(15)— — — (70)— 
Debt securities classified at amortised cost(278)(65)— — — (278)— 
Inflation risk
Debt securities classified at amortised cost(41)(65)— — — (41)
Total cash flow hedge(1,513)(743)— (1,370)— (1,513)28 
Hedge of net investment in foreign operations
USD foreign operations(240)— 857 — — (240)— 
EUR foreign operations(17)— (2)— — (17)— 
Other foreign operations(9)— 47 — 186 (9)— 
Total foreign operations(266)— 902 — 186 (266)— 
Note
a    Hedge ineffectiveness is recognised in net interest income.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
250

Notes to the financial statements
For the year ended 31 December 2021 continued
The following table shows the cash flow and net investment hedging instruments which are carried on the Group’s balance sheet:
Carrying valueNominal amountChange in fair value used as a basis to determine ineffectivenessNominal amount directly impacted by IBOR reform
Derivative assets Derivative liabilitiesLoan liabilities
Hedge typeRisk category£m£m£m£m£m£m
As at 31 December 2021
Cash flowInterest rate risk   102,629 (2,812)8,397 
Foreign exchange risk798   7,592 446  
Inflation risk (3) 4,092 (274) 
Total798 (3) 114,313 (2,640)8,397 
Net investmentForeign exchange risk37 (4)(11,212)13,635 (239) 
As at 31 December 2020
Cash flowInterest rate risk33 — — 65,042 1,151 18,195 
Foreign exchange risk351 — — 6,596 348 — 
Inflation risk— — 2,799 42 — 
Total386 — — 74,437 1,541 18,195 
Net investmentForeign exchange risk25 — (8,660)9,451 265 — 
There are 36 (2020: 29) foreign exchange risk cash flow hedges with an average foreign exchange rate of 137.85 JPY: 1 GBP (2020: 135.29 JPY: 1 GBP) across the relationships.
The effect on the income statement and other comprehensive income of recycling amounts in respect of cash flow hedges and net investment hedges of foreign operations is set out in the following table:
20212020
Amount recycled from other comprehensive income due to hedged item affecting income statementAmount recycled from other comprehensive income due to sale of investment, or cash flows no longer expected to occurAmount recycled from other comprehensive income due to hedged item affecting income statementAmount recycled from other comprehensive income due to sale of investment, or cash flows no longer expected to occur
Description of hedge relationship and hedged risk£m£m£m£m
Cash flow hedge of interest rate risk
Recycled to net interest income541 2 489 17 
Cash flow hedge of foreign exchange risk
Recycled to other income630  268 — 
Hedge of net investment in foreign operations
Recycled to other income (26)— (4)
A detailed reconciliation of the movements of the cash flow hedging reserve and the currency translation reserve is as follows:
20212020
Cash flow hedging reserveCurrency translation reserveCash flow hedging reserveCurrency translation reserve
£m£m£m£m
Balance on 1 January1,575 2,871 1,002 3,344 
Currency translation movements(7)(139)50 (743)
Hedging gains/(losses) for the year(2,273)(18)1,249 266 
Amounts reclassified in relation to cash flows affecting profit or loss(1,173)26 (510)
Tax1,025  (216)— 
Balance on 31 December(853)2,740 1,575 2,871 
In 2020, amounts recycled from other comprehensive income of £268m in respect of cash flow hedges of foreign exchange risk were presented within 'Hedging gains/(losses) for the year'. For 2021, the corresponding current year amounts of £630m were presented within 'Amounts reclassified in relation to cash flows affecting profit or loss'.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
251

Notes to the financial statements
For the year ended 31 December 2021 continued
15 Financial assets at fair value through other comprehensive income
Accounting for financial assets at fair value through other comprehensive income (FVOCI)
Financial assets that are debt instruments held in a business model that is achieved by both collecting contractual cash flows and selling and that contain contractual terms that give rise on specified dates to cash flows that are SPPI are measured at FVOCI. They are subsequently re-measured at fair value and changes therein (except for those relating to impairment, interest income and foreign currency exchange gains and losses) are recognised in other comprehensive income until the assets are sold. Interest (calculated using the effective interest method) is recognised in the income statement in net interest income (Note 3). Upon disposal, the cumulative gain or loss recognised in other comprehensive income is included in net investment income (Note 6).
In determining whether the business model is achieved by both collecting contractual cash flows and selling financial assets, it is determined that both collecting contractual cash flows and selling financial assets are integral to achieving the objective of the business model. The Group will consider past sales and expectations about future sales to establish if the business model is achieved.
For equity securities that are not held for trading, the Group may make an irrevocable election on initial recognition to present subsequent changes in the fair value of the instrument in other comprehensive income (except for dividend income which is recognised in profit or loss). Gains or losses on the de-recognition of these equity securities are not transferred to profit or loss. These assets are also not subject to the impairment requirements and therefore no amounts are recycled to the income statement. Where the Group has not made the irrevocable election to present subsequent changes in the fair value of the instrument in other comprehensive income, equity securities are measured at fair value through profit or loss.
20212020
£m£m
Debt securities and other eligible bills60,798 77,736 
Equity securities902 761 
Loans and advances53 191 
Financial assets at fair value through other comprehensive income61,753 78,688 
16 Financial liabilities designated at fair value
Accounting for liabilities designated at fair value through profit and loss
In accordance with IFRS 9, financial liabilities may be designated at fair value, with gains and losses taken to the income statement within net trading income (Note 5) and net investment income (Note 6). Movements in own credit are reported through other comprehensive income, unless the effects of changes in the liability's credit risk would create or enlarge an accounting mismatch in P&L. In these scenarios, all gains and losses on that liability (including the effects of changes in the credit risk of the liability) are presented in P&L. On derecognition of the financial liability no amount relating to own credit risk are recycled to the income statement. The Group has the ability to make the fair value designation when holding the instruments at fair value reduces an accounting mismatch (caused by an offsetting liability or asset being held at fair value), or is managed by the Group on the basis of its fair value, or includes terms that have substantive derivative characteristics (Note 14).
The details on how the fair value amounts are arrived at for financial liabilities designated at fair value are described in Note 17.
20212020
Fair valueContractual
amount due
on maturity
Fair valueContractual
amount due
on maturity
£m£m£m£m
Debt securities53,647 61,946 50,437 57,650 
Deposits29,246 29,673 21,706 22,107 
Repurchase agreements and other similar secured borrowing168,060 168,129 177,371 177,389 
Other financial liabilities7 7 251 251 
Financial liabilities designated at fair value250,960 259,755 249,765 257,397 
The cumulative own credit net loss recognised is £960m (2020: £954m loss).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
252

Notes to the financial statements
For the year ended 31 December 2021 continued
17 Fair value of financial instruments
Accounting for financial assets and liabilities – fair values
Financial instruments that are held for trading are recognised at fair value through profit or loss. In addition, financial assets are held at fair value through profit or loss if they do not contain contractual terms that give rise on specified dates to cash flows that are SPPI, or if the financial asset is not held in a business model that is either (i) a business model to collect the contractual cash flows or (ii) a business model that is achieved by both collecting contractual cash flows and selling. Subsequent changes in fair value for these instruments are recognised in the income statement in net investment income, except if reporting it in trading income reduces an accounting mismatch.
All financial instruments are initially recognised at fair value on the date of initial recognition (including transaction costs, other than financial instruments held at fair value through profit or loss) and depending on the subsequent classification of the financial asset or liability, may continue to be held at fair value either through profit or loss or other comprehensive income. The fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
Wherever possible, fair value is determined by reference to a quoted market price for that instrument. For many of the Group’s financial assets and liabilities, especially derivatives, quoted prices are not available and valuation models are used to estimate fair value. The models calculate the expected cash flows under the terms of each specific contract and then discount these values back to a present value. These models use as their basis independently sourced market inputs including, for example, interest rate yield curves, equities and commodities prices, option volatilities and currency rates.
For financial liabilities measured at fair value, the carrying amount reflects the effect on fair value of changes in own credit spreads derived from observable market data such as in primary issuance and redemption activity for structured notes.
On initial recognition, it is presumed that the transaction price is the fair value unless there is observable information available in an active market to the contrary. The best evidence of an instrument’s fair value on initial recognition is typically the transaction price. However, if fair value can be evidenced by comparison with other observable current market transactions in the same instrument, or is based on a valuation technique whose inputs include only data from observable markets, then the instrument should be recognised at the fair value derived from such observable market data.
For valuations that have made use of unobservable inputs, the difference between the model valuation and the initial transaction price (Day One profit) is recognised in profit or loss either: on a straight-line basis over the term of the transaction; or over the period until all model inputs will become observable where appropriate; or released in full when previously unobservable inputs become observable.
Various factors influence the availability of observable inputs and these may vary from product to product and change over time. Factors include the depth of activity in the relevant market, the type of product, whether the product is new and not widely traded in the marketplace, the maturity of market modelling and the nature of the transaction (bespoke or generic). To the extent that valuation is based on models or inputs that are not observable in the market, the determination of fair value can be more subjective, dependent on the significance of the unobservable input to the overall valuation. Unobservable inputs are determined based on the best information available, for example by reference to similar assets, similar maturities or other analytical techniques.
The sensitivity of valuations used in the financial statements to possible changes in significant unobservable inputs is shown on page 260.
Critical accounting estimates and judgements
The valuation of financial instruments often involves a significant degree of judgement and complexity, in particular where valuation models make use of unobservable inputs (‘Level 3’ assets and liabilities). This note provides information on these instruments, including the related unrealised gains and losses recognised in the period, a description of significant valuation techniques and unobservable inputs, and a sensitivity analysis.
Valuation
IFRS 13 Fair value measurement requires an entity to classify its assets and liabilities according to a hierarchy that reflects the observability of significant market inputs. The three levels of the fair value hierarchy are defined below with judgement applied in determining the boundary between Level 2 and 3 classification.
Quoted market prices – Level 1
Assets and liabilities are classified as Level 1 if their value is observable in an active market. Such instruments are valued by reference to unadjusted quoted prices for identical assets or liabilities in active markets where the quoted price is readily available, and the price represents actual and regularly occurring market transactions. An active market is one in which transactions occur with sufficient volume and frequency to provide pricing information on an ongoing basis.
Valuation technique using observable inputs – Level 2
Assets and liabilities classified as Level 2 have been valued using models whose inputs are observable either directly or indirectly. Valuations based on observable inputs include assets and liabilities such as swaps and forwards which are valued using market standard pricing techniques, and options that are commonly traded in markets where all the inputs to the market standard pricing models are observable.
Valuation technique using significant unobservable inputs – Level 3
Assets and liabilities are classified as Level 3 if their valuation incorporates significant inputs that are not based on observable market data (unobservable inputs). A valuation input is considered observable if it can be directly observed from transactions in an active market, or if there is compelling external evidence demonstrating an executable exit price. Unobservable input levels are generally determined via reference to observable inputs, historical observations or using other analytical techniques.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
253

Notes to the financial statements
For the year ended 31 December 2021 continued
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification:
Assets and liabilities held at fair value
20212020
Valuation technique usingValuation technique using
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
As at 31 December£m£m£m£m£m£m£m£m
Trading portfolio assets80,926 63,828 2,281 147,035 60,671 65,416 1,863 127,950 
Financial assets at fair value through the income statement5,093 177,167 9,712 191,972 4,503 162,142 8,506 175,151 
Derivative financial assets6,150 252,412 4,010 262,572 9,155 288,822 4,469 302,446 
Financial assets at fair value through other comprehensive income22,009 39,706 38 61,753 19,792 58,743 153 78,688 
Investment property  7 7 — — 10 10 
Total assets114,178 533,113 16,048 663,339 94,121 575,123 15,001 684,245 
Trading portfolio liabilities(27,529)(26,613)(27)(54,169)(24,391)(22,986)(28)(47,405)
Financial liabilities designated at fair value(174)(250,376)(410)(250,960)(159)(249,251)(355)(249,765)
Derivative financial liabilities(6,571)(244,253)(6,059)(256,883)(8,762)(285,774)(6,239)(300,775)
Total liabilities(34,274)(521,242)(6,496)(562,012)(33,312)(558,011)(6,622)(597,945)
The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type:
Level 3 assets and liabilities held at fair value by product type
20212020
AssetsLiabilitiesAssetsLiabilities
£m£m£m£m
Interest rate derivatives 1,091 (1,351)1,613 (1,615)
Foreign exchange derivatives 376 (374)144 (143)
Credit derivatives323 (709)196 (351)
Equity derivatives 2,220 (3,625)2,498 (4,112)
Corporate debt 1,205 (21)698 (3)
Reverse repurchase and repurchase agreements 13 (172)— (174)
Non-asset backed loans 6,405  6,394 — 
Asset backed securities 558  767 (24)
Equity cash products 393  542 — 
Private equity investments1,095 (6)873 (14)
Othera
2,369 (238)1,276 (186)
Total16,048 (6,496)15,001 (6,622)
Note
a    Other includes commercial real estate loans, asset backed loans, funds and fund-linked products, issued debt, government sponsored debt, commodity derivatives and investment property.

Valuation techniques and sensitivity analysis
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of the valuation techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative models.
Sensitivities are dynamically calculated on a monthly basis. The calculation is based on range or spread data of a reliable reference source or a scenario based on relevant market analysis alongside the impact of using alternative models. Sensitivities are calculated without reflecting the impact of any diversification in the portfolio.
The valuation techniques used, observability and sensitivity analysis for material products within Level 3, are described below.
Interest rate derivatives
Description: Derivatives linked to interest rates or inflation indices. The category includes futures, interest rate and inflation swaps, swaptions, caps, floors, inflation options, balance guaranteed swaps and other exotic interest rate derivatives.
Valuation: Interest rate and inflation derivatives are generally valued using curves of forward rates constructed from market data to project and discount the expected future cash flows of trades. Instruments with optionality are valued using volatilities implied from market inputs, and use industry standard or bespoke models depending on the product type.
Observability: In general, inputs are considered observable up to liquid maturities which are determined separately for each input and underlying. Unobservable inputs are generally set by referencing liquid market instruments and applying extrapolation techniques or inferred via another reasonable method.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
254

Notes to the financial statements
For the year ended 31 December 2021 continued
Foreign exchange derivatives
Description: Derivatives linked to the foreign exchange (FX) market. The category includes FX forward contracts, FX swaps and FX options. The majority are traded as over the counter (OTC) derivatives.
Valuation: FX derivatives are valued using industry standard and bespoke models depending on the product type. Valuation inputs include FX rates, interest rates, FX volatilities, interest rate volatilities, FX interest rate correlations and others as appropriate.
Observability: FX correlations, forwards and volatilities are generally observable up to liquid maturities which are determined separately for each input and underlying.
Unobservable inputs are set by referencing liquid market instruments and applying extrapolation techniques, or inferred via another reasonable method.
Credit derivatives
Description: Derivatives linked to the credit spread of a referenced entity, index or basket of referenced entities or a pool of referenced assets (e.g. a securitised product). The category includes single name and index credit default swaps (CDS) and total return swaps (TRS).
Valuation: CDS are valued on industry standard models using curves of credit spreads as the principal input. Credit spreads are observed directly from broker data, third party vendors or priced to proxies.
Observability: CDS contracts referencing entities that are actively traded are generally considered observable. Other valuation inputs are considered observable if products with significant sensitivity to the inputs are actively traded in a liquid market. Unobservable valuation inputs are generally determined with reference to recent transactions or inferred from observable trades of the same issuer or similar entities.
Equity derivatives
Description: Exchange traded or OTC derivatives linked to equity indices and single names. The category includes vanilla and exotic equity products.
Valuation: Equity derivatives are valued using industry standard models. Valuation inputs include stock prices, dividends, volatilities, interest rates, equity repurchase curves and, for multi-asset products, correlations.
Observability: In general, valuation inputs are observable up to liquid maturities which are determined separately for each input and underlying. Unobservable inputs are set by referencing liquid market instruments and applying extrapolation techniques, or inferred via another reasonable method.
Corporate debt
Description:Primarily corporate bonds.
Valuation: Corporate bonds are valued using observable market prices sourced from broker quotes, inter-dealer prices or other reliable pricing sources.
Observability: Prices for actively traded bonds are considered observable. Unobservable bonds prices are generally determined by reference to bond yields or CDS spreads for actively traded instruments issued by or referencing the same (or a similar) issuer.
Reverse repurchase and repurchase agreements
Description: Includes securities purchased under resale agreements, securities sold under repurchase agreements, and other similar secured lending agreements. The agreements are primarily short-term in nature.
Valuation: Repurchase and reverse repurchase agreements are generally valued by discounting the expected future cash flows using industry standard models that incorporate market interest rates and repurchase rates, based on the specific details of the transaction.
Observability: Inputs are deemed observable up to liquid maturities, and are determined based on the specific features of the transaction. Unobservable inputs are generally set by referencing liquid market instruments and applying extrapolation techniques, or inferred via another reasonable method.
Non-asset backed loans
Description: Largely made up of fixed rate loans.
Valuation: Fixed rate loans are valued using models that discount expected future cash flows based on interest rates and loan spreads.
Observability:Within this loan population, the loan spread is generally unobservable. Unobservable loan spreads are determined by incorporating funding costs, the level of comparable assets such as gilts, issuer credit quality and other factors.
Asset backed securities
Description: Securities that are linked to the cash flows of a pool of referenced assets via securitisation. The category includes residential mortgage backed securities, commercial mortgage backed securities, CDOs, collateralised loan obligations (CLOs) and other asset backed securities.
Valuation: Where available, valuations are based on observable market prices sourced from broker quotes and inter-dealer prices. Otherwise, valuations are determined using industry standard discounted cash flow analysis that calculates the fair value based on valuation inputs such as constant default rate, conditional prepayment rate, loss given default and yield. These inputs are determined by reference to a number of sources including proxying to observed transactions, market indices or market research, and by assessing underlying collateral performance.
Proxying to observed transactions, indices or research requires an assessment and comparison of the relevant securities’ underlying attributes including collateral, tranche, vintage, underlying asset composition (historical losses, borrower characteristics and loan attributes such as loan to value ratio and geographic concentration) and credit ratings (original and current).
Observability:Where an asset backed product does not have an observable market price and the valuation is determined using a discounted cash flow analysis, the instrument is considered unobservable.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
255

Notes to the financial statements
For the year ended 31 December 2021 continued
Equity cash products
Description: Includes listed equities, Exchange Traded Funds (ETF) and preference shares.
Valuation: Valuation of equity cash products is primarily determined through market observable prices.
Observability: Prices for actively traded equity cash products are considered observable. Unobservable equity prices are generally determined by reference to actively traded instruments that are similar in nature, or inferred via another reasonable method.
Private equity investments
Description: Includes investments in equity holdings in operating companies not quoted on a public exchange.
Valuation: Private equity investments are valued in accordance with the ‘International Private Equity and Venture Capital Valuation Guidelines’ which require the use of a number of individual pricing benchmarks such as the prices of recent transactions in the same or similar entities, discounted cash flow analysis and comparison with the earnings multiples of listed companies. While the valuation of unquoted equity instruments is subjective by nature, the relevant methodologies are commonly applied by other market participants and have been consistently applied over time.
Observability: Inputs are considered observable if there is active trading in a liquid market of products with significant sensitivity to the inputs. Unobservable inputs include earnings estimates, multiples of comparative companies, marketability discounts and discount rates.
Other
Description: Other includes commercial real estate loans,, asset backed loans, funds and fund-linked products, issued debt, government sponsored debt, commodity derivatives and investment property.
Assets and liabilities reclassified between Level 1 and Level 2
During the period, there were no material transfers between Level 1 and Level 2 (2020: there were no material transfers between Level 1 and Level 2).
Level 3 movement analysis
The following table summarises the movements in the Level 3 balances during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the year.
Asset and liability transfers between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
256

Notes to the financial statements
For the year ended 31 December 2021 continued
Analysis of movements in Level 3 assets and liabilities
As at 1 January 2021Total gains and (losses) in the period recognised in the income statementTotal gains or (losses) recognised in OCITransfers As at 31 December 2021
PurchasesSalesIssuesSettlementsTrading incomeOther incomeInOut
£m£m£m£m£m£m£m£m£m£m£m
Corporate debt151 310 (123) (12)38   41 (16)389 
Non-asset backed loans709 1,580 (1,409) (85)(1)  45 (81)758 
Asset backed securities686 209 (370)  (69)  114 (116)454 
Equity cash products214 45 (53) 4 23   80 (10)303 
Other103 117 (2) (61)(3)  248 (25)377 
Trading portfolio assets1,863 2,261 (1,957) (154)(12)  528 (248)2,281 
Non-asset backed loans5,580 1,380 (306) (748)(181)(174) 113 (17)5,647 
Equity cash products326 3 (247)   7  1  90 
Private equity investments874 166 (24) (9) 163  35 (110)1,095 
Other1,726 11,253 (9,983) (185)2 20  48 (1)2,880 
Financial assets at fair value through the income statement8,506 12,802 (10,560) (942)(179)16  197 (128)9,712 
Non-asset backed loans106         (106)0 
Asset backed securities47    (7)  (2)  38 
Financial assets at fair value through other comprehensive income153    (7)  (2) (106)38 
Investment property10  (2)   (1)   7 
Trading portfolio liabilities(28)(5)23   (6)  (12)1 (27)
Financial liabilities designated at fair value(355)(4) (101)66 21 (1) (68)32 (410)
Interest rate derivatives(2)20   105 (255)  90 (218)(260)
Foreign exchange derivatives1    40 (2)  10 (47)2 
Credit derivatives(155)(239)9  (45)34   10  (386)
Equity derivatives(1,614)90 (1) (15)(4)  (3)142 (1,405)
Net derivative financial instrumentsa
(1,770)(129)8  85 (227)  107 (123)(2,049)
Total8,379 14,925 (12,488)(101)(952)(403)14 (2)752 (572)9,552 
Note
a    The derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets are £4,010m (2020: £4,469m) and derivative financial liabilities are £6,059m (2020: £6,239m).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
257

Notes to the financial statements
For the year ended 31 December 2021 continued
Analysis of movements in Level 3 assets and liabilities
As at 1 January 2020Total gains and (losses) in the period recognised in the income statementTotal gains or (losses) recognised in OCITransfers As at 31 December 2020
PurchasesSalesIssuesSettlements Trading incomeOther incomeInOut
£m£m£m£m£m£m£m£m£m£m£m
Corporate debt120 77 (6) — (35)  12 (17)151 
Non-asset backed loans974 1,955 (2,182) (12)(10)  39 (55)709 
Asset backed securities656 458 (428) (40)(25)  90 (25)686 
Equity cash products392 5 (149) — (41)  11 (4)214 
Other122    — (21)  2  103 
Trading portfolio assets2,264 2,495 (2,765) (52)(132)  154 (101)1,863 
Non-asset backed loans5,494 1,102 (283) (706)426    (453)5,580 
Equity cash products835 15 (404) — (93)(36) 9  326 
Private equity investments900 84 (54) (3) (56) 15 (12)874 
Other1,271 3,718 (3,606) (32)32 (43) 386  1,726 
Financial assets at fair value through the income statement8,500 4,919 (4,347) (741)365 (135) 410 (465)8,506 
Non-asset backed loans343    (237)     106 
Asset backed securities86  (35) —   (4)  47 
Financial assets at fair value through other comprehensive income429  (35) (237)  (4)  153 
Investment property13  (2) —  (1)   10 
Trading portfolio liabilities (27)  — (1)    (28)
Financial liabilities designated at fair value(362) 3 (21)20 4  (38)38 (355)
Interest rate derivatives(206)17 (12) 85 109   (18)23 (2)
Foreign exchange derivatives(7)   21 (16)  (19)22 
Credit derivatives198 (125)24  (371)24   (21)116 (155)
Equity derivatives(819)(699)(43) 105 (101)  (13)(44)(1,614)
Net derivative financial instruments(834)(807)(31) (160)16   (71)117 (1,770)
Total10,010 6,580 (7,177)(21)(1,189)268 (132)(4)455 (411)8,379 
Unrealised gains and losses on Level 3 financial assets and liabilities
The following table discloses the unrealised gains and losses recognised in the year arising on Level 3 financial assets and liabilities held at year end.
Unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at year end
20212020
Income statementOther compre-
hensive
income
TotalIncome statementOther
compre-
hensive income
Total
Trading incomeOther incomeTrading incomeOther income
As at 31 December£m£m£m£m£m£m£m£m
Trading portfolio assets(67)  (67)(114)  (114)
Financial assets at fair value through the income statement(176)154  (22)399 (89) 310 
Fair value through other comprehensive income      (1)(1)
Investment property     (1) (1)
Trading portfolio liabilities(5)  (5)    
Financial liabilities designated at fair value16 (1) 15 20 (1) 19 
Net derivative financial instruments (196)  (196)(91)  (91)
Total(428)153  (275)214 (91)(1)122 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
258

Notes to the financial statements
For the year ended 31 December 2021 continued
Significant unobservable inputs
The following table discloses the valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 along with the range of values used for those significant unobservable inputs:
Valuation technique(s)a
Significant unobservable inputs2021 Range2020 Range
MinMaxMinMax
Unitsb
Derivative financial instrumentsc
Interest rate derivativesDiscounted cash flowsInflation forwards 3 %
Credit spread9 1,848 17 1,831 bps
Correlation ModelInflation forwards(20)(13)(20)(13)%
Comparable pricingPrice 38 — 84points
Option modelInflation volatility31 130 31 227 bps vol
Interest rate volatility5 600 489 bps vol
FX - IR correlation(20)78 (30)78 %
IR - IR correlation(100)99 (20)99 %
Credit derivativesDiscounted cash flowsCredit spread2 2,925 480 bps
Comparable pricingPrice  — 100points
Equity derivativesOption modelEquity volatility2 108 110 %
Equity - equity correlation10 100 (45)100 %
Discounted cash flowDiscounted margin(129)93 (225)3,000 bps
Foreign exchange derivativesOption ModelOption Volatility 100 — 30 points
Non-derivative financial instruments
Non-asset backed loansDiscounted cash flowsLoan spread31 1,552 31 1,518 bps
Credit spread200 300 200 300 bps
Price 112 — 104points
Yield3 10 %
Comparable pricingPrice 145 — 137points
Asset backed securitiesComparable pricingPrice 120 — 112points
Private equity investmentsEBITDA multipleEBITDA multiple16 20 14 16Multiple
Earnings multipleEarnings multiple5 28 28Multiple
Discounted cash flowCredit Spread725 1,916 1,387 1,916 bps
Discount margin8 10 10 %
Corporate debtComparable pricingPrice 284 — 127points
Discounted Cash FlowsLoan Spread229 854 — — bps
Price 100 — 104 points
Commercial Real Estate loansDiscounted cash flowsCredit spread68 543 146 483 bps
Equity cash productsDiscounted cash flowsDiscount Margin26 34 49 49 bps
Notes
a    A range has not been provided for Net Asset Value as there would be a wide range reflecting the diverse nature of the positions.
b The units used to disclose ranges for significant unobservable inputs are percentages, points and basis points. Points are a percentage of par; for example, 100 points equals 100% of par. A basis point equals 1/100th of 1%; for example, 150 basis points equals 1.5%.
c    Certain derivative instruments are classified as Level 3 due to a significant unobservable credit spread input into the calculation of the Credit Valuation Adjustment for the instruments. The range of significant unobservable credit spreads is between 32-1848bps (2020: 17-1,831bps).
The following section describes the significant unobservable inputs identified in the table above, and the sensitivity of fair value measurement of the instruments categorised as Level 3 assets or liabilities to increases in significant unobservable inputs. Where sensitivities are described, the inverse relationship will also generally apply.
Where reliable interrelationships can be identified between significant unobservable inputs used in fair value measurement, a description of those interrelationships is included below.
Forwards
A price or rate that is applicable to a financial transaction that will take place in the future.
In general, a significant increase in a forward in isolation will result in a fair value increase for the contracted receiver of the underlying (currency, bond, commodity, etc.), but the sensitivity is dependent on the specific terms of the instrument.
Credit spread
Credit spreads typically represent the difference in yield between an instrument and a benchmark security or reference rate. Credit spreads reflect the additional yield that a market participant demands for taking on exposure to the credit risk of an instrument and form part of the yield used in a discounted cash flow calculation.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
259

Notes to the financial statements
For the year ended 31 December 2021 continued
In general, a significant increase in credit spread in isolation will result in a movement in a fair value decrease for a cash asset.
For a derivative instrument, a significant increase in credit spread in isolation can result in a fair value increase or decrease depending on the specific terms of the instrument.
Volatility
Volatility is a measure of the variability or uncertainty in return for a given derivative underlying. It is an estimate of how much a particular underlying instrument input or index will change in value over time. In general, volatilities are implied from observed option prices. For unobservable options the implied volatility may reflect additional assumptions about the nature of the underlying risk, and the strike/maturity profile of a specific contract.
In general a significant increase in volatility in isolation will result in a fair value increase for the holder of a simple option, but the sensitivity is dependent on the specific terms of the instrument.
There may be interrelationships between unobservable volatilities and other unobservable inputs (e.g. when equity prices fall, implied equity volatilities generally rise) but these are generally specific to individual markets and may vary over time.
Correlation
Correlation is a measure of the relationship between the movements of two variables. Correlation can be a significant input into valuation of derivative contracts with more than one underlying instrument. Credit correlation generally refers to the correlation between default processes for the separate names that make up the reference pool of a CDO structure.
A significant increase in correlation in isolation can result in a fair value increase or decrease depending on the specific terms of the instrument.
Comparable price
Comparable instrument prices are used in valuation by calculating an implied yield (or spread over a liquid benchmark) from the price of a comparable observable instrument, then adjusting that yield (or spread) to account for relevant differences such as maturity or credit quality. Alternatively, a price-to-price basis can be assumed between the comparable and unobservable instruments in order to establish a value.
In general, a significant increase in comparable price in isolation will result in an increase in the price of the unobservable instrument. For derivatives, a change in the comparable price in isolation can result in a fair value increase or decrease depending on the specific terms of the instrument.
Loan spread
Loan spreads typically represent the difference in yield between an instrument and a benchmark security or reference rate. Loan spreads typically reflect credit quality, the level of comparable assets such as gilts and other factors, and form part of the yield used in a discounted cash flow calculation.
The ESHLA portfolio primarily consists of long-dated fixed rate loans extended to counterparties in the UK Education, Social Housing and Local Authority sectors. The loans are categorised as Level 3 in the fair value hierarchy due to their illiquid nature and the significance of unobservable loan spreads to the valuation. Valuation uncertainty arises from the long-dated nature of the portfolio, the lack of secondary market in the loans and the lack of observable loan spreads. The majority of ESHLA loans are to borrowers in heavily regulated sectors that are considered extremely low credit risk, and have a history of near zero defaults since inception. While the overall loan spread range is from 31bps to 1,552bps (2020: 31bps to 1,518bps), the vast majority of spreads are concentrated towards the bottom end of this range, with 97% of the loan notional being valued with spreads less than 200bps consistently for both years.
In general, a significant increase in loan spreads in isolation will result in a fair value decrease for a loan.
EBITDA multiple
EBITDA multiple is the ratio of the valuation of the investment to the earnings before interest, taxes, depreciation and amortisation.
In general, a significant increase in the multiple will result in a fair value increase for an investment.
Sensitivity analysis of valuations using unobservable inputs
20212020
Favourable changesUnfavourable changesFavourable changesUnfavourable changes
Income statementEquityIncome statementEquityIncome statementEquityIncome statementEquity
£m£m£m£m£m£m£m£m
Interest rate derivatives51  (79) 82 — (123)— 
Foreign exchange derivatives20  (28) — (11)— 
Credit derivatives111  (103) 55 — (44)— 
Equity derivatives187  (195) 174 — (179)— 
Corporate debt38  (28) 16 — (14)— 
Non-asset backed loans165  (256) 190 (409)(3)
Equity cash products42  (61) 158 — (141)— 
Private equity investments246  (236) 199 — (227)— 
Othera
20  (19) 23 — (23)— 
Total880  (1,005) 903 (1,171)(3)
Note
a    Other includes commercial real estate loans and asset backed loans, funds and fund-linked products, issued debt, government sponsored debt, commodity derivatives and investmen property.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
260

Notes to the financial statements
For the year ended 31 December 2021 continued
The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact of using alternative models, would be to increase fair values by up to £880m (2020: £906m) or to decrease fair values by up to £1,005m (2020: £1,174m) with substantially all the potential effect impacting profit and loss rather than reserves.
Fair value adjustments
Key balance sheet valuation adjustments are quantified below:
20212020
£m£m
Exit price adjustments derived from market bid-offer spreads(506)(493)
Uncollateralised derivative funding(127)(115)
Derivative credit valuation adjustments(212)(268)
Derivative debit valuation adjustments91 113 
Exit price adjustments derived from market bid-offer spreads
The Group uses mid-market pricing where it is a market maker and has the ability to transact at, or better than, mid price (which is the case for certain equity, bond and vanilla derivative markets). For other financial assets and liabilities, bid-offer adjustments are recorded to reflect the exit level for the expected close out strategy. The methodology for determining the bid-offer adjustment for a derivative portfolio involves calculating the net risk exposure by offsetting long and short positions by strike and term in accordance with the risk management and hedging strategy.
Bid-offer levels are generally derived from market quotes such as broker data. Less liquid instruments may not have a directly observable bid-offer level. In such instances, an exit price adjustment may be derived from an observable bid-offer level for a comparable liquid instrument, or determined by calibrating to derivative prices, or by scenario or historical analysis.
Exit price adjustments derived from market bid-offer spreads have increased by £13m to £506m.
Discounting approaches for derivative instruments
Collateralised
In line with market practice, the methodology for discounting collateralised derivatives takes into account the nature and currency of the collateral that can be posted within the relevant credit support annex (CSA). The CSA aware discounting approach recognises the ‘cheapest to deliver’ option that reflects the ability of the party posting collateral to change the currency of the collateral.
Uncollateralised
A fair value adjustment of £127m is applied to account for the impact of incorporating the cost of funding into the valuation of uncollateralised and partially collateralised derivative portfolios and collateralised derivatives where the terms of the agreement do not allow the rehypothecation of collateral received. This adjustment is referred to as the Funding Fair Value Adjustment (FFVA). FFVA has increased by £12m to £127m as a result of underlying moves in the exposure profile of the derivative portfolio in scope.
Derivative credit and debit valuation adjustments
CVA and DVA are incorporated into derivative valuations to reflect the impact on fair value of counterparty credit risk and Barclays’ own credit quality respectively. These adjustments are calculated for uncollateralised and partially collateralised derivatives across all asset classes. CVA and DVA are calculated using estimates of exposure at default, probability of default and recovery rates, at a counterparty level. Counterparties include (but are not limited to) corporates, sovereigns and sovereign agencies and supranationals.
Exposure at default is generally estimated through the simulation of underlying risk factors through approximating with a more vanilla structure, or by using current or scenario-based mark to market as an estimate of future exposure.
Probability of default and recovery rate information is generally sourced from the CDS markets. Where this information is not available, or considered unreliable, alternative approaches are taken based on mapping internal counterparty ratings onto historical or market-based default and recovery information.
CVA decreased by £56m to £212m as a result of tightening input counterparty credit spreads. DVA decreased by £22m to £91m as a result of tightening input own credit spreads.
Correlation between counterparty credit and underlying derivative risk factors, termed ‘wrong-way,’ or ‘right-way’ risk, is not systematically incorporated into the CVA calculation but is adjusted where the underlying exposure is directly related to the counterparty.
Barclays continues to monitor market practices and activity to ensure the approach to uncollateralised derivative valuation remains appropriate.
Portfolio exemptions
The Group uses the portfolio exemption in IFRS 13 Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
261

Notes to the financial statements
For the year ended 31 December 2021 continued
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, is £133m (2020: £116m) for financial instruments measured at fair value and £230m (2020: £247m) for financial instruments carried at amortised cost. There are additions of £59m (2020: £27m), and amortisation and releases of £42m (2020: £24m) for financial instruments measured at fair value and additions of £nil (2020: £6m) and amortisation and releases of £17m (2020: £14m) for financial instruments measured at amortised cost.
Third party credit enhancements
Structured and brokered certificates of deposit issued by Barclays are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the US. The FDIC is funded by premiums that Barclays and other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9 fair value option includes this third party credit enhancement. The on-balance sheet value of these brokered certificates of deposit amounted to £790m (2020: £1,494m).
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s balance sheet:
20212020
Carrying amountFair valueLevel 1Level 2Level 3Carrying amountFair valueLevel 1Level 2Level 3
As at 31 December£m£m£m£m£m£m£m£m£m£m
Financial assets
Loans and advances at amortised cost361,451 362,424 17,381 83,191 261,852 342,632 340,516 8,824 81,322 250,370 
Reverse repurchase agreements and other similar secured lending 3,227 3,227  3,227  9,031 9,031  9,031  
Financial liabilities
Deposits at amortised cost(519,433)(519,436)(434,431)(83,501)(1,504)(481,036)(481,106)(396,124)(82,874)(2,108)
Repurchase agreements and other similar secured borrowing (28,352)(28,358) (28,358) (14,174)(14,174) (14,174) 
Debt securities in issue (98,867)(100,657) (98,364)(2,293)(75,796)(77,813) (75,957)(1,856)
Subordinated liabilities (12,759)(13,334) (13,267)(67)(16,341)(16,918) (16,918) 
The fair value is an estimate of the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As a wide range of valuation techniques are available, it may not be appropriate to directly compare this fair value information to independent market sources or other financial institutions. Different valuation methodologies and assumptions can have a significant impact on fair values which are based on unobservable inputs.
Financial assets
The carrying value of financial assets held at amortised cost is determined in accordance with the relevant accounting policy in Note 19.
Loans and advances at amortised cost
The fair value of loans and advances, for the purpose of this disclosure, is derived from discounting expected cash flows in a way that reflects the current market price for lending to issuers of similar credit quality. Where market data or credit information on the underlying borrowers is unavailable, a number of proxy/extrapolation techniques are employed to determine the appropriate discount rates.
Reverse repurchase agreements and other similar secured borrowing
The fair value of reverse repurchase agreements approximates carrying amount as these balances are generally short dated and fully collateralised.
Financial liabilities
The carrying value of financial liabilities held at amortised cost is determined in accordance with the accounting policy in Note 1.
Deposits at amortised cost
In many cases, the fair value disclosed approximates carrying value because the instruments are short term in nature or have interest rates that reprice frequently, such as customer accounts and other deposits and short-term debt securities.
The fair value for deposits with longer-term maturities, mainly time deposits, are estimated using discounted cash flows applying either market rates or current rates for deposits of similar remaining maturities. Consequently, the fair value discount is minimal.
Repurchase agreements and other similar secured borrowing
The fair value of repurchase agreements approximates carrying amounts as these balances are generally short dated.
Debt securities in issue
Fair values of other debt securities in issue are based on quoted prices where available, or where the instruments are short dated, carrying amount approximates fair value.
Subordinated liabilities
Fair values for dated and undated convertible and non-convertible loan capital are based on quoted market rates for the issuer concerned or issuers with similar terms and conditions.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
262

Notes to the financial statements
For the year ended 31 December 2021 continued
18 Offsetting financial assets and financial liabilities
In accordance with IAS 32 Financial Instruments: Presentation, the Group reports financial assets and financial liabilities on a net basis on the balance sheet only if there is a legally enforceable right to set-off the recognised amounts and there is intention to settle on a net basis, or to realise the asset and settle the liability simultaneously. The following table shows the impact of netting arrangements on:
all financial assets and liabilities that are reported net on the balance sheet
all derivative financial instruments and reverse repurchase and repurchase agreements and other similar secured lending and borrowing agreements that are subject to enforceable master netting arrangements or similar agreements, but do not qualify for balance sheet netting.
The ‘Net amounts’ presented are not intended to represent the Group’s actual exposure to credit risk, as a variety of credit mitigation strategies are employed in addition to netting and collateral arrangements.
Amounts subject to enforceable netting arrangements
Amounts not subject to enforceable netting arrangementsc
Balance sheet totald
Effects of offsetting on-balance sheetRelated amounts not offset
Gross amounts
Amounts offseta
Net amounts reported on the balance sheetFinancial instruments
Financial collateralb
Net amount
£m£m£m£m£m£m£m£m
As at 31 December 2021
Derivative financial assets279,568 (24,137)255,431 (202,519)(40,485)12,427 7,141 262,572 
Reverse repurchase agreements and other similar secured lendinge
514,360 (370,003)144,357  (143,854)503 3,884 148,241 
Total assets793,928 (394,140)399,788 (202,519)(184,339)12,930 11,025 410,813 
Derivative financial liabilities(274,356)23,606 (250,750)202,519 34,321 (13,910)(6,133)(256,883)
Repurchase agreements and other similar secured borrowinge
(535,653)370,003 (165,650) 165,650  (30,762)(196,412)
Total liabilities(810,009)393,609 (416,400)202,519 199,971 (13,910)(36,895)(453,295)
As at 31 December 2020
Derivative financial assets342,649 (44,305)298,344 (233,080)(48,064)17,200 4,102 302,446 
Reverse repurchase agreements and other similar secured lendinge
448,134 (306,398)141,736 — (141,352)384 4,911 146,647 
Total assets790,783 (350,703)440,080 (233,080)(189,416)17,584 9,013 449,093 
Derivative financial liabilities(333,943)41,982 (291,961)233,080 46,804 (12,077)(8,814)(300,775)
Repurchase agreements and other similar secured borrowinge
(476,912)306,398 (170,514)— 170,514 — (21,031)(191,545)
Total liabilities(810,855)348,380 (462,475)233,080 217,318 (12,077)(29,845)(492,320)
Notes
a    Amounts offset for derivative financial assets additionally includes cash collateral netted of £3,815m (2020: £4,990m). Amounts offset for derivative financial liabilities additionally includes cash collateral netted of £4,346m (2020: £7,313m). Settlements assets and liabilities have been offset amounting to £22,837m (2020: £18,143m).
b    Financial collateral of £40,485m (2020: £48,064m) was received in respect of derivative assets, including £34,598m (2020: £43,291m) of cash collateral and £5,887m (2020: £4,773m) of non-cash collateral. Financial collateral of £34,321m (2020: £46,804m) was placed in respect of derivative liabilities, including £32,031m (2020: £42,730m) of cash collateral and £2,290m (2020: £4,074m) of non-cash collateral. The collateral amounts are limited to net balance sheet exposure so as to not include overcollateralisation.
c    This column includes contractual rights of set-off that are subject to uncertainty under the laws of the relevant jurisdiction.
d    The balance sheet total is the sum of ‘Net amounts reported on the balance sheet’ that are subject to enforceable netting arrangements and ‘Amounts not subject to enforceable netting arrangements’.
e    Reverse repurchase agreements and other similar secured lending of £148,241m (2020: £146,647m) is split by fair value £145,014m (2020: £137,616m) and amortised cost £3,227m (2020: £9,031m). Repurchase agreements and other similar secured borrowing of £196,412m (2020: £191,545m) is split by fair value £168,060m (2020: £177,371m) and amortised cost £28,352m (2020: £14,174m).
Derivative assets and liabilities
The ‘Financial instruments’ column identifies financial assets and liabilities that are subject to set-off under netting agreements, such as the ISDA Master Agreement or derivative exchange or clearing counterparty agreements, whereby all outstanding transactions with the same counterparty can be offset and close-out netting applied across all outstanding transactions covered by the agreements if an event of default or other predetermined events occur.
Financial collateral refers to cash and non-cash collateral obtained, typically daily or weekly, to cover the net exposure between counterparties by enabling the collateral to be realised in an event of default or if other predetermined events occur.
Repurchase and reverse repurchase agreements and other similar secured lending and borrowing
The ‘Financial instruments’ column identifies financial assets and liabilities that are subject to set-off under netting agreements, such as Global Master Repurchase Agreements and Global Master Securities Lending Agreements, whereby all outstanding transactions with the same counterparty can be offset and close-out netting applied across all outstanding transactions covered by the agreements if an event of default or other predetermined events occur.
Financial collateral typically comprises highly liquid securities which are legally transferred and can be liquidated in the event of counterparty default.
These offsetting and collateral arrangements and other credit risk mitigation strategies used by the Group are further explained in the Credit risk management section.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
263

Notes to the financial statements
For the year ended 31 December 2021 continued
Assets at amortised cost and other investments
The notes included in this section focus on the Group’s loans and advances and deposits at amortised cost, leases, property, plant and equipment and goodwill and intangible assets. Details regarding the Group’s liquidity and capital position can be found in the Treasury and capital risk section.
19 Loans and advances and deposits at amortised cost
Accounting for loans and advances and deposits held at amortised cost
Loans and advances to customers and banks, customer accounts, debt securities and most financial liabilities, are held at amortised cost. That is, the initial fair value (which is normally the amount advanced or borrowed) is adjusted for repayments and the amortisation of coupon, fees and expenses to represent the effective interest rate of the asset or liability. Balances deferred on-balance sheet as effective interest rate adjustments are amortised to interest income over the life of the financial instrument to which they relate.
Financial assets that are held in a business model to collect the contractual cash flows and that contain contractual terms that give rise on specified dates to cash flows that are SPPI, are measured at amortised cost. The carrying value of these financial assets at initial recognition includes any directly attributable transaction costs. Refer to Note 1 for details on ‘solely payments of principal and interest’.
In determining whether the business model is a ‘hold to collect’ model, the objective of the business model must be to hold the financial asset to collect contractual cash flows rather than holding the financial asset for trading or short-term profit taking purposes. While the objective of the business model must be to hold the financial asset to collect contractual cash flows this does not mean the Group is required to hold the financial assets until maturity. When determining if the business model objective is to collect contractual cash flows the Group will consider past sales and expectations about future sales.
Loans and advances and deposits at amortised cost
20212020
As at 31 December£m£m
Loans and advances at amortised cost to banks9,698 8,900 
Loans and advances at amortised cost to customers319,922 309,927 
Debt securities at amortised cost31,831 23,805 
Total loans and advances at amortised cost361,451 342,632 
Deposits at amortised cost from banks17,819 17,343 
Deposits at amortised cost from customers501,614 463,693 
Total deposits at amortised cost519,433 481,036 
20 Property, plant and equipment
Accounting for property, plant and equipment
The Group applies IAS 16 Property Plant and Equipment and IAS 40 Investment Properties.
Property, plant and equipment is stated at cost, which includes direct and incremental acquisition costs less accumulated depreciation and provisions for impairment, if required. Subsequent costs are capitalised if these result in enhancement of the asset.
Depreciation is provided on the depreciable amount of items of property, plant and equipment on a straight-line basis over their estimated useful economic lives. Depreciation rates, methods and the residual values underlying the calculation of depreciation of items of property, plant and equipment are kept under review to take account of any change in circumstances. The Group uses the following annual rates in calculating depreciation:
Annual rates in calculating depreciationDepreciation rate 
Freehold landNot depreciated
Freehold buildings and long-leasehold property (more than 50 years to run)
2-3.3%
Leasehold property over the remaining life of the lease (less than 50 years to run)Over the remaining life of the lease
Costs of adaptation of freehold and leasehold property
6-10%
Equipment installed in freehold and leasehold property
6-10%
Computers and similar equipment
17-33%
Fixtures and fittings and other equipment
9-20%
Costs of adaptation and installed equipment are depreciated over the shorter of the life of the lease or the depreciation rates noted in the table above.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
264

Notes to the financial statements
For the year ended 31 December 2021 continued
Investment property
The Group initially recognises investment property at cost, and subsequently at fair value at each balance sheet date, reflecting market conditions at the reporting date. Gains and losses on remeasurement are included in the income statement.
Investment
property
PropertyEquipment
Right of use assetsa
Total
£m£m£m£m£m
Cost
As at 1 January 202110 4,002 3,091 1,934 9,037 
Additions 274 189 32 495 
Disposals(2)(160)(74)(114)(350)
Exchange and other movements(1)15 4 68 86 
As at 31 December 20217 4,131 3,210 1,920 9,268 
Accumulated depreciation and impairment
As at 1 January 2021 (2,013)(2,421)(567)(5,001)
Depreciation charge (249)(222)(204)(675)
Impairmentb
 (106) (170)(276)
Disposals 136 66 60 262 
Exchange and other movements (23)(9)9 (23)
As at 31 December 2021 (2,255)(2,586)(872)(5,713)
Net book value 7 1,876 624 1,048 3,555 
Cost
As at 1 January 202013 3,938 2,986 1,826 8,763 
Additions— 193 246 85 524 
Disposals(1)(96)(100)(14)(211)
Exchange and other movements(2)(33)(41)37 (39)
As at 31 December 202010 4,002 3,091 1,934 9,037 
Accumulated depreciation and impairment
As at 1 January 2020— (1,901)(2,315)(332)(4,548)
Depreciation charge— (187)(223)(231)(641)
Impairment— (25)(2)(15)(42)
Disposals— 82 92 176 
Exchange and other movements— 18 27 54 
As at 31 December 2020— (2,013)(2,421)(567)(5,001)
Net book value 10 1,989 670 1,367 4,036 
Notes
a    Right of use (ROU) asset balances relate to property leases under IFRS 16. Refer to Note 21 for further details.
b    Impairment charge includes £266m related to structural cost action in relation to the real estate review.
Property rentals of £16m (2020: £11m) have been included in other income.
The fair value of investment property is determined by reference to current market prices for similar properties, adjusted as necessary for condition and location, or by reference to recent transactions updated to reflect current economic conditions. Discounted cash flow techniques may be employed to calculate fair value where there have been no recent transactions, using current external market inputs such as market rents and interest rates. Valuations are carried out by management with the support of appropriately qualified independent valuers.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
265

Notes to the financial statements
For the year ended 31 December 2021 continued
21 Leases
Accounting for leases
IFRS 16 applies to all leases with the exception of licenses of intellectual property, rights held by licensing agreement within the scope of IAS 38 Intangible Assets, service concession arrangements, leases of biological assets within the scope of IAS 41 Agriculture and leases of minerals, oil, natural gas and similar non-regenerative resources. IFRS 16 includes an accounting policy choice for a lessee to elect not to apply IFRS 16 to remaining assets within the scope of IAS 38 Intangible Assets which the Group has decided to apply.
When the Group is the lessee, it is required to recognise both:
A lease liability, measured at the present value of remaining cash flows on the lease, and
A right of use (ROU) asset, measured at the amount of the initial measurement of the lease liability, plus any lease payments made prior to commencement date, initial direct costs, and estimated costs of restoring the underlying asset to the condition required by the lease, less any lease incentives received.
Subsequently the lease liability will increase for the accrual of interest, resulting in a constant rate of return throughout the life of the lease, and reduce when payments are made. The right of use asset will amortise to the income statement over the life of the lease. The lease liability is remeasured when there is a change in one of the following:
Future lease payments arising from a change in an index or rate;
The Group’s estimate of the amount expected to be payable under a residual value guarantee; or
The Group’s assessment of whether it will exercise a purchase, extension or termination option.
When the lease liability is remeasured, a corresponding adjustment is made to the carrying amount of the ROU asset, or is recorded in the income statement if the carrying amount of the ROU asset has been reduced to nil.
On the balance sheet, the ROU assets are included within property, plant and equipment and the lease liabilities are included within other liabilities.
The Group applies the recognition exemption in IFRS 16 for leases with a term not exceeding 12 months. For these leases the lease payments are recognised as an expense on a straight line basis over the lease term unless another systematic basis is more appropriate.
When the Group is the lessor, the lease must be classified as either a finance lease or an operating lease. A finance lease is a lease which confers substantially all the risks and rewards of the leased assets on the lessee. An operating lease is a lease where substantially all of the risks and rewards of the leased asset remain with the lessor.
When the lease is deemed a finance lease, the leased asset is not held on the balance sheet; instead a finance lease receivable is recognised representing the minimum lease payments receivable under the terms of the lease, discounted at the rate of interest implicit in the lease.
When the lease is deemed an operating lease, the lease income is recognised on a straight-line basis over the period of the lease unless another systematic basis is more appropriate. The Group holds the leased assets on-balance sheet within property, plant and equipment.
As a Lessor
Finance lease receivables are included within loans and advances at amortised cost.
The following table sets out a maturity analysis of lease receivables, showing the lease payments to be received after the reporting date.
20212020
Gross investment in finance lease receivablesFuture finance incomePresent value of minimum lease payments
receivable
Unguaranteed residual valuesGross investment in finance lease receivablesFuture finance incomePresent value of minimum lease payments
receivable
Unguaranteed residual values
£m£m£m£m£m£m£m£m
Not more than one year29 (3)26  535 (26)509 70 
One to two year19 (2)17  312 (15)297 45 
Two to three year6  6  215 (12)203 52 
Three to four year2  2  107 (6)101 27 
Four to five year1  1  52 (3)49 18 
Over five years1  1  24 (1)23 13 
Total58 (5)53  1,245 (63)1,182 225 
Barclays Asset Finance provided leasing and other asset finance facilities across a broad range of asset types to business and individual customers. In 2021, the Group sold the leasing portfolio held by Barclays Asset Finance leading to a decrease in gross investment in finance lease receivables. There is no impairment allowance for finance lease receivables in current year (2020: £29m).
The Group does not have any material operating leases as a lessor.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
266

Notes to the financial statements
For the year ended 31 December 2021 continued
Finance lease income
Finance lease income is included within interest income. The following table shows amounts recognised in the income statement during the year.
20212020
£m£m
Finance income from net investment in lease21 55 
Profit/(loss) on sales1 (25)

As a Lessee
The Group leases various offices, branches and other premises under non-cancellable lease arrangements to meet its operational business requirements. In some instances, Barclays will sublease property to third parties when it is no longer needed to meet business requirements. Currently, Barclays does not have any material subleasing arrangements.
ROU asset balances relate to property leases only. Refer to Note 20 for a breakdown of the carrying amount of ROU assets.
The total expenses recognised during the year for short term leases were £3m (2020: £4m). The portfolio of short term leases to which Barclays is exposed at the end of the year is not dissimilar to the expenses recognised in the year.
Lease liabilities
20212020
£m£m
As at 1 January1,444 1,563 
Interest expense64 70 
New leases43 85 
Disposals(54)(15)
Cash payments(258)(306)
Exchange and other movements78 47 
As at 31 December (see Note 23) 1,317 1,444 
The below table sets out a maturity analysis of undiscounted lease liabilities, showing the lease payments to be paid after the reporting date.
Undiscounted lease liabilities maturity analysis
20212020
£m£m
Not more than one year230 255 
One to two years215 221 
Two to three years197 198 
Three to four years182 176 
Four to five years149 162 
Five to ten years503 557 
Greater than ten years163 248 
Total undiscounted lease liabilities as at 31 December1,639 1,817 
In addition to the cash flows identified above, Barclays is exposed to:
Variable lease payments: This variability will typically arise from either inflation index instruments or market based pricing adjustments. Currently, Barclays has 609 (2020: 809) leases out of the total 1,111 (2020: 1,329) leases which have variable lease payment terms based on market based pricing adjustments. Of the gross cash flows identified above, £1,196m (2020: £1,096m) is attributable to leases with some degree of variability predominately linked to market based pricing adjustments.
Extension and termination options: The table above represents Barclays best estimate of future cash out flows for leases, including assumptions regarding the exercising of contractual extension and termination options. The above gross cash flows have been reduced by £434m (2020: £446m) for leases where Barclays is highly expected to exercise an early termination option. However, there is no significant impact where Barclays is expected to exercise an extension option.
In 2021, the Group recorded a gain on sale relating to a sale and leaseback transaction of the Monaco branch premises of £33m.
The Group does not have any restrictions or covenants imposed by the lessor on its property leases which restrict its businesses.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
267

Notes to the financial statements
For the year ended 31 December 2021 continued
22 Goodwill and intangible assets
Accounting for goodwill and intangible assets
Goodwill
The carrying value of goodwill is determined in accordance with IFRS 3 Business Combinations and IAS 36 Impairment of Assets.
Goodwill arising on the acquisition of subsidiaries represents the excess of the fair value of the purchase consideration over the fair value of the Group’s share of the assets acquired and the liabilities and contingent liabilities assumed on the date of the acquisition.
Goodwill is reviewed annually for impairment, or more frequently when there are indications that impairment may have occurred. The test involves comparing the carrying value of a cash generating unit (CGU) including goodwill with the present value of the pre-tax cash flows, discounted at a rate of interest that reflects the inherent risks, of the CGU to which the goodwill relates, or the CGU's fair value if this is higher.
Intangible assets
Intangible assets other than goodwill are accounted for in accordance with IAS 38 Intangible Assets.
Intangible assets are initially recognised when they are separable or arise from contractual or other legal rights, the cost can be measured reliably and, in the case of intangible assets not acquired in a business combination, where it is probable that future economic benefits attributable to the assets will flow from their use.
For internally generated intangible assets, only costs incurred during the development phase are capitalised. Expenditure in the research phase is expensed when it is incurred.
Intangible assets are stated at cost (which is, in the case of assets acquired in a business combination, the acquisition date fair value) less accumulated amortisation and impairment, if any, and are amortised over their useful lives in a manner that reflects the pattern to which they contribute to future cash flows, generally using the amortisation periods set out below:
Annual rates in calculating amortisationAmortisation period
Goodwill Not amortised
Internally generated softwarea
12 months to 6 years
Other software
12 months to 6 years
Customer lists
12 months to 25 years
Licences and other
12 months to 25 years
Note
a    Exceptions to the above rate relate to useful lives of certain core banking platforms that are assessed individually and, if appropriate, amortised over longer periods ranging from 10 to 15 years.

Intangible assets are reviewed for impairment when there are indications that impairment may have occurred. Intangible assets not yet available for use are reviewed annually for impairment.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
268

Notes to the financial statements
For the year ended 31 December 2021 continued
Intangible assets
GoodwillInternally
generated
software
Other
software
Customer
lists
Licences
and other
Total
£m£m£m£m£m£m
2021
Cost
As at 1 January 20214,716 7,247 639 1,419 490 14,511 
Additions and disposals (52)(9)(5)404 338 
Exchange and other movements2 (15)(4)17 14 14 
As at 31 December 20214,718 7,180 626 1,431 908 14,863 
Accumulated amortisation and impairment
As at 1 January 2021(825)(3,779)(328)(1,252)(379)(6,563)
Disposals 894 15 5 3 917 
Amortisation charge (867)(51)(36)(44)(998)
Impairment charge (127)   (127)
Exchange and other movements (5) (17)(9)(31)
As at 31 December 2021(825)(3,884)(364)(1,300)(429)(6,802)
Net book value3,893 3,296 262 131 479 8,061 
2020
Cost
As at 1 January 20204,760 6,643 505 1,465 489 13,862 
Additions and disposals(37)646 131 — 22 762 
Exchange and other movements(7)(42)(46)(21)(113)
As at 31 December 20204,716 7,247 639 1,419 490 14,511 
Accumulated amortisation and impairment
As at 1 January 2020(861)(2,989)(279)(1,250)(364)(5,743)
Disposals37 97 10 — 147 
Amortisation charge— (771)(51)(43)(33)(898)
Impairment charge— (147)(6)— — (153)
Exchange and other movements(1)31 (2)41 15 84 
As at 31 December 2020(825)(3,779)(328)(1,252)(379)(6,563)
Net book value3,891 3,468 311 167 111 7,948 

Goodwill
Goodwill and Intangible assets are allocated to business operations according to business segments as follows:
20212020
GoodwillIntangiblesTotalGoodwillIntangiblesTotal
£m£m£m£m£m£m
Barclays UK3,560 1,233 4,793 3,560 1,618 5,178 
Barclays International291 2,930 3,221 289 2,435 2,724 
Head Office42 5 47 42 46 
Total3,893 4,168 8,061 3,891 4,057 7,948 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
269

Notes to the financial statements
For the year ended 31 December 2021 continued
Critical accounting estimates and judgements
Goodwill
Testing goodwill for impairment involves a significant amount of judgement. Goodwill is allocated to CGUs for the purpose of impairment testing. The review of goodwill for impairment involves calculating a value in use (VIU) valuation which is compared to the carrying value of a CGU associated with the goodwill to determine whether any impairment has occurred. This includes the identification of independent CGUs across the organisation and the allocation of goodwill to those CGUs.
The calculation of a value in use contains a high degree of uncertainty in estimating the future cash flows and the rates used to discount them. Key judgements include determining the carrying value of the CGU, the cash flows and discount rates used in the calculation.
The cash flow forecasts used by management involve judgement and are based upon a view of the future prospects of the business and market conditions at the point in time the assessment is prepared. The estimation of pre-tax cash flows is sensitive to the periods for which detailed forecasts are available and to assumptions regarding long-term sustainable cash flows.
The discount rates applied to the future cash flows also involve judgement as they can have a significant impact on the valuation. The discount rates used are compared to market participants to ensure that they are appropriate and based on an estimated cost of equity for each CGU.
The choice of a terminal growth rate used to determine the present value of the future cash flows of the CGUs is also a judgement that can impact the outcome of the assessment. The terminal growth rate and discount rates used may vary due to external market rates and economic conditions that are beyond management’s control.
Further details of some of the key judgements are set out below.
2021 impairment review
The 2021 impairment review was performed during Q4 2021 . In comparison to the prior year, the macroeconomic outlook has improved, with expectations of increased interest rates. However, unsecured balances are lower, reflecting reduced borrowing and higher repayments by customers. These factors impact favourably and adversely on the operating environments of the CGUs. A detailed assessment has been performed, with the approach and results of this analysis set out below.
Determining the carrying value of CGUs
The carrying value for each CGU is the sum of the tangible equity, goodwill and intangible asset balances associated with that CGU.
The Group manages the assets and liabilities of its CGUs with reference to the tangible equity of the respective businesses. That tangible equity is derived from the level of risk weighted assets (RWAs) and capital required to be deployed in the CGU and therefore reflects its relative risk, as well as the level of capital that management consider a market participant would be required to hold and retain to support business growth.
The goodwill held across the Group has been allocated to the CGU where it originated, based upon historical records. The intangible asset balances are allocated to the CGUs based upon their expected usage of these assets.
Cash flows
The five-year cash flows used in the calculation are based on the formally agreed medium term plans approved by the Board. These are prepared using macroeconomic assumptions which management consider reasonable and supportable, and reflect business agreed initiatives for the forecast period. The macroeconomic assumptions underpinning the medium term plan were determined in August 2021 and management has considered whether there are subsequent significant changes in those assumptions which would adversely impact the results of the impairment review.
As required by IAS 36, all estimates of future cash flows exclude cash inflows or outflows that are expected to arise from restructuring initiatives where a constructive obligation to carry out the plan does not yet exist.
In line with prior year treatment, the Education, Social Housing and Local Authority (ESHLA) portfolio has been excluded from the Business Banking CGU cash flows. This is a legacy loan portfolio which was previously within the Non-Core bank and was not part of the business to which the goodwill relates. As such, the cash flows relating to this portfolio have been excluded from the Business Banking VIU calculation.
The Personal Banking CGU cash flows reflect increases in the yield curve observed during the course of 2021 and have not been extended to a sixth year. The 2020 impairment review used a sixth year to reflect an observed 15bp inflexion point in the yield curve which was beyond the period of the medium term plan.
Discount rates
IAS 36 requires that the discount rate used in a value in use calculation reflects the pre-tax rate an investor would require if they were to choose an investment that would generate similar cash flows to those that the entity expects to generate from the asset. In determining the discount rate, management have identified the cost of equity associated with market participants that closely resemble the Group's CGUs and adjusted them for tax to arrive at the pre-tax equivalent rate. A range of discount rates have been used across the CGUs ranging from 12.5% to 15.1% (2020: 12.0% to 16.3%).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
270

Notes to the financial statements
For the year ended 31 December 2021 continued
Terminal growth rate
The terminal growth rate is used to estimate the effect of projecting cash flows to the end of an asset’s useful economic life. It is management’s judgement that the cash flows associated with the CGUs will grow in line with the major economies in which the Group operates. Inflation rates are used as an approximation of future growth rates and form the basis of the terminal growth rates applied. The terminal growth rate used is 2.0% (2020:2.0%).
Outcome of goodwill and intangibles review
The Personal Banking and Business Banking retail banking CGUs carry the majority of the Group’s goodwill balance, predominantly as a consequence of the Woolwich acquisition. The goodwill within Personal Banking was £2,752m (2020: £2,752m), of which £2,501m (2020: £2,501m) was attributable to Woolwich, and within Business Banking was £629m (2020: £629m), fully attributable to Woolwich. The recoverable amount for both Personal Banking and Business Banking have increased in comparison to the 2020 impairment review, reflective of improvements in the interest rate and macroeconomic outlook.
The largest portion of the Group’s intangible assets sit within the Cards and Payments CGU, with an allocation of £1,351m (2020: £1,096m). The extent to which the recoverable amount of the Cards and Payments CGU exceeds its carrying value has reduced in comparison to the 2020 impairment review as a result of investment in new intangible assets and a reduction in card balances, reflecting reduced borrowing and higher repayments by customers.
Based on management’s plans and assumptions the value in use exceeds the carrying value of the CGUs and no impairment has been indicated.
The outcome of the impairment review for Personal Banking, Business Banking and Cards and Payments are set out below:
Cash generating unitTangible equityGoodwillIntangiblesCarrying valueValue in useValue in use exceeding carrying valueValue in use exceeding carrying value 2020
£m£m£m£m£m£m£m
Personal Banking5,194 2,752 997 8,943 10,432 1,489 123 
Business Banking1,459 629 169 2,257 5,880 3,623 740 
Cards and Payments2,946 195 1,351 4,492 5,517 1,025 1,360 
Total9,599 3,576 2,517 15,692 21,829 6,137 2,223 
Sensitivity of key judgements
The CGUs are sensitive to possible adverse changes in the key assumptions that support the recoverable amount:
Cash flows: The medium term plans used to determine the cash flows used in the VIU calculation rely on macroeconomic forecasts, including interest rates, GDP and unemployment, and forecast levels of market and client activity. Interest rate assumptions impact planned cash flows from both customer income and structural hedge contributions and therefore cash flow expectations are highly sensitive to movements in the yield curve. The cash flows also contain assumptions with regards to the prudential and financial conduct regulatory environment which may be subject to change. Given the current level of economic uncertainty, a 10% reduction in cash flows has been provided to show the sensitivity of the outcome to a change in these key assumptions.
Discount rate: The discount rate should reflect the market risk-free rate adjusted for the inherent risks of the business it is applied to. Management have identified discount rates for comparable businesses and consider these to be a reasonable estimate of a suitable market rate for the profile of the business unit being tested. The risk that these discount rates may not be appropriate is quantified below and shows the impact of a 100 bps change in the discount rate.
Terminal growth rate: The terminal growth rate is used to estimate the cash flows into perpetuity based on the expected longevity of the CGUs' businesses. The terminal growth rate is sensitive to uncertainties in the macroeconomic environment. The risk that using inflation data may not be appropriate for its determination is quantified below and shows the impact of 100 bps change in the terminal growth rate.
Allocated capital rate: Tangible equity is allocated based on the level of risk weighted assets (RWAs) and capital required to be deployed in the CGU which is dependent on the relative risk of businesses. The capital ratio used in determining the level of tangible equity allocated to the CGU and its capital cash flows could move over time. The impact of a 50bps increase in capital ratio is quantified below.
The sensitivity of the value in use to key judgements in the calculations is set out below:
Cash generating unitCarrying valueValue in useValue in use exceeding carrying valueDiscount rateTerminal growth rateReduction in headroomChange required to reduce headroom to zero
100 bps increase in the discount rate100 bps decrease in terminal growth rate50 bps increase to allocated capital rate10% reduction in forecasted cash flowsDiscount rateTerminal growth rateAllocated capital rateCashflows
£m£m£m%%£m£m£m£m%%%%
Personal Banking8,943 10,432 1,489 14.2 2.0 (946)(655)(291)(1,219)1.7 (2.6)2.6 (12.2)
Cards and Payments4,492 5,517 1,025 14.7 2.0 (597)(433)(227)(774)1.8 (2.7)2.3 (13.3)
Total13,435 15,949 2,514 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
271

Notes to the financial statements
For the year ended 31 December 2021 continued
Accruals, provisions, contingent liabilities and legal proceedings
The notes included in this section focus on the Group’s accruals, provisions and contingent liabilities. Provisions are recognised for present obligations arising as consequences of past events where it is probable that a transfer of economic benefit will be necessary to settle the obligation, and it can be reliably estimated. Contingent liabilities reflect potential liabilities that are not recognised on the balance sheet.
23 Other liabilities
20212020
£m£m
Accruals and deferred income4,173 3,683 
Other creditors4,793 3,447 
Items in the course of collection due to other banks202 88 
Lease liabilities (refer to Note 21)1,317 1,444 
Liabilities included in disposal groups classified as held for sale20 — 
Other liabilities10,505 8,662 
24 Provisions
Accounting for provisions
The Group applies IAS 37 Provisions, Contingent Liabilities and Contingent Assets in accounting for non-financial liabilities.
Provisions are recognised for present obligations arising as consequences of past events where it is more likely than not that a transfer of economic benefit will be necessary to settle the obligation, which can be reliably estimated. Provision is made for the anticipated cost of restructuring, including redundancy costs, when an obligation exists; for example, when the Group has a detailed formal plan for restructuring a business and has raised valid expectations in those affected by the restructuring by announcing its main features or starting to implement the plan.
Critical accounting estimates and judgements
The financial reporting of provisions involves a significant degree of judgement and is complex. Identifying whether a present obligation exists and estimating the probability, timing, nature and quantum of the outflows that may arise from past events requires judgements to be made based on the specific facts and circumstances relating to individual events and often requires specialist professional advice. When matters are at an early stage, accounting judgements and estimates can be difficult because of the high degree of uncertainty involved. Management continues to monitor matters as they develop to re-evaluate on an ongoing basis whether provisions should be recognised, however there can remain a wide range of possible outcomes and uncertainties, particularly in relation to legal, competition and regulatory matters, and as a result it is often not practicable to make meaningful estimates even when matters are at a more advanced stage.
The complexity of such matters often requires the input of specialist professional advice in making assessments to produce estimates. Customer redress and legal, competition and regulatory matters are areas where a higher degree of professional judgement is required. The amount that is recognised as a provision can also be very sensitive to the assumptions made in calculating it. This gives rise to a large range of potential outcomes which require judgement in determining an appropriate provision level. See Note 26 for more detail of legal, competition and regulatory matters.
Undrawn contractually committed facilities and guaranteesa
Legal, competition and regulatory mattersSundry
provisions
Total
Onerous contractsRedundancy and restructuringCustomer redress
£m£m£m£m£m£m£m
As at 1 January 202128 158 1,064 497 268 289 2,304 
Additions6 316 124 188 72 198 904 
Amounts utilised(11)(82) (318)(62)(140)(613)
Unused amounts reversed(18)(25)(638)(54)(44)(101)(880)
Exchange and other movements (41)(8)(3)(8)33 (27)
As at 31 December 20215 326 542 310 226 279 1,688 
Note
a    Undrawn contractually committed facilities and guarantees provisions are accounted for under IFRS 9.
Provisions expected to be recovered or settled within no more than 12 months after 31 December 2021 were £1,534m (2020: £1,751m).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
272

Notes to the financial statements
For the year ended 31 December 2021 continued
Onerous contracts
Onerous contract provisions comprise an estimate of unavoidable costs involved with fulfilling the terms and conditions of contracts net of any expected benefits to be received.
Redundancy and restructuring
These provisions comprise the estimated cost of restructuring, including redundancy costs where an obligation exists. Additions made during the year relate to formal restructuring plans and have either been utilised, or reversed where total costs are now expected to be lower than the original provision amount.
Undrawn contractually committed facilities and guarantees
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure as ECL is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision. For further information, refer to the Credit risk section for loan commitments and financial guarantees on page 131.
Customer redress
Customer redress provisions comprise the estimated cost of making redress payments to customers, clients and counterparties for losses or damages associated with inappropriate judgement in the execution of the Group’s business activities.
Legal, competition and regulatory matters
The Group is engaged in various legal proceedings, both in the UK and a number of other overseas jurisdictions, including the US. For further information in relation to legal proceedings and discussion of the associated uncertainties, refer to Note 26.
Sundry provisions
This category includes provisions that do not fit into any of the other categories, such as fraud losses and dilapidation provisions.

25 Contingent liabilities and commitments
Accounting for contingent liabilities
Contingent liabilities are possible obligations whose existence will be confirmed only by uncertain future events and present obligations where the transfer of economic resources is uncertain or cannot be reliably measured. Contingent liabilities are not recognised on the balance sheet but are disclosed unless the likelihood of an outflow of economic resources is remote.
The following table summarises the nominal principal amount of contingent liabilities and commitments which are not recorded on-balance sheet:
20212020
£m£m
Guarantees and letters of credit pledged as collateral security15,549 15,665 
Performance guarantees, acceptances and endorsements5,797 5,944 
Total contingent liabilities and financial guarantees21,346 21,609 
  Of which: Financial guarantees carried at fair value231 229 
Documentary credits and other short-term trade related transactions1,584 1,086 
Standby facilities, credit lines and other commitments344,127 331,963 
Total commitments345,711 333,049 
  Of which: Loan commitments carried at fair value18,571 9,269 
Expected credit losses held against contingent liabilities and commitments equal £542m (2020: £1,064m) and are reported in Note 24. Further details on contingent liabilities relating to legal and competition and regulatory matters can be found in Note 26.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
273

Notes to the financial statements
For the year ended 31 December 2021 continued
26 Legal, competition and regulatory matters
The Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both, depending on the relevant facts and circumstances.
The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance with the relevant accounting policies applicable to Note 24, Provisions. We have not disclosed an estimate of the potential financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various matters detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed, such claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those matters.
Matters are ordered under headings corresponding to the financial statements in which they are disclosed.
1. Barclays PLC and Barclays Bank PLC
Investigations into certain advisory services agreements
FCA proceedings
In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Notices) finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing rules, and that Barclays PLC was also in breach of Listing Principle 3. The financial penalty provided in the Notices is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. Following the conclusion of the Serious Fraud Office (SFO) proceedings against certain former Barclays executives resulting in their acquittals, the FCA proceedings, which were stayed, have resumed and a hearing before the Regulatory Decisions Committee is scheduled for the first quarter of 2022.
Investigations into LIBOR and other benchmarks and related civil actions
Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks, such as LIBOR. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks.
USD LIBOR civil actions
The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and various state laws by manipulating USD LIBOR rates.
Putative class actions and individual actions seek unspecified damages with the exception of three lawsuits, in which the plaintiffs are seeking a combined total of approximately $100m in actual damages and additional punitive damages against all defendants, including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays Bank PLC has previously settled certain claims. Two class action settlements where Barclays Bank PLC has respectively paid $7.1m and $20m have received final court approval. Barclays Bank PLC also settled a further matter for $7.5m.
Sterling LIBOR civil actions
In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs have appealed the dismissal.
Japanese Yen LIBOR civil actions
In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims. The plaintiff has appealed the lower court’s dismissal of such claims.
In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs filed an amended complaint in 2020. In 2021, the case was dismissed as against most defendants, including the Barclays entities. The plaintiffs and remaining defendants are seeking reconsideration of the decision.
SIBOR/SOR civil action
In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR). In 2018, the court dismissed all claims against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs’ appeal of the dismissal of their claims was granted in March 2021 and the matter has been remanded to the lower court for further proceedings. Defendants’ petition for U.S. Supreme Court review was denied. Additionally, plaintiffs have filed an amended complaint, which defendants have moved to dismiss.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
274

Notes to the financial statements
For the year ended 31 December 2021 continued
ICE LIBOR civil actions
In 2019, several putative class actions were filed in the SDNY against a panel of banks, including Barclays PLC, Barclays Bank PLC, BCI, other financial institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE), asserting antitrust claims that defendants manipulated USD LIBOR through defendants’ submissions to ICE. These actions have been consolidated. The defendants’ motion to dismiss was granted in 2020 and the plaintiffs appealed. In February 2022, the dismissal was affirmed on appeal.
In August 2020, an ICE LIBOR-related action was filed by a group of individual plaintiffs in the US District Court for the Northern District of California on behalf of individual borrowers and consumers of loans and credit cards with variable interest rates linked to USD ICE LIBOR. Plaintiffs’ motions seeking, among other things, preliminary and permanent injunctions to enjoin the defendants from continuing to set LIBOR or enforce any financial instrument that relies in whole or in part on USD LIBOR were denied. The defendants have moved to dismiss the case.
Non-US benchmarks civil actions
Legal proceedings (which include the claims referred to below in ‘Local authority civil actions concerning LIBOR’) have been brought or threatened against Barclays Bank PLC (and, in certain cases, Barclays Bank UK PLC) and other banks in the UK in connection with alleged manipulation of LIBOR, EURIBOR and other benchmarks. Proceedings have also been brought in a number of other jurisdictions in Europe and Israel. Additional proceedings in other jurisdictions may be brought in the future.
Credit Default Swap civil action
A putative antitrust class action is pending in New Mexico federal court against Barclays Bank PLC, BCI, and various other financial institutions. The plaintiffs, the New Mexico State Investment Council and certain New Mexico pension funds, allege that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at settlement (i.e. the CDS final auction price). The plaintiffs allege violations of US antitrust laws and the CEA, and unjust enrichment under state law.
Foreign Exchange investigations and related civil actions
In 2015, the Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and the FCA in relation to investigations into certain sales and trading practices in the Foreign Exchange market.
The European Commission announced two settlements in May 2019 and the Group paid penalties totalling approximately €210m. In June 2019, the Swiss Competition Commission announced two settlements and the Group paid penalties totalling approximately CHF27m. In December 2021, the European Commission announced a final settlement which required the Group to pay penalties totalling approximately €54m, which amount has been provided for in previous periods. The financial impact of any ongoing matters is not expected to be material to the Group’s operating results, cash flows or financial position.
Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to alleged manipulation of Foreign Exchange markets.
FX opt out civil action
In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted out of the Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants. Some of the plaintiff’s claims were dismissed in 2020.
Retail basis civil action
In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs have filed an amended complaint.
Non-US FX civil actions
Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of other jurisdictions in Europe, Israel, Brazil and Australia and additional proceedings may be brought in the future.
These include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX, BCI and other financial institutions in the UK Competition Appeal Tribunal in 2019 following the settlements with the European Commission described above. Also in 2019, a separate claim was filed in the UK in the High Court of Justice (High Court), and subsequently transferred to the UK Competition Appeal Tribunal, by various banks and asset management firms against Barclays Bank PLC and other financial institutions alleging breaches of European and UK competition laws related to FX trading.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
275

Notes to the financial statements
For the year ended 31 December 2021 continued
Metals related civil actions
A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the prices of gold and gold derivative contracts in violation of the Antitrust Act and other federal laws. The parties have reached a joint settlement to resolve this matter for $50m, which is subject to court approval. The financial impact of Barclays’ share of the joint settlement is not expected to be material to the Group’s operating results, cash flows or financial position. A separate US civil complaint by a proposed class of plaintiffs against a number of banks, including Barclays Bank PLC, BCI and BX, alleging manipulation of the price of silver in violation of the CEA, the Antitrust Act and state antitrust and consumer protection laws, has been dismissed as against the Barclays entities. The plaintiffs have the option to seek the court’s permission to appeal.
Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc. and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices.
US residential mortgage related civil actions
There are various pending civil actions relating to US Residential Mortgage-Backed Securities (RMBS), including four actions arising from unresolved repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007. The unresolved repurchase requests had an original principal balance of approximately $2.1bn. The Trustees have also alleged that the relevant R&Ws may have been breached with respect to a greater (but unspecified) amount of loans than previously stated in the unresolved repurchase requests.
These repurchase actions are ongoing. In one repurchase action, the New York Court of Appeals held that claims related to certain R&Ws are time-barred. Barclays Bank PLC has reached settlements to resolve two of the repurchase actions, subject to final court approval. Final court approval has been granted in relation to one of those matters and payment will be completed in the first quarter of 2022. The other matter is scheduled for a hearing in 2022 to seek approval for the settlement. The financial impact of the settlement is not expected to be material to the Group’s operating results, cash flows or financial position. The remaining two repurchase actions are pending.
In 2020, a civil litigation claim was filed in the New Mexico First Judicial District Court by the State of New Mexico against six banks, including BCI, on behalf of two New Mexico state pension funds and the New Mexico State Investment Council relating to legacy RMBS purchases. As to BCI, the complaint alleges that the funds purchased approximately $22m in RMBS underwritten by BCI. The parties have reached a joint settlement to resolve this matter for $32.5m. The financial impact of BCI’s share of the joint settlement is not material to the Group’s operating results, cash flows or financial position.
Government and agency securities civil actions
Treasury auction securities civil actions
Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs have filed an amended complaint, which the defendants have moved to dismiss.
In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and state common law.
Supranational, Sovereign and Agency bonds civil actions
Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI, BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc. and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for US dollar-denominated Supranational, Sovereign and Agency bonds.
In one of the actions filed in the SDNY, the court granted the defendants’ motions to dismiss the plaintiffs’ complaint. The dismissal was affirmed on appeal and this matter is now concluded. The plaintiffs have voluntarily dismissed the other SDNY action. In the Federal Court of Canada action, the plaintiffs reached settlements with a small number of banks in 2020 (not including Barclays Capital Canada Inc.), but the plaintiffs have not commenced the class certification process and the action remains at an early stage.
Variable Rate Demand Obligations civil actions
Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints have been consolidated in the SDNY. In the consolidated SDNY class action, certain of the plaintiff’s claims were dismissed in November 2020 and defendants’ motion for partial dismissal of the amended consolidated complaint is pending. In the California action, the plaintiffs’ claims were dismissed in June 2021. The plaintiffs have appealed the dismissal.
Government bond civil actions
In a putative class action filed in the SDNY in 2019, plaintiffs alleged that BCI and certain other bond dealers conspired to fix the prices of US Government sponsored entity bonds in violation of US antitrust law. BCI agreed to a settlement of $87m, which received final court approval in 2020. Separately, various entities in Louisiana, including the Louisiana Attorney General and the City of Baton Rouge, commenced litigation against Barclays Bank PLC and other financial institutions making similar allegations as the SDNY class action plaintiffs. The parties have reached a settlement to resolve these matters. The financial impact of the settlement is not material to the Group’s operating results, cash flows or financial position.
In 2018, a separate putative class action against various financial institutions including Barclays PLC, Barclays Bank PLC, BCI, Barclays Bank Mexico, S.A., and certain other subsidiaries of the Group was consolidated in the SDNY. The plaintiffs asserted antitrust and state law claims arising out of an alleged conspiracy to fix the prices of Mexican Government bonds. The Barclays entities have settled the claim for $5.7m, and the settlement has received final court approval.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
276

Notes to the financial statements
For the year ended 31 December 2021 continued
Odd-lot corporate bonds antitrust class action
In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. Plaintiffs demand unspecified money damages. The defendants’ motion to dismiss was granted in 2021. Plaintiffs have appealed the dismissal.
Interest rate swap and credit default swap US civil actions
Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate swaps (IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages.
In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In 2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018 and 2019, respectively, the court dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss the federal and state antitrust claims, which remain pending.
BDC Finance L.L.C.
In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court), demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement (the Agreement). Following a trial, the court ruled in 2018 that Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs. BDC appealed. In January 2022, the appellate court reversed the trial court’s summary judgment decision in favour of Barclays Bank PLC and remanded the case to the lower court for further proceedings.
In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC’s conduct relating to the Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious interference with business and prospective business relations. This case is currently stayed.
Civil actions in respect of the US Anti-Terrorism Act
There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism that injured or killed plaintiffs or plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages.
The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. Plaintiffs have appealed in one action. The remaining actions are stayed pending a decision on the appeal. Out of the two actions in the SDNY, the court also granted the defendants’ motion to dismiss the first action, which is stayed pending a decision on the EDNY appeal. The second SDNY action is stayed, pending any appeal on the dismissal of the first.
Shareholder derivative action
In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees of the Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants have moved to dismiss.
Derivative transactions civil action
In 2021, Vestia (a Dutch housing association) brought a claim against Barclays Bank PLC in the UK in the High Court in relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2011, seeking damages of £329m. Barclays Bank PLC is defending the claim and has made a counterclaim.
Timeshare loans, skilled person review, and associated matters
In August 2020, the FCA granted an application by Clydesdale Financial Services Limited (CFS), which trades as Barclays Partner Finance and houses Barclays’ point-of-sale finance business, for a validation order with respect to certain loans to customers brokered between April 2014 and April 2016 by Azure Services Limited (ASL), a timeshare operator, which did not, at the point of sale, hold the necessary broker licence. As a condition to the validation order, the FCA required CFS to undertake a skilled person review of the assessment of affordability processes for the loans brokered by ASL (ASL Loans) as well as CFS’ policies and procedures for assessing affordability and oversight of brokers more generally, and dictated a remediation methodology in the event that ASL Loans did not pass the affordability test. CFS has voluntarily agreed to remediate the ASL Loans, which is expected to amount to £37.4m, in accordance with the FCA’s methodology and the remediation exercise is at an advanced stage. The remaining scope of the skilled person review is complete. The skilled person made a number of observations, some of which were adverse, about both current and historic affordability practices as well as current oversight practices. CFS is not required to conduct a full back book review but, subject to agreement with the FCA, will be reviewing discrete cohorts of loans to determine whether historic affordability and/or broker oversight practices may have caused customer harm. Where harm is identified, CFS’ intention is to remediate.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
277

Notes to the financial statements
For the year ended 31 December 2021 continued
Following on from the skilled person review, there is ongoing dialogue with the FCA regarding other loans brokered by ASL and entered into outside the April 2014 to April 2016 period. Separately there is ongoing dialogue with the Financial Ombudsman Service (FOS) regarding a number of other complaints involving timeshare loans.
It is not currently possible to predict the outcome of this dialogue with the FCA or the FOS or the financial impact on the Group.
2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC
Investigation into UK cards’ affordability
The FCA has been investigating certain aspects of the affordability assessment processes used by Barclays Bank UK PLC and Barclays Bank PLC for credit card applications made to Barclays’ UK credit card business. In October 2021, the FCA confirmed that this investigation was closed with no further action.
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax
In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has been appealed to the First Tier Tribunal (Tax Chamber).
Local authority civil actions concerning LIBOR
Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest rate submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the UK, certain local authorities brought claims in 2018 against Barclays Bank PLC and Barclays Bank UK PLC asserting that they entered into loans between 2006 and 2008 in reliance on misrepresentations made by Barclays Bank PLC in respect of its conduct in relation to LIBOR. Barclays Bank PLC and Barclays Bank UK PLC were successful in their applications to strike out the claims. The claims have been settled on terms such that the parties have agreed not to pursue these claims further and to bear their own costs. The financial impact of the settlements is not material to the Group's operating results, cash flows or financial position.
3. Barclays PLC
Alternative trading systems
In 2020, a claim was brought against Barclays PLC in the UK in the High Court by various shareholders regarding Barclays PLC’s share price based on the allegations contained within a complaint by the New York State Attorney General (NYAG) in 2014. Such claim was settled in 2016, as previously disclosed. The more recent claim seeks unquantified damages. The NYAG complaint was filed against Barclays PLC and BCI in the NY Supreme Court alleging, among other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX, BCI’s SEC-registered alternative trading system.
General
The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property, money laundering, financial crime, employment, environmental and other statutory and common law issues.
The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis.
At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters (including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s results, operations or cash flow for a particular period, depending on, among other things, the amount of the loss resulting from the matter(s) and the amount of profit otherwise reported for the reporting period.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
278

Notes to the financial statements
For the year ended 31 December 2021 continued
Capital instruments, equity and reserves
The notes included in this section focus on the Group’s loan capital and shareholders’ equity including issued share capital, retained earnings, other equity balances and interests of minority shareholders in our subsidiary entities (non-controlling interests). For more information on capital management and how the Group maintains sufficient capital to meet our regulatory requirements refer to the Capital risk management section.
27 Subordinated liabilities
Accounting for subordinated liabilities
Subordinated liabilities are measured at amortised cost using the effective interest method under IFRS 9.
20212020
£m£m
As at 1 January16,341 18,156 
Issuances1,890 1,438 
Redemptions(4,807)(3,464)
Other(665)211 
As at 31 December12,759 16,341 
Issuances of £1,890m comprise £855m EUR 1.125% Fixed Rate Resetting Subordinated Callable Notes and £724m USD 3.811% Fixed Rate Resetting Subordinated Callable Notes, both issued externally by Barclays PLC and £229m USD Floating Rate Notes and £82m ZAR Floating Rate Notes issued externally by Barclays subsidiaries.
Redemptions of £4,807m comprise £1,961m GBP 10% Fixed Rate Subordinated Notes, £1,339m EUR 6% Fixed Rate Subordinated Notes, £1,075m USD 10.179% Fixed Rate Subordinated Notes, £200m GBP 9.5% Subordinated Bonds and £86m EUR Subordinated Floating Rate Notes, issued externally by Barclays Bank PLC and £146m USD Floating Rate Notes issued externally by a Barclays subsidiary.
Other movements predominantly comprise foreign exchange movements, fair value hedge adjustments and reclassification from Debt Securities in Issue of £67m Undated Subordinated Loan Notes (secured) issued externally by a Barclays securitisation special purpose vehicle (SPV) in 2020.
Subordinated liabilities include accrued interest and comprise undated and dated subordinated liabilities as follows:
20212020
£m£m
Undated subordinated liabilities355 308 
Dated subordinated liabilities12,404 16,033 
Total subordinated liabilities12,759 16,341 
None of the Group’s subordinated liabilities are secured other than the £67m Undated Subordinated Loan Notes (secured).
Undated subordinated liabilitiesa
20212020
Initial call date£m£m
Barclays Bank PLC issued
Tier One Notes (TONs)
6% Callable Perpetual Core Tier One Notes
203215 17 
6.86% Callable Perpetual Core Tier One Notes (USD 179m)
2032194 205 
Reserve Capital Instruments (RCIs)
5.3304% Step-up Callable Perpetual Reserve Capital Instruments
203651 56 
Undated Notes
Junior Undated Floating Rate Notes (USD 38m)
Any interest payment date28 28 
Barclays securitisation SPV issued
Undated Subordinated Loan Notes (secured)
Undated Subordinated Loan Notes (secured) (GBP 67m)
At any time67 — 
Total undated subordinated liabilities355 308 
Note
a    Instrument values are disclosed to the nearest million.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
279

Notes to the financial statements
For the year ended 31 December 2021 continued
Undated subordinated liabilities
The undated subordinated liabilities that are issued by Barclays Bank PLC and its subsidiaries are for the development and expansion of the businesses and to strengthen the capital bases. The principal terms of such undated subordinated liabilities are described below:
Subordination
All undated subordinated liabilities rank behind the claims against Barclays Bank PLC of depositors and other unsecured unsubordinated creditors and holders of dated subordinated liabilities in the following order: Junior Undated Floating Rate Notes; followed by TONs and RCIs ranking pari passu with each other.
Interest
The Junior Undated Notes are floating rate notes where rates are fixed periodically in advance based on the related market rate.
The TONs and RCIs bear a fixed rate of interest until the initial call date. After the initial call date, in the event that they are not redeemed, the TONs and RCIs will bear interest at rates fixed periodically in advance based on market rates.
Payment of interest
No payment of principal or any interest may be made in relation to the TONs and RCIs unless Barclays Bank PLC satisfies a specified solvency test.
Barclays Bank PLC may elect to defer any payment of interest on the RCIs. Any such deferred payment of interest must be paid on the earlier of: (i) the date of redemption of the RCIs, and (ii) the coupon payment date falling on or nearest to the tenth anniversary of the date of deferral of such payment. Whilst such deferral is continuing, (i) neither Barclays Bank PLC nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of its ordinary shares or preference shares and (ii) certain restrictions on the redemption, purchase or reduction of their respective share capital and certain other securities also apply.
Barclays Bank PLC may elect to defer any payment of interest on the TONs if it determines that it is, or such payment would result in it being, in non-compliance with capital adequacy requirements and policies of the PRA. Any such deferred payment of interest will only be payable on a redemption of the TONs. Until such time as Barclays Bank PLC next makes a payment of interest on the TONs, (i) neither Barclays Bank PLC nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of their respective ordinary shares or preference shares, or make payments of interest in respect of Barclays Bank PLC’s Reserve Capital Instruments and (ii) certain restrictions on the redemption, purchase or reduction of their respective share capital and certain other securities also apply.
Repayment
All undated subordinated liabilities are repayable at the option of Barclays Bank PLC, generally in whole, at the initial call date and on any subsequent coupon or interest payment date. In addition, each issue of undated subordinated liabilities is repayable, at the option of Barclays Bank PLC in whole for certain tax reasons, either at any time, or on an interest payment date. There are no events of default except non-payment of principal or mandatory interest. Any repayments require the prior consent of the PRA.
Other
All issues of undated subordinated liabilities are non-convertible.
Undated Subordinated Loan Notes (secured)
The Undated Subordinated Loan Notes (secured) are direct, secured, subordinated and limited recourse obligations of the SPV issuer issued in connection with a securitisation of assets originated by a subsidiary of Barclays PLC. Payments of principal and interest are subject to the relevant priority of payments for the securitisation. The security is held on trust for the holders of such loan notes and the other secured creditors to the securitisation and any proceeds from the enforcement of such security shall be applied in accordance with the post enforcement priority of payments. Such loan notes have interest calculated periodically based on overnight market interest rates for Sterling and will mature on the first interest payment date following the date which is 12 months after the contractual maturity date of the longest dated remaining eligible receivable at the end of the revolving period for asset additions. Such loan notes may be accelerated upon the SPV issuer’s non-payment, breach of other obligations, material misrepresentation, insolvency, repudiation or change of control or it becomes unlawful for the SPV issuer to perform its obligations. The loans notes are non-convertible.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
280

Notes to the financial statements
For the year ended 31 December 2021 continued
Dated subordinated liabilitiesa
20212020
Initial call dateMaturity date£m£m
Barclays PLC issued
2% Fixed Rate Subordinated Callable Notes (EUR 1,500m)
202320281,283 1,384 
4.375% Fixed Rate Subordinated Notes (USD 1,250m)
2024974 990 
3.75% Fixed Rate Resetting Subordinated Callable Notes (GBP 500m)
20252030483 504 
3.75% Fixed Rate Resetting Subordinated Callable Notes (SGD 200m)
20252030113 119 
5.20% Fixed Rate Subordinated Notes (USD 2,050m)
20261,564 1,610 
1.125% Fixed Rate Resetting Subordinated Callable Notes (EUR 1,000m)
20262031833 — 
4.836% Fixed Rate Subordinated Callable Notes (USD 2,000m)
202720281,564 1,627 
5.088% Fixed-to-Floating Rate Subordinated Callable Notes (USD 1,500m)
202920301,162 1,213 
3.564% Fixed Rate Resetting Subordinated Callable Notes (USD 1,000m)
20302035696 703 
3.811% Fixed Rate Resetting Subordinated Callable Notes (USD 1,000m)
20412042782 — 
Barclays Bank PLC issued
6% Fixed Rate Subordinated Notes (EUR 1,500m)
2021 1,427 
9.5% Subordinated Bonds (ex-Woolwich Plc)
2021 221 
Subordinated Floating Rate Notes (EUR 100m)
2021 90 
10% Fixed Rate Subordinated Notes
2021 2,108 
10.179% Fixed Rate Subordinated Notes (USD 1,521m)
2021 1,101 
Subordinated Floating Rate Notes (EUR 50m)
202242 45 
6.625% Fixed Rate Subordinated Notes (EUR 1,000m)
2022889 982 
7.625% Contingent Capital Notes (USD 3,000m)
20221,133 1,132 
Subordinated Floating Rate Notes (EUR 50m)
202342 45 
5.75% Fixed Rate Subordinated Notes
2026322 351 
5.4% Reverse Dual Currency Subordinated Loan (JPY 15,000m)
202797 108 
6.33% Subordinated Notes
203259 64 
Subordinated Floating Rate Notes (EUR 68m)
204057 61 
External issuances by other subsidiaries2026311 146 
Total dated subordinated liabilities12,404 16,033 
Note
a    Instrument values are disclosed to the nearest million.

Dated subordinated liabilities
Dated subordinated liabilities are issued by Barclays PLC, Barclays Bank PLC and its subsidiaries for the development and expansion of their businesses and to strengthen their respective capital bases. The principal terms of the dated subordinated liabilities are described below:
Subordination
Dated subordinated liabilities issued by Barclays PLC ranks behind the claims against Barclays PLC of unsecured unsubordinated creditors but before the claims of the holders of its equity.
All dated subordinated liabilities externally issued by Barclays Bank PLC rank behind the claims against Barclays Bank PLC of depositors and other unsecured unsubordinated creditors but before the claims of the undated subordinated liabilities and the holders of its equity. The dated subordinated liabilities externally issued by other subsidiaries are similarly subordinated as the external subordinated liabilities issued by Barclays Bank PLC.
Interest
Interest on the Floating Rate Notes is fixed periodically in advance, based on the related market rates.
Interest on Fixed Rate Notes is set by reference to market rates at the time of issuance and fixed until maturity.
Interest on the 4.836% Fixed Rate Subordinated Callable Notes, 2% Fixed Rate Subordinated Callable Notes, 3.75% SGD Fixed Rate Resetting Subordinated Callable Notes, 3.75% GBP Fixed Rate Resetting Subordinated Callable Notes, 3.811% Fixed Rate Resetting Subordinated Callable notes, 1.125% Fixed Rate Resetting Subordinated Callable Notes, and the 3.564% Fixed Rate Resetting Subordinated Callable Notes are fixed until the call date. After the respective call dates, in the event that they are not redeemed, the interest rates will be reset and fixed until maturity based on a market rate. Interest on the 5.088% Fixed-to-Floating Rate Subordinated Callable Notes is fixed until the call date. After the call date, in the event that they are not redeemed, the interest rate will reset periodically in advance based on market rates.
Repayment
Those subordinated liabilities with a call date are repayable at the option of the issuer on such call date in accordance with the conditions governing the respective debt obligations, some in whole or in part, and some only in whole. The remaining dated subordinated liabilities outstanding at 31 December 2021 are redeemable only on maturity, subject in particular cases to provisions allowing an early redemption in the event of certain changes in tax law, or to certain changes in legislation or regulations.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
281

Notes to the financial statements
For the year ended 31 December 2021 continued
Any repayments prior to maturity require, in the case of Barclays PLC and Barclays Bank PLC, the prior consent of the PRA, or in the case of the overseas issues, the approval of the local regulator for that jurisdiction and of the PRA in certain circumstances.
There are no committed facilities in existence at the balance sheet date which permit the refinancing of debt beyond the date of maturity.
Other
The 7.625% Contingent Capital Notes will be automatically transferred from investors to Barclays PLC (or another entity within the Group) for nil consideration in the event the Barclays PLC transitional CET1 ratio falls below 7%.
28 Ordinary shares, share premium, and other equity
Called up share capital, allotted and fully paid
Number of sharesOrdinary share capitalOrdinary share premiumTotal share capital and share premium Other
equity instruments
m£m£m£m£m
As at 1 January 202117,359 4,340 297 4,637 11,172 
Issued to staff under share incentive plans37 9 51 60  
AT1 securities issuance    1,078 
Repurchase of shares(644)(161) (161) 
Other movements    9 
As at 31 December 202116,752 4,188 348 4,536 12,259 
As at 1 January 202017,322 4,331 263 4,594 10,871 
Issued to staff under share incentive plans37 34 43 — 
AT1 securities issuance— — — — 1,142 
AT1 securities redemption— — — — (831)
Other movements— — — — (10)
As at 31 December 202017,359 4,340 297 4,637 11,172 
Called up share capital
Called up share capital comprises 16,752m (2020: 17,359m) ordinary shares of 25p each.
Share repurchase
At the 2021 AGM on 5 May 2021, Barclays PLC was authorised to repurchase up to an aggregate of 1,737m of its ordinary shares of 25p. The authorisation is effective until the AGM in 2022 or the close of business on 30 June 2022, whichever is the earlier. During 2021, 644m shares were repurchased with a total nominal value of £161m (2020: none).
Other equity instruments
Other equity instruments of £12,259m (2020: £11,172m) include AT1 securities issued by Barclays PLC. The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date.
In 2021, there was one issuance of AT1 instruments, in the form of Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities, for £1,078m (2020: one issuance for £1,142m) which includes issuance costs of £4m (2020: £4m). There were no redemptions in 2021 (2020: one redemption of £831m).
AT1 equity instruments
20212020
Initial call date£m£m
AT1 equity instruments - Barclays PLC
7.875% Perpetual Subordinated Contingent Convertible Securitiesa
2022995 986 
7.875% Perpetual Subordinated Contingent Convertible Securities (USD 1,500m)
20221,131 1,131 
7.25% Perpetual Subordinated Contingent Convertible Securities
20231,245 1,245 
7.75% Perpetual Subordinated Contingent Convertible Securities (USD 2,500m)a
20231,924 1,925 
5.875% Perpetual Subordinated Contingent Convertible Securities
20241,244 1,244 
8% Perpetual Subordinated Contingent Convertible Securities (USD 2,000m)
20241,509 1,509 
7.125% Perpetual Subordinated Contingent Convertible Securitiesa
2025996 994 
6.375% Perpetual Subordinated Contingent Convertible Securities
2025996 996 
6.125% Perpetual Subordinated Contingent Convertible Securities (USD 1,500m)a
20251,141 1,142 
4.375% Perpetual Subordinated Contingent Convertible Securities (USD 1,500m)
20281,078 — 
Total AT1 equity instruments12,259 11,172 
Note
a    Reported net of securities held by the Group.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
282

Notes to the financial statements
For the year ended 31 December 2021 continued
The principal terms of the AT1 securities are described below:
AT1 securities rank behind the claims against Barclays PLC of 1) unsubordinated creditors; 2) claims which are expressed to be subordinated to the claims of unsubordinated creditors of Barclays PLC but not further or otherwise; or 3) claims which are, or are expressed to be, junior to the claims of other creditors of Barclays PLC, whether subordinated or unsubordinated, other than claims which rank, or are expressed to rank, pari passu with, or junior to, the claims of holders of the AT1 securities.
AT1 securities are undated and are redeemable, at the option of Barclays PLC, in whole on (i) the initial reset date, or on any fifth anniversary after the initial reset date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA.
AT1 securities bear a fixed rate of interest until the initial reset date. After the initial reset date, in the event that they are not redeemed, the AT1 securities will bear interest at rates fixed periodically in advance for five-year periods based on market rates.
Interest on the AT1 securities will be due and payable only at the sole discretion of Barclays PLC, and Barclays PLC has sole and absolute discretion at all times and for any reason to cancel (in whole or in part) any interest payment that would otherwise be payable on any interest payment date.
All AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully loaded CET1 ratio of the Group fall below 7%
29 Reserves
Currency translation reserve
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net investment in foreign operations, net of the effects of hedging.
Fair value through other comprehensive income reserve
The fair value through other comprehensive income reserve represents the changes in the fair value of fair value through other comprehensive income investments since initial recognition.
Cash flow hedging reserve
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to profit or loss when the hedged transactions affect profit or loss.
Own credit reserve
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods.
Other reserves and treasury shares
Other reserves relate to redeemed ordinary and preference shares issued by the Group.
Treasury shares relate to Barclays PLC shares held in relation to the Group’s various share schemes. These schemes are described in Note 32. Treasury shares are deducted from shareholders’ equity within other reserves. A transfer is made to retained earnings in line with the vesting of treasury shares held for the purposes of share-based payments.
20212020
£m£m
Currency translation reserve2,740 2,871 
Fair value through other comprehensive income reserve(283)
Cash flow hedging reserve(853)1,575 
Own credit reserve(960)(954)
Other reserves and treasury shares1,126 964 
Total1,770 4,461 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
283

Notes to the financial statements
For the year ended 31 December 2021 continued
30 Non-controlling interests
Profit attributable to non-controlling interestEquity attributable to non-controlling interestDividends paid to non-controlling interest
202120202021202020212020
£m£m£m£m£m£m
Barclays Bank PLC issued:
– Preference shares27 42 529 529 27 42 
– Upper Tier 2 instruments17 37 458 533 17 37 
Other non-controlling interests3 (1)2 23  — 
Total47 78 989 1,085 44 79 
In 2021, there were no issuances (2020: none) and one redemption of £75m (2020: £158m) relating to the 9.25% perpetual subordinated bonds.
Barclays Bank PLC and protective rights of non-controlling interests
Barclays PLC holds 100% of the voting rights of Barclays Bank PLC. As at 31 December 2021, Barclays Bank PLC has in issue preference shares and Upper Tier 2 instruments. These are non-controlling interests to the Group.
A fixed coupon rate is attached to all Upper Tier 2 instruments until the initial call date, with the exception of the 9% Bonds, which are fixed for the life of the issue and the Series 1, Series 2 and Series 3 Undated Notes, which are floating rate at rates fixed periodically in advance based on market rates.
After the initial call date, in the event they are not redeemed, coupon payments in relation to the 6.125% Undated Notes are fixed periodically in advance for five-year periods based on market rates. Coupon payments for all other Upper Tier 2 instruments are at rates fixed periodically in advance based on market rates.
The payment of preference share dividends and Upper Tier 2 coupons are typically at the discretion of Barclays Bank PLC, except for coupon payments that become compulsory where Barclays PLC has declared or paid a dividend on ordinary shares, or in certain cases, any class of preference shares, in the preceding six-month period. Coupons not paid becomes payable in each case if such a dividend is subsequently paid or in certain other circumstances. No dividend or coupon payments may be made unless Barclays Bank PLC satisfies a specified solvency test. Under the terms of these instruments, Barclays PLC may not pay dividends on ordinary shares until a dividend or coupon is next paid on these instruments or the instruments are redeemed or purchased by Barclays Bank PLC. There are no restrictions on Barclays Bank PLC’s ability to remit capital to the Parent as a result of these issued instruments.
Preference share redemptions are typically at the discretion of Barclays Bank PLC. Upper Tier 2 instruments are repayable, at the option of Barclays Bank PLC generally in whole at the initial call date and on any subsequent coupon payment date or, in the case of the 6.125% Undated Notes on any fifth anniversary after the initial call date. In addition, each issue of Upper Tier 2 instruments is repayable, at the option of Barclays Bank PLC, in whole for certain tax reasons, either at any time, or on an interest payment date. There are no events of default except non-payment of principal or mandatory interest. Any repayments or redemptions require the prior consent of the PRA, and in respect of the preference shares, any such redemption will be subject to the Companies Act 2006 and the Articles of Barclays Bank PLC.
20212020
Instrument£m£m
Preference Shares:
US Dollar Preference Shares318 318 
Euro Preference Shares211 211 
Total Barclays Bank PLC Preference Shares529 529 
Upper Tier 2 Instruments:
Undated Floating Rate Primary Capital Notes Series 193 93 
Undated Floating Rate Primary Capital Notes Series 2179 179 
5.03% Undated Reverse Dual Currency Subordinated Loan (JPY8bn)
39 39 
5.0% Reverse Dual Currency Undated Subordinated Loan (JPY12bn)
53 53 
Undated Floating Rate Primary Capital Notes Series 3 (£145m)
20 20 
9% Permanent Interest Bearing Capital Bonds (£100m)
40 40 
6.125% Undated Subordinated Notes (£550m)
34 34 
9.25% Perpetual Subordinated Bonds (ex Woolwich) (£150m)
 75 
Total Upper Tier 2 Instruments458 533 

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
284

Notes to the financial statements
For the year ended 31 December 2021 continued
Employee benefits
The notes included in this section focus on the costs and commitments associated with employing our staff.
31 Staff costs
Accounting for staff costs
The Group applies IAS 19 Employee benefits in its accounting for most of the components of staff costs.
Short-term employee benefits – salaries, accrued performance costs and social security are recognised over the period in which the employees provide the services to which the payments relate.
Performance costs – recognised to the extent that the Group has a present obligation to its employees that can be measured reliably and are recognised over the period of service that employees are required to work to qualify for the payments.
Deferred cash and share awards are made to employees to incentivise performance over the period employees provide services. To receive payment under an award, employees must provide service over the vesting period. The period over which the expense for deferred cash and share awards is recognised is based upon the period employees consider their services contribute to the awards. For past awards, the Group considers that it is appropriate to recognise the awards over the period from the date of grant to the date that the awards vest. In relation to awards granted from 2017, the Group, taking into account the changing employee understanding surrounding those awards, considered it appropriate for expense to be recognised over the vesting period including the financial year prior to the grant date.
The accounting policies for share-based payments, and pensions and other post-retirement benefits are included in Note 32 and Note 33 respectively.
202120202019
£m£m£m
Incentive awards granted:
Current year bonus1,278 1,090 1,058 
Deferred bonus667 490 432 
Total incentive awards granted1,945 1,580 1,490 
Reconciliation of incentive awards granted to income statement charge:
Less: deferred bonuses granted but not charged in current year(457)(335)(293)
Add: current year charges for deferred bonuses from previous years280 293 308 
Other differences between incentive awards granted and income statement charge(23)(34)(48)
Income statement charge for performance costs1,745 1,504 1,457 
Other income statement charges:
Salaries4,290 4,322 4,332 
Social security costs619 613 573 
Post-retirement benefitsa
539 519 501 
Other compensation costs431 479 480 
Total compensation costsb
7,624 7,437 7,343 
Other resourcing costs:
Outsourcing357 342 433 
Redundancy and restructuring296 102 132 
Temporary staff costs109 102 256 
Other125 114 151 
Total other resourcing costs887 660 972 
Total staff costs8,511 8,097 8,315 
Notes
a    Post-retirement benefits charge includes £289m (2020: £279m; 2019: £270m) in respect of defined contribution schemes and £250m (2020: £240m; 2019: £231m) in respect of defined benefit schemes.
b    £484m (2020: £451m; 2019: £439m) of Group compensation was capitalised as internally generated software and excluded from the Staff cost disclosed above .
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
285

Notes to the financial statements
For the year ended 31 December 2021 continued
32 Share-based payments
Accounting for share-based payments
The Group applies IFRS 2 Share-based Payments in accounting for employee remuneration in the form of shares.
Employee incentives include awards in the form of shares and share options, as well as offering employees the opportunity to purchase shares on favourable terms. The cost of the employee services received in respect of the shares or share options granted is recognised in the income statement over the period that employees provide services. The overall cost of the award is calculated using the number of shares and options expected to vest and the fair value of the shares or options at the date of grant.
The number of shares and options expected to vest takes into account the likelihood that performance and service conditions included in the terms of the awards will be met. Failure to meet the non-vesting condition is treated as a cancellation, resulting in an acceleration of recognition of the cost of the employee services.
The fair value of shares is the market price ruling on the grant date, in some cases adjusted to reflect restrictions on transferability. The fair value of options granted is determined using option pricing models to estimate the numbers of shares likely to vest. These take into account the exercise price of the option, the current share price, the risk-free interest rate, the expected volatility of the share price over the life of the option and other relevant factors. Market conditions that must be met in order for the award to vest are also reflected in the fair value of the award, as are any other non-vesting conditions – such as continuing to make payments into a share-based savings scheme.
The charge for the year arising from share-based payment schemes was as follows:
Charge for the year
202120202019
£m£m£m
Deferred Share Value Plan and Share Value Plan256 245 272 
Others216 184 206 
Total equity settled472 429 478 
Cash settled5 
Total share-based payments 477 431 481 
The terms of the main current plans are as follows:
Share Value Plan (SVP)
The SVP was introduced in March 2010. SVP awards have been granted to participants in the form of a conditional right to receive Barclays PLC shares or provisional allocations of Barclays PLC shares which vest or are considered for release over a period of three, five or seven years. Participants do not pay to receive an award or to receive a release of shares. For awards granted before December 2017, the grantor may also make a dividend equivalent payment to participants on release of a SVP award. SVP awards are also made to eligible employees for recruitment purposes. All awards are subject to potential forfeiture in certain leaver scenarios.
Deferred Share Value Plan (DSVP)
The DSVP was introduced in February 2017. The terms of the DSVP are materially the same as the terms of the SVP as described above, save that Executive Directors are not eligible to participate in the DSVP and the DSVP operates over market purchase shares only.
Other schemes
In addition to the SVP and DSVP, the Barclays Group operates a number of other schemes settled in Barclays PLC Shares including Sharesave (both UK and Ireland), Sharepurchase (both UK and overseas), and the Barclays Group Long Term Incentive Plan. A delivery of upfront shares to ‘Material Risk Takers’ can be made as a Share Incentive Award (Holding Period).
Share option and award plans
The weighted average fair value per award granted, weighted average share price at the date of exercise/release of shares during the year, weighted average contractual remaining life and number of options and awards outstanding (including those exercisable) at the balance sheet date were as follows:
20212020
Weighted average fair value per award granted in yearWeighted average share price at exercise/release during yearWeighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
Weighted average fair value per award granted in yearWeighted average share price at exercise/release during yearWeighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
££in years(000s)££in years(000s)
DSVP and SVPa,b
1.62 1.76 1413,859 1.06 1.24 1416,941 
Othersa
0.64-1.80
1.75-1.92
0-3
335,976 
0.23-1.24
1.04-1.68
0-3
356,033 
Notes
a    Options/award granted over Barclays PLC shares.
b    Weighted average exercise price is not applicable for SVP and DSVP awards as these are not share option schemes.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
286

Notes to the financial statements
For the year ended 31 December 2021 continued
SVP and DSVP are nil cost awards on which the performance conditions are substantially completed at the date of grant. Consequently, the fair value of these awards is based on the market value at that date.
Sharesave has a contractual life of 3 and five years, the expected volatility is 30.97% for 3 years and 29.76% for 5 years. The risk free interest rates used for valuations are 1.20% and 1.18% for 3 and 5 years respectively.
Movements in options and awards
The movement in the number of options and awards for the major schemes and the weighted average exercise price of options was:
DSVP and SVPa,b
Othersa,c
Number (000s)Number (000s)Weighted average ex. price (£)
202120202021202020212020
Outstanding at beginning of year/acquisition date 416,941 331,491 356,033 232,259 0.96 1.29 
Granted in the year187,667 232,379 120,385 365,166 1.43 0.84 
Exercised/released in the year(160,460)(132,376)(107,688)(123,042)1.38 1.22 
Less: forfeited in the year(30,289)(14,553)(24,489)(105,068)0.95 1.24 
Less: expired in the year — (8,265)(13,282)1.67 1.35 
Outstanding at end of year413,859 416,941 335,976 356,033 0.95 0.96 
Of which exercisable: — 28,609 30,833 1.23 1.66 
Notes
a    Options/award granted over Barclays PLC shares.
b    Weighted average exercise price is not applicable for SVP and DSVP awards as these are not share option schemes.
c    The number of awards within Others at the end of the year principally relates to Sharesave (number of awards exercisable at end of year was 8,821,715). The weighted average exercise price relates to Sharesave.
Awards and options granted under the Group’s share plans may be satisfied using new issue shares, treasury shares and market purchase shares. Awards granted under the DSVP may be satisfied using market purchase shares only.
There were no significant modifications to the share-based payments arrangements in 2021 and 2020.
As at 31 December 2021, the total liability arising from cash-settled share-based payments transactions was £5m (2020: £2m).
Holdings of Barclays PLC shares and hedges
Various employee benefit trusts established by the Group hold shares in Barclays PLC to meet obligations under the Barclays share-based payment schemes. The total number of Barclays shares held in these employee benefit trusts at 31 December 2021 was 12.9m (2020: 17.1m). Dividend rights have been waived on all these shares. The total market value of the shares held in trust based on the year end share price of £1.87 (2020: £1.27) was £24m (2020: £22m). For accounting of treasury shares, see Note 29.
The Group has entered into physically settled forward contracts to hedge the settlement of certain share-based payment schemes. The fixed forward price to be paid under these contracts is £416m and has been recorded in retained earnings.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
287

Notes to the financial statements
For the year ended 31 December 2021 continued
33 Pensions and post-retirement benefits
Accounting for pensions and post-retirement benefits
The Group operates a number of pension schemes and post-employment benefit schemes.
Defined contribution schemes – the Group recognises contributions due in respect of the accounting period in the income statement. Any contributions unpaid at the balance sheet date are included as a liability.
Defined benefit schemes – the Group recognises its obligations to members of each scheme at the period end, less the fair value of the scheme assets after applying the asset ceiling test.
Each scheme’s obligations are calculated using the projected unit credit method. Scheme assets are stated at fair value as at the period end.
Changes in pension scheme liabilities or assets (remeasurements) that do not arise from regular pension cost, net interest on net defined benefit liabilities or assets, past service costs, settlements or contributions to the scheme, are recognised in other comprehensive income. Remeasurements comprise experience adjustments (differences between previous actuarial assumptions and what has actually occurred), the effects of changes in actuarial assumptions, return on scheme assets (excluding amounts included in the interest on the assets) and any changes in the effect of the asset ceiling restriction (excluding amounts included in the interest on the restriction).
Post-employment benefit schemes – the cost of providing healthcare benefits to retired employees is accrued as a liability in the financial statements over the period that the employees provide services to the Group, using a methodology similar to that for defined benefit pension schemes.
Pension schemes
UK Retirement Fund (UKRF)
The UKRF is the Group’s main scheme, representing 97% of the Group’s total retirement benefit obligations. Barclays Bank PLC is the principal employer of the UKRF. The UKRF was closed to new entrants on 1 October 2012, and comprises 10 sections, the two most significant of which are:
Afterwork, which comprises a contributory cash balance defined benefit element, and a voluntary defined contribution element. The cash balance element is accrued each year and revalued until Normal Retirement Age in line with the increase in Retail Price Index (RPI) (up to a maximum of 5% p.a.). An increase of up to 2% a year may also be added at Barclays’ discretion. The costs of ill-health retirements and death in service benefits for Afterwork members are borne by the UKRF. The main risks that Barclays runs in relation to Afterwork are limited although additional contributions are required if pre-retirement investment returns are not sufficient to provide for the benefits.
The 1964 Pension Scheme. Most employees recruited before July 1997 built up benefits in this non-contributory defined benefit scheme in respect of service up to 31 March 2010. Pensions were calculated by reference to service and pensionable salary. From 1 April 2010, members became eligible to accrue future service benefits in either Afterwork or the Pension Investment Plan, a historic defined contribution section which is now closed to future contributions. The risks that Barclays runs in relation to the 1964 section are typical of final salary pension schemes, principally that investment returns fall short of expectations, that inflation exceeds expectations, and that retirees live longer than expected.
Barclays Pension Savings Plan (BPSP)
The BPSP is a defined contribution scheme providing benefits for all new UK hires from 1 October 2012, BPSP is not subject to the same investment return, inflation or life expectancy risks for Barclays that defined benefit schemes are. Members’ benefits reflect contributions paid and the level of investment returns achieved.
Other
Apart from the UKRF and the BPSP, Barclays operates a number of smaller pension and long-term employee benefits and post-retirement healthcare plans globally, the largest of which are the US defined benefit and defined contribution schemes. Many of the schemes are funded, with assets backing the obligations held in separate legal vehicles such as trusts. Others are operated on an unfunded basis. The benefits provided, the approach to funding, and the legal basis of the schemes, reflect local environments.
Governance
The UKRF operates under trust law and is managed and administered on behalf of the members in accordance with the terms of the Trust Deed and Rules and all relevant legislation. The Corporate Trustee is Barclays Pension Funds Trustees Limited, a private limited company and a wholly owned subsidiary of Barclays Bank PLC. The Trustee is the legal owner of the assets of the UKRF which are held separately from the assets of the Group.
The Trustee Board comprises six Management Directors selected by Barclays, of whom three are independent Directors with no relationship with Barclays (and who are not members of the UKRF), plus three Member Nominated Directors selected from eligible active staff, deferred and pensioner members who apply for the role.
The BPSP is a Group Personal Pension arrangement which operates as a collection of personal pension plans. Each personal pension plan is a direct contract between the employee and the BPSP provider (Legal & General Assurance Society Limited), and is regulated by the FCA.
Similar principles of pension governance apply to the Group’s other pension schemes, depending on local legislation.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
288

Notes to the financial statements
For the year ended 31 December 2021 continued
Amounts recognised
The following tables include amounts recognised in the income statement and an analysis of benefit obligations and scheme assets for all Group defined benefit schemes. The net position is reconciled to the assets and liabilities recognised on the balance sheet. The tables include funded and unfunded post-retirement benefits.
Income statement charge
202120202019
£m£m£m
Current service cost247 243 231 
Net finance cost(26)(40)(48)
Past service cost (4)— 
Other movements3 — 
Total224 200 183 

Balance sheet reconciliation
20212020
TotalOf which relates to UKRFTotalOf which relates to UKRF
£m£m£m£m
Benefit obligation at beginning of the year(33,190)(32,108)(30,333)(29,304)
Current service cost(247)(225)(243)(217)
Interest costs on scheme liabilities(422)(405)(573)(549)
Past service cost  — 
Remeasurement (loss)/gain – financial848 820 (3,439)(3,358)
Remeasurement (loss)/gain – demographic53 50 (281)(286)
Remeasurement (loss)/gain – experience(249)(259)244 237 
Employee contributions(4) (5)(1)
Benefits paid1,309 1,268 1,406 1,370 
Exchange and other movements3  30 — 
Benefit obligation at end of the year(31,899)(30,859)(33,190)(32,108)
Fair value of scheme assets at beginning of the year34,713 33,915 32,093 31,362 
Interest income on scheme assets448 434 613 595 
Employer contribution971 955 265 248 
Remeasurement – return on scheme assets greater than discount rate653 642 3,411 3,328 
Employee contributions4  
Benefits paid(1,309)(1,268)(1,406)(1,370)
Exchange and other movements(13) (268)(249)
Fair value of scheme assets at end of the year35,467 34,678 34,713 33,915 
Net surplus3,568 3,819 1,523 1,807 
Retirement benefit assets3,879 3,819 1,814 1,807 
Retirement benefit liabilities(311) (291)— 
Net retirement benefit assets3,568 3,819 1,523 1,807 
Included within the benefit obligation was £821m (2020: £867m) relating to overseas pensions and £219m (2020: £215m) relating to other post-employment benefits.
As at 31 December 2021, the UKRF’s scheme assets were in surplus versus IAS 19 obligations by £3,819m (2020: £1,807m). The movement for the UKRF was driven by £700m of deficit reduction contributions, higher corporate bond yields and favorable asset returns, partially offset by higher expected long term price inflation.
The weighted average duration of the benefit payments reflected in the defined benefit obligation for the UKRF is 16 years. The UKRF expected benefits are projected to be paid out for in excess of 50 years, although 25% of the total benefits are expected to be paid in the next 10 years; 30% in years 11 to 20 and 25% in years 20 to 30. The remainder of the benefits are expected to be paid beyond 30 years.
Of the £1,268m (2020: £1,370m) UKRF benefits paid out, £419m (2020: £520m) related to transfers out of the fund.
Where a scheme’s assets exceed its obligation, an asset is recognised to the extent that it does not exceed the present value of future contribution holidays or refunds of contributions (the asset ceiling). In the case of the UKRF the asset ceiling is not applied as, in certain specified circumstances such as wind-up, the Group expects to be able to recover any surplus. Similarly, a liability in respect of future minimum funding requirements is not recognised. The Trustee does not have a substantive right to augment benefits, nor do they have the right to wind up the plan except in the dissolution of the Group or termination of contributions by the Group. The application of the asset ceiling to other plans and recognition of additional liabilities in respect of future minimum funding requirements are considered on an individual plan basis.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
289

Notes to the financial statements
For the year ended 31 December 2021 continued
Critical accounting estimates and judgements
Actuarial valuation of the schemes’ obligation is dependent upon a series of assumptions. Below is a summary of the main financial and demographic assumptions adopted for the UKRF.
20212020
Key UKRF financial assumptions% p.a.% p.a.
Discount rate1.84 1.29 
Inflation rate (RPI)3.56 2.99 
The UKRF discount rate assumption for 2021 was based on a standard Willis Towers Watson RATE Link model. The RPI inflation assumption for 2021 was set by reference to the Bank of England’s implied inflation curve. The inflation assumption incorporates a deduction of 20 basis points as an allowance for an inflation risk premium. The methodology used to derive the discount rate and inflation assumptions is consistent with that used at the prior year end.
The UKRF’s post-retirement mortality assumptions are based on a best estimate assumption derived from an analysis in 2019 of the UKRF’s own post-retirement mortality experience, and taking account of recent evidence from published mortality surveys. An allowance has been made for future mortality improvements based on the 2020 core projection model published by the Continuous Mortality Investigation Bureau subject to a long-term trend of 1.5% per annum in future improvements. The methodology used is consistent with the prior year end, except that the 2019 core projection model was used at 2020. The table below shows how the assumed life expectancy at 60, for members of the UKRF, has varied over the past three years:
Assumed life expectancy202120202019
Life expectancy at 60 for current pensioners (years)
– Males27.327.227.1
– Females29.629.429.3
Life expectancy at 60 for future pensioners currently aged 40 (years)
– Males29.129.028.9
– Females31.431.231.1
The UKRF entered into a £5bn longevity swap in 2020 covering around a quarter of the pensioner liabilities. The swap is part of the UKRF’s investment portfolio and provide income in the event that pensions are paid out for longer than expected. The swap is not included directly within the balance sheet of Barclays PLC as it is an asset of the UKRF. At 31 December 2021, the swap is valued at nil (2020:nil) as experience since the swap was effected has been neutral.
Sensitivity analysis on actuarial assumptions
The sensitivity analysis has been calculated by valuing the UKRF liabilities using the amended assumptions shown in the table below and keeping the remaining assumptions the same as disclosed in the table above, except in the case of the inflation sensitivity where other assumptions that depend on assumed inflation have also been amended correspondingly. The difference between the recalculated liability figure and that stated in the balance sheet reconciliation table above is the figure shown. The selection of these movements to illustrate the sensitivity of the defined benefit obligation to key assumptions should not be interpreted as Barclays expressing any specific view of the probability of such movements happening.
Change in key assumptions
20212020
(Decrease)/ Increase in UKRF defined benefit obligation(Decrease)/ Increase in UKRF defined benefit obligation
£bn£bn
Discount rate
0.5% p.a. increase
(2.3)(2.5)
0.25% p.a. increase
(1.2)(1.3)
0.25% p.a. decrease
1.3 1.4 
0.5% p.a. decrease
2.6 2.9 
Assumed RPI
0.5% p.a. increase
1.6 1.8 
0.25% p.a. increase
0.8 0.9 
0.25% p.a. decrease
(0.8)(0.9)
0.5% p.a. decrease
(1.6)(1.8)
Life expectancy at 60
One year increase
1.2 1.2 
One year decrease
(1.2)(1.2)

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
290

Notes to the financial statements
For the year ended 31 December 2021 continued
Assets
A long-term investment strategy has been set for the UKRF, with its asset allocation comprising a mixture of equities, bonds, property and other appropriate assets. This recognises that different asset classes are likely to produce different long-term returns and some asset classes may be more volatile than others. The long-term investment strategy ensures, among other aims, that investments are adequately diversified.
The UKRF also employs derivative instruments, where appropriate, to achieve a desired exposure or return, or to match assets more closely to liabilities. The value of assets shown reflects the assets held by the scheme, with any derivative holdings reflected on a fair value basis.
The value of the assets of the schemes and their percentage in relation to total scheme assets were as follows:
Analysis of scheme assets
TotalOf which relates to UKRF
Quoteda
£m
Unquoteda
£m
Value
£m
% of total fair value of
scheme assets
%
Quoteda
£m
Unquoteda
£m
Value
£m
% of total fair value of
scheme assets
%
As at 31 December 2021
Equities 214 1,377 1,591 4.5 86 1,377 1,463 4.2 
Private equities 2,991 2,991 8.4  2,991 2,991 8.6 
Bonds - fixed government2,387 95 2,482 7.0 2,083 95 2,178 6.3 
Bonds - index-linked government13,478 679 14,157 39.9 13,455 679 14,134 40.8 
Bonds - corporate and other6,223 2,854 9,077 25.6 5,986 2,854 8,840 25.5 
Property14 1,490 1,504 4.3  1,490 1,490 4.3 
Infrastructure 1,815 1,815 5.1  1,815 1,815 5.2 
Cash and liquid assets189 1,577 1,766 5.0 176 1,577 1,753 5.1 
Mixed investment funds9  9      
Other19 56 75 0.2  14 14  
Fair value of scheme assets 22,533 12,934 35,467 100.0 21,786 12,892 34,678 100.0 
As at 31 December 2020
Equities 567 1,498 2,065 5.9 378 1,498 1,876 5.5 
Private equities— 2,233 2,233 6.4 — 2,233 2,233 6.6 
Bonds - fixed government4,205 110 4,315 12.4 3,932 110 4,042 11.9 
Bonds - index-linked government10,706 1,014 11,720 33.8 10,697 1,014 11,711 34.6 
Bonds - corporate and other7,439 1,678 9,117 26.3 7,214 1,678 8,892 26.2 
Property10 1,416 1,426 4.1 — 1,416 1,416 4.2 
Infrastructure— 1,812 1,812 5.2 — 1,812 1,812 5.3 
Cash and liquid assets64 1,830 1,894 5.5 46 1,830 1,876 5.5 
Mixed investment funds— — — — — — 
Other14 108 122 0.4 — 57 57 0.2 
Fair value of scheme assets 23,014 11,699 34,713 100.0 22,267 11,648 33,915 100.0 
Note
a    Valuations of unquoted assets are provided by the underlying managers or qualified independent valuers. Valuations of complex instruments are based on UKRF custodian valuations. All valuations are determined in accordance with relevant industry guidance.

Included within the fair value of scheme assets were nil (2020: nil) relating to shares in Barclays PLC and nil (2020: nil) relating to bonds issued by Barclays PLC. The UKRF also invests in pooled investment vehicles which may hold shares or debt issued by Barclays PLC.
The UKRF assets above do not include the Senior Notes asset referred to in the section below on Triennial Valuation, as these are non-transferable instruments and not recognised under IAS 19.
Approximately 45% of the UKRF assets are invested in liability-driven investment strategies; primarily UK gilts as well as interest rate and inflation swaps. These are used to better match the assets to its liabilities. The swaps are used to reduce the scheme’s inflation and duration risks against its liabilities.
Triennial valuation
The latest annual update as at 30 September 2021 showed the funding position had improved to a surplus of £0.6bn from a deficit of £0.9bn shown at 30 September 2020. The improvement was mainly due to £0.7bn of deficit reduction contributions and favourable asset returns, partially offset by higher expected long term price inflation.
The main differences between the funding and accounting assumptions are a different approach to setting the discount rate and a more conservative longevity assumption for funding.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
291

Notes to the financial statements
For the year ended 31 December 2021 continued
The deficit reduction contributions agreed with the UKRF Trustee as part of the 30 September 2019 triennial valuation recovery plan are shown in the table below.
Deficit reduction contributions under the 30 September 2019 valuation
Year£m
Cash paid:
2021700 
Future commitments:
2022294 
2023286 
2024 and beyond— 
During 2019 and 2020 the UKRF subscribed for non-transferrable listed senior fixed rate notes for £1,250m, backed by UK gilts (the Senior Notes). These Senior Notes entitle the UKRF to semi-annual coupon payments for five years, and full repayment in cash in three tranches: £250m in 2023, £750m in 2024, and £250m at final maturity in 2025. The regulatory capital impact, which otherwise would have occurred in 2019 and 2020 from the regular deficit reduction contributions, takes effect in 2023, 2024 and 2025 on maturity of the notes. As the UKRF's investment in these Senior Notes does not qualify as a plan asset under IAS 19, the £1,250m does not appear in the IAS 19 plan assets. The Senior Notes were issued by Heron Issuer Limited (Heron) for £500m and Heron Issuer Number 2 Limited (Heron 2) for £750m, entities consolidated within the Group under IFRS 10. Heron and Heron 2 acquired a total of £1,250m of gilts from Barclays Bank PLC for cash to support payments on the Senior Notes. There were no further transactions of this type in 2021.
The deficit reduction contributions are in addition to the regular contributions to meet the Group’s share of the cost of benefits accruing over each year. The next funding valuation of the UKRF is due to be completed in 2023 with an effective date of 30 September 2022.
Other support measures agreed which remain in place
Collateral – The UKRF Trustee and Barclays Bank PLC have entered into an arrangement whereby a collateral pool has been put in place to provide security for the UKRF funding deficit as it increases or decreases over time. The collateral pool is currently made up of government securities, and agreement was made with the Trustee to cover at least 100% of the funding deficit with an overall cap of £9bn. The arrangement provides the UKRF Trustee with dedicated access to the pool of assets in the event of Barclays Bank PLC not paying a deficit reduction contribution to the UKRF or in the event of Barclays Bank PLC’s insolvency. These assets are included within Note 38 Assets pledged, collateral received and assets transferred.
Support from Barclays PLC – In the event of Barclays Bank PLC not paying a deficit reduction contribution payment required by a specified pre-payment date, Barclays PLC has entered into an arrangement whereby it will be required to use, in first priority, dividends received from Barclays Bank UK PLC (if any) to invest the proceeds in Barclays Bank PLC (up to the maximum amount of the deficit reduction contribution unpaid by Barclays Bank PLC). The proceeds of the investment will be used to discharge Barclays Bank PLC’s unpaid deficit reduction contribution.
Participation – As permitted under the Financial Services and Markets Act 2000 (Banking Reform) (Pensions) Regulations 2016, Barclays Bank UK PLC is a participating employer in the UKRF and will remain so during a transitional phase until September 2025 as set out in a deed of participation. Barclays Bank UK PLC will make contributions for the future service of its employees who are currently Afterwork members and, in the event of Barclays Bank PLC’s insolvency during this period provision has been made to require Barclays Bank UK PLC to become the principal employer of the UKRF. Barclays Bank PLC’s Section 75 debt would be triggered by the insolvency (the debt would be calculated after allowing for the payment to the UKRF of the collateral above).
Defined benefit contributions paid with respect to the UKRF were as follows:
Contributions paid
£m
2021955 
2020748 
20191,231 
There were nil (2020: nil; 2019: nil) Section 75 contributions included within the Group’s contributions paid as no participating employers left the UKRF in 2021.
The Group’s expected contribution to the UKRF in respect of defined benefits in 2022 is £546m (2021: £959m). In addition, the expected contributions to UK defined contribution schemes in 2022 is £33m (2021: £35m) to the UKRF and £221m (2021: £209m) to the BPSP.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
292

Notes to the financial statements
For the year ended 31 December 2021 continued
Scope of consolidation
The notes included in this section present information on the Group’s investments in subsidiaries, joint ventures and associates and its interests in structured entities. Detail is also given on securitisation transactions the Group has entered into and arrangements that are held off-balance sheet.
34 Principal subsidiaries
The Group applies IFRS 10 Consolidated Financial Statements. The consolidated financial statements combine the financial statements of the Group and all its subsidiaries. Subsidiaries are entities over which the Group has control. Under IFRS 10, this is when the Group is exposed or has rights to variable returns from its involvement in the entity and has the ability to affect those returns through its power over the entity.
The Group reassesses whether it controls an entity if facts and circumstances indicate that there have been changes to its power, its rights to variable returns or its ability to use its power to affect the amount of its returns.
Intra-group transactions and balances are eliminated on consolidation and consistent accounting policies are used throughout the Group for the purposes of the consolidation. Changes in ownership interests in subsidiaries are accounted for as equity transactions if they occur after control has been obtained and they do not result in loss of control.
The significant judgements used in applying this policy are set out below.
Accounting for investment in subsidiaries
In the individual financial statements of Barclays PLC, investments in subsidiaries are stated at cost less impairment.
Principal subsidiaries for the Group are set out below. This includes those subsidiaries that are most significant in the context of the Group’s business, results or financial position.
Principal place of business or incorporationPercentage of voting rights heldNon-controlling interests - proportion of ownership interestsNon-controlling interests - proportion of voting interests
Company nameNature of business%%%
Barclays Bank PLCUnited KingdomBanking, holding company100 — 
Barclays Bank UK PLCUnited KingdomBanking, holding company100 — — 
Barclays Bank Ireland PLCIrelandBanking100 — — 
Barclays Execution Services LimitedUnited KingdomService company100 — — 
Barclays Capital Inc.United StatesSecurities dealing100 — — 
Barclays Capital Securities LimitedUnited KingdomSecurities dealing100 — — 
Barclays Securities Japan LimitedJapanSecurities dealing100 — — 
Barclays US LLCUnited StatesHolding company100 — — 
Barclays Bank DelawareUnited StatesCredit card issuer 100 — — 
The country of registration or incorporation is also the principal area of operation of each of the above subsidiaries.
Ownership interests are in some cases different to voting interests due to the existence of non-voting equity interests, such as preference shares. Refer to Note 30 for more information.
Determining whether the Group has control of an entity is generally straightforward based on ownership of the majority of the voting capital. However, in certain instances, this determination will involve judgement, particularly in the case of structured entities where voting rights are often not the determining factor in decisions over the relevant activities. This judgement will involve assessing the purpose and design of the entity. It will also often be necessary to consider whether the Group, or another involved party with power over the relevant activities, is acting as a principal in its own right or as an agent on behalf of others. 
There is also often considerable judgement involved in the ongoing assessment of control over structured entities. In this regard, where market conditions have deteriorated such that the other investors’ exposures to the structure’s variable returns have been substantively eliminated, the Group may conclude that the managers of the structured entity are acting as its agent and therefore will consolidate the structured entity.
An interest in equity voting rights exceeding 50% would typically indicate that the Group has control of an entity. However, the entity set out below is excluded from consolidation because the Group does not have exposure to its variable returns.
Percentage of voting rights heldEquity shareholders' fundsRetained profit for the year
Company nameCountry of registration or incorporation%£m£m
Palomino LimitedCayman Islands100 — — 
This entity is managed by an external counterparty and consequently is not controlled by the Group. Interests relating to this entity are included in Note 35.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
293

Notes to the financial statements
For the year ended 31 December 2021 continued
Significant restrictions
As is typical for a group of its size and international scope, there are restrictions on the ability of Barclays PLC to obtain distributions of capital, access the assets or repay the liabilities of members of its Group due to the statutory, regulatory and contractual requirements of its subsidiaries and due to the protective rights of non-controlling interests. These are considered below.
Regulatory requirements
Barclays’ principal subsidiary companies have assets and liabilities before intercompany eliminations of £1,833bn (2020: £1,795bn) and £1,737bn (2020: £1,703bn) respectively. Certain of these assets and liabilities are subject to prudential regulation and regulatory capital requirements in the countries in which they are regulated. These require entities to maintain minimum capital levels which cannot be returned to the parent company, Barclays PLC, on a going concern basis.
In order to meet capital requirements, subsidiaries may issue certain equity-accounted and debt-accounted financial instruments and non-equity instruments such as Tier 1 and Tier 2 capital instruments and other forms of subordinated liabilities. Refer to Note 27 and Note 28 for particulars of these instruments. These instruments may be subject to cancellation clauses or preference share restrictions that would limit the ability of the entity to repatriate the capital on a timely basis.
Liquidity requirements
Regulated subsidiaries of the Group are required to meet applicable PRA or local regulatory requirements pertaining to liquidity. Some of the regulated subsidiaries include Barclays Bank PLC and Barclays Capital Securities Limited (which are regulated on a combined basis under a Domestic Liquidity Sub-Group (DoLSub) arrangement), Barclays Bank UK PLC, Barclays Bank Ireland PLC, Barclays Capital Inc. and Barclays Bank Delaware. Refer to the Liquidity risk section for further details of liquidity requirements, including those of the Group’s significant subsidiaries.
Statutory requirements
The Group’s subsidiaries are subject to statutory requirements not to make distributions of capital and unrealised profits and generally to maintain solvency. These requirements restrict the ability of subsidiaries to make remittances of dividends to Barclays PLC, the ultimate parent, except in the event of a legal capital reduction or liquidation. In most cases, the regulatory restrictions referred to above exceed the statutory restrictions.
Asset encumbrance
The Group uses its financial assets to raise finance in the form of securitisations and through the liquidity schemes of central banks, as well as to provide security to the UK Retirement Fund. Once encumbered, the assets are not available for transfer around the Group. The assets typically affected are disclosed in Note 38.
Other restrictions
The Group is required to maintain balances with central banks and other regulatory authorities, and these amounted to £4,750m (2020: £3,392m).
35 Structured entities
A structured entity is an entity in which voting or similar rights are not the dominant factor in deciding who controls the entity. Voting rights may relate to administrative tasks only, with the relevant activities of the entity being directed by means of contractual arrangements. Structured entities are generally created to achieve a narrow and well-defined objective with restrictions around their ongoing activities.
Depending on the Group’s power over the activities of the entity and its exposure to and ability to influence its own returns, it may consolidate the entity. In other cases, it may sponsor or have exposure to such an entity but not consolidate it.
Consolidated structured entities
The Group has contractual arrangements which may require it to provide financial support to the following types of consolidated structured entities:
Securitisation vehicles: The Group uses securitisation as a source of financing and a means of risk transfer. Where entities are controlled by the Group, they are consolidated. Refer to Note 37 for further detail.
Commercial Paper (CP) conduits: These entities issue CP and use the proceeds to lend to clients as part of the Group's multi-seller conduit programme. The Group has provided £17.2bn (2020: £16.9bn) in contractual liquidity facilities to the CP conduits that the Group consolidates. These amounts represent the maximum the conduits can lend externally. The amounts of CP conduit lending (drawn and undrawn) to unconsolidated structured entities can be seen in Other interests in unconsolidated structured entities under multi-seller conduit programme in the Nature of interest table.
Employee benefit trusts: The Group provides capital contributions to employee benefit trusts to enable them to meet obligations to employees in relation to share-based remuneration arrangements.
Tender Option Bond (TOB) trusts: During 2021, the Group provided undrawn liquidity facilities of £3.3bn (2020: £2.9bn) to consolidated TOB trusts. These trusts invest in fixed income instruments issued by state, local or other municipalities in the United States, funded by long-term senior floating-rate notes and junior residual securities.
Unconsolidated structured entities
The term ‘unconsolidated structured entities’ refers to structured entities not controlled by Barclays, and are established either by Barclays or a third party. An interest in a structured entity is any form of contractual or non-contractual involvement which creates variability in returns arising from the performance of the entity for the Group. Such interests include holdings of debt or equity securities, derivatives that transfer financial risks from the entity to the Group, lending, loan commitments, financial guarantees and investment management agreements.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
294

Notes to the financial statements
For the year ended 31 December 2021 continued
The Group enters into transactions with unconsolidated structured entities in the normal course of business to facilitate customer transactions, to provide risk management services and for specific investment opportunities. This is predominantly within the CIB business. Structured entities may take the form of funds, trusts, securitisation vehicles, and private investment companies. The largest transactions for Barclays include loans and derivatives with hedge fund structures and special purpose entities, multi-seller conduit lending, holding notes issued by securitisation vehicles, and facilitating customer requirements through funds.
The nature and extent of the Group’s interests in structured entities is summarised below:
Summary of interests in unconsolidated structured entities
Secured financingShort-term traded interestsTraded derivativesOther interestsTotal
£m£m£m£m£m
As at 31 December 2021
Assets
Trading portfolio assets 7,170   7,170 
Financial assets at fair value through the income statement61,816   3,490 65,306 
Derivative financial instruments  5,160  5,160 
Financial assets at fair value through other comprehensive income   91 91 
Loans and advances at amortised cost   28,227 28,227 
Reverse repurchase agreements and other similar secured lending104    104 
Other assets   17 17 
Total assets61,920 7,170 5,160 31,825 106,075 
Liabilities
Derivative financial instruments  9,543  9,543 
As at 31 December 2020
Assets
Trading portfolio assets— 11,361 — — 11,361 
Financial assets at fair value through the income statement56,265 — — 2,864 59,129 
Derivative financial instruments— — 2,968 — 2,968 
Financial assets at fair value through other comprehensive income— — — 153 153 
Loans and advances at amortised cost— — — 20,946 20,946 
Reverse repurchase agreements and other similar secured lending10 — — — 10 
Other assets— — — 16 16 
Total assets56,275 11,361 2,968 23,979 94,583 
Liabilities
Derivative financial instruments— — 7,075 — 7,075 
Secured financing arrangements, short-term traded interests and traded derivatives are typically managed under market risk management policies described in the Market risk management section which includes an indication of the change of risk measures compared to last year. For this reason, the total assets of these entities are not considered meaningful for the purposes of understanding the related risks and so have not been presented. Other interests include conduits and lending where the interest is driven by normal customer demand. As at 31 December 2021, there were 5,891 (2020: 3,394) structured entities that Barclays entered into transactions with.
Secured financing
The Group routinely enters into reverse repurchase contracts, margin lending, stock borrowing and similar arrangements on normal commercial terms where the counterparty to the arrangement is a structured entity. Due to the nature of these arrangements, especially the transfer of collateral and ongoing margining, the Group is able to manage its variable exposure to the performance of the structured entity counterparty. The counterparties included in secured financing mainly include hedge fund limited structures, investment companies and special purpose entities.
Short-term traded interests
As part of its market making activities, the Group buys and sells interests in structured vehicles, which are predominantly debt securities issued by asset securitisation vehicles. Such interests are typically held individually or as part of a larger portfolio for no more than 90 days. In such cases, the Group typically has no other involvement with the structured entity other than the securities it holds as part of trading activities and its maximum exposure to loss is restricted to the carrying value of the asset.
Traded derivatives
The Group enters into a variety of derivative contracts with structured entities which reference market risk variables such as interest rates, foreign exchange rates and credit indices among other things. The main derivative types which are considered interests in structured entities include index-based and entity specific credit default swaps, balance guaranteed swaps, total return swaps, commodities swaps, and equity swaps. Interest rate swaps, foreign exchange derivatives that are not complex and which expose the Group to insignificant credit risk by being senior in the payment waterfall of a securitisation and derivatives that are determined to introduce risk or variability to a structured entity are not considered to be an interest in an entity and have been excluded from the disclosures.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
295

Notes to the financial statements
For the year ended 31 December 2021 continued

A description of the types of derivatives and the risk management practices are detailed in Note 14. The risk of loss may be mitigated through ongoing margining requirements as well as a right to cash flows from the structured entity which are senior in the payment waterfall. Such margining requirements are consistent with market practice for many derivative arrangements and in line with the Group’s normal credit policies.
Derivative transactions require the counterparty to provide cash or other collateral under margining agreements to mitigate counterparty credit risk. The Group is mainly exposed to settlement risk on these derivatives which is mitigated through daily margining. Total notional contract amounts were £217,055m (2020: £153,894m).
Except for credit default swaps where the maximum exposure to loss is the swap notional amount, it is not possible to estimate the maximum exposure to loss in respect of derivative positions as the fair value of derivatives is subject to changes in market rates of interest, exchange rates and credit indices which by their nature are uncertain. In addition, the Group’s losses would be subject to mitigating action under its traded market risk and credit risk policies that require the counterparty to provide collateral in cash or other assets in most cases.
Other interests in unconsolidated structured entities
The Group’s interests in structured entities not held for the purposes of short-term trading activities are set out below, summarised by the nature of the interest and limited to significant categories, based on maximum exposure to loss.
Nature of interest
Multi-seller conduit programmeLendingOtherTotal
Of which: Barclays owned, not consolidated entitiesa
£m£m£m£m£m
As at 31 December 2021
Financial assets at fair value through the income statement 70 3,420 3,490 3,335 
Financial assets at fair value through other comprehensive income 53 38 91  
Loans and advances at amortised cost5,184 14,538 8,505 28,227  
Other assets8 4 5 17  
Total on-balance sheet exposures5,192 14,665 11,968 31,825 3,335 
Total off-balance sheet notional amounts11,015 9,426  20,441  
Maximum exposure to loss16,207 24,091 11,968 52,266 3,335 
Total assets of the entity65,441 166,238 52,873 284,552 11,513 
As at 31 December 2020
Financial assets at fair value through the income statement— 98 2,766 2,864 2,698 
Financial assets at fair value through other comprehensive income— 106 47 153 — 
Loans and advances at amortised cost5,146 12,721 3,079 20,946 — 
Other assets16 — 
Total on-balance sheet exposures5,154 12,928 5,897 23,979 2,698 
Total off-balance sheet notional amounts11,750 7,555 — 19,305 — 
Maximum exposure to loss16,904 20,483 5,897 43,284 2,698 
Total assets of the entity87,004 159,804 44,362 291,170 11,008 
Note
a    Comprises of Barclays owned, not consolidated structured entities per IFRS 10 Consolidated Financial Statements, and Barclays sponsored entities, Refer to Note 34 Principal subsidiaries for more details on consolidation.
Maximum exposure to loss
Unless specified otherwise below, the Group’s maximum exposure to loss is the total of its on-balance sheet positions and its off-balance sheet arrangements, being loan commitments and financial guarantees. Exposure to loss is mitigated through collateral, financial guarantees, the availability of netting and credit protection held.
Multi-seller conduit programme
Barclays' multi-seller conduit programme engages in providing financing to various clients and holds whole or partial interests in pools of receivables or similar obligations. These instruments are protected from loss through over-collateralisation, seller guarantees, or other credit enhancements provided to the conduit entities. The Group’s off-balance sheet exposure included in the table above represents liquidity facilities that are provided to the conduit for the benefit of the holders of the commercial paper issued by the conduit and will only be drawn where the conduit is unable to access the commercial paper market. If these liquidity facilities are drawn, the Group is protected from loss through over-collateralisation, seller guarantees, or other credit enhancements provided to the conduit.
Lending
The portfolio includes lending provided by the Group to unconsolidated structured entities in the normal course of its lending business to earn income in the form of interest and lending fees and includes loans to structured entities that are generally collateralised by property, equipment or other assets. All loans are subject to the Group’s credit sanctioning process. Collateral arrangements are specific to the circumstances of each loan with additional guarantees and collateral sought from the sponsor of the structured entity for certain arrangements. During the period the Group incurred an impairment of £28m (2020: £23m) against such facilities.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
296

Notes to the financial statements
For the year ended 31 December 2021 continued
Other
This includes fair value loans with structured entities where the market risk is materially hedged with corresponding derivative contracts, interests in debt securities issued by securitisation vehicles and drawn and undrawn loan facilities to these entities. In addition, other includes investment funds with interests restricted to management fees based on performance of the fund and trusts held on behalf of beneficiaries with interests restricted to unpaid fees.
Assets transferred to sponsored unconsolidated structured entities
Barclays is considered to sponsor another entity if, it had a key role in establishing that entity, it transferred assets to the entity, the Barclays name appears in the name of the entity or it provides guarantees on the entity’s performance. As at 31 December 2021, assets transferred to sponsored unconsolidated structured entities were £1,662m (2020: £730m).
36 Investments in associates and joint ventures
Accounting for associates and joint ventures
The Group applies IAS 28 Investments in Associates and IFRS 11 Joint Arrangements. Associates are entities in which the Group has significant influence, but not control, over the operating and financial policies. Generally the Group holds more than 20%, but less than 50%, of their voting shares. Joint ventures are arrangements where the Group has joint control and rights to the net assets of the entity.
The Group’s investments in associates and joint ventures are initially recorded at cost and increased (or decreased) each year by the Group’s share of the post acquisition profit/(loss). The Group ceases to recognise its share of the losses of equity accounted associates when its share of the net assets and amounts due from the entity have been written off in full, unless it has a contractual or constructive obligation to make good its share of the losses. In some cases, investments in these entities may be held at fair value through profit or loss, for example, those held by private equity businesses.
The equity accounted Associates includes the Groups investment in the Business Growth Fund £699m (2020: £441m) which has increased due to a fair value gain in its investments by £220m (2020: £(23)m).
20212020
AssociatesJoint venturesTotalAssociatesJoint venturesTotal
£m£m£m£m£m£m
Equity accounted722 277 999 464 317 781 
Held at fair value through profit or loss 444 444 — 437 437 
Total722 721 1,443 464 754 1,218 
Summarised financial information for the Group’s equity accounted associates and joint ventures is set out below. The amounts shown are the Group’s share of the net income of the investees for the year ended 31 December 2021, with the exception of certain undertakings for which the amounts are based on accounts made up to dates not earlier than three months before the balance sheet date.
AssociatesJoint ventures
2021202020212020
£m£m£m£m
Profit/(loss) from continuing operations219 (24)35 24 
Other comprehensive income/(loss)1 (3)5 (6)
Total comprehensive income/(loss) from continuing operations220 (27)40 18 
Unrecognised shares of the losses of individually immaterial associates and joint ventures were £nil (2020: £nil).
The Barclays commitments and contingencies to its associates and joint ventures comprised unutilised credit facilities provided to customers of £1,760m (2020: £1,897m). In addition, the Group has made commitments to finance or otherwise provide resources to its joint ventures and associates of £482m (2020: £443m).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
297

Notes to the financial statements
For the year ended 31 December 2021 continued
37 Securitisations
Accounting for securitisations
The Group uses securitisations as a source of finance and a means of risk transfer. Such transactions generally result in the transfer of contractual cash flows from portfolios of financial assets to holders of issued debt securities.
Securitisations may, depending on the individual arrangement, result in continued recognition of the securitised assets and the recognition of the debt securities issued in the transaction; lead to partial continued recognition of the assets to the extent of the Group’s continuing involvement in those assets or lead to derecognition of the assets and the separate recognition, as assets or liabilities, of any rights and obligations created or retained in the transfer. Full derecognition only occurs when the Group transfers both its contractual right to receive cash flows from the financial assets, or retains the contractual rights to receive the cash flows, but assumes a contractual obligation to pay the cash flows to another party without material delay or reinvestment, and also transfers substantially all the risks and rewards of ownership, including credit risk, prepayment risk and interest rate risk.
In the course of its normal banking activities, the Group makes transfers of financial assets, either where legal rights to the cash flows from the asset are passed to the counterparty or beneficially, where the Group retains the rights to the cash flows but assumes a responsibility to transfer them to the counterparty. Depending on the nature of the transaction, this may result in derecognition of the assets in their entirety, partial derecognition or no derecognition of the assets subject to the transfer.
A summary of the main transactions, and the assets and liabilities and the financial risks arising from these transactions, is set out below:
Transfers of financial assets that do not result in derecognition
Securitisations
The Group was party to securitisation transactions involving its credit card balances and other personal lending. In these transactions, the assets, interests in the assets, or beneficial interests in the cash flows arising from the assets, are transferred to a special purpose entity, which then issues interest bearing debt securities to third party investors.
Securitisations may, depending on the individual arrangement, result in continued recognition of the securitised assets and the recognition of the debt securities issued in the transaction. Partial continued recognition of the assets to the extent of the Group’s continuing involvement in those assets can also occur or derecognition of the assets and the separate recognition, as assets or liabilities, of any rights and obligations created or retained in the transfer.
The following table shows the carrying amount of securitised assets that have not resulted in full derecognition, together with the associated liabilities, for each category of asset on the balance sheet:
20212020
AssetsLiabilities AssetsLiabilities
Carrying amount Fair valueCarrying amount Fair valueCarrying amount Fair valueCarrying amount Fair value
£m£m£m£m£m£m£m£m
Loans and advances at amortised cost
Credit cards, unsecured and other retail lending1,303 1,423 (1,225)(1,219)1,033 1,121 (1,019)(1,033)
Balances included within loans and advances at amortised cost represent securitisations where substantially all the risks and rewards of the asset have been retained by the Group.
The relationship between the transferred assets and the associated liabilities is that holders of notes may only look to cash flows from the securitised assets for payments of principal and interest due to them under the terms of their notes, although the contractual terms of their notes may be different to the maturity and interest of the transferred assets.
If Barclays transfers a financial asset but does not transfer or retain substantially all the risk and rewards of the asset and retains control over it, the transferred assets is recognised to the extent of Barclays’ continuing involvement. In 2021, financial assets of £249m (2020: £nil) was transferred in this manner and the carrying value of the asset representing continued involvement is included in the table above.
For transfers of assets in relation to repurchase agreements, refer to Note 38.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
298

Notes to the financial statements
For the year ended 31 December 2021 continued
Continuing involvement in financial assets that have been derecognised
In some cases, the Group may have transferred a financial asset in its entirety but may have continuing involvement in it. This arises in asset securitisations where loans and asset backed securities were derecognised as a result of the Group’s involvement with asset backed securities, residential mortgage backed securities and commercial mortgage backed securities. Continuing involvement largely arises from providing financing into these structures in the form of retained notes, which do not bear first losses.
The table below shows the potential financial implications of such continuing involvement:
Continuing involvementa
Gain/(loss) from continuing involvement
Carrying amountFair valueMaximum exposure to lossFor the year endedCumulative to Cumulative to 31 December
Type of transfer£m£m£m£m£m
2021
Asset backed securities25 25 25 1 2 
Residential mortgage backed securities574 574 574 3 4 
Commercial mortgage backed securities311 307 311 5 11 
Total910 906 910 9 17 
2020
Asset backed securities56 56 56 
Residential mortgage backed securities49 49 49 
Commercial mortgage backed securities243 237 243 
Total348 342 348 
Note
a    Assets which represent the Group’s continuing involvement in derecognised assets are recorded in Loans and advances at amortised cost and Debt securities at FVTP&L.

38 Assets pledged, collateral received and assets transferred
Assets are pledged or transferred as collateral to secure liabilities under repurchase agreements, securitisations and stock lending agreements or as security deposits relating to derivatives. Assets transferred are non-cash assets transferred to a third party that do not qualify for derecognition from the Group balance sheet, for example because Barclays retains substantially all the exposure to those assets under an agreement to repurchase them in the future for a fixed price.
Assets pledged or transferred as collateral include all assets categorised as encumbered in the disclosure on pages 221 to 223 of the Barclays PLC Pillar 3 Report 2021 (unaudited), other than those held in commercial paper conduits. In these transactions, the Group will be required to step in to provide financing itself under a liquidity facility if the vehicle cannot access the commercial paper market.
Where non-cash assets are pledged or transferred as collateral for cash received, the asset continues to be recognised in full, and a related liability is also recognised on the balance sheet. Where non-cash assets are pledged or transferred as collateral in an exchange for non-cash assets, the transferred asset continues to be recognised in full, and there is no associated liability as the non-cash collateral received is not recognised on the balance sheet. The Group is unable to use, sell or pledge the transferred assets for the duration of the transaction and remains exposed to interest rate risk and credit risk on these pledged assets. Unless stated, the counterparty's recourse is not limited to the transferred assets.
The following table summarises the nature and carrying amount of the assets pledged as security against these liabilities:
20212020
£m£m
Cash collateral and settlements66,138 72,042 
Loans and advances at amortised cost65,216 37,257 
Trading portfolio assets71,518 77,198 
Financial assets at fair value through the income statement5,595 5,584 
Financial assets at fair value through other comprehensive income13,748 22,185 
Assets pledged222,215 214,266 
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
299

Notes to the financial statements
For the year ended 31 December 2021 continued
The following table summarises the transferred financial assets and the associated liabilities:
Transferred assetsAssociated liabilities
£m£m
At 31 December 2021
Derivatives66,744 (66,744)
Repurchase agreements71,820 (49,543)
Securities lending arrangements69,316  
Other14,335 (12,121)
222,215 (128,408)
At 31 December 2020
Derivatives77,574 (77,574)
Repurchase agreements65,673 (44,076)
Securities lending arrangements61,183 — 
Other9,836 (7,408)
214,266 (129,058)
Included within Other are agreements where a counterparty's recourse is limited to the transferred assets. The relationship between the transferred assets and the associated liabilities is that holders of notes may only look to cash flows from the securitised assets for payments of principal and interest due to them under the terms of their notes.
Carrying valueFair value
Transferred assetsAssociated liabilitiesTransferred assetsAssociated liabilitiesNet position
£m£m£m£m£m
2021
Recourse to transferred assets only1,303 (1,225)1,423 (1,219)204 
2020
Recourse to transferred assets only1,033 (1,019)1,121 (1,033)88 
The Group has an additional £5.8bn (2020: £6.3bn) of loans and advances within its asset backed funding programmes that can readily be used to raise additional secured funding and are available to support future issuances.
Total assets pledged includes a collateral pool put in place to provide security for the UKRF funding deficit. Refer to Note 33 for further details.
Collateral held as security for assets
Under certain transactions, including reverse repurchase agreements and stock borrowing transactions, the Group is allowed to resell or re-pledge the collateral held. The fair value at the balance sheet date of collateral accepted and re-pledged or transferred to others was as follows:
20212020
£m£m
Fair value of securities accepted as collateral928,999 793,573 
Of which fair value of securities re-pledged/transferred to others814,448 685,300 
Additional disclosure has been included in collateral and other credit enhancements in the Risk review section. Assets pledged as collateral include all assets categorised as encumbered in the disclosure on pages 221 to 223 of the Barclays PLC Pillar 3 Report 2021 (unaudited).
The notes included in this section focus on related party transactions, Auditors’ remuneration and Directors’ remuneration. Related parties include any subsidiaries, associates, joint ventures and Key Management Personnel.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
300

Notes to the financial statements
For the year ended 31 December 2021 continued
Notes to the financial statements
Other disclosure matters
The notes included in this section focus on related party transactions, Auditors’ remuneration and Directors’ remuneration. Related parties include any subsidiaries, associates, joint ventures and Key Management Personnel.
39 Related party transactions and Directors’ remuneration
Related party transactions
Parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions, or one other party controls both.
Subsidiaries
Transactions between Barclays PLC and its subsidiaries meet the definition of related party transactions. Where these are eliminated on consolidation, they are not disclosed in the Group’s financial statements. Transactions between Barclays PLC and its subsidiaries are fully disclosed in Barclays PLC’s financial statements. A list of the Group’s principal subsidiaries is shown in Note 34.
Associates, joint ventures and other entities
The Group provides banking services to its associates, joint ventures and the Group pension funds (principally the UK Retirement Fund), providing loans, overdrafts, interest and non-interest bearing deposits and current accounts to these entities as well as other services. Group companies also provide investment management and custodian services to the Group pension schemes. All of these transactions are conducted on the same terms as third party transactions. Summarised financial information for the Group’s investments in associates and joint ventures is set out in Note 36.
Amounts included in the Group’s financial statements, in aggregate, by category of related party entity are as follows:
AssociatesJoint venturesPension funds
£m£m£m
For the year ended and as at 31 December 2021
Total income 50 5 
Credit impairment charges   
Operating expenses(20) (1)
Total assets 1,278 3 
Total liabilities177  81 
For the year ended and as at 31 December 2020
Total income— 10 
Credit impairment charges— — — 
Operating expenses(26)— (1)
Total assets— 1,388 
Total liabilities66 — 69 
Total liabilities includes derivatives transacted on behalf of the pension funds of £18m (2020: £13m).
Key Management Personnel
Key Management Personnel are defined as those persons having authority and responsibility for planning, directing and controlling the activities of Barclays PLC (directly or indirectly) and comprise the Directors and Officers of Barclays PLC, certain direct reports of the Group Chief Executive and the heads of major business units and functions.
The Group provides banking services to Key Management Personnel and persons connected to them. Transactions during the year and the balances outstanding were as follows:
Loans outstanding
20212020
£m£m
As at 1 January9.2 7.2 
Loans issued during the yeara
0.4 2.3 
Loan repayments during the yearb
(1.8)(0.3)
As at 31 December7.8 9.2 
Notes
a    Includes loans issued to existing Key Management Personnel and new or existing loans issued to newly appointed Key Management Personnel.
b    Includes loan repayments by existing Key Management Personnel and loans to former Key Management Personnel.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
301

Notes to the financial statements
For the year ended 31 December 2021 continued
No allowances for impairment were recognised in respect of loans to Key Management Personnel (or any connected person).
Deposits outstanding
20212020
£m£m
As at 1 January10.4 12.1 
Deposits received during the yeara
37.6 41.6 
Deposits repaid during the yearb
(38.9)(43.3)
As at 31 December9.1 10.4 
Notes
a    Includes deposits received from existing Key Management Personnel and new or existing deposits received from newly appointed Key Management Personnel.
b    Includes deposits repaid by existing Key Management Personnel and deposits of former Key Management Personnel.

Total commitments outstanding
Total commitments outstanding refers to the total of any undrawn amounts on credit cards and/or overdraft facilities provided to Key Management Personnel. Total commitments outstanding as at 31 December 2021 were £0.6m (2020: £0.9m).
All loans to Key Management Personnel (and persons connected to them) were made in the ordinary course of business; were made on substantially the same terms, including interest rates and collateral, as those prevailing at the same time for comparable transactions with other persons; and did not involve more than a normal risk of collectability or present other unfavourable features.
Remuneration of Key Management Personnel
Total remuneration awarded to Key Management Personnel below represents the awards made to individuals that have been approved by the Board Remuneration Committee as part of the latest remuneration decisions, and is consistent with the approach adopted for disclosures set out in the Directors’ Remuneration Report. Costs recognised in the income statement reflect the accounting charge for the year included within operating expenses. The difference between the values awarded and the recognised income statement charge principally relates to the recognition of deferred costs for prior year awards. Figures are provided for the period that individuals met the definition of Key Management Personnel.
20212020
£m£m
Salaries and other short-term benefits37.8 41.6 
Pension costs — 
Other long-term benefits8.5 8.2 
Share-based payments12.2 13.2 
Employer social security charges on emoluments7.2 7.2 
Costs recognised for accounting purposes65.7 70.2 
Employer social security charges on emoluments(7.2)(7.2)
Other long-term benefits – difference between awards granted and costs recognised3.1 — 
Share-based payments – difference between awards granted and costs recognised6.9 1.1 
Total remuneration awarded68.5 64.1 
Disclosure required by the Companies Act 2006
The following information regarding the Barclays PLC Board of Directors is presented in accordance with the Companies Act 2006:
20212020
£m£m
Aggregate emolumentsa
8.2 8.4 
Amounts paid under LTIPsb
1.2 — 
9.4 8.4 
Notes
a    The aggregate emoluments include amounts paid for the 2021 year. In addition, deferred share awards for 2021 with a total value at grant of £1.4m (2020: £0.6m) will be made to CS Venkatakrishnan and Tushar Morzaria which will only vest subject to meeting certain conditions.
b    The figure above for "Amounts paid under LTIPs" in 2021 relates to LTIP awards that were released to Jes Staley and Tushar Morzaria in 2021. This includes the first tranche of the 2017 LTIP, the release of which was delayed from June 2020 to March 2021. Dividend shares released on the awards are excluded. The LTIP figure in the single total figure table for Executive Directors' 2021 remuneration in the Directors' Remuneration report relates to the award that is scheduled to be released in 2022 in respect of the 2019-2021 LTIP cycle.

There were no pension contributions paid to defined contribution schemes on behalf of Directors (2020: £nil). There were no notional pension contributions to defined contribution schemes.
As at 31 December 2021, there were no Directors accruing benefits under a defined benefit scheme (2020: nil).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
302

Notes to the financial statements
For the year ended 31 December 2021 continued
Directors’ and Officers’ shareholdings and options
The beneficial ownership of ordinary share capital of Barclays PLC by all Directors and Officers of Barclays PLC (involving 22 persons) at 31 December 2021 amounted to 17,876,352 (2020: 27,470,067) ordinary shares of 25p each (0.11% of the ordinary share capital outstanding).
As at 31 December 2021, Executive Directors and Officers of Barclays PLC (involving 12 persons) held options to purchase a total of 62,268 (2020: 78,495) Barclays PLC ordinary shares of 25p each at a weighted average price of 93p under Sharesave.
Advances and credit to Directors and guarantees on behalf of Directors
In accordance with Section 413 of the Companies Act 2006, the total amount of advances and credits made available in 2021 to persons who served as Directors during the year was £0.2m (2020: £0.1m). The total value of guarantees entered into on behalf of Directors during 2021 was £nil (2020: £nil).
40 Auditor’s remuneration
Auditor’s remuneration is included within consultancy, legal and professional fees in administration and general expenses and comprises:
202120202019
£m£m£m
Audit of the Barclays Group's annual accounts9 10 
Other services:
Audit of the Company's subsidiariesa
41 38 35 
Other audit related feesb
10 10 
Other services2 
Total Auditor's remuneration62 59 56 
Notes
a    Comprises the fees for the statutory audit of subsidiaries both inside and outside the UK and fees for work performed by associates of KPMG in respect of the consolidated financial statements of the Company.
b    Comprises services in relation to statutory and regulatory filings. These include audit services for the review of the interim financial information under the Listing Rules of the UK listing authority.
Audit scope changes are finalised following the completion of the audit and recognised when agreed. The 2021 audit fee includes £3m (2020: £2m) relating to the previous year’s audit.
Under SEC regulations the remuneration of our auditors is required to be presented as follows: audit fees £55m (2020: £52m, 2019: £50m), audit-related fees £6m (2020: £6m, 2019: £5m), tax fees £nil (2020: £nil, 2019: £nil), and all other fees £1m (2020: £1m, 2019: £1m).
41 Interest rate benchmark reform
Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR has been a priority for global regulators. As a result, the UK’s Financial Conduct Authority (FCA) and other global regulators instructed market participants to prepare for the cessation of most LIBOR rates after the end of 2021, and to adopt “near Risk-Free Rates” (RFRs).
Pursuant to FCA announcements during 2021, panel bank submissions for all GBP, JPY and CHF LIBOR and Euro Overnight Index Average (EONIA) LIBOR tenors ceased, and representative LIBOR rates also ceased after 31 December 2021. For USD, certain actively used tenors will continue to be provided until June 2023, however in line with the US banking regulators’ joint statement, Barclays ceased issuing or entering into new contracts that use USD LIBOR as a reference rate from 31 December 2021, other than in relation to those allowable use cases set out under the FCA's prohibition notice (ref 21A). These include market making in support of client activity; or transactions that reduce or hedge the Barclays' or any client of the Barclays' US dollar LIBOR exposure on contracts entered into before 1 January 2022.
The Group’s exposure to rates subject to benchmark interest rate reform has been predominantly to GBP, USD, JPY and CHF LIBOR and EONIA with the vast majority concentrated in derivatives within the Corporate and Investment Bank. Some additional exposure resides on floating rate loans and advances, repurchase agreements and debt securities held and issued within the Corporate and Investment Bank. Retail lending and mortgage exposure in Barclays UK to LIBOR is minimal. Following transition activity in late 2021 and early 2022, GBP, USD (one week and two month tenors), JPY and CHF LIBOR and EONIA positions (“2021 scope”) have transitioned onto RFRs, and while there are a number of IBORs yet to cease, the Group’s risk exposure is now mainly to USD LIBOR.
There are key differences between IBORs and RFRs. IBORs are ‘term rates’, which means that they are published for a borrowing period (for example three months), and they are ‘forward-looking’, because they are published at the beginning of a borrowing period, based upon an estimated inter-bank borrowing cost for the period. RFRs are based upon overnight rates from actual transactions, and are therefore published after the end of the overnight borrowing period. Furthermore, IBORs include a credit spread over the RFRs. Therefore, to transition existing contracts and agreements to RFRs, adjustments for term and credit differences may need to be applied to RFR-linked rates. The methodologies for these adjustments have been determined through in-depth consultations by industry working groups, on behalf of the respective global regulators and related market participants.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
303

Notes to the financial statements
For the year ended 31 December 2021 continued
How the Group is managing the transition to alternative benchmark rates
Barclays has established a Group-wide LIBOR Transition Programme, with oversight from the Group Finance Director. The Transition Programme spans all business lines and has cross-functional governance which includes Legal, Compliance, Conduct Risk, Client Engagement and Communications, Risk, and Finance. The Transition Programme aims to drive strategic execution, and identify, manage and resolve key risks and issues as they arise. Barclays’ transition plans primarily focus on G5 currencies while providing quarterly updates on progress and exposures to the PRA/FCA and other regulators as required.
The Transition Programme follows a risk based approach, using recognised ‘change delivery’ control standards. Accountable Executives are in place within key working groups and workstreams, with overall Board oversight delegated to the Board Risk Committee and the Group Finance Director. Barclays performs a prominent stewardship role to drive orderly transition via our representation on official sector and industry working groups across all major jurisdictions and product classes. Additionally, the Group Finance Director is Chair of the UK’s ‘Working Group on Sterling Risk-Free Reference Rates’ (UK £RFRWG), whose mandate is to catalyse a broad-based transition to using SONIA (‘Sterling Overnight Index Average’) as the primary sterling interest rate benchmark in bond, loan and derivatives markets.
Approaches to transition exposure expiring post the expected end dates for LIBOR vary by product and nature of counterparty. The Group has actively engaged with the counterparties to transition or include appropriate fallback provisions and transition mechanisms in its floating rate assets and liabilities with maturities after 2021, when relevant IBORs excluding USD LIBOR cease to be published. The fallback will provide the relevant replacement rate, in the case of the ISDA Protocol this is the RFR plus a credit adjusted spread, that should be used post cessation or pre-cessation of the relevant IBOR. For the derivative population, adherence to the ISDA IBOR Fallbacks Protocol has provided Barclays with an efficient mechanism to amend outstanding trades to incorporate fallbacks. Beyond the ISDA IBOR Fallbacks Protocol, other options have included terminating or bilaterally agreeing new terms with counterparties. Derivative contracts facing central clearing counterparties have followed a market-wide, standardised approach to reform through a series of CCP-led conversions.
The FCA has authorised broad usage of synthetic LIBOR as a temporary solution for the ‘tough legacy’ population of unremediated contracts for GBP and JPY. Given cleared derivatives for the 2021 scope transitioned via CCP driven conversions, synthetic LIBOR does not apply in this context. Barclays’ strategy remains to actively transition LIBOR exposure where viable, and/or to implement and utilise robust contractual fallbacks where possible. Where contracts remain unremediated, they may be able to utilise synthetic LIBOR on a temporary basis. Barclays will continue to monitor, assess and limit the reliance on synthetic LIBOR.
As announced by the FCA on 5 March 2021, USD LIBOR tenors (except 1 week and 2 month tenors) will cease to be representative from 30 June 2023. As detailed above, the key area of focus for transition prior to 2022 was on the other non-USD IBOR currency-tenors that ceased to be published at the end of 2021. Cessation of new USD LIBOR trading and transition of USD LIBOR exposures is the priority for the Barclays LIBOR Transition Programme in 2022/23. Clients and colleagues have been notified that we have prohibited entering into new USD LIBOR transactions (with narrow permitted exceptions) from 1 January 2022 in line with regulatory expectations.
Whilst synthetic LIBOR will be published on a temporary basis for 1, 3 and 6 month tenors of GBP and JPY LIBOR to assist the transition of certain exposures, no synthetic rate has been announced for USD LIBOR. New York State legislation has been enacted (with US Federal legislation to follow) which provides a solution for contracts governed under New York law for USD LIBOR to the Secured Overnight Financing Rate (SOFR) transition with the additional benefit of statutory contract continuity and safe harbour protection. This contrasts with the legislation implemented in the UK which provides for statutory contract continuity with safe harbour protection only for the administrator, and could expose market participants to additional litigation risk. Clients have been engaged on the transition of their legacy USD LIBOR exposures through active transition or the implementation of fallbacks, and have been issued with communications on key regulatory developments in the transition away from USD LIBOR.
Progress made during 2021
During 2021, the Group delivered RFR product capabilities and alternatives to LIBOR across loans, bonds, securities financing transactions and derivatives required for LIBOR cessation to support transition of legacy contracts. Barclays has transitioned over 99% (by gross notional exposure) of legacy positions in those rates within the 2021 scope, onto new RFRs in line with official sector expectations and milestones. This has been achieved through bilateral negotiation of contracts with clients, including the use of appropriate fallback provisions (which became effective post 31 December 2021, however, note that the switch onto the RFR may not take place until next reset post 31 December 2021 and so exposures may still be reported as LIBOR) and taking part in large scale transition events at a number of Central Counterparty Clearing Houses (London Clearing House (LCH), Chicago Mercantile Exchange (CME), EUREX and Japan Securities Clearing Corporation (JSCC) for OTC derivatives and Intercontinental Exchange (ICE) EU and LCH CurveGlobal for exchange traded derivatives). In relation to those contracts yet to be transitioned, we remain in active dialogue with clients. Barclays transitioned the EONIA / LIBOR language in all active Credit Support Annexes (CSAs) via a number of mechanisms, primarily through bilateral CSA amendments but also by means of adherence to the ISDA 2021 EONIA Collateral Agreement Fallbacks Protocol. Barclays delivered technology and business process changes required to ensure operational readiness in preparation for LIBOR cessation and transitions to RFRs for those benchmark rates ceasing at the end of 2021. Any incremental Technology or Business Process changes required to support USD LIBOR cessation will be delivered ahead of 30 June 2023. Whilst the majority of IBOR exposures have moved to RFRs, where appropriate other rates such as fixed rates or Bank of England base rates have also been used.
Risks to which the Group is exposed as a result of the transition
Global regulators and central banks in the UK, US and EU have been driving international efforts to reform key benchmark interest rates and indices, such as LIBOR, which are used to determine the amounts payable under a wide range of transactions and make them more reliable and robust. These benchmark reforms have resulted in significant changes to the methodology and operation of certain benchmarks and indices, the adoption of RFRs, the discontinuation of certain reference rates (including LIBOR), and the introduction of implementing legislation and regulations. Specifically, regulators in the UK, US and EU have directed that certain non-US dollar LIBOR tenors cease at the end of 2021. Certain US dollar LIBOR tenors are to cease by the end of June 2023, and restrictions have been imposed on new use of USD LIBOR. Notwithstanding these developments, given the unpredictable consequences of benchmark reform, any of these developments could have an adverse impact on market participants, including the Group, in respect of any financial instruments linked to, or referencing, any of these benchmark interest rates.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
304

Notes to the financial statements
For the year ended 31 December 2021 continued
Uncertainty associated with such potential changes, including the availability and/or suitability of alternative RFRs, the participation of customers and third-party market participants in the transition process; challenges with respect to required documentation changes; and impact of legislation to deal with ‘certain legacy’ contracts that cannot convert into or add fall-back RFRs before cessation of the benchmark they reference, may adversely affect a broad range of transactions (including any securities, loans and derivatives which use LIBOR or any other affected benchmark to determine the amount of interest payable that are included in the Group’s financial assets and liabilities) that use these reference rates and indices, and present a number of risks for the Group, including, but not limited to:
Conduct risk: in undertaking actions to transition away from using certain reference rates (such as LIBOR) to new alternative RFRs, the Group faces conduct risks. These may lead to customer complaints, regulatory sanctions or reputational impact if the Group is considered to be (among other things) (i) undertaking market activities that are manipulative or create a false or misleading impression, (ii) misusing sensitive information or not identifying or appropriately managing or mitigating conflicts of interest, (iii) providing customers with inadequate advice, misleading information, unsuitable products or unacceptable service, (iv)not taking a consistent approach to remediation for customers in similar circumstances, (v) unduly delaying the communication and migration activities in relation to client exposure, leaving them insufficient time to prepare, or (vi) colluding or inappropriately sharing information with competitors.
Litigation risk: members of the Group may face legal proceedings, regulatory investigations and/or other actions or proceedings regarding (among other things) (i) the conduct risks identified above, (ii) the interpretation and enforceability of provisions in LIBOR-based contracts, and (iii) the Group’s preparation and readiness for the replacement of LIBOR with alternative RFRs.
Financial risk: the valuation of certain of the Group’s financial assets and liabilities may change. Moreover, transitioning to alternative RFRs may impact the ability of members of the Group to calculate and model amounts receivable by them on certain financial assets and determine the amounts payable on certain financial liabilities (such as debt securities issued by them) because certain alternative RFRs (such as SONIA and the SOFR) are look-back rates whereas term rates (such as LIBOR) allow borrowers to calculate at the start of any interest period exactly how much is payable at the end of such interest period. This may have a material adverse effect on the Group’s cash flows.
Pricing risk: changes to existing reference rates and indices, discontinuation of any reference rate or indices and transition to alternative RFRs may impact the pricing mechanisms used by the Group on certain transactions.
Operational risk: changes to existing reference rates and indices, discontinuation of any reference rate or index and transition to alternative RFRs may require changes to the Group’s IT systems, trade reporting infrastructure, operational processes, and controls. In addition, if any reference rate or index (such as LIBOR) is no longer available to calculate amounts payable, the Group may incur additional expenses in amending documentation for new and existing transactions and/or effecting the transition from the original reference rate or index to a new reference rate or index.
Accounting risk: an inability to apply hedge accounting in accordance with IAS 39 could lead to increased volatility in the Group’s financial results and performance.
Any of these factors may have a material adverse effect on the Group’s business, results of operations, financial condition, prospects and reputation. While a number of the above risks in relation to transition of legacy 2021 scope onto RFRs have been substantially mitigated, they remain relevant in relation to USD and related LIBOR rate transitions.
The Group does not expect material changes to its risk management approach and strategy as a result of interest rate benchmark reform.
The following table summarises the significant exposures impacted by interest rate benchmark reform:
GBP LIBORUSD LIBORJPY LIBOR CHF LIBOR
Othersb
Total
As at 31 December 2021
£m£m£m£m£m£m
Non-derivative financial assets
Loans and advances at amortised cost14,166 15,812 25 229 431 30,663 
Reverse repurchase agreements and other similar secured lending 186    186 
Financial assets at fair value through the income statement185 8,538 5 327 194 9,249 
Financial assets at fair value through other comprehensive income      
Non-derivative financial assets14,351 24,536 30 556 625 40,098 
Non-derivative financial liabilities
Debt securities in issue (6,137)(1,083)  (7,220)
Subordinated liabilities (1,088)  (113)(1,201)
Financial liabilities designated at fair value(708)(212)(920)
Non-derivative financial liabilities(708)(7,437)(1,083) (113)(9,341)
Equity
Other equity instruments (3,374)(92)  (3,466)
Standby facilities, credit lines and other commitmentsa
60,490 42,767 1,284 371 12,724 117,636 


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
305

Notes to the financial statements
For the year ended 31 December 2021 continued
GBP LIBORUSD LIBORJPY LIBOR CHF LIBOR
Othersb
Total
As at 31 December 2020
£m£m£m£m£m£m
Non-derivative financial assets
Loans and advances at amortised cost30,179 18,109 173 18 1,725 50,204 
Reverse repurchase agreements and other similar secured lending— 334 — — — 334 
Financial assets at fair value through the income statement3,496 6,373 — 283 209 10,361 
Financial assets at fair value through other comprehensive income186 114 — — 308 
Non-derivative financial assets33,861 24,930 173 301 1,942 61,207 
Non-derivative financial liabilities
Debt securities in issue(1,023)(10,718)(1,201)— — (12,942)
Subordinated liabilities(71)(1,592)— — — (1,663)
Financial liabilities designated at fair value(149)(1,273)(759)— (139)(2,320)
Non-derivative financial liabilities(1,243)(13,583)(1,960)— (139)(16,925)
Equity
Other equity instruments(3,500)(3,131)— — — (6,631)
Standby facilities, credit lines and other commitmentsa
18,944 74,011 — 74 15,951 108,980 
Notes
a    There has been a change on how exposures for multi currency loan facilities are reported in 2021, from base currency to the currency which needs to be remediated first. This has resulted in an increase in GBP LIBOR and a corresponding reduction in USD LIBOR exposure of £34bn. 2020 comparatives have not been restated to reflect this change.
b    Includes EUR LIBOR and SOR
The table above represents the exposures to interest rate benchmark reform by balance sheet account, which have yet to transition. The exposure disclosed is for positions with contractual maturities after 31 December 2021 (apart from USD, which is for maturities after 30 June 2023). Trades with exposures to other IBORs whose respective cessation dates is in the future and mature before that date have been excluded (2020: exposures are disclosed for maturities after 31 December 2021 for all rates). Balances reported at amortised cost are disclosed at their gross carrying value and do not include any expected credit losses that may be held against them.
The following table represents the derivative exposures to interest rate benchmark reform, which have yet to transition:
GBP LIBORUSD LIBOREONIAJPY LIBOR CHF LIBOR
Othersa
Total
As at 31 December 2021£m£m£m£m£m£m£m
Derivative notional contract amount
OTC interest rate derivatives240,183 2,283,236 7,811 140,357 4,396 61,937 2,737,920 
OTC interest rate derivatives - cleared by central counterparty 2,228,399    168,649 2,397,048 
Exchange traded interest rate derivatives 466,339     466,339 
OTC foreign exchange derivatives183,477 461,680  122,823 32,900 1,419 802,299 
OTC equity and stock index derivatives 9,949     9,949 
Derivative notional contract amount423,660 5,449,603 7,811 263,180 37,296 232,005 6,413,555 
GBP LIBORUSD LIBOREONIAJPY LIBOR CHF LIBOR
Othersa
Total
As at 31 December 2020£m£m£m£m£m£m£m
Derivative notional contract amount
OTC interest rate derivatives592,827 2,832,802 457,844 754,206 25,681 41,782 4,705,142 
OTC interest rate derivatives - cleared by central counterparty1,684,553 2,891,029 638,202 1,091,479 119,382 198,113 6,622,758 
Exchange traded interest rate derivatives300,182 333,705 — — 2,494 — 636,381 
OTC foreign exchange derivatives155,285 589,334 — 93,108 31,257 1,921 870,905 
OTC equity and stock index derivatives1,845 7,946 544 1,929 491 2,141 14,896 
Derivative notional contract amount2,734,692 6,654,816 1,096,590 1,940,722 179,305 243,957 12,850,082 
Note
a    Includes EUR LIBOR, SOR and STIBOR

The exposure disclosed is for positions with contractual maturities after 31 December 2021 (apart from USD, which is for maturities after 30 June 2023). Trades with exposures to other IBORs whose respective cessation dates is in the future and mature before that date have been excluded (2020: exposures are disclosed for maturities after 31 December 2021 for all rates). Derivatives are reported by using the notional contract amount and where derivatives have both pay and receive legs with exposure to benchmark reform such as cross currency swaps, the notional contract amount is disclosed for both legs. As at 31 December 2021, there were £256bn (2020: £264bn) of cross currency swaps where both the pay and receive legs are impacted by interest rate benchmark reform.
The Group also had £9bn (2020: £28bn) of Barclays issued debt retained by the group, impacted by the interest rate benchmark reform, in USD LIBOR (2020: predominately in GBP and USD LIBOR.)
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
306

Notes to the financial statements
For the year ended 31 December 2021 continued
Fallback clauses
The 31 December 2021 exposure has been broken up into those with robust fallbacks and those without. Fallbacks here are defined as any mechanism involving a ‘switch’ or ‘hardwire’ or a contractual agreement to transition to an automatically selected rate. One of the most commonly used is the ISDA 2020 IBOR Protocol published in October 2020 which enabled market participants to incorporate fallback provisions into legacy non-cleared derivatives and certain non-derivatives transactions. Market participants who have adhered to the ISDA 2020 IBOR Protocol agree, between adhering parties, that their legacy contracts will be amended to include the relevant fallback provisions. In addition to this, ISDA developed bilateral Swap Rate Fallbacks templates for GBP and JPY Swap Rate bilateral derivative trades with the GBP ICE Swap Rate fallback provisions being published in August 2021 and the JPY ISDA Swap Rate fallback provisions being published in November 2021. Whilst the fallback provisions have been applied to the majority of trades, with some limited exceptions being worked through, the switch to the replacement rate as a result of fallback provision inclusion may not take place until the next rate reset post the cessation or pre-cessation event.
The following tables present a breakdown of the exposures to IBOR reform (excluding USD LIBOR and other IBORs whose respective cessation dates is in the future) with fallbacks in place and those without:
With appropriate fallback clauseWithout appropriate fallback clause
GBP LIBORJPY LIBORCHF LIBOREUR LIBORTotalGBP LIBORJPY LIBORCHF LIBOREUR LIBORTotal
As at 31 December 2021£m£m£m£m£m£m£m£m£m£m
Non-derivative financial assets
Loans and advances at amortised cost9,434 5 215 412 10,066 4,732 20 14 19 4,785 
Financial assets at fair value through the income statement125 5 327 8 465 60   186 246 
Non-derivative financial assets9,559 10 542 420 10,531 4,792 20 14 205 5,031 
Non-derivative financial liabilities
Debt securities in issue (1,083)  (1,083)     
Subordinated liabilities          
Financial liabilities designated at fair value(708)   (708)     
Non-derivative financial liabilities(708)(1,083)  (1,791)     
Equity
Other equity instruments (92)  (92)     
Standby facilities, credit lines and other commitments36,573 653 371 9,362 46,959 23,917 631  3,362 27,910 

The majority of the remaining exposures without fallbacks in place are either undrawn facilities or syndicated facilities where the transition is led by a third party agent. Work is ongoing with clients and agents to transition facilities or insert fallbacks prior to the next rate reset. There may be some scenarios where synthetic LIBOR is temporarily used whilst Barclays continues to work with the client to remediate their exposures, with little expectation of longer term usage.
    
With appropriate fallback clauseWithout appropriate fallback clause
GBP LIBOREONIAJPY LIBORCHF LIBOREUR LIBORTotalGBP LIBOREONIAJPY LIBORCHF LIBOREUR LIBORTotal
As at 31 December 2021£m£m£m£m£m£m£m£m£m£m£m£m
Derivative notional contract amount
OTC interest rate derivatives230,967 7,568 135,719 4,361 3,626 382,241 9,216 243 4,638 35 403 14,535 
OTC foreign exchange derivatives183,203  122,822 32,900  338,925 274  1   275 
Derivative notional contract amount414,170 7,568 258,541 37,261 3,626 721,166 9,490 243 4,639 35 403 14,810 

Exposures that have not actively transitioned and do not have robust fallbacks in place will not necessarily need to apply the FCA’s approach to ‘tough legacy’ and utilise synthetic LIBOR rates. In many cases, work is ongoing to transition trades or insert fallbacks prior to the next rate reset. There may be some scenarios where synthetic LIBOR is temporarily used whilst Barclays continues to work with the client to remediate their exposures, with little expectation of longer term usage. It is also key to note that not all remaining exposures can leverage synthetic LIBOR. CHF LIBOR, EUR LIBOR and EONIA do not have any synthetic LIBOR available and only the more commonly used, 1M, 3M and 6M GBP LIBOR and JPY LIBOR tenors have a synthetic rate being published. The volume of these residual exposures is very low and work is focused on transitioning these prior to next reset.
The majority of remaining exposures where no synthetic rate is available are bilateral derivatives using GBP/JPY Swap Rates within the Markets businesses. The focus for these is agreeing the bilateral swap rate fallbacks that were published by ISDA in August (for GBP) and November (for JPY) 2021. Continued uptake of these bilateral fallbacks has been seen in early 2022.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
307

Notes to the financial statements
For the year ended 31 December 2021 continued
42 Barclays PLC (the Parent company)
Total income
Dividends received from subsidiaries
Dividends received from subsidiaries of £1,356m (2020: £763m, 2019: £1,560m) largely relates to dividends received from Barclays Bank PLC £794m, Barclays Bank UK PLC £510m and Barclays Execution Services Limited £82m.
The dividends received in 2020 from its banking subsidiaries were paid up to Barclays PLC prior to the announcement made by the PRA on 31March 2020 that capital be preserved for use in serving Barclays customers and clients through the extraordinary challenges presented by the COVID-19 pandemic. As part of a response to this announcement, Barclays PLC took steps to provide additional capital to its banking subsidiaries.
Other income
Other income of £659m (2020: £1,192m, 2019: £1,760m) includes £804m (2020: £857m, 2019: £813m) of income received from gross coupon payments on Barclays Bank PLC and Barclays Bank UK PLC issued AT1 securities and £250m (2020: £248m) of fair value and foreign exchange losses on other positions with subsidiaries.
Total assets and liabilities
Investment in subsidiaries
The investment in subsidiaries of £62,528m (2020: £58,886m) predominantly relates to investments in the ordinary shares of Barclays Bank PLC of £35,590m (2020: £35,590m) and their AT1 securities of £9,493m (2020: £8,425m), as well as investments in the ordinary shares of Barclays Bank UK PLC of £14,245m (2020: 11,675m) and their AT1 securities of £2,570m (2020: £2,570m). The increase of £3,642m during the year was predominantly driven by a £2,573m reversal of impairment in the cost of investment of Barclays Bank UK PLC and increased AT1 holdings of $1,500m in Barclays Bank PLC.
Impairment in subsidiaries
At the end of each reporting period an impairment review is undertaken in respect of investment in the ordinary shares of subsidiaries. Where impairment may be indicated a test of the carrying value against the recoverable value is performed. Impairment being indicated where the investment exceeds the recoverable amount. The recoverable amount is calculated as a value in use (VIU) which is derived from the present value of future cash flows expected to be received from the investment. The VIU calculations use forecast attributable profit based on financial budgets approved by management, covering a five year period as an approximation of future cash flows discounted using a pre-tax discount rate appropriate to the subsidiary being tested. A terminal growth rate has then been applied to the cash flows thereafter which is based upon expectations of future inflation rates. The review identified the value in use calculated was higher than the carrying value for all subsidiaries.
Due to the improved market conditions and interest rate environment for the Group’s UK banking business compared to December 2020 the review further identified that the accumulated impairment for the investment in Barclays Bank UK PLC of £2,573m no longer existed. The VIU of Barclays Bank UK PLC was found to be significantly higher than both the carrying amount of the investment and the gross cost of the investment and hence all accumulated impairment has been reversed in December 2021. For Barclays Bank UK PLC, a discount rate of 14.5% (2020: 13.8%) has been applied to the cash flow forecast. In determining the discount rate, management have identified a cost of equity associated with market participants that closely resemble the subsidiary and adjusted for tax to arrive at the pre-tax equivalent rate. A terminal growth rate of 2.0% (2020: 2.0%) has been used to calculate a terminal value for the investment based on inflation rates to approximate future long term growth.
Loans and advances in subsidiaries
During the year, loans and advances to subsidiaries decreased by £2,638m to £22,072m (2020: £24,710m). The decrease was driven by the maturity of £2,400m dated subordinated loans in relation to Barclays Bank PLC and the maturity of £1,100m dated subordinated notes in relation to Barclays Bank UK PLC. This was partially offset by c£1,600m new issuances of dated subordinated notes by Barclays Bank PLC to Barclays PLC.
Financial assets and liabilities designated at fair value
Financial liabilities designated at fair value of £16,319m (2020: £9,507m) primarily included new issuances during the year of $5,000m and €1,500m Fixed Rate Resetting Senior Callable Notes, €750m Floating Rate Senior Callable Notes and $500m Zero Coupon Callable Notes. The proceeds raised through these transactions were used to invest in subsidiaries of Barclays PLC and are included within the financial assets designated at fair value through the income statement balance of £25,091m (2020: £17,521m). The effect of changes in the liabilities’ fair value, including those due to credit risk, is expected to offset the changes in the fair value of the related financial asset in the income statement The difference between the financial liabilities’ carrying amount and the contractual amount on maturity is £271m (2020: £324m).
Subordinated liabilities and debt securities in issue
During the year, Barclays PLC issued €1,000m and $1,000m of Fixed Rate Resetting Subordinated Callable Notes, which are included within the subordinated liabilities balance of £9,301m (2020: £7,724m). Debt securities in issue of £25,658m (2020: £28,428m) have reduced in the year due to the maturity of positions with subsidiaries.
Management of internal investments, loans and advances
Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their regulatory and business needs. Barclays PLC may invest capital and funding into Barclays Bank PLC, Barclays Bank UK PLC and other Group subsidiaries such as Barclays Execution Services Limited and the US Intermediate Holding Company (IHC).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
308

Notes to the financial statements
For the year ended 31 December 2021 continued
Total equity
Called up share capital and share premium
Called up share capital and share premium of Barclays PLC is £4,536m (2020: £4,637m). The decrease in the year is primarily due to 644m shares repurchased with a total nominal value of £161m. This decrease was offset by shares issued under employee share schemes.
Other equity instruments
Other equity instruments of £12,241m (2020: £11,169m) comprises AT1 securities issued by Barclays PLC. AT1 securities are perpetual subordinated contingent convertible securities structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. During the year there has been a new AT1 issuance with principal amount totaling $1,500m (£1,078m). For further details, please refer to Note 28.
Further information on the parent company financials are detailed on pages 221 to 223.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
309

Shareholder information
Annual General Meeting (AGM)
The Barclays PLC 2022 AGM will be held on Wednesday 4 May 2022 at 11:00 (UK time) at Manchester Central Convention Complex, Petersfield, Manchester, M2 3GX and on an electronic platform as described in the Notice of Meeting, to be published on the Company's website (home.barclays/agm).
Keep your personal details up to date
Please remember to tell Equiniti if:
you move
you need to update your bank or building society details.
If you are a Shareview member, you can update your bank or building society account or address details online. If you are not a Shareview member and you hold 2,500 shares or less, you can update details quickly and easily over the telephone using the Equiniti contact details overleaf. If you hold more than 2,500 shares you will need to write to Equiniti.
Dividends
The Barclays PLC 2021 full year dividend for the year ended 31 December 2021 will be 4.0p per share, making the 2021 total dividend 6.0p per share.
Save time and receive your dividends faster by having them paid directly into your bank or building society account
It is easy to set up payment directly to your bank account by completing a bank mandate, meaning your money will be in your bank account on the dividend payment date. If you hold 2,500 shares or less, you can provide your bank or building society details quickly and easily over the telephone using the Equiniti contact details overleaf. If you hold more than 2,500 shares, please contact Equiniti for details of how to change your payment instruction.
Dividend Reinvestment Plan
Barclays offers a share alternative in the form of a dividend reinvestment plan (DRIP) for those shareholders who wish to elect to use their dividend payments to purchase additional ordinary shares, rather than receive a cash payment. The DRIP is provided and administered by Barclays’ registrar, Equiniti . Further details regarding the DRIP can be found at home.barclays/dividends and www.shareview.co.uk/info/drip.
Dividend Payments
Barclays has made the decision that from February 2023, dividends will no longer be paid by cheque. All future dividends will be credited to a shareholder’s nominated bank account or building society. We believe this decision is beneficial for our shareholders to safeguard dividends by using a more secure payment method, as well as removing our environmental impact of printing and posting cheques. We will be writing to shareholders with more information about our intention to cease payment of dividends by cheque when we send out our full year dividend stationery.
Managing your shares online
Shareview
Barclays shareholders can go online to manage their shareholding and find out about Barclays performance by joining Shareview. Through Shareview, you:
will receive the latest updates from Barclays direct to your email;
can update your address and bank details online;
can vote in advance of general meetings.
To join Shareview, please follow these three easy steps:
Step 1 Go to portfolio.shareview.co.uk
Step 2 Register for electronic communications by following the instructions on screen
Step 3 You will be sent an activation code in the post the next working day
Returning funds to shareholders
Over 60,000 shareholders did not cash their Shares Not Taken Up (SNTU) cheque following the Rights Issue in September 2013. In 2021, we continued the tracing process to reunite these shareholders with their SNTU monies and any unclaimed dividends and by the end of the year, we had returned approximately £480,309 to our shareholders, in addition to approximately £27,000 in 2020, £23,000 returned in 2019, £65,000 returned in 2018, £212,000 returned in 2017, £1.65m returned in 2016 and £2.2m in 2015.
Reducing our Environmental Impact
In line with our targets to reduce our environmental footprint, as part of our Notice of AGM mailing we will be writing to those shareholders who currently receive a paper copy of our Annual Report to ask them to reconsider their shareholder communication preferences. The Annual Report will continue to be available online at home.barclays/investor-relations/reports-and-events/annual-reports/.
Useful contact details
Equiniti
The Barclays share register is maintained by Equiniti. If you have any questions about your Barclays shares, please contact Equiniti by visiting shareview.co.uk
0371 384 2055a
(in the UK)
+44 121 415 7004
(from overseas)
0371 384 2255a
(for the hearing impaired in the UK)
+44 121 415 7028
(for the hearing impaired from overseas)
Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA
To find out more, contact Equiniti or visit: home.barclays/dividends
American Depositary Receipts (ADRs)
ADRs represent the ownership of Barclays PLC shares which are traded on the New York Stock Exchange. ADRs carry prices, and pay dividends, in US dollars.
If you have any questions about ADRs, please contact Shareowner Services:
StockTransfer@equiniti.com or visit adr.com
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
310

Shareholder information
+1 800 990 1135
(toll free in the US and Canada)
+1 651 453 2128
(outside the US and Canada)
Shareowner Services, PO Box 64504, St Paul, MN 55164-0504, USA
Delivery of ADR certificates and overnight mail
Shareowner Services, 1110 Centre Point Curve, Suite 101, Mendota Heights, MN 55120, USA
Qualifying US and Canadian resident ADR holders should contact Shareowner Services for further details regarding the DRIP
Shareholder Relations
To give us your feedback or if you have any questions, please contact:
privateshareholderrelations@barclays.com
Shareholder Relations, Barclays PLC, 1 Churchill Place, London E14 5HP
Share price
Information on the Barclays share price and other share price tools are available at: home.barclays/investorrelations
Alternative formats
Shareholder documents can be provided in large print, audio CD or Braille free of charge by calling Equiniti.
0371 384 2055a
(in the UK)
+44 121 415 7004
(from overseas)
Audio versions of the Strategic Report will also be available at the AGM.
Key dates
5 April 2022
Full year dividend payment date
28 April 2022
Q1 Results Announcement
4 May 2022
Annual General Meeting at 11.00am
Shareholder security
Shareholders should be wary of any cold calls with an offer to buy or sell shares. Fraudsters use persuasive and high pressure techniques to lure shareholders into high-risk investments or scams. You should treat any unsolicited calls with caution.
Please keep in mind that firms authorised by the Financial Conduct Authority (FCA) are unlikely to contact you out of the blue. You should consider getting independent financial or professional advice from someone unconnected to the respective firm before you hand over any money.
Report a scam
If you suspect that you have been approached by fraudsters please tell the FCA using the share fraud reporting form at fca.org.uk/scams. You can also call the FCA Helpline on 0800 111 6768 or through Action Fraud on 0300 123 2040.
Note
aLines open 8.30am to 5.30pm (UK time) Monday to Friday, excluding public holidays.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
311

Additional information

Additional shareholder information
Articles of Association
Barclays PLC (the “Company”) is a public limited company registered in England and Wales under company number 48839. Barclays, originally named Barclay & Company Limited, was incorporated in England and Wales on 20 July 1896 under the Companies Acts 1862 to 1890 as a company limited by shares. The company name was changed to Barclays Bank Limited on 17 February 1917 and it was registered on 15 February 1982 as a public limited company under the Companies Acts 1948 to 1980. On 1 January 1985, the company changed its name to Barclays PLC.
Under the Companies Act 2006 a company’s Memorandum of Association now need only contain the names of the subscribers and the number of shares each subscriber has agreed to take. For companies in existence as of 1 October 2009, all other provisions which were contained in the company’s Memorandum of Association, including the company’s objects, are now deemed to be contained in the company’s articles. The Companies Act 2006 also states that a company’s objects are unrestricted unless the company’s articles provide otherwise.
The current Articles of Association were adopted at the Company’s Annual General Meeting (“AGM”) on 5 May 2021, in substitution for and to the exclusion of Articles adopted on 30 April 2010 and amended on 25 April 2013.
The following is a summary and explanation of the current Articles of Association, which are available for inspection.
Directors
(i)The minimum number of Directors (excluding alternate Directors) is five. There is no maximum limit. There is no age limit for Directors.
(ii)Excluding executive remuneration and any other entitlement to remuneration for extra services (including service on board committees) under the Articles, a Director is entitled to a fee at a rate determined by the Board but the aggregate fees paid to all Directors shall not exceed £2,000,000 per annum or such higher amount as may be approved by an ordinary resolution of the Company. Each Director is entitled to reimbursement for all reasonable travelling, hotel and other expenses properly incurred by him/her in or about the performance of his/her duties.
(iii)No Director may act (either himself/herself or through his/her firm) as an auditor of the Company. A Director may hold any other office of the Company on such terms as the Board shall determine.
(iv)At each AGM of the Company, one third of the Directors (rounded down) are required under the Articles of Association to retire from office by rotation and may offer themselves for re-election. The Directors so retiring are first, those who wish to retire and not offer themselves for re-election, and, second those who have been longest in office (and in the case of equality of service length are selected by lot). Other than a retiring Director, no person shall (unless recommended by the Board) be eligible for election unless a member notifies the Company Secretary in advance of his/her intention to propose a person for election. It is Barclays’ practice that all Directors offer themselves for re-election annually in accordance with the UK Corporate Governance Code.
(v)The Board has the power to appoint additional Directors or to fill a casual vacancy amongst the Directors. Any Director so appointed holds office until the next AGM, when he/she may offer himself/herself for reappointment. He/she is not taken into account in determining the number of Directors retiring by rotation.
(vi)The Board may appoint any Director to any executive position or employment in the Company on such terms as they determine.
(vii)The Company may by ordinary resolution remove a Director before the expiry of his/her period of office (without prejudice to a claim for damages for breach of contract or otherwise) and may by ordinary resolution appoint another person who is willing to act to be a Director in his/her place.
(viii)A Director may appoint either another Director or some other person approved by the Board to act as his/her alternate with power to attend Board meetings and generally to exercise the functions of the appointing Director in his/her absence (other than the power to appoint an alternate).
(ix)The Board may authorise any matter in relation to which a Director has, or can have, a direct interest that conflicts, or possibly may conflict with, the Company’s interests. Only Directors who have no interest in the matter being considered will be able to authorise the relevant matter and they may impose limits or conditions when giving authorisation if they think this is appropriate.
(x)A Director may hold positions with or be interested in other companies and, subject to legislation applicable to the Company and the FCA’s requirements, may contract with the Company or any other company in which the Company is interested. A Director may not vote or count towards the quorum on any resolution concerning any proposal in which he/she (or any person connected with him/her) has a material interest (other than by virtue of his/her interest in securities of the Company) or if he/she has a duty which conflicts or may conflict with the interests of the Company, unless the resolution relates to any proposal:
(a)to indemnify a Director or provide him/her with a guarantee or security in respect of money lent by him/her to, or any obligation incurred by him/her or any other person for the benefit of (or at the request of), the Company (or any other member of the Group);
(b)to indemnify or give security or a guarantee to a third party in respect of a debt or obligation of the Company (or any other member of the Group) for which the Director has personally assumed responsibility;
(c)to obtain insurance for the benefit of Directors;
(d)involving the acquisition by a Director of any securities of the Company (or any other member of the Group) pursuant to an offer to existing holders of securities or to the public;
(e)that the Director underwrite any issue of securities of the Company (or any other member of the Group);
(f)concerning any other company in which the Director is interested as an officer or creditor or Shareholder but, broadly, only if he/she (together with his/her connected persons) is directly or indirectly interested in less than 1% of either any class of the issued equity share capital or of the voting rights of that company; and
(g)concerning any other arrangement for the benefit of employees of the Company (or any other member of the Group) under which the Director benefits or stands to benefit in a similar manner to the employees concerned and which does not give the Director any advantage which the employees to whom the arrangement relates would not receive.
(xi)A Director may not vote or be counted in the quorum on any resolution which concerns his/her own employment or appointment to any office of the Company or any other company in which the Company is interested.
(xii)Subject to applicable legislation, the provisions described in sub-paragraphs (x) and (xi) may be relaxed or suspended by an ordinary resolution of the members of the Company or any applicable governmental or other regulatory body.
(xiii)A Director is required to hold an interest in ordinary shares having a nominal value of at least £500, which currently equates to 2,000 Ordinary Shares unless restricted from acquiring or holding such interest by any applicable law or regulation or any applicable governmental or other regulatory body. A Director may act before acquiring those shares but must acquire the qualification shares within two months from his/her appointment. Where a Director is unable to acquire the requisite number of shares within that time owing to law, regulation or requirement of any governmental or other relevant authority, he/she must acquire the shares as soon as reasonably practicable once the restriction(s) end.
(xiv)The Board may exercise all of the powers of the Company to borrow money, to mortgage or charge its undertaking, property and uncalled capital and to issue debentures and other securities.
Classes of Shares
The Company only has Ordinary Shares in issue. The Articles of Association also provide for pound sterling preference shares of £100 each, US dollar preference shares of US$100 each, US dollar preference shares of $0.25 each, euro preference shares of €100 each and yen preference shares of ¥10,000 each (together, the “Preference Shares”). In accordance with the authority granted at the AGM on 5 May 2021, Preference Shares may be issued by the Board from time to time in one or more series with such rights and subject to such restrictions and limitations as the Board may determine. No Preference Shares have been issued to date.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
312

Additional information



Dividends
Subject to the provisions of the Articles and applicable legislation, the Company in general meeting may declare dividends on the Ordinary Shares by ordinary resolution, but any such dividend may not exceed the amount recommended by the Board. The Board may also pay interim or final dividends if it appears they are justified by the Company’s financial position.
Each Preference Share confers the right to a preferential dividend (“Preference Dividend”) payable in such currency at such rates (whether fixed or calculated by reference to or in accordance with a specified procedure or mechanism), on such dates and on such other terms as may be determined by the Board prior to allotment thereof.
The Preference Shares rank in regard to payment of dividends in priority to the holders of Ordinary Shares and any other class of shares in the Company ranking junior to the Preference Shares.
Dividends may be paid on the Preference Shares if, in the opinion of the Board, the Company has sufficient distributable profits, after payment in full or the setting aside of a sum to provide for all dividends payable on (or in the case of shares carrying a cumulative right to dividends, before) the relevant dividend payment date on any class of shares in the Company ranking pari passu with or in priority to the relevant series of Preference Shares as regards participation in the profits of the Company.
If the Board considers that the distributable profits of the Company available for distribution are insufficient to cover the payment in full of Preference Dividends, Preference Dividends shall be paid to the extent of the distributable profits on a pro rata basis.
Notwithstanding the above, the Board may, at its absolute discretion, determine that any Preference Dividend which would otherwise be payable may either not be payable at all or only payable in part.
If any Preference Dividend on a series of Preference Shares is not paid, or is only paid in part, for the reasons described above, holders of Preference Shares will not have a claim in respect of such non-payment.
If any dividend on a series of Preference Shares is not paid in full on the relevant dividend payment date, a dividend restriction shall apply. The dividend restriction means that, subject to certain exceptions, neither the Company nor Barclays Bank may (a) pay a dividend on, or (b) redeem, purchase, reduce or otherwise acquire, any of their respective ordinary shares, other preference shares or other share capital ranking equal or junior to the relevant series of Preference Shares until the earlier of such time as the Company next pays in full a dividend on the relevant series of Preference Shares or the date on which all of the relevant series of Preference Shares are redeemed.
All unclaimed dividends payable in respect of any share may be invested or otherwise made use of by the Board for the benefit of the Company until claimed. If a dividend is not claimed after 12 years of it becoming payable, it is forfeited and reverts to the Company. The Company shall hold the net proceeds from the sale of shares owned by untraced Shareholders for a period of six years after which the proceeds shall belong to the Company.
The Board may, with the approval of an ordinary resolution of the Company, offer Shareholders the right to choose to receive an allotment of additional fully paid Ordinary Shares instead of cash in respect of all or part of any dividend. The Company currently provides a dividend reinvestment programme but has the option to provide a scrip dividend programme pursuant to an authority renewed at the AGM on 1 May 2018.
Redemption and Purchase
Subject to applicable legislation and the rights of the other shareholders, any share may be issued on terms that it is, at the option of the Company or the holder of such share, redeemable. The Directors are authorised to determine the terms, conditions and manner of redemption of any such shares under the Articles of Association.
Calls on capital
The Directors may make calls upon the members in respect of any monies unpaid on their shares. A person upon whom a call is made remains liable even if the shares in respect of which the call is made have been transferred. Interest will be chargeable on any unpaid amount called at a rate determined by the Board (of not more than 20% per annum).
If a member fails to pay any call in full (following notice from the Board that such failure will result in forfeiture of the relevant shares), such shares (including any dividends declared but not paid) may be forfeited by a resolution of the Board, and will become the property of the Company. Forfeiture shall not absolve a previous member for amounts payable by him/her (which may continue to accrue interest).
The Company also has a lien over all partly paid shares of the Company for all monies payable or called on that share and over the debts and liabilities of a member to the Company. If any monies which are the subject of the lien remain unpaid after a notice from the Board demanding payment, the Company may sell such shares.
Annual and other general meetings
The Company is required to hold an AGM in addition to such other general meetings as the Directors think fit. The type of the meeting will be specified in the notice calling it. Under the Companies Act 2006, the AGM must be held within six months of the financial year end. A general meeting may be convened by the Board on requisition in accordance with the applicable legislation.
In the case of an AGM, a minimum of 21 clear days’ notice is required. The notice must be in writing and must specify the place, the day and the hour of the meeting, and the general nature of the business to be transacted. A notice convening a meeting to pass a special resolution shall specify the intention to propose the resolution as such. The accidental failure to give notice of a general meeting or the non-receipt of such notice will not invalidate the proceedings at such meeting.
Subject as noted above, all Shareholders are entitled to attend and vote at general meetings. The Articles do, however, provide that arrangements may be made for simultaneous attendance at a satellite meeting place or, if the meeting place is inadequate to accommodate all members and proxies entitled to attend, another meeting place may be arranged to accommodate such persons other than that specified in the notice of meeting, in which case Shareholders may be excluded from the principal place. The Articles also allow for a hybrid meeting, whereby Shareholders may attend by electronic means or physically.
Holders of Preference Shares have no right to receive notice of, attend or vote at, any general meetings of the Company as a result of holding Preference Shares.
Notices
A document or information may be sent by the Company in hard copy form, electronic form, by being made available on a website, or by another means agreed with the recipient, in accordance with the provisions set out in the Companies Act 2006. Accordingly, a document or information may only be sent in electronic form to a person who has agreed to receive it in that form or, in the case of a company, who has been deemed to have so agreed pursuant to applicable legislation. A document or information may only be sent by being made available on a website if the recipient has agreed to receive it in that form or has been deemed to have so agreed pursuant to applicable legislation, and has not revoked that agreement.
In respect of joint holdings, documents or information shall be sent to the joint holder whose name stands first in the register.
A member who (having no registered address within the UK) has not supplied an address in the UK at which documents or information may be sent in hard copy form, or an address to which notices, documents or information may be sent or supplied by electronic means, is not entitled to have documents or information sent to him/her.
In addition, the Company may cease to send notices to any member who has been sent documents on two consecutive occasions over a period of at least 12 months and when each of those documents is returned undelivered or notification is received that they have not been delivered.
Capitalisation of profits
The Company may, by ordinary resolution, upon the recommendation of the Board capitalise all or any part of an amount standing to the credit of a reserve or fund to be set free for distribution provided that amounts from the share premium account, capital redemption reserve or any profits not available for distribution should be applied
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
313

Additional information

only in paying up unissued shares to be allotted to members credited as fully paid and no unrealised profits shall be applied in paying up debentures of the Company or any amount unpaid on any share in the capital of the Company.
Indemnity
Subject to applicable legislation, every current and former Director or other officer of the Company (other than any person engaged by the company as auditor) shall be indemnified by the Company against any liability in relation to the Company, other than (broadly) any liability to the Company or a member of the Group, or any criminal or regulatory fine.
Dividends on the ordinary shares of Barclays PLC
The dividends declared for each of the last five years were:
Pence per 25p ordinary share
20212020201920182017
Half year2.00 — 3.00 2.50 1.00 
Full year4.00 1.00 — 4.00 2.00 
Total6.00 1.00 3.00 6.50 3.00 
US Dollars per 25p ordinary share
20212020201920182017
Half year0.03 — 0.04 0.03 0.01 
Full year0.05 0.01 — 0.05 0.02 
Total0.08 0.01 0.04 0.08 0.03 
The gross dividends applicable to an American Depositary Share (ADS) representing four ordinary shares, before deduction of withholding tax, are as follows:
US Dollars per American Depositary Share
20212020201920182017
Half year0.11 — 0.15 0.13 0.05 
Full year0.22 0.06 — 0.21 0.10 
Total0.33 0.06 0.15 0.34 0.15 
The final dividends shown above are expressed in Dollars translated at the closing spot rate for Pounds Sterling as determined by Bloomberg at 5pm in New York City (the ‘Closing Spot Rate’) on the latest practicable date for inclusion in this report. No representation is made that Pounds Sterling amounts have been, or could have been, or could be, converted into Dollars at these rates.
Trading market for ordinary shares of Barclays PLC
The principal trading market for Barclays PLC ordinary shares is the London Stock Exchange. At the close of business on 31 December 2021,16,752,457,128 ordinary shares were in issue.
Ordinary share listings were also obtained on the New York Stock Exchange (NYSE) with effect from 9 September 1986. Trading on the NYSE is in the form of ADSs under the symbol ‘BCS’. Each ADS represents four ordinary shares and is evidenced by an American Depositary Receipt (ADR). The ADR depositary is JP Morgan Chase Bank, N.A. Details of trading activity are published in the stock tables of leading daily newspapers in the US.
There were 393 ADR holders and 1,626 recorded holders of ordinary shares with US addresses at 31 December 2021, whose shareholdings represented approximately 3.78% of total outstanding ordinary shares on that date. Since a certain number of the ordinary shares and ADRs were held by brokers or other nominees, the number of recorded holders in the US may not be representative of the number of beneficial holders or of their country of residence.
Shareholdings at 31 December 2021a
Number of shareholdersPercentage of holdersShares heldPercentage of capital
%%
Classification of shareholders
Personal Holders226,12397.70 384,793,4712.30 
Banks and Nominees1,8550.80 13,917,495,42083.09 
Other Companies3,3481.50 2,448,162,58714.61 
Insurance Companies1 208 
Pension Funds1 5,442 
Total231,331 100 16,752,457,128 100 
Shareholding range
1 - 10016,9237.32 620,911 
101 - 25049,35621.34 10,045,9780.06 
251 - 50062,66427.09 21,946,0870.13 
501 - 1,00036,80615.91 26,004,6710.16 
1,001 - 5,00046,09519.93 102,207,1170.61 
5,001 - 10,00010,1104.37 71,061,6690.42 
10,001 - 25,0006,0232.60 91,233,6180.54 
25,001 - 50,0001,4540.63 49,600,7700.30 
50,001 and over1,9000.82 16,379,736,30797.78 
Total231,331 100.0016,752,457,128 100 
United States Holdings1,626 0.704,193,907 0.03
Note
aThese figures do not include Barclays Sharestore members.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
314

Additional information



Taxation of UK holders
The following is a summary of certain UK tax issues which are likely to be material to the holding and disposal of Ordinary Shares of Barclays PLC or ADSs representing such Ordinary Shares (the ‘Shares’).
It is based on the current laws of England and Wales, UK tax law and the practice of Her Majesty’s Revenue and Customs (‘HMRC’), each of which may be subject to change, possibly with retrospective effect. It is a general guide for information purposes and should be treated with appropriate caution. It is not intended as tax advice and it does not purport to describe all of the tax considerations that may be relevant to a prospective purchaser, holder or disposer of Shares. In particular, save where expressly stated to the contrary, this summary deals with shareholders who are resident and, in the case of individuals, domiciled in (and only in) the UK for UK tax purposes, who hold their Shares as investments (other than under an individual savings account) and who are the absolute beneficial owners of their Shares and any dividends paid on them.
The statements are not addressed to: (i) shareholders who own (or are deemed to own) 10% or more of the voting power of Barclays PLC; (ii) shareholders who hold Shares as part of hedging transactions; (iii) investors who have (or are deemed to have) acquired their Shares by virtue of an office or employment; and (iv) shareholders who hold Shares in connection with a trade, profession or vocation carried on in the UK (whether through a branch or agency or, in the case of a corporate shareholder, through a permanent establishment, or otherwise). It does not discuss the tax treatment of classes of shareholder subject to special rules, such as dealers in securities.
Persons who are in any doubt as to their tax position should consult their professional advisers. Persons who may be liable to taxation in jurisdictions other than the UK in respect of their acquisition, holding or disposal of Shares are particularly advised to consult their professional advisers as to whether they are so liable.
(i)Taxation of dividends
In accordance with UK law, Barclays PLC pays dividends on the Shares without any deduction or withholding for or on account of any taxes imposed by the UK government or any UK taxing authority.
The total dividends (including any dividends paid by Barclays PLC) paid to a UK resident individual shareholder in a tax year (the ‘Total Dividend Income’) will generally form part of that shareholder’s total income for UK income tax purposes, and will be subject to UK income tax at the rates discussed below.
For dividends paid on or after 6 April 2016, the rate of UK income tax applicable to the Total Dividend Income will depend on the amount of the Total Dividend Income and the UK income tax band(s) that the Total Dividend Income falls within when included as part of the shareholder’s total income for UK income tax purposes for that tax year.
For the tax year from 6 April 2021 to 5 April 2022 (inclusive), a nil rate of UK income tax applies to the first £2,000 of Total Dividend Income received by an individual shareholder in that tax year (the ‘Nil Rate Amount’). For the 2018-2019, 2019-2020 and 2020-2021 tax years, the Nil Rate Amount was £2,000. For the 2016-2017 and 2017-2018 tax years, the Nil Rate Amount was £5,000.
Where the Total Dividend Income received by an individual shareholder in a tax year exceeds the relevant Nil Rate Amount for that tax year, the excess amount (the ‘Remaining Dividend Income’) will be subject to UK income tax at the following current rates:
(a) at the rate of 7.5% on any portion of the Remaining Dividend Income that falls within the basic tax band;
(b) at the rate of 32.5% on any portion of the Remaining Dividend Income that falls within the higher tax band; and
(c) at the rate of 38.1% on any portion of the Remaining Dividend Income that falls within the additional tax band.
In determining the tax band the Remaining Dividend Income falls within for a tax year, the individual shareholder’s Total Dividend Income for the tax year in question (including the portion comprising the Nil Rate Amount) will be treated as the top slice of the shareholder’s total income for UK income tax purposes.
Subject to special rules for small companies, UK resident shareholders within the charge to UK corporation tax will not generally be subject to UK corporation tax on the dividends paid on the Shares, provided the dividend falls within an exempt class and certain conditions are met.
(ii)Taxation of shares under the Dividend Re-Investment Plan
Where a shareholder elects to purchase Shares using their cash dividend as part of the Dividend Re-Investment Plan, such shareholder will generally be liable for UK tax on the amount of the dividend as described in (i) Taxation of dividends above, in the same way as the shareholder would have been on the receipt of a cash dividend. For capital gains purposes, the base cost of Shares purchased under the Dividend Re-Investment Plan will be the amount of the cash dividend used to purchase such Shares.
(iii)Taxation of capital gains
The disposal of Shares (including, for the avoidance of doubt, any shares purchased as part of the Dividend Re-Investment Plan or previously purchased as part of the Scrip Dividend Programme) may, depending on the shareholder’s circumstances, give rise to a liability to UK tax on chargeable capital gains.
Where Shares are sold, a liability to UK tax may result if the proceeds from that sale exceed the sum of the base cost of the Shares sold and any other allowable deductions such as share dealing costs and, in certain circumstances, indexation relief (discussed further below). To arrive at the total base cost of any Barclays PLC shares held, in appropriate cases the amount subscribed for rights taken up in 1985, 1988 and 2013 must be added to the cost of all such shares held. For this purpose, current legislation permits the market valuation at 31 March 1982 to be substituted for the original cost of shares purchased before that date, subject to certain exceptions for shareholders within the charge to UK corporation tax. Shareholders other than those within the charge to UK corporation tax should note that, following the Finance Act 2008, no indexation allowance will be available. Following the Finance Act 2018, shareholders within the charge to UK corporation tax may be eligible for indexation allowance for the period of ownership of their Shares up to December 2017, but no indexation allowance will be available in respect of the period of ownership starting on or after 1 January 2018.
Chargeable capital gains may also arise from the gifting of Shares to connected parties such as relatives (although not spouses or civil partners) and family trusts.
The calculations required to compute chargeable capital gains may be complex. Shareholders are advised to consult their personal financial adviser if further information regarding a possible tax liability in respect of their holdings of shares is required.
(iv)Stamp duty and stamp duty reserve tax
Dealings in Shares (including, for the avoidance of doubt, any Shares purchased as part of the Dividend Re-Investment Plan or previously purchased as part of the Scrip Dividend Programme) will generally be subject to UK stamp duty or stamp duty reserve tax (although see the comments below as regards ADSs in the section ‘Taxation of US holders – UK stamp duty and stamp duty reserve tax’). Any document effecting the transfer on sale of Shares will generally be liable to stamp duty at 0.5% of the consideration paid for that transfer (rounded up to the next £5). An unconditional agreement to transfer Shares, or any interest therein, will generally be subject to stamp duty reserve tax at 0.5% of the consideration given. Such liability to stamp duty reserve tax will be cancelled, or a right to a repayment (generally with interest) in respect of the stamp duty reserve tax liability will arise, if the agreement is completed by a duly stamped transfer within six years of the agreement having become unconditional. Both stamp duty and stamp duty reserve tax are normally the liability of the transferee.
Paperless transfers of Shares within CREST are liable to stamp duty reserve tax rather than stamp duty.
Stamp duty reserve tax on transactions settled within the CREST system or reported through it for regulatory purposes will be collected by CREST.
Special rules apply to certain categories of person, including intermediaries, market makers, brokers, dealers and persons connected with depositary arrangements and clearance services.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
315

Additional information

(v)Inheritance tax
An individual may be liable to inheritance tax on the transfer of Shares (including, for the avoidance of doubt, any Shares purchased as part of the Dividend Re-Investment Plan or previously purchased as part of the Scrip Dividend Programme). Where an individual is so liable, inheritance tax may be charged on the amount by which the value of his or her estate is reduced as a result of any transfer by way of gift or other gratuitous transaction made by them or treated as made by them.
Taxation of US Holders
The following is a summary of certain US federal income tax considerations and certain UK tax considerations to the purchase, ownership and disposition of Ordinary Shares of Barclays PLC or ADSs representing such Ordinary Shares (the "Shares") that are likely to be relevant for US Holders (as defined below) who own the Shares as capital assets for tax purposes. This discussion is not a comprehensive analysis of all the potential US or UK tax consequences that may be relevant to US Holders and does not discuss particular tax consequences that may be applicable to US Holders who may be subject to special tax rules, such as banks, brokers or dealers in securities or currencies, traders in securities that elect to use a mark-to-market method of accounting for securities holdings, financial institutions, tax-exempt organisations, regulated investment companies, life insurance companies, entities or arrangements that are treated as partnerships for US federal income tax purposes (or partners therein), holders that own or are treated as owning 10% or more of the stock of Barclays PLC measured either by voting power or value, holders that hold Shares as part of a straddle or a hedging or conversion transaction, holders that purchase or sell Shares as part of a wash sale, holders whose functional currency is not the US Dollar, or holders who are resident, or who are carrying on a trade, in the UK. The summary also does not address state or local taxes or any aspect of US federal taxation other than US federal income taxation (such as the estate and gift tax, the alternative minimum tax or the Medicare tax on net investment income). Investors are advised to consult their tax advisers regarding the tax implications of their particular holdings, including the consequences under applicable state and local law, and in particular whether they are eligible for the benefits of the Treaty (as defined below).
This discussion is based on the Internal Revenue Code of 1986, as amended (the ‘Code’), its legislative history, existing and proposed regulations, published rulings and court decisions, and on the Double Taxation Convention between the UK and the US as entered into force in March 2003 (the ‘Treaty’), and, in respect of UK tax, the Estate and Gift Tax Convention between the UK and the US as entered into force on 11 November 1979 (the ‘Estate and Gift Tax Convention’), the current UK tax law and the practice of HMRC, all of which are subject to change, possibly on a retroactive basis. This discussion is based in part upon the representations of the ADR Depositary and the assumption that each obligation of the Deposit Agreement and any related agreement will be performed in accordance with its terms.
A “US Holder” is a beneficial owner of Shares that is a citizen or resident of the United States or a US domestic corporation or that otherwise is subject to US federal income taxation on a net income basis in respect of such Shares and that is fully eligible for benefits under the Treaty.
In general, the holders of ADRs evidencing ADSs will be treated as owners of the underlying Ordinary Shares for the purposes of the Treaty, the Estate and Gift Tax Convention, and the Code. Generally, exchanges of shares for ADRs and ADRs for shares will not be subject to US federal income tax or to UK capital gains tax.
Taxation of dividends
Subject to the PFIC rules discussed below, the gross amount of any distribution of cash or property with respect to the Shares (including any amount withheld in respect of UK taxes) that is paid out of Barclays PLC’s current or accumulated earnings and profits (as determined for US federal income tax purposes) will be includable in a US Holder’s taxable income as ordinary dividend income on the day such US Holder receives the dividend, in the case of Ordinary Shares, or the date the Depositary receives the dividends, in the case of ADRs, and will not be eligible for the dividends-received deduction allowed to corporations under the Code.
Subject to certain exceptions for short-term positions, dividends paid by Barclays PLC to an individual with respect to the Shares will generally be subject to taxation at a preferential rate if the dividends are “qualified dividend income.” Dividends paid on the Shares will be treated as qualified dividend income if (i) the Shares are readily tradable on an established securities market in the United States or Barclays PLC is eligible for the benefits of a comprehensive tax treaty with the United States that the US Treasury determines is satisfactory for purposes of this provision and that includes an exchange of information program, and (ii) Barclays PLC was not a PFIC (as defined below) in the year of the distribution or the immediately preceding taxable year. The ADRs are listed on the New York Stock Exchange, and will qualify as readily tradable on an established securities market so long as they are so listed. In addition, the US Treasury has determined that the Treaty meets the requirements for reduced rates of taxation, and Barclays PLC believes that it is eligible for the benefits of the Treaty. Based on its audited financial statements and relevant market and shareholder date, Barclays PLC believes that it was not treated as a PFIC for US federal income tax purposes with respect to its 2020 or 2021 taxable years. In addition, based on its audited financial statements and current expectations regarding the value and nature of its assets, the sources and nature of its income, and relevant market and shareholder data, Barclays PLC does not anticipate becoming a PFIC for its current taxable year or in the foreseeable future.
Dividends paid by Barclays PLC to a US Holder with respect to the Shares will not be subject to UK withholding tax. For foreign tax credit purposes, dividends will generally be income from sources outside the US and will generally be “passive” income for purposes of computing the foreign tax credit allowable to a US Holder.
The amount of the dividend distribution includable in income will be the US Dollar value of the distribution, determined at the spot Pound Sterling/US Dollar rate on the date the dividend distribution is includable in income, regardless of whether the payment is in fact converted into US Dollars. Generally, any gain or loss resulting from currency exchange fluctuations during the period from the date the dividend payment is includable in income to the date the payment is converted into US Dollars will be treated as ordinary income or loss and, for foreign tax credit limitation purposes, from sources within the US, and will not be eligible for the special tax rates applicable to qualified dividend income.
Distributions in excess of current or accumulated earnings and profits, as determined for US federal income tax purposes, will be treated as a return of capital to the extent of the US Holder’s basis in the Shares and thereafter as capital gain. Because Barclays PLC does not currently maintain calculations of earnings and profits for US federal income tax purposes, US Holders should expect that distributions with respect to the Shares will generally be treated as dividends.
US Holders that receive a distribution of additional shares or rights to subscribe for additional shares as part of a pro rata distribution to all our shareholders generally will not be subject to US federal income tax in respect of the distribution, unless the US Holder has the right to receive cash or property, in which case the US Holder will be treated as if it received cash equal to the fair market value of the distribution.
Taxable sale or other disposition of Shares
Subject to the PFIC rules discussed below, upon a sale or other taxable disposition of the Shares, US Holders generally will not be subject to UK tax, but will realise gain or loss for US federal income tax purposes in an amount equal to the difference between the US Dollar value of the amount realised on the disposition and the US Holder’s adjusted tax basis in the Shares, as determined in US Dollars. Such gain or loss will be capital gain or loss, and will generally be long-term capital gain or loss if the Shares have been held for more than one year. Long-term capital gain of a noncorporate US Holder is generally taxed at preferential rates. The gain or loss will generally be income or loss from sources within the United States for foreign tax credit limitation purposes. The deductibility of capital losses is subject to limitations.
Taxation of passive foreign investment companies (PFICs)
Barclays PLC believes that its Shares should not be treated as stock of a passive foreign investment company (“PFIC”) for US federal income tax purposes, but this conclusion is a factual determination that is made annually and thus may be subject to change. In general, Barclays PLC will be a PFIC with respect to a US Holder if, for any taxable year in which a US Holder holds the Shares, either (i) at least 75% of the gross income of Barclays PLC for the taxable year is passive income, or (ii) at least 50% of the value, generally determined on the basis of a quarterly average, of Barclays PLC’s assets is attributable to assets that produce or are held for the production of passive income (including cash). With certain exceptions, a US Holder’s Shares will be treated as stock of a PFIC if Barclays PLC was a PFIC at any time during such holder’s holding period in its Shares.
If Barclays PLC were to be treated as a PFIC with respect to a US Holder, unless such US Holder elected to be taxed annually on a mark-to-market basis with respect to its Shares, such gain and certain “excess distributions” would be treated as having been realised ratably over a US Holder’s holding period for the Shares and generally would be taxed at the highest tax rate in effect for each such year to which the gain was allocated, together with an interest charge in respect of the tax attributable to each such year.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
316

Additional information



UK stamp duty and stamp duty reserve tax
No obligation to pay UK stamp duty will arise on the transfer on sale of an ADS, provided that any instrument of transfer is not executed in, and remains at all times outside, the UK. No UK stamp duty reserve tax is payable in respect of an agreement to transfer an ADS. For the UK stamp duty and stamp duty reserve tax implications of dealings in Ordinary Shares, see the section “Taxation of UK holders – (iv) Stamp duty and stamp duty reserve tax” above.
UK estate and gift tax
Under the Estate and Gift Tax Convention, Shares held by an individual US holder who is US domiciled for the purposes of the Estate and Gift Tax Convention and who is not for such purposes a UK national generally will not, provided any US federal estate or gift tax chargeable has been paid, be subject to UK inheritance tax on the individual’s death or on a lifetime transfer of Shares, except in certain cases where the Shares are comprised in a settlement (unless the settlor was US domiciled and not a UK national at the time of the settlement), are part of the business property of a UK permanent establishment of an enterprise, or pertain to a UK fixed base of an individual used for the performance of independent personal services. In cases where the Shares are subject to both UK inheritance tax and US federal estate or gift tax, the Estate and Gift Tax Convention generally provides a credit against US federal tax liability for the amount of any inheritance tax paid in the UK.
Foreign Financial Asset Reporting
Certain US Holders that own “specified foreign financial assets” with an aggregate value in excess of US$50,000 on the last day of the taxable year or US$75,000 at any time during the taxable year are generally required to file an information statement along with their tax returns, currently on Form 8938, with respect to such assets. “Specified foreign financial assets” include any financial accounts held at a non-US financial institution, as well as securities issued by a non-US issuer that are not held in accounts maintained by financial institutions. The understatement of income attributable to “specified foreign financial assets” in excess of US$5,000 extends the statute of limitations with respect to the tax return to six years after the return was filed. US Holders who fail to report the required information could be subject to substantial penalties. Prospective investors are encouraged to consult with their own tax advisors regarding the possible application of these rules, including the application of the rules to their particular circumstances.
Backup Withholding and Information Reporting
Dividends paid on, and proceeds from the sale or other disposition of, the Shares to a US Holder generally may be subject to the information reporting requirements of the Code and may be subject to backup withholding unless the US Holder provides an accurate taxpayer identification number and makes any other required certification or otherwise establishes an exemption. Backup withholding is not an additional tax. The amount of any backup withholding from a payment to a US Holder will be allowed as a refund or credit against the US Holder’s US federal income tax liability, provided the required information is furnished to the US Internal Revenue Service (“IRS”) in a timely manner.
A holder that is not a US Holder may be required to comply with certification and identification procedures in order to establish its exemption from information reporting and backup withholding.
FATCA Risk Factor
In certain circumstances, payments on shares or ADSs may be subject to US withholding taxes on “passthru payments,” starting on the date that is two years after the date on which final regulations defining this concept are adopted in the United States. Under the “Foreign Account Tax Compliance Act” (or “FATCA”), as well as intergovernmental agreements between the United States and other countries and implementing laws in respect of the foregoing, certain US-source payments (including dividends and interest) and certain payments made by, and financial accounts held with, entities that are classified as financial institutions under FATCA are subject to a special information reporting and withholding tax regime. Regulations implementing withholding in respect of “passthru payments” under FATCA have not yet been adopted or proposed. The United States has entered into an intergovernmental agreement regarding the implementation of FATCA with the UK (the “UK IGA”). Under the UK IGA, as currently drafted, it is not expected that Barclays PLC will be required to withhold tax under FATCA on payments made with respect to the shares or ADSs. However, significant aspects of when and how FATCA will apply remain unclear, and no assurance can be given that withholding under FATCA will not become relevant with respect to payments made on or with respect to the shares or ADSs in the future. Investors should consult their own tax advisers regarding the potential impact of FATCA.
The Barclays Group has registered with the Internal Revenue Service (“IRS”) for FATCA. The Global Intermediary Identification Number (GIIN) for Barclays PLC in the United Kingdom is E1QAZN.00000.LE.826 and it is a Reporting Model 1 FFI. The GIINs for other parts of the Barclays Group or Barclays branches outside of the UK may be obtained from your usual Barclays contact on request. The IRS list of registered Foreign Financial Institutions is publicly available on the IRS website.
Exchange controls and other limitations affecting security holders
Other than certain economic sanctions which may be in force from time to time, there are currently no UK laws, decrees or regulations which would affect the transfer of capital or remittance of dividends, interest and other payments to holders of Barclays securities who are not residents of the UK. There are also no restrictions under the Articles of Association of Barclays PLC, or (subject to the effect of any such economic sanctions) under current UK laws, which relate only to non-residents of the UK, and which limit the right of such non-residents to hold Barclays securities or, when entitled to vote, to do so.
Documents on display
It is possible to read and copy documents that have been filed by Barclays PLC with the US Securities and Exchange Commission via commercial document retrieval services, and from the website maintained by the US Securities and Exchange Commission at www.sec.gov.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
317

Additional information

Fees and charges payable by a holder of ADSs
The ADR depositary collects fees for delivery and surrender of ADSs directly from investors depositing ordinary shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them.
The charges of the ADR depositary payable by investors are as follows:
Type of serviceADR depositary actionsFee
ADR depositary or substituting the underlying shares
Issuance of ADSs against the deposit of ordinary shares, including deposits and issuances in respect of:
Share distributions, stock splits, rights issues, mergers
Exchange of securities or other transactions or event or other distribution affecting the ADSs or deposited securities
$5.00 or less per 100 ADSs (or portion thereof) evidenced by the new ADSs delivered
Receiving or distributing cash dividendsDistribution of cash dividends
$0.02 or less per ADSa
Selling or exercising rightsDistribution or sale of securities, the fee being in an amount equal to the fee for the execution and delivery of ADSs which would have been charged as a result of the deposit of such securities$5.00 or less per each 100 ADSs (or portion thereof)
Withdrawing an underlying ordinary shareAcceptance of ADSs surrendered for withdrawal of deposited ordinary shares$5.00 or less for each 100 ADSs (or portion thereof)
General depositary services, particularly those charged on an annual basisOther services performed by the ADR depositary in administering the ADS programNo fee currently payable
Expenses of the ADR depositary
Expenses incurred on behalf of Holders in connection with:
Expenses of the ADR depositary in connection with the conversion of foreign currency into US dollars (which are paid out of such foreign currency)
Taxes and other governmental charges
Cable, telex and facsimile transmission/delivery
Transfer or registration fees, if applicable, for the registration of transfers or underlying ordinary shares
Any other charge payable by ADR depositary or its agents
Expenses payable at the sole discretion of the ADR depositary by billing Holders or by deducting charges from one or more cash dividends or other cash distributions
Note
aThe fee in relation to the distribution of cash dividends was $0.0043273 per ADS in respect of dividends paid in the year ended 31 December 2021.

Fees and payments made by the ADR depositary to Barclays
The ADR depositary has agreed to provide Barclays with an amount based on any cash dividend, issuance and cancellations fees charged during each twelve-month period for expenses incurred by Barclays in connection with the ADS program. Barclays is entitled to $643,109.26 for the year ended 31 December 2021, though such amount has not yet been paid to Barclays by the ADR depositary. In 2021, Barclays received $373,733 relating to ADR activity for the year ended 31 December 2020.
Under certain circumstances, including non-routine corporate actions, removal of the ADR depositary or termination of the ADS program by Barclays, Barclays may be charged by the ADR depositary certain fees (including in connection with depositary services, certain expenses paid on behalf of Barclays, an administrative fee, fees for non-routine services and corporate actions and any other reasonable fees/expenses incurred by the ADR depositary).

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
318

Additional information



NYSE Corporate Governance Statement
As our main listing is on the London Stock Exchange, we follow the UK Corporate Governance Code. However, as Barclays also has American Depositary Receipts listed on the New York Stock Exchange (NYSE), we are also subject to the NYSE’s Corporate Governance Rules (NYSE Rules). We are exempt from most of the NYSE Rules, which US domestic companies must follow, because we are a non-US company listed on the NYSE. However, we are required to provide an Annual Written Affirmation to the NYSE of our compliance with the applicable NYSE Rules and must also disclose any significant differences between our corporate governance practices and those followed by domestic US companies listed on the NYSE. Key differences between the Code and NYSE Rules are set out here:
Director Independence
NYSE Rules require the majority of the Board to be independent. The Code requires at least half of the Board (excluding the Chairman) to be independent. The NYSE Rules contain different tests from the Code for determining whether a Director is independent. We follow the Code’s recommendations as well as developing best practices among other UK public companies. The independence of our non-executive Directors is reviewed by the Board on an annual basis and it takes into account the guidance in the Code and the criteria we have established for determining independence, which are described in the Directors’ Report.
Board Committees
We have a Board Nominations Committee and a Board Remuneration Committee, both of which are broadly similar in purpose and constitution to the Committees required by the NYSE Rules and whose terms of reference comply with the Code’s requirements. The NYSE Rules state that both Committees must be composed entirely of independent Directors. As the Group Chairman was independent on appointment, the Code permits him to chair the Board Nominations Committee. Except for this appointment, both Committees are composed solely of non-executive Directors, whom the Board has determined to be independent. We comply with the NYSE Rules requirement that we have a Board Audit Committee comprised solely of independent non-executive Directors as defined under Rule 10A-3. However, we follow the Code recommendations, rather than the NYSE Rules, regarding the responsibilities of the Board Audit Committee (except for applicable mandatory responsibilities under the Sarbanes-Oxley Act), although both are broadly comparable. Although the NYSE Rules state that the Board Audit Committee is to take responsibility for risk oversight, Barclays has an additional Board Committee which addresses different areas of risk management. To enhance Board governance of risk, Barclays has the Board Risk Committee. A full description of the Board Risk Committee can be found in the Directors’ Report.
Corporate Governance Guidelines
The NYSE Rules require domestic US companies to adopt and disclose corporate governance guidelines. There is no equivalent recommendation in the Code but the Board Nominations Committee has developed corporate governance guidelines, ‘Corporate Governance in Barclays’, which have been approved and adopted by the Board.
Code of Ethics
The NYSE Rules require that domestic US companies adopt and disclose a code of business conduct and ethics for Directors, officers and employees. The Barclays Way was introduced in 2013, this is a Code of Conduct which outlines the Values and Behaviours which govern our way of working across our business globally. The Barclays Way has been adopted on a Group-wide basis by all Directors, Officers and employees. The Barclays Way is available to view on the Barclays website at home.barclays/about-barclays/barclays-values.
Shareholder Approval of Equity-compensation Plans
The NYSE listing standards require that shareholders must be given the opportunity to vote on all equity-compensation plans and material revisions to those plans. We comply with UK requirements, which are similar to the NYSE standards. However, the Board does not explicitly take into consideration the NYSE’s detailed definition of what are considered ‘material revisions’.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
319

Additional information

Major shareholders
Major shareholders do not have different voting rights from those of other shareholders. Information provided to the Company by substantial shareholders pursuant to the FCA’s Disclosure Guidance and Transparency Rules are published via a Regulatory Information Service and is available on the Company’s website.
Refer to the Directors’ report, Other statutory information section for a breakdown of major shareholders as at 31 December 2021. Comparatives for 2020 and 2019 are presented below.
As at 31 December 2020, the Company had been notified under Rule 5 of the Disclosure and Transparency Rules of the UKLA of the following holdings of voting rights in its shares:
2020
HolderNumber of Barclays shares
% of total voting rights attached to issued share capitala
BlackRock Incb
944,022,2095.78 
Qatar Holding LLCc
1,017,455,6905.86 
Sherborne Investorsd
943,949,0895.48 
The Capital Group Companies Ince
843,819,4874.87 
Norges Bank521,031,8523.00 

Notes
aThe percentage of voting rights detailed above was calculated at the time of the relevant disclosures made in accordance with Rule 5 of the Disclosure Guidance and Transparency Rules.
bTotal shown includes 6,687,206 contracts for difference to which voting rights are attached. Part of the holding is held as American Depositary Receipts. On 28 January 2020, BlackRock Inc. disclosed by way of a Schedule 13G filed with the Securities Exchange Commission beneficial ownership of 1,303,744,297 ordinary shares of the company as at 31 December 2020,,representing 7.5% of that class of shares.
cQatar Holding LLC is wholly-owned by Qatar Investment Authority.
dWe understand from disclosures that the Sherborne shares are held via three funds ultimately controlled by Edward Bramson and Stephen Welker in their capacity as managing directors of Sherborne Investors Management GP, LLC (Sherborne Management GP), and Sherborne Investors GP, LLC. Sherborne Management GP is the general partner of Sherborne Investors Management LP (Sherborne Investors) which is the investment manager of each of the three funds beneficially interested in the Sherborne shares being Whistle Investors LLC, Whistle Investors II LLC and Whistle Investors III LLC. Amendment No.2 to a Schedule 13D filing, filed on 7 November 2019, also disclosed that certain funded derivative transactions, which were used to purchase 505,086,254 of such shares, have been extended to expire on various dates during the period beginning 14 December 2021 (previously 21 October 2019) and ending 22 July 2022 (previously 16 March 2021).
eThe Capital Group Companies Inc (CG) holds its shares via CG Management companies. Part of the CG holding is held as American Depositary Receipts.

As at 31 December 2019, the Company had been notified under Rule 5 of the Disclosure and Transparency Rules of the UKLA of the following holdings of voting rights in its shares:
2019
HolderNumber of Barclays shares
% of total voting rights attached to issued share capitala
BlackRock Incb
1,039,595,1566.02 
Qatar Holding LLCc
1,017,455,6905.87 
Sherborne Investorsd
943,949,0895.48 
The Capital Group Companies Ince
855,511,3854.96 
Notes
aThe percentage of voting rights detailed above was calculated at the time of the relevant disclosures made in accordance with Rule 5 of the Disclosure Guidance and Transparency Rules.
bTotal shown includes 6,950,721 contracts for difference to which voting rights are attached. Part of the holding is held as American Depositary Receipts. On 4 February 2020, BlackRock Inc. disclosed by way of a Schedule 13G filed with the Securities Exchange Commission beneficial ownership of 1,149,011,610 ordinary shares of the company, representing 6.6% of that class of shares.
cQatar Holding LLC is wholly-owned by Qatar Investment Authority.
dWe understand from disclosures that the Sherborne shares are held via three funds ultimately controlled by Edward Bramson and Stephen Welker in their capacity as managing directors of Sherborne Investors Management GP, LLC (Sherborne Management GP), and Sherborne Investors GP, LLC. Sherborne Management GP is the general partner of Sherborne Investors Management LP (Sherborne Investors) which is the investment manager of each of the three funds beneficially interested in the Sherborne shares being Whistle Investors LLC, Whistle Investors II LLC and Whistle Investors III LLC. Amendment No.2 to a Schedule 13D filing, filed on 7 November 2019, also disclosed that certain funded derivative transactions, which were used to purchase 505,086,254 of such shares, have been extended to expire on various dates during the period beginning 14 December 2021 (previously 21 October 2019) and ending 22 July 2022 (previously 16 March 2021).
eThe Capital Group Companies Inc (CG) holds its shares via CG Management companies. Part of the CG holding is held as American Depositary Receipts.



Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
320

Additional information



Disclosure controls and procedures
The Chief Executive, C.S. Venkatakrishnan, and the Group Finance Director, Tushar Morzaria, conducted with Group Management an evaluation of the effectiveness of the design and operation of the Group’s disclosure controls and procedures of each of Barclays PLC as at 31 December 2021, which are defined as those controls and procedures designed to ensure that information required to be disclosed in reports filed or submitted under the US Securities Exchange Act of 1934 is recorded, processed, summarised and reported within the time periods specified in the US Securities and Exchange Commission’s rules and forms. As of the date of the evaluation, the Chief Executive and Group Finance Director concluded that the design and operation of these disclosure controls and procedures were effective.
Board of Directors
See the Directors’ report for biographies.
Group Executive Committee
Officers of the GroupDate of Appointment as Officer
C S VenkatakrishnanGroup Chief Executive2021
Paul ComptonGlobal Head of the Corporate & Investment Bank and President of Barclays Bank PLC (BBPLC)2016
Alistair CurrieGlobal Head of Consumer Banking and Payments2019
Matt HammersteinCEO, Barclays UK2019
Tushar MorzariaGroup Finance Director2013
Laura PadovaniGroup Chief Compliance Officer2017
Mark Ashton RigbyGroup Chief Operating Officer, Chief Executive Officer, BX2019
Tristram RobertsGroup HR Director2015
Taalib ShaahGroup Chief Risk Officer2020
Stephen ShapiroGroup General Counsel and Company Secretary2017
Sasha WigginsGroup Head of Public Policy and Corporate Responsibility2020
C.S. Venkatakrishnan, Group Chief Executive, Executive Director
See the Directors’ report for biography.
Tushar Morzaria, Group Finance Director, Executive Director
See the Directors’ report for biography.
Mark Ashton-Rigby, Group Chief Operating Officer, Chief Executive Officer, BX
In his role as Group Chief Operating Officer, Mark is responsible for Barclays Operations and Technology, leading on the ambition to be a world-class provider of simple, efficient, innovative and secure Operation and Technology services to Barclays’ trading entities, generating sustainable growth and returns. Mark’s responsibilities also include Real Estate, Controls, and the Chief Data Office. Mark is also Chief Executive Officer, Barclays Execution Services (BX). In that capacity, Mark leads the continuous enhancement of Barclays’ operating structure, to drive efficiency across the organisation and generate excellent outcomes for our customers and clients. Mark joined Barclays in September 2016 as Group Chief Information Officer. In this role, Mark was responsible for the bank’s global technology systems and infrastructure, and led on the transformation of the technology foundations across our retail and wholesale businesses. The increased digitisation of our consumer offering demonstrates that our technology infrastructure and innovation capabilities are a competitive advantage for Barclays, building a compelling client value proposition. Prior to joining Barclays, Mark was Chief Information Officer for JP Morgan’s Corporate and Investment bank. Prior to that, he held various Senior Technology roles at UBS and Deutsche Bank.
Paul Compton, Global Head of the Corporate & Investment Bank and President of Barclays Bank PLC
Paul Compton is Global Head of Corporate & Investment Bank, and President of Barclays Bank PLC (BBPLC), and a member of the Group Executive Committee of Barclays, based in New York. Paul leads the provision of funding, financing, strategic and risk management for money managers, financial institutions, governments, supranational organisations and corporate clients, and is responsible for overseeing the Corporate and Investment Bank, which comprises our global Banking, Markets and Corporate Banking businesses. Prior to his appointment as Global Head of Corporate and Investment Bank & President of Barclays Bank PLC in November 2021, Paul served as Global Head of Investment Banking and Co-President of BBPLC and previously as Barclays Group Chief Operating Officer, and as Chief Executive Officer of Barclays Execution Services (BX), delivering operations and technology services to Barclays businesses globally. Before joining Barclays in 2016, Paul served for nearly two decades in a variety of senior roles at JPMorgan Chase, including Group Chief Administrative Officer, and Chief Financial Officer and Chief Administrative Officer of the Investment Bank.
Prior to JPMorgan, Paul spent 10 years as a Principal at Ernst & Young in the Brisbane, Australia and New York offices.
Alistair Currie, Global Head of Consumer Banking and Payments
Alistair became Global Head of Consumer Banking and Payments in November 2021. He leads the ongoing transformation of the consumer banking and payments business as they become more digitally focussed, efficient and returns driven, whilst delivering excellent customer service. Alistair joined Barclays in August 2017 as Chief Operating Officer & Head of Product for Corporate Banking and is a member of the Corporate Banking and the Barclays International COO Executive Committees. In October 2017 Alistair became Co-Head of Corporate Banking and in September 2018 Alistair was appointed as Head of Corporate Banking. Prior to joining Barclays, Alistair was at the ANZ Banking Group in Australia where he most recently held the role of Group Chief Operating Officer, responsible for technology, shared services, operations and property, and played a key role in the ANZ’s digital transformation. Before taking up this role in 2011, he had previously joined ANZ in 2008 as Managing Director, Transaction Banking. Before ANZ, Alistair spent 18 years at HSBC in a variety of international banking roles in the UK, Middle East and Asia including President and CEO of HSBC, Taiwan, between 2007 and 2008. As Regional Head of Trade Services, HSBC Asia Office in Hong Kong from 2004 to 2007, Alistair further developed HSBC’s market-leading trade finance position in the region and from 2001 to 2004, he was COO, Wells Fargo HSBC Trade Bank NA, San Francisco. With 27 years as a banking professional, Mr. Currie has a wealth of experience in institutional, large corporate, mid-corporate and consumer client segments as well as transaction banking, trade finance, cash management and technology, and a track record in delivering business transformation and high quality customer outcomes.
Matt Hammerstein, CEO, Barclays UK
Matt Hammerstein is the CEO for Barclays Bank UK, covering Retail Banking, Investments and Wealth UK, Business Banking and Barclaycard UK. Prior to becoming CEO, Matt was Head of Retail Lending covering both the secured and unsecured lending businesses. Matt joined Barclays in 2004 as Director of Group Strategy, later progressing to become the Group Chief of Staff; a key strategic role in which he provided vital support to the Group CEO during the financial crisis. Matt went on to manage Barclays Group Corporate Strategy and Corporate Relations, Barclays Customer and Client Experience in Retail and Business Banking and Barclays UK Retail Products and Segments. Before Joining Barclays, Matt was a Senior Management Consultant at Marakon Associates where he worked for 12 years in the financial services, consumer products and energy sectors within the Americas and Europe. Matt is a member of the BBUK Board and sits on the Money and Pensions Service Adult Advisory Group. Matt is also a Member of the FCA Practitioner Panel and Trustee of the Charities Aid Foundation AMERICA and active ambassador in Barclays for inclusion, wellbeing and anything that makes the workplace more fun.


Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
321

Additional information

Laura Padovani, Group Chief Compliance Officer
Laura is currently the Group Chief Compliance Officer for Barclays and has worked at the bank since joining as the Head of Global Compliance Services in 2015. In 2016, Laura's role was expanded to cover the Compliance Chief of Staff Office, where she would deputise for the Chief Compliance Officer in various capacities.. Laura joined from American Express and has over 25 years of financial services experience. She started her career with American Express in Argentina in 1991 where she established the first Compliance office and co-ordinated their Legal function. Laura moved to New York in 1997 to assist with the development of the Global Anti-Money Laundering Program for American Express. In 2000, Laura broadened her Financial Services experience moving to Aviva as the Head of International Compliance responsible for all non-UK offices across North America, Europe and Asia Pacific. Laura returned to American Express in 2004 focused on Global Consumer Financial Services and European Emerging Markets, and then as the Global Head of International Regulatory Compliance. Laura is fluent in Spanish and Italian and has been involved in many networking initiatives for Women, both at American Express and now at Barclays.
Tristram Roberts, Group HR Director
Tristram is the Group Human Resources Director and a member of the Group Executive Committee. Tristram joined Barclays in July 2013 as HR Director for the Investment Bank. His remit was expanded in May 2014 to include HR responsibilities for Barclays Non-Core, and he became the Group HR Director in December 2015. Prior to Barclays, Tristram was Head of Human Resources for Global Functions and Operations & Technology at HSBC, as well as Group Head of Performance and Reward. Previously, he was Group Reward and Policy Director for Vodafone Group plc. Tristram began his career in consulting. He became a partner with Arthur Andersen in 2001 and was subsequently a partner with both Deloitte and KPMG.
Taalib Shaah, Group Chief Risk Officer
Taalib Shaah is Group Chief Risk Officer for Barclays, based in London. He is responsible for helping to define, set and manage the risk profile of the bank and leads the risk management organisation across the group. He is a member of the Group Executive Committee. Taalib joined Barclays in late 2014 as Chief Risk Officer for the Investment Bank and in 2017 assumed the role of Chief Risk Officer for Barclays International (BBPLC), responsible for the Corporate and Investment Bank, the Private Bank and the Cards & Payments business. He assumed his current role in October 2020. Prior to Barclays, Taalib spent four years at Citigroup where he was most recently Chief Risk Officer for Market Risk, Real Estate Credit, Treasury, Private Equity and Head of Model Validation. Previously, Taalib spent 17 years at Credit Suisse, working in various areas, including risk and the front office. He began his career at Ernst and Young.
Stephen Shapiro, Group General Counsel and Company Secretary
Stephen previously served as the Group Company Secretary and Deputy General Counsel of SABMiller plc. Prior to this, he practised law as a partner in a law firm in South Africa, and subsequently in corporate law and M&A at Hogan Lovells in the UK. He was appointed as Group Company Secretary of Barclays in November 2017 and was subsequently appointed Group General Counsel in August 2020, in addition to his role as Company Secretary. Stephen is an active industry contributor and serves as a member of the GC100 Executive Committee, the association of General Counsel and Company Secretaries working in FTSE 100 companies, having previously served as Vice Chair until January 2022. Stephen also previously served as Chairman of the ICC UK’s Committee on Anti-Corruption.
Sasha Wiggins, Group Head of Public Policy and Corporate Responsibility
Sasha Wiggins is the Group Head of Public Policy and Corporate Responsibility at Barclays, based in London. She is a member of the bank’s Group Executive Committee. Sasha is responsible for leading Barclays’ efforts in tackling climate change, and for integrating the bank’s ambition and commitments to help accelerate the transition to a low-carbon economy into the business. She also has accountability for the bank’s sustainability and citizenship agendas, and for ensuring the company’s societal purpose is present in strategic decision-making at the highest levels in the organisation. In addition, Sasha has overall responsibility for Corporate Relations and Regulatory Relations, and is also Group Chief of Staff to the Group Chief Executive. Sasha joined Barclays in 2002, progressing through a number of roles in the Private Bank. In 2015, she was appointed CEO of Barclays Bank Ireland, overseeing the Corporate Banking and Wealth businesses in the region. She subsequently became Head of East and South East for UK Corporate Banking coverage in 2017 where she was responsible for developing and executing the bank’s strategy for the mid-corporate client segment. Sasha was appointed the Group Chief of Staff in 2018, and assumed her current role in May 2020, joining the Group Executive Committee. Sasha has significant experience of communicating with stakeholders, including C-suite clients, regulators, Government Ministers, as well as the media. She is a fellow of the Chartered Institute for Securities & Investment and has over 20 years investment experience. Sasha also dedicates considerable time and energy to the diversity agenda, speaking at many internal and external events.
Repurchase of shares
MonthPeriodTotal Shares PurchasedAverage Price Paid Per Share (pence)Total Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Number (or Approximate GBP Value) of Shares that May Yet be Purchased Under the Plans or Programs
Jan-21Month 1
Feb-21Month 2£700,000,000 
Mar-21Month 3142,567,773183.32p142,567,773£438,642,389 
Apr-21Month 4234,788,978186.82p377,356,751£ 
May-21Month 5
Jun-21Month 6
Jul-21Month 7£500,000,000 
Aug-21Month 880,240,000181.78p457,596,751£354,138,380 
Sep-21Month 973,323,060181.94p530,919,811£220,737,358 
Oct-21Month 1039,152,859197.36p570,072,670£143,465,034 
Nov-21Month 1174,271,728193.16p644,344,398£ 
Dec-21Month 12

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
322

Additional information



Section 13(r) to the US Securities Exchange Act of 1934 (Iran sanctions and related disclosure)
Section 13(r) of the U.S. Securities Exchange Act of 1934 as amended (the “Exchange Act”) requires each SEC reporting issuer to disclose in its annual and, if applicable, quarterly reports whether it or any of its affiliates have knowingly engaged in certain activities, transactions or dealings relating to Iran or with the Government of Iran or certain designated natural persons or entities involved in terrorism or the proliferation of weapons of mass destruction during the period covered by the report. The requirement includes disclosure of activities not prohibited by U.S. or other law even if conducted outside the U.S. by non-U.S. companies or affiliates in compliance with local law. Pursuant to Section 13(r) of the Exchange Act we note the following in relation to activity occurring in 2021, the period covered by this annual report, or in relation to activity we became aware of in 2021 relating to disclosable activity prior to the reporting period. Except as noted below, Barclays intends to continue the activities described. Barclays does not allocate profits at the level of these activities, which in any event would not be significant, and we therefore report only gross revenue where measurable. Barclays attributed revenue of approximately GBP 14,290 in relation to the activities disclosed below.
Legacy Guarantees
Between 1992 and 2006, Barclays entered into several guarantees for the benefit of Iranian banks in connection with the supply of goods and services by Barclays customers to Iranian buyers (the “Iranian guarantees”). These were counter guarantees issued to Iranian banks to support guarantees issued by these banks to the Iranian buyers. The Iranian banks and a number of the Iranian buyers were either subsequently designated as Specially Designated Nationals and Blocked Persons (“SDN”) by the U.S. Department of the Treasury, Office of Foreign Assets Control (“OFAC”), or are owned by the Government of Iran. In addition, between 1993 and 2005, Barclays entered into similar guarantees for the benefit of a Syrian bank that was subsequently designated pursuant to the Weapons of Mass Destruction Proliferators Sanctions Regulations (“WMDPSR”) in August 2011 (the “WMDPSR guarantees”).
These guarantees were issued either on:
i.an “extend or pay” basis, which means that, although the guarantee is of limited duration on its face, until there is full performance under the contract to provide goods and services, the terms of the guarantee require Barclays to maintain the guarantee or pay the beneficiary bank the full amount of the guarantee; or
ii.the basis that Barclays obligations can only be discharged with the consent of the beneficiary counterparty.
Barclays is not able to exit its obligations under the above guarantees unilaterally, and thus it maintains a limited legacy portfolio of these guarantees, which were in compliance with applicable laws and regulations at the time they were entered into. Barclays intends to terminate the guarantees where an agreement can be reached with the counterparty, in accordance with applicable laws and regulations. Barclays attributed no revenue in 2021 in relation to the Iranian guarantees. Barclays attributed revenue of approximately GBP 14,000 in 2021 in relation to the WMDPSR guarantees.
Lease Payments
Barclays is party to a long-term lease, entered into in 1979, with the National Iranian Oil Company (“NIOC”), pursuant to which Barclays rents part of NIOC House in London for a Barclays branch. The lease is for 60 years, contains no early termination clause, and has 18 years remaining. Barclays makes quarterly lease payments in GBP to the bank account of an entity that is owned by the Government of Iran. This bank account is maintained with an Iranian SDN bank that is ultimately owned by the Government of Iran. The payments are made in accordance with applicable laws and regulations. Barclays attributed no revenue in 2021 in relation to this activity.
Local Clearing Systems
Banks based in the United Arab Emirates (“UAE”), including certain Iranian SDN banks, participate in the various banking payment and settlement systems used in the UAE (the “UAE Clearing Systems”). Barclays, by virtue of its banking activities in the UAE, participates in the UAE Clearing Systems, in accordance with applicable laws and regulations. In order to mitigate the risk of engaging in transactions in which participant Iranian SDN banks may be involved, Barclays has implemented restrictions relating to its involvement in the UAE Clearing Systems. Barclays attributed no revenue in 2021 in relation to this activity.
Banks based in the United Arab Emirates (“UAE”), including certain Iranian banks that are SDNs, participate in the various banking payment and settlement systems used in the UAE (the “UAE Clearing Systems”). Barclays, by virtue of its banking activities in the UAE, participates in the UAE Clearing Systems, in accordance with applicable laws and regulations. In order to mitigate the risk of engaging in transactions in which participant Iranian SDN banks may be involved, Barclays has implemented restrictions relating to its involvement in the UAE Clearing Systems. Barclays attributed no revenue in 2020 in relation to this activity.
Payments Notified
A Barclays customer was designated pursuant to the Global Terrorism Sanctions Regulations (“GTSR”) in March 2016. Barclays continued to receive credit card repayments from this customer in accordance with applicable laws and regulations. A block continues to be applied to the card to prevent any further spending. Barclays attributed revenue of approximately GBP 115 in 2021 in relation to this activity.
Barclays maintains a customer relationship with a UK-incorporated medical manufacturing company. In 2021, Barclays processed a number of payments, for the benefit of our customer, relating to the export of medical devices to a privately-owned Iranian entity. The end users of these medical devices include hospitals, medical universities, or clinics that may be owned or controlled by, or affiliated with, the Government of Iran. The payments were made in accordance with applicable laws and regulations and all payments were received from the privately-owned Iranian entity; no payments were received directly from any SDN or entity owned or controlled by, or affiliated with, the Government of Iran. Although OFAC has issued general licenses relating to the sale of medical devices to Iran, these licenses do not apply to sales of non-U.S. origin items by non-U.S. persons. Barclays attributed revenue of approximately GBP 120 in 2021 in relation to this activity.
Barclays maintains customer relationships with several individuals who are employed by a UK-based SDN entity that is ultimately owned by the Government of Iran. Payments are received in GBP from a UK-based payment services company and are credited to the customers’ accounts with Barclays. The payments are processed in accordance with applicable laws and regulations. No payments are received directly from any entity owned by the Government of Iran or any SDN. Barclays attributed no revenue in 2021 in relation to this activity.
Barclays maintains a relationship with Her Majesty's Revenue & Customs, a UK Government agency, which receives funds from Iranian SDN banks in relation to the settlement of tax liabilities with the UK Government. The payments were processed in accordance with applicable laws and regulations. Barclays attributed revenue of approximately GBP 25 in 2021 in relation to this activity.
Barclays processed a number of payments to embassies of the Government of Iran in Europe in relation to customers paying fees for renewing or replacing passports, visa applications, and other administrative matters. The payments were processed in accordance with applicable laws and regulations. Barclays attributed no revenue in 2021 in relation to this activity.
Barclays maintains a customer relationship with a UK-incorporated charity that works in the areas of blood cancer and stem cell transplantation. In 2021, Barclays processed one EUR payment, on behalf of our customer, where the ultimate beneficiary of the payment was a medical organization affiliated with the Government of Iran. The payment was for the procurement of a blood sample from an individual in Iran, and the associated injections, medical testing, advice, and assessments. The payment was processed in accordance with applicable laws and regulations. Barclays attributed revenue of approximately GBP 10 in 2021 in relation to this activity.
In June 2021, a Barclays customer was designated pursuant to the GTSR. The customer had two accounts with Barclays, with total balances of less than GBP 15, both of which were inactive since 2015. Barclays exited the relationship with the customer, placed the nominal funds in an internal sundry account, and closed the accounts. Barclays attributed no revenue in 2021 in relation to this activity.
In 2021, Barclays processed one GBP payment from a law firm in Germany to a law firm in the UK, which is a customer of Barclays. The German law firm is representing an Iranian SDN airline, ultimately owned by the Government of Iran, in arbitration proceedings in France. The payment was for legal advice provided by the Barclays law firm customer to the German law firm in relation to the proceedings. The payment was processed in accordance with applicable laws and regulations. Barclays attributed revenue of approximately GBP 10 in 2021 in relation to this activity.
In 2020, Barclays processed one USD payment identified in 2021 as being on behalf of a Barclays MSB customer’s client that was affiliated with an entity designated pursuant to the GTSR. Barclays attributed revenue of approximately GBP 10 in 2020 in relation to this activity.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
323

Additional information

Summary of Barclays Group share and cash plans and long-term incentive plans
Barclays operates a number of share, cash and long-term incentive plans. The principal plans used for awards made in or, in respect of, the 2021 performance year are shown in the table below. Awards are granted by the Barclays PLC Board Remuneration Committee (the “Committee”), and are subject to the applicable plan rules (as amended from time to time). Share awards are granted over ordinary shares in Barclays PLC (“Shares”). Barclays has a number of employee benefit trusts which operate in conjunction with these plans. In some cases the trustee purchases Shares in the market to satisfy awards; in others, new issue or treasury Shares may be used to satisfy awards where the appropriate shareholder approval has been obtained.
Summary of principal share and cash plans and long-term incentive plans
Name of planEligible employeesExecutive Directors eligibleDeliveryDesign details
Deferred Share Value Plan (DSVP)All employees (excluding Directors)NoDeferred Share awards, typically released in instalments over a three, five or seven year period, dependent on future service and subject to malus provisions
Plan typically used for mandatory deferral of a proportion of bonus into Shares where bonus is above a threshold (set annually by the Committee).
This plan typically works in tandem with the CVP (below).
DSVP awards vest over three, five or seven years dependent on future service.
Vesting is subject to malus, suspension provisions and the other provisions of the rules of the DSVP.
For awards granted before 2018, dividend equivalents may be released based on the number of Shares under award that are released.
On cessation of employment, eligible leavers (as set out in the rules of the DSVP) normally remain eligible for release (on the scheduled release dates) subject to the Committee and/or trustee discretion. For other leavers, awards will normally lapse.
On change of control, awards may vest at the Committee’s and/or trustee’s discretion.
For DSVP awards made to Material Risk Takers (“MRTs”), a holding period of either 6 or 12 months will apply to Shares (after tax) on release.
Share Value Plan (SVP)All employees (including executive Directors)YesDeferred Share awards, typically released in instalments over a three, five or seven year period, dependent on future service and subject to malus provisions
The SVP is in all material respects the same as the DSVP described above. The principle differences are that (i) executive Directors may only participate in the SVP and (ii) under the DSVP, if a MRT whose award is deferred over five or seven years resigns after the third anniversary of grant, they will automatically be treated as an eligible leaver in respect of any unvested tranches of that award.
Cash Value Plan (CVP)All employees (including Executive Directors)YesDeferred cash award typically released in instalments over a three, five or seven year period, dependent on future service and subject to malus provisions
The CVP is typically used for mandatory deferral of a proportion of bonus where bonus is above a threshold (set annually by the Committee.
This plan typically works in tandem with the DSVP.
CVP awards vest over three, five or seven years dependent on future service.
Vesting is subject to malus, suspension provisions and the other provisions of the rules of the CVP.
Participants granted awards before 2020 may be awarded a service credit of 10% of the initial value of the award on the third anniversary of a grant.
Change of control and leaver provisions are as for DSVP.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
324

Additional information



Barclays Long Term Incentive Plan (LTIP)Selected employees (including executive Directors)YesAwards over Shares subject to risk-adjusted performance conditions and malus provisions
Awarded on a discretionary basis with participation reviewed by the Committee.
Awards only vest if the risk-adjusted performance conditions are satisfied over a three year period.
LTIP awards vest over seven years dependent on future service.
Vesting is subject to malus, suspension provisions and the other provisions of the rules of the LTIP.
Any Shares released under the LTIP award (after payment of tax) will be subject to an additional holding period of no less than the minimum regulatory requirements (currently 12 months).
On cessation of employment, eligible leavers normally remain eligible for release (on the scheduled release dates) pro-rated for time and performance. For other leavers, awards will normally lapse.
On change of control, awards may vest at the Committee’s discretion.
SharesaveAll employees in the UK and IrelandYesOptions over Shares at a discount of 20%, with Shares delivered or cash value of savings returned after three to five years
HMRC tax advantaged plan in the UK and approved by the Revenue Commissioners in Ireland.
Opportunity to purchase Shares at a discount price (currently a 20% discount) set on award date with savings made over three or five year term.
Maximum individual savings of £300 per month or the Euro equivalent in Ireland.
On cessation of employment, eligible leavers may exercise options and acquire Shares to the extent of their savings for six months.
On change of control, participants may exercise options and acquire Shares to the extent of their savings for six months.
SharepurchaseAll employees in the UKYesShares purchased from gross salary deductions and Dividend/Matching Shares are held in trust for three to five years
HMRC tax advantaged plan in the UK.
Participants may purchase up to £1,800 of Shares each tax year (“Partnership Shares”).
Barclays matches the first £600 of Partnership Shares on a one for one basis for each tax year (“Matching Shares”).
Dividends received are awarded as Dividend Shares.
Partnership Shares may be withdrawn at any time (though if removed prior to three years from award, the corresponding Matching Shares are forfeited).
Depending on reason for and timing of leaving, Matching Shares may be forfeited.
On change of control, participants are able to instruct the Sharepurchase trustee how to act or vote on their behalf in relation to their Shares.
Global SharepurchaseEmployees in certain non-UK jurisdictionsYesShares purchased from net salary deductions and Dividend/Matching Shares are held in trust for three to five years
Global Sharepurchase is an extension of the Sharepurchase plan (above).
Operates in substantially the same way as Sharepurchase but without the tax advantages.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
325

Additional information

Environmental, Social and Governance (ESG)
Our approach to environmental and social issues is becoming increasingly integrated in the work we do across our business and is subject to the governance and oversight of our management and Board structures.
The ESG section sets out an overview of our approach to ESG, including how we think about, and measure, our environmental and social impact. Our approach is informed by our engagement with our stakeholders, including with customers and clients, colleagues, investors, regulators and wider society.
Say on Climate
In line with our commitment to offer shareholders a ‘Say on Climate’, we will be publishing an update on our climate strategy, targets and methodology in advance of the 2022 Annual General Meeting. This will include 2030 targets for two new sectors, Cement and Metals (Steel).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
326

Additional information



Our strategy
Our universal bank model provides us with strength and stability, and we have priorities to sustain and grow our business.

Strategic priorities to sustain and grow

1. Deliver next-generation, digitised consumer businesses
As technology transforms consumer financial services, we are building and delivering improved products and services for our customers, leveraging our payments interconnection and improving our efficiency.
Investing in digital capabilities to improve service for customers and unlock new sources of income:
accelerating digital access and adoption, while ensuring we do not leave customers behind
building more cost-effective infrastructure
using the quality and scale of our data to better understand customer needs, anticipate trends and deliver more competitive products and services.
Realising value from investment in Payments across the Group.
Expanding unsecured lending in the UK, US and Europe through Corporate partnerships.
Create a competitive Wealth franchise to efficiently service our customers’ evolving needs.

2. Deliver sustainable growth for the CIB
As the capital markets grow, we will seek to maintain our market position as a top six1 global investment bank while investing in new capabilities for our clients.
Building consistent strength in investment banking, expanding in new economy sectors, Equity business and M&A.
Prioritising digital investment to ensure we are an electronic first markets business, while growing our share in Securitised Products and Macro Rates, FX, and EM.
Capture greater client flow in Equities and disrupt Prime financing.
Broaden corporate banking product capability, particularly in Europe and US.
Selectively expand the CIB internationally, including in the Middle East and China.

3. Capture opportunities as we transition to a low-carbon economy
We want to be alongside customers and clients as they transition to a low-carbon economy, using our advisory and financial expertise to help them navigate this period of extraordinary change.
Using our financial and capital markets expertise to support the scale-up of low-carbon technologies, infrastructure and capacity.
Supporting clients to decarbonise by providing advice and finance, including supporting transition away from fossil fuels.
Continuing to develop green and sustainable banking products, including green mortgages, bonds, loans and investment funds.
Investing equity capital in sustainability-focused start-ups with growth potential.
Continuing to make progress to become a net zero bank by 2050, including aligning all of our financing to the goals of the Paris Agreement.

Note
1 Top 6 Global Investment Bank supported by #6 ranking in Investment Banking (Source : Dealogic) and #6 ranking in Global Markets (Source : Coalition Greenwich, FY21 Preliminary Competitor analysis)
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
327

Additional information

Our climate strategy
Addressing climate change is an urgent and complex challenge. It requires a fundamental transformation of the global economy, so that society stops adding to the total amount of Greenhouse Gases (GHG) in the atmosphere. The financial sector has a critical role to play in supporting the economy to reach this goal. It is estimated that at least $3-5 trillion1 of additional investment will be needed each year, for the next 30 years, in order to finance the transition. At Barclays, we are determined to play our part. In March 2020, we announced our ambition to be a net zero bank by 2050, becoming one of the first banks to do so. We have a strategy, in three parts, to turn that ambition into action:

1. Achieving net zero operations
As part of our ambition to be a net zero bank by 2050, Barclays is working to achieve net zero operations. Barclays has been carbon neutral2 for its scope 1,3 scope 24 and scope 3 (business travel) emissions since 2020. We intend to remain carbon neutral, while investing in the continued decarbonisation of our operations.
We are defining net zero operations as the state in which we will achieve a GHG reduction of our scope 1 and scope 2 emissions of at least 90% against a 2018 baseline and use carbon removals to neutralise any limited operational emissions that we cannot yet eliminate.
2. Reducing our financed emissions
Most of our emissions result from the activities of the clients that we finance and those generated in their respective value chains. These are so-called ‘financed emissions’ and fall within the general definition of scope 3 emissions.
In November 2020, we published details of our strategy for measuring and managing alignment of our financing with the goals and timelines of the Paris Agreement. Our approach is underpinned by BlueTrack™,5 a methodology we have developed for measuring our financed emissions and tracking them at a portfolio level against the goals of the Paris Agreement. BlueTrack builds on and extends existing industry approaches to cover not only lending but also capital markets financing. This better reflects the breadth of our support for clients through our investment bank.
We are setting ambitious targets, informed by Paris-aligned benchmark scenarios, to reduce our financed emissions. We also have clear restrictions on financing certain energy sector activities, including relating to thermal coal, oil sands, hydraulic fracturing (‘fracking’) and projects in the Arctic Circle.
We have used BlueTrack™ to assess the financed emissions of our client portfolios in the Energy and Power sectors, prioritising these two sectors because they are responsible for up to three-quarters of all GHG emissions globally and because Barclays has meaningful exposure to them. Therefore, they represented the most appropriate starting place from which to make a significant difference. In November 2020, we set a target for a 30% reduction in the CO2 intensity of our Power portfolio by 2025, as well as a target for a 15% CO2 reduction in absolute emissions of our Energy portfolio by 2025.
3. Financing the transition
Barclays is providing the green and sustainable finance required to transform the economies we serve. We are channeling investment, including our own capital, into new green technologies and infrastructure project that will build up low-carbon energy capability.
Barclays continued to make progress in 2021 against our sustainable finance commitments to facilitate £150bn of social, environmental and sustainability-linked financing from 2018 to 2025; and to facilitating £100bn of green financing by 2030. On a cumulative basis, by year end 2021, we have facilitated a total of £193.3bn in social, environmental and sustainability-linked financing, since 2018. We facilitated £29.8bn of green financing in 2021, up 70% from £17.6bn in 2020 and comprised of:
labelled, 'use of proceeds' and business mix financing in environmental categories (£22.6bn in 2021), and
sustainability-linked financing that incorporates environmental performance targets (£7.2bn in 2021).
Managing climate-related risks
Our strategy is underpinned by the way we assess and manage our exposure to climate-related risk. From 2022, Climate Risk will be a Principal Risk under Barclays’ Enterprise Risk Management Framework.
Notes
1 “$3-5trn as estimated in the GFMA/BCG (Global Financial Markets Association/Boston Consulting Group) Climate Finance Markets and the Real Economy report, December 2020.
2 We are defining carbon neutral as first reducing carbon dioxide emissions then counterbalancing carbon dioxide emissions from scope 1, scope 2 and scope 3 (business travel) with carbon offsets.
3 Scope 1 emissions include our direct GHG emissions from natural gas, fuel oil, company cars and HFC refrigerants.
4 Scope 2 emissions include our indirect GHG emissions from purchased electricity and purchased steam and chilled water.
5 Further information and a detailed methodology white paper are available online, see home.barclays/sustainability/our-position-on-climate-change/bluetrack/.

Important information
In preparing the ESG section within the Form 20-F, we have:
i.made a number of key judgements, estimations and assumptions, and the processes and issues involved are complex. This is for example the case in relation to financed emissions, classification of environmental and social financing and operational emissions and measurement.
ii.used ESG and climate data, models and methodologies, that we consider to be appropriate and suitable for these purposes as at the date on which they were deployed. However, these data, models and methodologies are not of the same standard as those available in the context of other financial information, nor subject to the same or equivalent disclosure standards, historical reference points, benchmarks or globally accepted accounting principles. There is an inability to rely on historical data as a strong indicator of future trajectories, in the case of climate change and its evolution. Outputs of models, processed data and methodologies will also be affected by underlying data quality which can be hard to assess.
The data, models and methodologies used and the judgements, estimates or assumptions made are rapidly evolving and this may directly or indirectly affect the metrics, data points and targets contained in this section of the Form 20-F. We continue to review and develop our approach to data, models and methodologies in line with market principles and standards as this subject area matures. Further development of accounting and/or reporting standards could impact (potentially materially) the performance metrics, data points and targets referenced in this report. In future reports we may present some or all of the information for this reporting period using updated or more granular data or improved models, methodologies, market practices or standards. Such re-presented information may result in different outcomes than those included in this section of the Form 20-F. Where information is re-presented from time to time, we will identify this and (where we think it is appropriate) include an explanation. It is important for readers and users of this report to be aware that direct like-for-like comparisons of each piece of information disclosed may not always be possible from one reporting period to another.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
328

Additional information



Related undertakings
The Group’s corporate structure consists of a number of related undertakings, comprising subsidiaries, joint ventures, associates and significant other interests. A full list of these undertakings, the country of incorporation and the ownership of each share class is set out below. The information is provided as at 31 December 2021.
The entities are grouped by the countries in which they are incorporated. The profits earned by the activities of these entities are in some cases taxed in countries other than the country of incorporation, for example where the entity carries on business through a branch in a territory outside of that its country of incorporation . Barclays’ 2021 Country Snapshot provides details of where the Group carries on its business, where its profits are subject to tax and the taxes it pays in each country it operates in.
Wholly owned subsidiaries
Unless otherwise stated the undertakings below are wholly owned and consolidated by Barclays and the share capital disclosed comprises ordinary and/or common shares, 100% of the nominal value of which is held by the Group subsidiaries.
Notes
ADirectly held by Barclays PLC
BPartnership Interest
CMembership Interest
DTrust Interest
EGuarantor
FPreference Shares
GA Preference Shares
HB Preference Shares
IOrdinary/Common Shares in addition to other shares
JA Ordinary Shares
KB Ordinary Shares
LC Ordinary Shares
MF Ordinary Shares
NW Ordinary Shares
OFirst Preference Shares, Second Preference shares
PRegistered Address not in country of incorporation
QCore Shares, Insurance (Classified) Shares
RB, C, D, E, F, G, H, I and K Class Shares
SA Unit Shares, B Unit Shares
TNon-Redeemable Ordinary Shares
UA Shares – Tranche I, Premium – Tranche I, C Shares - Tranche II, Premium - Tranche II
VClass A, B, C, D, E, F, H, H2012 and J Ordinary Shares
WClass A and Class B Shares
XPEF Carry Shares
ZNot Consolidated (see Note 36 Structured entities)
AAUSD Linked Ordinary Shares
BBRedeemable Class B Shares
CCCapital Contribution Shares
DDNominal Shares
EEClass A Redeemable Preference Shares
FFClass B Redeemable Preference Shares
GGFirst Class Common Shares, Second Class Common Shares
HHEuro Preference Shares
IITracker 1 Euro, GBP, USD Shares, UDS Tracker 2 Shares, USD Tracker 3 Shares
Wholly owned subsidiariesNote
United Kingdom
– 1Churchill Place, London, E145HP
Aequor Investments Limited 
Ardencroft Investments Limited
B D & B Investments Limited
B.P.B. (Holdings) Limited
Barclay Leasing Limited 
Barclays Aldersgate Investments Limited
Barclays Asset Management Limited 
Barclays Bank PLCA, HH
Barclays Bank UK PLCA
Barclays Capital Asia Holdings Limited
Barclays Capital Finance Limited
Barclays Capital Japan Securities Holdings Limited
Barclays Capital Nominees (No.2) Limited 
Barclays Capital Nominees (No.3) Limited 
Barclays Capital Nominees Limited
Barclays Capital Securities Client Nominee Limited
Barclays Capital Securities LimitedF
Barclays CCP Funding LLPB
Barclays Converted Investments (No.2) Limited
Wholly owned subsidiariesNote
Barclays Direct Investing Nominees Limited
Barclays Directors Limited
Barclays Equity Holdings Limited
Barclays Execution Investment Services Limited
Barclays Execution Services LimitedA
Barclays Executive Schemes Trustees Limited
Barclays Financial Planning Nominee Company Limited
Barclays Funds Investments Limited
Barclays Global Shareplans Nominee Limited
Barclays Group Holdings Limited
Barclays Group Operations Limited (In Liquidation)
Barclays Industrial Development Limited
Barclays Industrial Investments Limited
Barclays Insurance Services Company Limited
Barclays International Holdings Limited 
Barclays Investment Management Limited 
Barclays Investment Solutions Limited
Barclays Leasing (No.9) Limited
Barclays Long Island Limited
Barclays Marlist Limited
Wholly owned subsidiariesNote
Barclays Nominees (George Yard) LimitedZ
Barclays Pension Funds Trustees LimitedZ
Barclays Principal Investments LimitedA, J, K
Barclays Private Bank 
Barclays SAMS Limited
Barclays Security Trustee Limited A
Barclays Services (Japan) Limited
Barclays Shea Limited
Barclays Singapore Global Shareplans Nominee Limited
Barclays Term Funding Limited Liability Partnership B
Barclays UK Investments Limited
Barclays Unquoted Investments Limited
Barclays Unquoted Property Investments Limited
Barclays Wealth Nominees Limited
Barclayshare Nominees Limited
Barcosec Limited
Barsec Nominees Limited
BB Client Nominees Limited
BMI (No.9) Limited
BNRI ENG 2014 Limited PartnershipB
BNRI ENG GP LLPB
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
329

Additional information

Wholly owned subsidiariesNote
BNRI England 2010 Limited PartnershipB
BNRI England 2011 Limited PartnershipB
BNRI England 2012 Limited PartnershipB
Carnegie Holdings LimitedI, J, K
Chapelcrest Investments Limited
Clydesdale Financial Services Limited
Cobalt Investments Limited
Cornwall Home Loans Limited
CPIA England 2009 Limited PartnershipB
CPIA England No.2 Limited PartnershipB
DMW Realty Limited
Dorset Home Loans Limited
Durlacher Nominees Limited 
Eagle Financial and Leasing Services (UK) Limited
Finpart Nominees Limited 
FIRSTPLUS Financial Group Limited 
Foltus Investments Limited
Global Dynasty Natural Resource Private B
Equity Limited Partnership
Globe Nominees Limited
Hawkins Funding Limited
Heraldglen Limited 
Isle of Wight Home Loans Limited
J.V. Estates Limited
Kirsche Investments Limited
Long Island Assets Limited
Maloney Investments Limited
Menlo Investments Limited
Mercantile Credit Company Limited
Mercantile Leasing Company (No.132) Limited
MK Opportunities LPB
Murray House Investment Management Limited
(In Liquidation)
Naxos Investments Limited
North Colonnade Investments Limited
Northwharf Investments LimitedX
Northwharf Nominees Limited
Radbroke Mortgages UK Limited
Real Estate Participation Management Limited
Real Estate Participation Services Limited
Relative Value Investments UK Limited Liability PartnershipB
Relative Value Trading Limited
Roder Investments No. 1 LimitedII
Roder Investments No. 2 LimitedII
RVT CLO Investments LLPB
Solution Personal Finance Limited
Surety Trust Limited
Sustainable Impact Capital Limited
Swan Lane Investments Limited
US Real Estate Holdings No.1 Limited
US Real Estate Holdings No.2 Limited
US Real Estate Holdings No.3 Limited
US Real Estate Holdings No.4 Limited
US Real Estate Holdings No.5 Limited
US Real Estate Holdings No.6 Limited
Wedd Jefferson (Nominees) Limited
Westferry Investments Limited
Woolwich Homes Limited
Woolwich Qualifying Employee Share
Ownership Trustee Limited
Zeban Nominees Limited
Wholly owned subsidiariesNote
Hill House, 1 Little New Street, London, EC4A 3TR
Barclays Nominees (Branches) Limited (In
Liquidation)
Gerrard Management Services Limited (In Liquidation)
Lombard Street Nominees Limited (In Liquidation)
Barclays (Barley) Limited (In Liquidation)J
- 5 The North Colonnade, London, E14 4BB
Leonis Investments LLPB
- Aurora Building, 120 Bothwell Street, Glasgow, G2 7JS
R.C. Grieg Nominees Limited
- 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ
BNRI PIA Scot GP Limited
BNRI Scots GP, LLPB
Pecan Aggregator LPB, Z
-Logic House, Waterfront Business Park, Park, FleetRoad,Fleet, GU513SB
The Logic Group Enterprises Limited
The Logic Group Holdings LimitedJ
- 9, allée Scheffer, L-2520, Luxembourg
Barclays Claudas Investments PartnershipB, P
Barclays Pelleas Investments Limited PartnershipB, P
Barclays Blossom Finance General Partnership B, P
- 745 Seventh Avenue, New York NY 10019
Alynore Investments Limited PartnershipB, P
Argentina
- 855 Leandro N.Alem Avenue, 8th Floor,
Buenos Aires
Compañía Sudamerica S.A.
- Marval, O’Farrell & Mairal, Av. Leandro N.
Alem 882, Buenos Aires, C1001AAQ
Compañia Regional del Sur S.A.
Brazil
- Av. Brigadeiro Faria Lima, No. 4.440, 12th
Floor, Bairro Itaim Bibi, Sao Paulo, CEP,
04538-132
Barclays Brasil Assessoria Financeira Ltda
BNC Brazil Consultoria Empresarial Ltda
Canada
- 333 Bay Street, Suite 4910, Toronto ON M5H 2R2
Barclays Capital Canada Inc.
- Stikeman Elliot LLP, 199 Bay Street, 5300
Commerce Court West, Toronto ON M5L 1B9
Barclays Corporation Limited
- 5 The North Colonnade London, E14 4BB
CPIA Canada HoldingsB, P
Wholly owned subsidiariesNote
Cayman Islands 
Maples Corporate Services Limited, PO Box 309, Ugland House, George Town, Grand Cayman, KY1-1104
Alymere Investments Limited
Analytical Trade UK Limited
Barclays Capital (Cayman) Limited
Barclays Securities Financing LimitedG,H, I
Barclays US Holdings LimitedJ, F
Braven Investments No.1 Limited
Calthorpe Investments Limited
Capton Investments Limited
Claudas Investments LimitedI,EE,FF
Claudas Investments Two Limited
CPIA Investments No.1 Limited (In Liquidation)V
CPIA Investments No.2 Limited
Gallen Investments Limited
Hurley Investments No.1 Limited
JV Assets LimitedL
Mintaka Investments No. 4 Limited
OGP Leasing Limited
Palomino LimitedZ
Pelleas Investments Limited
Pippin Island Investments Limited
Razzoli Investments Limited F, I
RVH Limited F, I
Wessex Investments Limited
- Walkers Corporate Limited, Cayman Corporate Centre, 27 Hospital Road, George Town, KY1-9008
Long Island Holding B Limited
Germany
- TaunusTurm, Taunustor 1, 60310, Frankfurt
 Barclays Capital Effekten GmbH (In Liquidation)
- Stuttgarter Straße 55-57, 73033 Göppingen
Holding Stuttgarter Straße GmbH (In Liquidation)
Guernsey
-P.O. Box 33, Dorey Court, Admiral Park, St. Peter Port, GY1 4AT
Barclays Insurance Guernsey PCC LimitedQ
-PO BOX 41, Floor 2, Le Marchant House, Le Truchot, St Peter Port, GY1 3BE
Barclays Nominees (Guernsey) Limited
(In Liquidation)
Hong Kong
-42nd floor Citibank Tower, Citibank Plaza, 3 Garden Road
Barclays Bank (Hong Kong Nominees) Limited
(in Liquidation)
Barclays Capital Asia Nominees Limited (In
Liquidation)
- Level 41, Cheung Kong Center, 2 Queen's Road, Central
Barclays Capital Asia Limited
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
330

Additional information



Wholly owned subsidiariesNote
India
- 208 Ceejay House, Shivsagar Estate, Dr A Beasant Road, Worli, Mumbai, 400 018
Barclays Securities (India) Private Limited
Barclays Wealth Trustees (India) Private Limited
- 5th to 12th Floor (Part), Building G2, Gera Commerzone SEZ, Survey No.65, Kharadi, Pune, 411014
Barclays Global Service Centre Private Limited
- Level 10, Block B6, Nirlon Knowledge Park, Off Western Express Highway, Goregaon, (East) Mumbai, 400063
Barclays Investments & Loans (India) Private Limited F. I
Ireland
- One Molesworth Street, Dublin 2, D02RF29
Barclaycard International Payments Limited
Barclays Bank Ireland Public Limited Company
Barclays Europe Client Nominees Designated Activity Company Z
Barclays Europe Firm Nominees DesignatedZ
Activity Company
Barclays Europe Nominees Designated Z
Activity Company
- 25-28 North Wall Quay, Dublin 1, D01H104
Erimon Home Loans Ireland Limited
-70 Sir John Rogerson’s Quay, Dublin 2
Barclays Finance Ireland Limited
Isle of Man
- P O Box 9, Victoria Street, Douglas, IM99 1AJ
Barclays Nominees (Manx) Limited
Barclays Private Clients International LimitedJ, K
-2nd Floor, St Georges Court, Upper Church Street, Douglas, IM1 1EE
Barclays Holdings (Isle of Man) Limited (In Liquidation)
Japan
- 10-1, Roppongi 6-chome, Minato-ku, Tokyo
Barclays Funds and Advisory Japan Limited
Barclays Securities Japan LimitedI, G
Barclays Wealth Services Limited
Jersey
- 2nd Floor, Gaspé House, 66-72 Esplanade, St. Helier, JE1 1GH
Barclays Services Jersey Limited
- 5 Espalanade, St Helier, JE2 3QA
Barclays Wealth Management Jersey Limited
BIFML PTC Limited
- 13 Library Place, St Helier, JE4 8NE
Barclays Nominees (Jersey) LimitedZ
Barclaytrust Channel Islands LimitedZ
- Estera Trust (Jersey) Limited, 13-14 Esplanade, St Helier, JE1 1EE
MK Opportunities GP Ltd
Korea, Republic of
- A-1705 Yeouido Park Center, 28-3 Yeouido-dong, Yeongdeungpo-gu, Seoul
Barclays Korea GP Limited
Wholly owned subsidiariesNote
Luxembourg
- 9, allée Scheffer, L-2520
Barclays Alzin Investments S.à r.l.W
Barclays Bayard Investments S.à r.l.J, K
Barclays Bedivere Investments S.à r.l.
Barclays Bordang Investments S.à r.l.W
Barclays BR Investments S.à r.l. 
Barclays Cantal Investments S.à r.l.
Barclays Capital Luxembourg S.à r.l.
Barclays Capital Trading Luxembourg S.à r.l.W
Barclays Claudas Investments S.à r.l.
Barclays Equity Index Investments S.à r.l.
Barclays International Luxembourg Dollar
Holdings S.à r.l.
Barclays Lamorak Investments S.à r.l.T
Barclays Leto Investments S.à r.l.
Barclays Luxembourg EUR Holdings S.à r.lT
Barclays Luxembourg Finance S.à r.l.
Barclays Luxembourg GBP Holdings S.à r.l.T
Barclays Luxembourg Global Funding S.à r.l.
Barclays Luxembourg Holdings S.à r.l.I, AA
Barclays Luxembourg Holdings SSCB
Barclays Pelleas Investments S.à r.l.
- 68-70 Boulevard de la Petrusse, L-2320
Adler Toy Holding Sarl
-10 rue du Cha'teau d'Eau, Leudelange, L-3364
BPM Management GP SARL
Mauritius
C/O Rogers Capital Corporate Services Limited, 3rd Floor, Rogers House, No.5 President John Kennedy Street, Port Louis
Barclays Capital Mauritius Limited (In Liquidation)
Barclays Capital Securities Mauritius Limited
- Fifth Floor, Ebene Esplanade, 24 Cybercity, Ebene
Barclays Mauritius Overseas Holdings Limited
Mexico
- Paseo de la Reforma 505, 41 Floor, Torre Mayor, Col. Cuauhtemoc, CP 06500
Barclays Bank Mexico, S.A.K, M
Barclays Capital Casa de Bolsa, S.A. de C.V.K, M
Grupo Financiero Barclays Mexico, S.A. de C.V.K, M
Servicios Barclays, S.A. de C.V.
Monaco
- 31 Avenue de la Costa, Monte Carlo BP 339
Barclays Private Asset Management (Monaco) S.A.M
Saudi Arabia
- 3rd Floor Al Dahna Center, 114 Al-Ahsa Street, PO Box 1454, Riyadh 11431
Barclays Saudi Arabia (In Liquidation)
Singapore 
- 10 Marina Boulevard, #25-01 Marina Bay Financial Centre, Tower 2, 018983
Barclays Capital Futures (Singapore) Private
Limited (In Liquidation)
Barclays Capital Holdings (Singapore) Private
Limited (In Liquidation)
Barclays Merchant Bank (Singapore) Ltd.
Wholly owned subsidiariesNote
Spain
- Calle Jose, Abascal 51, 28003, Madrid
Barclays Tenedora De Inmuebles SL.
BVP Galvani Global, S.A.U.
Switzerland
- Chemin de Grange Canal 18-20, PO Box 3941, 1211, Geneva
Barclays Bank (Suisse) SA
Barclays Switzerland Services SA
BPB Holdings SA
United States
 - Corporation Service Company, 251 Little Falls Drive, Wilmington, DE 19808
Analytical Trade Holdings LLC
Analytical Trade Investments LLCBB
Barclays Bank Delaware
Barclays Capital Derivatives Funding LLCC
Barclays Capital Energy Inc.
Barclays Capital Equities Trading GPB
Barclays Capital Holdings Inc. H, I
Barclays Capital Real Estate Finance Inc.
Barclays Capital Real Estate Holdings Inc.
Barclays Capital Real Estate Inc.
Barclays Commercial Mortgage Securities LLCC
Barclays Dryrock Funding LLCC
Barclays Electronic Commerce Holdings Inc.
Barclays Financial LLCC
Barclays Group US Inc.
Barclays Oversight Management Inc.
Barclays Receivables LLCC
Barclays Services Corporation
Barclays Services LLCC
Barclays US CCP Funding LLCC
Barclays US Investments Inc.J, K
Barclays US LLC
BCAP LLCC
Crescent Real Estate Member LLCC
Curve Investments GPB
Gracechurch Services Corporation
Lagalla Investments LLC
Long Island Holding A LLCC
LTDL Holdings LLCC
Marbury Holdings LLC
Preferred Liquidity, LLCJ
Procella Investments No.2 LLCC
Procella Investments No.3 LLCC
Relative Value Holdings, LLC
Surrey Funding Corporation
Sussex Purchasing Corporation
Sutton Funding LLCC
TPProperty LLCC
US Funding (VISA B Acquisition) LLCC
US Secured Investments LLCCC
Verain Investments LLC
Wilmington Riverfront Receivables LLCJ, K
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
331

Additional information

Wholly owned subsidiariesNote
- Aon Insurance Managers, 76 Paul Street Suite, 500, Burlington VT 05401
Barclays Insurance U.S. Inc.
-Corporation Service Company, 80 State Street, Albany, NY, 12207-2543
Barclays Equity Holdings Inc.
- Corporation Service Company, 100 Pearl Street, 17th Floor, MC-CSC1, Hartford, CT 06103
Barclays Capital Inc.
Glenwood Ave, Suite 550, Raleigh, NC, 27608
Barclays US GPF Inc.
Equifirst Corporation (In Liquidation)
Zimbabwe
-2 Premium Close, Mount Pleasant Business Park Park, Mount Pleasant, Harare
Branchcall Computers (Pvt) Limited
Other Related Undertakings
Unless otherwise stated, the undertakings below are consolidated and the share capital disclosed comprises ordinary and/or common shares which are held by subsidiaries of the Group. The Group’s overall ownership percentage is provided for each undertaking.
Other Related Undertakings%Note
United Kingdom
– 1 Churchill Place, London, E14 5HP
Barclaycard Funding PLC75.00J
PSA Credit Company Limited (In Liquidation)50.00J, L
Barclays Covered Bond Funding LLP (In Liquidation)50.00B
Barclays Covered Bonds Limited
Liability Partnership50.00B
– St Helen’s, 1 Undershaft, London, EC3P 3DQ
Igloo Regeneration (General Partner) Limited25.00L, Z
– 3-5 London Road, Rainham, Kent, ME8 7RG
Trade Ideas Limited20.00Z
– 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ
Equistone Founder Partner II L.P.20.00B, Z
Equistone Founder Partner III L.P.35.00B, Z
– Enigma, Wavendon Business Park Milton Keynes, MK178LX
19.50Z
Intelligent Processing Solutions Limited
– 65A Basinghall Street, London, EC2V 5DZ
Cyber Defence Alliance Limited25.00E, Z
–C/o BDP LLP, Two Snow Hill, Queensway, Birmingham, B4 6GA
GW City Ventures Limited (In Liquidation)50.00K, Z
GN Tower Limited (In Liquidation)50.00Z
– 55 Baker Street, London, W1U 7EU
Formerly H Limited (In Liquidation)70.32J,Z
– Haberfield Old Moor Road, Wennington, Lancaster, LA2 8PD
Full House Holdings Limited67.42J,Z
– 13-15 York Buildings, London, WC2N 6JU
Other Related Undertakings%Note
BGF Group PLC24.62Z
– Aurora House, 120 Bothwell Street, Glasgow, G2 7JT
Buchanan Wharf (Glasgow) Management Limited78.00E
- Aldwych House, 71-91 Aldwych
London, WC2B 4HN
Huntress Group Limited19.4J, Z
Korea, Republic of
– 18th Floor, Daishin Finance Centre, 343, Samil-daero, Jung-go, Seoul
Woori BC Pegasus Securitization Specialty Co., Limited70.00CC
Luxembourg
– 9, allee Scheffer, L-2520
BNRI Limehouse No.1 Sarl96.30R
Preferred Funding S.a r.l.33.33FF
Preferred Investments S.a r.l.33.33FF, I
Malta
– RS2 Buildings, Fort Road, Mosta MST 1859
RS2 Software PLC18.25Z
South Africa
- 9 Elektron Road, Techno Park, Stellenbosch 7600
Imalivest Mineral Resources LP66.63J, Z
United States of America
- Corporation Services Company, 251 Little Falls, Drive Wilmington, DE 19808
DG Solar Lessee, LLC75.00C, Z
-Corporation Trust Company, Corporation Trust Centre, 1209 Orange Street, Wilmington DE 19801
DG Solar Lessee II, LLC75.00C, Z
VS BC Solar Lessee I LLC50C, Z
Subsidiaries by virtue of control
The related undertakings below are Subsidiaries in accordance with s.1162 Companies Act 2006 as Barclays can exercise dominant influence or control over them.
Subsidiaries by virtue of control%Note
United Kingdom
– 1 Churchill Place, London, E14 5HP
Oak Pension Asset Management Limited0.00Z
Water Street Investments Limited0.00Z
Cayman Islands
– PO Box 309GT, Ugland House, South Church Street, Grand Cayman, KY1-1104
Hornbeam Limited0.00Z
Guernsey
- P.O. Box 33, Dorey Court, Admiral Park, St. Peter Port, GY1 4AT
Barclays UKRF No.1 IC Limited0.00Z
Barclays UKRF ICC Limited0.00Z
Joint Ventures
The related undertakings below are Joint Ventures in accordance with s. 18, Schedule 4, The Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 and are proportionally consolidated.
Joint Ventures%Note
United Kingdom
– All Saints Triangle, Caledonian Road, London, N1 9UT
Vaultex UK Limited50.00
Joint management factors
The Joint Venture Board comprises two Barclays representative Directors, two JV partner Directors and three non-JV partner Directors. The Board are responsible for setting the Company strategy and budgets.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
332

Additional unaudited information
Deposits
Deposits
Deposits include deposits from banks and customer accounts.
202120202019
Average for the year ended 31 December£m£m£m
Deposits at amortised cost
UK412,631 364,736 329,811 
Europe42,417 47,365 39,191 
Americas36,031 37,032 31,531 
Asia10,094 12,509 8,809 
Africa8,815 8,865 7,589 
Total deposits at amortised cost509,988 470,507 416,930 
202120202019
For the year ended 31 Decembera
£m£m£m
Deposits at amortised cost519,433481,036 415,788 
In offices in the United Kingdom:
Current and demand accounts
- interest free147,203 132,484 98,207 
- interest bearing46,997 40,543 34,362 
Savings accounts156,543 145,376 128,290 
Other time deposits - retail74,056 70,125 64,774 
Other time deposits - wholesale8,956 11,549 14,585 
Total repayable in offices in the United Kingdom433,755 400,077 340,218 
In offices outside the United Kingdom:
Current and demand accounts
- interest free17,186 15,309 10,613 
- interest bearing15,762 13,772 12,932 
Savings accounts15,055 14,940 14,110 
Other time deposits37,675 36,938 37,915 
Total repayable in offices outside the United Kingdom85,678 80,959 75,569 
Notes
aThe UK/Non-UK deposit analysis is based on the location of the office where the transactions are recorded.
bThe country analysis in the table above is based on the location of the counterparty with which the deposits at amortised cost are recorded.

Deposits at amortised cost in offices in the United Kingdom received from non-residents amounted to £38,999m (2020: £34,370m).
Of the deposits at amortised cost disclosed in the above table, there are uninsured deposits of £297,433m (2020: £270,036m; 2019: £234,788m) which are not insured through the UK Financial Services Compensation Scheme (FSCS) or other similar deposits schemes.

Uninsured other time deposits
202120202019
£m£m£m
3 months or less97,10589,22791,970
3 to 6 months11,97313,6557,519
6 to 12 months5,0666,2845,126
12 months and over2,0152,3293,140
Total116,160111,495107,756
As at 31 December 2021, £263m (2020: £649m; 2019: £869m) of U.S. time deposits were in excess of the Federal Deposit Insurance Corporation insurance limit.

Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
333

Additional unaudited information
Average deposits at amortised cost and the average interest rate paid
The following tables present average deposits at amortised cost and their associated interest expense by deposit type.
Average deposits at amortised costInterest expenseAverage interest rate
For the year ended 31 December 2021£m£m%
Current and demand accounts
- interest free154,338   
- interest bearing61,987 59 0.1 
Savings accounts170,312 249 0.1 
Other time deposits - retail20,166 40 0.2 
Other time deposits - wholesale103,185 213 0.2 
Total 509,988 561 0.1 

Average deposits at amortised costInterest expenseAverage interest rate
For the year ended 31 December 2020£m£m%
Current and demand accounts
- interest free128,094   
- interest bearing52,374 89 0.2 
Savings accounts154,453 415 0.3 
Other time deposits - retail25,400 101 0.4 
Other time deposits - wholesale110,186 425 0.4 
Total 470,507 1,030 0.2 

Average deposits at amortised costInterest expenseAverage interest rate
For the year ended 31 December 2019£m£m%
Current and demand accounts
- interest free105,108   
- interest bearing47,492 203 0.4 
Savings accounts141,985 645 0.5 
Other time deposits - retail26,437 275 1.0 
Other time deposits - wholesale95,908 1,326 1.4 
Total 416,930 2,449 0.6 








Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
334

Additional unaudited information
Commitments and contractual obligations
Commercial commitments include guarantees, contingent liabilities and standby facilities.
Commercial commitments
Amount of commitment expiration per period
Less than one yearBetween one to three yearsBetween three to five yearsAfter five yearsTotal amounts committed
£m£m£m£m£m
As at 31 December 2021
Guarantees and letters of credit pledged as collateral security15,549    15,549 
Performance guarantees, acceptances and endorsements5,797    5,797 
Documentary credits and other short-term trade related transactions1,584    1,584 
Standby facilities, credit lines and other commitments344,055 72   344,127 
As at 31 December 2020
Guarantees and letters of credit pledged as collateral security15,642 23 — — 15,665 
Performance guarantees, acceptances and endorsements5,942 — — 5,944 
Documentary credits and other short-term trade related transactions1,086 — — — 1,086 
Standby facilities, credit lines and other commitments331,374 359 202 28 331,963 
Contractual obligations include debt securities and purchase obligations.
Contractual obligations
Payments due by period
Less than one yearBetween one to three yearsBetween three to five yearsAfter five yearsTotal
£m£m£m£m£m
As at 31 December 2021
Long-term debta
48,592 20,438 16,376 37,331 122,737 
Purchase obligations943 1,010 383 24 2,360 
Total49,535 21,448 16,759 37,355 125,097 
As at 31 December 2020
Long-term debta
32,723 19,182 15,867 34,899 102,671 
Purchase obligations981 1,387 342 125 2,835 
Total33,704 20,569 16,209 35,024 105,506 
Note
aLong-term debt has been prepared to reflect cash flows on an undiscounted basis, which includes interest payments.
Net cash flows from derivatives used to hedge long-term debt amount to £1.4bn (2020: £3.3bn).
Further information on the contractual maturity of the Group’s assets and liabilities is given in the Liquidity risk section.

Securities
Investment securities include securities reported within loans and advances at amortised cost and financial assets at fair value through other comprehensive income.
Investment debt securities include government securities held as part of the Group’s treasury management portfolio for asset and liability, liquidity and regulatory purposes and are for use on a continuing basis in the activities of the Group. In addition, the Group holds as investments listed and unlisted corporate securities.
Maturities and yield of investment debt securities
Maturing within one yearMaturing after one but within five yearsMaturing after five but within ten yearsMaturing after ten yearsTotal
AmountYieldAmountYieldAmountYieldAmountYieldAmountYield
As at 31 December 2021£m%£m%£m%£m%£m%
Loans and advances at amortised cost3,2331.5 %18,0401.1 %7211.8 %9,8501.0 %31,8441.1 %
Financial assets at fair value through other comprehensive income8,378 0.9 %25,221 1.1 %17,331 1.0 %9,868 1.5 %60,798 1.1 %
Total book value11,611 43,261 18,052 19,718 92,642 

The yield for each range of maturities is calculated by dividing the annualised interest income prevailing at the reporting date by the book value of securities held at that date.
The above table is only for debt securities held at the reporting date and does not include associated hedges.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
335

Additional unaudited information
Average balance sheet
Average balances are based upon monthly averages.
Assets2021
Average balanceInterest incomeInterest expenseᵃTotal net interestRate
£m£m£m£m%
Cash and balances at central banksUK100,193 112  112 0.1 
Cash and balances at central banksNon-UK130,496 72 (304)(232)(0.2)
Cash and balances at central banksTotal230,689 184 (304)(120)(0.1)
Loans and advances at amortised costUK294,367 7,183  7,183 2.4 
Loans and advances at amortised costNon-UK61,695 2,357 (1)2,356 3.8 
Loans and advances at amortised costb
Total356,062 9,540 (1)9,539 2.7 
Cash collateralUK50,363 112 (28)84 0.2 
Cash collateralNon-UK20,358 24 (37)(13)(0.1)
Cash collateralTotal70,721 136 (65)71 0.1 
Reverse repurchase agreementsUK1,417 14  14 1.0 
Reverse repurchase agreementsNon-UK4,078 7 (4)3 0.1 
Reverse repurchase agreementsTotal5,495 21 (4)17 0.3 
Interest earning assets at fair value through other comprehensive incomeUK67,279 512  512 0.8 
Interest earning assets at fair value through other comprehensive incomeNon-UK3,058 38  38 1.2 
Interest earning assets at fair value through other comprehensive incomeTotal70,337 550  550 0.8 
Other interest and similar incomec
809 (248)561  
Total interest earning assets not at fair value through income statement733,304 11,240 (622)10,618 1.4 
Less: interest and similar expense(3,167)622 (2,545)
Net interest733,304 8,073  8,073 
Financial assets at fair value through income statementUK192,829 
Financial assets at fair value through income statementNon-UK103,188 
Financial assets at fair value through income statementTotal296,017 
Total interest earning assets1,029,321 
Impairments(6,949)
Non-interest earning assets416,393 
Total1,438,765 
Percentage of total average interest earning assets in offices outside the UK31%
Notes
aNegative interest earned on assets (which is presented within interest and similar expense in the statutory accounts) is included in determining the total net interest figure. This presentation is deemed appropriate to represent the return associated with each asset class in the table.
bLoans and advances at amortised cost include all doubtful lending. Interest receivable on such lending has been included to the extent to which either cash payments have been received or interest has been accrued in accordance with the income recognition policy of the Barclays Group.
cOther interest and similar income principally includes interest income relating to hedging activity.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
336

Additional unaudited information
Assets2020
Average balanceInterest incomeInterest expenseᵃTotal net interestRate
£m£m£m£m%
Cash and balances at central banksUK79,242 133 (19)114 0.1 
Cash and balances at central banksNon-UK123,183 142 (281)(139)(0.1)
Cash and balances at central banksTotal202,425 275 (300)(25)— 
Loans and advances at amortised costUK286,214 7,194 — 7,194 2.5 
Loans and advances at amortised costNon-UK72,177 2,986 (4)2,982 4.1 
Loans and advances at amortised costb
Total358,391 10,180 (4)10,176 2.8 
Cash collateralUK65,225 214 (31)183 0.3 
Cash collateralNon-UK18,110 36 — 36 0.2 
Cash collateralTotal83,335 250 (31)219 0.3 
Reverse repurchase agreementsUK1,893 16 — 16 0.8 
Reverse repurchase agreementsNon-UK8,917 (9)(5)(0.1)
Reverse repurchase agreementsTotal10,810 20 (9)11 0.1 
Interest earning assets at fair value through other comprehensive incomeUK71,931 721 — 721 1.0 
Interest earning assets at fair value through other comprehensive incomeNon-UK2,927 55 — 55 1.9 
Interest earning assets at fair value through other comprehensive incomeTotal74,858 776 — 776 1.0 
Other interest and similar incomec
391 — 391 — 
Total interest earning assets not at fair value through income statement729,819 11,892 (344)11,548 1.6 
Less: interest and similar expense(3,770)344 (3,426)
Net interest729,819 8,122 — 8,122 
Financial assets at fair value through income statementUK187,927 
Financial assets at fair value through income statementNon-UK76,369 
Financial assets at fair value through income statementTotal264,296 
Total interest earning assets994,115 
Impairments(7,969)
Non-interest earning assets425,438 
Total1,411,584 
Percentage of total average interest earning assets in offices outside the UK30%
Notes
aNegative interest earned on assets (which is presented within interest and similar expense in the statutory accounts) is included in determining the total net interest figure. This presentation is deemed appropriate to represent the return associated with each asset class in the table.
bLoans and advances at amortised cost include all doubtful lending. Interest receivable on such lending has been included to the extent to which either cash payments have been received or interest has been accrued in accordance with the income recognition policy of the Barclays Group.
cOther interest and similar income principally includes interest income relating to hedging activity.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
337

Additional unaudited information
Assets2019
Average balanceInterest incomeInterest expenseᵃTotal net interestRate
£m£m£m£m%
Cash and balances at central banksUK70,371 465 (28)437 0.6 
Cash and balances at central banksNon-UK101,423 626 (233)393 0.4 
Cash and balances at central banksTotal171,794 1,091 (261)830 0.5 
Loans and advances at amortised costUK271,607 8,682 — 8,682 3.2 
Loans and advances at amortised costNon-UK71,976 3,768 (3)3,765 5.2 
Loans and advances at amortised costb
Total343,583 12,450 (3)12,447 3.6 
Cash collateralUK59,446 394 (14)380 0.6 
Cash collateralNon-UK7,400 49 — 49 0.7 
Cash collateralTotal66,846 443 (14)429 0.6 
Reverse repurchase agreementsUK2,990 57 — 57 1.9 
Reverse repurchase agreementsNon-UK2,041 11 — 11 0.5 
Reverse repurchase agreementsTotal5,031 68 — 68 1.4 
Interest earning assets at fair value through other comprehensive incomeUK63,366 957 — 957 1.5 
Interest earning assets at fair value through other comprehensive incomeNon-UK2,961 75 — 75 2.5 
Interest earning assets at fair value through other comprehensive incomeTotal66,327 1,032 — 1,032 1.6 
Other interest and similar incomec
372 — 372 — 
Total interest earning assets not at fair value through income statement653,581 15,456 (278)15,178 2.3 
Less: interest and similar expense(6,049)278 (5,771)
Net interest653,581 9,407 — 9,407 
Financial assets at fair value through income statementUK192,300 
Financial assets at fair value through income statementNon-UK68,031 
Financial assets at fair value through income statementTotal260,331 
Total interest earning assets913,912 
Impairments(6,574)
Non-interest earning assets356,756 
Total1,264,094 
Percentage of total average interest earning assets in offices outside the UK28%
Notes
aNegative interest earned on assets (which is presented within interest and similar expense in the statutory accounts) is included in determining the total net interest figure. This presentation is deemed appropriate to represent the return associated with each asset class in the table.
bLoans and advances at amortised cost include all doubtful lending. Interest receivable on such lending has been included to the extent to which either cash payments have been received or interest has been accrued in accordance with the income recognition policy of the Barclays Group.
cOther interest and similar income principally includes interest income relating to hedging activity.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
338

Additional unaudited information
Liabilities2021
Average balanceInterest expenseInterest incomeᵃTotal net interestRate
£m£m£m£m%
Deposits at amortised costUK285,772 343 (55)288 0.1 
Deposits at amortised costNon-UK69,090 217 (76)141 0.2 
Deposits at amortised costTotal354,862 560 (131)429 0.1 
Federal funds purchasedUK     
Federal funds purchasedNon-UK788 1  1 0.1 
Federal funds purchasedb
Total788 1  1 0.1 
Cash collateralUK44,903 41 (40)1  
Cash collateralNon-UK16,036 22  22 0.1 
Cash collateralTotal60,939 63 (40)23  
Debt securities in issueUK54,023 1,218  1,218 2.3 
Debt securities in issueNon-UK12,790 95  95 0.7 
Debt securities in issueTotal66,813 1,313  1,313 2.0 
Commercial paperUK13,034 3 (26)(23)(0.2)
Commercial paperNon-UK11,337 24 (6)18 0.2 
Commercial paperc
Total24,371 27 (32)(5) 
Subordinated liabilitiesUK13,738 500  500 3.6 
Subordinated liabilitiesNon-UK227 7  7 3.1 
Subordinated liabilitiesTotal13,965 507  507 3.6 
Repurchase agreementsUK19,247 31  31 0.2 
Repurchase agreementsNon-UK2,542 1 (45)(44)(1.7)
Repurchase agreementsTotal21,789 32 (45)(13)(0.1)
Other interest and similar expensec
 664 (374)290  
Total interest bearing liabilities not at fair value through P&L543,527 3,167 (622)2,545 0.5 
Interest bearing liabilities at fair value through P&LUK269,183 
Interest bearing liabilities at fair value through P&LNon-UK55,757 
Interest bearing liabilities at fair value through P&LTotal324,940 
Total interest bearing liabilities868,467 
Interest free customer depositsUK139,159 
Interest free customer depositsNon-UK15,179 
Interest free customer depositsTotal154,338 
Other non-interest bearing liabilities348,085 
Shareholders' equity67,875 
Total1,438,765 
Percentage of total average interest bearing liabilities in offices outside the UK19%
Notes
aNegative interest earned on liabilities (which is presented within interest and similar income in the statutory accounts) is included in determining the total net interest figure. This presentation is deemed appropriate to represent the return associated with each asset class in the table.
bFollowing a change in reporting requirements, federal funds purchased and commercial paper have been presented separately for the average balance sheet. Federal funds purchased were previously shown within deposits at amortised cost and commercial paper was previously shown within debt securities in issue. Prior year comparatives have been re-presented.
cOther interest and similar expense principally includes interest expense relating to hedging activity.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
339

Additional unaudited information
Liabilities2020
Average balanceInterest expenseInterest incomeᵃTotal net interestRate
£m£m£m£m%
Deposits at amortised costUK272,031 586 (15)571 0.2 
Deposits at amortised costNon-UK70,227 443 (15)428 0.6 
Deposits at amortised costTotal342,258 1,029 (30)999 0.3 
Federal funds purchasedUK— — — — — 
Federal funds purchasedNon-UK155 — 0.6 
Federal funds purchasedb
Total155 — 0.6 
Cash collateralUK52,869 96 (31)65 0.1 
Cash collateralNon-UK13,921 38 — 38 0.3 
Cash collateralTotal66,790 134 (31)103 0.2 
Debt securities in issueUK56,775 980 — 980 1.7 
Debt securities in issueNon-UK13,358 274 (2)272 2.0 
Debt securities in issueTotal70,133 1,254 (2)1,252 1.8 
Commercial paperUK10,754 26 — 26 0.2 
Commercial paperNon-UK10,185 80 — 80 0.8 
Commercial paperb
Total20,939 106 — 106 0.5 
Subordinated liabilitiesUK18,845 662 — 662 3.5 
Subordinated liabilitiesNon-UK220 — 3.6 
Subordinated liabilitiesTotal19,065 670 — 670 3.5 
Repurchase agreementsUK19,694 68 — 68 0.3 
Repurchase agreementsNon-UK1,321 (5)0.2 
Repurchase agreementsTotal21,015 75 (5)70 0.3 
Other interest and similar expensec
— 501 — 501 — 
Total interest bearing liabilities not at fair value through income statement540,355 3,770 (68)3,702 0.7 
Interest bearing liabilities at fair value through income statementUK240,792 
Interest bearing liabilities at fair value through income statementNon-UK51,890 
Interest bearing liabilities at fair value through income statementTotal292,682 
Total interest bearing liabilities833,037 
Interest free customer depositsUK115,234 
Interest free customer depositsNon-UK12,860 
Interest free customer depositsTotal128,094 
Other non-interest bearing liabilities381,243 
Shareholders' equity69,210 
Total1,411,584 
Percentage of total average interest earning liabilities in offices outside the UK19%
Notes
aNegative interest earned on liabilities (which is presented within interest and similar income in the statutory accounts) is included in determining the total net interest figure. This presentation is deemed appropriate to represent the return associated with each asset class in the table.
bFollowing a change in reporting requirements, federal funds purchased and commercial paper have been presented separately for the average balance sheet. Federal funds purchased were previously shown within deposits at amortised cost and commercial paper was previously shown within debt securities in issue. Prior year comparatives have been re-presented.
cOther interest and similar expense principally includes interest expense relating to hedging activity.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
340

Additional unaudited information
Liabilities2019
Average balanceInterest expenseInterest incomeᵃTotal net interestRate
£m£m£m£m%
Deposits at amortised costUK244,387 1,306 — 1,306 0.5 
Deposits at amortised costNon-UK67,257 1,137 (1)1,136 1.7 
Deposits at amortised costTotal311,644 2,443 (1)2,442 0.8 
Federal funds purchasedUK— — — — — 
Federal funds purchasedNon-UK299 — 2.0 
Federal funds purchasedb
Total299 — 2.0 
Cash collateralUK50,638 214 (10)204 0.4 
Cash collateralNon-UK8,332 82 — 82 1.0 
Cash collateralTotal58,970 296 (10)286 0.5 
Debt securities in issueUK52,655 1,109 — 1,109 2.1 
Debt securities in issueNon-UK15,839 536 (2)534 3.4 
Debt securities in issueTotal68,494 1,645 (2)1,643 2.4 
Commercial paperUK8,398 25 — 25 0.3 
Commercial paperNon-UK9,891 236 — 236 2.4 
Commercial paperb
Total18,289 261 — 261 1.4 
Subordinated liabilitiesUK19,499 1,046 — 1,046 5.4 
Subordinated liabilitiesNon-UK374 22 — 22 5.9 
Subordinated liabilitiesTotal19,873 1,068 — 1,068 5.4 
Repurchase agreementsUK14,655 127 — 127 0.9 
Repurchase agreementsNon-UK2,381 20 — 20 0.8 
Repurchase agreementsTotal17,036 147 — 147 0.9 
Other interest and similar expensec
— 183 — 183 — 
Total interest bearing liabilities not at fair value through income statement494,605 6,049 (13)6,036 1.2 
Interest bearing liabilities at fair value through income statementUK232,242 
Interest bearing liabilities at fair value through income statementNon-UK62,304 
Interest bearing liabilities at fair value through income statementTotal294,546 
Total interest bearing liabilities789,151 
Interest free customer depositsUK94,733 
Interest free customer depositsNon-UK10,375 
Interest free customer depositsTotal105,108 
Other non-interest bearing liabilities307,952 
Shareholders' equity61,883 
Total1,264,094 
Percentage of total average interest earning liabilities in offices outside the UK21%
Notes
aNegative interest earned on liabilities (which is presented within interest and similar income in the statutory accounts) is included in determining the total net interest figure. This presentation is deemed appropriate to represent the return associated with each asset class in the table.
bFollowing a change in reporting requirements, federal funds purchased and commercial paper have been presented separately for the average balance sheet. Federal funds purchased were previously shown within deposits at amortised cost and commercial paper was previously shown within debt securities in issue. Prior year comparatives have been re-presented.
cOther interest and similar expense principally includes interest expense relating to hedging activity.























Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
341

Additional unaudited information

Changes in total interest – volume and rate analysis
The following tables allocate changes in interest between changes in volume and changes in interest rates for the last two years. Volume and rate variances have been calculated on the movement in the average balances and the change in the interest rates on average interest earning assets and average interest bearing liabilities. Where variances have arisen from changes in both volumes and interest rates, these have been allocated proportionately between the two.
Interest income
2021/2020 Change due to increase/(decrease) in:2020/2019 Change due to
increase/(decrease) in:
Total changeVolumeRateTotal changeVolumeRate
£m£m£m£m£m£m
Cash and balances at central banksUK(2)26 (28)(323)47 (370)
Cash and balances at central banksNon-UK(93)(8)(85)(532)71 (603)
Cash and balances at central banksTotal(95)18 (113)(855)118 (973)
Loans and advances at amortised costUK(11)202 (213)(1,488)447 (1,935)
Loans and advances at amortised costNon-UK(626)(411)(215)(783)10 (793)
Loans and advances at amortised costTotal(637)(209)(428)(2,271)457 (2,728)
Cash collateralUK(99)(36)(63)(197)32 (229)
Cash collateralNon-UK(49)4 (53)(13)39 (52)
Cash collateralTotal(148)(32)(116)(210)71 (281)
Reverse repurchase agreementsUK(2)(5)3 (41)(16)(25)
Reverse repurchase agreementsNon-UK8 2 6 (16)(21)
Reverse repurchase agreementsTotal6 (3)9 (57)(11)(46)
Interest earning assets at fair value through other comprehensive incomeUK(209)(45)(164)(236)116 (352)
Interest earning assets at fair value through other comprehensive incomeNon-UK(17)2 (19)(20)(1)(19)
Interest earning assets at fair value through other comprehensive incomeTotal(226)(43)(183)(256)115 (371)
Other interest and similar income170  170 19 — 19 
Total interest receivable(930)(269)(661)(3,630)750 (4,380)
Interest expense
2021/2020 Change due to
increase/(decrease) in:
2020/2019 Change due to
increase/(decrease) in:
Total changeVolumeRateTotal changeVolumeRate
£m£m£m£m£m£m
Deposits at amortised costUK(283)28 (311)(735)125 (860)
Deposits at amortised costNon-UK(287)(7)(280)(708)48 (756)
Deposits at amortised costTotal(570)21 (591)(1,443)173 (1,616)
Federal funds purchased UK   — — — 
Federal funds purchased Non-UK 2 (2)(5)(2)(3)
Federal funds purchaseda
Total 2 (2)(5)(2)(3)
Cash collateralUK(64)(9)(55)(139)(148)
Cash collateralNon-UK(16)5 (21)(44)36 (80)
Cash collateralTotal(80)(4)(76)(183)45 (228)
Debt securities in issueUK238 (50)288 (129)82 (211)
Debt securities in issueNon-UK(177)(12)(165)(262)(68)(194)
Debt securities in issueTotal61 (62)123 (391)14 (405)
Commercial paperUK(49)5 (54)(5)
Commercial paperNon-UK(62)8 (70)(156)(163)
Commercial papera
Total(111)13 (124)(155)13 (168)
Subordinated liabilitiesUK(162)(184)22 (384)(34)(350)
Subordinated liabilitiesNon-UK(1) (1)(14)(7)(7)
Subordinated liabilitiesTotal(163)(184)21 (398)(41)(357)
Repurchase agreementsUK(37)(2)(35)(59)35 (94)
Repurchase agreementsNon-UK(46) (46)(18)(6)(12)
Repurchase agreementsTotal(83)(2)(81)(77)29 (106)
Other interest and similar expense(211) (211)318 — 318 
Total interest payable(1,157)(216)(941)(2,334)231 (2,565)
Note
aFollowing a change in reporting requirements, federal funds purchased and commercial paper have been presented separately for the average balance sheet. Federal funds purchased were previously shown within deposits at amortised cost and commercial paper was previously shown within debt securities in issue. Prior year comparatives have been re-presented.



Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
342

Additional unaudited information
Credit risk additional disclosure
This section of the report contains supplementary information that is more detailed or contains longer histories than the data presented in the Risk review section.
Risk elements in loans and advances at amortised cost
Loans assessed as Stage 3 credit impaired
Stage 3 credit impaired loans are loans in default assessed for lifetime expected credit losses. Further details on the approach to expected credit loss provisioning, including the classification into stages of gross exposures and approach to the measurement of lifetime expected credit losses, can be found in Note 1 Significant Accounting Policies.
This risk element in loans and advances may be analysed between the United Kingdom and Rest of the World as follows:
Risk elements in loans and advances at amortised cost
20212020201920182017a
As at 31 December£m£m£m£m£m
Gross stage 3 credit impaired loans (2017: Individually impaired loans)
United Kingdom4,432 4,828 4,552 5,150 2,648 
Rest of the world2,803 4,169 3,371 3,353 1,756 
Total7,235 8,997 7,923 8,503 4,404 
Total risk elements in loans and advances at amortised cost
United Kingdom4,432 4,828 4,552 5,150 2,648 
Rest of the world2,803 4,169 3,371 3,353 1,756 
Total7,235 8,997 7,923 8,503 4,404 
Note
aThe comparatives for 2017 have been presented on an IAS 39 basis.
Interest forgone on risk elements in loans and advances at amortised cost
202120202019a
£m£m£m
Interest income that would have been recognised under the original contractual terms
United Kingdom74 117 108 
Rest of the World39 69 83 
Total 113 186 191 
Note
aPrior year comparatives have been restated to ensure a consistent basis of reporting with 2020.
Potential problem loans
Potential problem loans are those loans for which serious doubt exists as to the ability of the borrower to continue to comply with repayment terms in the near future.
The loans and advances at amortised cost by product disclosure in the credit risk section includes gross exposure and associated impairment allowance for assets classified as Stage 2, but not past due i.e. assets satisfying the criteria for a Significant Increase in Credit Risk, but which are still complying with repayment terms.
Forbearance measures consist of concessions towards a debtor that is experiencing or is about to experience difficulties in meeting their financial commitments. Both performing and non-performing forbearance assets are classified as Stage 3 except where it is established that the concession granted has not resulted in diminished financial obligation and that no other regulatory definition of default criteria has been triggered, in which case the asset is classified as Stage 2. The minimum probationary period for non-performing forbearance is 12 months and for performing forbearance, 24 months. Hence, a minimum of 36 months is required for non-performing forbearance to move out of a forborne state. Further details can be found in the credit risk section.
In order to assess asset credit quality, 12-month PDs are used to map assets into strong, satisfactory, higher risk or credit impaired. A credit risk profile by internal PD grade for gross loans and advances at amortised cost and allowance for ECL is shown in the credit risk section, analysing each of these categories by stage.
Wholesale accounts that are deemed to contain heightened levels of risk are recorded on graded watchlists comprising four categories, graded in line with the perceived severity of the risk attached to the lending, and its probability of default. Where a counterparty’s financial health gives grounds for concern, it is immediately placed into the appropriate category. Once an account has been placed on a watchlist, the exposure is monitored and, where appropriate, exposure reductions are effected. Further information on monitoring weaknesses in portfolios can be found in the Barclays PLC Pillar 3 Report 2021 (unaudited).



















Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
343

Additional unaudited information
Impairment

Allocation of the allowance for credit losses
Balance at end of period applicable to:Amounts % of loans in each category to total loans
20212020201920182017
2021a
2020a
201920182017
As at 31 December£m£m£m£m£m£m£m£m£m£m
Loans and advances at amortised cost to banks243122.9 %2.7 %2.9 %3.2 %2.9 %
Loans and advances at amortised cost to customers5,727 8,3206,2966,7654,65097.1 %97.2 %96.9 %96.6 %97.1 %
Financial assets at fair value through other comprehensive income — — —  %0.1 %0.2 %0.2 %— %
Loans and advances100.0 %100.0 %100.0 %100.0 %100.0 %

Net charge offs during the period to average loans outstanding during
Balance at end of period applicable to:Amounts
20212020201920182017
As at 31st December£m£m£m£m£m
Loans and advances at amortised cost to banks
Net charge off
Average loans9,8799,51610,77310,0459,418
Ratio % %— %— %— %— %
Loans and advances at amortised cost to customers
Net charge off2,0771,5651,7581,6961,995
Average loans318,527327,443321,151312,817286,650
Ratio %0.7 %0.5 %0.5 %0.5 %0.7 %
Financial assets at fair value through other comprehensive income
Net charge off
Average loans110418409647
Ratio % %— %— %— %— %

Consolidated basis
Allowance for credit losses to total loans outstanding duringAmounts
20212020201920182017
As at 31st December£m£m£m£m£m
Allowance for credit losses5,7298,3256,2996,7674,652
Total loans outstanding335,402327,342328,286328,104328,700
Ratio %1.7 %2.5 %1.9 %2.1 %1.4 %
Notes
a Total loans outstanding includes Loans and advances at amortized cost and FVOCI.
b Allowance for credit losses: Impairment allowance reduced to £5.7bn (2020: £8.3bn), driven by amounts written-off for £1,872m, ECL release of £374m due to favorable macro-economic outlook and exchange and other adjustments of £385m.
c Loans outstanding: Gross loans and advances increased to £335bn (2020: £327bn), reflecting increases in Barclays International and Barclays UK, partially offset by decrease in Italisn home loans.










Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
344

Additional unaudited information
Maturity analysis of gross loans and advances
20 F-Maturity analysis of gross loans and advances
Less than 1 yearOne to five
years
Five to fifteen
years
Over fifteen
years
Total
As at 31st December 2021£m£m£m£m£m
Loans and advances at amortised cost to banks9,700    9,700 
Loans and advances at amortised cost to customers41,792 81,081 75,736 127,040 325,649 
FVOCI53    53 
Loans and advances at fair value through profit and loss30,401 2,829 2,805 2,633 38,668 
Traded loans12,525    12,525 
Total gross loans and advances94,471 83,910 78,541 129,673 386,595 
Less than 1 yearOne to five
years
Five to fifteen
years
Over fifteen
years
Total
As at 31 December 2020£m£m£m£m£m
Loans and advances at amortised cost to banks8,904 — — — 8,904 
Loans and advances at amortised cost to customers37,194 72,050 87,999 121,004 318,247 
FVOCI85 106 — — 191 
Loans and advances at fair value through profit and loss23,799 1,369 2,699 3,012 30,879 
Traded loans8,348 — — — 8,348 
Total gross loans and advances78,330 73,525 90,698 124,016 366,569 

Interest rate sensitivity of gross loans and advances. Maturity > 1 year
20212020
Fixed rateVariable rateTotalFixed rateVariable rateTotal
As at 31 December£m£m£m£m£m£m
Loans and advances at amortised cost to banks   — — — 
Loans and advances at amortised cost to customers153,212 130,645 283,857 141,307 139,745 281,052 
Financial assets at fair value through other comprehensive income   — 106 106 
Loans and advances at fair value through profit and loss6,084 2,183 8,267 5,076 2,005 7,081 
Total loans and advances159,296 132,828 292,124 146,383 141,856 288,239 

Notional principal amounts of credit derivatives
202120202019
As at 31 December£m£m£m
Credit derivatives held or issued for trading purposes1,272,104 847,845 825,516 
Note
aIncludes credit derivatives held as economic hedges which are not designated as hedges for accounting purposes.

Related party transactions additional disclosure
For US disclosure purposes, the aggregate emoluments of all Directors and Officers of Barclays PLC who held office during the year (2021: 26 persons, 2020: 28 persons, 2019: 31 persons) for the year ended 31 December 2021 amounted to £65.7m (2020: £70.2m, 2019: £68.0m). In addition, the aggregate amount set aside for the year ended 31 December 2021, to provide pension benefits for the Directors and Officers amounted to £nil (2020: £nil, 2019: £0.1m).
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
345

Glossary of terms
‘Advanced-Internal Ratings Based (A-IRB)’ See ‘Internal Ratings Based (IRB)’.
‘Acceptances and endorsements’ An acceptance is an undertaking by a bank to pay a bill of exchange drawn on a customer, for which reimbursement by the customer is normally immediate. Endorsements are to change the payee of a bill of exchange but with no change to the bank’s liability.
‘Additional Tier 1 (AT1) capital’ AT1 capital largely comprises eligible non-common equity capital securities and any related share premium.
‘Additional Tier 1 (AT1) securities’ Non-common equity securities that are eligible as AT1 capital.
‘Advanced Measurement Approach (AMA)’ Under the AMA, banks are allowed to develop their own empirical model to quantify required capital for operational risk. Banks can only use this approach subject to approval from their local regulators.
‘Agencies’ Bonds issued by state and / or government agencies or government-sponsored entities.
‘Agency Mortgage-Backed Securities’ Mortgage-Backed Securities issued by government-sponsored entities.
‘All price risk (APR)’ An estimate of all the material market risks, including rating migration and default for the correlation trading portfolio.
‘American Depository Receipts (ADR)’ A negotiable certificate that represents the ownership of shares in a non-US company (e.g. Barclays) trading on US financial markets.
‘Americas’ Geographic segment comprising the US, Canada and countries where Barclays operates within Latin America.
‘Annual Earnings at Risk (AEaR)’ A measure of the potential change in Net Interest Income (NII) due to an interest rate movement over a one-year period.
‘Annualised cumulative weighted average lifetime PD’ The probability of default over the remaining life of the asset, expressed as an annual rate, reflecting a range of possible economic scenarios.
‘Application scorecards’ Algorithm based decision-making tools used to aid business decisions and manage credit risk based on available customer data at the point of application for a product.
‘Arrears’ Customers are said to be in arrears when they are behind in fulfilling their obligations with the result that an outstanding loan is unpaid or overdue. Such customers are also said to be in a state of delinquency. When a customer is in arrears, their entire outstanding balance is said to be delinquent, meaning that delinquent balances are the total outstanding loans on which payments are overdue.
‘Asia’ Geographic segment comprising countries where Barclays operates within Asia and the Middle East.
‘Asset Backed Commercial Paper (ABCP)’ Typically short-term notes secured on specified assets issued by consolidated special purpose entities for funding purposes.
‘Asset Backed Securities (ABS)’ Securities that represent an interest in an underlying pool of referenced assets. The referenced pool can comprise any assets which attract a set of associated cash flows but are commonly pools of residential or commercial mortgages and, in the case of a Collateralised Debt Obligation (CDO), the referenced pool may be ABS or other classes of assets.
‘Attributable profit’ Profit after tax that is attributable to ordinary equity holders of Barclays adjusted for the after tax amounts of capital securities classified as equity.
‘Average allocated tangible equity’ Calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. 
‘Average tangible shareholders’ equity’ Calculated as the average of the previous month’s period end tangible equity and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period.
‘Average UK leverage ratio’ As per the PRA rulebook, calculated as the average capital measure based on the last day of each month in the quarter divided by the average exposure measure for the quarter, where the average exposure is based on each day in the quarter.
‘Back testing’ Includes a number of techniques that assess the continued statistical validity of a model by simulating how the model would have predicted recent experience.
‘Bank of England (BoE)’ The central bank of the United Kingdom with devolved responsibility for managing monetary policy and to oversee regulation of the UK’s financial sector. Through the Prudential Regulation Committee, the BoE exercises control over the PRA.
‘Barclays Africa’ or ‘Absa’ or ‘Absa Group Limited’ Barclays Africa Group Limited (now Absa Group Limited), which was previously a subsidiary of the Barclays Group. Following a sell down of shares resulting in a loss of control, the Barclays Group’s shareholding in Absa Group Limited is now classified as a financial asset at fair value through other comprehensive income (FVOCI).
‘Balance weighted Loan to Value (LTV) ratio’ In the context of the credit risk disclosures on secured home loans, a means of calculating marked to market LTVs derived by calculating individual LTVs at account level and weighting it by the balances to arrive at the average position. Balance weighted Loan to Value ratio is calculated using the following formula: LTV = ((loan 1 balance x Marked to market (MTM) LTV% for loan 1) + (loan 2 balance x Marked to market (MTM) LTV% for loan 2) + ...) / total outstandings in portfolio.
‘Barclaycard Consumer UK’ The UK Barclaycard business.
‘Barclays’ or ’Barclays Group’ Barclays PLC, together with its subsidiaries.
‘Barclays Bank Group’ Barclays Bank PLC, together with its subsidiaries.
‘Barclays Bank UK Group’ Barclays Bank UK PLC, together with its subsidiaries.
‘Barclays Operating Businesses’ The core Barclays businesses operated by Barclays UK (which include the UK Personal Banking; UK Business Banking and the Barclaycard Consumer UK businesses) and Barclays International (the large UK Corporate business; the International Corporate and Private Bank businesses; the Investment Bank; the Barclaycard International business; and Payments).
‘Barclays Execution Services’ or ‘BX’ or ‘Group Service Company’ Barclays Execution Services Limited, the Group services company set up to provide services to Barclays UK and Barclays International to deliver operational continuity.
‘Barclays International’ The segment of Barclays held by Barclays Bank PLC.  The division includes the large UK Corporate business; the International Corporate and Private Bank businesses; the Investment Bank; the Barclaycard International business; and Payments.
‘Barclays UK’ The segment of Barclays held by Barclays Bank UK PLC.  The division includes the UK Personal Banking; UK Business Banking and the Barclaycard Consumer UK businesses. Following a transfer from Barclays International in Q2 2020, this segment also includes Barclays Partner Finance (BPF).
‘Basel 3’ The third of the Basel Accords, setting minimum requirements and standards that apply to internationally active banks. Basel 3 is a set of measures developed by the Basel Committee on Banking Supervision aiming to strengthen the regulation, supervision and risk management of banks.
‘Basel Committee on Banking Supervision (BCBS)’ or ‘The Basel Committee’ A forum for regular cooperation on banking supervisory matters which develops global supervisory standards for the banking industry. Its 45 members are officials from central banks or prudential supervisors from 28 jurisdictions.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
346

Glossary of terms
‘Basic Indicator Approach (BIA)’ Under the BIA, banks are required to hold regulatory capital for operational risk equal to 15% of the annual average, calculated over a rolling three-year period, of the relevant income indicator for the bank as whole.
‘Basis point(s)’ or ‘bp(s)’ One hundredth of a per cent (0.01%); 100 basis points is 1%. The measure is used for quoting movements in interest rates, yields on securities and for other purposes.
‘Basis risk’ Index/tenor risk that arises when floating rate products are linked to different interest rate indices, which are imperfectly correlated, especially under stressed market conditions.
‘Behavioural scorecards’ Algorithm-based decision tools used to aid business decisions and manage credit risk based on existing customer data derived from account usage.
‘Book quality’ In the context of the Capital Risk section of the Barclays PLC Annual Report, changes in RWAs caused by factors such as underlying customer behaviour or demographics leading to changes in risk profile.
‘Book size’ In the context of the Capital Risk section of the Barclays PLC Annual Report, changes in RWAs driven by business activity, including net originations or repayments.
‘Bounce Back Loan Scheme (BBLS)’ A UK Government (British Business Bank) backed loan scheme which allowed small and medium-sized businesses to borrow between £2,000 and £50,000. The UK Government guarantees 100% of the loan and pays the first 12 months of interest on behalf of the borrowers, subject to terms and conditions.
‘Business Banking’ Business Banking in Barclays UK offers specialist advice, products and services to small and medium-sized enterprises in the UK.
‘Business scenario stresses’ Multi-asset scenario analysis of extreme, but plausible, events that may impact the market risk exposures of the Investment Bank.
‘Buy to let mortgage’ A mortgage whereby the intention of the customer is to let the property at origination.
‘Capital Conservation Buffer (CCB)’ A capital buffer of 2.5% of a bank’s total exposures that needs to be met with an additional amount of Common Equity Tier 1 capital above the 4.5% minimum requirement for Common Equity Tier 1 set out in CRR. Its objective is to conserve a bank’s capital by ensuring that banks build up surplus capital outside periods of stress which can be drawn down if losses are incurred.
‘Capital ratios’ Key financial ratios measuring the bank's capital adequacy or financial strength expressed as a percentage of RWAs.
‘Capital Requirements Directive (CRD)’ Directive 2013/36/EU, a component of the CRD IV package which accompanies the Capital Requirements Regulation and sets out macroprudential standards including the countercyclical capital buffer and capital buffers for systemically important institutions. Directive (EU) 2019/878, published as part of the EU Risk Reduction Measure package amends CRD. These amendments entered into force from 27 June 2019, with EU member states required to adopt the measures within the Directive by 28 December 2020. CRD forms part of UK law pursuant to the European Union (Withdrawal) Act 2018, as amended, and is subject to the temporary transitional powers available to UK regulators to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022.
‘Capital Requirements Regulation (CRR)’ Regulation (EU) No 575/2013, a component of the CRD IV package which accompanies the Capital Requirements Directive and sets out detailed rules for capital eligibility, the calculation of RWAs, the measurement of leverage, the management of large exposures and minimum standards for liquidity. Between 27 June 2019 and 28 June 2023, this regulation will be amended in line with the requirements of amending Regulation (EU) 2019/876 (CRR II). CRR, as amended by CRR II, forms part of UK law pursuant to the European Union (Withdrawal) Act 2018, as amended, and is subject to the temporary transitional powers available to UK regulators to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022.
‘Capital Requirements Regulation II (CRR II)’ Regulation (EU) 2019/876, amending Regulation (EU) No 575/2013 (CRR). This is a component of the EU Risk Reduction Measure package. The requirements set out in CRR II will be introduced between 27 June 2019 and 28 June 2023. CRR, as amended by CRR II, forms part of UK law pursuant to the European Union (Withdrawal) Act 2018, as amended, and is subject to the temporary transitional powers available to UK regulators to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022. Following a consultation process in 2021 the PRA finalised their implementation of the CRR II package through Policy Statement 22/21. The finalised requirements were implemented in the UK with effect from 1 January 2022.
‘Capital requirements on the underlying exposures (KIRB)’ An approach available to banks when calculating RWAs for securitisation exposures. This is based upon the RWA amounts that would be calculated under the IRB approach for the underlying pool of securitised exposures in the program, had such exposures not been securitised.
‘Capital resources’ Common Equity Tier 1, Additional Tier 1 capital and Tier 2 capital that are eligible to satisfy capital requirements under CRD. Referred to as ‘own funds’ within EU regulatory texts.
‘Capital risk’ The risk that the Barclays Group has an insufficient level or composition of capital to support its normal business activities and to meet its regulatory capital requirements under normal operating environments or stressed conditions (both actual and as defined for internal planning or regulatory testing purposes). This includes the risk from the Barclays Group’s pension plans.
‘Central Counterparty’ or ‘Central Clearing Counterparties (CCPs)’ A clearing house mediating between the buyer and the seller in a financial transaction, such as a derivative contract or repurchase agreement (repo). Where a central counterparty is used, a single bi-lateral contract between the buyer and seller is replaced with two contracts, one between the buyer and the CCP and one between the CCP and the seller. The use of CCPs allows for greater oversight and improved credit risk mitigation in over-the-counter (OTC) markets.
‘Charge-off’ In the retail segment this refers to the point in time when collections activity changes from the collection of arrears to the recovery of the full balance. This is normally when six payments are in arrears.
‘Client Assets’ Assets managed or administered by the Barclays Group on behalf of its clients including assets under management (AUM), custody assets, assets under administration and client deposits.
‘Climate risk’ The impact on Financial and Operational Risks arising from climate change through physical risks, risks associated with transitioning to a lower carbon economy and connected risks arising as a result of second order impacts of these two drivers on portfolios.
Physical risks: Physical risks resulting from a changing climate can be event driven (acute risks), including increased severity of extreme weather events such as cyclones, hurricanes and flood. Longer term shifts in climate patterns (chronic risks) arise from sustained higher temperatures that may cause rises in sea levels, rising mean temperatures and more severe weather events. These changes are likely to lead to risks for sovereigns, business models and supply chains.
Transition risks: The transition to a lower carbon economy will involve significant rapid policy, regulatory and legal changes, as evolving technology and markets adapt to a changing climate and associated impacts. These changes will lead to risks for sovereigns, business models and supply chains.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
347

Glossary of terms
Connected risks: The second-order risks arising from physical or transition risk impacts. Connected risk is diverse, impacting customer and wholesale portfolios.
‘CLOs and Other insured assets’ Highly-rated CLO positions wrapped by monolines, non-CLOs wrapped by monolines and other assets wrapped with Credit Support Annex (CSA) protection.
‘Collateralised Debt Obligation (CDO)’ A security issued by a third party which references Asset Backed Securities and/or certain other related assets purchased by the issuer. CDOs may feature exposure to sub-prime mortgage assets through the underlying assets.
‘Collateralised Loan Obligation (CLO)’ A security backed by repayments from a pool of commercial loans. The payments may be made to different classes of owners (in tranches).
‘Collateralised Mortgage Obligation (CMO)’ A security backed by mortgages. A special purpose entity receives income from the mortgages and passes them on to investors in the security.
‘Combined Buffer Requirement (CBR)’ In the context of the CRD capital obligations, the total Common Equity Tier 1 capital required to meet the combined requirements of the Capital Conservation Buffer, the GSII Buffer, the counter-cyclical buffer, and the OSII buffer if applicable to a firm.
‘Commercial paper (CP)’ Short-term notes issued by entities, including banks, for funding purposes.
‘Commercial real estate (CRE)’ Commercial real estate includes office buildings, industrial property, medical centres, hotels, retail stores, shopping centres, farm land, multifamily housing buildings, warehouses, garages, industrial properties and other similar properties. Commercial real estate loans are loans backed by a package of commercial real estate. Note: for the purposes of the Credit Risk section, the UK CRE portfolio includes property investment, development, trading and housebuilders but excludes social housing contractors.
‘Commissions and other incentives’ Includes commission-based arrangements, guaranteed incentives and Long Term Incentive Plan awards.
‘Committee of Sponsoring Organisations of the Treadway Commission Framework (COSO)’ A joint initiative of five private sector organisations dedicated to the development of frameworks and providing guidance on enterprise risk management, internal control and fraud deterrence.
‘Commodity derivatives’ Exchange traded and over-the-counter (OTC) derivatives based on an underlying commodity (e.g. metals, precious metals, oil and oil related products, power and natural gas).
‘Commodity risk’ Measures the impact of changes in commodity prices and volatilities, including the basis between related commodities (e.g. Brent vs. WTI crude prices).
‘Common Equity Tier 1 (CET1) capital’ The highest quality form of regulatory capital under CRR that comprises common shares issued and related share premium, retained earnings and other reserves, less specified regulatory adjustments.
‘Common Equity Tier 1 (CET1) ratio’ A measure of Common Equity Tier 1 capital expressed as a percentage of RWAs.
‘Compensation: income ratio’ The ratio of compensation expense over total income. Compensation represents total staff costs less non-compensation items consisting of outsourcing, staff training, redundancy costs and retirement costs.
‘Comprehensive Capital Analysis and Review (CCAR)’ An annual exercise, required by and evaluated by the Federal Reserve, through which the largest bank holding companies operating in the US assess whether they have sufficient capital to continue operations through periods of economic and financial stress and have robust capital-planning processes that account for their unique risks.
‘Comprehensive Risk Capital Charge (CRCC)’ An estimate of all the material market risks, including rating migration and default for the correlation trading portfolio.
‘Comprehensive Risk Measure (CRM)’ An estimate of all the material market risks, including rating migration and default for the correlation trading portfolio. Also referred to as All Price Risk (APR) and Comprehensive Risk Capital Charge (CRCC).
‘Conduct risk’ The risk of detriment to customers, clients, market integrity, competition or Barclays from the inappropriate supply of financial services, including instances of wilful or negligent misconduct.
‘Constant Currency Basis’ Excluding the impact of foreign currency conversion to GBP when comparing financial results in two different financial periods.
‘Consumer, Cards and Payments (CC&P)’ International Cards and Consumer Bank (including Barclays US Consumer Bank and Barclaycard Germany), Unified Payments (including merchant acquiring and commercial payments) and Private Bank.
‘Contingent Capital Notes (CCNs)’ Interest bearing debt securities issued by the Barclays Group or its subsidiaries that are either permanently written off or converted into an equity instrument from the issuer's perspective in the event of the Common Equity Tier 1 (CET1) ratio of the relevant Barclays Group entity falling below a specific level, or at the direction of regulators.
‘Conversion Trigger’ Used in the context of Contingent Capital Notes and AT1 securities. A conversion trigger event occurs when the CET1 ratio of the bank falls below a certain level (the trigger) as defined in the Terms & Conditions of the instruments issued. See ‘Contingent Capital Notes (CCNs)’.
‘Coronavirus Business Interruption Loan Scheme (CBILS)’ A loan scheme by the British Business Bank (BBB) to support UK based small and medium-sized businesses (turnover of up to £45 million) adversely impacted by COVID-19. The CBILS scheme provided loans of up to £5 million which are backed by an 80% UK Government (BBB) guarantee. The UK Government will pay interest and fees for the first 12 months on behalf of the borrowers, subject to terms and conditions.
'Coronavirus Large Business Interruption Loan Scheme (CLBILS)’ A loan scheme by the British Business Bank (BBB) to support UK based medium-sized businesses (turnover above £45 million, but with no access to CCFF) adversely impacted by COVID-19. The CLBILS scheme provided loans of up to £200 million which are backed by an 80% UK Government (BBB) guarantee.
‘Corporate and Investment Bank (CIB)’ Barclays Corporate and Investment Bank businesses which form part of Barclays International.
‘Correlation risk’ Refers to the change in marked to market value of a security when the correlation between the underlying assets changes over time.
‘Cost of Equity’ The rate of return targeted by the equity holders of a company.
‘Cost: income jaws’ Relationship of the percentage change movement in operating expenses relative to total income.
‘Cost: income ratio’ Total operating expenses divided by total income.
‘Countercyclical Capital Buffer (CCyB)’ An additional buffer introduced as part of the CRD IV package that requires banks to have an additional cushion of CET 1 capital with which to absorb potential losses, enhancing their resilience and contributing to a stable financial system.
‘Countercyclical leverage ratio buffer (CCLB)’ A macroprudential buffer that has applied to specific PRA regulated institutions since 2018 and is calculated at 35% of any risk weighted countercyclical capital buffer set by the Financial Policy Committee (FPC).  The CCLB applies in addition to the minimum of 3.25% and any G-SII additional leverage ratio buffer that applies.
‘Counterparty credit risk (CCR)’ The risk that a counterparty to a transaction could default before the final settlement of a transaction’s cash flows. In the context of RWAs, a component of RWAs that represents the risk of loss from derivatives, repurchase agreements and similar transactions as a result of the default of the counterparty.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
348

Glossary of terms
‘Coverage ratio’ This represents the percentage of impairment allowance reserve against the gross exposure.
‘Covered bonds’ Debt securities backed by a portfolio of mortgages that are segregated from the issuer’s other assets solely for the benefit of the holders of the covered bonds.
‘Covid Corporate Finance Facility (CCFF)’ Bank of England (BOE) scheme to support liquidity among larger investment grade firms which make a material UK contribution, helping to bridge coronavirus disruption to their cash flows. The Bank of England provided liquidity by purchasing short-term debt in the form of commercial paper from corporates. Barclays acts as dealer.
‘CRD IV’ The Fourth Capital Requirements Directive, comprising an EU Directive and an accompanying Regulation (CRR) that together prescribe EU capital adequacy and liquidity requirements, and which implements Basel 3 in the European Union.
‘CRD V’ The Fifth Capital Requirements Directive, comprising an EU amending Directive and an accompanying amending Regulation (CRR II) that together prescribe EU capital adequacy and liquidity requirements, and which implements enhanced Basel 3 proposals in the European Union.
‘Credit conversion factor (CCF)’ A factor used to estimate the risk from off-balance sheet commitments for the purpose of calculating the total Exposure at Default (EAD) used to calculate RWAs.
‘Credit default swaps (CDS)’ A contract under which the protection seller receives premiums or interest-related payments in return for contracting to make payments to the protection buyer in the event of a defined credit event. Credit events normally include bankruptcy, payment default on a reference asset or assets, or downgrades by a rating agency.
‘Credit derivatives (CDs)’ An arrangement whereby the credit risk of an asset (the reference asset) is transferred from the buyer to the seller of the protection.
‘Credit impairment charges’ Also known as ‘credit impairment’. Impairment charges on loans and advances to customers and banks and impairment charges on fair value through other comprehensive income assets and reverse repurchase agreements.
‘Credit market exposures’ Assets and other instruments relating to commercial real estate and leveraged finance businesses that have been significantly impacted by the deterioration in the global credit markets. The exposures include positions subject to fair value movements in the Income Statement, positions that are classified as loans and advances, and available for sale and other assets.
‘Credit quality step’ In the context of the Standardised Approach to calculating credit risk RWAs, a “credit quality assessment scale” maps the credit assessments of a recognised credit rating agency or export credit agency to certain credit quality steps that determine the risk weight to be applied to an exposure.
‘Credit rating’ An evaluation of the creditworthiness of an entity seeking to enter into a credit agreement.
‘Credit risk’ The risk of loss to Barclays from the failure of clients, customers or counterparties, including sovereigns, to fully honour their obligations to Barclays, including the whole and timely payment of principal, interest, collateral and other receivables. In the context of RWAs, it is the component of RWAs that represents the risk of loss in loans and advances and similar transactions resulting from the default of the counterparty.
‘Credit risk mitigation’ A range of techniques and strategies used to actively mitigate credit risks to which the bank is exposed. These can be broadly divided into three types: collateral, netting and set-off, and risk transfer.
‘Credit spread’ The premium over the benchmark or risk-free rate required by the market to accept a lower credit quality.
‘Credit Valuation Adjustment (CVA)’ The difference between the risk-free value of a portfolio of trades and the market value which takes into account the counterparty’s risk of default. The CVA therefore represents an estimate of the adjustment to fair value that a market participant would make to incorporate the credit risk of the counterparty due to any failure to perform contractual agreements.
‘CRR leverage exposure’ Calculated in accordance with Article 429 of the CRR.
‘CRR leverage ratio’ Calculated using the CRR definition of “Tier 1 capital” for the numerator and the CRR definition of “leverage exposure” as the denominator.
‘Customer assets’ Represents loans and advances to customers. Average balances are calculated as the sum of all daily balances for the year to date divided by number of days in the year to date.
‘Customer deposits’ In the context of the Liquidity Risk section, money deposited by all individuals and companies that are not credit institutions. Such funds are recorded as liabilities in the Barclays Group’s balance sheet under “deposits at amortised cost”.
‘Customer liabilities’ See ‘Customer deposits’.
‘Daily Value at Risk (DVaR)’ An estimate of the potential loss which might arise from market movements under normal market conditions, if the current positions were to be held unchanged for one business day, measured to a specified confidence level.
‘DBRS’ DBRS Morningstar, a credit rating agency.
‘Debit Valuation Adjustment (DVA)’ The opposite of Credit Valuation Adjustment (CVA). It is the difference between the risk-free value of a portfolio of trades and the market value which takes into account the Barclays Group’s risk of default. The DVA, therefore, represents an estimate of the adjustment to fair value that a market participant would make to incorporate the credit risk of the Barclays Group due to any failure to perform on contractual obligations. The DVA decreases the value of a liability to take into account a reduction in the remaining balance that would be settled should the Barclays Group default or not perform any contractual obligations.
‘Debt buybacks’ Purchases of the Barclays Group’s issued debt securities, including equity accounted instruments, leading to their de-recognition from the balance sheet.
‘Debt securities in issue’ Transferable securities evidencing indebtedness of the Barclays Group. These are liabilities of the Barclays Group and include certificates of deposit and commercial paper.
‘Default grades’ The Barclays Group classifies ranges of default probabilities into a set of 21 intervals called default grades, in order to distinguish differences in the probability of default risk.
‘Default fund contributions’ The contribution made by members of a central counterparty (CCP).  All members are required to contribute to this fund in advance of using a CCP. The default fund can be used by the CCP to cover losses incurred by the CCP where losses are greater than the margins provided by a defaulting member.  
‘Derivatives netting’ Adjustments applied across asset and liability mark-to-market derivative positions pursuant to legally enforceable bilateral netting agreements and eligible cash collateral received in derivative transactions that meet the requirements of BCBS 270 (Basel III leverage ratio framework and disclosure requirements).
‘Diversification effect’ Reflects the fact that the risk of a diversified portfolio is smaller than the sum of the risks of its constituent parts. It is measured as the sum of the individual asset class DVaR estimates less the total DVaR.
‘Dodd-Frank Act (DFA)’ The US Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.
‘Domestic Liquidity Sub-Group Arrangement (DoLSub)’ An intra-group capital and liquidity support agreement that secures certain regulatory permissions authorised by the Prudential Regulation Authority (PRA).
‘Economic Value of Equity (EVE)’ A measure of the potential change in value of expected future cash flows due to an adverse interest rate movement, based on existing balance sheet run-off profile.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
349

Glossary of terms
'Effective Expected Positive Exposure (EEPE)' The weighted average over time of effective expected exposure. The weights are the proportion that an individual exposure represents of the entire exposure horizon time interval.
‘Effective interest rate (EIR)’ As defined in IFRS 9 Financial Instruments, effective interest rate is the rate that exactly discounts estimated future cash payments or receipts through the expected life of the financial asset or financial liability to the gross carrying amount of a financial asset or to the amortised cost of a financial liability.
‘Eligible liabilities’ Liabilities and capital instruments that are eligible to meet MREL that do not already qualify as own funds.
‘Encumbrance’ The use of assets to secure liabilities, such as by way of a lien or charge.
‘Enterprise Risk Management Framework (ERMF)’ The Barclays Group’s risk management responsibilities are laid out in the Enterprise Risk Management Framework, which describes how Barclays identifies and manages risk. The framework identifies the principal risks faced by the Barclays Group, sets out risk appetite requirements, sets out roles and responsibilities for risk management, and sets out risk committee structure.
‘Equities’ Trading businesses encompassing Cash Equities, Equity Derivatives & Equity Financing.
‘Equity and stock index derivatives’ Derivatives whose value is derived from equity securities. This category includes equity and stock index swaps and options (including warrants, which are equity options listed on an exchange). The Barclays Group also enters into fund-linked derivatives, being swaps and options whose underlyings include mutual funds, hedge funds, indices and multi-asset portfolios. An equity swap is an agreement between two parties to exchange periodic payments, based upon a notional principal amount, with one side paying fixed or floating interest and the other side paying based on the actual return of the stock or stock index. An equity option provides the buyer with the right, but not the obligation, either to purchase or sell a specified stock, basket of stocks or stock index at a specified price or level on or before a specified date.
‘Equity risk’ In the context of trading book capital requirements, the risk of change in market value of an equity investment.
‘Equity structural hedge’ An interest rate hedge in place to reduce earnings volatility of the overnight / short term equity investment and to smooth the income over a medium/long term.
‘EU Risk Reduction Measure package’ A collection of amending Regulations and Directives that update core EU regulatory texts and which came into force on 27 June 2019.
‘Euro Interbank Offered Rate (EURIBOR)’ A benchmark interest rate at which banks can borrow funds from other banks in the European interbank market.
‘Europe’ Geographic segment comprising countries in which Barclays operates within the EU (excluding the UK), Northern Continental and Eastern Europe.
‘European Banking Authority (EBA)’ The EBA is an independent EU Authority which works to ensure effective and consistent prudential regulation and supervision across the European banking sector. Its overall objectives are to maintain financial stability in the EU and to safeguard the integrity, stability, efficiency and orderly functioning of the banking sector.
‘European Securities and Markets Authority (ESMA)’ An independent European Supervisory Authority with the remit of enhancing the protection of investors and reinforcing stable and well-functioning financial markets in the European Union.
‘Eurozone’ Represents the 19 European Union countries that have adopted the Euro as their common currency. The 19 countries are Austria, Belgium, Cyprus, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Portugal, Slovakia, Slovenia and Spain.
‘Expected Credit Losses (ECL)’ A present value measure of the credit losses expected to result from default events that may occur during a specified period of time. ECLs must reflect the present value of cash shortfalls, and the unbiased and probability weighted assessment of a range of outcomes.
‘Expected Losses’ A regulatory measure of anticipated losses for exposures captured under an internal ratings-based credit risk approach for capital adequacy calculations. It is measured as the Barclays Group's modelled view of anticipated losses based on Probability of Default (PD), Loss Given Default (LGD) and Exposure at Default (EAD), with a one-year time horizon.
’Expert lender models’ Models of risk measures that are used for parts of the portfolio where the risk drivers are specific to a particular counterparty, but where there is insufficient data to support the construction of a statistical model. These models utilise the knowledge of credit experts that have in depth experience of the specific customer type being modelled.
‘Exposure’ Generally refers to positions or actions taken by a bank, or consequences thereof, that may put a certain amount of a bank’s resources at risk.
‘Exposure at Default (EAD)’ The estimation of the extent to which the Barclays Group may be exposed to a customer or counterparty in the event of, and at the time of, that customer or counterparty’s default. At default, the customer may not have drawn the loan fully or may already have repaid some of the principal, so that exposure may be less than the approved loan limit.
‘External Credit Assessment Institutions (ECAI)’ Institutions whose credit assessments may be used by credit institutions for the determination of risk weight exposures according to CRR.
‘External ratings based approach / internal assessment approach (Sec ERBA / IAA)’ Under the SEC-ERBA approach, regulatory capital is assigned to securitisation tranches on the basis of their external credit rating. SEC-ERBA approach can also be used for unrated ABCP exposures where the institution has the regulatory permission to use the Internal Assessment approach (IAA) to assign a credit rating to the unrated ABCP exposure.
‘Federal Housing Finance Agency (FHFA)’ An independent federal agency in the United States that oversees the secondary mortgage market and regulates Fannie Mae and Freddie Mac, as well as 11 Federal Home Loan banks. The FHFA also sets the Housing Price Index (HPI) in the United States.
‘Federal Reserve Board (FRB)’ The Board of Governors of the Federal Reserve System, commonly known as the Federal Reserve Board, is responsible for- amongst other things – setting monetary policy in the US.
'FICC' Represents Macro (including rates and currency), Credit and Securitised products.
'Financial Policy Committee (FPC)' The Bank of England’s Financial Policy Committee identifies, monitors and takes action to remove or reduce systemic risks with a view to protecting and enhancing the resilience of the UK financial system. The FPC also has a secondary objective to support the economic policy of the UK Government.
'Foundation Internal Ratings Based (F-IRB)’ See ‘Internal Ratings Based (IRB)’.
‘Financial Conduct Authority (FCA)’ The statutory body responsible for conduct of business regulation and supervision of UK authorised firms. The FCA also has responsibility for the prudential regulation of firms that do not fall within the PRA’s scope.
‘Financial Services Compensation Scheme (FSCS)’ The UK’s fund for compensation of authorised financial services firms that are unable to pay claims.
‘Financial collateral comprehensive method (FCCM)’ A counterparty credit risk exposure calculation approach which applies volatility adjustments to the market value of exposure and collateral when calculating RWA values.
‘Financial Stability Board (FSB)’ An international body that monitors and makes recommendations about the global financial system. It promotes international financial stability by coordinating national financial authorities and international standard-setting bodies as they work toward developing strong regulatory, supervisory and other financial sector policies. It fosters a level playing field by encouraging coherent implementation of these policies across sectors and jurisdictions.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
350

Glossary of terms
‘Fitch’ A credit rating agency.
‘Forbearance Programmes’ Forbearance programmes assist customers in financial difficulty through agreements to accept less than contractual amounts due where financial distress would otherwise prevent satisfactory repayment within the original terms and conditions of the contract. These agreements may be initiated by the customer, Barclays or a third party and include approved debt counselling plans, minimum due reductions, interest rate concessions and switches from capital and interest repayments to interest-only payments.
‘Foreclosures in Progress’ The process by which the bank initiates legal action against a customer with the intention of terminating a loan agreement whereby the bank may repossess the property used as collateral for the loan subject to local law and recover amounts it is owed.
‘Foreign exchange derivatives’ The Barclays Group’s principal exchange rate-related contracts are forward foreign exchange contracts, currency swaps and currency options. Forward foreign exchange contracts are agreements to buy or sell a specified quantity of foreign currency, usually on a specified future date at an agreed rate. Currency swaps generally involve the exchange, or notional exchange, of equivalent amounts of two currencies and a commitment to exchange interest periodically until the principal amounts are re-exchanged on a future date. Currency options provide the buyer with the right, but not the obligation, either to purchase or sell a fixed amount of a currency at a specified exchange rate on or before a future date. As compensation for assuming the option risk, the option writer generally receives a premium at the start of the option period.
‘Foreign exchange risk’ In the context of DVaR, the impact of changes in foreign exchange rates and volatilities.
‘Full time equivalent’ Full time equivalent units are the on-job hours paid for employee services divided by the number of ordinary-time hours normally paid for a full-time staff member when on the job (or contract employees where applicable).
‘Fully loaded’ When a measure is presented or described as being on a fully loaded basis, it is calculated without applying the transitional provisions set out in Part Ten of CRR.
‘Funded credit protection’ A technique of credit risk mitigation where the reduction of the credit risk on the exposure of an institution derives from the right of that institution, in the event of the default of the counterparty or on the occurrence of other specified credit events relating to the counterparty, to liquidate, or to obtain transfer or appropriation of, or to retain certain assets or amounts, or to reduce the amount of the exposure to, or to replace it with the amount of the difference between the amount of the exposure and the amount of a claim on the institution.
‘Gains on acquisitions’ The amount by which an acquirer’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities, recognised in a business combination, exceeds the cost of the combination.
‘General Data Protection Regulation (GDPR)’ GDPR (Regulation (EU) 2016/679) is a regulation intended to strengthen and unify data protection for all individuals within the European Union. GDPR forms part of UK law pursuant to the European Union (Withdrawal) Act 2018, as amended.
‘General market risk’ The risk of a price change in a financial instrument due to a change in the level of interest rates or owing to a broad equity market movement unrelated to any specific attributes of individual securities.
‘Global-Systemically Important Banks (G-SIBs or G-SIIs)’ Global financial institutions whose size, complexity and systemic interconnectedness, mean that their distress or failure would cause significant disruption to the wider financial system and economic activity. The Financial Stability Board and the Basel Committee on Banking Supervision publish a list of global systemically important banks.
‘G-SII additional leverage ratio buffer (G-SII ALRB)’ A macroprudential buffer that applies to G-SIBs and other major domestic UK banks and building societies, including banks that are subject to ring-fencing requirements. The G-SII ALRB will be calibrated as 35% (on a phased basis) of the combined buffers that apply to the bank.
‘GSII Buffer’ Common Equity Tier 1 capital required to be held under CRD to ensure that G-SIBs build up surplus capital to compensate for the systemic risk that such institutions represent to the financial system.
’Grandfathering’ In the context of capital resources, the phasing in of the application of instrument eligibility rules which allows CRR and CRR II non-compliant capital instruments to be included in regulatory capital subject to certain thresholds which decrease over the transitional period.
‘Gross charge-off rates’ Represents the balances charged-off to recoveries in the reporting period, expressed as a percentage of average outstanding balances excluding balances in recoveries. Charge-off to recoveries generally occurs when the collections focus switches from the collection of arrears to the recovery of the entire outstanding balance, and represents a fundamental change in the relationship between the bank and the customer. This is a measure of the proportion of customers that have gone into default during the period.
‘Gross Domestic Product (GDP)’ Measures the total value of goods and services produced in a country within a specific time period.
‘Gross write-off rates’ Expressed as a percentage and represent balances written off in the reporting period divided by gross loans and advances held at amortised cost at the balance sheet date.
‘Gross new lending’ New lending advanced to customers during the period.
‘Guarantee’ Unless otherwise described, an undertaking by a third party to pay a creditor should a debtor fail to do so. It is a form of credit substitution.
‘Head Office’ Comprises head office, Barclays Services FTE and legacy businesses.
‘High-Net-Worth’ Businesses within Barclays UK and Barclays International that provide banking and other services to high net worth customers.
‘High quality liquidity assets (HQLA)’ It comprises eligible and unencumbered cash or assets that can be converted into cash at little or no loss of value in private markets, to meet liquidity needs arising from a liquidity stress scenario or event. Please refer to ‘Level 1 assets’ and ‘Level 2 assets’.
‘High Risk’ In retail banking, ‘High Risk’ is defined as the subset of up-to-date customers who, either through an event or observed behaviour, exhibit potential financial difficulty. Where appropriate, these customers are proactively contacted to assess whether assistance is required.
‘Home loan’ A loan to purchase a residential property. The property is then used as collateral to guarantee repayment of the loan. The borrower gives the lender a lien against the property and the lender can foreclose on the property if the borrower does not repay the loan per the agreed terms. Also known as a residential mortgage.
‘IHC’ or ‘US IHC’ Barclays US LLC, the intermediate holding company established by Barclays in July 2016, which holds most of Barclays’ subsidiaries and assets in the US.
'Internal Model Approach (IMA)’ In the context of RWAs, RWAs for which the exposure amount has been derived via the use of a PRA approved internal market risk model.
'Internal Model Method (IMM)’ In the context of RWAs, RWAs for which the exposure amount has been derived via the use of a PRA approved internal counterparty credit risk model.
‘Identified Impairment (II)’ Specific impairment allowances for financial assets, estimated individually.
‘IFRS 9 transitional arrangements’ Following the application of IFRS 9 as of 1 January 2018, Article 473a of CRR permits institutions to phase-in the impact on capital and leverage ratios of the impairment requirements under the new accounting standard.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
351

Glossary of terms
‘Impairment Allowances’ A provision held on the balance sheet as a result of the raising of a charge against profit for expected losses in the lending book. An impairment allowance may either be identified or unidentified, and individual or collective.
‘Income’ Total income, unless otherwise specified.
‘Incremental Risk Charge (IRC)’ An estimate of the incremental risk arising from rating migrations and defaults for traded debt instruments beyond what is already captured in specific market risk VaR for the non-correlation trading portfolio.
‘Independent Validation Unit (IVU)’ The function within the bank responsible for independent review, challenge and approval of all models.
‘Individual liquidity guidance (ILG)’ Guidance given to a bank about the amount, quality and funding profile of liquidity resources that the PRA has asked the bank to maintain.
‘Inflation risk’ In the context of DVaR, the impact of changes in inflation rates and volatilities on cash instruments and derivatives.
‘Insurance Risk’ The risk of the Barclays Group’s aggregate insurance premiums received from policyholders under a portfolio of insurance contracts being inadequate to cover the claims arising from those policies.
‘Interchange’ Income paid to a credit card issuer for the clearing and settlement of a sale or cash advance transaction.
‘Interest-only home loans’ Under the terms of these loans, the customer makes payments of interest only for the entire term of the mortgage, although customers may make early repayments of the principal within the terms of their agreement. The customer is responsible for repaying the entire outstanding principal on maturity, which may require the sale of the mortgaged property.
‘Interest rate derivatives’ Derivatives linked to interest rates. This category includes interest rate swaps, collars, floors options and swaptions. An interest rate swap is an agreement between two parties to exchange fixed rate and floating rate interest by means of periodic payments based upon a notional principal amount and the interest rates defined in the contract. Certain agreements combine interest rate and foreign currency swap transactions, which may or may not include the exchange of principal amounts. A basis swap is a form of interest rate swap, in which both parties exchange interest payments based on floating rates, where the floating rates are based upon different underlying reference indices. In a forward rate agreement, two parties agree a future settlement of the difference between an agreed rate and a future interest rate, applied to a notional principal amount. The settlement, which generally occurs at the start of the contract period, is the discounted present value of the payment that would otherwise be made at the end of that period.
‘Interest rate risk’ The risk of interest rate volatility adversely impacting the Barclays Group’s Net Interest Margin. In the context of the calculation of market risk DVaR, measures the impact of changes in interest (swap) rates and volatilities on cash instruments and derivatives.
‘Interest rate risk in the banking book (IRRBB)’ The risk that the Barclays Group is exposed to capital or income volatility because of a mismatch between the interest rate exposures of its (non-traded) assets and liabilities.
‘Internal Assessment Approach (IAA)’ One of three types of calculation that a bank with permission to use the Internal Ratings Based (IRB) approach may apply to securitisation exposures. It consists of mapping a bank's internal rating methodology for credit exposures to those of an External Credit Assessment Institution (ECAI) to determine the appropriate risk weight based on the ratings based approach. Its applicability is limited to ABCP programmes related to liquidity facilities and credit enhancement.
‘Internal Capital Adequacy Assessment Process (ICAAP)’ It describes how the Group identifies, manages and qualifies the risks it is exposed to, in pursuit of its business strategy. It assesses whether the quality and quantity of capital is available to absorb capital losses for the risks the firm undertakes. The capital adequacy is assessed on a point of time basis and on a forward looking basis taking into account baseline and stressed economic capital conditions.
‘Internal Ratings Based (IRB)’ An approach under the CRR framework that relies on the bank’s internal models to derive the risk weights. The IRB approach is divided into two alternative applications, Advanced and Foundation:
Advanced IRB (A-IRB): the bank uses its own estimates of Probability of Default (PD), Loss Given Default (LGD) and credit conversion factor to model a given risk exposure.
Foundation IRB (F-IRB): the bank applies its own PD as for Advanced, but it uses standard parameters for the LGD and the credit conversion factor. The Foundation IRB approach is specifically designed for wholesale credit exposures. Hence retail, equity, securitisation positions and non-credit obligations asset exposures are treated under standardised or A-IRB.
‘Internal Ratings Based approach (SEC-IRBA)’ This is a method to calculate risk-weighted exposure amounts for securitisation positions. Under this method, an institution must be able to model regulatory capital requirements for underlying exposures in the securitisation as if these had not been securitised (‘KIRB’), subject to certain other inputs and criteria.
‘IRB Roadmap’ introduction of several EBA technical standards and sets of guidelines developed with the intent to reduce unwarranted variability across firms in IRB Risk-Weighted Assets for Credit Risk, PRA confirmed UK firms to implement these changes from 1 January 2022.
‘Investment Bank’ The Barclays Group’s investment bank which consists of origination led and returns focused Global Markets and Investment Banking businesses, which forms part of the Corporate and Investment Bank segment of Barclays International.
‘Investment Banking Fees’ In the context of Investment Bank analysis of Total Income, fees generated from origination activity businesses – including financial advisory, debt and equity underwriting.
‘Investment grade’ A debt security, treasury bill or similar instrument with a credit rating of AAA to BBB as measured by external credit rating agencies.
‘ISDA Master Agreement’ The most commonly used master contract for OTC derivative transactions internationally. It is part of a framework of documents, designed to enable OTC derivatives to be documented fully and flexibly. The framework consists of a master agreement, a schedule, confirmations, definitions booklets, and a credit support annex. The ISDA Master Agreement is published by the International Swaps and Derivatives Association, commonly known as “ISDA”.
‘Key Risk Scenarios (KRS)’ Key Risk Scenarios are a summary of the extreme potential risk exposure for each Key Risk in each business and function, including an assessment of the potential frequency of risk events, the average size of losses and three extreme scenarios. The Key Risk Scenario assessments are a key input to the Advanced Measurement Approach calculation of regulatory and economic capital requirements.
‘Large exposure’ A large exposure is defined as the total exposure of a bank to a counterparty or group of connected clients, whether in the banking book or trading book or both, which in aggregate equals or exceeds 10% of the bank's eligible capital.
‘Legal risk’ The risk of loss or imposition of penalties, damages or fines from the failure of the Barclays Group to meet its legal obligations including regulatory or contractual requirements.
‘Lending’ In the context of Investment Bank analysis of Total Income, lending income includes Net Interest Income (NII), gains or losses on loan sale activity, and risk management activity relating to the loan portfolio.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
352

Glossary of terms
‘Letters of credit’ A letter typically used for the purposes of international trade guaranteeing that a debtor’s payment to a creditor will be made on time and in full. In the event that the debtor is unable to make payment, the bank will be required to cover the full or remaining amount of the purchase.
‘Level 1 assets’ High quality liquid assets under the Basel Committee’s Liquidity Coverage Ratio (LCR), including cash, central bank reserves and higher quality government securities.
‘Level 2 assets’ High quality liquid assets under the Basel Committee’s Liquidity Coverage Ratio (LCR), Level 2A assets, including, e.g. lower quality government securities, covered bonds and corporate debt securities, and Level 2B assets, including, e.g. lower rated corporate bonds, residential mortgage backed securities and equities that meet certain conditions.
‘Lifetime expected credit losses’ An assessment of expected losses associated with default events that may occur during the life of an exposure, reflecting the present value of cash shortfalls over the remaining expected life of the asset.
‘Lifetime Probability’ The likelihood of accounts entering default during the expected remaining life of the asset.
‘Liquidity Coverage Ratio (LCR)’ The ratio of the stock of high quality liquid assets to expected net cash outflows over the next 30 days. High-quality liquid assets should be unencumbered, liquid in markets during a time of stress and, ideally, be central bank eligible. These include cash and claims on central governments and central banks.
‘Liquidity Pool’ The Barclays Group liquidity pool comprises cash at central banks and highly liquid collateral specifically held by the Barclays Group as a contingency to enable the bank to meet cash outflows in the event of stressed market conditions.
‘Liquidity Risk’ The risk that the Barclays Group is unable to meet its contractual or contingent obligations, or that it does not have the appropriate amount, tenor and composition of funding and liquidity to support its assets.
‘Liquidity risk appetite (LRA)’ The level of liquidity risk that the Barclays Group chooses to take in pursuit of its business objectives and in meeting its regulatory obligations.
‘Liquidity Risk Management Framework (the Liquidity Framework)’ The Liquidity Risk Management Framework, which is sanctioned by the Board Risk Committee, incorporates liquidity policies, systems and controls that the Barclays Group has implemented to manage liquidity risk within tolerances approved by the Board and regulatory agencies.
‘Litigation and conduct charges’ or ‘Litigation and conduct’ Litigation and conduct charges include regulatory fines, litigation settlements and conduct-related customer redress.
‘Loan loss rate’ Quoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date.
‘Loan to deposit ratio’ or ‘Loan: deposit ratio’ Loans and advances at amortised costs divided by deposits at amortised cost.
‘Loan to value (LTV) ratio’ Expresses the amount borrowed against an asset (i.e. a mortgage) as a percentage of the appraised value of the asset. The ratios are used in determining the appropriate level of risk for the loan and are generally reported as an average for new mortgages or an entire portfolio. Also see ‘Marked to market (MTM) LTV ratio’.
‘London Interbank Offered Rate (LIBOR)’ A benchmark interest rate at which banks can borrow funds from other banks in the London interbank market.
‘Loss Given Default (LGD)’ The percentage of Exposure at Default (EAD) that will not be recovered following default. LGD comprises the actual loss (the part that is not expected to be recovered), together with the economic costs associated with the recovery process.
‘Management VaR’ A measure of the potential loss of value arising from unfavourable market movements at a specific confidence level, if current positions were to be held unchanged for a predefined period. Corporate and Investment Bank uses Management VaR with a two-year equally weighted historical period, at a 95% confidence level, with a one day holding period.
‘Mandatory break clause’ In the context of counterparty credit risk, a contract clause that means a trade will be ended on a particular date.
‘Marked to market approach’ A counterparty credit risk exposure calculation approach which uses the current marked to market value of derivative positions as well as a potential future exposure add-on to calculate an exposure to which a risk weight can be applied. This is also known as the Current Exposure Method.
‘Marked to market (MTM) LTV ratio’ The loan amount as a percentage of the current value of the asset used to secure the loan. Also see ‘Balance weighted Loan to Value (LTV) ratio’ and ‘Valuation weighted Loan to Value (LTV) ratio.’
‘Market risk’ The risk of loss arising from potential adverse changes in the value of the Barclays Group’s assets and liabilities from fluctuations in market variables including, but not limited to, interest rates, foreign exchange, equity prices, commodity prices, credit spreads, implied volatilities and asset correlations.
‘Master netting agreement’ An agreement that provides for a single net settlement of all financial instruments and collateral covered by the agreement in the event of the counterparty’s default, bankruptcy or insolvency, resulting in a reduced exposure.
‘Master trust securitisation programme’ A securitisation structure where a trust is set up for the purpose of acquiring a pool of receivables. The trust issues multiple series of securities backed by these receivables.
‘Material Risk Takers (MRTs)’ Categories of staff whose professional activities have or are deemed to have a material impact on Barclays’ risk profile, as determined in accordance with the European Banking Authority regulatory technical standard on the identification of such staff.
‘Maximum Distributable Amount (MDA)’ The MDA is a factor representing the available distributable profit whilst remaining in excess of its combined buffer requirement. CRD IV places restrictions on a bank’s dividend decisions depending on its proximity to meeting the buffer.
‘Medium-Term Notes’ Corporate notes (or debt securities) continuously offered by a company to investors through a dealer. Investors can choose from differing maturities, ranging from nine months to 30 years. They can be issued on a fixed or floating coupon basis or with an exotic coupon; with a fixed maturity date (non-callable) or with embedded call or put options or early repayment triggers. MTNs are most generally issued as senior, unsecured debt.
‘Methodology and policy’ In the context of the Capital Risk section of the Barclays PLC Annual Report, the effect on RWAs of methodology changes driven by regulatory policy changes.
‘MiFID II’ Refers to either the Markets in Financial Instruments Directive 2014/65/EC and the Markets in Financial Instruments Regulation 600/2014 (as amended from time to time), which together are European Union law that provide harmonised regulation for investment services across the member states of the European Economic Area, or these rules and regulations as they form part of UK law pursuant to the European Union (Withdrawal) Act 2018 (as amended from time to time), as applicable.
‘Minimum requirement for own funds and eligible liabilities (MREL)’ A European Union wide requirement under the Bank Recovery and Resolution Directive for all European banks and investment banks to hold a minimum level of equity and/or loss absorbing eligible liabilities to ensure the operation of the bail-in tool to absorb losses and recapitalise an institution in resolution. An institution’s MREL requirement is set by its resolution authority. Amendments in the EU Risk Reduction Measure package are designed to align MREL and TLAC for EU G-SIBs.
‘Model risk’ The risk of the potential adverse consequences from financial assessments or decisions based on incorrect or misused model outputs and reports.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
353

Glossary of terms
‘Model updates’ In the context of the Capital Risk section of the Barclays PLC Annual Report, changes in RWAs caused by model implementation, changes in model scope or any changes required to address model malfunctions.
‘Model validation’ Process through which models are independently challenged, tested and verified to prove that they have been built, implemented and used correctly, and that they continue to be fit-for-purpose.
‘ModelledVaR’ In the context of RWAs, market risk calculated using Value at Risk models laid down by the CRR and supervised by the PRA.
‘Money market funds’ Investment funds typically invested in short-term debt securities.
‘Monoline derivatives’ Derivatives with a monoline insurer such as credit default swaps referencing the underlying exposures held.
‘Moody’s’ A credit rating agency.
‘Mortgage Servicing Rights (MSR)’ A contractual agreement in which the right to service an existing mortgage is sold by the original lender to another party that specialises in the various functions involved with servicing mortgages.
‘Multilateral development banks’ Financial institutions created for the purposes of development, where membership transcends national boundaries.
‘National discretion’ Discretions in CRD given to EU member states to allow the local regulator additional powers in the application of certain CRD rules in its jurisdiction.
‘Net asset value per share’ Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, by the number of issued ordinary shares.
‘Net Interest Income (NII)’ The difference between interest income on assets and interest expense on liabilities.
‘Net Interest Margin (NIM)’ Net Interest Income (NII) divided by the sum of average customer assets.
‘Net investment income’ Changes in the fair value of financial instruments designated at fair value, dividend income and the net result on disposal of available for sale assets.
‘Net Stable Funding Ratio (NSFR)’ The ratio of available stable funding to required stable funding over a one-year time horizon, assuming a stressed scenario. The ratio is required to be over 100%. Available stable funding would include such items as equity capital, preferred stock with a maturity of over one year, or liabilities with a maturity of over one year. The required amount of stable funding is calculated as the sum of the value of the assets held and funded by the institution, multiplied by a specific required stable funding factor assigned to each particular asset type, added to the amount of potential liquidity exposure multiplied by its associated required stable funding factor.
‘Net trading income’ Gains and losses arising from trading positions which are held at fair value, in respect of both market-making and customer business, together with interest, dividends and funding costs relating to trading activities.
‘Net write-off rate’ Expressed as a percentage and represents balances written off in the reporting period less any post write-off recoveries divided by gross loans and advances held at amortised cost at the balance sheet date.
‘Net written credit protection’ In the context of leverage exposure, the net notional value of credit derivatives protection sold and credit derivatives protection bought.
‘New bookings’ The total of the original balance on accounts opened in the reporting period, including any applicable fees and charges included in the loan amount.
‘Non-asset backed debt instruments’ Debt instruments not backed by collateral, including government bonds, US agency bonds, corporate bonds, commercial paper, certificates of deposit, convertible bonds, corporate bonds and issued notes.
‘Non-Model Method (NMM)’ In the context of RWAs, counterparty credit risk, RWAs where the exposure amount has been derived through the use of CRR norms, as opposed to an internal model.
‘Non-Traded Market Risk’ The risk that the current or future exposure in the banking book (i.e. non-traded book) will impact the bank's capital and/or earnings due to adverse movements in Interest or foreign exchange rates.
‘Non-Traded VaR’ Reflects the volatility in the value of the fair value through other comprehensive income (FVOCI) investments in the liquidity pool which flow directly through capital via the FVOCI reserve. The underlying methodology to calculate non-traded VaR is similar to Traded Management VaR, but the two measures are not directly comparable. The Non-Traded VaR represents the volatility to capital driven by the FVOCI exposures. These exposures are in the banking book and do not meet the criteria for trading book treatment.
‘Notch’ A single unit of measurement in a credit rating scale.
‘Notional amount’ The nominal or face amount of a financial instrument, such as a loan or a derivative, that is used to calculate payments made on that instrument.
‘Open Banking’ The Payment Services Directive (PSD2) and the Open API standards and data sharing remedy imposed by the UK Competition and Markets Authority following its Retail Banking Market Investigation Order.
‘Operating leverage’ Operating expenses compared to total income less credit impairment charges and other provisions.
‘Operational risk’ The risk of loss to the bank from inadequate or failed processes or systems, human factors or due to external events (e.g. fraud) where the root cause is not due to credit or market risks.
‘Operational Riskdata eXchange Association (ORX)’ The Operational Riskdata eXchange Association (ORX) is a not-for-profit industry association dedicated to advancing the measurement and management of operational risk in the global financial services industry. Barclays is a member of ORX.
‘Origination led’ Focus on high-margin, low-capital fee-based activities and related hedging opportunities.
‘O-SII Buffer’ As part of the implementation of CRD V requirements in the UK, the Other Systemically Important Institutions (O-SII) Buffer replaces the CRD IV Systemic Risk Buffer. For implementation in January 2021, the O-SII Buffer was set at the same rate as a firms’ previous SRB buffer.
‘Other systemically important institutions (OSII)’ Other systemically important institutions are institutions that are deemed to create risk to financial stability due to their systemic importance.
‘Over-the-counter (OTC) derivatives’ Derivative contracts that are traded (and privately negotiated) directly between two parties. They offer flexibility because, unlike standardised exchange-traded products, they can be tailored to fit specific needs.
‘Overall capital requirement’ The overall capital requirement is the sum of capital required to meet the total of a Pillar 1 requirement, a Pillar 2A requirement, a Global Systemically Important Institution (G-SII) buffer, a Capital Conservation Buffer (CCB) and a Countercyclical Capital Buffer (CCyB).
‘Own credit’ The effect of changes in the Barclays Group’s own credit standing on the fair value of financial liabilities.
‘Owner occupied mortgage’ A mortgage where the intention of the customer was to occupy the property at origination.
‘Own funds’ The sum of Tier 1 and Tier 2 capital.
‘Own funds and eligible liabilities ratio’ A risk-based ratio representing the own funds and eligible liabilities of the institution expressed as a percentage of total RWAs.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
354

Glossary of terms
‘Past due items’ Refers to loans where the borrower has failed to make a payment when due under the terms of the loan contract.
‘Payment Protection Insurance (PPI) redress’ Provision for the settlement of PPI mis-selling claims and related claims management costs.
‘Pension Risk’ The risk of the Barclays Group’s earnings and capital being adversely impacted by the Barclays Group’s defined benefit obligations increasing or the value of the assets backing these defined benefit obligations decreasing due to changes in both the level and volatility of prices.
‘Performance costs’ The accounting charge recognised in the period for performance awards. For deferred incentives and long-term incentives, the accounting charge is spread over the relevant periods in which the employee delivers service.
‘Personal Banking’ The business within the UK that offer retail solutions to help customers with their day-to-day banking needs.
‘Period end allocated tangible equity’ Allocated tangible equity is calculated as 13.5% (2020: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting assumptions the Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group’s tangible shareholders’ equity and the amounts allocated to businesses.
‘Pillar 1 requirements’ The minimum regulatory capital requirements to meet the sum of credit (including counterparty credit), market risk and operational risk.
‘Pillar 2A requirements’ The additional regulatory capital requirement to meet risks not captured under Pillar 1 requirements. These requirements are the outcome of the bank’s Internal Capital Adequacy Assessment Process (ICAAP) and the complementary supervisory review and evaluation carried out by the PRA.
‘Post-Model Adjustment (PMA)’ In the context of Basel models, a PMA is a short term increase in regulatory capital applied at portfolio level to account for model input data deficiencies, inadequate model performance or changes to regulatory definitions (e.g. definition of default) to ensure the model output is accurate, complete and appropriate.
‘Potential Future Exposure (PFE) on derivatives’ A regulatory calculation in respect of the Barclays Group’s potential future credit exposure on both exchange traded and OTC derivative contracts, calculated by assigning a standardised percentage (based on the underlying risk category and residual trade maturity) to the gross notional value of each contract.
‘PRA waivers’ PRA approvals that specifically give permission to the bank to either modify or waive existing rules. Waivers are specific to an organisation and require applications being submitted to and approved by the PRA.
‘Primary securitisations’ The issuance of securities (bonds and commercial papers) for fund-raising.
‘Primary Stress Tests’ In the context of Traded Market Risk, Stress Testing provides an estimate of potentially significant future losses that might arise from extreme market moves or scenarios. Primary Stress Tests apply stress moves to key liquid risk factors for each of the major trading asset classes.
‘Prime Services’ Involves financing of fixed income and equity positions using Repo and stock lending facilities. The Prime Services business also provides brokerage facilitation services for hedge fund clients offering execution and clearance facilities for a variety of asset classes.
‘Principal’ In the context of a loan, the amount borrowed, or the part of the amount borrowed which remains unpaid (excluding interest).
‘Private equity investments’ Investments in equity securities in operating companies not quoted on a public exchange. Investment in private equity often involves the investment of capital in private companies or the acquisition of a public company that results in the delisting of public equity. Capital for private equity investment is raised by retail or institutional investors and used to fund investment strategies such as leveraged buyouts, venture capital, growth capital, distressed investments and mezzanine capital.
‘Principal Risks’ The principal risks affecting the Barclays Group, as described in the Risk Review section of the Barclays PLC Annual Report.
‘Pro-cyclicality’ Movements in financial variables (including capital requirements) following natural fluctuations in the economic cycle, where the subsequent impact on lending or other market behaviours acts as an amplification of the economic cycle by the financial sector.
‘Probability of Default (PD)’ The likelihood that a loan will not be repaid and will fall into default. PD may be calculated for each client who has a loan (normally applicable to wholesale customers/clients) or for a portfolio of clients with similar attributes (normally applicable to retail customers). To calculate PD, Barclays assesses the credit quality of borrowers and other counterparties and assigns them an internal risk rating. Multiple rating methodologies may be used to inform the rating decision on individual large credits, such as internal and external models, rating agency ratings, and for wholesale assets market information such as credit spreads. For smaller credits, a single source may suffice such as the result from an internal rating model.
‘Product structural hedge’ An interest rate hedge put in place to reduce earnings volatility on product balances with instant access (such as non-interest bearing current accounts and managed rate deposits) and to smoothen the income over a medium/long term.
‘Properties in Possession held as ‘Loans and Advances to Customers'’ Properties in the UK and Italy where the customer continues to retain legal title but where the bank has enforced the possession order as part of the foreclosure process to allow for the disposal of the asset or the court has ordered the auction of the property.
‘Properties in Possession held as ‘Other Real Estate Owned’’ Properties in South Africa where the bank has taken legal ownership of the title as a result of purchase at an auction or similar and treated as ‘Other Real Estate Owned’ within other assets on the bank’s balance sheet.
‘Proprietary trading’ When a bank, brokerage or other financial institution trades on its own account, at its own risk, rather than on behalf of customers, so as to make a profit for itself.
‘Prudential Regulation Authority (PRA)’ The statutory body responsible for the prudential supervision of banks, building societies, insurers and a small number of significant investment banks in the UK. The PRA is a subsidiary of the Bank of England.
‘Prudential Valuation Adjustment (PVA)’ A calculation which adjusts the accounting values of positions held on balance sheet at fair value to comply with regulatory valuation standards, which place greater emphasis on the inherent uncertainty around the value at which a trading book position could be exited.
‘Public benchmark’ Unsecured medium term notes issued in public syndicated transactions.
‘Qualifying central bank claims’ An amount calculated in line with the PRA policy statement allowing banks to exclude claims on the central bank from the calculation of the leverage exposure measure, as long as these are matched by deposits denominated in the same currency and of identical or longer maturity. From 1 January 2022, ‘matching deposits’ will become ‘matching liabilities’ increasing the scope of matching possible against central bank claims.
‘Qualifying Revolving Retail Exposure (QRRE)’ In the context of the IRB approach to credit risk RWA calculations, an exposure meeting the criteria set out in Capital Requirements Regulation (CRR Article 154.4). It includes most types of credit card exposure.
‘Rates’ In the context of Investment Bank income analysis, trading revenue relating to government bonds and interest rate derivatives.
‘Re-aging’ The returning of a delinquent account to up-to-date status without collecting the full arrears (principal, interest and fees).
‘Real Estate Mortgage Investment Conduits (REMICs)’ An entity that holds a fixed pool of mortgages and that is separated into multiple classes of interests for issuance to investors.
‘Recovery book’ Represents the total amount of exposure which has been transferred to recovery units who set and implement strategies to recover the Group’s exposure.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
355

Glossary of terms
‘Recovery book Impairment Coverage Ratio’ Impairment allowance held against recoveries balances expressed as a percentage of balance in recoveries.
‘Recovery book proportion of outstanding balances’ Represents the amount of recoveries (gross month-end customer balances of all accounts that have charged-off) as at the period end compared to total outstanding balances. The size of the recoveries book would ultimately have an impact on the overall impairment requirement on the portfolio. Balances in recovery will decrease if assets are written-off, amounts are collected, or assets are sold to a third party (i.e. debt sale).
‘Regulatory capital’ The amount of capital that a bank holds to satisfy regulatory requirements.
‘Renegotiated loans’ Loans are generally renegotiated either as part of an ongoing customer relationship or in response to an adverse change in the circumstances of the borrower. In the latter case, renegotiation can result in an extension of the due date of payment or repayment plans under which the Barclays Group offers a concessionary rate of interest to genuinely distressed borrowers. This will result in the asset continuing to be overdue, and individually impaired if the renegotiated payments of interest and principal will not recover the original carrying amount of the asset. In other cases, renegotiation will lead to a new agreement, which is treated as a new loan.
‘Repurchase agreement (Repo)’ or ‘Reverse repurchase agreement (Reverse repo)’ Arrangements that allow counterparties to use financial securities as collateral for an interest bearing cash loan. The borrower agrees to sell a security to the lender subject to a commitment to repurchase the asset at a specified price on a given date. For the party selling the security (and agreeing to repurchase it in the future), it is a Repurchase agreement or Repo; for the counterparty to the transaction (buying the security and agreeing to sell in the future), it is a Reverse repurchase agreement or Reverse repo.
‘Reputation risk’ The risk that an action, transaction, investment or event will reduce trust in the Barclays Group’s integrity and competence by clients, counterparties, investors, regulators, employees or the public.
‘Re-securitisations’ The repackaging of securitised products into securities. The resulting securities are therefore securitisation positions where the underlying assets are also predominantly securitisation positions.
‘Reserve Capital Instruments (RCIs)’ Hybrid issued capital securities which may be debt or equity accounted, depending on the terms.
‘Residential Mortgage-Backed Securities (RMBS)’ Securities that represent interests in a group of residential mortgages. Investors in these securities have the right to cash received from future mortgage payments (interest and/or principal).
‘Residual maturity’ The remaining contractual term of a credit obligation associated with a credit exposure.
‘Restructured loans’ Comprises loans where, for economic or legal reasons related to the debtor’s financial difficulties, a concession has been granted to the debtor that would not otherwise be considered. Where the concession results in the expected cash flows discounted at the original effective interest rate being less than the loan’s carrying value, an impairment allowance will be raised.
‘Retail Loans’ Loans to individuals or small and medium sized enterprises rather than to financial institutions and larger businesses. It includes both secured and unsecured loans such as mortgages and credit card balances, as well as loans to certain smaller business customers, typically with exposures up to £3m or with a turnover of up to £5m.
‘Return on average Risk Weighted Assets’ Statutory profit after tax as a proportion of average RWAs.
‘Return on average tangible shareholders’ equity (RoTE)’ Profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill.
‘Return on average allocated tangible equity’ Profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity.
‘Risk appetite’ The level of risk that Barclays is prepared to accept whilst pursuing its business strategy, recognising a range of possible outcomes as business plans are implemented.
‘Risk weighted assets (RWAs)’ A measure of a bank’s assets adjusted for their associated risks. Risk weightings are established in accordance with the Basel rules as implemented by CRR and local regulators.
‘Risks not in VaR (RNIVS)’ Refers to all the key market risks which are not captured or not well captured within the VaR model framework.
‘Sarbanes-Oxley requirements’ The Sarbanes-Oxley Act 2002 (SOX), which was introduced by the US Government to safeguard against corporate governance scandals such as Enron, WorldCom and Tyco. All US-listed companies must comply with SOX.
‘Second Lien’ Debt that is issued against the same collateral as higher lien debt but that is subordinate to such higher lien debt. In the case of default, compensation for this debt will only be received after the first lien has been repaid and thus represents a riskier investment than the first lien.
‘Secondary Stress Tests’ Secondary stress tests are used in measuring potential losses arising from illiquid market risks that cannot be hedged or reduced within the time period covered in Primary Stress Tests.
‘Secured Overnight Financing Rate (SOFR)’ A broad measure of the cost of borrowing cash overnight collateralized by U.S. Treasury securities in the repurchase agreement (repo) market.
‘Securities Financing Transactions (SFT)’ In the context of RWAs, any of the following transactions: a repurchase transaction, a securities or commodities lending or borrowing transaction, or a margin lending transaction whereby cash collateral is received or paid in respect of the transfer of a related asset.
‘Securities Financing Transactions adjustments’ In the context of leverage ratio, a regulatory add-on calculated as exposure less collateral, taking into account master netting agreements.
‘Securities lending arrangements’ Arrangements whereby securities are legally transferred to a third party subject to an agreement to return them at a future date. The counterparty generally provides collateral against non-performance in the form of cash or other assets.
‘Securitisation’ Typically, a process by which debt instruments, such as mortgage loans or credit card balances, are aggregated into a pool, which is used to back new securities. A company sells these pools of assets to a special purpose vehicle (SPV) which then issues securities backed by the assets. This allows the credit quality of the assets to be separated from the credit rating of the original borrower and transfers risk to external investors.
‘Set-off clauses’ In the context of counterparty credit risk, contract clauses that allow Barclays to set off amounts owed to us by a counterparty against amounts owed by us to the counterparty.
‘Settlement balances’ Receivables or payables recorded between the date (the trade date) a financial instrument (such as a bond) is sold, purchased or otherwise closed out, and the date the asset is delivered by or to the entity (the settlement date) and cash is received or paid.
‘Settlement Netting’ Netting approach used in the calculation of the leverage exposure measure whereby firms may calculate their exposure value of regular way purchases and sales awaiting settlement in accordance with Article 429g of CRR, as amended by Regulation (EU) 2019/876 (CRR 2).
‘Settlement risk’ The risk that settlement in a transfer system will not take place as expected, usually owing to a party defaulting on one or more settlement obligations.
‘Significant Increase in Credit Risk (SICR)’ Barclays assesses when a significant increase in credit risk has occurred based on quantitative and qualitative assessments.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
356

Glossary of terms
‘Slotting’ Slotting is internal Barclays terminology for what is known as “Specialised Lending” in the IRB approach as described in Capital Requirements Regulation (CRR Article 147.8). A standard set of rules are required to be used in credit risk RWA calculations, based upon an assessment of factors such as the financial strength of the counterparty. The requirements for the application of the Specialised Lending approach are detailed in CRR Article 153.5.
‘Small and Medium-Sized Enterprises (SME)’ An enterprise which employs fewer than 250 persons and which has an annual turnover which does not exceed EUR 50 million, and / or an annual balance sheet total not exceeding EUR 43 million. Within the SME category, a small enterprise is defined as an enterprise which employs fewer than 50 persons and whose annual turnover and/or annual balance sheet total does not exceed EUR 10 million. This is defined in accordance with Commission Recommendation 2003/361/EC of 6 May 2003 concerning the definition of micro, small and medium sized enterprises.
‘Software intangibles benefit’ This benefit was introduced as part of the EU response package to the COVID-19 pandemic.  It will be reversed as part of the UK implementation of CRR II from 1 January 2022, at which point software assets will be fully deducted from CET 1 capital.
‘Sovereign exposure(s)’ Exposures to central governments, including holdings in government bonds and local government bonds.
‘Specific market risk’ A risk that is due to the individual nature of an asset and can potentially be diversified or the risk of a price change in an investment due to factors related to the issuer or, in the case of a derivative, the issuer of the underlying investment.
‘Spread risk’ Measures the impact of changes to the swap spread, i.e. the difference between swap rates and government bond yields.
‘Stage 1’ This represents financial instruments where the credit risk of the financial instrument has not increased significantly since initial recognition. Stage 1 financial instruments are required to recognise a 12 month expected credit loss allowance.
‘Stage 2’ This represents financial instruments where the credit risk of the financial instrument has increased significantly since initial recognition. Stage 2 financial instruments are required to recognise a lifetime expected credit loss allowance.
‘Stage 3’ This represents financial instruments where the financial instrument is considered impaired. Stage 3 financial instruments are required to recognise a lifetime expected credit loss allowance.
‘Standard & Poor’s’ A credit rating agency.
'Standardised Approach for Counterparty Credit Risk (SA-CCR)' The approach for the calculation of exposure at default for derivative and long-settlement transactions being introduced in the UK under CRR II, from 1 January 2022.  This is a more risk sensitive approach that replaces the Current Exposure Method (CEM) and Standardised Method (SM) applicable under CRR.
‘Standardised approach (SEC-SA)’ This is a method to calculate risk-weighted exposure amounts for securitisation positions. Under this method, an institution must be able calculate regulatory capital requirements per standardized approach for underlying exposures in the securitisation as if these had not been securitised (‘KSA’), subject to certain other inputs and criteria.
‘Standby facilities, credit lines and other commitments’ Agreements to lend to a customer in the future, subject to certain conditions. Such commitments are either made for a fixed period, or have no specific maturity but are cancellable by the lender subject to notice requirements.
‘Statutory’ Line items of income, expense, profit or loss, assets, liabilities or equity stated in accordance with the requirements of the UK Companies Act 2006 and the requirements of International Financial Reporting Standards (IFRS).
‘Statutory return on average shareholders’ equity’ Statutory profit after tax attributable to ordinary shareholders as a proportion of average shareholders’ equity.
‘STD’ / ‘Standardised Approach’ A method of calculating RWAs that relies on a mandatory framework set by the regulator to derive risk weights based on counterparty type and a credit rating provided by an External Credit Assessment Institute.
‘Sterling Over Night Index Average (SONIA)’ Reflects bank and building societies’ wholesale overnight funding rates in the sterling unsecured market administrated and calculated by the Bank of England.
‘Stress Testing’ A process which involves identifying possible future adverse events or changes in economic conditions that could have unfavourable effects on the Barclays Group (either financial or non-financial), assessing the Barclays Group’s ability to withstand such changes, and identifying management actions to mitigate the impact.
‘Stressed Value at Risk (SVaR)’ An estimate of the potential loss arising from a 12-month period of significant financial stress calibrated to 99% confidence level over a 10-day holding period.
‘Structured entity’ An entity in which voting or similar rights are not the dominant factor in deciding control. Structured entities are generally created to achieve a narrow and well defined objective with restrictions around their ongoing activities.
‘Structural FX’ Foreign currency positions taken to hedge against the adverse effect of exchange rates on capital ratios.  Under Article 352(2) of the CRR the PRA may permit banks to exclude such Structural FX positions from the calculation of its market risk RWAs. On the 15th December 2021 the PRA issued Barclays this permission; taking effect from 31 December 2021.  Any long FX positions that are in excess of what is required to hedge the adverse effects of exchange rates on the bank’s capital ratio are not in scope of this exemption and will therefore be captured under the standardised market risk approach.
‘Structural hedge’ or ‘hedging’ An interest rate hedge in place to reduce earnings volatility and to smoothen the income over a medium/long term on positions that exist within the balance sheet and do not re-price in line with market rates. See also ‘Equity structural hedge’ and ‘Product structural hedge’.
‘Structural model of default’ A model based on the assumption that an obligor will default when its assets are insufficient to cover its liabilities.
‘Structured credit’ Includes the legacy structured credit portfolio primarily comprising derivative exposures and financing exposures to structured credit vehicles.
‘Structured finance or structured notes’ A structured note is an investment tool that pays a return linked to the value or level of a specified asset or index and sometimes offers capital protection if the value declines. Structured notes can be linked to equities, interest rates, funds, commodities and foreign currency.
‘Sub-prime’ Sub-prime is defined as loans to borrowers typically having weakened credit histories that include payment delinquencies and potentially more severe problems such as court judgments and bankruptcies. They may also display reduced repayment capacity as measured by credit scores, high debt-to-income ratios, or other criteria indicating heightened risk of default.
‘Subordinated liabilities’ Liabilities which, in the event of insolvency or liquidation of the issuer, are subordinated to the claims of depositors and other creditors of the issuer.
‘Supranational bonds’ Bonds issued by an international organisation, where membership transcends national boundaries (e.g. the European Union or World Trade Organisation).
‘Synthetic Securitisation Transactions’ Securitisation transactions effected through the use of derivatives.
‘Tangible Net Asset Value (TNAV)’ Shareholders’ equity excluding non-controlling interests adjusted for the deduction of intangible assets and goodwill.
‘Tangible Net Asset Value per share’ Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
357

Glossary of terms
‘Tangible shareholders’ equity’ Shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill.
‘Term premium’ Additional interest required by investors to hold assets with a longer period to maturity.
‘The Fundamental Review of the Trading Book (FRTB)’ A comprehensive suite of capital rules developed by the Basel Committee on Banking Supervision as part of Basel III and applicable to banks’ wholesale trading activities.
‘The Standardised Approach (TSA)’ Under TSA, banks are required to hold regulatory capital for operational risk equal to the annual average, calculated over a rolling three-year period, of the relevant income indicator (across all business lines), multiplied by a supervisory defined percentage factor by business lines.
‘The three lines of defence’ The three lines of defence operating model enables Barclays to separate risk management activities between those client facing areas of the Barclays Group and associated support functions responsible for identifying risk, operating within applicable limits and escalating risk events (first line); colleagues in Risk and Compliance who establish the limits, rules and constraints under which the first line operates and monitor their performance against those limits and constraints (second line); and, colleagues in Internal Audit who provide assurance to the Board and Executive Management over the effectiveness of governance, risk management and control over risks (third line). The Legal function does not sit in any of the three lines, but supports them all. The Legal function is, however, subject to oversight from Risk and Compliance with respect to operational and conduct risks.
‘Tier 1 capital’ The sum of the Common Equity Tier 1 capital and Additional Tier 1 capital.
‘Tier 1 capital ratio’ The ratio which expresses Tier 1 capital as a percentage of RWAs under CRR.
‘Tier 2 (T2) capital’ A type of capital as defined in the CRR principally composed of capital instruments, subordinated loans and share premium accounts where qualifying conditions have been met.
‘Tier 2 (T2) securities’ Securities that are treated as Tier 2 (T2) capital for the purposes of CRR.
‘Total balances on forbearance programmes coverage ratio’ Impairment allowance held against Forbearance balances expressed as a percentage of balance in forbearance.
‘Total capital ratio’ Total regulatory capital as a percentage of RWAs.
‘Total Loss Absorbing Capacity (TLAC)’ A standard published by the FSB which is applicable to G-SIBs and requires a G-SIB to hold a prescriptive minimum level of instruments and liabilities that should be readily available for bail-in within resolution to absorb losses and recapitalise the institution.
‘Total outstanding balance’ In retail banking, total outstanding balance is defined as the gross month-end customer balances on all accounts including accounts charged off to recoveries.
‘Total return swap’ An instrument whereby the seller of protection receives the full return of the asset, including both the income and change in the capital value of the asset. The buyer of the protection in return receives a predetermined amount.
‘Traded Market Risk’ The risk of a reduction to earnings or capital due to volatility of trading book positions.
‘Trading book’ All positions in financial instruments and commodities held by an institution either with trading intent, or in order to hedge positions held with trading intent.
‘Traditional Securitisation Transactions’ Securitisation transactions in which an underlying pool of assets generates cash flows to service payments to investors.
‘Transitional’ When a measure is presented or described as being on a transitional basis, it is calculated in accordance with the transitional provisions set out in Part Ten of CRR.
‘Treasury and Capital Risk’ This comprises of Liquidity Risk, Capital Risk and Interest Rate Risk in the banking book.
‘Twelve month expected credit losses’ The portion of the lifetime ECL arising if default occurs within 12 months of the reporting date (or shorter period if the expected life is less than 12 months), weighted by the probability of said default occurring.
‘Twelve month PD’ The likelihood of accounts entering default within 12 months of the reporting date.
‘Unencumbered’ Assets not used to secure liabilities or not otherwise pledged.
‘United Kingdom (UK)’ Geographic segment where Barclays operates comprising the UK. Also see ‘Europe’.
‘UK Bank Levy’ A levy that applies to UK banks, building societies and the UK operations of foreign banks. The levy is payable based on a percentage of the chargeable equity and liabilities of the bank on its balance sheet date.
‘UK leverage exposure’ Calculated as per the PRA rulebook, where the exposure calculation also includes the FPC’s recommendation to allow banks to exclude claims on the central bank from the calculation of the leverage exposure measure, as long as these are matched by deposits denominated in the same currency and of identical or longer maturity. From 1 January 2022, ‘matched by deposits’ will change to ‘match by liabilities’.
‘UK leverage ratio’ As per the PRA rulebook, means a bank’s Tier 1 capital divided by its total exposure measure, with this ratio expressed as a percentage. In October 2021, PRA issued Policy Statement 21/21 whereby a single UK Leverage Ratio requirement is adopted and changes to the definition of Leverage Exposure Measure and reporting and disclosure requirements have become applicable from 1 January 2022.
‘Unfunded credit protection’ A technique of credit risk mitigation where the reduction of the credit risk on the exposure of an institution derives from the obligation of a third party to pay an amount in the event of the default of the borrower or the occurrence of other specified credit events.
‘US Partner Portfolio’ Co-branded credit card programs with companies across various sectors including travel, entertainment and retail.
‘US Residential Mortgage-Backed Securities’ Securities that represent interests in a group of US residential mortgages.
‘Valuation weighted Loan to Value (LTV) ratio’ In the context of credit risk disclosures on secured home loans, a means of calculating marked to market LTVs derived by comparing total outstanding balance and the value of total collateral we hold against these balances. Valuation weighted Loan to Value ratio is calculated using the following formula: LTV = total outstandings in portfolio/total property values of total outstandings in portfolio.
‘Value at Risk (VaR)’ A measure of the potential loss of value arising from unfavourable market movements at a specific confidence level and within a specific timeframe.
‘Weighted off balance sheet commitments’ Regulatory add-ons to the leverage exposure measure based on credit conversion factors used in the Standardised Approach to credit risk.
‘Wholesale loans’ or ‘wholesale lending’ Lending to larger businesses, financial institutions and sovereign entities.
‘Working Group on Sterling Risk-Free Reference Rates (RFRWG)’ A group mandated with catalysing a broad-based transition to using SONIA (‘Sterling Overnight Index Average’) as the primary sterling interest rate benchmark in bond, loan and derivatives markets.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
358

Glossary of terms
‘Write-off (gross)’ The point where it is determined that an asset is irrecoverable, or it is no longer considered economically viable to try to recover the asset or it is deemed immaterial or full and final settlement is reached and the shortfall written off. In the event of write-off, the customer balance is removed from the balance sheet and the impairment allowance held against the asset is released. Net write-offs represent gross write-offs less post write-off recoveries.
‘Wrong-way risk’ Arises in a trading exposure when there is significant correlation between the underlying asset and the counterparty, which in an event of default would lead to a significant mark to market loss. When assessing the credit exposure of a wrong-way trade, analysts take into account the correlation between the counterparty and the underlying asset as part of the sanctioning process.
Barclays PLC Annual Report on Form 20-F 2021
Barclays PLC
home.barclays/annualreport
359


EXHIBIT INDEX
Exhibit
Description
1.1
2.1
Long Term Debt Instruments: Barclays PLC is not party to any single instrument relating to long-term debt pursuant to which a total amount of securities exceeding 10% of its total assets (on a consolidated basis) is authorised to be issued. Barclays PLC hereby agrees to furnish to the Securities and Exchange Commission (the “Commission”), upon its request, a copy of any instrument defining the rights of holders of its long-term debt or the rights of holders of the long-term debt of any of its subsidiaries for which consolidated or unconsolidated financial statements are required to be filed with the Commission.
2.2
4.1
4.2 
4.3
4.4
4.5
4.6
4.7
4.8
4.9
4.10
4.11
4.12
4.13
4.14
4.15
4.16
4.17
4.18
8.1
12.1
13.1
15.1
99.1
101.INSXBRL Instance Document
101.SCHXBRL Taxonomy Extension Schema
101.CALXBRL Taxonomy Extension Schema Calculation Linkbase
101.DEFXBRL Taxonomy Extension Schema Definition Linkbase
101.LABXBRL Taxonomy Extension Schema Label Linkbase
101.PREXBRL Taxonomy Extension Schema Presentation Linkbase



Signatures
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorised the undersigned to sign this annual report on its behalf.
Date February 23, 2022
Barclays PLC
(Registrant)
By/s/ Tushar Morzaria
Tushar Morzaria, Group Finance Director

Exhibit 2.2
DESCRIPTION OF SECURITIES
REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT
As of December 31, 2021, Barclays PLC (“Barclays,” the “Company,” “we,” “us,” and “our”) had four classes of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (the “Act”): our Ordinary Shares; our American Depositary Receipts (ADRs); our Senior Debt Securities; and our Subordinated Debt Securities. Barclays PLC and its consolidated subsidiaries is referred to as the “Group.”
A. Description of Ordinary Shares
This summary of the general terms and provisions of our ordinary shares does not purport to be complete and is subject to and qualified in its entirety by reference to our Articles of Association (the “Articles”), which is incorporated herein by reference to the Form 6-K filed on August 11, 2021 (Film No. 211163288)
Barclays has ordinary shares in issue which are in registered form and are governed by the laws of England and Wales. The shareholders of Barclays passed an ordinary resolution on May 5, 2021 to increase its share capital by the creation of new shares of up to £825,000,000 in relation to any issue of securities that automatically convert into or are exchanged for ordinary shares of Barclays, which authorization expires on the earlier of the end of Barclays’ Annual General Meeting to be held in 2022 and the close of business on June 30, 2022, unless otherwise renewed or passed pursuant to a separate resolution. As at December 31, 2021 there were 16,752,457,128 ordinary shares in issue, each having a nominal value of 25 pence per share. Our ordinary shares are admitted to trading on the London Stock Exchange under the symbol “BARC”.
Our Articles contain provisions to the following effect:
Dividends
Subject to the provisions of the Articles and applicable legislation, Barclays at any general meeting may declare dividends on the ordinary shares by ordinary resolution, but such dividends may not exceed the amount recommended by the board of directors of Barclays (the “Board”). The Board may also declare and pay interim or final dividends if it appears they are justified by our financial position.
All unclaimed dividends payable in respect of any share may be invested or otherwise made use of by the Board for the benefit of Barclays until claimed. If a dividend is not claimed after 12 years of it becoming payable, it is forfeited and reverts to us.
Barclays operates a Scrip Dividend Programme that enables eligible shareholders to elect to receive new ordinary shares issued by Barclays PLC instead of a cash dividend.
Under the terms of the 6.278% non-cumulative callable preference shares, Series 1 and the Euro non-cumulative callable preference shares issued by our subsidiary, Barclays Bank PLC, if Barclays Bank PLC does not declare and pay in full any dividend on such preference shares on a dividend payment date (or if Barclays Bank PLC declares the dividend but fails to pay it or set aside the amount of the payment in full), we may not declare or pay a dividend on our ordinary shares or redeem, purchase, reduce or otherwise acquire any of our share capital (or set aside any sum or establish any sinking fund for the redemption, purchase or otherwise acquisition thereof) until the earlier of the (a) the dividend payment date on which Barclays Bank PLC next declares and pays in full a dividend on such preference shares and (b) the date on or by which all of such preference shares are either redeemed in full or purchased by or for Barclays Bank PLC’s account.
Under the terms of the 6.86% Callable Perpetual Core Tier One Notes, the 6% Callable Perpetual Core Tier One Notes and the 5.3304% Step-up Callable Perpetual Reserve Capital Instruments issued by our subsidiary, Barclays Bank PLC, if Barclays Bank PLC defers a coupon payment, we may not declare or pay a dividend on our ordinary shares or redeem, purchase, reduce or otherwise acquire any of our share capital until Barclays Bank PLC next makes a coupon payment in accordance with the terms and conditions of such instruments.
Voting
Every member who is present or represented (including by a proxy) at any general meeting of Barclays, and who is entitled to vote, has one vote on a show of hands, unless a poll is properly demanded (provided that votes at hybrid meetings, which are hosted on an electronic platform and physically hosted at a specific location simultaneously, shall be decided on a poll). A person is considered “present” at a general meeting, for purposes of physical meeting, if such person is present in-person and, for purposes of hybrid meetings, if such person is present in-person or by means of an electronic platform. Every proxy present has one vote, except that the proxy will have one vote for and one vote against a resolution if he/she has been instructed to vote for and against the resolution by different members or in one direction by a member while another member has permitted the proxy discretion as to how to vote. On a poll, every member who is present or represented and who is entitled to vote has one vote for every share held. In the case of joint holders, only the vote of the senior holder (as determined by order in the share register) or his proxy may be counted. If any sum payable remains unpaid in relation to a member’s shareholding, that member is not entitled to vote that share or exercise any other right in relation to a meeting of Barclays unless the Board otherwise determines.
If any member, or any other person appearing to be interested in any of our ordinary shares, is served with a notice under Section 793 of the Companies Act 2006 (the “Companies Act”) and does not supply us with the information required in the notice, then (unless the Board otherwise decides, and subject to applicable law) (i) that member shall not be entitled to attend or vote at any meeting of Barclays, and (ii) if the shares of the defaulting member represent 0.25% or more of the issued shares of the relevant class, dividends or other monies payable on those shares shall be retained by us and no transfer of those shares shall be registered (other than certain specified “excepted transfers”). These sanctions cease to have effect seven days after we have received the information requested, or when we are notified that an “excepted transfer” of all of the relevant shares to a third party has occurred, or as the Board otherwise determines.
The Articles provide that one-third of the directors shall retire from office and not offer themselves for re-election at each annual general meeting. In accordance with the UK Corporate Governance Code, all directors, who are otherwise not retiring from office, are subject to annual re-election by shareholders.
Transfers
Ordinary shares may be held in either certificated or uncertificated form. Certificated ordinary shares shall be transferred in writing in any usual or other form approved by the Board and executed by or on behalf of the transferor. Transfers of uncertificated ordinary shares shall be made in accordance with the Companies Act and Uncertificated Securities Regulations 2001, as amended.
The Board is not bound to register a transfer of partly paid ordinary shares, or fully paid shares in exceptional circumstances approved by the Financial Conduct Authority (the “FCA”). The Board may also decline to register an instrument of transfer of certificated ordinary shares unless (i) it is duly stamped and deposited at the prescribed place and accompanied by the share certificate(s) and such other evidence as reasonably required by the Board to evidence right to transfer, (ii) it is in respect of one class of shares only, and (iii) it is in favor of a single transferee or not more than four transferees (except in the case of executors or trustees of a member).
Redemption
Subject to applicable legislation and the rights of the other shareholders, any share may be issued on terms that it is, at our option or the option of the holder of such share, redeemable. The directors are authorized to determine the terms, conditions and manner of redemption of any such shares under the Articles.
Calls on capital
The directors may make calls upon the members in respect of any monies unpaid on their shares. A person upon whom a call is made remains liable even if the shares in respect of which the call is made have been transferred. Interest will be chargeable on any unpaid amount called at a rate determined by the Board (of not more than 20% per annum).




If a member fails to pay any call in full (following notice from the Board that such failure will result in forfeiture of the relevant shares), such shares (including any dividends declared but not paid) may be forfeited by a resolution of the Board, and will become the property of Barclays. Forfeiture shall not absolve a previous member for amounts payable by him/her (which may continue to accrue interest).
Barclays also has a lien over all of our partly paid shares for all monies payable or called on that share and over the debts and liabilities of a member to Barclays. If any monies which are the subject of the lien remain unpaid after a notice from the Board demanding payment, we may sell such shares.
Variation of Rights
The rights attached to any class of shares may be varied either with the consent in writing of the holders of at least 75% in nominal value of the issued shares of that class (excluding any share of that class held as treasury shares) or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class.
The rights of shares shall not (unless expressly provided by the rights attached to such shares) be deemed varied by the creation of further shares ranking equally with them.
Winding Up
In the winding up of Barclays (whether the liquidation is voluntary or by the court) the liquidator may, on obtaining any sanction required by law, divide among the members in kind the whole or any part of the assets of Barclays, whether or not the assets consist of property of one kind or of different kinds, and vest the whole or any part of the assets in trustees upon such trusts for the benefit of the members as he, with the like sanction, shall determine. For this purpose the liquidator may set the value he deems fair on a class or classes of property, and may determine on the basis of that valuation and in accordance with the then-existing rights of members how the division is to be carried out between members or classes of members. The liquidator may not, however, distribute to a member without his consent an asset to which there is attached a liability or potential liability for the owner.
Limitations on Share Ownership
There are no limitations on the rights of shareholders to own securities. In addition, there are no restrictions imposed by the Articles or (subject to the effect of any economic sanctions that may be in force from time to time) by current UK laws which relate to non-residents or foreign shareholders and which limit the rights of such non-residents or foreign shareholders to hold or (when entitled to do so) exercise voting rights on the ordinary shares.
B. Description of American Depositary Shares
This summary of the general terms and provisions of our American Depositary Shares (“ADSs”) does not purport to be complete and is subject to and qualified in its entirety by our Form F-6 filed on December 7, 2021 (Commission file No. 333-261527), which is incorporated by reference, including the exhibits thereto. In the following description, a “Holder” is the person registered with the Depositary (as defined below).
General
American Depositary Receipts (“ADRs”) evidencing ADSs are issuable pursuant to a second amended and restated deposit agreement dated August 11, 2008, as amended on August 14, 2013, April 4, 2014, March 13, 2018 and December 7, 2021, among Barclays, JP Morgan Chase Bank, N.A., as depositary (the “Depositary”), and the Holders from time to time of ADRs (the “Deposit Agreement”). The principal executive office of the Depositary is 383 Madison Avenue, Floor 11, New York, New York 10179. Each ADS represents the right to receive four ordinary shares of Barclays. An ADR may evidence any number of ADSs.
Voting
Upon receipt of notice of any meeting or solicitation of consents or proxies of holders of ordinary shares and at Barclays’ written request, the Depositary shall, to the extent permitted by applicable laws, mail the information in such notice to the Holders along with instructions for the voting of their respective ADSs.
Upon the written request of a Holder, the Depositary shall endeavor, insofar as practical, to vote or cause to be voted the amount of ordinary shares represented by the ADSs in accordance with the Holder’s instructions. The Depositary shall not vote the ordinary shares except in accordance with such instructions.
Holders will not be entitled to vote ordinary shares directly.
Collecting and Distributing Dividends
The Depositary will distribute all cash dividends, other cash distributions, or net cash proceeds on the sale of securities, property or rights, that it receives in respect of deposited ordinary shares to Holders, after payment of any charges and fees provided for in the Deposit Agreement, in proportion to their holdings of ADSs. The cash amount distributed will be reduced by any amounts that Barclays or the Depositary must withhold on account of taxes.
If Barclays makes a non-cash distribution in respect of any deposited ordinary shares, the Depositary will distribute the property it receives to Holders, after deduction or upon payment of any taxes, charges and fees provided for in the Deposit Agreement, in proportion to their holdings of ADSs. If a distribution that Barclays makes in respect of deposited ordinary shares consists of a dividend in, or free distribution of, ordinary shares, the Depositary may, and will, if Barclays requests, distribute to Holders, in proportion to their holdings of ADSs, additional ADRs evidencing an aggregate number of ADSs representing the amount of ordinary shares received as such dividend or free distribution. If the Depositary does not distribute additional ADRs, each ADS will from then forward also represent the additional ordinary shares distributed in respect of the deposited ordinary shares before the dividend or free distribution. The Depositary may withhold any such distribution of ADRs if it has not received satisfactory assurances from Barclays that such distribution does not require registration under the Securities Act of 1933 (“Securities Act”) or is exempt from registration under the provisions of the Securities Act.
Procedures for Transmitting Notices, Reports and Proxy Soliciting Material
In addition to the procedures for transmitting notices discussed above under “Voting,” the Depositary shall make available for inspection by Holders, at its principal executive office and at any other designated transfer offices, any reports and communications, including any proxy material, received from Barclays which are both (i) received by the Depositary or the custodian or the nominee of either of them as the holder of the ordinary shares and (ii) made generally available by Barclays to the holders of such ordinary shares. If requested in writing by Barclays, the Depositary shall arrange for the transmittal or mailing of such notices, and any other reports or communications made generally available to holders of the ordinary shares, to all Holders.
Sale or Exercising of Rights
If Barclays makes a distribution of rights to subscribe for additional ordinary shares or any other rights of any nature and offers such rights to holders of deposited securities, the Depositary will exercise its discretion as to the procedure for making such rights available to Holders or of




disposing of such rights and making the net proceeds available to any Holders, in each case in proportion to their holdings of ADSs. If, by the terms of the rights issue or for any other reason, the Depositary may not make such rights available to Holders or dispose of such rights and make the net proceeds available to Holders, the Depositary may generally allow the rights to lapse. If the Depositary has distributed rights to all or certain Holders, then upon the instruction of such Holders and payment of any applicable purchase price, fees, expenses and charges, the Depositary shall exercise such rights to purchase ordinary shares on behalf of such Holders. Ordinary shares purchased by the Depositary will be deposited and ADRs will be delivered to such Holders. The Depositary will not be responsible for any failure to determine that it may be lawful or practicable to make such rights available to Holders in general or any Holder in particular.
Deposit or Sale of Securities Resulting from Dividends, Splits or Plans of Reorganization
If Barclays makes a distribution payable at the election of the holders of ordinary shares in either cash or additional ordinary shares that it wishes to be made available to Holders, the Depositary shall consult with Barclays to determine whether it is lawful and reasonably practicable to make such elective distribution available to Holders. The Depositary shall make such elective distribution available to Holders only if, among other things, Barclays has timely requested that the elective distribution is available to Holders and the Depositary shall have determined that such distribution is reasonably practicable. If the conditions for making the elective distribution available to Holders are satisfied, the Depositary will establish procedures to enable Holders to elect the receipt of either cash or additional ADSs. If the conditions for making the elective distribution available to Holders are not satisfied, the Depositary will, to the extent permitted by law, distribute either cash or additional ADSs to the Holders on the basis of the same determination as is made in the local market in respect of the ordinary shares for which no election is made. There can be no assurance that Holders generally, or any Holder in particular, will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of ordinary shares.
If the Depositary determines that any distribution of property, other than cash, ordinary shares or rights to ordinary shares, cannot be made proportionately among Holders or if for any other reason, including any requirement that Barclays or the Depositary withhold an amount on account of taxes or other governmental charges, the Depositary deems that such a distribution is not feasible, the Depositary may dispose of all or part of the property in any manner, including by public or private sale, that it deems equitable and practicable. The Depositary will then distribute the net proceeds of any such sale (net of any fees and expenses of the Depositary provided for in the Deposit Agreement) to Holders as in the case of a distribution received in cash.
In circumstances where the provisions of the Deposit Agreement governing distributions of ordinary shares do not apply, upon any change in nominal value, change in par value, split-up, consolidation or any other reclassification of ordinary shares, or upon any recapitalization, reorganization, merger or consolidation or sale of assets affecting Barclays or to which it is a party, any securities which shall be received by the Depositary or a custodian in exchange for or in conversion of or in respect of ordinary shares, shall be treated as new ordinary shares under the Deposit Agreement, and ADSs shall thenceforth represent the new ordinary shares so received in exchange or conversion, unless additional ADRs are delivered. In any such case the Depositary may execute and deliver additional ADRs as in the case of a dividend in ordinary shares, or call for the surrender of outstanding ADRs to be exchanged for new ADRs specifically describing such new ordinary shares.
Amendment and Termination of the Deposit Agreement
The form of ADRs evidencing ADSs and any provisions of the Deposit Agreement relating to those ADRs may at any time and from time to time be amended by agreement between Barclays and the Depositary, without the consent of the Holders, in any respect which Barclays may deem necessary or advisable. Any amendment that imposes or increases any fees or charges, other than taxes and other governmental charges, registration fees, transmission costs, delivery costs or other such expenses, or that otherwise prejudices any substantial existing right of the Holders, will not take effect as to any ADRs until 30 days after notice of the amendment has been given to the Holders. Every Holder of any ADR, at the time an amendment becomes effective, will be deemed to continue to hold the ADR and to consent and agree to the amendment and to be bound by the Deposit Agreement or the ADR as amended. No amendment may impair the right of any Holder to surrender ADRs and receive in return the ordinary shares represented by the ADSs.
Whenever Barclays directs, the Depositary has agreed to terminate the Deposit Agreement as to ADRs evidencing ADSs by mailing a termination notice to the Holders then outstanding at least 30 days before the date fixed in the notice of termination. The Depositary may likewise terminate the Deposit Agreement as to ADRs evidencing ADSs by mailing a termination notice to Barclays and the Holders then outstanding if at any time 90 days shall have expired since the Depositary delivered a written notice to Barclays of its election to resign and a successor depositary shall not have been appointed and accepted its appointment.
If any ADRs evidencing ADSs remain outstanding after the date of any termination, the Depositary will then: (i) discontinue the registration of transfers of those ADRs; (ii) suspend the distribution of dividends to Holders; and (iii) not give any further notices or perform any further acts under the Deposit Agreement, except those listed below, with respect to those ADRs. The Depositary will, however, continue to collect dividends and other distributions pertaining to the ordinary shares. It will also continue to sell rights and other property as provided in the Deposit Agreement and deliver ordinary shares, together with any dividends or other distributions received with respect to them and the net proceeds of the sale of any rights or other property, in exchange for ADRs surrendered to it.
At any time after the expiration of six months from the date of termination of the Deposit Agreement as to ADRs evidencing ADSs, the Depositary may sell the ordinary shares then held. The Depositary will then hold uninvested the net proceeds of any such sales, together with any other cash then held by it under the Deposit Agreement in respect of those ADRs, unsegregated and without liability for interest, for the pro rata benefit of the Holders of ADRs that have not previously been surrendered.
Rights of Holders to Inspect the Transfer Books of the Depositary and the List of Holders
The Depositary will keep books for the registration and transfer of ADRs. These books will be open for inspection by Holders at all reasonable times. However, this inspection may not be for the purpose of communicating with Holders in the interest of a business or object other than Barclays business or a matter related to the Deposit Agreement or the ADRs.
Restrictions on the Right to Transfer or Withdraw the Underlying Securities
As a condition precedent to the execution and delivery, registration of transfer, split-up, combination or surrender of any ADR or withdrawal of any deposited securities, the Depositary, custodian or registrar may require payment from the depositor of ADSs or the presenter of the ADRs of a sum sufficient to reimburse it for any tax or other governmental charge and any stock transfer or registration fee with respect thereto (including any such tax or charge and fee with respect to ordinary shares being deposited or withdrawn) and payment of any applicable fees as therein provided, may require the production of proof satisfactory to it as to the identity and genuineness of any signature and may also require compliance with any regulations the Depositary may establish consistent with the provisions of the Deposit Agreement.
The delivery of ADRs against deposits of ADSs generally or against deposits of particular ADSs may be suspended, or the transfer of ADRs in particular instances may be refused, or the registration of transfer of outstanding ADRs generally may be suspended, during any period when the transfer books of the Depositary or Barclays or those maintained by the foreign registrar are closed, or if any such action is deemed necessary or advisable by the Depositary or Barclays at any time or from time to time because of any requirement of law or of any government or governmental body or commission, or under any provision of the Deposit Agreement, or, as long as it would be permitted under the transfer agency rules applicable to the Depositary, for any other reason.




Notwithstanding the provisions of the Deposit Agreement and the ADRs, the surrender of outstanding ADRs and withdrawal of ADSs may not be suspended subject only to (i) temporary delays caused by closing the transfer books of the Depositary or Barclays or the deposit of ADSs in connection with voting at a shareholders’ meeting, or the payment of dividends, (ii) the payment of fees, taxes and similar charges, and (iii) compliance with any U.S. or foreign laws or governmental regulations relating to the ADRs or to the withdrawal of the deposited securities. Without limitation of the foregoing, the Depositary will not knowingly accept for deposit any shares required to be registered under the provisions of the Securities Act, unless a registration statement is in effect as to such shares.
Limitations on the Depositary’s Liability
The Depositary shall not incur any liability to any Holder or beneficial owners of ADRs, if by reason of any provision of any present or future law or regulation of the United Kingdom, United States or any other country, or of any governmental or regulatory authority or stock exchange or regulated market or automated quotation system, or by reason of any provision, present or future, of the Articles of the Company, or by reason of any provision of any securities issued or distributed by Barclays, or any offering or distribution thereof, or by reason of any act of God or war or terrorism or other circumstances beyond its control, the Depositary shall be prevented or forbidden from or be subject to any civil or criminal penalty on account of doing or performing any act or thing which by the terms of the Deposit Agreement it is provided shall be done or performed; nor shall the Depositary incur any liability to any Holder or beneficial owner of any ADR by reason of any non-performance or delay, caused as aforesaid, in the performance of any act or thing which by the terms of the Deposit Agreement it is provided shall or may be done or performed, or by reason of any exercise of, or failure to exercise, any discretion provided for in the Deposit Agreement. Where, by the terms of a distribution of a dividend, or an offering or distribution of rights, such distribution or offering may not be made available to Holders, and the Depositary may not dispose of such distribution or offering on behalf of such Holders and make the net proceeds available to such Holders, then the Depositary shall not make such distribution or offering, and shall allow any rights, if applicable, to lapse.
The Depositary assumes no obligation nor shall it be subject to any liability under the Deposit Agreement to any Holders or beneficial owners of any ADR (including, without limitation, liability with respect to the validity or worth of any deposited securities), except that it agrees to perform its obligations specifically set forth in the Deposit Agreement without gross negligence or bad faith.
The Depositary shall not be under any obligation to appear in, prosecute or defend any action, suit or other proceeding in respect of any deposited securities or in respect of the ADRs, which in its opinion may involve it in expense or liability, unless indemnity satisfactory to it against all expense and liability shall be furnished as often as may be required. The Depositary shall not be liable for any action or non-action by it in reliance upon the advice of or information from legal counsel, accountants, any person presenting ordinary shares for deposit, any Holder or beneficial owner of ADSs or any other person believed by it in good faith to be competent to give such advice or information. The Depositary shall not be liable for any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the Depositary or in connection with any matter arising wholly after the removal or resignation of the Depositary, provided that in connection with the issue out of which such potential liability arises the Depositary performed its obligations without negligence or bad faith while it acted as Depositary.
The Depositary shall not be responsible for any failure to carry out any instructions to vote any of the deposited securities, or for the manner in which any such vote is cast (provided that any such action or nonaction is in good faith) or the effect of any such vote.
The Depositary shall not be liable for the failure by any Holder or beneficial owner to obtain the benefits of credits or refunds of non-U.S. tax paid against such Holder’s or beneficial owner’s income tax liability. The Depositary shall not incur any liability for any tax or tax consequences that may be incurred by Holders or beneficial owners on account of their ownership or disposition of the ADRs or ADSs.
The Depositary is under no obligation to inform Holders or any other holders of an interest in any ADSs about the requirements of English law, rules or regulations or any changes therein or thereto.
Notwithstanding anything to the contrary set forth in the Deposit Agreement or any ADR, the Depositary and its agents may fully respond to any and all demands or requests for information maintained by or on its behalf in connection with the Deposit Agreement, any Holder(s) or beneficial owner(s), any ADR or ADRs or otherwise related hereto to the extent such information is requested or required by or pursuant to any lawful authority, including without limitation laws, rules, regulations, administrative or judicial process, banking, securities or other regulators.
The Depositary shall not incur any liability for the content of any information submitted to it by or on behalf of Barclays for distribution to the Holders or for any inaccuracy of any translation thereof, for any investment risk associated with acquiring an interest in deposited securities, for the validity or worth of the deposited securities, for the credit-worthiness of any third party, for allowing any rights to lapse upon the terms of the Deposit Agreement or for the failure or timeliness of any notice from Barclays.
The Depositary shall not be responsible for, and shall incur no liability in connection with or arising from, the insolvency of any custodian that is not a branch or affiliate of JPMorgan Chase Bank, N.A. The Depositary shall not be liable for the acts or omissions made by, or the insolvency of, any securities depository, clearing agency or settlement system. The Depositary shall not have any liability for the price received in connection with any sale of securities, the timing thereof or any delay in action or omission to act nor shall it be responsible for any error or delay in action, omission to act, default or negligence on the part of the party so retained in connection with any such sale or proposed sale.
Neither the Company nor the Depositary nor any of their respective agents shall be liable to Holders or beneficial owners for any indirect, special, punitive or consequential damages or lost profits.




C. Description of Debt Securities
As of December 31, 2021, we had the following series of debt securities registered pursuant to Section 12(b) of the Act, which are all listed on the New York Stock Exchange:
Debt Securities (class/ interest rate)PrincipalInterest Payment Dates (in arrear)Issue DateMaturity DateRedemption rights
Make-Whole Redemption Date(3)/
Par Redemption Date(4) (when applicable)
Events of DefaultProspectus SupplementIndenture
4.375% Fixed Rate Subordinated Notes due 2024US$1,250,000,000March 11 and September 11September 11, 2014September 11, 2024
Tax Redemption,(1)
Regulatory Event Redemption(2)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
N/A
Dated Subordinated Enforcement Events(8)
Prospectus Supplement dated September 4, 2014Dated Subordinated Debt Securities Indenture dated September 11, 2014
3.65% Fixed Rate Senior Notes due 2025US$2,000,000,000March 16 and September 16March 16, 2015March 16, 2025
Tax Redemption(1)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
N/A
Senior Events of Default(5)
Prospectus Supplement dated March 9, 2015
Senior Debt Securities Indenture dated November 10, 2014
5.25% Fixed Rate Senior Notes due 2045US$1,500,000,000February 17 and August 17August 17, 2015August 17, 2045
Tax Redemption(1)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
N/A
Senior Events of Default(5)
Prospectus Supplement dated August 10, 2015
Senior Debt Securities Indenture dated November 10, 2014
4.375% Fixed Rate Senior Notes due 2026US$2,500,000,000January 12 and July 12January 12, 2016January 12, 2026
Tax Redemption(1)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
N/A
Senior Events of Default(5)
Prospectus Supplement dated January 5, 2016
Senior Debt Securities Indenture dated November 10, 2014
5.20% Fixed Rate Subordinated Notes due 2026US$2,050,000,000May 12 and November 12May 12, 2016May 12, 2026
Tax Redemption,(1)
Regulatory Event Redemption(2)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
N/A
Dated Subordinated Enforcement Events(8)
Prospectus Supplement dated May 5, 2016
Dated Subordinated Debt Securities Indenture dated September 11, 2014
Floating Rate Senior Notes due 2023 (3 month USD LIBOR plus 1.625% p.a.)US$750,000,000January 10, April 10, July 10 and October 10January 10, 2017January 10, 2023
Tax Redemption,(1)
Par Redemption(4)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
Par Redemption Date: January 10, 2022(13)
Senior Events of Default(6)
Prospectus Supplement dated January 3, 2017
Senior Debt Securities Indenture dated November 10, 2014





3.684% Fixed Rate Senior Notes due 2023US$1,500,000,000January 10 and July 10January 10, 2017January 10, 2023
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption(4)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after July 10, 2017 to (but excluding) January 10, 2022
Par Redemption Date: January 10, 2022(13)
Senior Events of Default(6)
Prospectus Supplement dated January 3, 2017
Senior Debt Securities Indenture dated November 10, 2014
4.337% Fixed Rate Senior Notes due 2028US$1,250,000,000January 10 and July 10January 10, 2017January 10, 2028
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption(4)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after July 10, 2017 to (but excluding) January 8, 2027
Par Redemption Date: January 8, 2027
Senior Events of Default(6)
Prospectus Supplement dated January 3, 2017
Senior Debt Securities Indenture dated November 10, 2014
4.950% Fixed Rate Senior Notes due 2047US$1,500,000,000January 10 and July 10January 10, 2017January 10, 2047
Tax Redemption,(1)
Make-Whole Redemption(3)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after July 10, 2017
Senior Events of Default(6)
Prospectus Supplement dated January 3, 2017
Senior Debt Securities Indenture dated November 10, 2014
4.836% Fixed Rate Subordinated Callable Notes due 2028US$2,000,000,000May 9 and November 9May 9, 2017May 9, 2028
Tax Redemption,(1)
Regulatory Event Redemption,(2)
Par Redemption(4)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
Par Redemption Date: May 7, 2027
Dated Subordinated Enforcement Events(8)
Prospectus Supplement dated May 2, 2017
Dated Subordinated Debt Securities Indenture dated May 9, 2017
3.250% Fixed Rate Senior Notes due 2033GBP1,250,000,000January 17January 17, 2018January 17, 2033
Tax Redemption,(1)
Make-Whole Redemption,(3)
Loss Absorption Disqualification Event, Redemption(4)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after July 17, 2018
Senior Events of Default,(6)
Senior Enforcement Events(7)
Prospectus Supplement dated January 8, 2018
Senior Debt Securities Indenture dated January 17, 2018





4.338% Fixed-to-Floating Rate Senior Notes due 2024 (From and including May 16, 2023: 3 month USD LIBOR plus 1.356% p.a.)
Terms provide for the replacement of LIBOR.(9)
US$1,250,000,000
Fixed Rate: May 16 and November 16 each year until (and including) May 16, 2023
Floating Rate: August 16, 2023, November 16, 2023, February 16, 2024 and May 16, 2024
May 16, 2018May 16, 2024
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after November 16, 2018 to (but excluding) May 16, 2023
Par Redemption Date: May 16, 2023
Senior Events of Default(6)
Senior Enforcement Events(7)
Prospectus Supplement dated May 9, 2018Senior Debt Securities Indenture dated January 17, 2018
Floating Rate Senior Notes due 2024 (3 month USD LIBOR plus 1.380% p.a.)
Terms provide for the replacement of LIBOR(9)
US$1,500,000,000February 16, May 16, August 16 and November 16May 16, 2018May 16, 2024
Tax Redemption,(1)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Par Redemption Date: May 16, 2023
Senior Events of Default,(6)
Senior Enforcement Events(7)
Prospectus Supplement dated May 9, 2018Senior Debt Securities Indenture dated January 17, 2018
4.972% Fixed-to-Floating Rate Senior Notes due 2029 (From and including May 16, 2028: 3 month USD LIBOR plus 1.902% p.a.)
Terms provide for the replacement of LIBOR(9)
US$1,750,000,000
Fixed Rate: May 16 and November 16 each year until (and including) May 16, 2028
Floating Rate: August 16, 2028, November 16, 2028, February 16, 2029 and May 16, 2029
May 16, 2018May 16, 2029
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after November 16, 2028 to (but excluding) May 16, 2028
Par Redemption Date: May 16, 2028
Senior Events of Default,(6)
Senior Enforcement Events(7)
Prospectus Supplement dated May 9, 2018Senior Debt Securities Indenture dated January 17, 2018





4.610% Fixed-to-Floating Rate Senior Notes due 2023 (From and including February 15, 2022: 3 month USD LIBOR plus 1.40% p.a.)
Terms provide for the replacement of LIBOR(9)
US$2,500,000,000
Fixed Rate: February 15 and August 15 each year until (and including) February 15, 2022
Floating Rate: May 15, 2022, August 15, 2022, November 15, 2022 and February 15, 2023
November 15, 2018February 15, 2023
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after May 15, 2019 to (but excluding) February 15, 2022
Par Redemption Date: February 15, 2022(14)
Senior Events of Default,(6)
Senior Enforcement Events(7)
Prospectus Supplement dated November 7, 2018Senior Debt Securities Indenture dated January 17, 2018
Floating Rate Senior Notes due 2023 (3 month USD LIBOR plus 1.43% p.a.)
Terms provide for the replacement of LIBOR(9)
US$750,000,000February 15, May 15, August 15 and November 15November 15, 2018February 15, 2023
Tax Redemption,(1)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Par Redemption Date: February 15, 2022(14)
Senior Events of Default,(6)
Senior Enforcement Events(7)
Prospectus Supplement dated November 7, 2018

Senior Debt Securities Indenture dated January 17, 2018
3.932% Fixed-to-Floating Rate Senior Notes due 2025 (From and including May 7, 2024: 3 month USD LIBOR plus 1.610% p.a.)
Terms provide for “Benchmark Events” (defined below) that would trigger the replacement of LIBOR(10)
US$2,000,000,000
Fixed Rate: May 7 and November 7 each year until (and including) May 7, 2024
Floating Rate:
August 7, 2024, November 7, 2024, February 7, 2025 and May 7, 2025
May 7, 2019May 7, 2025
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after November 7, 2019 to (but excluding) May 7, 2024
Par Redemption Date: May 7, 2024
Senior Enforcement Events(7)
Prospectus Supplement dated April 30, 2019Senior Debt Securities Indenture dated January 17, 2018





5.088% Fixed-to-Floating Rate Subordinated Notes due 2030 (From and including June 20, 2029: 3 month USD LIBOR plus 3.054% p.a.)
Terms provide for “Benchmark Events” (defined below) that would trigger the replacement of LIBOR(10)
US$1,500,000,000
Fixed Rate: June 20 and December 20 each year until (and including) June 20, 2029
Floating Rate: September 20, 2029, December 20, 2029, March 20, 2030 and June 20, 2030
June 20, 2019June 20, 2030
Tax Redemption,(1) Regulatory Event Redemption,(2)
Par Redemption (4)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
Par Redemption Date: June 20, 2029
Dated Subordinated Enforcement Events(8)
Prospectus Supplement dated June 13, 2019Dated Subordinated Debt Securities Indenture dated as of May 9, 2017
2.852% Fixed-to-Floating Rate Senior Notes due 2026
(From and including May 7, 2025: 3 month USD LIBOR plus 2.452% p.a.)
Terms provide for “Benchmark Transition Provisions” (as defined below) that would trigger the substitution of LIBOR(11)
$1,750,000,000
Fixed Rate:
May 7 and November 7 each year until (and including) May 7, 2025
Floating Rate: August 7, 2025, November 7, 2025, February 7, 2026 and May 7, 2026
May 7, 2020May 7, 2026
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after November 7, 2020 to (but excluding) May 7, 2025
Par Redemption Date: May 7, 2025
Senior Enforcement Events(7)
Prospectus Supplement dated April 30, 2020

Senior Debt Securities Indenture dated January 17, 2018





2.645% Fixed Rate Resetting Senior Callable Notes due 2031
(From and including June 24, 2030: The then-prevailing U.S. Treasury Rate, plus 1.900%)(12)
$1,000,000,000June 24 and December 24June 24, 2020June 24, 2031
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after December 24, 2020 to (but excluding) June 24, 2030
Par Redemption Date: June 24, 2030
Senior Enforcement Events(7)
Prospectus Supplement dated June 17, 2020Senior Debt Securities Indenture dated January 17, 2018
3.564% Fixed Rate Resetting Subordinated Callable Notes due 2035
(From and including September 23, 2030: The then-prevailing U.S. Treasury Rate, plus 2.900%)(12)
$1,000,000,000March 23 and September 23September 23, 2020September 23, 2035
Tax Redemption,(1)
Regulatory Event Redemption,(2)
Par Redemption(4)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
Par Redemption Date: September 23, 2030
Dated Subordinated Enforcement Events(8)
Prospectus Supplement dated September 16, 2020Dated Subordinated Debt Securities Indenture dated as of May 9, 2017
1.007% Fixed Rate Resetting Senior Callable Notes due 2024
(From and including December 10, 2023: The then-prevailing U.S. Treasury Rate, plus 0.800%)(12)
$1,500,000,000June 10 and December 10December 10, 2020December 10, 2024
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after June 10, 2021 to (but excluding) December 10, 2023
Par Redemption Date: December 10, 2023
Senior Enforcement Events(7)
Prospectus Supplement dated December 3, 2020Senior Debt Securities Indenture dated January 17, 2018





2.667% Fixed Rate Resetting Senior Callable Notes due 2032
(From and including March 10, 2031: The then-prevailing U.S. Treasury Rate, plus 1.20%)
$1,000,000,000March 10 and September 10March 10, 2021March 10, 2032
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after September 10, 2021 (but excluding) March 10, 2031
Par Redemption Date: March 10, 2031
Senior Enforcement Events(7)
Prospectus Supplement dated March 5, 2021Senior Debt Securities Indenture dated January 17, 2018
3.811% Fixed Rate Resetting Subordinated Callable Notes due 2042
(From and including March 10, 2041: The then-prevailing U.S. Treasury Rate, plus 1.70%)
$1,000,000,000March 10 and September 10March 10, 2021March 10, 2042
Tax Redemption,(1)
Regulatory Event Redemption,(2)
Par Redemption,(4)
Notice Period: Not less than 30 nor more than 60 days’ prior notice.
Par Redemption Date: March 10, 2041
Dated Subordinated Enforcement Events(8)
Prospectus Supplement dated March 5, 2021Dated Subordinated Debt Securities Indenture dated as of May 9, 2017
2.279% Fixed Rate Resetting Senior Callable Notes due 2027
(From and including November 24, 2026: The then-prevailing U.S. Treasury Rate, plus 1.05%)
$1,750,000,000May 24 and November 24November 24, 2021November 24, 2027
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after May 24, 2022 to (but excluding) November 24, 2026
Par Redemption Date: November 24, 2026
Senior Enforcement Events(7)
Prospectus Supplement dated November 17, 2021Senior Debt Securities Indenture dated January 17, 2018





2.894% Fixed Rate Resetting Senior Callable Notes due 2032
(From and including November 24, 2031: The then-prevailing U.S. Treasury Rate, plus 1.30%)
$1,250,000,000May 24 and November 24November 24, 2021November 24, 2032
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after May 24, 2022 to (but excluding) November 24, 2031
Par Redemption Date: November 24, 2031
Senior Enforcement Events(7)
Prospectus Supplement dated November 17, 2021Senior Debt Securities Indenture dated January 17, 2018
3.330% Fixed Rate Resetting Senior Callable Notes due 2042
(From and including November 24, 2041: The then-prevailing U.S. Treasury Rate, plus 1.30%)
$1,000,000,000May 24 and November 24November 24, 2021November 24, 2042
Tax Redemption,(1)
Make-Whole Redemption,(3)
Par Redemption,(4)
Loss Absorption Disqualification Event, Redemption(5)
Notice Period: Not less than 15 nor more than 60 days’ prior notice.
Make-Whole Redemption Date: At any time on or after May 24, 2022 to (but excluding) November 24, 2026
Par Redemption Date: November 24, 2041
Senior Enforcement Events(7)
Prospectus Supplement dated November 17, 2021Senior Debt Securities Indenture dated January 17, 2018
(1) Tax Redemption means that we have the right to redeem any series of debt securities on the terms described below under “Tax Redemption.”
(2) Regulatory Event Redemption means that we have the right to redeem any series of Dated Subordinated Debt Securities on the terms described below under “Regulatory Event Redemption.”
(3) Make-Whole Redemption means that we have the right to redeem certain series of debt securities on the terms described below under clause (i) of “Optional Redemption.”
(4) Par Redemption means that we have the right to redeem certain series of debt securities on the terms described below under clause (ii) of “Optional Redemption.”
(5) Loss Absorption Disqualification Event Redemption means that we have the right to redeem certain series of Senior Debt Securities on the terms described below under “Loss Absorption Disqualification Event Redemption.”
(6) Senior Events of Default means that the events of default described below under “Senior Events of Default” are applicable to the relevant series of debt securities.
(7) Senior Enforcement Events means that the enforcement events and remedies described below under “Senior Enforcement Events” are applicable to the relevant series of debt securities.
(8) Dated Subordinated Enforcement Events means that the enforcement events and remedies described below under “Dated Subordinated Enforcement Events” are applicable to the relevant series of debt securities.
(9) The terms of the applicable series of debt securities provide substituted interest rates when LIBOR (as defined below) is temporarily or permanently unavailable as described under “LIBOR Replacement.
(10) The terms of the applicable series of debt securities specify certain “Benchmark Events” that would trigger substitution of LIBOR when LIBOR is temporarily or permanently unavailable, as defined and described below under “LIBOR Replacement.”
(11) The terms of the applicable series of debt securities specify “Benchmark Transition Provisions” that would trigger substitution of LIBOR or the then-current Benchmark (as defined below) when LIBOR or the then-current Benchmark is temporarily or permanently unavailable, as defined and described below under “Benchmark Transition Provisions.”
(12) The terms of the applicable series of debt securities provide for subsequent fixed interest rates from and including the reset date as specified in this table (the “Reset Date”), as described below under “InterestFixed Rate Resetting Notes – Interest.
(13) These Notes were redeemed on January 10, 2022.
(14) These Notes were redeemed on February 15, 2022.






The summary set out below of the general terms and provisions of our debt securities does not purport to be complete and is subject to and qualified by reference to, all of the definitions and provisions of the relevant indenture (as listed in the table above), any supplement to the relevant indenture and the form of the instrument representing each series of debt securities. Certain terms, unless otherwise defined here, have the meaning given to them in the relevant indenture.
General
The debt securities of any series are either our senior obligations (the “Senior Debt Securities”) or our dated subordinated obligations (the “Dated Subordinated Debt Securities” and, together with the Senior Debt Securities, are referred to herein as the “debt securities”).
Neither the Senior Debt Securities nor the Dated Subordinated Debt Securities are secured by any assets or property of Barclays or any of its subsidiaries or affiliates (including Barclays Bank PLC, its subsidiary).
Each series of Senior Debt Securities was issued under an indenture, entered into between us and The Bank of New York Mellon, London Branch, as “Trustee” (each, a “Senior Debt Securities Indenture”). Each series of Dated Subordinated Debt Securities was issued under an indenture, entered into between us and The Bank of New York Mellon, London Branch, as Trustee (each, a “Dated Subordinated Debt Securities Indenture”). With respect to each series of debt securities, the relevant Senior Debt Securities Indenture or Dated Subordinated Debt Securities Indenture (as applicable) is set forth in the table above, and any respective supplements thereto are referred to in this description individually as an “indenture” and collectively as the “indentures.” The terms of the debt securities include those stated in the relevant indenture and any supplements thereto, and those terms made part of the relevant indenture by reference to the U.S. Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). Each series of debt securities listed in the table above was issued pursuant to an effective registration statement and a related prospectus and prospectus supplement setting forth the terms of the relevant series of debt securities.
The indentures do not limit the amount of debt securities that we may issue. Unless otherwise provided in the terms of a series of debt securities, a series may be reopened, without notice to or consent of any holder of outstanding debt securities, for issuances of additional debt securities of that series. The debt securities of each series and any additional new debt securities of the same series would be treated as a single series for all purposes under the relevant indenture.
Holders of debt securities have no voting rights except as described below under “Modification and Waiver,” “Senior Events of Default,” “Dated Subordinated Enforcement Events and Remedies,” and “Limitation on Suits.”
The debt securities are not subject to any sinking fund.
Interest
As of December 31, 2021, we had four categories of registered Senior Debt Securities: (i) fixed rate Senior Debt Securities; (ii) floating rate Senior Debt Securities (“Floating Rate Notes”); (iii) fixed-to-floating rate Senior Debt Securities; and (iv) fixed rate resetting Senior Debt Securities; and three categories of registered Dated Subordinated Debt Securities: (i) fixed rate Dated Subordinated Debt Securities; (ii) fixed rate resetting Dated Subordinated Debt Securities (together with the fixed rate resetting Senior Debt Securities, the “Fixed Rate Resetting Notes,” and the Fixed Rate Resetting Notes, together with the fixed rate Senior Debt Securities and the fixed rate Dated Subordinated Debt Securities, the “Fixed Rate Notes”); and (iii) fixed-to-floating rate Dated Subordinated Debt Securities (together with the fixed-to-floating rate Senior Debt Securities, the “Fixed-to-Floating Rate Notes”). The relevant interest rates, interest rate amounts and interest payment dates of the debt securities are set out in the table above. Interest on the Fixed Rate Notes (including the fixed rate interest period of the Fixed-to-Floating Rate Notes) is computed on the basis of a 360-day year of twelve 30-day months, and, in the case of the Floating Rate Notes (including the floating rate interest period of the Fixed-to-Floating Rate Notes), on the basis of the actual number of days in each floating rate interest period and a 360-day year during any floating rate interest period. For the 3.250% Fixed Rate Senior Notes due 2033, where interest is to be calculated in respect of a period which is equal to or shorter than an interest period, interest will be calculated on the basis of the actual number of days in the relevant period, from and including the last date on which interest was paid on such debt securities, to, but excluding, the next date on which interest falls due, divided by the number of days in the interest period in which the relevant period falls (including the first such day but excluding the last). This payment convention is referred to as ACTUAL/ACTUAL (ICMA), defined based on the definition in the International Capital Market Association Primary Market Handbook.
Payments
Payment of principal of and interest on the debt securities, so long as the debt securities are represented by global securities, are made in immediately available funds. If any scheduled fixed rate interest payment date is not a Business Day (as defined below), we will pay interest on the next succeeding Business Day, but interest on that payment will not accrue during the period from and after the scheduled fixed rate interest payment date. If any scheduled floating rate interest payment date, other than the maturity date, would fall on a day that is not a Business Day, the floating rate interest payment date will be postponed to the next succeeding Business Day, except that if that Business Day falls in the next succeeding calendar month, the floating rate interest payment date will be the immediately preceding Business Day.
Payments in respect of debt securities denominated in U.S. dollars are made to holders of record on the close of business on the Business Day immediately preceding each interest payment date (or, if the debt securities are held in definitive form, the 15th Business Day preceding each interest payment date). Beneficial interests in the global securities denominated in U.S. dollars trade in the same-day funds settlement system of DTC, and secondary market trading activity in such interests will therefore settle in same-day funds. A “Business Day” means any weekday other than one on which banking institutions are authorized or obligated by law or executive order to close in London, England or in the City of New York, United States.
With respect to the 3.250% Fixed Rate Senior Notes due 2033, which are denominated in sterling (the “Sterling-denominated Notes”), payment of principal and interest payments in respect of this series of debt securities are payable in sterling to holders of record on the close of business (in the relevant Clearing System) on the Clearing System Business Day (each, as defined below) immediately preceding each interest payment date (or, if these debt securities are held in definitive form, the 15th Business Day preceding each interest payment date).
With respect to the Sterling-denominated Notes, “Clearing Systems” means Clearstream Banking S.A. (“Clearstream”)and/or Euroclear SA/NV (“Euroclear”), and shall include any successor clearing systems; and “Clearing System Business Day” means a day on which each Clearing System for which any global certificate is being held is open for business.
Beneficial interests in the Sterling-denominated Notes trade in accordance with the normal rules and operating procedures of Clearstream, Luxembourg and/or Euroclear, and secondary market trading activity in such interests will be settled using the procedures applicable to conventional eurobonds in same-day funds.
If sterling is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or is no longer used for the settlement of transactions by public institutions within the international banking community, then all payments in respect of the Sterling-denominated Notes will be made in U.S. dollars until sterling is again available to us or so used. The amount payable on any date in sterling will be converted into U.S. dollars at the Market Exchange Rate (as defined below) as of the close of business on the second Business Day prior to the relevant payment date or, if such Market Exchange Rate is not then available, on the basis of the then most recent U.S. dollar/sterling exchange rate available on or prior to the second Business Day prior to the relevant payment date as determined by us in our sole discretion. “Market Exchange Rate” means the noon buying rate in The City of New York for cable transfers of sterling as certified for customs purposes (or, if not so certified, as otherwise determined) by the Federal Reserve Bank of New York.
Any payment in respect of the Sterling-denominated Notes so made in U.S. dollars will not constitute an event of default under the relevant indenture or the terms of this series of debt securities. Neither the Trustee nor the paying agent will be responsible for obtaining exchange rates, effecting currency conversions or otherwise handling redenominations. Holders of this series of debt securities will be subject to foreign exchange risks as to payments of principal and interest that may have important economic and tax consequences to them.
Fixed Rate Resetting Notes – Interest





The applicable per annum interest rate on the Fixed Rate Resetting Notes, from (and including) the Reset Date (as set out in the table above) to (but excluding) the Maturity Date (as set out in the table above) will be equal to the sum, as determined by The Bank of New York Mellon, London branch, as Calculation Agent, of the then-prevailing U.S. Treasury Rate (as defined below) on the second Business Day immediately preceding the relevant Reset Date (the “Reset Determination Date”), plus a certain percentage (“margin”) as set forth in the table above.
“U.S. Treasury Rate” means, with respect to the period from and including the Reset Date to the Maturity Date (the “Reset Period”), the rate per annum equal to: (1) the yield, under the heading which represents the average for the week immediately prior to the Reset Determination Date, appearing in the most recently published statistical release designated “H.15,” or any successor publication that is published by the Board of Governors of the Federal Reserve System that establishes yields on actively traded U.S. Treasury securities adjusted to constant maturity, under the caption “Treasury constant maturities,” for the term to maturity as specified in the relevant prospectus supplement; or (2) if such release (or any successor release) is not published during the week immediately prior to the Reset Determination Date or does not contain such yields, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue (as defined below), calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price (as defined below) for the Reset Determination Date.
If the U.S. Treasury Rate cannot be determined, for whatever reason, as described under (1) or (2) above, “U.S. Treasury Rate” means the rate in percentage per annum as notified by the Calculation Agent to us equal to the yield on U.S. Treasury securities having the term to maturity, as specified in the relevant prospectus supplement, as set forth in the most recently published statistical release designated “H.15” under the caption “Treasury constant maturities” (or any successor publication that is published weekly by the Board of Governors of the Federal Reserve System and that establishes yields on actively traded U.S. Treasury securities adjusted to constant maturity under the caption “Treasury constant maturities” for the term to maturity as specified in the relevant prospectus supplement) at 5:00 p.m. (New York City time) on the last available date preceding the Reset Determination Date on which such rate was set forth in such release (or any successor release).
“Comparable Treasury Issue” means, with respect to the Reset Period, the U.S. Treasury security or securities selected by us with a maturity date on or about the last day of the Reset Period and that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities denominated in U.S. dollars and having the term to maturity as specified in the relevant prospectus supplement.
“Comparable Treasury Price” means, with respect to the Reset Determination Date, (i) the arithmetic average of the Reference Treasury Dealer Quotations ( as defined below) for the Reset Determination Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, (ii) if fewer than five such Reference Treasury Dealer Quotations are received, the arithmetic average of all such quotations, or (iii) if fewer than two such Reference Treasury Dealer Quotations are received, then such Reference Treasury Dealer Quotation.
“Reference Treasury Dealer” means, with respect to the Reset Determination Date, each of up to five banks selected by us, or the affiliates of such banks, which are (i) primary U.S. Treasury securities dealers, and their respective successors, or (ii) market makers in pricing corporate bond issues denominated in U.S dollars.
“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and the Reset Determination Date, the arithmetic average, as determined by the Calculation Agent, of the bid and offered prices (such prices being obtained by us and furnished to the Calculation Agent) for the applicable Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, at 11:00 a.m. (New York City time) on the Reset Determination Date.
Floating Rate Interest – LIBOR
The Floating Rate Notes and, during the relevant floating rate interest periods for each series of Fixed-to-Floating Rate Notes, the Fixed-to-Floating Rate Notes, will bear interest at a floating rate, reset quarterly, plus the margin as set forth in the table above.
The Bank of New York Mellon, London branch, as Calculation Agent, determines the floating interest rate for each floating rate interest period by reference to the then-current three-month U.S. dollar London Interbank Offered Rate (“LIBOR”) on the applicable interest determination date. The interest determination date for each floating rate interest period is the second London banking day (being any day on which dealings in U.S. dollars are transacted in the London interbank market) preceding the applicable floating rate interest payment date.
Calculation of LIBOR
With respect to any interest determination date, LIBOR is the offered rate for deposits in U.S. dollars having a maturity of three months that appears on Reuters Page LIBOR01 as of the applicable time specified in the relevant prospectus supplement, on that interest determination date. If no such rate appears on Reuters Page LIBOR01 on such interest determination date, LIBOR will be determined for such interest determination date on the basis of the rates at which deposits in U.S. dollars for the period of three months are offered to prime banks in the London interbank market by the principal London offices of each of four major reference banks in the London interbank market, as selected and identified by us (the “reference banks”), at the applicable time as specified in the relevant prospectus supplement, on that interest determination date and in a principal amount that is representative for a single transaction in U.S. dollars in that market at that time. If at least two such quotations are provided, LIBOR on such interest determination date will be the arithmetic mean of those quotations. If fewer than two such quotations are provided, LIBOR on such interest determination date will be the arithmetic mean of the rates quoted at approximately 11:00 a.m., in the City of New York, on the interest determination date by three major banks in The City of New York, selected and identified by us, for loans in U.S. dollars to leading European banks, for a period of three months, commencing on the related interest reset date, and in a principal amount that is representative for a single transaction in U.S. dollars in that market at that time. If at least two such rates are so provided, LIBOR on the interest determination date will be the arithmetic mean of such rates. If fewer than two such rates are so provided, LIBOR on the interest determination date will be equal to LIBOR in effect with respect to the immediately preceding interest determination date or, in the case of the first interest determination date for the 2.852% Fixed-to-Floating Rate Senior Notes due 2026, the rate of interest for the relevant interest rate period will be equal to the fixed interest rate for such series of debt securities.
In this section, “Reuters Page LIBOR01” means the display that appears on Reuters Page LIBOR01 or any page as may replace such page on such service (or any successor service) for the purpose of displaying London interbank offered rates of major banks for U.S. dollars.
LIBOR Replacement
Following the FCA’s announcement in July 2017 that it will no longer persuade or compel banks to submit rates for the calculation of LIBOR to the administrator of LIBOR after 2021, the terms of certain series of debt securities issued from May 2018 (listed in the table above) include LIBOR replacement provisions in the event that LIBOR is, for example, discontinued or ceases to be published, such that it is no longer possible to calculate the floating rate interest in the manner set out above.
Replacement of LIBOR
For those debt securities for which “Terms provide for the replacement of LIBOR” is indicated in the table above, the following provisions for the replacement of LIBOR apply. In addition, for those debt securities for which “Terms provide for Benchmark Events (as defined below) that would trigger the replacement of LIBOR” is also indicated in the table above, the following provisions for the replacement of LIBOR apply following the occurrence of a Benchmark Event.
(i)We shall use reasonable endeavours to appoint an Independent Adviser to determine a Successor Rate (as defined below) or, alternatively, if there is no Successor Rate, an Alternative Reference Rate (as defined below);
(ii)If we are unable to appoint an Independent Adviser, or the Independent Adviser appointed fails to determine either a Successor Rate or whether an Alternative Reference Rate may be used, we may ourselves make such a determination regarding the applicable floating interest rate for the affected debt securities;
(iii)If a Successor Rate or an Alternative Reference Rate (as applicable) is determined in accordance with clause (i) or (ii), such Successor Rate or Alternative Reference Rate (as applicable) shall be LIBOR for each of the future interest periods (subject to the subsequent operation of, and to any applicable adjustment described in clause (iv) below); provided, however, that if clause (ii) applies and we do not, or are also unable to, determine either a Successor Rate or whether an Alternative Reference Rate may be used, the floating interest rate applicable to the next succeeding floating rate interest period shall be equal to the floating interest rate last determined in relation to the affected debt securities (or,





alternatively, in the case of the applicable series of Floating Rate Notes, if there has not been a first floating rate interest payment date in respect of such debt securities, or in the case of the applicable series of Fixed-to-Floating Rate Notes, if there has not been a first floating rate interest period in respect of such debt securities, the floating interest rate shall be the relevant first floating rate of interest or the fixed interest rate, as applicable pursuant to the prospectus supplement for the relevant debt securities);
(iv)If we or the Independent Adviser (as applicable) determines that an Adjustment Spread (as defined below) should be applied to the Successor or Alternative Reference Rate (as applicable) and determines the quantum of, or a formula or methodology for determining, such Adjustment Spread, then such Adjustment Spread shall be applied to the Successor Rate or the Alternative Reference Rate (as applicable) and the Floating Rate of Interest shall be the aggregate of (a) the Successor Rate or the Alternative Reference Rate (as applicable), (b) the Adjustment Spread, and (c) the Margin; failing which, such Successor Rate or Alternative Reference Rate (as applicable) will apply without an Adjustment Spread. We or the Independent Adviser may also specify certain changes to the terms of the affected debt securities including, but not limited to, the margin, relevant day count, relevant screen page, Business Day, interest determination date and/or the definition of LIBOR, and the method for determining the fallback rate in relation to the affected debt securities, in order to follow market practice in relation to the chosen Successor Rate, the Alternative Reference Rate (as applicable) and/or the Adjustment Spread.
The Trustee and Calculation Agent will effect any amendments to the relevant documentation (including the indenture and the terms of the debt securities) that are required to give effect to the provisions described above. Consent of the holders of the affected debt securities will not be required in connection with implementing a Successor Rate, Alternative Reference Rate (as applicable) and/or any Adjustment Spread or such other changes, including for the execution of any documents, amendments or other steps by the Trustee or the Calculation Agent (if required).
We will give prompt notice to the Trustee, the Calculation Agent and the holders of the debt securities following the determination of any Successor Rate, Alternative Reference Rate (as applicable) and/or any Adjustment Spread, and specify the effective date(s) for such Successor Rate, Alternative Reference Rate (as applicable) and/or any Adjustment Spread and any consequential changes made to the provisions as described above.
Notwithstanding the above, determination of any Successor Rate, Alternative Reference Rate or any Adjustment Spread, and any other related changes to the debt securities, shall be made in accordance with the relevant Capital Regulations (if applicable), as defined in the prospectus supplement for the relevant series of debt securities.
For the purposes of this section:
“Adjustment Spread” means a spread (which may be positive or negative) or formula or methodology for calculating a spread, which the Independent Adviser (in consultation with us) or we, as issuer (as applicable), determine is required to be applied to the Successor Rate or the Alternative Reference Rate (as applicable) in order to reduce or eliminate, to the extent reasonably practicable in the circumstances, any economic prejudice or benefit (as applicable) to holders of the debt securities as a result of the replacement of LIBOR with the Successor Rate or the Alternative Reference Rate (as applicable) and is the spread, formula or methodology which:
(i)in the case of a Successor Rate, is recommended in relation to the replacement of LIBOR with the Successor Rate by any “Relevant Nominating Body” (as that term is defined in the prospectus supplement for the relevant series of debt securities); or
(ii)in the case of a Successor Rate for which no such recommendation has been made or in the case of an Alternative Reference Rate, the Independent Adviser (in consultation with us) or we, as issuer (as applicable) determine is recognized or acknowledged as being in customary market usage in international debt capital markets transactions which reference LIBOR, where such rate has been replaced by the Successor Rate or the Alternative Reference Rate (as applicable); or
(iii)if no such customary market usage is recognized or acknowledged, the Independent Adviser (in consultation with us) or we, as issuer, in its/our discretion (as applicable), determine (acting in good faith and in a commercially reasonable manner) to be appropriate;
“Alternative Reference Rate” means the rate that the Independent Adviser or we, as issuer (as applicable) determine has replaced LIBOR in customary market usage in the international debt capital markets for the purposes of determining rates of interest in respect of bonds denominated in U.S. dollars and of a comparable duration to the relevant floating rate interest period, or, if the Independent Adviser or we, as issuer (as applicable) determine that there is no such rate, such other rate as the Independent Adviser or we, as issuer (as applicable) determines in its/our discretion (acting in good faith and in a commercially reasonable manner) is most comparable to LIBOR;
“Benchmark Event” means:
LIBOR has ceased to be published on the relevant screen page as a result of such benchmark ceasing to be calculated or administered; or
a public statement by the administrator of LIBOR that it has ceased, or will cease, publishing such reference rate permanently or indefinitely (in circumstances where no successor administrator has been appointed that will continue publication of such reference rate); or
a public statement by the supervisor of the administrator of LIBOR that such reference rate has been or will be permanently or indefinitely discontinued; or
a public statement by the supervisor of the administrator of LIBOR as a consequence of which such reference rate will be prohibited from being used or that its use will be subject to restrictions or adverse consequences either generally, or in respect of the debt securities; or
a public statement by the supervisor of the administrator of LIBOR that, in the view of such supervisor, such reference rate is no longer representative of an underlying market or the methodology to calculate such reference rate has materially changed; or
it has or will become unlawful for the Calculation Agent or us to calculate any payments due to be made to any holder of the debt securities using LIBOR (including, without limitation, under the Benchmark Regulation (EU) 2016/1011, if applicable).
“Independent Adviser” means an independent financial institution of international repute or other independent financial adviser experienced in the international debt capital markets, in each case appointed by us at our own expense;
“Successor Rate” means the reference rate (and related alternative screen page or source, if applicable) that the Independent Adviser or we, as issuer (as applicable) determines is a successor to or replacement of LIBOR which is formally recommended by any Relevant Nominating Body.
Benchmark Transition Provisions
For the 2.852% Fixed-to-Floating Rate Senior Notes due 2026, if we or our designee determine on or prior to any interest determination date that a Benchmark Transition Event and its related Benchmark Replacement Date (each, as defined below) have occurred with respect to LIBOR or the then-current Benchmark, then the provisions set forth below under this section (the “Benchmark Transition Provisions”) will thereafter apply to all determinations of the applicable floating interest rate for such debt securities; provided that no Benchmark Replacement (as defined below) will be adopted if and to the extent that we determine, in our sole discretion, that such Benchmark Replacement prejudices, or could reasonably be expected to prejudice, after the application of the applicable Benchmark Replacement Adjustment, the Benchmark Replacement Conforming Changes (each, as defined below) and the further decisions and determinations as described below, the eligibility of such debt securities to count towards the Group’s minimum requirement for own funds and eligible liabilities for purposes of, and in accordance with, the Capital Regulations; provided further that, if we have determined not to adopt the Benchmark Replacement in accordance with the proviso set forth above and a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to LIBOR or the then-current Benchmark, the floating interest rate for such floating rate interest period and subsequent floating rate interest periods will be equal to the applicable floating interest rate in effect for the immediately preceding floating rate interest period or, in the case of the first interest determination date, the rate of interest for such floating rate interest period and subsequent floating rate interest periods will be equal to the applicable fixed interest rate. In accordance with the Benchmark Transition Provisions, after a Benchmark Transition Event and its related Benchmark Replacement Date have occurred, the amount of interest that will be payable for each floating rate interest period will be an annual rate equal to the sum of the Benchmark Replacement and the margin.
If we or our designee determine that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time (as defined below) in respect of any determination of the Benchmark on any date, the Benchmark Replacement will replace the then-current Benchmark for all purposes in respect of such determination on such date and all determinations on all subsequent dates.
In connection with the implementation of a Benchmark Replacement, we or our designee has the right to make any Benchmark Replacement Conforming Changes from time to time.





“Benchmark” means, initially, LIBOR; provided that if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to LIBOR or the then-current Benchmark, then “Benchmark” means the applicable Benchmark Replacement.
“Benchmark Replacement” means the Interpolated Benchmark with respect to the then-current Benchmark, plus the Benchmark Replacement Adjustment for such Benchmark; provided that if we or our designee cannot determine the Interpolated Benchmark as of the Benchmark Replacement Date, then “Benchmark Replacement” means the first alternative set forth in the order below that can be determined by us or our designee as of the Benchmark Replacement Date:
(1)the sum of: (a) Term SOFR and (b) the Benchmark Replacement Adjustment;
(2)the sum of: (a) Compounded SOFR and (b) the Benchmark Replacement Adjustment;
(3)the sum of: (a) the alternate rate of interest that has been selected or recommended by the Relevant Governmental Body as the replacement for the then-current Benchmark for the applicable Corresponding Tenor and (b) the Benchmark Replacement Adjustment;
(4)the sum of: (a) the ISDA Fallback Rate and (b) the Benchmark Replacement Adjustment; or
(5)the sum of: (a) the alternate rate of interest that has been selected by us or our designee as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to any industry-accepted rate of interest as a replacement for the then-current Benchmark for U.S. dollar denominated floating rate debt securities at such time and (b) the Benchmark Replacement Adjustment.
“Benchmark Replacement Adjustment” means the first alternative set forth in the order below that can be determined by us or our designee as of the Benchmark Replacement Date:
(1)the spread adjustment, or method for calculating or determining such spread adjustment that has been selected, or recommended by the Relevant Governmental Body for the applicable Unadjusted Benchmark Replacement;
(2)if the applicable Unadjusted Benchmark Replacement is equivalent to the ISDA Fallback Rate, then the ISDA Fallback Adjustment;
(3)the spread adjustment that has been selected by us or our designee giving due consideration to any industry-accepted spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the then-current Benchmark with the applicable Unadjusted Benchmark Replacement for U.S. dollar denominated floating rate debt securities at such time.
“Benchmark Replacement Conforming Changes” means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of interest period, timing and frequency of determining rates and making payments of interest, rounding of amounts or tenors, and other administrative matters) that we or our designee decide may be appropriate to reflect the adoption of such Benchmark Replacement in a manner substantially consistent with market practice (or, if we or our designee decide that adoption of any portion of such market practice is not administratively feasible or if we or our designee determine that no market practice for use of the Benchmark Replacement exists, in such other manner as we or our designee determine is reasonably necessary).
“Benchmark Replacement Date” means the earliest to occur of the following events with respect to the then-current Benchmark:
(1)in the case of clause (1) or (2) of the definition of “Benchmark Transition Event,” the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of the Benchmark permanently or indefinitely ceases to provide the Benchmark; or
(2)in the case of clause (3) of the definition of “Benchmark Transition Event,” the date of the public statement or publication of information referenced therein.
If the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination.
“Benchmark Transition Event” means:
(1)a public statement by the administrator of the then-current Benchmark that it has ceased, or will cease, publishing such Benchmark permanently or indefinitely (in circumstances where no successor administrator has been appointed that will continue publication of such Benchmark); or
(2)a public statement by the supervisor of the administrator of the then-current Benchmark that such reference rate has been or will be permanently or indefinitely discontinued; or
(3)a public statement by the supervisor of the administrator of the then-current Benchmark announcing that such Benchmark is no longer representative.
“Compounded SOFR” means the compounded average of daily SOFR rates for the applicable Corresponding Tenor, with the rate, or methodology for this rate, and conventions for this rate being established by us in accordance with:
(1)the rate, or methodology for this rate, and conventions for this rate selected or recommended by the Relevant Governmental Body for determining Compounded SOFR; provided that:
(2)if, and to the extent that, we or our designee determine that Compounded SOFR cannot be determined in accordance with clause (1) above, then the rate, or methodology for this rate, and conventions for this rate that have been selected by us or our designee giving due consideration to any industry-accepted market practice for U.S. dollar denominated floating rate notes at such time.
“Corresponding Tenor” with respect to a Benchmark Replacement means a tenor (including overnight) having approximately the same length (disregarding business day adjustment) as the applicable tenor for the then-current Benchmark.
“designee” means a designee as selected and separately appointed by us as designee for the notes in writing.
“Federal Reserve Bank of New York’s Website” means the website of the FRBNY at http://www.newyorkfed.org, or any successor source.
“Interpolated Benchmark” with respect to the Benchmark means the rate determined for the Corresponding Tenor by interpolating on a linear basis between: (1) the Benchmark for the longest period (for which the Benchmark is available) that is shorter than the Corresponding Tenor and (2) the Benchmark for the shortest period (for which the Benchmark is available) that is longer than the Corresponding Tenor.
“ISDA Definitions” means the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. (“ISDA”) or any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time.
“ISDA Fallback Adjustment” means the spread adjustment (which may be a positive or negative value or zero) that would apply for derivatives transactions referencing the ISDA Definitions to be determined upon the occurrence of an index cessation event with respect to the Benchmark for the applicable tenor.
“ISDA Fallback Rate” means the rate that would apply for derivatives transactions referencing the ISDA Definitions to be effective upon the occurrence of an index cessation date with respect to the Benchmark for the applicable tenor excluding the applicable ISDA Fallback Adjustment.
“Reference Time” with respect to any determination of the Benchmark means (1) if the Benchmark is LIBOR, 11:00 a.m. (London time) on the day that is two London Banking Days preceding the date of such determination, and (2) if the Benchmark is not LIBOR, the time determined by us or our designee in accordance with the Benchmark Replacement Conforming Changes.





“Relevant Governmental Body” means the Federal Reserve Board and/or the FRBNY, or a committee officially endorsed or convened by the Federal Reserve Board and/or the FRBNY or any successor thereto.
“SOFR” with respect to any day means the secured overnight financing rate published for such day by the FRBNY, as the administrator of the benchmark (or a successor administrator), on the Federal Reserve Bank of New York’s Website (or any successor source).
“Term SOFR” means the forward-looking term rate for the applicable Corresponding Tenor based on SOFR that has been selected or recommended by the Relevant Governmental Body.
“Unadjusted Benchmark Replacement” means the Benchmark Replacement excluding the Benchmark Replacement Adjustment.
Ranking
Senior Debt Securities
Our Senior Debt Securities constitute our direct, unconditional, unsecured and unsubordinated obligations ranking pari passu without any preference among themselves. In the event of our winding-up or administration, the Senior Debt Securities will rank pari passu with all our other outstanding unsecured and unsubordinated obligations, present and future, except such obligations as are preferred by operation of law.
Pursuant to the UK Banks and Building Societies (Priorities on Insolvency) Order 2018, the Senior Debt Securities will constitute our ordinary non-preferential debt and will rank in priority to secondary non-preferential debts and tertiary non-preferential debts. The terms “ordinary non-preferential debt”, “secondary-non preferential debt” and “tertiary non-preferential debt” shall have the meanings given to each of them in such Order and any other law or regulation applicable to us which is amended by such Order, as each may be amended or replaced from time to time.
Dated Subordinated Debt Securities
Our Dated Subordinated Debt Securities constitute our direct, unsecured and subordinated obligations ranking pari passu without any preference among themselves. In the event of our winding-up or administration, the claims of the Trustee, on behalf of the holders of the Dated Subordinated Debt Securities (but not the rights and claims of the Trustee in its personal capacity under the relevant Dated Subordinated Debt Securities Indenture), and the holders of the Dated Subordinated Debt Securities against us, in respect of such Dated Subordinated Debt Securities (including any damages or other amounts (if payable)) will:
(i)     be subordinated to the claims of all senior creditors (as defined below);
(ii)     rank at least pari passu with the claims of any subordinated creditors of Barclays which in each case by law rank, or by their terms are expressed to rank, pari passu with the Dated Subordinated Debt Securities; and
(iii)     rank senior to Barclays’ ordinary shares, preference shares and any junior subordinated obligations (which may include any of the junior subordinated obligations which are identified in the relevant prospectus supplement as “junior obligations”) or other securities which in each case either by law rank, or by their terms are expressed to rank, junior to the Dated Subordinated Debt Securities.
“Senior creditors” with respect to a particular series of Dated Subordinated Debt Securities, means creditors of Barclays who are: (1) unsubordinated creditors; (2) subordinated creditors (whether in the event of a winding-up or administration of Barclays or otherwise) other than (x) those whose claims by law rank, or by their terms are expressed to rank, pari passu with or junior to the claims of the holders of the relevant series of Dated Subordinated Debt Securities or (y) any claims which are identified in the relevant prospectus supplement as being in respect of “Parity Obligations” or “Junior Obligations”; or (3) in the case of the 5.088% Fixed-to-Floating Rate Subordinated Notes due 2030, the 3.564% Fixed Rate Resetting Subordinated Callable Notes due 2035, and the 3.811% Fixed Rate Resetting Subordinated Callable Notes due 2042, creditors in respect of any secondary non-preferential debts (as defined in the Banks and Building Societies (Priorities on Insolvency) Order 2018 and any other law or regulation applicable to Barclays which is amended by this order). As of December 31, 2021, the aggregate amount of outstanding indebtedness senior to the Dated Subordinated Debt Securities is GBP £42,625 million.
No Set-off
For the Dated Subordinated Debt Securities and the Senior Debt Securities issued on or after January 3, 2017, subject to applicable law, no holder of debt securities may exercise any claim or plead any right of set-off, compensation or retention in respect of any amount owed to it by us in connection with the debt securities and the relevant indenture. By its acquisition of the debt securities, each holder and beneficial owner shall be deemed to have waived all such rights of set-off, compensation or retention. No holder of debt securities shall be entitled to proceed directly against us except as described below under “Limitation on Suits.
For the Senior Debt Securities issued prior to 2017, subject to applicable law, the Trustee and holders of the debt securities by their acceptance thereof will be deemed to have waived any right of set-off or counterclaim with respect to the relevant debt securities or the relevant indenture that they might otherwise have against us.
Redemption
We may, in the circumstances set out below, redeem the debt securities prior to their specified maturity date. Holders of the debt securities have no right to require us to redeem the debt securities. The debt securities of any series to be redeemed will also stop bearing interest on the relevant redemption date. We will give prior notice of any proposed redemption to holders of debt securities denominated in U.S. dollars via DTC or, in respect of the Sterling-denominated Notes, via Clearstream, Luxembourg and/or Euroclear, or, if the relevant debt securities are held in definitive form, to the holders at their addresses shown on the register for such debt securities. The notice period required for any proposed redemption is set out in the table above.
Notwithstanding the foregoing, for the Dated Subordinated Debt Securities and certain series of Senior Debt Securities issued on or after January 3, 2017, we may redeem the relevant series of debt securities only if we have obtained prior regulatory consent for such redemption to the extent that such consent is required by the Capital Regulations, as defined in the prospectus supplement for the relevant series of debt securities to be redeemed.
If we have elected to redeem any series of debt securities but prior to the payment of the redemption amount the Relevant U.K. Resolution Authority exercises its U.K. Bail-in Power (see “—Exercise of U.K. Bail-in Power” below) in respect of the debt securities, the relevant redemption notice shall be automatically rescinded and shall be of no force and effect, and no payment of the redemption amount will be due and payable.
Tax Redemption
We have the right to redeem any series of debt securities, in whole but not in part, at a redemption price equal to 100% of their principal amount together with any accrued but unpaid interest, if any, upon the occurrence of certain events related to taxation as described in the relevant prospectus supplement.
If, as a result of a change in, or amendment to, the tax laws or regulations of the United Kingdom (or any political subdivision or authority thereof or therein that has the power to tax) (a “Taxing Jurisdiction”), including any treaty to which the relevant Taxing Jurisdiction is a party, or a change in an official application of those tax laws or regulations, including a decision of any court or tribunal, which becomes effective on or after the date on





which the debt securities are issued (or, in the case of additional securities of the same series, the date on which the original securities are issued), we: (i) will or would be required to pay holders any additional amounts (as described below under “Payment of Debt Security Additional Amounts”); (ii) would not be entitled to claim a deduction in respect of any payments in computing our taxation liabilities or the amount of the deduction would be materially reduced; or (iii) are unable to have losses or deductions set against the profits or gains, or profits or gains offset by the losses or deductions, of companies with which we are or would otherwise be so grouped for applicable United Kingdom tax purposes (each such change in law or regulation or the official application thereof, a “Tax Event”), we may redeem the affected series of debt securities.
In addition, in respect of the 3.250% Fixed Rate Senior Notes due 2033, 4.338% Fixed-to-Floating Rate Senior Notes due 2024, 4.972% Fixed-to-Floating Rate Senior Notes due 2029, Floating Rate Senior Notes due 2024, 4.610% Fixed-to-Floating Rate Senior Notes due 2023, Floating Rate Senior Notes due 2023 (3 month USD LIBOR plus 1.43% p.a.), 3.932% Fixed-to-Floating Rate Senior Notes due 2025, 2.852% Fixed-to-Floating Rate Senior Notes due 2026, 2.645% Fixed Rate Resetting Senior Callable Notes due 2031,1.007% Fixed Rate Resetting Senior Callable Notes due 2024, 2.667% Fixed Rate Resetting Senior Callable Notes due 2032, 2.279% Fixed Rate Resetting Senior Callable Notes due 2027, 2.894% Fixed Rate Resetting Senior Callable Notes due 2032, and 3.330% Fixed Rate Resetting Senior Callable Notes due 2042, we may also, at our option, redeem such series of debt securities, in whole but not in part, if we are required to issue definitive certificated notes in the events specified under the relevant prospectus relating to the termination of a global security and, as a result, we become obligated to pay holders any additional amounts (as described below under “Payment of Debt Security Additional Amounts”).
We may also redeem the 5.088% Fixed-to-Floating Rate Subordinated Notes due 2030, the 3.564% Fixed Rate Resetting Subordinated Callable Notes due 2035 and the 3.811% Fixed Rate Resetting Subordinated Callable Notes due 2042, if, as a result of a Tax Event, we become obligated (i) to treat such debt securities or any part thereof as a derivative or an embedded derivative for United Kingdom tax purposes; or (ii) to bring into account a taxable credit if the principal amount of such debt securities were written down or converted.
Optional Redemption
We have the right to redeem certain series of debt securities (as specified in the table above), at our option (i) in whole or in part, at any time during a fixed period specified in the prospectus supplement for the series of debt securities to be redeemed, at a redemption price equal to the higher of (a) 100% of the principal amount of such debt securities to be redeemed and (b) as determined by the Determination Agent (as defined below), the sum of the present values of the principal (discounted from the date of the Par Redemption specified in the relevant prospectus supplement (the “Par Redemption Date”)) and remaining payments of interest to be made on any scheduled fixed rate interest payment date to the Par Redemption Date for the debt securities to be redeemed (not including accrued but unpaid interest, if any, on the principal amount of the debt securities) discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the then-current Optional Redemption Treasury Rate (as defined below) plus a specified margin, together with, in either case of (a) or (b) above, accrued but unpaid interest, if any, on the principal amount of the debt securities to be redeemed to (but excluding) the redemption date (the “Make-Whole Redemption”); and/or (ii) in whole but not in part, on the applicable Par Redemption Date specified in the table above for the series of debt securities to be redeemed, at a redemption price equal to 100% of their principal amount together with accrued but unpaid interest, if any.
The Optional Redemption Treasury Rate shall be calculated by the Determination Agent on the third Business Day preceding the redemption date. In determining the Treasury Rate, the below terms have the following meaning:
“Optional Redemption Treasury Rate” means, with respect to the redemption date, the rate per annum equal to: (1) the yield, under the heading which represents the average for the week immediately prior to the calculation date, appearing in the most recently published statistical release designated “H.15”, or any successor publication that is published by the Board of Governors of the Federal Reserve System that establishes yields on actively traded U.S. Treasury securities adjusted to constant maturity, under the caption “Treasury constant maturities”, for the maturity most closely corresponding to the Par Redemption Date of the debt securities being redeemed (if no maturity is within three months before or after the Par Redemption Date of the debt securities to be redeemed, yields for the two published maturities most closely corresponding to the Optional Redemption Comparable Treasury Issue shall be determined and the Optional Redemption Treasury Rate shall be interpolated or extrapolated from such yields on a straight-line basis, rounding to the nearest month); or (2) if such release (or any successor release) is not published during the week immediately prior to the calculation date or does not contain such yields, the rate per annum equal to the semi-annual equivalent yield to maturity of the Optional Redemption Comparable Treasury Issue, calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Optional Redemption Comparable Treasury Price for such redemption date; provided that, if the period from the redemption date to the Par Redemption Date is less than one year, the weekly average yield on actually traded U.S. Treasury securities adjusted to a constant maturity of one year will be used.
“Optional Redemption Comparable Treasury Issue” means, with respect to the redemption date, the U.S. Treasury security selected by the Determination Agent as having an actual or interpolated maturity comparable with the remaining term to the Par Redemption Date of the debt securities, that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities denominated in U.S. dollars and of comparable maturity to the remaining term to the Par Redemption Date of the debt securities.
“Optional Redemption Comparable Treasury Price” means, with respect to the redemption date, (i) the arithmetic average of the Optional Redemption Reference Treasury Dealer Quotations for such redemption date (calculated on the third Business Day preceding such redemption date), after excluding the highest and lowest such Optional Redemption Reference Treasury Dealer Quotations, or (ii) if fewer than five such Optional Redemption Reference Treasury Dealer Quotations are received, the arithmetic average of all such quotations, or (iii) if fewer than two such Optional Redemption Reference Treasury Dealer Quotations are received, then such Optional Redemption Reference Treasury Dealer Quotation.
“Determination Agent” means an investment bank or financial institution of international standing selected by Barclays and which may be an affiliate of Barclays.
“Optional Redemption Reference Treasury Dealer” means each of up to five banks selected by Barclays (following, where practicable, consultation with the Determination Agent, if applicable), or the affiliates of such banks, which are (i) primary U.S. government securities dealers, and their respective successors, or (ii) market makers in pricing corporate bond issues.
“Optional Redemption Reference Treasury Dealer Quotations” means, with respect to each Optional Redemption Reference Treasury Dealer and the redemption date, the arithmetic average, as determined by the Determination Agent, of the bid and offered prices for the applicable Optional Redemption Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) at 11:00 a.m., New York time, on the third Business Day preceding such redemption date.
Loss Absorption Disqualification Event Redemption
We have the right to redeem certain series of the senior debt securities (as specified in the table above), in whole but not in part, at a redemption price amount equal to 100% of the principal amount of the debt securities being redeemed together with accrued but unpaid interest, if any, upon the occurrence of a Loss Absorption Regulations Event (as defined below) which results, or would be likely to result (in our opinion, or the opinion of the Prudential Regulation Authority (“PRA”) or any other relevant national or European authority), in a Loss Absorption Disqualification Event (as defined below) with respect to the relevant debt securities to be redeemed.
“Loss Absorption Disqualification Event” means the whole or any part of the outstanding aggregate principal amount of the relevant debt securities at any time being excluded from or ceasing to count towards our and/or the Group’s own funds and eligible liabilities and/or loss absorbing capacity, in each case for the purposes of, and in accordance with, the relevant Capital Regulations, provided that a Loss Absorption Disqualification Event shall not occur if such whole or part of the outstanding principal amount of the relevant debt securities is excluded from, or ceases to count towards, such own funds and eligible liabilities and/or loss absorbing capacity due to the remaining maturity of such debt securities being less than the period prescribed in the prospectus supplement for the relevant debt securities.
“Loss Absorption Regulations Event” means that (i) any Capital Regulations become effective with respect to Barclays and/or the Group or (ii) there is an amendment to, or change in, any Capital Regulations, or any change in the official application of any Capital Regulations, which becomes effective with respect to Barclays and/or the Group.
Regulatory Event Redemption





If there is a change in the regulatory classification of the Dated Subordinated Debt Securities that occurs on or after their issue date and that does, or would be likely to, result in the whole or any part of the outstanding aggregate principal amount of such Dated Subordinated Debt Securities at any time being excluded from or ceasing to count towards, the Group’s tier 2 capital, we may, at our option, at any time, redeem the affected Dated Subordinated Debt Securities, in whole but not in part, at an amount equal to 100% of their principal amount together with accrued but unpaid interest, if any.
Payment of Debt Security Additional Amounts
We will pay any amounts to be paid by us on any series of debt securities without deduction or withholding for, or on account of, any and all present or future income, stamp and other taxes, levies, imposts, duties, charges, fees, deductions or withholdings (“Taxes”) now or hereafter imposed, levied, collected, withheld or assessed by or on behalf of a Taxing Jurisdiction, unless the deduction or withholding is required by law. If at any time a Taxing Jurisdiction requires us to deduct or withhold Taxes, we will pay the additional amounts of, or in respect of, the principal of, any premium, if any, and any interest on, the debt securities (“Debt Security Additional Amounts”) that are necessary so that the net amounts paid to the holders, after the deduction or withholding, shall equal the amounts which would have been payable had no such deduction or withholding been required. However, certain exceptions are set forth in the relevant prospectus and/or prospectus supplement for a particular series of debt securities.
The relevant Indentures for each series of the debt securities provide that we will not pay Debt Security Additional Amounts for Taxes that are payable because:
(i)     the holder or the beneficial owner of the debt securities is a domiciliary, national or resident of, or engages in business or maintains a permanent establishment or is physically present in, a Taxing Jurisdiction requiring that deduction or withholding, or otherwise has some connection with the Taxing Jurisdiction other than the holding or ownership of the debt security, or the collection of any payment of, or in respect of, the principal of, any premium or any interest on, any debt securities of the relevant series;
(ii)     except in the case of our winding-up in England, the relevant debt security is presented for payment in the United Kingdom;
(iii)     the relevant debt security is presented for payment more than 30 days after the date payment became due or was provided for, whichever is later, except to the extent that the holder would have been entitled to the Debt Security Additional Amounts on presenting the debt security for payment at the close of such 30-day period;
(iv) the holder or the beneficial owner of the relevant debt securities or the beneficial owner of any payment of (or in respect of) principal of, premium, if any, or any interest on debt securities failed to make any necessary claim or to comply with any certification, identification or other requirements concerning the nationality, residence, identity or connection with the Taxing Jurisdiction of such holder or beneficial owner, if such claim or compliance is required by statute, treaty, regulation or administrative practice of the Taxing Jurisdiction as a condition to relief or exemption from such Taxes;
(v)     such Taxes are imposed on a payment to an individual and are required to be made pursuant to the European Union Directive on the taxation of savings income, adopted on June 3, 2003, or any law implementing or complying with, or introduced in order to conform to, such Directive;
(vi)     the relevant debt security is presented for payment by or on behalf of a holder who would have been able to avoid such deduction or withholding by presenting the relevant debt security to another paying agent in a member state of the European Union or elsewhere; or
(vii) if the Taxes would not have been imposed or would have been excluded under one of the preceding points if the beneficial owner of, or person ultimately entitled to obtain an interest in, the debt securities had been the holder of the debt securities.
However, the terms of the 3.684% Fixed Rate Senior Notes due 2023, 4.337% Fixed Rate Senior Notes due 2028, 4.950% Fixed Rate Senior Notes due 2047 and Floating Rate Senior Notes due 2023 (3 month USD LIBOR plus 1.625% p.a.) do not include the exception set out under paragraph (v) above. The Dated Subordinated Debt Securities Indenture dated May 9, 2017 and the Senior Debt Securities Indenture dated January 17, 2018 and the debt securities issued pursuant thereto, do not include the exceptions set out under paragraphs (v) and (vi) above.
Modification and Waiver
We and the Trustee may make certain modifications and amendments to the indenture applicable to each series of debt securities without the consent of the holders of the debt securities. We may make other modifications and amendments with the consent of the holder(s) of not less than, in the case of the Senior Debt Securities, a majority of, or in the case of the Dated Subordinated Debt Securities, 66 23% in aggregate principal amount of the debt securities of the series outstanding under the applicable indenture that are affected by the modification or amendment. However, we may not make any modification or amendment without the consent of the holder of each affected debt security that would:
change the terms of any debt security to change the stated maturity date of its principal amount;
change the principal amount of, or any premium, or rate of interest, with respect to any debt security;
reduce the amount of principal on a discount debt security that would be due and payable upon an acceleration of the maturity date of any series of debt securities;
change our obligation, or any successor’s, to pay Debt Security Additional Amounts;
change the places at which payments are payable or the currency of payment;
impair the right to sue for the enforcement of any payment due and payable;
reduce the percentage in aggregate principal amount of outstanding debt securities of the series necessary to modify or amend the relevant indenture or to waive compliance with certain provisions of the relevant indenture and any past event of default or enforcement event (in each case, as defined in the relevant indenture);
change our obligation to maintain an office or agency in the place and for the purposes specified in the relevant indenture;
modify the subordination provisions, if any, or the terms and conditions of our obligations in respect of the due and punctual payment of the amounts due and payable on the debt securities, in either case in a manner adverse to the holders; or
modify the foregoing requirements or the provisions of the relevant indenture relating to the waiver of any past event of default or enforcement event (in each case, as defined in the relevant indenture) or covenants, except as otherwise specified.
Unless the relevant prospectus supplement provides otherwise, in addition, any variations in the terms and conditions of Dated Subordinated Debt Securities of any series, including modifications relating to the subordination or redemption provisions of such Dated Subordinated Debt Securities, can only be made in accordance with the rules and requirements of the PRA, as and to the extent applicable from time to time.
Events of Default and Enforcement Events and Remedies
Senior Debt Securities
Senior Events of Default
With respect to the Senior Debt Securities for which “Senior Events of Default” is indicated in the table above, each of the following is a “Senior Event of Default”:
Failure to pay any principal or interest on any Senior Debt Securities of that series within 14 days from the due date for payment and such failure to pay persists for a further 14 days following written notice from the Trustee or from holders of 25% in principal amount of the Senior Debt Securities of that series requiring us to make payment, unless such payment was withheld in order to comply with a law, regulation or order of any court of competent jurisdiction;





Breach of any covenant or warranty of the relevant Senior Debt Securities Indenture (other than payment, as stated above) and that breach is not remedied within 21 days following written notice from the Trustee or from holders of at least 25% in principal amount of the Senior Debt Securities of that series requiring us to remedy the breach; or
Either an English court of competent jurisdiction issues an order which is not successfully appealed within 30 days, or an effective shareholders’ resolution is validly adopted, for our winding-up (other than under or in connection with a scheme of reconstruction, merger or amalgamation not involving bankruptcy or insolvency).
If a Senior Event of Default occurs and is continuing, the Trustee or the holders of at least 25% in outstanding principal amount of the affected series of Senior Debt Securities may declare such Senior Debt Securities to be due and repayable immediately (and such Senior Debt Securities shall thereby become due and repayable) at their outstanding principal amount (or at such other repayment amount as may be specified in or determined in accordance with the relevant indenture) together with accrued interest, if any. The Trustee may at its discretion and without further notice institute such proceedings as it may think suitable against us to enforce payment. Subject to the provisions included in the relevant indenture for the indemnification of the Trustee, the holders of a majority in aggregate principal amount of the outstanding Senior Debt Securities of the affected series have the right to direct the Trustee to take enforcement action with respect to that series; provided that such direction does not conflict with any rule of law or the relevant indenture, and is not unjustly prejudicial to the holder(s) of any Senior Debt Securities of that series not taking part in the direction, in either case as determined by the Trustee in its sole discretion. The Trustee may also take any other action, not inconsistent with the direction, that it deems proper.
The holders of a majority of the aggregate principal amount of the outstanding Senior Debt Securities of any affected series may also waive any past Event of Default with respect to the affected series, except any default in respect of either:
the payment of principal of, or any premium or interest on, any Senior Debt Securities; or
a covenant or provision of the relevant indenture which cannot be modified or amended without the consent of each holder of Senior Debt Securities of the series.
Subject to exceptions, the Trustee may (but is not obligated to), without the consent of the holders, waive or authorize an Event of Default if, in the opinion of the Trustee, such waiver or authorization would not be materially prejudicial to the interests of the holders.
The Trustee must give notice to each affected holder within 90 days of a default with respect to the Senior Debt Securities of any series, unless the default has been cured or waived. However, except in the case of a default in the payment of the principal of, or premium, if any, or interest, if any, on the Senior Debt Securities, the Trustee will be entitled to withhold notice if a trust committee of responsible officers of the Trustee determine in good faith that withholding of notice is in the interest of the holders.
We are required to furnish to the Trustee annually a statement as to our compliance with all conditions and covenants under the relevant Senior Debt Securities Indenture.
Notwithstanding any contrary provisions, nothing shall impair the right of a holder, absent the holder’s consent, to sue for any payments due but unpaid with respect to the Senior Debt Securities.
Senior Enforcement Events
With respect to the Senior Debt Securities for which “Senior Events of Default, Senior Enforcement Events” or “Senior Enforcement Events” is indicated in the table above, “Senior Enforcement Events” means:
Winding-up – If (i) a court of competent jurisdiction in England (or such other jurisdiction in which we may be organized) makes an order for our winding-up which is not successfully appealed within 30 days of the making of such order, (ii) our shareholders adopt an effective resolution for our winding-up (other than, in the case of either (i) or (ii) above, under or in connection with a scheme of reconstruction, merger or amalgamation not involving a bankruptcy or insolvency) or (iii) following the appointment of an administrator of Barclays, the administrator gives notice that it intends to declare and distribute a dividend (each a “Senior Winding-up Event”), the outstanding principal amount of the Senior Debt Securities together with any accrued but unpaid interest thereon will become immediately due and payable.
Non-payment – If we fail to pay any amount that has become due and payable under the Senior Debt Securities and such failure continues for 14 days, the Trustee may give us notice of such failure. If within a period of 14 days following the provision of such notice, the failure continues and has not been cured or waived (a “Non-Payment Event”), the Trustee may at its discretion and without further notice to us institute proceedings in England (or such other jurisdiction in which we may be organized) (but not elsewhere) for our winding-up and/or prove in our winding-up and/or claim in our liquidation or administration.
Breach of a Performance Obligation – The Trustee may also, without further notice, institute such proceedings against us as the Trustee may deem fit to enforce any other term, obligation or condition binding on us under the Senior Debt Securities or the relevant Senior Debt Securities Indenture (i.e., other than any payment obligation of Barclays under or arising from the Senior Debt Securities or the relevant Senior Debt Securities Indenture, including, without limitation, payment of any principal or interest, including Debt Security Additional Amounts) (such obligation, a “Performance Obligation”); provided always that the Trustee (acting on behalf of the holders of the Senior Debt Securities) and the holders of the Senior Debt Securities may not enforce, and may not be entitled to enforce or otherwise claim, against us any judgment or other award given in such proceedings that requires the payment of money by us, whether by way of damages or otherwise (a “Monetary Judgment”), except by proving such Monetary Judgment in our winding-up and/or by claiming such Monetary Judgment in our administration. In respect of the 2.279% Fixed Rate Resetting Senior Callable Notes due 2027, 2.894% Fixed Rate Resetting Senior Callable Notes due 2032, and 3.330% Fixed Rate Resetting Senior Callable Notes due 2042, by its acquisition of the Senior Debt Securities of the relevant series, each holder of such notes acknowledges and agrees that such holder will not seek to enforce or otherwise claim, and will not direct the Trustee (acting on behalf of the holders of such notes) to enforce or otherwise claim, a Senior Monetary Judgment against us in connection with our breach of a Senior Performance Obligation (each as defined herein), except by proving such Senior Monetary Judgment in our winding-up and/or by claiming such Senior Monetary Judgment in our administration.
With respect to the Senior Debt Securities for which “Senior Events of Default, Senior Enforcement Events” is indicated in the table above, if inclusion of the Senior Events of Default set out above under “Senior Events of Default” in the terms of the Senior Debt Securities results, or would be likely to (in the opinion of Barclays, the PRA or any other relevant national or European authority) result, in a Loss Absorption Disqualification Event following a Loss Absorption Regulations Event that occurs on or after the issue date of such Senior Debt Securities, then we may, at our option, without the need for us to obtain any consent from any holder of the Senior Debt Securities, determine that the Senior Events of Default will no longer apply to the Senior Debt Securities and will be replaced in their entirety by the Senior Enforcement Events.
In respect of all series of Senior Debt Securities to which Senior Enforcement Events apply, other than as set out above and subject to the Trust Indenture Act remedies specified below, no remedy against us will be available to the Trustee (acting on behalf of the holders of the Senior Debt Securities) or the holders of the Senior Debt Securities whether for the recovery of amounts owing in respect of such Senior Debt Securities or under the relevant Senior Debt Securities Indenture or in respect of any breach by us of any of our obligations under or in respect of the terms of such Senior Debt Securities or under the relevant Senior Debt Securities Indenture.
Trust Indenture Act Remedies
Notwithstanding the limitation on remedies specified above, (i) the Trustee will have such powers as are required to be authorized to it under the Trust Indenture Act in respect of the rights of the holders of the Senior Debt Securities under the provisions of the Indenture and (ii) nothing shall impair the right of a holder of the Senior Debt Securities under the Trust Indenture Act, absent such holder’s consent, to sue for any payment due but unpaid with respect to the Senior Debt Securities. No holder of Senior Debt Securities shall be entitled to proceed directly against us except as described under “Limitation on Suits” below.
Dated Subordinated Debt Securities
Dated Subordinated Enforcement Events





With respect to the Dated Subordinated Debt Securities, under the terms of each Dated Subordinated Debt Securities Indenture, a “Dated Subordinated Enforcement Event” shall occur (i) upon the occurrence of Dated Subordinated Winding-Up Event, (ii) upon the occurrence of a Dated Subordinated Non-Payment Event or (iii) upon a breach by us of a Dated Subordinated Performance Obligation with respect to the relevant series of the Dated Subordinated Debt Securities:
Winding-Up Event – If (i) a court of competent jurisdiction in England (or such other jurisdiction in which we may be organized) makes an order for our winding-up which is not successfully appealed within 30 days of the making of such order, (ii) our shareholders adopt an effective resolution for our winding-up (other than, in the case of either (i) or (ii) above, under or in connection with a scheme of reconstruction, merger or amalgamation not involving a bankruptcy or insolvency) or (iii) following the appointment of an administrator of Barclays, the administrator gives notice that it intends to declare and distribute a dividend (each a “Dated Subordinated Winding-up Event”), the outstanding principal amount of the Dated Subordinated Debt Securities together with any accrued but unpaid interest thereon will become immediately due and payable.
Non-Payment EventIf we fail to pay any amount that has become due and payable with respect to the Dated Subordinated Debt Securities and such failure continues for 14 days, the Trustee may give us notice of such failure. If payment is not made, or our failure to pay has not been waived, within a period of 14 days following the provision of such notice, the Trustee may at its discretion and without further notice to us institute proceedings in England (or such other jurisdiction in which we may be organized) (but not elsewhere) for our winding-up and/or prove in our winding-up and/or claim in our liquidation or administration.
Breach of a Performance Obligation – The Trustee may also, without further notice, institute such proceedings against us as it deems fit to enforce any other term, obligation or condition binding on us under the relevant Dated Subordinated Debt Securities or Dated Subordinated Debt Securities Indenture (i.e., other than any payment obligation as described above, including, without limitation, payment of any principal or interest, including Debt Security Additional Amounts) (such obligation, a “Dated Subordinated Performance Obligation”); provided always that the Trustee and the holders of such Dated Subordinated Debt Securities may not enforce or otherwise claim against us any judgment or other award given in such proceedings that requires the payment of money by us, whether by way of damages or otherwise (a “Dated Subordinated Monetary Judgment”), except by proving such Monetary Judgment in our winding-up and/or by claiming such Monetary Judgment in our administration.
Other than the limited remedies specified in this section and subject to “Trust Indenture Act Remedies” below, no remedy against us will be available to the Trustee (acting on behalf of the holders of the Dated Subordinated Debt Securities) or the holders of the Dated Subordinated Debt Securities whether for the recovery of amounts owed by us, or in respect of any breach by us of any of our obligations, under or in respect of such Dated Subordinated Debt Securities or under the relevant Dated Subordinated Debt Securities Indenture.
If a Dated Subordinated Enforcement Event occurs and is continuing with respect to any series of the Dated Subordinated Debt Securities, the Trustee will have no obligation to take any action at the direction of any holders of such series of the Dated Subordinated Debt Securities, unless they have offered the Trustee security or indemnity satisfactory to the Trustee in its sole discretion.
The holders of a majority in aggregate principal amount of the outstanding Dated Subordinated Debt Securities of a series shall have the right to direct the time, method and place of conducting any proceeding in the name of and on the behalf of the Trustee for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to such series of the Dated Subordinated Debt Securities; provided such direction does not conflict with any rule of law or the relevant Dated Subordinated Debt Securities Indenture and is not unjustly prejudicial to the holder(s) of such series of the Dated Subordinated Debt Securities not taking part in the direction, in either case, as determined by the Trustee in its sole discretion. The Trustee may also take any other action, consistent with the direction, that it deems proper.
The Trustee will, within ninety (90) days of a Dated Subordinated Enforcement Event with respect to the Dated Subordinated Debt Securities of any series, give to each affected holder of the Dated Subordinated Debt Securities of the affected series notice of any default known to the Trustee, unless the default has been cured or waived. However, the Trustee will be entitled to withhold notice if a trust committee of responsible officers of the Trustee determine in good faith that withholding of notice is in the interest of the holders.
We are required to furnish to the Trustee annually a statement as to our compliance with all conditions and covenants under the relevant Dated Subordinated Debt Securities Indenture.
Trust Indenture Act Remedies
Notwithstanding the limitation on remedies specified above, (i) the Trustee will have such powers as are required to be authorized to it under the Trust Indenture Act in respect of the rights of the holders of the Dated Subordinated Debt Securities under the provisions of the relevant Dated Subordinated Debt Indenture and (ii) nothing shall impair the right of a holder of the Dated Subordinated Debt Securities under the Trust Indenture Act, absent such holder’s consent, to sue for any payment due but unpaid with respect to the Dated Subordinated Debt Securities; provided that, in the case of each of (i) and (ii) above, any payments in respect of, or arising from, the Dated Subordinated Debt Securities, including any payments or amounts resulting or arising from the enforcement of any rights under the Trust Indenture Act in respect of the Dated Subordinated Debt Securities, are subject to the subordination provisions set forth in the relevant Dated Subordinated Debt Indenture.
Limitation on Suits
Before a holder of debt securities may bypass the Trustee and bring its own lawsuit or other formal legal action or take other steps to enforce its rights or protect its interests relating to the debt securities, the following must occur:
The holder must give the Trustee written notice that an event of default or enforcement event (in each case, as defined in the relevant indenture) has occurred and remains uncured, and include any other information stipulated by the relevant indenture.
The holders of 25% in principal amount of all outstanding debt securities of the relevant series must make a written request that the Trustee take action because of the default, and the holder must offer to the Trustee indemnity or security satisfactory to the Trustee in its sole discretion against the cost and other liabilities of taking that action.
The Trustee must not have taken action for 60 days after receipt of the above notice and offer of any security and/or indemnity (subject to the terms of the relevant indenture), and the Trustee must not have received an inconsistent direction from the majority in principal amount of all outstanding debt securities of the relevant series during that period.
Notwithstanding any contrary provisions, nothing shall impair the right of a holder, absent the holder’s consent, to sue for any payments due but unpaid with respect to the debt securities.
Exercise of U.K. Bail-in Power
The Relevant U.K. Resolution Authority (which refers to any authority with the ability to exercise a U.K. Bail-in Power) may exercise the bail-in tool in respect of Barclays, as issuer, and the debt securities. Holders of the debt securities are bound by the exercise of any U.K. Bail-in Power (as defined in the prospectus supplement for the relevant series of debt securities) by the Relevant U.K. Resolution Authority. This is not a waiver of any rights holders of debt securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the Relevant U.K. Resolution Authority in breach of laws applicable in England.
Generally, exercise of any U.K. Bail-in Power by the Relevant U.K. Resolution Authority may result in (i) the cancellation of all, or a portion, of the principal amount of, or interest on, the debt securities; and/ or (ii) the conversion of all, or a portion of, the principal amount of, or interest on, the debt securities into shares or other securities or other obligations of Barclays or another person, including by means of a variation of the terms of the debt securities to give effect to the exercise by the Relevant U.K. Resolution Authority of such U.K. Bail-in Power.
Holders of debt securities should review the provisions relating to U.K. Bail-in Power included in the relevant prospectus supplement for such debt securities, including the section entitled “Risk Factors” therein.





No repayment of the principal amount of the debt securities or payment of interest on the debt securities shall become due and payable after the exercise of any U.K. Bail-in Power by the Relevant U.K. Resolution Authority unless such repayment or payment would be permitted to be made by Barclays under the laws and regulations of the United Kingdom and the European Union applicable to Barclays.
The exercise of the U.K. Bail-in Power by the Relevant U.K. Resolution Authority with respect to the debt securities shall not constitute a Senior Event of Default, a Senior Enforcement Event or a Dated Subordinated Enforcement Event, as applicable.
Upon the exercise of any U.K. Bail-in Power by the Relevant U.K. Resolution Authority with respect to the debt securities, the Trustee shall not be required to take any further directions from holders of the debt securities pursuant to the applicable indenture which authorizes holders of a majority in aggregate principal amount of the outstanding debt securities of the relevant series of Debt Securities to direct certain actions relating to the relevant debt securities and (b) the applicable indentures impose no duties upon the Trustee whatsoever with respect to the exercise of any U.K. Bail-in Power by the Relevant U.K. Resolution Authority. Notwithstanding the foregoing, if, following the completion of the exercise of the U.K. Bail-in Power by the Relevant U.K. Resolution Authority in respect of the debt securities, the debt securities remain outstanding (for example, if the exercise of the U.K. Bail-in Power results in only a partial write-down of the principal of the debt securities), then the Trustee’s duties under the relevant Senior Debt Securities Indenture or Dated Subordinated Debt Securities Indenture (as applicable) will apply with respect to the relevant debt securities following such completion to the extent agreed by Barclays and the Trustee, pursuant to a supplemental indenture to the applicable indenture, or an amendment thereto.
Consolidation, Merger and Sale of Assets; Assumption
We may, without the consent of holders of any outstanding debt securities, consolidate, amalgamate with or merge into any other corporation, or convey or transfer or lease our properties and assets substantially as an entirety to any Person (as defined below), provided that:
the Person formed by such consolidation or amalgamation, or into which Barclays is merged, or the Person which acquires by conveyance or transfer, or which leases the properties and assets of Barclays substantially as an entirety expressly assumes by supplemental indenture all of Barclays’ obligations under the outstanding debt securities and the relevant indentures;
immediately after giving effect to such transaction, no Senior Event of Default (or Senior Winding-up Event, as defined above) or Dated Subordinated Winding-up Event, as applicable, and no event which, after notice or lapse of time or both, would become a Senior Event of Default (or Senior Winding-up Event, as defined above) or Dated Subordinated Winding-up Event, as applicable, shall have happened and be continuing; and
we have delivered to the Trustee an officer’s certificate and an opinion of counsel, each stating that such consolidation, amalgamation, merger, conveyance or transfer and such supplemental indenture comply with the relevant indenture and that all conditions precedent relating to such transaction have been complied with.
The successor Person formed by such consolidation or amalgamation or into which Barclays is merged or the Person to which such conveyance or transfer is made will succeed to and be substituted for, and may exercise every right and power of, Barclays under the relevant indenture with the same effect as if such successor Person had been named as the issuer, and thereafter, the predecessor Person shall be relieved of all obligations and covenants under the relevant indenture and the relevant series of debt securities.
In this section, “Person” means any individual, corporation, partnership, joint venture, association, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof.
Satisfaction and Discharge
When (i) Barclays delivers to the Trustee all outstanding debt securities of any series (other than debt securities which have been replaced or paid because they were destroyed, lost or stolen) for cancellation, or (ii) all outstanding debt securities of any series have become due and payable or are by their terms due and payable within one year whether at maturity or are to be called for redemption within one year under arrangements satisfactory to the Trustee, and in the case of clause (ii) Barclays deposits or causes to be deposited with the Trustee funds sufficient to pay and discharge all claims with respect to all outstanding debt securities of any series, including accrued interest thereon, if any, at maturity or upon redemption of such debt securities, and if in either case, Barclays pays all other sums related to the debt securities of such series payable under the relevant indenture by Barclays, and Barclays has delivered to the Trustee an officer’s certificate and an opinion of counsel, each stating that all conditions precedent relating to the satisfaction and discharge of the relevant indenture have been complied with, then the indenture shall (subject to certain surviving provisions) cease to be of further effect with respect to such series of debt securities, and the Trustee, at Barclays’ expense, shall execute proper instruments acknowledging satisfaction and discharge of the relevant indenture with respect to such series of debt securities.
Defeasance and Discharge
For the Dated Subordinated Debt Securities issued under the Dated Subordinated Debt Securities Indenture dated September 11, 2014, at our option, either (1) we shall be deemed to have been discharged from our obligations with respect to any series of Dated Subordinated Debt Securities after the applicable conditions set forth below have been satisfied, or (2) we shall cease to be under any obligation to comply with any term, provision or condition set forth for the relevant Dated Subordinated Debt Securities, at any time after the applicable conditions set forth below have been satisfied:
(a)we shall have deposited or caused to be deposited irrevocably with the Trustee or its agent as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the holders of the relevant Dated Subordinated Debt Securities and the holders of any coupons appertaining thereto (i) money in an amount, or (ii) U.S. government obligations which through the payment of interest and principal in respect thereof in accordance with their terms will provide, not later than the due date of any payment, money in an amount, or (iii) a combination of (i) and (ii), in each case sufficient, in the opinion (with respect to (ii) and (iii)) of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge, and which shall be applied by the Trustee (or any such other qualifying trustee) to pay and discharge, the principal of (and premium, if any) and interest on, the outstanding Dated Subordinated Debt Securities of such series and any coupons appertaining thereto;
(b)no event which is, or after notice or lapse of time or both would become, a Dated Subordinated Enforcement Event with respect to the relevant Dated Subordinated Debt Securities shall have occurred and be continuing at the time of such deposit;
(c)we must deliver to the Trustee an opinion of counsel to the effect that holders of the Dated Subordinated Debt Securities of such series will not recognize income, gain or loss for Federal income tax purposes as a result of such exercise of option and will be subject to U.S. federal income tax on the same amount and in the same manner and at the same times as would have been the case if such option had not been exercised, and, in the case of Dated Subordinated Debt Securities being discharged, such opinion shall be accompanied by a private letter ruling to that effect received from the United States Internal Revenue Service or a revenue ruling pertaining to a comparable form of transaction to that effect published by the United States Internal Revenue Service; and
(d)we shall have delivered to the Trustee an officer’s certificate and an opinion of counsel, each stating that all conditions precedent have been complied with, and an opinion of counsel to the effect that the exercise of the option set out under this section would not cause such Dated Subordinated Debt Securities to be delisted;
The Trustee and Paying Agent
The Bank of New York Mellon, London Branch, One Canada Square, London E14 5AL, United Kingdom, acts as the Trustee under the indentures and initial principal paying agent for the debt securities.
Governing Law





The debt securities, the relevant Senior Debt Securities Indenture and the relevant Dated Subordinated Debt Securities Indenture are governed by and construed in accordance with the laws of the State of New York, except that any applicable subordination provisions of each series of Dated Subordinated Debt Securities and any applicable provisions relating to waiver of set-off of each series of Dated Subordinated Debt Securities and the Senior Debt Securities issued under the Senior Debt Securities Indenture dated January 17, 2018 and the related provisions in the relevant indenture are governed by and construed in accordance with English law.



BARCLAYS PLC
RULES OF THE
BARCLAYS LONG TERM INCENTIVE PLAN

Approved by shareholders of Barclays PLC on 5 May 2021
Adopted by the Board Remuneration Committee of Barclays PLC on 22 June 2021



The Plan is a discretionary benefit offered by Barclays Group for the benefit of its employees. Its main purpose is to align the interest of the employees with Barclays’ long term business goals and performance. The Plan is an incentive for the employees' future performance and commitment to the goals of the Barclays Group.
Securities purchased or received under the Plan, any cash received under the Plan and any gains obtained under the Plan are not part of salary for any purpose (except to any extent required by statute).
The Plan is being offered for the first time in 2022 and the Board Remuneration Committee of Barclays PLC shall have the right to decide, in its sole discretion, whether or not awards will be granted in 2022 or in the future. The detailed rules of the Plan are set out overleaf.
10868-5-399-v0.8
- 1-
70-40492187



CONTENTS
RulePage


1.    Definitions and Interpretation
2.    Grant of Awards
3.    Limits
4.    Vesting of Awards
5.    Consequences of Vesting
6.    Exercise of Options
7.    Cash Alternative
8.    Lapse of Awards
9.    Leavers and deceased participants
10.    Takeovers and Other Corporate Events
11.    Adjustment of Awards
12.    Alterations
13.    Miscellaneous
SCHEDULE 1: FORFEITABLE AWARDS    21
SCHEDULE 2: CASH AWARDS    .22
SCHEDULE 3: UNITED STATES ADDENDUM    23

10868-5-399-v0.8
- i-
70-40492187



1.DEFINITIONS AND INTERPRETATION
1.1In the Plan, unless the context otherwise requires:
"Assessment Period" means the period from the start of the Pre Grant Financial Year to the end of the Performance Period;
"Award" means a Conditional Award, a Forfeitable Award, an Option, a Provisional Allocation or such other form of award as determined by the Committee on or before the Grant Date which may relate to Shares or to Capital Instruments;
"Board" means the board of directors of the Company or a duly authorised committee of the Board or a duly authorised person;
"Capital Instrument" means a capital instrument or security issued by a Member of the Group from time to time;
"Cash Award" means an Award which relates to a cash sum granted under Schedule 2 to the Plan;
"Committee" means the remuneration committee of the Board (or a duly authorised committee thereof or a duly authorised person) or, on and after the occurrence of a corporate event described in Rule 10 (Takeovers and other corporate events), the remuneration committee of the Board as constituted immediately before such event occurs;
"Company" means Barclays PLC (registered in England and Wales with registered number 48839);
"Conditional Award" means a conditional right to acquire Securities granted under the Plan;
"Control" means control within the meaning of section 995 of the Income Tax Act 2007;
“Coupon" means an amount paid as interest or a similar payment in respect of a Capital Instrument subject to an Award over all or part of the Vesting Period;
"Coupon Equivalent Amount" means an amount equal to the value of any Coupons paid on the Capital Instruments subject to an Award which would have been paid to the Participant in respect of the Capital Instruments acquired on the exercise of an Option or Vesting of a Conditional Award or Provisional Allocation between the Grant Date and the date on which the Option first became exercisable or the Conditional Award or Provisional Allocation Vested as the case may be, had those Capital Instruments been beneficially owned by the Participant during that period;
"Dividend Equivalent Amount" means an amount equal to the aggregate dividends (excluding any related tax credits and any dividends of a special or exceptional nature unless the Committee in its absolute discretion determines that they shall be included) which would have been paid to the Participant in respect of the Shares acquired on the exercise of an Option or Vesting of a Conditional Award or Provisional Allocation between the Grant Date and the date on which the Option first became exercisable or the Conditional Award or Provisional Allocation Vested, as the case may be, had those Shares been beneficially owned by the Participant during that period;
"Early Vesting Date" means either:
(a)the date of cessation of employment of a Participant in the circumstances referred to in Rule 9.1 (Deceased Participants) and Rule 9.2 (Good leavers); or
(b)a date of notification referred to in Rule 10.1 (General offers), the date of the relevant event referred to in Rule 10.2 (Schemes of arrangement and winding up) or the date of Vesting referred to in Rule 10.3 (Demergers and similar events);
"Exercise Period" means the period referred to in Rule 5.2 (Options) during which an Option may be exercised;
"Eligible Employee" means any person who is an employee or former employee (including an executive director) of a Participating Company and who is deemed eligible to participate by the Committee;
"Employer" means the current or former Member of the Group that employs the Participant at the relevant time;
10868-5-399-v0.8
- 1-
70-40492187



"Forfeitable Award" means the transfer of the beneficial interest in Forfeitable Securities to a Participant and the subsequent holding of that interest in accordance with the Plan;
"Forfeitable Securities" means Securities comprised in a Forfeitable Award which are subject to certain restrictions and forfeiture under the Plan;
"Grant Date" means the date on which an Award is granted;
"Involved in an Investigation" means:
(c)where a current or former employee:
(i)is suspended from employment or placed on paid leave in connection with a disciplinary or regulatory matter (whether internal or external); or
(ii)is the subject of, undergoing or involved in an investigation in connection with a disciplinary or regulatory matter (whether internal or external); or
(iii)by virtue of his or her line management responsibilities could become the subject of, undergo or become involved in an investigation in connection with a disciplinary or regulatory matter (whether internal or external); or
(b)any other category of employee or former employee as determined by the Committee from time to time in its discretion;
"ITEPA" means the Income Tax (Earnings and Pensions) Act 2003;
"Listing Rules" means the Listing Rules published by the UKLA;
"London Stock Exchange" means London Stock Exchange plc or any successor to that company;
"Market Value" means, in relation to a Security and / or an Option on any date, such value of a Security and/or Option as the Committee reasonably determines;
"Member of the Group" means:
(c)a Participating Company or a body corporate which is the Company's holding company (within the meaning of section 1159 of the Companies Act 2006) or a Subsidiary of the Company's holding company; and
(d)a body corporate which is a subsidiary undertaking (within the meaning of section 1162 of that Act) of a body corporate within paragraph (a) above and has been designated by the Board for this purpose
and "Group" shall be construed accordingly;
"Normal Vesting Date" means the date on which an Award vests under Rule 4.1 (Timing of Vesting: Normal Vesting Date);
"Option" means a right to acquire Securities granted under the Plan which is designated as an option by the Committee;
"Option Price" means the amount, if any, payable on the exercise of an Option;
"Participant" means a person who holds an Award including his personal representatives;
"Participating Company" means the Company or any Subsidiary of the Company;
"Performance Condition" means a condition related to performance which is specified by the Committee under Rule 2.1 (Terms of grant);
“Performance Period” means the period over which a Performance Condition will be assessed;
"Plan" means the Barclays Long Term Incentive Plan as amended from time to time;
10868-5-399-v0.8
- 2-
70-40492187



"Pre Grant Financial Year" means the last full financial year of the Company ending immediately before the Grant Date;
"Provisional Allocation" means a provisional award of Securities which does not constitute the acquisition by a Participant of an interest in the Securities awarded to him or the acquisition of a right to acquire those Securities;
"Risk Committee" means the Barclays Group Risk Committee (or a duly authorised committee thereof or a duly authorised person);
"Rules" means the rules of the Plan as set out in this document and "Rule" shall be construed accordingly;
Security” means a Capital Instrument or a Share as the context requires;
"Shares" means fully paid ordinary shares in the capital of the Company;
"Subsidiary" means a body corporate which is a subsidiary (within the meaning of section 1159 of the Companies Act 2006);
"Tax Liability" means any amount of tax or social security contributions for which a Participant would or may be liable and for which any Member of the Group or former Member of the Group would or may be obliged to (or would or may suffer a disadvantage if it were not to) account to any relevant authority;
"UKLA" means the United Kingdom Listing Authority;
"US Participant" means a Participant who (i) is resident in, or a citizen or green card holder of, the United States of America on the Grant Date, (ii) is otherwise subject to US taxation on the Grant Date or (iii) becomes subject to US taxation prior to exercise or Vesting of an Award;
"Vest" means:
(e)in relation to a Conditional Award, a Participant becoming entitled to have Securities transferred to him (or his nominee account) subject to the Rules;
(f)in relation to an Option, it becoming exercisable;
(g)in relation to a Forfeitable Award, the restrictions imposed on the Forfeitable Securities under the Plan ceasing to apply;
(h)in relation to a Provisional Allocation, the Committee determining in its absolute discretion to release some or all of the Securities subject to the Provisional Allocation
and "Vesting" shall be construed accordingly;
"Vesting Period" means the period starting on the Grant Date and ending on the date on which Securities subject to an Award actually Vest; and
"Vested Securities" means those Securities in respect of which an Award has Vested.
Any reference in the Plan to any enactment includes a reference to that enactment as from time to time modified, extended or re-enacted. Where the context permits, the singular shall include the plural and vice versa and the masculine gender shall include the feminine.
Expressions in italics and headings are for guidance only and do not form part of the Plan.
2.GRANT OF AWARDS
1.1Terms of grant
Subject to Rule 2.6 (Timing of grant), Rule 2.8 (Approvals and consents) and Rule 3 (Limits), the Committee may from time to time, in its absolute discretion, grant Awards to such Eligible Employees as it shall, in it absolute discretion, select in accordance with:
10868-5-399-v0.8
- 3-
70-40492187



(a)the Rules; and
(b)such additional terms (whether a Performance Condition and/or any other terms) as the Committee may specify, including (without limitation) the application of an additional holding period applying to the Securities following Vesting as the Committee may decide at its absolute discretion.
The Committee may grant an Award taking account of the performance of the Eligible Employee, the Group and/or any relevant business unit in the Pre Grant Financial Year and subject to such Performance Condition as it, in its absolute discretion, thinks fit which must (save as otherwise provided in the Rules) be fulfilled before the Award may Vest. No such Performance Condition may subsequently be altered unless circumstances occur which cause the Committee to determine that such Performance Condition shall have ceased to be appropriate, whereupon the Committee may, in its absolute discretion, alter the Performance Condition or replace it with a new Performance Condition which will, in the reasonable opinion of the Committee, be not materially less difficult to satisfy than the unaltered Performance Condition would have been but for the event in question.
1.2Grant of Award to US Participant
Where an Award is granted under Rule 2.1 (Terms of grant) to a US Participant, such Award shall be subject to the provisions of Schedule 3 to the Plan (United States Addendum).
1.3Method of grant
An Award shall be granted as follows:
(a)a Conditional Award or an Option shall be granted by deed executed by the Company;
(b)if an Award is an Option, the Committee shall determine the Option Price (if any) on or before the Grant Date provided that the Committee may reduce or waive such Option Price on or prior to the exercise of the Option;
(c)a Forfeitable Award shall be granted by the procedure set out in Schedule 1 to the Plan (Grant of a Forfeitable Award);
(d)an Award that is not a Conditional Award, an Option or a Forfeitable Award shall be granted by the procedure set out by the Company from time to time.
Each Participant shall, as soon as reasonably practicable after the Grant Date, be issued with a certificate or notification evidencing his Award and setting out its terms and conditions (including whether the Participant will be required to pay the nominal value of any Securities that he receives under this Award) and any Performance Condition determined under Rule 2.1 (Terms of grant).
1.4Dividend Equivalent Amount and Coupon Equivalent Amount
The Committee may in its absolute discretion determine to provide a Dividend Equivalent Amount or Coupon Equivalent Amount, as applicable, to the Participant on the Vesting of an Award. The Dividend Equivalent Amount or Coupon Equivalent Amount may be satisfied, at the absolute discretion of the Committee:
(a)in cash, subject to any deductions on account of any Tax Liability as may be required by law or as the Committee may consider necessary or desirable, as soon as reasonably practicable after the exercise or Vesting of the Award; and/or
(b)in whole or in part by the issue or transfer to the Participant (or his nominee account) of the number of Securities which could be subscribed or purchased using the cash amount (or part thereof) of the Dividend Equivalent Amount or Coupon Equivalent Amount at a price equal to the Market Value of the Securities on the date of payment. Rule 4.3 (Restrictions on Vesting: regulatory and tax issues) and Rule 4.5 (Payment of Tax Liability) shall apply as if the provision of Securities was the Vesting of an Award.
Any Dividend Equivalent Amount or Coupon Equivalent Amount does not form part of a Participant's Award. This Rule shall not apply in the case of any Forfeitable Award under which a Participant is entitled to receive dividends or any Coupon from the Grant Date.
10868-5-399-v0.8
- 4-
70-40492187



1.5Method of satisfying Awards
Unless specified to the contrary by the Committee on the Grant Date:
(a)an Award of Shares may be satisfied:
(i)    by the issue of new Shares; and/or
(ii)    by the transfer of Shares out of treasury; and/or
(iii)    by the transfer of Shares (other than the transfer of Shares out of treasury); and
(b)an Award of Capital Instruments may be satisfied by the issue of new Capital Instruments and/or by the transfer of Capital Instruments.
The Committee may decide to change the way in which it is intended that an Award granted as a Conditional Award, an Option or a Provisional Allocation may be satisfied after it has been granted, having regard to the provisions of Rule 3 (Limits).
1.6Timing of grant
Subject to Rule 2.8 (Approvals and consents), an Award may be granted:
(a)in the 6 weeks beginning with:
(i)the date on which the Plan is approved by the shareholders of the Company; or
(ii)the dealing day after the date on which the Company announces its results for any period; or
(iii)the removal of any restrictions imposed on the Committee or the Company which prevented an Award from being granted in the period mentioned in (ii); or
(iv)the date on which changes to any legislation or regulations affecting the Plan are announced or made; or
(b)at any other time when the Committee so decides, provided that it is not restricted from granting Awards at that time by law or regulation
but an Award may not be granted after 4 May 2031 (being the expiry of the period of 10 years beginning with the date on which the Plan is approved by the shareholders of the Company).
1.7Non-transferability and bankruptcy
An Award granted to any person shall not be transferred, assigned, charged or otherwise disposed of except on his death to his personal representatives and shall lapse immediately on any attempt to do so and shall lapse immediately if he is declared bankrupt.
1.8Approvals and consents
The grant of any Award shall be subject to obtaining any approval or consent required under the Listing Rules, any relevant securities dealing code of the Company, the City Code on Takeovers and Mergers, or any other UK or overseas regulation or enactment.
3.LIMITS
1.15 per cent. in 10 years limit
An Award shall not be granted in any calendar year if, at the time of its proposed Grant Date, it would cause the number of Shares allocated in the period of 10 calendar years ending with that calendar year under the Plan and under any other executive share plan adopted by the Company to exceed such number as represents 5 per cent. of the ordinary share capital of the Company in issue at that time.
10868-5-399-v0.8
- 5-
70-40492187



1.210 per cent. in 10 years limit
An Award shall not be granted in any calendar year if, at the time of its proposed Grant Date, it would cause the number of Shares allocated in the period of 10 calendar years ending with that calendar year under the Plan and under any other employee share plan adopted by the Company to exceed such number as represents 10 per cent. of the ordinary share capital of the Company in issue at that time.
1.3Meaning of "allocated"
For the purposes of Rules 3.1 (5 per cent. in 10 years limit) and 3.2 (10 per cent. in 10 years limit):
(a)Shares are allocated when an option, award or other contractual right to acquire unissued Shares or Shares transferred out of treasury is granted and, where Shares are issued or Shares transferred out of treasury are transferred otherwise than pursuant to an option, award or other contractual right to acquire Shares, when those Shares are issued or Shares transferred out of treasury;
(b)any Shares which have been issued or which may be issued (or any Shares transferred out of treasury or which may be transferred out of treasury) to any trustees to satisfy the exercise of any option, award or other contractual right granted under any employee share plan shall count as allocated unless they are already treated as allocated under this Rule; and
(c)for the avoidance of doubt, existing Shares other than Shares that are transferred out of treasury or over which options, awards or other contractual rights are granted shall not count as allocated.
1.4Post-grant events affecting numbers of "allocated" Shares
For the purposes of Rule 3.3 (Meaning of "allocated"):
(a)where:
(i)any option, award or other contractual right to acquire unissued Shares or treasury Shares is released or lapses (whether in whole or in part); or
(ii)after the grant of an option, award or other contractual right the Committee determines that:
(A)where an amount is normally payable on its exercise it shall be satisfied without such payment but instead by the payment of cash equal to the gain made on its exercise; or
(B)it shall be satisfied by the transfer of existing Shares (other than Shares transferred out of treasury)
the unissued Shares or treasury Shares which consequently cease to be subject to the option, award or other contractual right shall not count as allocated; and
(b)the number of Shares allocated in respect of an option, award or other contractual right shall be such number as the Board shall reasonably determine from time to time.
1.5Changes to investor guidelines
Shares transferred out of treasury shall cease to count as allocated Shares for the purposes of Rule 3.4 (Post-grant events affecting numbers of "allocated" Shares) if institutional investor guidelines cease to require such Shares to be so counted.
1.6Individual limits
The maximum total Market Value of Securities over which Awards may be granted (or where relevant, in the case of an Option, the Market Value of any such Option that may be granted) during any financial year of the Company is:
(a)in the case of an Eligible Employee who is an executive director of the Company, the lower of:
10868-5-399-v0.8
- 6-
70-40492187



(i)500% of his salary (as defined in this Rule); and
(ii)the limits set out in the Company's directors' remuneration policy, as amended from time to time; and
(b)in the case of an Eligible Employee who is not an executive director of the Company, such percentage of his salary (as defined in this Rule) as the Committee decides is fair and reasonable.
For the purpose of this Rule 3.6, an Eligible Employee’s salary shall be taken to be his base salary and any role based allowances or, in the case of an executive director of the Company, his fixed pay (in each case excluding benefits in kind), expressed as an annual rate payable by the Participating Companies to him on the Grant Date (or such earlier date as the Committee shall determine). Where a payment of salary is made in a currency other than sterling, the payment shall be treated as equal to the equivalent amount of sterling determined by using any rate of exchange which the Committee may reasonably select.
1.7Effect of limits
Any Award shall be limited and take effect so that the limits in this Rule 3 (Limits) are complied with.
1.8Restriction on use of unissued Shares and Shares transferred out of treasury
No Shares may be issued or Shares transferred out of treasury to satisfy the Vesting of any Award or the exercise of any Option to the extent that such issue or transfer would cause the number of Shares allocated (as defined in Rule 3.3 (Meaning of "allocated") and adjusted under Rule 3.4 (Post-grant events affecting numbers of "allocated" Shares)) to exceed the limits in Rules 3.1 (5 per cent. in 10 years limit) and 3.2 (10 per cent. in 10 years limit) except where there is a variation of share capital of the Company which results in the number of Shares so allocated exceeding such limits solely by virtue of that variation.
4.VESTING OF AWARDS
1.1Timing of Vesting: Normal Vesting Date
Subject to Rule 4.3 (Restrictions on Vesting: regulatory and tax issues), an Award that is not a Provisional Allocation shall Vest on the later of:
(a)the date on which the Committee determines whether or not any Performance Condition and any other condition imposed on the Vesting of the Award has been satisfied (in whole or part); and
(b)the date or dates determined by the Committee as the Normal Vesting Date(s)
except where earlier Vesting occurs on an Early Vesting Date under Rule 9 (Leavers and deceased Participants) or Rule 10 (Takeovers and other corporate events).
In the case of a Provisional Allocation, the Committee shall, in its absolute discretion, determine whether an Award may Vest on the later of the dates specified in (a) and (b) above.
1.2Extent of Vesting
An Award shall only Vest to the extent:
(a)that any Performance Condition is satisfied on the Normal Vesting Date or, if appropriate, the Early Vesting Date;
(b)as permitted by any other term imposed on the Vesting of the Award; and
(c)in relation to Vesting before the Normal Vesting Date, as permitted by Rule 9 (Leavers and deceased Participants) or Rule 10 (Takeovers and other corporate events).
Where, under Rule 9 (Leavers and deceased Participants) or Rule 10 (Takeovers and other corporate events), an Award would (subject to the satisfaction of any Performance Condition) Vest before the end of the full period over which performance would be measured under the Performance Condition then,
10868-5-399-v0.8
- 7-
70-40492187



unless provided to the contrary by the Performance Condition, the extent to which the Performance Condition has been satisfied in such circumstances shall be determined by the Committee on such reasonable basis as it decides.
1.3Restrictions on Vesting: regulatory and tax issues
An Award shall not Vest unless and until the following conditions are satisfied:
(a)the Vesting of the Award, and the issue or transfer of Securities after such Vesting would be lawful in all relevant jurisdictions and in compliance with the Listing Rules, any relevant securities dealing code of the Company, the City Code on Takeovers and Mergers and any other relevant UK or overseas regulation or enactment;
(b)if, on the Vesting of the Award, a Tax Liability would arise by virtue of such Vesting and the Committee decides that such Tax Liability shall not be satisfied by the sale of Securities pursuant to Rule 4.5 (Payment of Tax Liability) then the Participant must have entered into arrangements acceptable to the Committee that the relevant Member of the Group will receive the amount of such Tax Liability;
(c)the Participant has entered into such arrangements as the Committee requires (and where permitted in the relevant jurisdiction) to satisfy a Member of the Group's liability to social security contributions in respect of the Vesting of the Award; and
(d)where the Committee requires, the Participant has entered into, or agreed to enter into, a valid election under Part 7 of ITEPA (Employment income: election for full or partial disapplication of Chapter 2 Part 7 of ITEPA) or any similar arrangement in any overseas jurisdiction.
For the purposes of this Rule 4.3, references to Member of the Group include any former Member of the Group.
1.4Tax liability before Vesting
If a Participant will, or is likely to, incur any Tax Liability before the Vesting of an Award then that Participant must enter into arrangements acceptable to any relevant Member of the Group to ensure that it receives the amount of such Tax Liability. If no such arrangement is made then the Participant shall be deemed to have authorised the Company to sell or procure the sale of sufficient of the Securities subject to his Award on his behalf to ensure that the relevant Member of the Group receives the amount required to discharge the Tax Liability and the number of Securities subject to his Award shall be reduced accordingly.
For the purposes of this Rule 4.4, references to Member of the Group include any former Member of the Group.
1.5Payment of Tax Liability
The Participant authorises the Company to sell or procure the sale of sufficient Vested Securities on or following the Vesting of his Award on his behalf to ensure that any relevant Member of the Group or former Member of the Group receives the amount required to discharge the Tax Liability which arises on Vesting except to the extent that the Committee decides that all or part of the Tax Liability shall be funded in a different manner in which case Rule 4.3 (b) (Restrictions on Vesting: regulatory and tax issues) shall apply.
1.6Prudent Financial Control
Notwithstanding any other provision of the Plan, and irrespective of whether any Performance Condition attached to an Award has been satisfied, if the Committee determines in its absolute discretion that over the whole or any part of the Vesting Period the underlying financial health of the Group has significantly deteriorated such that there are severe financial constraints on the Group which preclude or limit the Group's ability to facilitate funding of Awards then:
(a)the Committee may in its absolute discretion determine that the number of Securities subject to an Award that may otherwise Vest may be limited, reduced (to nil if appropriate) and/or made subject to any other condition as the Committee considers in its absolute discretion appropriate; and
10868-5-399-v0.8
- 8-
70-40492187



(b)in the absence of any determination under Rule 4.6(a), the Vesting of any Securities that may otherwise Vest (including any Securities that have not Vested due to the exercise of discretion under Rule 4.6 (a)) shall be suspended until such time as the Committee lifts such suspension or exercises discretion under Rule 4.6(a) provided that to the extent that the Committee has not lifted such suspension or exercised discretion under Rule 4.6(a) within 3 years from the date specified at the Grant Date as the final date on which such Securities may Vest, any Award over such Securities shall lapse in its entirety, unless otherwise determined by the Committee in exceptional circumstances.
1.7Conduct conditions
Notwithstanding any other provision of the Plan, and irrespective of whether any Performance Condition attached to an Award has been satisfied, the Committee may determine in its absolute discretion that the number of Securities subject to an Award that may otherwise Vest may be reduced (to nil if appropriate) at any time at its discretion including (but without limitation) as a result of:
(a)the Group or any Subsidiary's financial statements having been materially restated at any time whether before or during the Vesting Period other than restatement due to a change in accounting policy or to rectify a minor error;
(b)the Group or any business unit having suffered a material downturn in its financial performance at any time whether before or during the Vesting Period;
(c)the Participant having, in the reasonable opinion of the Committee, following consultation with his Employer, deliberately misled the management of the Company, the market and/or the Company's shareholders regarding the financial performance of the Group or of any Subsidiary at any time whether before or during the Vesting Period;
(d)the Participant's actions at any time whether before or during the Vesting Period having, in the reasonable opinion of the Committee, following consultation with his Employer, caused harm to the reputation of the Group and/or the Participant's business unit;
(e)the Participant's actions at any time whether before or during the Vesting Period having, in the reasonable opinion of the Committee, following consultation with his Employer, amounted to misconduct or a material error;
(f)the Group or the business in which the Participant works having, in the reasonable opinion of the Committee, following consultation with the Risk Committee, suffered a material failure of risk management whether before or during the Vesting Period;
(g)the Participant's actions having, in the reasonable opinion of the Committee, following consultation with his Employer, amounted to negligence, incompetence or poor performance at any time whether before or during the Vesting Period; or
(h)any other matter which, in the reasonable opinion of the Committee, is required to be taken into account to comply with prevailing legal and / or regulatory requirements, which for the avoidance of doubt, includes any regulations or guidance published by a regulator from time to time.
For the purposes of this Rule 4.7, the determination of what constitutes "negligence", "incompetence", "poor performance" and "misconduct" shall be determined by the Committee acting in good faith, following consultation with the Employer.
1.8Change of jurisdiction
If a Participant relocates to another jurisdiction before his Award Vests and, as a result of the relocation, the Participant or any Member of the Group would be subject to additional tax or social security on the Vesting of the Award or the Vesting of the Award in that other jurisdiction would be subject to any regulatory restriction, approval or consent, the Committee may determine that the Award may:
(a)vest on such terms and during such period preceding the date on which the Participant relocates as the Committee may determine; or
(b)lapse and be replaced with the grant of such other form of Award as the Committee may specify.
10868-5-399-v0.8
- 9-
70-40492187



1.9Suspension
Notwithstanding any other provision of the Plan, and irrespective of whether any Performance Condition attached to an Award has been satisfied, if, at the time that an Award is due to Vest, a Participant is Involved in an Investigation then the Committee in its absolute discretion, following consultation with his Employer, may determine that any Vesting shall be suspended until such time as the Committee lifts such suspension and exercises its discretion to allow the Award to Vest or otherwise reduces the Award (to nil, if appropriate) in accordance with Rule 4.7 provided that if a Participant ceases to be employed by the Group in accordance with Rule 9.3 then the Award shall lapse in its entirety and/or provided further that to the extent that the Committee has not lifted such suspension or exercised its discretion under this Rule 4.9 within 5 years from the date of any such suspension, then all such Awards shall be forfeited and lapse in their entirety, unless the Committee, in exceptional circumstances, determines otherwise.
5.CONSEQUENCES OF VESTING
1.1Conditional Awards and Provisional Allocations
On or as soon as reasonably practicable after the Vesting of a Conditional Award or a Provisional Allocation, the Committee shall, subject to Rule 4.5 (Payment of Tax Liability) and any arrangement made under Rules 4.3(b) and 4.3(c) (Restrictions on Vesting: regulatory and tax issues), transfer or procure the transfer of the Vested Securities to the Participant (or his nominee account).
1.2Options
An Option shall, subject to Rule 6.1 (Restrictions on the exercise of an Option: regulatory and tax issues), be exercisable in respect of Vested Securities for a period determined by the Committee at the Grant Date in its absolute discretion, but being a period of no longer than 10 years from the Grant Date, beginning with the date on which the Option Vests unless it lapses earlier under Rule 9.3 (Cessation of employment in other circumstances), Rule 10.1 (General offers), Rule 10.2 (Schemes of arrangement and winding up) or Rule 10.3 (Demergers and similar events).
If an Option is not exercised during the last 30 days of the Exercise Period because of any regulatory restrictions referred to in Rule 6.1(a) (Restrictions on the exercise of an Option: regulatory and tax issues), the Committee may extend the period during which the Option may be exercised so as to permit the Option to be exercised as soon as those restrictions cease to apply.
1.3Forfeitable Award
On the Vesting of a Forfeitable Award, the Vested Securities shall cease to be subject to the restrictions imposed on the Forfeitable Securities under the Plan and the Committee shall, subject to Rule 4.5 (Payment of Tax Liability) and any arrangement made under Rules 4.3(b) and 4.3(c) (Restrictions on Vesting: regulatory and tax issues), transfer or procure the transfer of the legal title to the Vested Securities and/or any documents of title relating to the Vested Securities to the Participant (or his nominee account ) on or as soon as reasonably practicable after Vesting.
6.EXERCISE OF OPTIONS
1.1Restrictions on the exercise of an Option: regulatory and tax issues
An Option which has Vested may not be exercised unless the following conditions are satisfied:
(a)the exercise of the Option and the issue or transfer of Securities after such exercise would be lawful in all relevant jurisdictions and in compliance with the Listing Rules, any relevant securities dealing code of the Company, the City Code on Takeovers and Mergers and any other relevant UK or overseas regulation or enactment;
(b)if, on the exercise of the Option, a Tax Liability would arise by virtue of such exercise and the Committee decides that such Tax Liability shall not be satisfied by the sale of Securities pursuant to Rule 6.4 (Payment of Tax Liability) then the Participant must have entered into arrangements acceptable to the Committee that the relevant Member of the Group will receive the amount of such Tax Liability;
(c)the Participant has entered into such arrangements as the Committee requires (and where permitted in the relevant jurisdiction) to satisfy a Member of the Group’s liability to social security contributions in respect of the exercise of the Option; and
10868-5-399-v0.8
- 10-
70-40492187



(d)where the Committee requires, the Participant has entered into, or agreed to enter into, a valid election under Part 7 of ITEPA (Employment income: elections to disapply tax charge on restricted securities) or any similar arrangement in any overseas jurisdiction.
For the purposes of this Rule 6.1, references to Member of the Group include any former Member of the Group.
1.2Exercise in whole or part
An Option must be exercised to the maximum extent possible at the time of exercise unless the Committee decides that a Participant may exercise the Option in respect of such fewer number of Securities as it decides.
1.3Method of exercise
The exercise of any Option shall be effected in the form and manner prescribed by the Committee. Unless the Committee acting fairly and reasonably determines otherwise, any notice of exercise shall, subject to Rule 6.1 (b) (Restrictions on the exercise of an Option: regulatory and tax issues), take effect only when the Committee receives it, together with payment of any relevant Option Price (or, if the Committee so permits, an undertaking to pay that amount).
1.4Payment of Tax Liability
The Participant authorises the Company to sell or procure the sale of sufficient Vested Securities on or following exercise of his Option on his behalf to ensure that any relevant Member of the Group receives the amount required to discharge the Tax Liability which arises on such exercise except to the extent that the Committee decides that all or part of the Tax Liability shall be funded in a different manner in which case Rule 6.1 (Restrictions on the exercise of an Option: regulatory and tax issues) shall apply.
1.5Transfer or allotment timetable
As soon as reasonably practicable after an Option has been exercised, the Company shall, subject to Rule 6.4 (Payment of Tax Liability) and any arrangement made under Rules 6.1(b) and 6.1(c) (Restrictions on exercise: regulatory and tax issues), transfer or procure the transfer to him (or his nominee account) or, if appropriate, allot to him (or his nominee account) the number of Securities in respect of which the Option has been exercised.
7.CASH ALTERNATIVE
1.1Committee determination
Where a Conditional Award or Provisional Allocation Vests or where an Option has been exercised and Vested Securities have not yet been allotted or transferred to the Participant (or his nominee), the Committee may determine that, in substitution for his right (if any) to acquire such number of Vested Securities as the Committee may decide (but in full and final satisfaction of his right (if any) to acquire those Securities), he shall be paid by way of additional employment income a sum equal to the cash equivalent (as defined in Rule 7.3 (Cash equivalent)) of that number of Securities in accordance with the following provisions of this Rule 7.    
1.2Limitation on the application of Rule 7.1
Rule 7.1 (Committee determination) shall not apply in relation to an Award made to a Participant in any jurisdiction where the presence of Rule 7.1 (Committee determination) would cause the grant of the Award to be unlawful or for it to fall outside any applicable securities law exclusion or exemption or adverse tax or social security contributions consequences for the Participant or any Member of the Group as determined by the Committee, provided that this Rule 7.2 shall apply only if its application would prevent the occurrence of a consequence referred to in this Rule 7.2.
1.3Cash equivalent
For the purpose of this Rule 7, the cash equivalent of a Security is:
(a)in the case of a Conditional Award or a Provisional Allocation, the Market Value of a Security on the day when the Award Vests;
10868-5-399-v0.8
- 11-
70-40492187



(b)in the case of an Option, the Market Value of a Security on the day when the Option is exercised reduced by the Option Price in respect of that Security.
1.4Payment of cash equivalent
Subject to Rule 7.5 (Deductions), as soon as reasonably practicable after the Committee has determined under Rule 7.1 (Committee determination) that a Participant shall be paid a sum in substitution for his right to acquire any number of Vested Securities:
(a)the Company shall pay to him or procure the payment to him of that sum in cash; and
(b)if he has already paid the Company for those Securities, the Company shall return to him the amount so paid by him.
1.5Deductions
There shall be deducted from any payment under this Rule 7 such amounts (on account of tax or similar liabilities) as may be required by law or as the Committee may reasonably consider to be necessary or desirable.
8.LAPSE OF AWARDS
An Award shall lapse in accordance with the Rules or to the extent it does not Vest under these Rules. On the lapse of all or any part of a Forfeitable Award, the beneficial interest (and, if appropriate, the legal interest) of the Forfeitable Securities in respect of which such Award has lapsed shall be transferred for no (or nominal) consideration to any person specified by the Committee.
9.LEAVERS AND DECEASED PARTICIPANTS
1.1Deceased Participants
If a Participant dies at a time when he is a director or employee of a Member of the Group before the Normal Vesting Date then, subject to Rule 4.3 (Restrictions on Vesting: regulatory and tax issues) and the remainder of this Rule, his Award (provided it is not a Provisional Allocation) shall Vest on the earlier of the Normal Vesting Date and the date on which the Committee is notified of the death. In the case of a Provisional Allocation, the Committee shall, in its absolute discretion, decide whether the Award should Vest.
1.2Good leavers
If a Participant ceases to be a director or employee of a Member of the Group before the Normal Vesting Date by reason of:
(a)retirement with the agreement of his Employer;
(b)ill health, injury or disability;
(c)redundancy (within the meaning of the Employment Rights Act 1996) or any overseas equivalent;
(d)his office or employment being with either a company which ceases to be a Member of the Group or relating to a business or part of a business which is transferred to a person who is not a Member of the Group; or
(e)for any other reason, if the Committee so decides at its discretion (provided, in the case of an executive director of the Company, that any discretion is exercised in accordance with the Company's directors' remuneration policy, as amended from time to time),
then subject to Rule 4.3 (Restrictions on Vesting: regulatory and tax issues), Rule 10 (Takeovers and other corporate events) and the remainder of this Rule, his Award (provided it is not a Provisional Allocation) shall Vest on the Normal Vesting Date unless the Committee decides that his Award shall Vest on the date of cessation. In the case of a Provisional Allocation, the Committee shall, in its absolute discretion, decide whether the Award should Vest (provided, in the case of an executive director of the Company, that any discretion is exercised in accordance with the Company's directors' remuneration policy, as amended from time to time).
10868-5-399-v0.8
- 12-
70-40492187



1.3Cessation of employment in other circumstances
If a Participant ceases to be a director or employee of a Member of the Group for any reason other than those specified in Rule 9.1 (Deceased Participants) or Rule 9.2 (Good leavers) then any Award held by him shall lapse immediately on such cessation.
1.4Meaning of ceasing employment
A Participant shall not be treated for the purposes of this Rule 9 as ceasing to be a director or employee of a Member of the Group until such time as he is no longer a director or employee of any Member of the Group. If any Participant ceases to be such a director or employee before the Vesting of his Award in circumstances where he retains a statutory right to return to work then he shall be treated as not having ceased to be such a director or employee until such time (if at all) as he ceases to have such a right to return to work while not acting as an employee or director.
1.5Death following cessation of employment
If a Participant dies following cessation of employment in circumstances where his Award did not lapse but it has not Vested by the time of his death, it shall Vest on the Normal Vesting Date unless the Committee decides that his Award shall Vest immediately on his death to the extent determined by reference to the time of cessation of employment in accordance with Rule 9.1 (Deceased Participants).
1.6Calculating number of Securities which Vest
For the purposes of this Rule, the Committee shall determine the number of Securities which Vest by applying the Performance Condition and any condition imposed on the Vesting of Awards and shall reduce the number of Securities pro rata as follows, unless the Committee decides otherwise in its absolute discretion to reflect any unexpired part of the Assessment Period as at the time that the Participant ceases to be a director or employee.
10.TAKEOVERS AND OTHER CORPORATE EVENTS
1.1General offers
If any person (or group of persons acting in concert):
(a)obtains Control of the Company as a result of making a general offer to acquire Securities; or
(b)having obtained Control of the Company makes such an offer and such offer becomes unconditional in all respects
the Committee shall, subject to Rule 10.5 (Internal reorganisations), have absolute discretion to determine whether Awards shall, subject to Rule 4.3 (Restrictions on Vesting: regulatory and tax issues), Vest if they have not then Vested. In the case of any Option that the Committee allows to Vest, that Option may, subject to Rule 6.1 (Restrictions on exercise: regulatory and tax issues) be exercised within one month of the date on which the Committee determines that Vesting is permitted, but to the extent that an Option is not exercised within that period, that Option shall (regardless of any other provision of the Plan) lapse at the end of that period.
1.2Schemes of arrangement and winding up
In the event that:
(a)a compromise or arrangement is sanctioned by the Court under section 899 of the Companies Act 2006 in connection with or for the purposes of a change in Control of the Company; or
(b)the Company passes a resolution for a voluntary winding up of the Company; or
(c)an order is made for the compulsory winding up of the Company
the Committee shall, subject to Rule 10.5 (Internal reorganisations), have absolute discretion to determine whether Awards shall, subject to Rule 4.3 (Restrictions on Vesting: regulatory and tax issues), Vest if they have not then Vested. In the case of any Option that the Committee allows to Vest, that Option may, subject to Rule 6.1 (Restrictions on exercise: regulatory and tax issues) be exercised within one month of the date on which the Committee determines that Vesting is permitted, but to the
10868-5-399-v0.8
- 13-
70-40492187



extent that an Option is not exercised within that period, that Option shall (regardless of any other provision of the Plan) lapse at the end of that period.
1.3Demerger and similar events
If a demerger, special dividend or other similar event is proposed which, in the opinion of the Committee, would affect the market price of Shares to a material extent, then the Committee may, at its discretion, decide that Awards shall Vest on such terms as the Committee may decide
1.4Rollover
If any company ("Acquiring Company") obtains Control of the Company as a result of making an offer referred to in Rule 10.1 (General offers) or a compromise or arrangement referred to in Rule 10.2(a) (Schemes of arrangement and winding up) any Participant may, by agreement with the Acquiring Company, release any Award ("Old Award") in consideration of the grant to him of an Award ("New Award") which is equivalent to the Old Award except that it will be over securities in the Acquiring Company or some other company.
The Rules will apply to any New Award granted under this Rule 10.4 as if references to Securities were references to securities over which the New Award is granted and references to the Company were references to the company whose securities are subject to the New Award.
1.5Internal reorganisations
In the event that:
(a)an Acquiring Company is expected to obtain Control of the Company as a result of an offer referred to in Rule 10.1 (General offers) or a compromise or arrangement referred to in Rule 10.2(a) (Schemes of arrangement and winding up); and
(b)at least 75% of the securities in the Acquiring Company are expected to be held by substantially the same persons who immediately before the obtaining of Control of the Company were shareholders in the Company then the Committee, with the consent of the Acquiring Company, may decide before the obtaining of such Control that an Award shall not Vest under Rule 10.1 (General offers) or Rule 10.2 (Schemes of arrangement and winding up) but shall be automatically surrendered in consideration for the grant of a New Award under Rule 10.4 (Rollover).
1.6Corporate events: reduction in number of Vested Securities
If an Award Vests under any of Rules 10.1 (General offers) to 10.3 (Demerger and similar events), the Committee shall determine the number of Vested Securities of that Award by the following steps:
(a)applying any Performance Condition and any other condition imposed on the Vesting of the Award; and
(b)if the Committee so decides, by applying a pro rata reduction to the number of Securities determined under Rule 10.6(a) to reflect the unexpired part of the Assessment Period.
If an Award Vests under any of Rules 10.1 (General offers) to 10.3 (Demerger and similar events) after the holder of that Award has ceased to be a director or employee of a Member of the Group then Rule 9.6 (Calculating number of Securities which Vest) shall take precedence over this Rule 10.6.
11.ADJUSTMENT OF AWARDS
1.1General rule
In the event of any variation of the share capital of the Company or a demerger, special dividend or other similar event which affects the market price of Securities to a material extent the Committee may make such adjustments as it considers appropriate under Rule 11.2 (Method of adjustment).
1.2Method of adjustment
An adjustment made under this Rule shall be to one or more of the following:
10868-5-399-v0.8
- 14-
70-40492187



(a)the number of Securities comprised in an Award;
(b)subject to Rule 11.3 (Adjustment below nominal value), the Option Price; and
(c)where any Award has Vested or Option has been exercised but no Securities have been transferred or allotted after such Vesting or exercise, the number of Securities which may be so transferred or allotted and (if relevant) the price at which they may be acquired.
1.3Adjustment below nominal value
An adjustment under Rule 11.2 (Method of adjustment) may have the effect of reducing the price at which Shares may be subscribed for on the exercise of an Option to less than their nominal value, but only if and to the extent that the Board is authorised:
(a)to capitalise from the reserves of the Company a sum equal to the amount by which the nominal value of the Shares in respect of which the Option is exercised and which are to be allotted after such exercise exceeds the price at which the Shares may be subscribed for; and
(b)to apply that sum in paying up such amount on such Shares
so that on exercise of any Option in respect of which such a reduction shall have been made the Board shall capitalise that sum (if any) and apply it in paying up that amount.
12.ALTERATIONS
1.1General rule on alterations
Except as described in Rule 12.2 (Shareholder approval) and Rule 12.4 (Alterations to disadvantage of Participants), the Committee may at any time alter the Plan or the terms of any Award.
1.2Shareholder approval
Except as described in Rule 12.3 (Exceptions to shareholder approval), no alteration to the advantage of an individual to whom an Award has been or may be granted shall be made under Rule 12.1 (General rule on alterations) to the provisions concerning:
(a)eligibility;
(b)the individual limits on participation;
(c)the overall limits on the issue of Shares or the transfer of Shares out of treasury;
(d)the basis for determining a Participant’s entitlement to, and the terms of, Securities or cash provided under the Plan;
(e)the adjustments that may be made in the event of any variation of capital; and
(f)the terms of this Rule 12.2
without the prior approval by ordinary resolution of the members of the Company in general meeting.
1.3Exceptions to shareholder approval
Rule 12.2 (Shareholder approval) shall not apply to any minor alteration to benefit the administration of the Plan, to take account of a change in legislation or to obtain or maintain favourable tax, exchange control or regulatory treatment for Participants or any Member of the Group.
1.4Alterations to disadvantage of Participants
No alteration or modification to the material disadvantage of Participants (other than to any Performance Condition) shall be made under Rule 12.1 (General rule on alterations) unless:
(a)the Committee shall have invited every relevant Participant to indicate whether or not he approves the alteration and the alteration is approved by a majority of those Participants who have given such an indication; or
10868-5-399-v0.8
- 15-
70-40492187



(b)such alteration, modification, suspension or termination is deemed necessary to ensure consistency with Barclays remuneration policy and / or practices (as amended from time to time) or to ensure the Group’s compliance with prevailing legal and/or regulatory requirements, which for the avoidance of doubt, includes any regulations or guidance published by a regulator from time to time.
13.MISCELLANEOUS
1.1Administration
The Plan shall be administered by the Committee whose decisions on any matter connected with the Plan shall be final and binding.
In the event of any dispute or disagreement as to the interpretation of the Plan, or as to any question or right arising from or relating to the Plan, the decision of the Committee shall be final and binding upon all persons. The exercise of any power or discretion by the Committee shall not be open to question by any person and a Participant or former Participant shall have no rights in relation to the exercise of or omission to exercise any such power or discretion.
1.2Employment
The rights and obligations of any Participant under the terms of his office or employment with any Member of the Group shall not be affected by his participation in the Plan or any right which he may have to participate in it. Participants shall waive any and all rights to compensation or damages in consequence of the termination of the office of employment for any reason whatsoever (and regardless of whether such termination is lawful or unlawful) insofar as such rights arise or may arise from his ceasing to have rights under the Plan as a result of such termination. Participation in the Plan shall not confer a right to continued employment upon any individual who participates in it. The grant of any Award under the Plan does not imply that any further Award will be granted nor that a Participant has any right to receive any further Award. The terms of the Plan are separate from and do not form a term of or any part of or create any obligations or rights pursuant to an individual's contract of employment.
1.3Resolution of Disputes
Any dispute arising out of or in connection with the Plan, including any question regarding its existence, validity or termination, shall be referred to and finally resolved by arbitration under the LCIA Rules, which rules are deemed incorporated by reference into this Rule. In the event of arbitration:
(a)the number of arbitrators shall be one;
(b)the seat, or legal place, of arbitration shall be London;
(c)the language to be used in arbitral proceedings shall be English.
The Committee and, by accepting the Award, any Participant waive any right of application to determine a preliminary point of law or appeal on a point of law under Section 45 and 69 of the Arbitration Act 1996.
1.4Share rights
All Shares allotted under the Plan shall rank equally in all respects with Shares then in issue except for any rights attaching to such Shares by reference to a record date before the date of the allotment.
Where Vested Shares are transferred to Participants (or their nominee account) or, in the case of Forfeitable Securities, released from their restrictions under the Plan, Participants will be entitled to all rights attaching to such Shares by reference to a record date on or after the date of such transfer or release of such restrictions.
1.5Notices
Any notice or other communication under or in connection with the Plan may be given in such manner as the Board consider to be appropriate, which may include communication by email or intranet or by personal delivery or by sending the same by post, in the case of a company to its registered office, and in the case of an individual to his last known address, or, where he is a director or employee of a
10868-5-399-v0.8
- 16-
70-40492187



Member of the Group, either to his last known address or to the address of the place of business at which he performs the whole or substantially the whole of the duties of his office or employment.
Where any such notice or other communication is given by a Participant to the Company, it shall be effective only on receipt by the Company.
1.6Third parties
No third party has any rights under the Contracts (Rights of Third Parties) Act 1999 to enforce any term of the Plan.
1.7Benefits not pensionable
Benefits provided under the Plan shall not be pensionable.
1.8Severability of Provisions
If any provision in this Plan is for any reason held by any Court or other competent authority of any jurisdiction to be illegal, invalid or unenforceable in whole or in part, the remaining provisions of this Plan shall continue to be valid and, if appropriate, the affected provision and the legality, validity or enforceability of such provision in any other jurisdiction shall be unaffected.
1.9Data Protection
If a Participant is employed outside the European Economic Area or the UK and consent is needed for the collection, processing or transfer of their personal data under applicable local law, by participating in the Plan, the Participant gives their consent for the purposes of the Plan.
For the purposes of compliance with the General Data Protection Regulation (EU) 2016/679, and any UK or other legal or regulatory equivalent, the Company will separately provide a Participant with information on the collection, processing and transfer of their personal data, including the grounds for processing.
If UK law diverges from EU law, then any references in the Rules to EU legislation will be interpreted as to the UK equivalent legislation, as in force from time to time.
1.10Governing Law
This Plan shall be construed, administered and governed in all respects under and by the law of England and Wales.

10868-5-399-v0.8
- 17-
70-40492187



SCHEDULE 1 - GRANT OF A FORFEITABLE AWARD
On or before the grant of a Forfeitable Award, each employee selected for such an Award must enter into an agreement with the Company under the terms of which the employee agrees both in respect of the Securities comprised in the Award at the Grant Date and any additional Securities that may become subject to the Award under Rule 2.4 (Dividend Equivalent Amount and Coupon Equivalent Amount):
(a)to have full beneficial ownership of the Securities;
(b)unless the Committee decides otherwise, to waive his right to all cash and scrip dividends on his Forfeitable Securities until Vesting;
(c)that he will not assign, transfer, charge or otherwise dispose of any Forfeitable Securities or any interest in such Forfeitable Securities until Vesting save as otherwise required by the Rules;
(d)if required by the Committee, to enter into any elections under Part 7 of ITEPA and any election to transfer, or any agreement to pay, secondary Class 1 National Insurance contributions (or their equivalents in any jurisdiction) in relation to his Forfeitable Securities; and
(e)to sign any documentation to give effect to the terms of the Forfeitable Award.
On (or as soon as practicable after) the Grant Date (or as soon as practicable after the payment date of the relevant dividend in the case of additional Shares that are to become subject to the Forfeitable Award under Rule 2.4 (Dividend Equivalent Amount and Coupon Equivalent Amount)) either the legal ownership of the Forfeitable Securities shall be held on the Participant’s behalf by a nominee as chosen from time to time by the Committee or the Participant shall deposit the share certificate (or any other document of title) relating to the Forfeitable Securities together with a signed but otherwise uncompleted instrument of transfer with such person as the Committee may from time to time decide.

10868-5-399-v0.8
- 18-
70-40492187



SCHEDULE 2 - CASH AWARDS
The Rules of the Plan shall apply to a Cash Award granted or to be granted under this Schedule as if it was a Conditional Award, an Option or a Provisional Allocation over Securities as determined by the Committee, except as set out in this Schedule. References in the Rules of the Plan to Securities shall be read as references to a cash sum where the context so requires. Where there is any conflict between the Rules and this Schedule, the terms of this Schedule shall prevail.
(a)The Committee may grant or procure the grant of a Cash Award.
(b)The Committee shall determine the form of a Cash Award (Conditional Award, Option or Provisional Allocation) on or before the Grant Date of that Cash Award.
(c)Each Cash Award shall relate to a given number of notional Securities.
(d)On or as soon as reasonably practicable after the Vesting of a Cash Award structured as a Conditional Award or a Provisional Allocation, the holder of that Award shall be entitled to a cash sum which shall be equal to the "Cash Value" of the notional Vested Securities.
(e)A Cash Award structured as an Option shall be exercisable in respect of notional Vested Securities for a period determined by the Committee at the Grant Date in its absolute discretion (being a period of no longer than 10 years from the Grant Date) beginning with the date on which the Cash Award Vests (unless it lapses earlier under Rule 9.3 (Cessation of employment in other circumstances) or Rule 10 (Takeovers and other corporate events)). Following the exercise of a Cash Award structured as an Option, the holder of that Award shall be entitled to a cash sum which shall be equal to the "Cash Value" of the notional Vested Securities less the Option Price (if any).
(f)For the purposes of this Schedule:
(i)    the Cash Value of a notional Security is the Market Value of a Security on the date of Vesting of a Cash Award structured as a Conditional Award or a Provisional Allocation and on the date of exercise of a Cash Award structured as an Option; and
(ii)    the Market Value of a Security on any day shall be determined in accordance with Rule 7.3 (Cash equivalent).
(g)Any cash sum payable under paragraphs (d) or (e) above shall be paid by the Employer as soon as practicable after the Vesting of the Cash Award under paragraph (d) or its exercise under paragraph (e), net of any deductions (on account of any Tax Liabilities) as may be required by law.
(h)For the avoidance of doubt, a Cash Award shall not confer any right on the holder of such an Award to receive Securities or any interest in Securities.

10868-5-399-v0.8
- 19-
70-40492187



SCHEDULE 3 - UNITED STATES ADDENDUM1
This Schedule shall apply for all US Participants who are Eligible Employees. Where a Participant becomes a US Participant after the grant of an Award, such Award is modified in a manner consistent with this Schedule. Where there is any conflict between the Rules and this Schedule, the terms of this Schedule shall prevail.
Except as noted in this Schedule, the Rules described in the Plan apply to Awards granted under this Schedule.
Notwithstanding anything in the Plan to the contrary, Awards granted to a US Participant shall be subject to the following provisions, as applicable:
(a)The award documentation provided for Conditional Awards and Awards otherwise subject to section 409A of the United States Internal Revenue Code of 1988, as amended ("Section 409A") shall include the scheduled payment/settlement date(s) for such Award.
(b)The grant of Dividend Equivalent Amounts and Coupon Equivalent Amounts under Rule 2.4 (Dividend Equivalent Amount and Coupon Equivalent Amount) shall not apply to Options.
(c)Rule 4.6 (Prudent Financial Control) shall not apply to a Conditional Award or any other Award that is subject to Section 409A, unless any delay in payment/settlement of the Award described in Rule 4.6 (Prudent Financial Control) is legally required under applicable law (within the meaning of US Treasury Regulation Section 1.409A-2(b)(7)(ii)) or the payment would otherwise jeopardise the Company’s ability to continue as a “going concern” (within the meaning of US Treasury Regulation Section 1.409A-3(d)).
(d)Notwithstanding anything to the contrary in Rule 4.9 (Disciplinary suspension), if, at the time that an Award to a US Participant that is subject to Section 409A (other than an Award under which a Participant is determined not to have a "legally binding right" within the meaning of Section 409A) is due to Vest, a Participant is Involved in an Investigation, then the Committee may decide at its discretion to lapse any such Award. Thereafter, the Committee, at its absolute discretion, following consultation with the Participant's Employer, may determine within 5 years from the date of any such lapse, whether to grant such Participant a new Award on terms as determined by the Committee.
(e)Notwithstanding Rule 5.1 (Conditional Awards and Provisional Allocations), payment/settlement with respect to any:
(i)Provisional Allocation or another Award that is exempt from Section 409A or any Dividend Equivalent Amount or Coupon Equivalent Amount shall be made no later than 2½ months following the end of the calendar year in which such Award or amount Vests; and
(ii)Conditional Award or any other Award that is subject to Section 409A shall be made as soon as practicable following the scheduled payment/settlement date but in no event more than 30 days thereafter, except as otherwise permitted under Section 409A; provided, however, that to the extent a Participant dies before the Normal Vesting Date, such Participant’s Awards shall be paid/settled as soon as practicable following the date of death, but only to the extent then Vested.
(f)Any determination described in Rule 7.1 (Committee determination) shall not be permitted to the extent that such determination or payment of cash would cause a delay in the payment or taxability of the applicable Award, unless such deferral is in compliance with Section 409A.
(g)Notwithstanding anything in Rule 9.2 (Good leavers) or Rule 10 (Takeovers and other corporate events) to the contrary, in the case of a Conditional Award or other Award that is subject to Section 409A, the provisions of Rule 9.2 (Good leavers) or Rule 10 (Takeovers and other corporate events) as the case may be, may be invoked to accelerate the Vesting of such Award but not the payment or settlement of such Award. Such Award shall be paid or settled on the originally-scheduled payment/settlement date, unless otherwise permitted under Section 409A.
(h)Adjustments made pursuant to Rule 11 (Adjustment of Awards) with respect to any Award granted to a US Participant shall be made in accordance with US Treasury Regulation Section 1.409A-1(b)(5).
(i)To the extent that a Participant who has been granted an Option becomes subject to US taxation and his Option is determined to have been granted with an option price less than “fair market value” on the
1     No Awards in the form of nil-cost Options over Securities or other Options over Capital Instruments shall be granted to US Participants.
10868-5-399-v0.8
- 20-
70-40492187



Grant Date as defined in US Treasury Regulation Section 1.409A-1(b)(5), his Option shall be exercisable only as follows: (i) if the Option is Vested in the year that the Participant becomes subject to US taxation, the Option shall be exercisable only in the first calendar year after the year in which the Participant becomes subject to US taxation; and (ii) if the Option is not Vested in the year that the Participant becomes subject to US taxation, the Option shall be exercisable only in the first calendar year after the year in which the substantial risk of forfeiture (within the meaning of Section 409A) lapses.
(j)The provisions of this Schedule shall also apply to Cash Awards granted under Schedule 2 to the Plan (Cash Awards) to the same extent that this Schedule applies to other Conditional Awards, Provisional Allocations or Options.
(k)In the event that a Participant is a "specified employee" (within the meaning of US Treasury Regulation Section 1.409A-1(i)) as of the date of the Participant’s “separation from service” (within the meaning of US Treasury Regulation Section 1.409A-1(h)) and if any Award both (i) constitutes a “deferral of compensation” within the meaning of Section 409A and (ii) cannot be paid or provided in the manner otherwise provided without subjecting the Participant to “additional tax”, interest or penalties under Section 409A, then, to the extent necessary to avoid penalties under Section 409A, no Award that is a deferral of compensation shall be paid or settled prior to the first day of the seventh month following the Participant’s separation from service.



10868-5-399-v0.8
- 21-
70-40492187


Summary of Key Terms

Introduction to this Section

This section is intended as an “at a glance” summary of the key terms of your employment. We therefore recommend that you read these terms in conjunction with the enclosed Detailed Terms and Conditions which together form your contract of employment (your “Agreement”). You should also refer to Appendix 1 to the Detailed Terms and Conditions which sets out definitions of the terms used in your Agreement.


Name
C. S. Venkatakrishnan
Employing Company
Barclays PLC (the “Company”).
Position
Your role will be Group Chief Executive. You will also be a member of the Group Executive Committee.

You will also be an Executive Director of Barclays PLC and Barclays Bank PLC reporting to the Barclays Group Chairman, subject to the Articles of Association as amended from time to time.

You acknowledge that by virtue of your role you will be a PRA Senior Manager.
Start Date
Your start date for the purposes of this Agreement will be 1 November 2021. Your start date for the purposes of your continuous employment with the Barclays Group is 17 March 2016.
Initial Place of Work
1 Churchill Place, London, E14 5HP and such other locations and offices as reasonably required in the performance of your duties.
Working Hours
Business hours from Monday to Friday, plus such additional hours as are required for the proper performance of your duties.



Fixed Pay
£2.7 million per annum (or such other amount as may be set out in any Barclays Directors’ Remuneration Policy approved by shareholders and as applicable from time to time) to be delivered 50% in cash, subject to tax and other statutory deductions and payable on the 23rd of each month. The remaining 50% will be delivered in Barclays PLC shares (“Shares”) delivered quarterly in equal amounts subject to a holding period (which for the avoidance of doubt is not a vesting or forfeiture condition) and to you completing a section 431 tax election before the first delivery of Shares. The number of Shares to be delivered for any quarter will be calculated by reference to the 10 a.m. market price on the London Stock Exchange on the date of delivery.

The Shares will be deposited with Barclays Nominee Limited (the “Nominee”), after sufficient Shares have been withheld to satisfy tax and other statutory deductions, and will be subject to a holding period during which the Shares may not be sold, transferred, charged, pledged, mortgaged or otherwise encumbered. These restrictions will lift as to 20% of the Shares on each of the first, second, third, fourth and fifth anniversaries of the date on which the Shares are deposited with the Nominee.

If your employment terminates, the Shares to be delivered on the next quarterly delivery date shall be pro-rated for the number of days from the start of the relevant quarter to your termination date. If Barclays elects to terminate your employment with pay in lieu of notice, you will not receive any Shares that would otherwise have accrued during your notice period.
Discretionary Incentive Award
You may be eligible to be considered for an award under the discretionary incentive arrangements the Barclays Group has in place from time to time, at the absolute discretion of the Barclays Group and subject to you being eligible at the relevant time up to a maximum value of 93% of Fixed Pay or such other maximum, as may be set out in any Barclays Directors’ Remuneration Policy approved by shareholders and as applicable from time to time.
Pension and other benefits
You will be entitled to an annual pension allowance of 5% of Fixed Pay, or such other percentage as may be set out in any Barclays Directors’ Remuneration Policy, approved by shareholders and as applicable from time to time, subject to tax and other statutory deductions. You are eligible to participate in the “My Rewards” programme.
Relocation
Your relocation benefits are set out in Schedule 1 (attached).



Barclays Long Term Incentive Plan

You will be eligible to be considered on an annual basis for participation in Barclays Long Term Incentive Plan or an alternative long term incentive plan at the Company’s discretion (the “Barclays LTIP”) in any year in which such a plan is operated by the Company, subject to the rules of the Barclays LTIP in force from time to time, up to a maximum value at grant of 140% of Fixed Pay, or such other maximum as may be set out in any Barclays Directors’ Remuneration Policy approved by shareholders and as applicable from time to time.
Annual Leave
Your annual leave entitlement is 30 days per year plus the usual UK public holidays. Further details are included in the Detailed Terms and Conditions.


Notice Period
The Company may terminate your employment by giving you twelve months’ written notice. You may terminate your employment by giving the Company six months’ written notice. Further information on Notice is included in the Detailed Terms and Conditions.
Overtime
You will not receive any additional remuneration or time off in lieu for work performed in addition to your normal hours of work.


Data Privacy
The Company processes employee information for administrative and other purposes related to your employment and the conduct of the business of the Barclays Group (the "Agreed Purposes"). Processing includes obtaining, holding, editing, destroying and disclosing employee information to any Barclays Group company and/or any third parties (for example, insurers, pension scheme trustees, banks and other employers following a business transfer or merger) for the Agreed Purposes ("Processing" or "Process"). The Agreed Purposes may include disclosing information to Regulators and/or to future employers in any regulatory reference or as otherwise required by law.
 
The Company may transfer employee information to any Barclays Group company and/or any third parties (for example, insurers, pension scheme trustees, banks and other employers following a business transfer or merger) in order to Process employee information for the Agreed Purposes.
 
You agree to provide your employee information to the Company and accept and understand that it will be processed for the Agreed Purposes in connection with your employment. This may include transfers to recipients based in another country to your place of employment (either within or outside the European Economic Area).
 
You agree that the Company and/or any Barclays Group company may monitor and/or record your use of office equipment, for example, e-mail, internet (including chats and blogs), telephones and mobile telephones for the purposes of compliance with Company procedures and policies, maintenance, security and regulatory requirements or as permitted by law.
Confidentiality
During your employment with the Company you will have access to, and be entrusted with, confidential information and trade secrets relating to the Company, the Barclays Group and any of our clients and customers. During and after your employment you must comply with all policies and procedures relating to confidentiality, confidential information and trade secrets and any stricter policy which applies to your role.
Post-Termination Restrictions
Full details of the restrictions you will be bound by are included in the Detailed Terms and Conditions.
Acceptance


By signing this Agreement, you agree to be bound by the terms of the Agreement. This includes the Summary of Key Terms, any applicable Schedules and the enclosed Detailed Terms and Conditions. This Agreement sets out the complete and exclusive agreement between you and the Company and supersedes all proposals or prior agreements, oral or written and all other communications between the parties relating to the subject matter of this Agreement. In the event of any conflict between the Summary of Key Terms and any applicable Schedules and the Detailed Terms and Conditions, the


Detailed Terms and Conditions will prevail. In addition, by accepting this offer you will be deemed to confirm that you have received, read, understood, agree and will comply with the requirements detailed in the Detailed Terms and Conditions.


Yours sincerely,




_______________________    ________________________     
Tristram Roberts        Date





I have read, understood and agree to the terms of the Agreement (including the terms set out in the Detailed Terms and Conditions section).




________________________    ________________________
Signature            Date



Schedule 1
Relocation Assistance

1.    This Schedule is annexed to the Agreement and sets out the terms that apply to your relocation.

2.    You shall be eligible for the following discretionary benefits (“Relocation Assistance”) in connection with your move to the United Kingdom, covering:

(i)    Immigration Assistance

Barclays Executive Services Team will arrange for a third party vendor to assist you and your accompanying dependant family members in obtaining the correct work and resident permits and spousal visas in order to work legally in the United Kingdom.

(ii)    Flight

The Company will reimburse reasonable First Class air travel to transport you and your accompanying dependant family members from the United States to the United Kingdom when you/they relocate to the UK. You should book this on the most direct and cost-efficient route using Barclays Global Travel Services in the United States. The Company will also arrange travel for you and your accompanying dependant family members from the arrival airport to your accommodation.

(iii)    Accommodation

(a)The Company will arrange accommodation in the UK for you, and make a contribution towards the associated costs of up to £6,550 per month paid directly to the accommodation provider, until 31 October 2023 or such time as your accompanying family members relocate to the UK (whichever is the earlier).

(b)The Company will provide the support of a third party supplier in negotiating the lease of a property in the United Kingdom.

(c)The Company will assist you in finding a home in the United Kingdom by providing you with the services of its usual home search agency, and verifying your employment status as required for a personal lease.

(iv)    Storage

The Company will pay for temporary storage of your household effects up to a maximum of 90 days in the United Kingdom, but this benefit will cease when your long-term accommodation becomes available for occupation prior to the end of the 90-day period. The Company will cover the cost of a single delivery from storage to your permanent residence.


(v)    Removals Assistance



The Company will bear the costs for packing, unpacking, transport and insurance (insurance up to a maximum value of GBP 125,000) of your household up to agreed limits in line with the international relocation programme or such other relevant policy that may apply to you and as amended from time to time.

Shipment by sea or road        40ft Container
Air freight            1000 lbs

There are several items for which Barclays will not bear the costs of shipping as set forth in the international relocation programme and these include, but are not restricted to, pets, plants, wines, spirits, boats, pianos or other objects which require special handling.

You will be advised of the company that will assist you with your household goods shipment. The relocation company will then contact you to undertake a survey of your requirements. Following the survey, the relocation company will submit a quote to the Company for the cost of moving your personal effects to the United Kingdom. Actual packing and shipment of your goods can only occur after the Company has seen and approved the relocation company quote.

(vi)    Tax

To assist you in tax compliance matters, the Company will pay the reasonable fees associated with our global tax provider preparing and completing your United States and United Kingdom annual tax return (which arises as a consequence of your employment or former employment with the Company) for years in which you receive remuneration in respect of your employment with the Company.

3.    The benefits outlined in paragraph 2 (iii) (a) will only be available for use up to 31 October 2023. Your entitlement to all of the benefits outlined in paragraph 2 (with the exception of 2 (vi)) will cease on 31 October 2023 or at such time as your accompanying family members relocate to the UK (whichever is the earlier). If any of the benefits outlined in that paragraph are not used, no cash in lieu of that benefit will be paid.

4.    If, before the end of the 12-month period beginning on the Start Date:

(i)    you serve notice to terminate your employment or otherwise end your employment, or

(ii)    you are dismissed by reason of gross misconduct,

the total gross cash value of any Relocation Assistance will become immediately repayable to the Company plus the cost to the Company of providing you with the relevant non-cash benefits.

5.    Paragraph 5 of the Detailed Terms and Conditions shall apply to any amounts which become payable to the Company as a result of this Schedule.

6.    The benefits and payments set out in paragraph 2 are subject to the international relocation programme or such other relevant policy that may apply to you and as amended from time to


time; but in the event of any conflict between those paragraphs and the policy, the terms of the policy shall prevail (except that in no event shall the terms of the policy supersede the provisions of paragraphs 2(iii)(a) or 3 above).

7.    In the event that any United Kingdom and / or United States income taxes and / or employee social security contributions would arise on the provision of any of the benefits set out in this Schedule 1, the Company shall either make a direct payment to the applicable tax revenue authority or provide you with a payment equal to the amount of any such income taxes and / or employee social security contributions, in each case grossed up to take account of any further income taxes and / or employee social security contributions due in respect of that payment.



Detailed Terms and Conditions

Introduction

About the Detailed Terms and Conditions

The purpose of the Detailed Terms and Conditions is to provide you with the relevant information on what the Company and the Barclays Group expects from its employees.

The Detailed Terms and Conditions also set out a list of key practices, guidelines and processes that the Barclays Group has developed to reflect our values, purpose and behaviour and as part of our high performance culture and, in accordance with your contractual obligations, must be adhered to at all times. Further information and policies can be found on the Barclays intranet site.

It is important that we review our policies, practices, guidelines and processes to ensure that we stay at the leading edge, enabling us to be one of the most admired financial services companies in the world. From time to time, our policies and procedures do change and you must familiarise yourself with them periodically throughout your employment. References in the Detailed Terms and Conditions to a policy, practice, guideline and / or process generally are references to the relevant policy, practice, guideline and / or process in force at the relevant time.

These detailed terms and conditions also refer to the Barclays Values. You will be expected to act in accordance with the Values as a Barclays employee, and in particular, to follow our Code of Conduct (known as the Barclays Way) at all times. The Barclays Way and further information on Barclays Values (Respect, Integrity, Service, Excellence and Stewardship) are available on the Barclays Group intranet site.

You should also refer to Appendix 1 which sets out definitions of the terms used in the Detailed Terms and Conditions.
























Your Detailed Terms and Conditions of Employment

1.Introduction to this Section

This section sets out your detailed terms and conditions of employment and should be read alongside your enclosed Summary of Key Terms and any applicable Schedules. These documents form your employment agreement with the Company and are referred to in this document as your or the “Agreement”. They replace your existing terms and conditions of employment. By signing the Agreement, you confirm that you have read, understood and agree to the terms set out in the Detailed Terms and Conditions.

2.Ongoing conditions

This offer of employment and your continued employment are conditional on all Regulatory approvals required for your role as Group Chief Executive having been obtained and not having been withdrawn by the Company or a Barclays Group company following consultation with the Regulator and to your remaining fit and proper to carry out your role at all times (as assessed by the Company at its absolute discretion).

3.Place of Work and Mobility    

Your place of work is as set out in your Summary of Key Terms. However, you may need to travel to other locations and offices as reasonably required in the performance of your duties. You agree that you will travel to such places (both inside and outside the UK) as the Company may reasonably require from time to time. Should the Company need to permanently change your place of work, you will be given reasonable notice of any such change.

4.Duties

4.1.During your employment with the Company you (i) acknowledge that your seniority and the fiduciary nature of your position place you in a position of trust; and (ii) agree that you will:

(a)act in a manner consistent with and which supports our purpose and values and in particular the Barclays Values;

(b)devote the whole of your working time and attention to the business of the Company and the Barclays Group;

(c)diligently and faithfully perform such duties and exercise such powers and functions as may reasonably be assigned to you by the Company in relation to its business and that of the Barclays Group to the best of your ability and with integrity, due skill, care and diligence;

(d)use your best efforts to promote and protect the interests of the Company and the Barclays Group and not do anything to harm those interests;

(e)comply with your Statement of Responsibilities and with the Conduct Rules in force from time to time;

(f)comply with all reasonable requests, instructions and regulations given by the Company and the Barclays Group and promptly provide such explanations, information and assistance as to your activities in the business of the Company and the Barclays Group as they may reasonably need;

(g)neither engage in any activities which would detract from the proper performance of your duties under this Agreement, nor (without the prior written consent of the Company) in any capacity including as director, shareholder, principal, consultant, agent, partner or employee engage or be concerned or interested directly or indirectly in any other trade, business or occupation whatsoever. This paragraph will not prevent you holding for investment purposes only, shares or securities which do not exceed three per cent (3%) in nominal value of the share capital or stock of any class of any company quoted on a recognised stock exchange;

(h)comply with the conflicts of interest policy applicable to you and will not engage or be interested in any activities which place you in a position where your interests conflict improperly with those of the Barclays Group, its clients, customers or shareholders. The Company recognises that, on occasion, a conflict of interest may arise which is unavoidable. In such circumstances you must make the Group Chairman or Barclays


Group Compliance aware of the issue immediately. You must not act in relation to the matter, without their written direction or approval;

(i)comply with any policies and procedures applicable to you in relation to any Barclays Group company or Regulatory authorisation (including, but not limited to, any policy or procedure applicable to any Certified Role or Senior Manager role you hold from time to time); and

(j)report any actual or proposed unlawful activity or behaviour affecting the Barclays Group by you or any other employee, officer, contractor of the Barclays Group or any other person to the Group Chairman (or, if they are potentially involved in such unlawful activity or behaviour, to the other members of the Board) immediately on becoming aware of it.

4.2    As you are to be a director and officer of the Barclays Group you shall be a beneficiary of the indemnification of directors of officers in the articles of association of Barclays PLC (article 146) as amended from time to time. You will also have the benefit of such directors’ and officers’ liability insurance as may be purchased by Barclays from time to time, subject to its terms and conditions.

5.Fixed Pay

5.1    50% of your Fixed Pay will be paid monthly in cash on or around 23rd of each month and is subject to tax and other applicable withholdings. The remaining 50% will be delivered in Shares, quarterly in equal amounts subject to a holding period (restrictions lifting as to 20% on the first, second, third, fourth and fifth anniversaries of the date on which the Shares are deposited with the Barclays nominee). Your Fixed Pay and allowances will accrue on a daily basis and will be paid pro rata if you are employed for part of a month, for that element payable in cash, or for part of a quarter, for that element delivered in Shares. The Fixed Pay set out in the Summary of Key Terms is your Fixed Pay prior to participation in any salary sacrifice arrangements. If you participate in any such arrangements via My Rewards, your Fixed Pay would be reduced as appropriate to reflect the terms of your participation, and your post sacrifice Fixed Pay will be reflected in your payslip.

5.2    Your Fixed Pay will be reviewed (including its delivery), without commitment to increase, if and when a new Directors’ Remuneration Policy is approved by shareholders or at any other time permissible under any Barclays Directors’ Remuneration Policy approved by shareholders and as applicable from time to time. The Company may deduct from any payments to you any money owed to any Barclays Group Company.

6.Discretionary incentive award

6.1    You may be eligible to be considered for a discretionary incentive award on an annual basis up to a maximum of 93% of Fixed Pay, or such other maximum as set out in any Barclays Directors’ Remuneration Policy approved by shareholders and as applicable from time to time. The value, form, conditions of delivery and timing of any such awards are at the Barclays Group’s discretion, in accordance with its approach to discretionary incentive awards, as amended from time to time. This discretion includes the right to make the award or a proportion of the award in a form other than cash, including an award of Shares and to defer an element of an award under the terms of a Barclays Group incentive plan.

6.2    Any discretionary incentive award will only be made if, at that time, you are in employment with the Barclays Group and are not under notice of the termination of your employment (whether given or received) subject to the discretion of the Remuneration Committee to be applied in accordance with the terms of any Barclays Directors’ Remuneration Policy approved by shareholders and as applicable from time to time.

6.3    You will be eligible to be considered on an annual basis for participation in the Barclays Long Term Incentive Plan or an alternative long term incentive plan at the Company’s discretion (the “Barclays LTIP”) in any year in which such a plan is operated by the Company subject to the rules of the Barclays LTIP in force from time to time, up to a maximum value at grant of 140% of Fixed Pay or such other maximum, as set out in any Barclays Director’s Remuneration Policy approved by shareholders and as applicable from time to time. Any award or recommendation shall be at the absolute discretion of the Company.

6.4    If you are subject to any investigation or disciplinary process at the time when communication, payment or making of any payment and/or award would otherwise occur, then the delivery of that payment and/or award will be suspended. If on conclusion of any investigation and/or disciplinary process, you are dismissed for gross misconduct or cause and/or have committed


any serious breach of the Risk and/or Compliance requirements of the Barclays Group, then no payment and / or award will be made to you. If no disciplinary action (or disciplinary action short of dismissal) is taken against you, then a payment and/or award may be made to you after the conclusion of that process. However, the amount of any award and/or payment to which you are entitled may be reduced by the Company in its sole discretion. For the avoidance of doubt, any award and/or payment may be reduced to nil in such circumstances.

6.5    Notwithstanding paragraph 6.4 any unpaid or unvested award (or portion of an unpaid or unvested award) may be reduced (‘malused’) (to nil if appropriate) at the discretion of a Barclays Group company. For the avoidance of doubt, a Barclays Group company may exercise its discretion including as a result of:

(a)Barclays PLC or any subsidiary's financial statements having been materially restated for the period for which the award was made other than restatement due to a change in accounting policy or to rectify a minor error; or

(b)The Barclays Group or any business unit having suffered a material downturn in its financial performance; or

(c)Your actions having, in the reasonable opinion of the Remuneration Committee, following consultation with the Company:

i.deliberately misled the management of the Company, the market and/or Barclays shareholders regarding the financial performance of Barclays or of any subsidiary;

ii.caused harm to the reputation of the Barclays Group;

iii.amounted to misconduct, negligence, incompetence or poor performance (“misconduct”, "negligence", "incompetence", and "poor performance" as determined by the Remuneration Committee acting in good faith, following consultation with the Company); or

(d)The Barclays Group or any of its subsidiaries, in the reasonable opinion of the Remuneration Committee, following consultation with the Barclays Board Risk Committee, has suffered a material failure of risk management.

6.6     Should a Barclays Group company become aware that the amount of any award that has been paid or released to you was calculated on the basis of any false, incorrect or misstated information, then, that company may, within one year of any such payment or release being made, request that you repay any amount (or part of any amount) as may be determined in that company’s discretion, acting in good faith. You agree that in the event a repayment obligation arises the Company is authorised to deduct the appropriate amount from your Fixed Pay or any other amounts due to you.

6.7    Within the Barclays Group, certain roles are designated as “Material Risk Taker” (MRT) roles. As you are a MRT and PRA Senior Manager, at any time within a seven year period (extending to ten years in the circumstances described below) from the date on which any variable remuneration is awarded to you in respect of a period for which you are a MRT and Senior Manager (the “Relevant Variable Remuneration”), if a Barclays Group company determines that:

(a)your actions or omissions at any time have, in the reasonable opinion of the Barclays Group company amounted to misbehaviour or material error; and/or

(b)a Barclays Group company or the relevant business unit has suffered a material failure of risk management,

then, without prejudice to any Barclays Group company’s other remedies, the Barclays Group company may require that you repay an amount, not exceeding the value of the Relevant Variable Remuneration. The repayment (‘clawback’) shall be of such value as may be determined in the Barclays Group company’s discretion acting in good faith, to such Barclays Group company and on such terms as it may direct.

Please note that as you are a PRA Senior Manager, the seven year period can be extended to ten years in circumstances where either Barclays or a Regulator (including any overseas authority) has commenced an investigation which could potentially lead to the application of clawback were it not for the expiry of the seven year clawback period.



In respect of paragraph (b) above, the Barclays Group company shall take into account your proximity to the applicable failure and your level of responsibility before any request for repayment is made. In respect of paragraphs (a) and (b) above, before any request for repayment is made, the Barclays Group company shall take into consideration whether you (i) have participated in, or were responsible for, conduct which resulted in significant losses to the Barclays Group or (ii) failed to meet appropriate standards of fitness and propriety.

For the avoidance of doubt, the whole or any part of the Relevant Variable Remuneration can be clawed back if the Barclays Group company makes its determination within seven years (or ten years in the circumstances described above) from the date that the Relevant Variable Remuneration was awarded to you even if an event falling within (a) or (b) above occurred prior to the date of the award.

The determination of what constitutes “misbehaviour”, “material error”, “material failure of risk management”, “significant losses” and “appropriate standards of fitness and propriety” shall all be determined by the Barclays Group company acting in good faith.

You agree that in the event a Barclays Group company makes a repayment determination, you shall repay the amount subject to that determination within the time period specified in the determination. You further agree and provide authorisation for the Company and any other Barclays Group company to deduct the appropriate repayment amount from your Fixed Pay or any other amounts due to you, to the full extent permitted under local law, whether from the Company or any other Barclays Group company.

You acknowledge that (in addition to its rights at paragraph 17 (Amendments to terms and conditions of employment) the terms of this paragraph 6.7 may be amended by the Company to the extent deemed reasonably necessary in order to comply with law, regulations or guidance published by any regulatory authority or other relevant authority from time to time.

This paragraph shall apply in addition to the general right of repayment set out in paragraph 6.6 of the Agreement.

6.8    A payment of cash and / or a release of Shares or other instruments under an award will be subject to tax and other applicable withholdings and will be subject to the rules of any applicable incentive plan as amended from time to time. For the avoidance of doubt, any tax liability which arises in excess of the statutory withholdings that the Company is required to make will be your responsibility.

6.8    A release or grant of Shares will only be made at a time when Barclays is not subject to any restrictions (such as the requirements of the Market Abuse Regulation as to closed and / or prohibited periods) on the granting or release of awards.

6.9    You agree that you will not put in place personal hedging strategies, insurance contracts or any other arrangements designed to undermine the risk alignment effects (whether by means of share price fluctuations, the operation of malus and / or clawback or by any other means) of your variable remuneration. Contravening this restriction would be considered a disciplinary offence, which could result in action up to and including dismissal for cause/gross misconduct.

6.10    For the avoidance of doubt, any awards made to you will not form part of your pensionable pay.

6.11    You have no contractual right to receive an award, and the making of an award in any year does not give rise to any obligation on the Barclays Group to, or legitimate expectation that the Barclays Group will, make an award in any future year.

7.Benefits

7.1    The Company operates My Rewards, a flexible benefits programme for its employees that provides you with the opportunity to choose your benefits from a range included in the programme. Benefits available to you are set out in full on the My Rewards website.

7.2    The Company has the right at its absolute discretion to amend or withdraw the benefits included in My Rewards at any time and without any compensation or notice to you and / or replace My Rewards with an alternative programme at its discretion.

7.3    Participation in any benefits scheme under My Rewards is subject to the rules of the relevant schemes, which may vary from time to time, and is subject to you satisfying any applicable requirements of the insurers or third party providers (where relevant). Scheme rules, including any exclusions or terms and conditions relevant to participation, will be published via My Rewards. Employees must read the guidance provided. Help lines are published to aid


employees in the event of any query. Any failure to meet scheme rules will result in exclusion from participation.

8.Annual Leave

8.1    Your annual leave entitlement is set out in the Summary of Key Terms. The Company’s annual leave year runs from 1 April to the 31 March the following year. Your annual leave dates must be agreed in advance with the Group Chairman. You are obliged to take all your annual leave entitlement in the relevant year. However, a maximum of 5 days’ annual leave may be carried over to the next annual leave year with the express written consent of the Group Chairman.

8.2        If your employment begins during the annual leave year, your annual leave entitlement (plus any Bank or Public Holidays which fall during this period), will be calculated pro rata. On leaving the Company’s employment, the Company reserves the right to ask you to take any unused accrued annual leave during your Notice Period. Alternatively, at the Company’s sole discretion you may be paid Fixed Pay pro rata in lieu of any (accrued but untaken) annual leave entitlement. If you have taken more annual leave than your accrued entitlement, you may be required to repay to the Company an amount equivalent to any annual leave taken in excess of your pro rata annual leave entitlement, and the Company is authorised to deduct the appropriate amount from your final cash instalment of your Fixed Pay or any other sum owed by the Company to you at the Termination Date.
9.Intellectual Property

9.1For the purposes of this paragraph:

"Intellectual Property Rights" means (i) copyright and related rights, patents, know-how, rights in undisclosed or confidential information, trade secrets, database rights, Inventions, semi-conductor topography rights, and rights in trademarks and designs (whether registered or unregistered), (ii) applications for registration, and the right to apply for registration, for any of the same, (iii) rights to use such assets listed in (i), (ii) and (iv) under licences, consents, orders, statutes or otherwise, and (iv) all other intellectual property rights and equivalent or similar forms of protection existing anywhere in the world;

“Invention” means any invention, idea, discovery, development, improvement or innovation made, whether or not patentable or capable of registration, and whether or not recorded in any medium; and

"Works" means all documents, materials, software, photographic or graphic works of any type, and other materials in any medium or format (whether in final form or otherwise and including any preparatory materials) which are created or developed, or are in the process of being created or developed by you or on your behalf or by the Company in the course of your employment with the Company or for the benefit of the Company (whether conceived, or made during normal working hours, in your normal place of work, using Company premises or resources or in conjunction with others, or otherwise).

9.2You will promptly disclose and deliver up to the Company all and any Works. You agree to provide the Company with all originals and copies of all correspondence, documents and other materials in whatever medium or form relating to or concerning the Works and the Intellectual Property Rights they contain.

9.3You agree that you will only use the Works to perform your obligations under your Agreement and that you will not make personal copies of any Works other than for the purposes of your employment with the Company.

9.4You acknowledge that you have, and will have at all times while you are employed by the Company, a special obligation to further the interests of the undertakings of the Company.

9.5Works and all and any Intellectual Property Rights in the Works (including current and future Intellectual Property Rights) (“Company IPR”) shall belong to and automatically vest in and be the absolute property of the Company, or such Barclays Group company as the Company may direct, to the fullest extent permitted by law.

9.6To the extent that ownership of the Works and Company IPR does not automatically vest in the Company by operation of law, you hereby assign to the Company (or such Barclays Group company as the Company may direct) with your entire right, title and interest in, all Works and Company IPR. This assignment shall take effect upon the creation of each of the Works (or part of the Works) and / or Company IPR.



9.7You agree that you will immediately, upon request and at the Company’s expense, provide all such documents and assistance as may be necessary to vest the Works and Company IPR in the Company, to enable the Company to enjoy the full benefit of the Company IPR, and to enable the Company to enforce its Intellectual Property Rights against third parties or defend claims brought against the Company in relation to any Company IPR.

9.8You unconditionally and irrevocably waive your moral rights in relation to existing and future Works and Company IPR, including your right to be identified as the author of the Works and not to have the Works subject to derogatory treatment. You acknowledge that, except as may be expressly provided by law, no further remuneration or compensation other than that provided for under your Agreement is or may become due to you in respect of your compliance with this paragraph 9.

9.9When your Agreement expires or terminates, for whatever reason, you will immediately deliver up to the Company all Works in your possession or under your control, and under no circumstances may any Works be retained by you except with the prior written consent of the Company. 

10.Confidentiality

10.1During your employment with the Company or at any time afterwards, you must not disclose to any person or make use of any Confidential Information or trade secrets that you have obtained in the course of your employment. This includes information that you have acquired in the course of your employment concerning the business or affairs of the Company and/or any other Barclays Group company or our customers, clients, suppliers or agents. You are required to use your best efforts to prevent the unauthorised publication or disclosure of any such Confidential Information. Exceptions to this are the use of information for the proper performance of your duties under your Agreement, where the Company has given written consent or disclosure is required by law, or where the information is already in or comes into the public domain (other than by your unauthorised disclosure). For the avoidance of doubt, nothing in your Agreement shall preclude you from making a “protected disclosure” within the meaning of section 43A of the Employment Rights Act 1996 to the Prudential Regulation Authority, the Financial Conduct Authority or, if applicable, to an overseas regulator within the meaning of section 195(3) of the Financial Services and Markets Act 2000. Nothing in this agreement or any other agreement with or confidentiality obligations informed by the Company or any member of the Barclays Group is intended to or shall prevent you from raising concerns in line with Barclays’ internal reporting processes or making any disclosure to governmental bodies, law enforcement authorities and/or regulators as permitted or required under applicable law or regulation.

10.2During your employment or at any time afterwards, you must not make any copy or record (whether recorded in writing, on computer disc, electronically or otherwise) of any Confidential Information, unless this is required for the proper performance of your duties under your Agreement. Any such information belongs to the Barclays Group and must be returned by you either at any time during the course of your employment on the request of the Company and, in any event, immediately on termination of your employment.

10.3For the purposes of your Agreement, “Confidential Information” means information concerning the business, affairs, finance, clients or trade connections of the Company, any member of the Barclays Group, or any of their customers, clients, suppliers or agents. This includes but is not limited to:

(a)commercially sensitive information or trade secrets;

(b)corporate and marketing strategy, business development plans, sales reports and research results;

(c)business methods and processes, technical information and know-how relating to the Barclays Group’s business and which is not available to the public generally, including inventions, designs, programmes, techniques, database systems, formulae and ideas;

(d)business contacts, lists or details of clients and suppliers and details of contacts with them, their business or affairs, including client names and client contact details, financial and personal affairs, and trading history and methodology;



(e)information on employees and the terms and conditions of their employment, details of employee benefits, incentive schemes/plans, salary scales and/or current or anticipated trade union/employee disputes;

(f)information or details of any actual, potential or threatened litigation, legal action, claim, dispute or arbitration against or with any member of the Barclays Group or any current or former director, officer or employee of the Barclays Group in such capacity and any information in respect of provisions for any such action;

(g)budgets, management accounts, trading statements and other financial reports;

(h)unpublished price sensitive information relating to shares or securities listed or dealt in on any recognised stock exchange; and

(i)any other information which any member of the Barclays Group or any of its employees or consultants has identified (orally, in writing, or by its or their actions) as being secret or confidential in nature or which would reasonably be considered as confidential.
11.Regulatory compliance and dealing codes

11.1The nature of the Barclays Group’s business is such that it is authorised and regulated by the Regulator.

11.2It is your responsibility to know, understand and comply with all legal, regulatory and governance obligations, including the provisions of the Risk and Compliance requirements that are relevant to you. If you are in any doubt as to your responsibilities in this regard or the rules which apply to you, you must contact Barclays Group Compliance. You must at all times and in all respects comply with the UK Corporate Governance Code.

11.3As you are an Approved Person you must comply with the Regulator's statement of principles and code of practice for Approved Persons, or any equivalent principles or standards as in force from time to time. Failure to comply with any of the above may result in investigation by the Regulator, the Company, and / or disciplinary action and / or performance management being taken against you by the Company which may result in the termination of your employment.

11.4You agree to be bound by and comply with the Barclays Group Securities Dealing Code and with any more stringent dealing rules applicable to you or the area of the business in which you work. In particular, you agree not to make any investment, directly or indirectly, in any company or business which is a customer or client of the Barclays Group and which may in the reasonable opinion of the Company be expected to cause your personal or family interests to conflict with your duty to the Company in any respect. You also agree to comply with any shareholding requirement that is communicated from time to time.

11.5Any incentives or compensation payable to you by the Company or a Barclays Group company (under this Agreement or otherwise, including any guaranteed or conditional amounts and including, where applicable, the payment and settlement schedule and split of cash and Shares as set out in your Agreement) are subject to limitation or modification to the extent reasonably deemed necessary by the Barclays Group company including in order to remain consistent with Barclays Group remuneration policies and practices (as amended from time to time) or to comply with laws and regulations, including any regulations or guidance published by the Regulator (or other regulatory authority) from time to time.

12.Data Protection

The Barclays Group is committed to protecting your personal data. The Company will use your information for administrative and other purposes related to your employment and the conduct of the business of the Barclays Group, for example for remuneration and benefits, and for monitoring of employee compliance with IT policies and applicable law concerning the use of IT systems. The Company may share your information with our trusted third parties (for example insurers, pension scheme trustees, banks and other employers following a business transfer or merger or in the form of references) for these purposes, which may include recipients in another country. The Company may also be required to share your information with UK and overseas regulators and authorities in connection with their duties. For more detailed information on how and why the Company uses your information, including the rights in relation to your personal data, and the legal grounds for using it, please refer to Barclays staff fair processing notices, which can be found on your intranet, or you can request a copy from us.





13.Expenses

Any expenses incurred by you must be approved and claimed in accordance with the applicable expenses policy and procedures in force from time to time.

14.Attendance at work

Your Summary of Key Terms will provide you with details of the particular working pattern that applies to you, and any specific arrangements that may apply regarding changes to this pattern.

15.Sickness absence

15.1If you are unable to work through ill health or injury you must report this to the Group Chairman (or such other person as may be notified to you from time to time). You shall be required to provide the Company with satisfactory evidence of your incapacity in accordance with the provisions set out on your intranet. You may be asked to submit to an examination by a medical practitioner of the Company’s choice, and you hereby agree to co-operate with such an examination and to authorise the full disclosure of any resulting report to Barclays.

15.2Your entitlement to and/or the payment of Fixed Pay and any allowances during periods of sickness will be subject to the absolute discretion of the Company, you following the requirements regarding notification and certification of absence as set out on your intranet and the Company being satisfied that you are unable to work due to illness or injury. The Company’s policy in place at the time of absence on the payment of Fixed Pay and allowances during periods of sickness can be found on your intranet.

15.3The Company reserves the express right to terminate employment due to ill health, injury or other incapacity. This includes during periods when you are in receipt of sick pay or any form of income protection or ill health payment, whether under a Company benefit scheme or otherwise.

16.Other absences from work

Approval should be obtained in advance from the Group Chairman for extended periods of absence during working hours. If unexpected circumstances mean that this is not possible, you should inform the Group Chairman as soon as possible.

17.Amendments to terms and conditions of employment

17.1The Company reserves the right to review, revise, amend, replace or withdraw the contents of the Agreement and introduce new policies, practices, guidelines and procedures from time to time to reflect the changing needs of the business or any changes in legislation or regulation from time to time (including but not limited to any changes in accordance with clause 11.5).

17.2For the avoidance of doubt, where the Company retains a discretion under this Agreement (including but not limited to the discretion to make incentive award(s) to you, any matters considered in the decision whether to make such an award and the value, form, conditions and timing of delivery of any such award(s)) such discretion cannot be limited or fettered in any way other than by agreement between you and the Company which is documented formally in writing on the Company's headed paper by an authorised member of the Human Resources Department.

18.Allocation of duties

You and the Company agree that your duties will be commensurate and consistent with your positions as contemplated by this Agreement.

19.Leaving Barclays

19.1Subject to paragraph 2 of these Detailed Terms and Conditions the Company and you may each terminate your Agreement in accordance with the “Notice Period” paragraph set out in your Summary of Key Terms. In addition:

(a)your employment may also be terminated by the Company without notice or pay in lieu of notice if you commit an act of gross misconduct or cause, which may include failure to comply with any policies and/or procedures including those referred to in this Agreement, lack of competence, serious breach of this Agreement or improper or unethical behaviour; and



(b)    the Company may (without notice, pay in lieu of notice or incurring any obligation to pay compensation) immediately terminate your employment if you:

i.are convicted of any criminal offence (other than a minor offence which, in the opinion of the Company, does not affect your position as an employee of the Company); or

ii.are guilty of any act of dishonesty or serious misconduct or any conduct which brings or is intended to bring any member of the Barclays Group or yourself into disrepute or may damage the business or affairs of the Barclays Group;

iii.or have been found by the Company to have materially or repeatedly breached or have not complied with the terms of this Agreement (or otherwise fail or refuse to carry out the duties assigned to you); or

iv.have breached or otherwise failed to adhere to the Barclays Group sanctions policy or process; or

v.cease to hold or fail to obtain any regulatory approvals or consents which are required for the effective discharge by you of any duties assigned to you under this Agreement; or

vi.materially breach the rules of the Regulator (including any Conduct Rules) or are deemed by the Company at any time in its absolute discretion not to be fit and proper to carry out your role; or

vii.breach any Barclays Group rules on anti-bribery or anti-corruption; or

viii.become bankrupt (or equivalent in any other jurisdiction) or become the subject of an interim order under the Insolvency Act 1986 or make any arrangements or composition with your creditors.

This sub paragraph is not exhaustive and does not restrict any other right which the Company may have (whether at common law or otherwise) to terminate your employment summarily.

19.2The termination of your employment will not affect any terms of your Agreement which are intended to operate after the Termination Date, including the paragraphs relating to Intellectual Property, Confidentiality and Post Employment Restrictions.

19.3On termination of your employment, irrespective of the reason, or at any other time when asked by the Company, you will:

(a)immediately return to the Company all vehicles, equipment and documents, whether electronic or otherwise, and any other property (of any kind) (security pass, business cards, etc) relating to the business of or belonging to the Barclays Group, together with all copies of any such documents that you have in your possession or under your control;

(b)irretrievably delete any information relating to the business of the Company or the Barclays Group stored on any computer or storage device and all information derived from the same in your possession or control and held outside of any Barclays Group premises, including, but not limited to, any tokens, applications or other data held on personal devices;

(c)resign with immediate effect from any directorships, offices or other appointments you hold within or connected to Barclays or the Barclays Group and in the event of your failure to do so, hereby irrevocably authorise the Company to appoint some person in your name and on your behalf to sign and deliver such resignations and do all things requisite to give effect to such resignations referred to in this paragraph 19.3(c);

(d)if so requested, ensure a full and timely handover of your Senior Manager responsibilities and comply with any handover policy in force from time to time;

(e)confirm in writing that you have complied fully with the terms of this paragraph and provide evidence of compliance as the Company may request; and

(f)provide Barclays or any member of the Barclays Group with such assistance as it may reasonably require in the conduct of any proceedings, or in connection with any


investigations or regulatory reviews, that has or have arisen or may arise in any jurisdiction, in which Barclays or its legal advisers believes you may be able to provide assistance. This shall include, without limitation, providing documents or other records of your activities on behalf of Barclays or any member of the Barclays Group, making yourself available for interviews with Barclays’ counsel or any regulatory body or governmental authority as may be reasonably requested by Barclays, providing assistance in drafting witness statements and/or attending court or tribunal to give evidence on behalf of any member of the Barclays Group. For the avoidance of doubt, you may be required to provide such assistance in any such jurisdiction as determined by Barclays. Barclays will pay your reasonable expenses incurred in providing such assistance unless your assistance is compelled by a court of competent jurisdiction.

20.Payment in lieu of notice

20.1The Company reserves the right in its sole and absolute discretion to terminate your employment and this Agreement with immediate effect (whether or not notice has been given by either party) by giving notice in writing to you of its intention to make a payment in lieu of notice. If it does so, the Company shall make you a payment in lieu of notice equal to the cash portion of your Fixed Pay which you would have been entitled to receive if you had worked during your Notice Period or, if your Notice Period has started, the unexpired portion (the “Payment in Lieu”). Where the Company elects to make a Payment in Lieu of some or all of your Notice Period, your employment shall terminate on the date specified by the Company, regardless of when the Payment in Lieu is paid to you.

20.2    Any Payment in Lieu will be paid less tax and any applicable withholdings. You will not be entitled to receive any payment in respect of annual leave entitlement that would have accrued during the period for which the Payment in Lieu is made.

20.3    Any Payment in Lieu may at the Company’s absolute discretion be paid as a lump sum within one month of the Termination Date or in equal monthly instalments from the date on which notice is served until what would have been the end of the Notice Period provided always that if after exercising its discretion to make a Payment in Lieu the Company becomes aware of any grounds that would permit it to summarily terminate your employment any payments due under this paragraph 20.3 will cease to be payable and the net value of any Payment in Lieu that has been received by you shall be repaid as a debt to the Company within 30 days of the Company notifying you of this repayment obligation.

20.4    If the Company elects to pay the Payment in Lieu in instalments and while such payments are being made you commence alternative employment or the provision of services under a consultancy agreement, then for each month that instalments of the Payment in Lieu remain payable, the Company shall be entitled to reduce the amounts due to you by the amount of any salary, fees, benefits or bonus received by you from any alternative employment or engagement. In the event that the Company exercises its discretion to terminate your employment under this paragraph, you shall use your reasonable efforts to secure alternative employment or an engagement as a consultant as soon as reasonably practicable, subject to your obligations under this paragraph 20 and the payment of the instalments shall be conditional upon you providing the Company with reasonable evidence of such efforts.

21.Garden leave and suspension

21.1The Company may suspend you at any time from the performance of all or any of your duties:

(a)for the whole or any part of any applicable Notice Period; or

(b)for such periods and on such terms as is necessary to allow any investigation to take place (including, but not limited to an investigation by a Regulator or an investigation under the Company’s investigations or disciplinary procedures).

21.2During any period of suspension, the Company will be under no obligation to provide work for or assign any duties to you and may require you not to attend any premises of any member of the Barclays Group (other than as a customer) and may require you to:

(a)not speak to, contact or otherwise communicate with or engage with any director, consultant, agent, supplier, contractor or employee of any member of the Barclays Group other than to carry out your personal banking, or any person, firm or company who, at the date of such suspension or exclusion is a client or customer of any member of the Barclays Group unless they are members of your immediate family;



(b)meet with representatives from the Company in order to facilitate a handover of work and provide assistance with ongoing business activity; and

(c)take any annual leave which you have accrued.

21.3    During any period of suspension:

(a)your employment with the Company and the terms of your Agreement will continue and you will continue to be bound by your obligations under it (except as expressly set out in this paragraph) including, but not limited to, your obligations of confidentiality, good faith and fidelity to the Company; and

(b)you shall continue to receive your Fixed Pay, and all contractual benefits in the usual way unless the Company is prevented by law from paying you.

22.Post termination restrictions

22.1You agree with the Company (for itself and as trustee and agent for each member of the Barclays Group) that you will not, whether directly or indirectly, on your own behalf or on behalf of or in conjunction with any other person, firm, company or other entity:

(a)for a period of 6 months from the Termination Date approach, solicit or deal with any person, firm, company or other entity who is or was a customer, client or supplier of the Company or the Barclays Group and with whom you had material dealings in the course of your employment with the Company or in respect of whom you were aware of material and confidential information, in both cases within the 12 month period immediately prior to the Termination Date. Nothing in this paragraph will prohibit you from seeking or doing business which is not in direct or indirect competition with the business of the Barclays Group; and

(b)for a period of 6 months from the Termination Date, carry on, set up, be employed, engaged or interested (whether as a director, officer, shareholder, investor, principal, consultant, agent, partner or employee) in a business in the UK or in any country in the world in which the Barclays Group carries on business which is competitive or plans to be competitive with the Barclays Group in the provision of banking or financial services and such other services carried on by the Barclays Group at the date on which your employment terminates and (i) with which you were actively involved in the 12 months prior to the earlier of the termination date of your employment and the Garden Leave Date; or (ii) in respect of which you had access to financial data or confidential information. The provisions of this sub paragraph shall not, at any time following the date on which your employment terminates, prevent you from holding for investment purposes only shares or securities which do not exceed three per cent (3%) in nominal value of the share capital or stock of any class of any company quoted on a recognised stock exchange and, in addition, shall not prohibit the seeking or doing of business not in competition with the business of the Barclays Group; and

(c)for a period of 12 months from the Termination Date solicit or entice away or attempt to solicit or entice away or employ or engage any director, officer or employee of executive status in the Barclays Group with whom you had material dealings within the 12 month period immediately prior to the Termination Date. For the purposes of this paragraph “employee of executive status” will include without limitation any employee of the Barclays Group with a corporate grading of Managing Director, Director, Vice President (or equivalent grades, or anything which replaces these grades) and any employees of the Barclays Group with a lower corporate grading where in the 12 months prior to the Termination Date, you have had line manager responsibilities in relation to that employee or they have had line manager responsibilities themselves or have been engaged in work or projects which in the Company’s reasonable opinion are key to its business and / or mean that they are in possession of material and confidential information relating to the Barclays Group.

22.2Each of the restrictions contained in this paragraph are considered by the parties to be reasonable in all the circumstances as at the date of this Agreement. However, the parties agree that if any one or more of such restrictions will be judged to be void as going beyond what is reasonable in all the circumstances for the protection of the interests of the Barclays Group, but would be enforceable if words were deleted or one or more of the duration, range of activities and area covered were reduced in scope, the restrictions will be deemed to apply with such modifications as may be necessary to make them valid and effective. Any such modification will not affect the validity of any other restriction contained in this Agreement and it is agreed that each restriction in this paragraph will be construed as separate and individual restrictions.



22.3You agree that if, during either your employment with the Company or the period of the restrictions set out in this paragraph you receive an offer of employment or engagement, you will provide a copy of these restrictions to the offeror as soon as reasonably practicable after receiving the offer.

23.Further terms

23.1No omission to exercise or delay in exercising any right, power or remedy of the Company under your Agreement will constitute a waiver of that right, power or remedy.

23.2During your employment:

(a)the Company may at its discretion require that you undergo screening, including for criminal record, sanctions list and/or credit reference checks from time to time. It is anticipated that any such screening would only be undertaken if required for regulatory purposes or in order to comply with the minimum standards for the role you are undertaking; and

(b)you should advise the Company should any of the circumstances as set out in paragraph 19.1(b) of this Agreement arise or be brought against you.

23.3You acknowledge that in entering into your Agreement you have not relied on any representation or undertaking by the Company or any member of the Barclays Group whether oral or in writing, except as expressly incorporated into your Agreement.

23.4You consent to the Company monitoring your use of all Company resources and its communication and electronic equipment (including without limitation the telephone, internet blackberry, software applications and email systems) and information stored on the Company’s computer equipment, as described in your local acceptable use policy in accordance with the Barclays Group procedure and / or guidance on electronic communications. A copy of the policy that applies to you can be found on your intranet.

23.5You understand that you may, during your employment, be granted awards under the terms of one or more of the Company’s long term incentive plans or any incentive or bonus plan operated by the Barclays Group. If, on termination of your employment, you lose any of the rights or benefits under any such plans you will not be entitled, by way of compensation for loss of office or otherwise, to any compensation for the loss of any rights under any such plans.

23.6If your employment is terminated at any time by reason of any reconstruction or amalgamation of the Company or any Barclays Group company, whether by winding up or otherwise, and you are offered employment with any concern or undertaking involved in or resulting from the reconstruction or amalgamation on terms which (considered in their entirety) are no less favourable to any material extent than the terms of your Agreement, you shall have no claim against the Company or any such undertaking arising out of or connected with the termination.

24.Certifications

24.1It is your responsibility to be aware of and adhere to any lawful contractual agreement, duty or obligation you may have to any other persons, including any third party’s rights in respect of confidential information and/or intellectual property. It is the Company’s expectation that you will comply with any and all such lawful contracts, duties or obligations.
24.2You agree and certify that:

(a)having made such enquiries as set out above, you are not precluded or restricted by any term of any agreement, undertaking or court order or any duty or obligation to any third party (including but not limited to prior employers) from entering into your Agreement or undertaking or properly performing any of the duties of your employment with the Company or that you have disclosed any relevant obligations to the Group Chairman, and that they have confirmed that this does not prevent you from entering into this Agreement;

(b)when participating in any screening process during your employment, the information that you provide in connection your ongoing employment shall be true and accurate at the time it is given;



(c)you are not currently the subject of an investigation by any company or body into suspected bribery or corruption activity, and have never been, the subject of such an investigation where either: (i) the investigation was concluded and your conduct found to amount to misconduct; or (ii) where the investigation did not reach a conclusion because your employment (or engagement) with that company or body was terminated during the investigation (whether by mutual consent or by voluntary termination or otherwise);

(d)you are not currently, and have never been, the subject of an investigation into suspected criminal activity involving elements of dishonesty (including theft or fraud) or anti- competitive behaviour;

(e)you will not during your employment with the Company breach any third party’s rights in respect of confidential information and/or intellectual property; and

(f)you will immediately report to the Group Chairman, to compliance or to HR any matters which may impact your fitness and propriety to carry out your Approved Person role; and

(g)you will immediately report to the Group Chairman, compliance or to HR any breach of a Conduct Rule by yourself or any third party of which you become aware.

Any breach of these certifications will entitle Barclays to immediately terminate your employment.

25.Third party rights

Any member of the Barclays Group may enforce the terms of this contract subject to and in accordance with the Contract (Rights of Third Parties) Act 1999. Other than members of the Barclays Group, a person who is not a party to your Agreement will have no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its terms.

26.Working Time

You agree that you have unmeasured working time for the purposes of Regulation 20 of the Working Time Regulations 1998.

27.Governing law

Your Agreement is governed in accordance with the laws of England and Wales. The parties irrevocably submit to the exclusive jurisdiction of the courts of England and Wales in relation to any legal action or proceedings that arise out of or in connection with this Agreement.

28.Section 409A of the U.S Internal Revenue Code of 1986

28.1During your employment with the Company (and where applicable after your employment has terminated) you must comply with all applicable Barclays Group policies and procedures and any legal and / or statutory and / or regulatory obligations, including (but not limited to) Barclays Group policies and procedures on, and any other obligations relating to, anti-bribery and corruption. Such policies and procedures may be amended from time to time by the Barclays Group. Failure to do so may result in disciplinary action being taken against you, up to and including dismissal.

28.2The following provisions will apply to the compensation and benefits payable to you under your Agreement and the other plans and policies of the Company to the extent you are subject to Section 409A of the U.S. Internal Revenue Code of 1986, as amended (“Section 409A”).

28.3The obligations under your Agreement and the Company’s plans and policies, including the incentive plans, are intended to comply with the requirements of Section 409A or an exemption or exclusion therefrom and shall in all respects be administered in accordance with such intent. Notwithstanding the foregoing, nothing contained herein shall constitute an indemnity or obligation of any kind of the Company to pay any taxes, penalties or interest or other amounts payable by you in connection with the application of Section 409A. Any payments that qualify for the “short term deferral” exception under the U.S. Treasury Regulations Section 1.409A-1(b)(4), the “separation pay” exception under U.S. Treasury Regulations Section 1.409A-1(b)(9)(iii) or any other exception under Section 409A shall be paid under the applicable exceptions to the greatest extent possible. Your right to receive any instalment payments pursuant to this Agreement shall be treated as a right to receive a series of separate payments for purposes of Section 409A.



28.4All reimbursements and in-kind benefits that constitute deferred compensation within the meaning of Section 409A provided under your Agreement or otherwise shall be made or provided in accordance with the requirements of Section 409A, including, without limitation, that (a) in no event shall reimbursements by the Company under your Agreement be made later than the end of the calendar year next following the calendar year in which the applicable fees and expenses were incurred, (b) the amount of in-kind benefits that the Company is obligated to pay or provide in any given calendar year shall not affect the in-kind benefits that the Company is obligated to pay or provide in any other calendar year and (c) your right to have the Company pay or provide such reimbursements and in-kind benefits may not be liquidated or exchanged for any other benefit.

28.5If you are a ‘specified employee’ within the meaning of Section 409A (as determined in accordance with the methodology established by the Company as in effect on your date of termination), amounts that constitute “nonqualified deferred compensation” within the meaning of Section 409A that would otherwise be payable under this Agreement or otherwise during the six (6) month period immediately following the date of termination on account of your “separation from service” shall instead by paid as soon as practicable after the date that is six (6) months following your “separation from service” within the meaning of Section 409A.

29.Key policies, procedures and practices

29.1    During your employment with the Company (and where applicable after your employment has terminated) you must comply with all applicable Barclays Group policies and procedures and any legal and / or statutory and / or regulatory obligations, including (but not limited to) Barclays Group policies and procedures on, and any other obligations relating to, anti-bribery and corruption. Such policies and procedures may be amended from time to time by the Barclays Group. Failure to do so may result in disciplinary action being taken against you, up to and including dismissal.

29.2    You should familiarise yourself with all policies and procedures that apply to your grade and business area as set out on your intranet. The Barclays Way (Code of Conduct) and the policies, guidelines and procedures on the following issues are particularly important (although this is not intended as a comprehensive list):
anti-bribery and anti-corruption
anti-money laundering
competition and anti-trust
fraud
our Regulator’s business principles
disclosure obligations
data protection, confidential information and Chinese walls
diversity and inclusion
bullying, harassment and discrimination
managing people, including on various types of leave and our disciplinary, capability and grievance policies
conduct policies, including smoking, dress at work and personal relationships at work
electronic and other forms of communications, including social media
personal account and share dealing
conflicts of interest and outside business interests and affiliations
market conduct
gifts and entertainment
health and safety
whistleblowing or raising concerns

29.3    Unless otherwise stated, these policies, guidelines and procedures do not form part of your Agreement.

29.4    The disciplinary and grievance rules and procedures which are applicable to your employment are set out on your intranet and may be amended from time to time by the Barclays Group. These rules and procedures do not form part of your Agreement. If you wish to appeal against a disciplinary decision you should apply in writing to the Group Chairman or HR contact in accordance with the Company's disciplinary procedure. If you wish to raise a grievance, please apply in writing to the Group Chairman or HR contact in accordance with the Company's grievance procedure.



APPENDIX 1

Definitions and interpretation

In the Detailed Terms and Conditions, the following terms have the following meanings:

"Approved Person" means any role where approval of the Regulator is required for the person to carry out that role.

Barclays” means Barclays PLC.

Barclays Group” means Barclays, the Company and any company which is from time to time:

(a)a holding company (as defined by Section 1159 of the Companies Act 2006) of Barclays;
(b)a subsidiary (as defined by Section 1159 of the Companies Act 2006) of Barclays or of its holding company;
(c)a company over which Barclays has control within the meaning of Section 1124 of the Corporation Tax Act 2010; or
(d)a subsidiary undertaking (as defined by Section 1162 of the Companies Act 2006) of Barclays;

and “Barclays Group company” will be interpreted accordingly.

Company” means your employing entity within the Barclays Group.

Conduct Rule” means any conduct rule specified by the Regulator from time to time which is applicable to you.

“Notice Period” means the notice period as set out in your Summary of Key Terms.

Regulator” means the Financial Conduct Authority and / or the Prudential Regulation Authority, as may be applicable, or any successor or applicable regulatory authority.

“Remuneration Committee” means the Barclays Board Remuneration Committee (or any duly authorised delegate thereof).

Risk and/or Compliance requirements” means a control or regulatory issue of business unit significance that is identified by the Company in its absolute discretion.

Senior Manager” means an individual defined as a senior manager under the SMR.

Share” means an ordinary share in Barclays PLC.

SMR” means Senior Manager’s Regime.

Statement of Responsibilities” means a written statement of responsibilities allocated to you in your capacity as Senior Manager.

“Start Date” means the start date as set out in your Summary of Key Terms.

Termination Date” means the date on which your employment terminates.

Some capitalised terms in the Detailed Terms and Conditions are as defined in your Summary of Key Terms and any applicable Schedules unless stated otherwise. References to any statute or legislation will include any modification, re-enactment or extension of that legislation.


image_0a.jpg

Barclays PLC
    1 Churchill Place    London
    E14 5HP
17 December 2020        

Julia Wilson



Dear Julia,

Following your recent discussions with Nigel Higgins, Chairman of Barclays PLC, I am pleased to confirm your appointment as an independent non-executive director of Barclays PLC (the ‘Company’ or ‘BPLC’). BPLC and its subsidiaries and associated companies are referred to as the 'Barclays Group' in this letter.

1.Appointment

(a)This letter and its enclosures are a contract for services and not a contract of employment. Reference to your appointment in this letter means any or all of the offices as set out in 1(b) - (c) below.

(b)With effect from 1 April 2021, you will serve as an independent non-executive director of BPLC.

(c)During your appointment, you may be required to serve on Committees (whether standing or ad hoc) of the Board of Directors of BPLC (the 'BPLC Board'), membership of which will be agreed with you at the time. Committee membership will be considered on appointment and will be subject to accepted principles of good governance and the needs of the BPLC Board at the time. In that regard, the Board has approved your appointment as a member of the BPLC Audit Committee with effect from your appointment date.

2.Term

(a)Subject to the termination provisions in section 3 below, your appointment will be for an initial term of 3 years from the date of your appointment and subject to the annual re-election by shareholders (see below). On or before the expiry of your initial term, and subject to the needs of the BPLC Board at the time, you may be invited to serve for a further term of up to three years. Non-executive directors will not usually serve for more than six years, however this is subject to the discretion of the Board Nominations Committee.
(b)Your appointment, including any extension of your term, is subject to the following:

i.the Company’s Articles of Association;
ii.annual re-election by shareholders at the BPLC AGM, in accordance with the UK Corporate Governance Code;
iii.your ongoing ability to satisfy the standards and obligations applicable to directors of public companies, and, in particular, any regulatory standards expected of directors of banks and financial services firms, including if applicable, the need for regulatory
1



approval and other requirements placed on directors under the Senior Managers Regime including compliance with the Senior Manager and Individual Conduct Rules;
iv.your ongoing fitness to serve as a company director and/or, if applicable, in a Senior Manager function;
v.your ongoing performance and contribution to the BPLC Board, as assessed by the BPLC Board having regard to relevant information, including the annual review of the effectiveness of the BPLC Board and individual directors and the importance of such contribution is to the Company’s continued long-term sustainable success;
vi.the needs of the BPLC Board having regard to the skills, knowledge and experience required to oversee the business, which may change over time.

(c)You undertake to inform the Company Secretary or Chair of BPLC or relevant regulatory authority of any change in your personal or professional circumstances that might impact your ability to continue in your role as an independent non-executive director of BPLC. This includes, but is not limited to:

i.You being charged with and/or convicted of a criminal offence (other than an offence under any road traffic legislation in the United Kingdom or elsewhere for which a fine or non-custodial penalty is imposed);
ii.You becoming bankrupt (or its equivalent status in any other jurisdiction) or become insolvent or enter into any arrangements or composition with your creditors; and
iii.You being subject to personal sanction in respect of any of your other roles, or guilty of a breach of the Senior Manager or Individual Conduct Rules, any serious misconduct or conduct which is calculated or likely to bring the Barclays Group or any of its directors or subsidiaries into disrepute or which conflicts with the Barclays Values, a copy of which will be included in your appointment pack.

3. Termination

(a)Your appointment is conditional upon you satisfying and maintaining on an ongoing basis, the requirements of section 2 above.

(b)This appointment can be terminated at any time by either party giving notice in writing to the other. Both parties agree that, in order to facilitate an orderly exit and succession, and where circumstances permit, they will provide reasonable notice to the other of their intentions to terminate the appointment. In accordance with the UK Corporate Governance Code, if you choose to resign and have concerns about the operation of the BPLC Board or the Management of the Company then you should provide a written statement to the Chair for circulation to the BPLC Board, which outlines your concerns.

(c)There is no entitlement to any payment for loss of office. Regardless of the reason for termination, you will only be entitled to such fees and expenses as have accrued and are due to you as at the date of termination.

(d)Prior to the termination of your appointment, to the extent applicable and if so requested, you will prepare and provide to the Company a handover note in respect of your Senior Manager responsibilities in accordance with the Company's policy, or otherwise in a form prescribed by the Company sufficient for it to comply with its obligations in that respect.

(e)On termination of your appointment, you will immediately deliver to the Company all documents, records, papers or other company property which may be in your possession or
2



under your control and which relate in any way to the business affairs of the Company or the Barclays Group. You agree not to retain any copies or duplicates in any format.

(f)On termination of your appointment and whether or not you have formally resigned from your position, you will be deemed to have done so with effect from the date of termination. You agree that, on termination, relevant members of the Barclays Group are entitled to issue any announcements and make any filings or notifications required as a result of you ceasing to be a director.

4.Fees

(a)In respect of your appointment, you will receive a fee (‘Fee’) of:
i.£90,000 per year payable in respect of your directorship of BPLC;
ii.£30,000 per year payable in respect of your membership of the BPLC Audit Committee; and
iii.Such other fee as shall be payable in respect of any other Committee memberships as advised to you on appointment to a Committee.
(b)The Fee is payable monthly in arrears by direct credit into your nominated bank account less any tax and any other statutory deductions. On termination, you will only be entitled to such amount of the Fee as has accrued at the date of termination.

(c)Any reasonable out of pocket expenses that you incur in performing your duties will be reimbursed in accordance with our standard expenses policy, a copy of which is available on request.

(d)The Fee may be subject to any amendment or qualification as required by any law, regulation or regulatory authority including but not limited to tax and national insurance deductions as applicable.

(e)To ensure alignment with the Barclays Group’s interests, all directors of BPLC are encouraged to hold shares in BPLC. All dealings are subject to the Barclays Group Securities Dealing Code, a copy of which is available on request. You will be required to take £30,000 of your Fee, after tax and any other statutory deductions, in BPLC shares (‘Shares’). The Shares will be purchased twice a year after the announcement of the BPLC full and half-year financial results. The Shares will be held on your behalf until the termination of your appointment; an agreement setting out the details for signature and return will be included in your appointment pack.

(f)There is no contractual entitlement to any increase in your Fee during your appointment. Directors’ fees are reviewed periodically by the BPLC Board Remuneration Committee and benchmarked to the market.

(g)Aside from the Fee, you are not eligible to receive any contractual benefits. As a non-executive director, you are not eligible to participate in any benefit schemes, including but not limited to the Barclays Group’s incentive award, long term incentive schemes and the Barclays Group’s pension scheme, nor to receive any payment or cash allowances in lieu.

5.Directors Share Qualification

Under the Company's Articles of Association, you are required to hold £500 in nominal value (2,000 Shares of 25p each) of BPLC within two months of your appointment. In accordance with the Barclays Group Securities Dealing Code, you must obtain clearance to deal before you
3



acquire these or any other BPLC securities. If you would like assistance in purchasing these Shares, please let me know and I will arrange this for you.

6.Role as a non-executive director

(a)The attached role profile will form part of your contract for services. The role profile may be changed from time to time, and once notified to you, shall be deemed to replace the attached and form part of your contract for services.

(b)As an independent non-executive director, your primary responsibilities include providing effective oversight and constructive challenge, helping to develop proposals on strategy and then fully empowering the executive directors to implement the strategy.

(c)Non-executive directors have the same legal responsibilities and duties as any other director and are required to take decisions in the best interests of the Company. The BPLC Board as a whole is collectively responsible for promoting the long-term sustainable success of the Company, generating value for shareholders and contributing to wider society. All directors must act with integrity, lead by example and promote the desired culture. The BPLC Board is responsible for: supervising the Company's affairs by providing effective and entrepreneurial leadership within a framework of prudent and effective controls and risk management; establishing the Company's purpose, values and strategy and ensuring that these align with the Company's culture; ensuring that the necessary resources are in place for the Company to meet its objectives and measure performance against them; reviewing management performance, offering specialist advice and holding management to account; and ensuring effective engagement with, and encourage participation from, shareholders and stakeholders and ensuring that workforce policies and practices are consistent with the Company’s values and support its long-term sustainable success.

(d)During your appointment you agree to diligently perform such duties, responsibilities and functions (whether statutory, fiduciary or common law) as are consistent with your position and role profile as an independent non-executive director and with any relevant Barclays Group policies and procedures.

(e)To the extent applicable, during your appointment you will discharge your responsibilities under the Statement of Responsibilities allocated to you by the Company and in your capacity as a Senior Manager maintain appropriate records in respect thereof.

7.Time Commitment
(a)In accepting this appointment, you confirm that you are able to allocate sufficient time to meet the expectations of your role on the BPLC Board including being available to devote additional time to the role during periods of increased activity or in response to market developments. Directors are also expected to attend the BPLC AGM, usually held in April / May and be available afterwards to meet with and answer questions from shareholders.

(b)The agreement of the BPLC Board must be sought before accepting additional appointments to any other company, corporate body, or entity, during your tenure that might affect the time that you are able to devote to your role.

(c)All directors are expected to attend all Board meetings. The BPLC Board is expected to formally meet up to eight times a year and on an ad-hoc basis as required. Some of the meetings may be
4



held overseas. You will also be required to attend meetings of Committees of which you are a member.

(d)There is a standing invitation to all non-executive directors to attend any other BPLC Board Committee meeting. Please inform the relevant BPLC Committee Chair if you wish to attend a meeting of which you are not a member.

(e)Directors are expected to set aside sufficient time to consider the papers in advance of BPLC Board and Committee meetings. Papers are normally circulated to directors in the week prior to the relevant meeting.

(f)Your expected average time commitment for your role as a BPLC non-executive director is 35-40 days per year, including membership of any Committees.

8.Conflicts of interests and outside interests

(a)As a director you have a duty to avoid conflicts of interest and to disclose personal interests in contracts.

(b)It is accepted and acknowledged that you have business activities and other interests outside of the Company such as but not limited to: directorships, trusteeships, advisory positions, shareholdings or other significant commitments. Subject to such interests not giving rise to an actual or potential conflict, the Company does not object to you continuing with such interests provided they have been fully disclosed (including but not limited to, details of the associated time commitments and notification of any commercial relationship with the Barclays Group) and accepted by the Company prior to your appointment. Should you become aware of any actual or potential conflicts of interest in the course of your appointment, these should be discussed with the Chair of BPLC as soon as possible and authorised by the BPLC Board. All conflicts must be recorded in accordance with the BPLC Board’s stated policy.

(c)As set out above, you must seek permission from the BPLC Board before taking on any additional outside interests.


9.Induction, Values and Support

(a)To assist directors in making a contribution to the BPLC Board as quickly as possible, all directors are offered a comprehensive induction programme, details of which will be provided to you when you join the BPLC Board. We will also provide briefings on the details of procedures regarding the disclosure of any conflicts of interest, data protection, the control of inside information and for obtaining clearance to deal in BPLC securities.

(b)The Barclays Values (Respect, Integrity, Service, Excellence and Stewardship) are a central part of everything we do. The Values form a critical part of how the Barclays Group is changing, as well as our purpose and behaviours. You will be expected to act in accordance with the Values as a non-executive director of the Company, and, in particular, to follow our Code of Conduct (known as the Barclays Way).

(c)As a non-executive director, you are expected to devote sufficient time to developing and refreshing your knowledge and skills to ensure that you have the knowledge and understanding
5



to contribute to the BPLC Board effectively. On-going training and briefings on particular topics will be made available for this purpose, including any topics that you may request.

(d)As Group General Counsel and Company Secretary, I am available to all directors to support the effective and efficient discharge of their duties and to assist with any queries.

(e)Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a director. Where it is deemed appropriate for you to seek advice from independent legal advisers, you may, with the prior written agreement of the Company Secretary, seek independent advice at the Company's expense.

10.Confidentiality

(a)You will appreciate that the business of the Company and the Barclays Group is a specialised and competitive business. In the course of your appointment you will have access to and knowledge of, the trade secrets and confidential information of the Company and the Barclays Group. You acknowledge that the disclosure of any trade secrets or confidential information to actual or potential competitors of the Company and/or any Barclays Group company would place the Company and/or the Barclays Group at a serious competitive disadvantage and would do serious damage, financial and/or otherwise, to its or their business and business development and would cause immeasurable harm.

(b)You must neither during the term of your appointment (except in the proper performance of the duties of your office or with the express written consent of the BPLC Board) nor at any time (without limit) after the termination of your appointment except where disclosure is required by law, by an order of a competent court or by a regulatory body:

i.publish, divulge or communicate to any person, company, business entity or other organisation or to the media or any social media;
ii.use for your own purposes or for any purposes other than those of the Company or the Barclays Group; or
iii.through any failure to exercise due care and diligence, permit or cause any unauthorised disclosure of any confidential information

(c)These restrictions shall cease to apply to any information which shall become available to the public generally otherwise than through any breach by you of the provisions of this letter or other default of yours.

(d)All notes, memoranda, records and documents (in whatever form or media held) that you make during the term of your appointment in performing your duties as non-executive director will belong to the Barclays Group and will be handed over to the Company together with any copies promptly from time to time on reasonable request of any Barclays Group company and at the end of your appointment.

(e)Nothing in this letter, including but not limited to the provisions on confidentiality above, is intended to or shall prevent you from raising concerns in line with the Company's internal reporting processes or making any disclosure to governmental bodies, law enforcement authorities and/or regulators as permitted or required under applicable law or regulation (including but not limited to a “protected disclosure” within the meaning of Part 43A (Protected
6



Disclosures) of the Employment Rights Act 1996 and to any protected disclosures made about matters previously disclosed to another recipient).

11.Dealing in Barclays Securities

(a)Your attention is drawn to the requirements under both law and regulation regarding the disclosure of price sensitive information. Matters relating to BPLC may from time to time give rise to price sensitive information which must be held under strict confidentiality conditions.

(b)Your responsibilities will be explained to you as part of your induction. You should avoid taking any action that might risk a breach of these requirements. If you need any assistance in understanding your obligations, please contact me.

12.Indemnification and insurance

(a)As a statutory director of BPLC you will have the benefit of and are able to rely upon an indemnity from BPLC. Your indemnity is of course in addition to any other protection available to you by virtue of the provisions of statute, common law or indeed any specific contract.

(b)To formalise the indemnification arrangements referred to above, you will be issued with a deed of indemnity from BPLC and instructions on what steps you need to take to enter into the deed and to accept its terms and conditions.

(c)As a UK statutory director you will be deemed to be an insured person for the purpose of the Barclays Group’s current policy of Directors’ and Officers’ Liability Insurance subject to its terms and conditions.

13.Data Privacy

(a)The Company and any Barclays Group company shall process your personal information for HR, compliance, administrative and other purposes related to your appointment and the conduct of the business of the Barclays Group, for the purposes of the Company's legitimate interest or as required by law (the 'Agreed Purposes'). Processing includes obtaining, holding, editing, destroying or disclosing your personal information to any Barclays Group company and/or any third parties (for example, insurers, banks and new Barclays Group companies following a business transfer or merger) for the Agreed Purposes (‘Processing’ or ‘Process’). The Company may also transfer your information to any other Barclays Group company and/or any third parties (for example, insurers, banks and new Barclays Group companies following a business transfer or merger) in order to Process your personal information for the Agreed Purposes.

(b)You agree to comply with all applicable laws, regulations and policies of Barclays Group in relation to data protection and privacy. Further, you agree to provide your personal information to the Company and the Barclays Group and consent to the Processing of that information for the Agreed Purposes. This may include transfers to recipients based in another country to your place of appointment (either within or outside the EEA).

14.Facilitation of tax evasion

During your appointment, you will not knowingly do anything or omit to do anything to facilitate tax evasion, whether in the United Kingdom or in any other jurisdiction, and will immediately report to the BPLC Board any concerns or suspicions of tax evasion, the facilitation thereof or other financial crime by employees, agents, suppliers, customers and clients of the Barclays Group.
7




This letter and enclosures set out the main terms of your appointment and on acceptance will constitute a contract for services.

Please confirm your acceptance of the appointment as set out in this letter by signing and returning the enclosed duplicate letter. If I can help with any further information, please do not hesitate to contact me.
    
Yours sincerely,


Stephen Shapiro
Group General Counsel and Company Secretary
Barclays PLC

Enclosures:
Role Profile for BPLC non-executive directors
Dates for BPLC Board and Committee meetings

I agree to the terms and conditions of my appointment as set out in this letter dated 17 December 2020.

Signed:

Name:
Julia Wilson

Date:

8


image_0.jpg

Barclays PLC
    1 Churchill Place    London
    E14 5HP
8 February 2022        

Robert Berry
c/o 1 Churchill Place
London
E14 5HP


Dear Robert,

Following your discussions with Nigel Higgins, Chairman of Barclays PLC, I am pleased to confirm your appointment as an independent non-executive director of Barclays PLC (the ‘Company’ or ‘BPLC’). BPLC and its subsidiaries and associated companies are referred to as the 'Barclays Group' in this letter.

1.Appointment

(a)This letter and its enclosures are a contract for services and not a contract of employment. Reference to your appointment in this letter means any or all of the offices as set out in 1(b) - (c) below.

(b)With effect from 8 February 2022, you will serve as an independent non-executive director of BPLC.

(c)During your appointment, you may be invited to serve on Committees (whether standing or ad hoc) of the Board of Directors of BPLC (the 'BPLC Board'), membership of which will be agreed with you at the time. As discussed with Nigel, you are invited to join the BPLC Board Risk and Audit Committees, in each case with effect from 1 March 2022, and in respect of the BPLC Board Risk Committee as Chair of the Committee (subject to regulatory approval).

2.Term

(a)Subject to the termination provisions in section 3 below, your appointment will be for an initial term of 3 years from the date of your appointment and subject to the annual re-election by shareholders (see below). On or before the expiry of your initial term, and subject to the needs of the BPLC Board at the time, you may be invited to serve for a further term of up to three years. Non-executive directors will not usually serve for more than six years, however this is subject to the discretion of the Board Nominations Committee.
(b)Your appointment, including any extension of your term, is subject to the following:

i.the Company’s Articles of Association;
ii.annual re-election by shareholders at the BPLC AGM, in accordance with the UK Corporate Governance Code;
iii.your ongoing ability to satisfy the standards and obligations applicable to directors of public companies, and, in particular, any regulatory standards expected of directors of
1


banks and financial services firms, including if applicable, the need for regulatory approval and other requirements placed on directors under the Senior Managers Regime including compliance with the Senior Manager and Individual Conduct Rules;
iv.your ongoing fitness to serve as a company director and/or, if applicable, in a Senior Manager function;
v.your ongoing performance and contribution to the BPLC Board, as assessed by the BPLC Board having regard to relevant information, including the annual review of the effectiveness of the BPLC Board and individual directors and the importance of such contribution is to the Company’s continued long-term sustainable success;
vi.the needs of the BPLC Board having regard to the skills, knowledge and experience required to oversee the business, which may change over time.

(c)You undertake to inform the Company Secretary or Chair of BPLC or relevant regulatory authority of any change in your personal or professional circumstances that might impact your ability to continue in your role as an independent non-executive director of BPLC. This includes, but is not limited to:

i.You being charged with and/or convicted of a criminal offence (other than an offence under any road traffic legislation in the United Kingdom or elsewhere for which a fine or non-custodial penalty is imposed);
ii.You becoming bankrupt (or its equivalent status in any other jurisdiction) or become insolvent or enter into any arrangements or composition with your creditors; and
iii.You being subject to personal sanction in respect of any of your other roles, or guilty of a breach of the Senior Manager or Individual Conduct Rules, any serious misconduct or conduct which is calculated or likely to bring the Barclays Group or any of its directors or subsidiaries into disrepute or which conflicts with the Barclays Values, a copy of which will be included in your appointment pack.

3. Termination

(a)Your appointment is conditional upon you satisfying and maintaining on an ongoing basis, the requirements of section 2 above.

(b)This appointment can be terminated at any time by either party giving notice in writing to the other. Both parties agree that, in order to facilitate an orderly exit and succession, and where circumstances permit, they will provide reasonable notice to the other of their intentions to terminate the appointment. In accordance with the UK Corporate Governance Code, if you choose to resign and have concerns about the operation of the BPLC Board or the Management of the Company then you should provide a written statement to the Chair for circulation to the BPLC Board, which outlines your concerns.

(c)There is no entitlement to any payment for loss of office. Regardless of the reason for termination, you will only be entitled to such fees and expenses as have accrued and are due to you as at the date of termination.

(d)Prior to the termination of your appointment, to the extent applicable and if so requested, you will prepare and provide to the Company a handover note in respect of your Senior Manager responsibilities in accordance with the Company's policy, or otherwise in a form prescribed by the Company sufficient for it to comply with its obligations in that respect.

2


(e)On termination of your appointment, you will immediately deliver to the Company all documents, records, papers or other company property which may be in your possession or under your control and which relate in any way to the business affairs of the Company or the Barclays Group. You agree not to retain any copies or duplicates in any format.

(f)On termination of your appointment and whether or not you have formally resigned from your position, you will be deemed to have done so with effect from the date of termination. You agree that, on termination, relevant members of the Barclays Group are entitled to issue any announcements and make any filings or notifications required as a result of you ceasing to be a director.

4.Fees

(a)In respect of your appointment, you will receive a fee (‘Fee’) of:
i.£90,000 per year payable in respect of your directorship of BPLC;
ii.£30,000 per year payable in respect of your membership of the BPLC Audit Committee;
iii.£80,000 per year payable in respect of your Chairmanship of the BPLC Risk Committee; and
iv.Such other fee as shall be payable in respect of any other Committee memberships as advised to you on appointment to a Committee.
(b)The Fee is payable monthly in arrears by direct credit into your nominated bank account less any tax and any other statutory deductions. On termination, you will only be entitled to such amount of the Fee as has accrued at the date of termination.

(c)Any reasonable out of pocket expenses that you incur in performing your duties will be reimbursed in accordance with our standard expenses policy, a copy of which is available on request.

(d)The Fee may be subject to any amendment or qualification as required by any law, regulation or regulatory authority including but not limited to tax and national insurance deductions as applicable.

(e)To ensure alignment with the Barclays Group’s interests, all directors of BPLC are encouraged to hold shares in BPLC. All dealings are subject to the Barclays Group Securities Dealing Code, a copy of which is available on request. You will be required to take £30,000 of your Fee, after tax and any other statutory deductions, in BPLC shares (‘Shares’).  The Shares will be purchased twice a year after the announcement of the BPLC full and half-year financial results. The Shares will be held on your behalf until the termination of your appointment; an agreement setting out the details for signature and return will be included in your appointment pack.

(f)There is no contractual entitlement to any increase in your Fee during your appointment. Directors’ fees are reviewed periodically by the BPLC Board Remuneration Committee and benchmarked to the market.

(g)Aside from the Fee, you are not eligible to receive any contractual benefits. As a non-executive director, you are not eligible to participate in any benefit schemes, including but not limited to the Barclays Group’s incentive award, long term incentive schemes and the Barclays Group’s pension scheme, nor to receive any payment or cash allowances in lieu.

5.Role as a non-executive director
3



(a)The attached role profile will form part of your contract for services. The role profile may be changed from time to time, and once notified to you, shall be deemed to replace the attached and form part of your contract for services.

(b)As an independent non-executive director, your primary responsibilities include providing effective oversight and constructive challenge, helping to develop proposals on strategy and then fully empowering the executive directors to implement the strategy.

(c)Non-executive directors have the same legal responsibilities and duties as any other director and are required to take decisions in the best interests of the Company. The BPLC Board as a whole is collectively responsible for promoting the long-term sustainable success of the Company, generating value for shareholders and contributing to wider society. All directors must act with integrity, lead by example and promote the desired culture. The BPLC Board is responsible for: supervising the Company's affairs by providing effective and entrepreneurial leadership within a framework of prudent and effective controls and risk management; establishing the Company's purpose, values and strategy and ensuring that these align with the Company's culture; ensuring that the necessary resources are in place for the Company to meet its objectives and measure performance against them; reviewing management performance, offering specialist advice and holding management to account; and ensuring effective engagement with, and encourage participation from, shareholders and stakeholders and ensuring that workforce policies and practices are consistent with the Company’s values and support its long-term sustainable success.

(d)During your appointment you agree to diligently perform such duties, responsibilities and functions (whether statutory, fiduciary or common law) as are consistent with your position and role profile as an independent non-executive director and with any relevant Barclays Group policies and procedures.

(e)To the extent applicable, during your appointment you will discharge your responsibilities under the Statement of Responsibilities allocated to you by the Company and in your capacity as a Senior Manager maintain appropriate records in respect thereof.

6.Time Commitment
(a)In accepting this appointment, you confirm that you are able to allocate sufficient time to meet the expectations of your role on the BPLC Board including being available to devote additional time to the role during periods of increased activity or in response to market developments. Directors are also expected to attend the BPLC AGM, usually held in April / May and be available afterwards to meet with and answer questions from shareholders.

(b)The agreement of the BPLC Board must be sought before accepting additional appointments to any other company, corporate body, or entity, during your tenure that might affect the time that you are able to devote to your role.

(c)All directors are expected to attend all Board meetings. The BPLC Board is expected to formally meet up to eight times a year and on an ad-hoc basis as required. Some of the meetings may be held overseas. You will also be required to attend meetings of Committees of which you are a member.

4


(d)There is a standing invitation to all non-executive directors to attend any other BPLC Board Committee meeting. Please inform the relevant BPLC Committee Chair if you wish to attend a meeting of which you are not a member.

(e)Directors are expected to set aside sufficient time to consider the papers in advance of BPLC Board and Committee meetings. Papers are normally circulated to directors in the week prior to the relevant meeting.

(f)Your expected average time commitment for your role as a BPLC non-executive director is 50 days per year, including membership of the BPLC Board Risk and Audit Committees.

7.Conflicts of interests and outside interests

(a)As a director you have a duty to avoid conflicts of interest and to disclose personal interests in contracts.

(b)It is accepted and acknowledged that you have business activities and other interests outside of the Company such as but not limited to: directorships, trusteeships, advisory positions, shareholdings or other significant commitments. Subject to such interests not giving rise to an actual or potential conflict, the Company does not object to you continuing with such interests provided they have been fully disclosed (including but not limited to, details of the associated time commitments and notification of any commercial relationship with the Barclays Group) and accepted by the Company prior to your appointment. Should you become aware of any actual or potential conflicts of interest in the course of your appointment, these should be discussed with the Chair of BPLC as soon as possible and authorised by the BPLC Board. All conflicts must be recorded in accordance with the BPLC Board’s stated policy.

(c)As set out above, you must seek permission from the BPLC Board before taking on any additional outside interests.

8.Induction, Values and Support

(a)To assist directors in making a contribution to the BPLC Board as quickly as possible, all directors are offered a comprehensive induction programme, details of which will be provided to you when you join the BPLC Board. We will also provide briefings on the details of procedures regarding the disclosure of any conflicts of interest, data protection, the control of inside information and for obtaining clearance to deal in BPLC securities.

(b)The Barclays Values (Respect, Integrity, Service, Excellence and Stewardship) are a central part of everything we do. The Values form a critical part of how the Barclays Group is changing, as well as our purpose and behaviours. You will be expected to act in accordance with the Values as a non-executive director of the Company, and, in particular, to follow our Code of Conduct (known as the Barclays Way).

(c)As a non-executive director, you are expected to devote sufficient time to developing and refreshing your knowledge and skills to ensure that you have the knowledge and understanding to contribute to the BPLC Board effectively. On-going training and briefings on particular topics will be made available for this purpose, including any topics that you may request.

(d)As Group General Counsel and Company Secretary, I am available to all directors to support the effective and efficient discharge of their duties and to assist with any queries.
5



(e)Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a director. Where it is deemed appropriate for you to seek advice from independent legal advisers, you may, with the prior written agreement of the Company Secretary, seek independent advice at the Company's expense.

9.Confidentiality

(a)You will appreciate that the business of the Company and the Barclays Group is a specialised and competitive business. In the course of your appointment you will have access to and knowledge of, the trade secrets and confidential information of the Company and the Barclays Group. You acknowledge that the disclosure of any trade secrets or confidential information to actual or potential competitors of the Company and/or any Barclays Group company would place the Company and/or the Barclays Group at a serious competitive disadvantage and would do serious damage, financial and/or otherwise, to its or their business and business development and would cause immeasurable harm.

(b)You must neither during the term of your appointment (except in the proper performance of the duties of your office or with the express written consent of the BPLC Board) nor at any time (without limit) after the termination of your appointment except where disclosure is required by law, by an order of a competent court or by a regulatory body:

i.publish, divulge or communicate to any person, company, business entity or other organisation or to the media or any social media;
ii.use for your own purposes or for any purposes other than those of the Company or the Barclays Group; or
iii.through any failure to exercise due care and diligence, permit or cause any unauthorised disclosure of any confidential information

(c)These restrictions shall cease to apply to any information which shall become available to the public generally otherwise than through any breach by you of the provisions of this letter or other default of yours.

(d)All notes, memoranda, records and documents (in whatever form or media held) that you make during the term of your appointment in performing your duties as non-executive director will belong to the Barclays Group and will be handed over to the Company together with any copies promptly from time to time on reasonable request of any Barclays Group company and at the end of your appointment.

(e)Nothing in this letter, including but not limited to the provisions on confidentiality above, is intended to or shall prevent you from raising concerns in line with the Company's internal reporting processes or making any disclosure to governmental bodies, law enforcement authorities and/or regulators as permitted or required under applicable law or regulation (including but not limited to a “protected disclosure” within the meaning of Part 43A (Protected Disclosures) of the Employment Rights Act 1996 and to any protected disclosures made about matters previously disclosed to another recipient).

10.Dealing in Barclays Securities

6


(a)Your attention is drawn to the requirements under both law and regulation regarding the disclosure of price sensitive information. Matters relating to BPLC may from time to time give rise to price sensitive information which must be held under strict confidentiality conditions.

(b)Your responsibilities will be explained to you as part of your induction. You should avoid taking any action that might risk a breach of these requirements. If you need any assistance in understanding your obligations, please contact me.

11.Indemnification and insurance

(a)As a statutory director of BPLC you will have the benefit of and are able to rely upon an indemnity from BPLC. Your indemnity is of course in addition to any other protection available to you by virtue of the provisions of statute, common law or indeed any specific contract.

(b)To formalise the indemnification arrangements referred to above, you will be issued with a deed of indemnity from BPLC and instructions on what steps you need to take to enter into the deed and to accept its terms and conditions.

(c)As a UK statutory director you will be deemed to be an insured person for the purpose of the Barclays Group’s current policy of Directors’ and Officers’ Liability Insurance subject to its terms and conditions.

12.Data Privacy

(a)The Company and any Barclays Group company shall process your personal information for HR, compliance, administrative and other purposes related to your appointment and the conduct of the business of the Barclays Group, for the purposes of the Company's legitimate interest or as required by law (the 'Agreed Purposes'). Processing includes obtaining, holding, editing, destroying or disclosing your personal information to any Barclays Group company and/or any third parties (for example, insurers, banks and new Barclays Group companies following a business transfer or merger) for the Agreed Purposes (‘Processing’ or ‘Process’). The Company may also transfer your information to any other Barclays Group company and/or any third parties (for example, insurers, banks and new Barclays Group companies following a business transfer or merger) in order to Process your personal information for the Agreed Purposes.

(b)You agree to comply with all applicable laws, regulations and policies of Barclays Group in relation to data protection and privacy. Further, you agree to provide your personal information to the Company and the Barclays Group and consent to the Processing of that information for the Agreed Purposes. This may include transfers to recipients based in another country to your place of appointment (either within or outside the EEA).

13.Facilitation of tax evasion

During your appointment, you will not knowingly do anything or omit to do anything to facilitate tax evasion, whether in the United Kingdom or in any other jurisdiction, and will immediately report to the BPLC Board any concerns or suspicions of tax evasion, the facilitation thereof or other financial crime by employees, agents, suppliers, customers and clients of the Barclays Group.

This letter and enclosures set out the main terms of your appointment and on acceptance will constitute a contract for services.

7


Please confirm your acceptance of the appointment as set out in this letter by signing and returning the enclosed duplicate letter. If I can help with any further information, please do not hesitate to contact me.
    
Yours sincerely,



Stephen Shapiro
Group General Counsel and Company Secretary
Barclays PLC

Enclosures:
Role Profile for BPLC non-executive directors
Role Profile for BPLC Board Risk Committee Chair
Dates for BPLC Board and Committee meetings


I agree to the terms and conditions of my appointment as set out in this letter dated 8 February 2022.

Signed:

Name:
Robert Berry

Date:

8

Exhibit 12.1
CERTIFICATIONS FILED PURSUANT TO 17 CFR 240. 13(A) - 14(A)
I, C.S. Venkatakrishnan, certify that:
1.I have reviewed this annual report on Form 20-F of Barclays PLC;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4.The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and
5.The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s boards of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
Date: February 23, 2022
/s/ C.S. Venkatakrishnan
C.S. Venkatakrishnan
Title: Group Chief Executive
Barclays PLC




I, Tushar Morzaria, certify that:
1.I have reviewed this annual report on Form 20-F of Barclays PLC;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4.The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and
5.The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s boards of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
Date: February 23, 2022
/s/ Tushar Morzaria
Tushar Morzaria
Title: Group Finance Director
Barclays PLC


Exhibit 13.1
CERTIFICATIONS FILES PURSUANT TO 17 CFR 240. 13(A) AND 18 U.S.C
SECTION 906 CERTIFICATION
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each undersigned officer of Barclays PLC, a public limited company incorporated under the laws of England and Wales (“Barclays”), hereby certifies, to such officer’s knowledge, that:
The Annual Report on Form 20-F for the year ended December 31, 2021 (the “Report”) of Barclays fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Barclays.
Date: February 23, 2022
/s/ C.S. Venkatakrishnan
C.S. Venkatakrishnan
Title: Group Chief Executive
Barclays PLC
Date: February 23, 2022
/s/ Tushar Morzaria
Tushar Morzaria
Title: Group Finance Director
Barclays PLC


Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors Barclays PLC:


We consent to the incorporation by reference in the registration statement (No: 333-223156) on Form F-3 and in the registration statements (Nos: 333-236905, 333-236904, 333-225082, 333-216361, 333-195098, 333- 183110, 333-173899, 333-167232, 333-153723, 330-254570 and 333-261584) on Form S-8 of Barclays PLC of our report dated February 22, 2022, with respect to the consolidated balance sheets of Barclays PLC as of December 31, 2021 and 2020, the related consolidated income statements, statements of comprehensive income, statements of changes in equity, and cash flow statements for each of the years in the three-year period ended December 31, 2021, and the related notes and specific disclosures described in Note 1 to the consolidated financial statements as being part of the consolidated financial statements, and the effectiveness of internal control over financial reporting as of December 31, 2021, which report appears in the December 31, 2021 annual report on Form 20-F of Barclays PLC.

/s/ KPMG LLP
London, United Kingdom
February 23, 2022


Capitalisation and Indebtedness
Exhibit 99.1
The following table sets out the Group’s capitalisation, indebtedness and contingent liabilities on a consolidated basis, in accordance with IFRS, as at 31 December 2021.
2021
As at 31 Decemberm
Share Capital of Barclays PLC
Ordinary shares - issued and fully paid shares of £0.25 each16,752
£m
Group equity
Called up share capital and share premium4,536
Other equity instruments12,259
Other reserves1,770
Retained earnings50,657
Total equity excluding non-controlling interests69,222
Non-controlling interests989
Total equity70,211
Group indebtedness
Subordinated liabilities12,759
Debt securities in issue98,867
Total indebtedness111,626
Total capitalisation and indebtedness181,837
Group contingent liabilities and commitments
Guarantees and letters of credit pledged as collateral security15,549
Performance guarantees, acceptances and endorsements5,797
Total contingent liabilities21,346
Documentary credits and other short-term trade related transactions1,584
Standby facilities, credit lines and other commitments344,127
Total commitments345,711